Citrus Sinensis ID: 040785
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.929 | 0.870 | 0.367 | 1e-122 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.877 | 0.811 | 0.356 | 1e-117 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.907 | 0.886 | 0.367 | 1e-115 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.854 | 0.815 | 0.343 | 1e-104 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.520 | 0.511 | 0.458 | 1e-100 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.849 | 0.796 | 0.320 | 1e-80 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.341 | 0.331 | 0.405 | 2e-56 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.383 | 0.579 | 0.358 | 1e-51 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.343 | 0.569 | 0.390 | 6e-49 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.375 | 0.345 | 0.369 | 6e-49 |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 283/771 (36%), Positives = 422/771 (54%), Gaps = 44/771 (5%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQT-VVLIHV-----AQRTSVSSVSSQSQVYDASA 71
+ VA+ S++ + WA + G L+H+ + T + + S+V D
Sbjct: 22 VVVALSGSSKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDDVV 81
Query: 72 TTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLG 131
T ++++ Q ++ + R+ + +++E ++ AI E V+ +I+ +V+G
Sbjct: 82 TA--YRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDSIDRIVIG 139
Query: 132 APSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPFT---------- 181
SR F RK AD+ S +S P+FC +YVVSKGK+S R + T
Sbjct: 140 GSSRSFFSRK--ADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSERTN 197
Query: 182 ------SPLLDQLQSQNDISDTQSR-YSMNLRDRTSFKPRMSFEESAKSPARGRGFDRKS 234
P D + D+QSR S+ +R F P ++ + S G D
Sbjct: 198 SSSGSSGPTSDSSDVMSSAHDSQSRPLSLPVRRMQHF-PAIAGQASVPMETSSVGSDETR 256
Query: 235 FMD-SSESDTDISFV--SSGRPSSDHSPSMH-YEFVDVGRNSRISTSSEHSLGSFRLGLR 290
M +E D+S + SS +S +P YE + + S+SS G+F
Sbjct: 257 CMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYE---ERKEAMSSSSSNREYGNFGTRFS 313
Query: 291 YNDRSSPYDLSSISQDSGATSCSCSSQ----NLDEVEAEMRRLKLELKQTMDMYSTACKE 346
++ S SQ + S + S Q N + E+ +L+ EL+ +MY+ A E
Sbjct: 314 WSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTE 373
Query: 347 ALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELE 406
A +K EL + RL+E +LEE + E A LAEKE+ + A AE+ + AE E
Sbjct: 374 TFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERAERE 433
Query: 407 AQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGP 466
+R AE +++ E + L + L+Y+ + E+I AT F+E KIG G YG
Sbjct: 434 IAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGA 493
Query: 467 VYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYL 526
VYKC L HT VKVL+ Q QFQ+E+E+LS IRHP++VLLLGACPE G +VYEY+
Sbjct: 494 VYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYM 553
Query: 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586
NGSL+DR+F+ N+PPL W +RFRIA E+A L+FLH++KP+P++HRDLKP NILLDHN
Sbjct: 554 ENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHN 613
Query: 587 YVSKISDVGLARLVPA--VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGIL 644
+VSK+ DVGL+ +V ++ T Y TS GT CYIDPEYQ+TG + KSD+YS G++
Sbjct: 614 FVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMI 673
Query: 645 LLQLITAKQPMGLTHFVERSIE-NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKD 703
LLQL+TAK + LTHFVE +++ N ++LD +WP EET A LAL C+ELR KD
Sbjct: 674 LLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKD 733
Query: 704 RPDLGKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMTMQDVLSDP 754
RPDL +LP L L+++A+++ +F G S P + + ++DV+++P
Sbjct: 734 RPDLKDQILPALENLKKVAEKARN-SFSGVSTQPPTHFICPL-LKDVMNEP 782
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 423 bits (1088), Expect = e-117, Method: Compositional matrix adjust.
Identities = 272/763 (35%), Positives = 403/763 (52%), Gaps = 77/763 (10%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQT-VVLIHVAQRTSVSSVSSQSQVYDASA----- 71
+AVA++ K S++ + WA + + G T L++V R VS + + + A +
Sbjct: 24 VAVAINGKKKSKYVVFWALEKFIPEGFTDFKLLYV--RPPVSYIPTPMGIAVAVSELRED 81
Query: 72 TTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLG 131
+ ++++ D ++ ++ R+ ++ +LL+ ++ AI E ++ + LV+G
Sbjct: 82 VVSAYKQELDWSANEMLRPYKKMFERRKVQVEVLLLDSLEPAAAIAEEIAGTGVTKLVIG 141
Query: 132 APSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSA------------- 178
R F RK D+ S ++ A P FC +YV+SKGK++S R + A
Sbjct: 142 MSLRGFFSRKI--DMSSLIATAVPRFCTVYVISKGKLASVRPSESDASGSIRFERSSSTS 199
Query: 179 -----PFTSPLLDQLQSQNDISDTQSRYSMNLRDRTSFKPRMSFEESAKSPARGRGFDRK 233
P P S +S+ QSR S F P + + + A+
Sbjct: 200 GSTDSPRLPPEYQDFLSA--VSEAQSRVS-------PFSPALKHSMGSNAVAQ------- 243
Query: 234 SFMDSSESDTDISFVSSGR------------PSSDHSPSMHYEFVDVGRNSRISTSS--- 278
MD+S S TD VS+GR + D S S + NS TS
Sbjct: 244 --MDTSSSGTDQEEVSTGRGMEIVHSGIEGKKNKDESFSASFPMGTEAYNSMSWTSKWRD 301
Query: 279 --------------EHSLGSFRLGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEA 324
H L + G + S ++ G S + N +
Sbjct: 302 HEDRREMRSSSSSNNHDLVNMDWGAVVPENYSWVSHTASHMSDGLLSVHSITDNQVNLNF 361
Query: 325 EMRRLKLELKQTMDMYSTACKEALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEK 384
E+ +L+ ELK +MY+ A E + A +K EL + R +E +L E + EE A A K
Sbjct: 362 EIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDTASK 421
Query: 385 ERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIE 444
E+ R + A++ AE K + EA R AE +++ E ++L + ++Y+ YT E
Sbjct: 422 EKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHYTWE 481
Query: 445 DIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR 504
+I AT F E+ KIG G YG VYKC L HT AVKVL Q QF +E+E+LS IR
Sbjct: 482 EIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILSKIR 541
Query: 505 HPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
HP++VLLLGACPE G +VYEY+ NGSLDDR+ +TPP+ W +RFRIA E+A+ L+FLH
Sbjct: 542 HPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALVFLH 601
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA-VAENVTQYHLTSTAGTFCYID 623
++KP P++HRDLKPGNILLDHN+VSK+ DVGL+ +V + T + TS GT CYID
Sbjct: 602 KSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLCYID 661
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI-ENGTLGEMLDPTVTDWP 682
PEYQ+TG++ KSDVYSLG+++LQLITAK + +TH VE +I ++ +LD WP
Sbjct: 662 PEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAGSWP 721
Query: 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADES 725
+T A L L C+E+RR+DRPDL ++P L RLR++AD++
Sbjct: 722 ISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKA 764
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1071), Expect = e-115, Method: Compositional matrix adjust.
Identities = 283/771 (36%), Positives = 402/771 (52%), Gaps = 61/771 (7%)
Query: 6 GNGVKKTGGNGLIAVAV-----DK--DKSSQHALKWAADNLLNRGQTVVLIHVAQR-TSV 57
G G K G +AVAV DK S+ A++WA DNLL + V+IHV TS+
Sbjct: 12 GGGPKAEEGQLFVAVAVKGLIGDKLGGAGSRRAVRWAVDNLLPKADKFVMIHVIPTITSI 71
Query: 58 SSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAIT 117
+ + ++ + P +++ + + +K+ + T
Sbjct: 72 PTPNILILMFTRMWVVTAGDRLPVEEVEESVVEMYVRDVKKEYE---------------T 116
Query: 118 EYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNAS-- 175
+V F + R VP +V + AP+ C +Y+V K +I++K
Sbjct: 117 VFVPFLKMCKSTRSTKRYFRSRRTKGTGVPLTVLRYAPETCEVYIVCKDRITTKSMDPLI 176
Query: 176 RSAPFTSPLLDQLQSQNDISDTQSRYSMNLRDRTSFKPRMSFEESAKSPARGRGF----- 230
P TSP + +D + LR T PR S E + A R
Sbjct: 177 NREPCTSP--HAAATAHDFLRDWAASFHTLRSPTLPDPRQSTEAGTRRSASARELRFEAL 234
Query: 231 -----DRKSFMDSSESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSF 285
K+ S S + R SD P ++Y D + T + ++ +
Sbjct: 235 SLTCNKPKTPQSSKASSATTPEIFRRRRGSD-IPQLNYSDFD-----KTCTKPQSNVENI 288
Query: 286 RLGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACK 345
R +DRS P S+ S +E E+ RLK EL+ T+ Y AC+
Sbjct: 289 VSEHRDSDRSPP----ETSRKSKKVE----------IEEEVERLKNELQSTVFKYKQACE 334
Query: 346 EALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAEL 405
E + K L L+E +R+ A EE + A E+ R AV+ E AK +
Sbjct: 335 ELFSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKERYMKAVKEVETAKALLAR 394
Query: 406 EAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYG 465
E +R AE+N L+ E K L D RYR+YTIE+I AT+ F+ + IGEGGYG
Sbjct: 395 EFCQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIVTATEGFSPEKVIGEGGYG 454
Query: 466 PVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEY 525
VY+C LD TP AVKV+R D + + +F +E+EVLS +RHP++VLLLGACPE G +VYEY
Sbjct: 455 KVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGCLVYEY 514
Query: 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH 585
L NGSL++ IF R N PPL W RFR+ E+A GL FLH +KPEP+VHRDLKPGNILL+
Sbjct: 515 LENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGNILLNR 574
Query: 586 NYVSKISDVGLARLVPAVA-ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGIL 644
NYVSKI+DVGLA+LV VA +NVT Y + AGT YIDPEY +TG + KSD+Y+ GI+
Sbjct: 575 NYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLYAFGII 634
Query: 645 LLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDR 704
+LQL+TA+ P G+ VE +++ GTL EMLD +VTDWP ET A++ L+C+E R +DR
Sbjct: 635 ILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEFRCRDR 694
Query: 705 PDLGKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMTMQDVLSDPQ 755
PDL V+P L RL E A+ + + G +L S + +++++ +P+
Sbjct: 695 PDLKSEVIPVLKRLVETANSKVKKE--GSNLRAPSHYFCPI-LREIMEEPE 742
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (971), Expect = e-104, Method: Compositional matrix adjust.
Identities = 265/771 (34%), Positives = 394/771 (51%), Gaps = 103/771 (13%)
Query: 18 IAVAVDKDKSSQHALKWAADNL-LNRGQTVVLIHVAQRTSV------SSVSSQSQVYDAS 70
+A+A+ S++ +KWA + ++ T LIH+ + + + VS ++ + +
Sbjct: 34 VALAISGSIKSKNVIKWALNKFGSDKNVTFKLIHIHPKITTLPTASGNIVSISEELEEVA 93
Query: 71 ATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDV--------------LLEDVDIVKAI 116
A Q K+ L F+ C RK +K + +LE + AI
Sbjct: 94 AAYRQKVMQETKET--LLKPFKKMCERKKLKIDETRFESSLTKVAVELQVLESNSVAVAI 151
Query: 117 TEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKI-------- 168
T+ V+ I +L++G S+ R + D+ +S+S + + C +YVVS G +
Sbjct: 152 TKEVNQHLISNLIIGRSSQAASSRNY--DITASISASVSNLCTVYVVSNGGVHILAKDTS 209
Query: 169 -SSKRNASRSAPFTSPLLDQLQSQNDISDTQSRYSMNLRDRTSFKPRMSFEESAKSPARG 227
+ + + S + F SD S ++ T RM P
Sbjct: 210 DTERNDTSIESGFERTSSSCSSGSGANSDVMSN-ALKSNPHTLSNKRMQ-----NLPTIV 263
Query: 228 RGFDRKSFMDSSESD------TDISFVSSGR--PSSDHSPSMHYEFVDVG--RNSRISTS 277
RG S+ESD +D + +S R P + S S + +F D +++ S S
Sbjct: 264 RGVSVPMETSSTESDETKKRSSDAAEEASKRSSPETSRSVSWNPQFRDFDERKDAMSSMS 323
Query: 278 SEHSLGSFR--LGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQ 335
S G+ LG + D +QD+ L+E+ +L+ EL+
Sbjct: 324 SNFEYGNVVTPLGHYFTD----------NQDT-----------LNEIS----KLRAELRH 358
Query: 336 TMDMYSTACKEALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKE-RARCKAAVE 394
+MY+ A E LD R+L E +F E L+L E E + K E
Sbjct: 359 AHEMYAVAQVET--------------LDASRKLNELKFEE---LTLLEHETKGIAKKETE 401
Query: 395 AAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTK-DLRYRRYTIEDIEEATQFF 453
E KR E EA +R AEM E+ E + + L+Y+ +T E+I AT F
Sbjct: 402 KFE-QKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSF 460
Query: 454 TESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
+E KIG G YG VYKC L HT AVKVL + QF +E+E+LS IRHP++VLLLG
Sbjct: 461 SEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLG 520
Query: 514 ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
ACP++G +VYEY+ NGSL+DR+F+ ++ P+ W R RIA E+A+ L+FLH++KP P++H
Sbjct: 521 ACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIH 580
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPA---VAENVTQYHLTSTAGTFCYIDPEYQQTG 630
RDLKP NILL+HN+VSK+ DVGL+ ++ A ++ T Y TS GT CYIDPEYQ+TG
Sbjct: 581 RDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTG 640
Query: 631 MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGT---LGEMLDPTVTDWPFEETL 687
+ KSDVY+ G+++LQL+T +Q M LT+ VE ++EN L ++LD +WP EET
Sbjct: 641 RISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETR 700
Query: 688 GFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFFGGSLGPS 738
A LALQC+ELR KDRPDL +LP L L+++AD++ S PS
Sbjct: 701 QLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQPPS 751
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 367 bits (941), Expect = e-100, Method: Compositional matrix adjust.
Identities = 195/425 (45%), Positives = 270/425 (63%), Gaps = 18/425 (4%)
Query: 325 EMRRLKLELKQTMDMYSTACKEALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEK 384
E+ +LK+EL+ MY+ A E + A +K +L + R +E RL+ EE A + E
Sbjct: 298 ELEKLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEM 357
Query: 385 ERARCKAAVEAAEAAKRIAELEAQRRLSAEMNR---LKESDEVKIASSNLSTKDLRYRRY 441
ER R + A AE + E E + RL AE KE ++ A + +Y ++
Sbjct: 358 ERERQEDAENEAELVRECIERETEERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKF 417
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLS 501
E+I EAT F++ KIG GGYG VY+C L HT VAVKVL D + QF +E+E+LS
Sbjct: 418 EWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILS 477
Query: 502 CIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIF-RRGNT-----PPLSWQQRFRIAAE 555
IRHP+++LLLGACPE G +VYEY+ NGSL++R+ RR N PPL W +RFRIA E
Sbjct: 478 KIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWE 537
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV---PAVAENVTQYHL 612
IA+ L FLH +P P+VHRDLKP NILLD N VSKI DVGL+++V P+ A V ++
Sbjct: 538 IASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHASTV--FNE 595
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--ENGTL 670
T GTF YIDPEYQ+TG++ +SD+Y+ GI+LLQL+TA+ MGL H +E+++ + G
Sbjct: 596 TGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKF 655
Query: 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTF 730
E+LD T DWP +E + L+C+E+R++DRPDLGK +LP L RL+E+A S+ +
Sbjct: 656 TEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVA--SIARNM 713
Query: 731 FGGSL 735
F +L
Sbjct: 714 FADNL 718
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 301 bits (772), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 236/736 (32%), Positives = 367/736 (49%), Gaps = 72/736 (9%)
Query: 18 IAVAVDKDKS-SQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDA--SATTN 74
I VAVDK + S+ L WA N G+ + LIHV Q + + + A
Sbjct: 47 IFVAVDKHVAKSKSTLIWALQN--TGGKKICLIHVHQPSQMIPLMGAKFPVGAVKEEEVR 104
Query: 75 PHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPS 134
+++ +++ + + C ++ ++ + +E I I + +S I LV+GA +
Sbjct: 105 VFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQLISELGIRKLVMGAAA 164
Query: 135 RHGFIRK---FKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASR---SAPFTSP----- 183
+ R+ K+ V + AP C I+ KG + R A+ + + SP
Sbjct: 165 DRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREATMDDTESEYASPRPSIS 224
Query: 184 LLDQLQSQNDISDTQSRYSMNLRDRTSFKPRMSFEESAKSPARGRGFDRKSFMDSSESDT 243
D LQ+ S +S + R +++ + + + GR D D E ++
Sbjct: 225 ASDLLQT---FSTPESEHQHISRVQSTDSVQQLVSNGSSTEQSGRVSDGSLNTDEEERES 281
Query: 244 DISFVSSGRPSSDHSPSMHYEF---VDVGRNSRISTSSEHSLGSFRLGLRYNDRSSPYDL 300
D S V+ S F VD N +I R + +
Sbjct: 282 DGSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKI-------------------RKATSEA 322
Query: 301 SSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACK-----EALVAKQKAL 355
S Q++ A + + ++A +RR K Q+ YS K E VAK+K
Sbjct: 323 HSSKQEAFAETLRRQKAEKNALDA-IRRAK----QSESAYSEELKRRKDTEIAVAKEKE- 376
Query: 356 ELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAE-----AAKRIAELEAQRR 410
+ ++E +EE + A ++ E + A+ +E A K + +L +R
Sbjct: 377 RFITIKNEQEVIMEELQSAMAQK-AMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDERE 435
Query: 411 -LSAEMNR-LKESDEVKIASSNLSTKDLRYRRY----TIEDIEEATQFFTESRKIGEGGY 464
L E +R L+E++E++ S+ T L+ +Y + +IEEAT F + KIGEGGY
Sbjct: 436 ELQTERDRALREAEELR---SHAETSTLQLPQYFTDFSFSEIEEATNHFDSTLKIGEGGY 492
Query: 465 GPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYE 524
G +Y L HT VA+K+L P+++QG ++Q+E++VLS +RHPN++ L+GACPE +VYE
Sbjct: 493 GSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYE 552
Query: 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584
YL GSL+DR+ + N+PPLSWQ R RIA EI L+FLH K LVH DLKP NILLD
Sbjct: 553 YLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLD 612
Query: 585 HNYVSKISDVGLARLV-PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGI 643
N VSK+SD G L+ P +++V T GT Y+DPE +G L KSDVYS GI
Sbjct: 613 SNLVSKLSDFGTCSLLHPNGSKSVR----TDVTGTVAYLDPEASSSGELTPKSDVYSFGI 668
Query: 644 LLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKD 703
+LL+L+T + + +++ V+ +++NGTL ++LDP DWPF + A+LAL+C E ++
Sbjct: 669 ILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSEN 728
Query: 704 RPDLGKVVLPELNRLR 719
RPDLG V L +R
Sbjct: 729 RPDLGTEVWRVLEPMR 744
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 113/279 (40%), Positives = 170/279 (60%), Gaps = 12/279 (4%)
Query: 441 YTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVL 500
Y+ +I EAT F S K+GEG YG VYK L H VAVK+L + +F+R +E+L
Sbjct: 448 YSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEIL 507
Query: 501 SCIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
S +RHPN+V L+GACPE ++Y+Y+ NGSL+D N P LSW+ R RIA+EI + L
Sbjct: 508 SRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSAL 567
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
LFLH P ++H +LKP ILLD N V+KI+D G+++L+P + + H
Sbjct: 568 LFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGLDKSDPH--------- 617
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTD 680
+DP Y + + ++SD+Y+ GI+LLQL+T + G+ V+ ++EN + +LD + D
Sbjct: 618 -VDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGD 676
Query: 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719
WP A +A++C + +RPDL VVL ++R++
Sbjct: 677 WPVARGKKLANVAIRCCKKNPMNRPDLA-VVLRFIDRMK 714
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 115/321 (35%), Positives = 180/321 (56%), Gaps = 21/321 (6%)
Query: 441 YTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVL 500
++ +D+E+AT+ F +R++G+ YG YK + + V +K+ + + FQ+E+ +L
Sbjct: 147 FSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKL-----SSSQKLFQQEVSIL 201
Query: 501 SCIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
RHPN++ +G C E +VYE+L NG+L+DRI N+ PLSW R +I EI L
Sbjct: 202 RQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWYNRTQIIGEICCAL 261
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL---VPAVAENVTQYHLTSTAG 617
LFLH K LVH DL+P NIL+D NY SKI + G++ L + N+T
Sbjct: 262 LFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFPPNLT--------A 313
Query: 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPT 677
Y+DPE+ TG L SDVYSLG+++L+L+T P+ L+ V ++ + +L ++D +
Sbjct: 314 RLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALGSDSLHLLIDKS 373
Query: 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGK---VVLPELNRLRELADESMGQTFFGGS 734
DWP+ E A + L C+ + RK RPDL +V+ L R A Q+ G S
Sbjct: 374 AGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAATWPYLQSASGDS 433
Query: 735 LGPSSKSNASMTMQDVLSDPQ 755
P++ ++M +++ DPQ
Sbjct: 434 SVPAAFI-CPISM-EIMKDPQ 452
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 112/287 (39%), Positives = 166/287 (57%), Gaps = 18/287 (6%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREI 497
R YT+ ++E AT E IGEGGYG VY+ L D T VAVK L + Q +F+ E+
Sbjct: 140 RWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEV 199
Query: 498 EVLSCIRHPNMVLLLGACPE--YGIIVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAA 554
EV+ +RH N+V LLG C E Y ++VY+++ NG+L+ I G+ PL+W R I
Sbjct: 200 EVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIIL 259
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
+A GL +LH+ +VHRD+K NILLD + +K+SD GLA+L+ + + VT T
Sbjct: 260 GMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVT----TR 315
Query: 615 TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM---------GLTHFVERSI 665
GTF Y+ PEY TGML KSD+YS GIL++++IT + P+ L +++ +
Sbjct: 316 VMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMV 375
Query: 666 ENGTLGEMLDPTVTDWPFEETLGFAKL-ALQCSELRRKDRPDLGKVV 711
N E++DP + + P + L L AL+C + RP +G ++
Sbjct: 376 GNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHII 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 116/314 (36%), Positives = 176/314 (56%), Gaps = 20/314 (6%)
Query: 415 MNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKC-YLD 473
MN + S I+ N +T DL E++ AT F+ + K+G+GG+G VYK LD
Sbjct: 489 MNEVVISSRRHISREN-NTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLD 547
Query: 474 HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531
+AVK L + QG +F+ E+++++ ++H N+V LL C + G +++YEYL N SL
Sbjct: 548 GQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSL 607
Query: 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591
D +F + L+WQ RF I IA GLL+LHQ ++HRDLK NILLD KI
Sbjct: 608 DSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKI 667
Query: 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA 651
SD G+AR+ + T+ + GT+ Y+ PEY G+ +KSDV+S G+LLL++I++
Sbjct: 668 SDFGMARI---FGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISS 724
Query: 652 KQPMG---------LTHFVERSIENGTLGEMLDPTVTD----WPFEETLGFAKLALQCSE 698
K+ G L V R+ + G E++DP +TD + E L ++ L C +
Sbjct: 725 KRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQ 784
Query: 699 LRRKDRPDLGKVVL 712
R +DRP + V+L
Sbjct: 785 ERAEDRPTMSLVIL 798
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| 255544480 | 786 | ATP binding protein, putative [Ricinus c | 0.955 | 0.950 | 0.691 | 0.0 | |
| 449454329 | 888 | PREDICTED: U-box domain-containing prote | 0.962 | 0.847 | 0.647 | 0.0 | |
| 449530610 | 772 | PREDICTED: U-box domain-containing prote | 0.925 | 0.937 | 0.657 | 0.0 | |
| 356557193 | 777 | PREDICTED: U-box domain-containing prote | 0.964 | 0.970 | 0.628 | 0.0 | |
| 356547485 | 769 | PREDICTED: U-box domain-containing prote | 0.952 | 0.968 | 0.632 | 0.0 | |
| 297844612 | 757 | kinase family protein [Arabidopsis lyrat | 0.933 | 0.964 | 0.620 | 0.0 | |
| 15219360 | 758 | Protein kinase protein with adenine nucl | 0.933 | 0.963 | 0.619 | 0.0 | |
| 359476012 | 796 | PREDICTED: U-box domain-containing prote | 0.948 | 0.932 | 0.635 | 0.0 | |
| 297842679 | 752 | predicted protein [Arabidopsis lyrata su | 0.921 | 0.958 | 0.634 | 0.0 | |
| 9954729 | 784 | Similar to protein kinases [Arabidopsis | 0.933 | 0.931 | 0.601 | 0.0 |
| >gi|255544480|ref|XP_002513301.1| ATP binding protein, putative [Ricinus communis] gi|223547209|gb|EEF48704.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2579), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/764 (69%), Positives = 624/764 (81%), Gaps = 17/764 (2%)
Query: 1 MWQPKGNGVKKTGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSV 60
MW PK NG KK G GL+AVA+DKDK SQ+ALKWA +NLL++GQTVV V V+S
Sbjct: 1 MWLPKTNGSKK-AGTGLVAVAIDKDKGSQNALKWALENLLSKGQTVV--LVHVLHRVASY 57
Query: 61 SSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYV 120
+ D ++TT + Q DK ++LFL+FRCYCTRKD++C D++LED D+VK + EYV
Sbjct: 58 TGPGYTCDFNSTT---KHQLDKMTKELFLSFRCYCTRKDVQCLDIVLEDQDVVKGLVEYV 114
Query: 121 SFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPF 180
S+AAIE+LV+GA SRHGFIRKFKAD+P+SVSK APDFCN+YV+SKGKISS R ASRSAP+
Sbjct: 115 SYAAIENLVIGA-SRHGFIRKFKADIPTSVSKGAPDFCNVYVISKGKISSMRQASRSAPY 173
Query: 181 TSPLLDQLQSQND-----ISDTQSRYSMNLRDRTSF-KPRMSFEESAKSPAR--GRGFDR 232
SPL+DQ+QSQ+ SDT S +S ++R KPR+S +ES KSP GR F+
Sbjct: 174 ASPLIDQIQSQSSRPSDASSDTLSMHSGSMRAECPVVKPRISLDESFKSPFERGGRAFNV 233
Query: 233 KSFMDSSESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSFRLGLRYN 292
KSF + +S+TDISFVSSGRPS+D S S+ +F+D SR+STSSE S GS R G ++N
Sbjct: 234 KSFAEFMDSETDISFVSSGRPSTDRSSSVALDFIDSCLTSRLSTSSETSFGSIRSGPKFN 293
Query: 293 DRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACKEALVAKQ 352
D SS ++ S+ S +SGATS S SSQ++D++EAEMRRLKLELKQTMDMYSTACKEAL AKQ
Sbjct: 294 DCSSLHEFSTFSHESGATSFSGSSQSMDDMEAEMRRLKLELKQTMDMYSTACKEALTAKQ 353
Query: 353 KALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLS 412
KA+EL RWR++EERR+EEA+ AEE ALS +KE+ARC+AA+EAAEAAK+IAELEAQ+RL+
Sbjct: 354 KAVELHRWRVEEERRMEEAKLAEEAALSAVQKEKARCRAAMEAAEAAKKIAELEAQKRLN 413
Query: 413 AEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL 472
E+ LKE++E+K L+ +DLRYRRY+IE+IE+AT++F ESR IGEGGYGPVYKCYL
Sbjct: 414 VELRALKEAEEMKKVMDALAQQDLRYRRYSIEEIEQATEYFAESRMIGEGGYGPVYKCYL 473
Query: 473 DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGSLD 532
DHTPVAVKVLRPDAAQGRSQFQRE+EVLS IRHPNMVLLLGACPEYG++VYEY+A GSLD
Sbjct: 474 DHTPVAVKVLRPDAAQGRSQFQREVEVLSLIRHPNMVLLLGACPEYGVLVYEYMAKGSLD 533
Query: 533 DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592
D +FRRGNTP L WQ RFRIAA+IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV KIS
Sbjct: 534 DCLFRRGNTPVLPWQLRFRIAAQIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVCKIS 593
Query: 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAK 652
DVGLARLVPAVAENVTQYH+TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGI+LLQLITAK
Sbjct: 594 DVGLARLVPAVAENVTQYHMTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQLITAK 653
Query: 653 QPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712
PMGLTH VE++IE G+ E+LDP V DWP EE L FAKLALQC+ELRRKDRPDLGK VL
Sbjct: 654 PPMGLTHMVEQAIEKGSFKEILDPAVGDWPMEEALTFAKLALQCAELRRKDRPDLGKEVL 713
Query: 713 PELNRLRELADESMGQTFFGGSLGPSSKSN--ASMTMQDVLSDP 754
PEL RLR LA+E M G S GPS + + T Q+V+SDP
Sbjct: 714 PELERLRSLAEEDMNHMLLGSSGGPSPHHSYVSRTTTQEVISDP 757
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454329|ref|XP_004144908.1| PREDICTED: U-box domain-containing protein 35-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2512), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/774 (64%), Positives = 604/774 (78%), Gaps = 21/774 (2%)
Query: 1 MWQPKGNGVKKT-------GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQ 53
MW KGN V GGNGL+A+ +D++K SQ+AL+WAA++L+ +GQTV+LIHV
Sbjct: 1 MWLQKGNSVNSVKKVGAGGGGNGLVAIGIDREKGSQNALRWAAEHLIGKGQTVILIHVVH 60
Query: 54 RTSVSSVSSQSQVY----DASATTN-PHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLE 108
R S ++ S + D S+T++ PH +Q + Q RD+FLTF CYCTRKDI+C D++LE
Sbjct: 61 RPSSAAASLIGEAIICNTDGSSTSDSPHIQQLEMQTRDIFLTFHCYCTRKDIQCLDIILE 120
Query: 109 DVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKI 168
D DIVKA+TEYVS+AAIE LVLGAPSRHGFIR + + SSVSK APDFC +YV+SKGK+
Sbjct: 121 DTDIVKALTEYVSYAAIETLVLGAPSRHGFIRFKSSSMGSSVSKGAPDFCTVYVISKGKV 180
Query: 169 SSKRNASRSAPFTSPLLDQLQSQND---ISDTQSRYSMNLRDRTSFKPRMSFEESAKSPA 225
SS +NASRSAPFTSPLLD+LQ + R+ NLRDRTSFKPR +E+ KSP
Sbjct: 181 SSVKNASRSAPFTSPLLDRLQKLSKPIVKGSITPRHKFNLRDRTSFKPRSFQDETIKSPY 240
Query: 226 RGRGFDRKSFMDSS----ESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHS 281
G +R S ES++DISF+SSGRPS+D S S+ +++ D G R STSSEHS
Sbjct: 241 -SHGGERTCISKFSGGFSESESDISFISSGRPSTDRSSSVAFDYSDSG-PPRFSTSSEHS 298
Query: 282 LGSFRLGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYS 341
S ++ D S+ D SS+S +S TSCS SSQNLDEVE EMRRLKLELKQTM+MYS
Sbjct: 299 FTSLPFKPKWADLSNLNDFSSVSDESCRTSCSWSSQNLDEVELEMRRLKLELKQTMEMYS 358
Query: 342 TACKEALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKR 401
TACKEAL AKQKA+EL WR +EE++LEEAR A+E A+++AE+ERARC+AA+EAA+AAKR
Sbjct: 359 TACKEALTAKQKAMELNNWRREEEQKLEEARLAQEAAMAIAEQERARCRAAMEAADAAKR 418
Query: 402 IAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGE 461
IAELE+ +R + EM +KE++E++ A NL+ D+RYRRY+IE++E AT+ F +SRKIGE
Sbjct: 419 IAELESHKRANLEMKAVKEAEEMQKALKNLAQSDIRYRRYSIEEVESATEHFAQSRKIGE 478
Query: 462 GGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGII 521
GGYGPV++C LDHT VAVKVLRPDA QGR+QFQ+EI++LSCIRHPNMVLLLGACPEYGI+
Sbjct: 479 GGYGPVFRCRLDHTSVAVKVLRPDATQGRTQFQQEIDILSCIRHPNMVLLLGACPEYGIL 538
Query: 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNI 581
VYEY++NGSL+DR+FR+GNTP + WQ RFRIAAEIATGLLFLHQTKPEPLVHRDLKP NI
Sbjct: 539 VYEYMSNGSLEDRLFRKGNTPVIPWQLRFRIAAEIATGLLFLHQTKPEPLVHRDLKPANI 598
Query: 582 LLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSL 641
LLDHNYVSKISDVGLARL+PAVAENVTQ ++TS AGTFCYIDPEYQQTGMLGVKSDVYSL
Sbjct: 599 LLDHNYVSKISDVGLARLLPAVAENVTQCYVTSAAGTFCYIDPEYQQTGMLGVKSDVYSL 658
Query: 642 GILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRR 701
GI+LLQLITAK MGL H V RSIE GT E LDP V DWP E+TL FAKLAL+C+ELRR
Sbjct: 659 GIMLLQLITAKPAMGLAHHVARSIEKGTFQEFLDPAVVDWPVEQTLCFAKLALECAELRR 718
Query: 702 KDRPDLGKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMTMQDVLSDPQ 755
KDRPDL VVLPEL +LRE +E M S G S + T QDV+SDPQ
Sbjct: 719 KDRPDLASVVLPELEKLREFGEEMMEHMESRDSSGSISSFSHPSTEQDVMSDPQ 772
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449530610|ref|XP_004172287.1| PREDICTED: U-box domain-containing protein 52-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 965 bits (2495), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/745 (65%), Positives = 591/745 (79%), Gaps = 21/745 (2%)
Query: 1 MWQPKGNGVKKT-------GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQ 53
MW KGN V GGNGL+A+ +D++K SQ+AL+WAA++L+ +GQTV+LIHV
Sbjct: 1 MWLQKGNSVNSVKKVGAGGGGNGLVAIGIDREKGSQNALRWAAEHLIGKGQTVILIHVVH 60
Query: 54 RTSVSSVSSQSQVY----DASATTN-PHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLE 108
R S ++ S + D S+T++ PH +Q + Q RD+FLTF CYCTRKDI+C D++LE
Sbjct: 61 RPSSAAASLIGEAIICNTDGSSTSDSPHIQQLEMQTRDIFLTFHCYCTRKDIQCLDIILE 120
Query: 109 DVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKI 168
D DIVKA+TEYVS+AAIE LVLGAPSRHGFIR + + SSVSK APDFC +YV+SKGK+
Sbjct: 121 DTDIVKALTEYVSYAAIETLVLGAPSRHGFIRFKSSSMGSSVSKGAPDFCTVYVISKGKV 180
Query: 169 SSKRNASRSAPFTSPLLDQLQSQND---ISDTQSRYSMNLRDRTSFKPRMSFEESAKSPA 225
SS +NASRSAPFTSPLLD+LQ + R+ NLRDRTSFKPR +E+ KSP
Sbjct: 181 SSVKNASRSAPFTSPLLDRLQKLSKPIVKGSITPRHKFNLRDRTSFKPRSFQDETIKSPY 240
Query: 226 RGRGFDRKSFMDSS----ESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHS 281
G +R S ES++DISF+SSGRPS+D S S+ +++ D G R STSSEHS
Sbjct: 241 -SHGGERTCISKFSGGFSESESDISFISSGRPSTDRSSSVAFDYSDSG-PPRFSTSSEHS 298
Query: 282 LGSFRLGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYS 341
S ++ D S+ D SS+S +S TSCS SSQNLDEVE EMRRLKLELKQTM+MYS
Sbjct: 299 FTSLPFKPKWADLSNLNDFSSVSDESCRTSCSWSSQNLDEVELEMRRLKLELKQTMEMYS 358
Query: 342 TACKEALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKR 401
TACKEAL AKQKA+EL WR +EE++LEEAR A+E A+++AE+ERARC+AA+EAA+AAKR
Sbjct: 359 TACKEALTAKQKAMELNNWRREEEQKLEEARLAQEAAMAIAEQERARCRAAMEAADAAKR 418
Query: 402 IAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGE 461
IAELE+ +R + EM +KE++E++ A NL+ D+RYRRY+IE++E AT+ F +SRKIGE
Sbjct: 419 IAELESHKRANLEMKAVKEAEEMQKALKNLAQSDIRYRRYSIEEVESATEHFAQSRKIGE 478
Query: 462 GGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGII 521
GGYGPV++C LDHT VAVKVLRPDA QGR+QFQ+EI++LSCIRHPNMVLLLGACPEYGI+
Sbjct: 479 GGYGPVFRCRLDHTSVAVKVLRPDATQGRTQFQQEIDILSCIRHPNMVLLLGACPEYGIL 538
Query: 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNI 581
VYEY++NGSL+DR+FR+GNTP + WQ RFRIAAEIATGLLFLHQTKPEPLVHRDLKP NI
Sbjct: 539 VYEYMSNGSLEDRLFRKGNTPVIPWQLRFRIAAEIATGLLFLHQTKPEPLVHRDLKPANI 598
Query: 582 LLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSL 641
LLDHNYVSKISDVGLARL+PAVAENVTQ ++TS AGTFCYIDPEYQQTGMLGVKSDVYSL
Sbjct: 599 LLDHNYVSKISDVGLARLLPAVAENVTQCYVTSAAGTFCYIDPEYQQTGMLGVKSDVYSL 658
Query: 642 GILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRR 701
GI+LLQLITAK MGL H V RSIE GT E LDP V DWP E+TL FAKLAL+C+ELRR
Sbjct: 659 GIMLLQLITAKPAMGLAHHVARSIEKGTFQEFLDPAVVDWPVEQTLCFAKLALECAELRR 718
Query: 702 KDRPDLGKVVLPELNRLRELADESM 726
KDRPDL VVLPEL +LRE +E M
Sbjct: 719 KDRPDLASVVLPELEKLREFGEEMM 743
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557193|ref|XP_003546902.1| PREDICTED: U-box domain-containing protein 35-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2475), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/772 (62%), Positives = 596/772 (77%), Gaps = 18/772 (2%)
Query: 1 MW--QPKGNGVKKTGGNG-LIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSV 57
MW PK +G++K GG L+AVA+DK+K SQ+ALKWA D LL RGQTV+LIHV TS
Sbjct: 1 MWLPNPKASGIRKGGGGNGLVAVAIDKNKGSQYALKWAVDCLLTRGQTVILIHVLHGTS- 59
Query: 58 SSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAIT 117
S VS ++++ +P Q D I+DLFLTF CYCTRKDI+C DVLLED D+VKAIT
Sbjct: 60 SPVSKVIICNISNSSASPGSYQLDNTIKDLFLTFHCYCTRKDIQCLDVLLEDTDVVKAIT 119
Query: 118 EYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRS 177
EYVS+AAIE+LV+GA SRHGFIR + SS+SK APDFC ++V+SKGK+SS RNA+R
Sbjct: 120 EYVSYAAIENLVVGATSRHGFIRFKSSSASSSISKGAPDFCTVFVISKGKVSSVRNATRP 179
Query: 178 APFTSPLLDQL-----QSQNDISDTQSRYSMNLRDRTSFKPRMSFEESAKSP-ARGRGFD 231
A TSPLL + Q Q ++ SR MNLRDRTS KP +ES KSP RGRG
Sbjct: 180 AAHTSPLLSHIHDLISQVQTQPAEISSR-RMNLRDRTSIKPHSQADESFKSPFVRGRGMG 238
Query: 232 RKSFMDSSESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSFRLGLRY 291
S +D ESDTDISFVSS RPSS S S+ Y+++D GR SR+ST+S+HS GS RLGL++
Sbjct: 239 GMSCVDFPESDTDISFVSSERPSSGRSSSV-YDYIDTGRTSRLSTNSDHSFGSTRLGLKF 297
Query: 292 NDRSSPYDL-SSISQDSGATSCSCSSQNLDEV-EAEMRRLKLELKQTMDMYSTACKEALV 349
N PY +S S +S TS S SSQ++DEV EA+MRRLKLEL Q M+MYSTAC+EA +
Sbjct: 298 N----PYSPDTSFSHESCTTSFSYSSQSVDEVVEADMRRLKLELTQRMEMYSTACREAYI 353
Query: 350 AKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQR 409
++QK +EL RL+EE++++EAR A+E A+++AEKE+ARC+AA+E AEA+K+IAE+E R
Sbjct: 354 SQQKFMELTHQRLEEEKKIDEARLAQEAAMAIAEKEKARCRAAMETAEASKKIAEVETHR 413
Query: 410 RLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYK 469
R S E+ LKE++E++ NL+ D+RYRRY IE+IE AT FF+ES++IGEGGYG VYK
Sbjct: 414 RASVEVKALKEAEEMRKLLENLAQTDVRYRRYCIEEIETATNFFSESQRIGEGGYGLVYK 473
Query: 470 CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANG 529
CYLDHTPVAVKVLRPDAAQG+SQFQ+EI++LSC+RHPNMVLLLGACPEYGI++YEY+ANG
Sbjct: 474 CYLDHTPVAVKVLRPDAAQGKSQFQQEIDILSCMRHPNMVLLLGACPEYGILIYEYMANG 533
Query: 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589
SL+D +F++ N LSWQ RFRIAAEI TGLLFLHQTKPEPLVHRDLKPGNILLD NYVS
Sbjct: 534 SLEDCLFQKKNKSVLSWQLRFRIAAEIGTGLLFLHQTKPEPLVHRDLKPGNILLDQNYVS 593
Query: 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLI 649
KISDVGLARLVPAVAENVTQ +TS AGT CYIDPEYQQTGMLGVKSDVYSLGI+ LQL+
Sbjct: 594 KISDVGLARLVPAVAENVTQCCMTSAAGTLCYIDPEYQQTGMLGVKSDVYSLGIIFLQLL 653
Query: 650 TAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGK 709
T + PMGL H SIE T EMLDP+VT WP E+ L AK+A++C+ELRRKDRPDL K
Sbjct: 654 TGRPPMGLAHLAGESIEKDTFVEMLDPSVTGWPLEQALCLAKIAVKCAELRRKDRPDLAK 713
Query: 710 VVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMTMQDVLSDPQPWNSES 761
+VLPEL++LR+ A+++M F G S + + QDV+SD + +SES
Sbjct: 714 LVLPELDKLRDFAEQNMSMPIFLGCTASSPSHSEAFVHQDVISDLRLVHSES 765
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547485|ref|XP_003542142.1| PREDICTED: U-box domain-containing protein 35-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2462), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/773 (63%), Positives = 594/773 (76%), Gaps = 28/773 (3%)
Query: 1 MW--QPKGNGVKKTGG-NGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSV 57
MW PK +G++K GG NGL+AVA+DKDK SQ+ALKWA D LL RGQT++LIHV TS
Sbjct: 1 MWLPSPKASGIRKGGGVNGLVAVAIDKDKGSQYALKWAVDCLLTRGQTLILIHVLHGTSS 60
Query: 58 SSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAIT 117
S+ SQ Y Q D I+DLFLTF CYC RK+I+C DVLLED D+VKAIT
Sbjct: 61 PVSSASSQSY-----------QLDNNIKDLFLTFHCYCRRKEIQCLDVLLEDTDVVKAIT 109
Query: 118 EYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRS 177
EYVS+AAIE+LV+GA SRHGFIR FK+ SS+SK APDFCN+ V+SKGK+SS R A+R
Sbjct: 110 EYVSYAAIENLVVGATSRHGFIR-FKSSASSSISKGAPDFCNVSVISKGKVSSVRKATRP 168
Query: 178 APFTSPLLDQLQSQNDISDTQSRYS---MNLRDRTSFKPRMSFEESAKSP-ARGRGFDRK 233
TSPLL + N+ Q S MNL DRTS KP +ES KSP RGRG D
Sbjct: 169 TSHTSPLLSHIHDLNNRGKNQHEISSRPMNLGDRTSIKPHGWLDESIKSPFVRGRGMDGM 228
Query: 234 SFMDSSESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSFRLG-LRYN 292
S MD ESDTDISFVSS RPSS S S+ Y+++DVGR SR+ST+S+ S GS RLG L++N
Sbjct: 229 SCMDFPESDTDISFVSSERPSSGRSSSV-YDYIDVGRTSRVSTNSDRSFGSTRLGALKFN 287
Query: 293 DRSSPYDLSSISQDSGATSCSCSSQNLDEV-EAEMRRLKLELKQTMDMYSTACKEALVAK 351
+ +SP +S S +S ATS S S Q+ DE EA+MRRLKL+LKQT+ MYSTAC++AL ++
Sbjct: 288 NPNSPD--TSFSHESSATSFSYSLQSEDEAAEADMRRLKLQLKQTIKMYSTACRQALASQ 345
Query: 352 QKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRL 411
QK +EL RL+EE++++EAR A+E A+++AEKE+ARC+ A+E AEA+K+IAE+E RR
Sbjct: 346 QKLMELTHLRLEEEKKIQEARLAQEAAMAIAEKEKARCRVAMETAEASKKIAEVETHRRA 405
Query: 412 SAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY 471
E+ LKE +E + NL+ D+RYRRY +E+IE AT +F+E ++IGEGGYGPVYKCY
Sbjct: 406 GVEVKALKEVEEKRKLLDNLALTDVRYRRYCVEEIEAATNYFSELQRIGEGGYGPVYKCY 465
Query: 472 LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGSL 531
LDHTPVAVKVLRPDAAQG+SQFQ+EI++LSC+RHPNMVLLLGACPEYGI++YEY+ANGSL
Sbjct: 466 LDHTPVAVKVLRPDAAQGKSQFQQEIDILSCMRHPNMVLLLGACPEYGILIYEYMANGSL 525
Query: 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591
+D +F++ N LSWQ RFRIAAEI TGLLFLHQ KPEPLVHRDLKPGNILLD NYVSKI
Sbjct: 526 EDCLFKKKNKRVLSWQLRFRIAAEIGTGLLFLHQAKPEPLVHRDLKPGNILLDQNYVSKI 585
Query: 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA 651
SDVGLARLVPAVAENVTQ +TS AGTFCYIDPEYQQTGMLGVKSDVYSLGI+ LQL+T
Sbjct: 586 SDVGLARLVPAVAENVTQCCMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGIIFLQLLTG 645
Query: 652 KQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
+ P+GL H E SIE T EMLDP+VTDWP E+ L AK+A++C+ELRRKDRPDL K+V
Sbjct: 646 RAPIGLAHHAEESIEKDTFVEMLDPSVTDWPLEQALCLAKIAVKCAELRRKDRPDLAKLV 705
Query: 712 LPELNRLRELADESMGQT--FFGGSLGPS-SKSNASMTMQDVLSDPQPWNSES 761
LPEL++LR+ A+++M T G PS S S ASM QDV+SD Q +SES
Sbjct: 706 LPELDKLRDFAEQNMTMTMPIILGCTAPSPSHSEASM-QQDVISDLQLAHSES 757
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297844612|ref|XP_002890187.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297336029|gb|EFH66446.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/759 (62%), Positives = 580/759 (76%), Gaps = 29/759 (3%)
Query: 1 MWQPKGNGVKKTGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSV 60
MW PK + K +G +A+A+DKDKSSQ+A+KW +NL RGQT+ LIHV +
Sbjct: 1 MWLPKADATNKGTRSGSVAIAIDKDKSSQNAIKWTLENLATRGQTLALIHVLPK------ 54
Query: 61 SSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYV 120
SQS + T H++Q +KQ +DLF++F C+C+RK+I C DV+LEDVD VKAI EYV
Sbjct: 55 -SQSSLDIEEGIT--HKQQMEKQTKDLFVSFHCFCSRKEIHCLDVVLEDVDKVKAIVEYV 111
Query: 121 SFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPF 180
+ +AIE+LVLGAPSR+ F+R+FK D+P+SVSK APDFCN+YV+SKGKISS RNASR AP+
Sbjct: 112 TVSAIENLVLGAPSRNSFMRRFKTDLPTSVSKTAPDFCNVYVISKGKISSLRNASRPAPY 171
Query: 181 -TSPLLDQLQSQNDISDTQSRYSMNL----RDRTSFK---PRMSFEESAKSPARGRG-FD 231
S LL ++ + I+ + + N R R S R+ + + G F
Sbjct: 172 HPSVLLSEVDNHETIALERKHKTANTPALPRGRRSVDSDGTRLGLPKPPHGHMKLVGDFS 231
Query: 232 RK----SFMDSSESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSFRL 287
SF+ +S+ ++D+SF+SSGRPS D S S Y+ + R SR+STSSE S+GS RL
Sbjct: 232 DSESEFSFISASQQESDLSFISSGRPSVDRS-SFTYDLPESARTSRMSTSSEQSIGSHRL 290
Query: 288 GLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACKEA 347
G+++ D S S++S +SG TSCS SSQ+LD+VEA+MRRL+LELKQTMDMYS+AC+EA
Sbjct: 291 GIKFTDLSYLNGSSTVSDESGRTSCSYSSQSLDDVEAQMRRLRLELKQTMDMYSSACREA 350
Query: 348 LVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEA 407
L A+ +A ELQ+ R +EERRLEE + EE A+S+ E ERA+ K A+EAAEAA R+AE+EA
Sbjct: 351 LTARHEATELQKLRTEEERRLEELKMTEEIAMSMVENERAKAKTALEAAEAANRLAEVEA 410
Query: 408 QRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPV 467
+RR+ AEM LKESD S +RYR+YT+++IEE T F ESRK+GEGGYGPV
Sbjct: 411 KRRVHAEMKVLKESDSFSRHSI------VRYRKYTVQEIEEGTANFAESRKVGEGGYGPV 464
Query: 468 YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLA 527
++ +LDHT VAVKVLRPDAAQGRSQF +E+EVLSCIRHPNMVLLLGACPEYGI+VYEY+A
Sbjct: 465 FRGHLDHTSVAVKVLRPDAAQGRSQFHKEVEVLSCIRHPNMVLLLGACPEYGILVYEYMA 524
Query: 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587
GSLDDR+FRRGNTPP+SWQ RFRIAAEIATGLLFLHQTKPEP+VHRDLKPGN+LLDHNY
Sbjct: 525 KGSLDDRLFRRGNTPPISWQLRFRIAAEIATGLLFLHQTKPEPIVHRDLKPGNVLLDHNY 584
Query: 588 VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQ 647
VSKISDVGLARLVPAVAENVTQY +TS AGTFCYIDPEYQQTGMLGVKSDVYSLGI+LLQ
Sbjct: 585 VSKISDVGLARLVPAVAENVTQYRVTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQ 644
Query: 648 LITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707
L+TAKQPMGL ++VE++IE GTL +MLDP V DWP EE L AKL+LQC+ELRRKDRPDL
Sbjct: 645 LLTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDWPLEEALSLAKLSLQCAELRRKDRPDL 704
Query: 708 GKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMT 746
GK V+PELNRLRE+ +ES+ F+ G S S S T
Sbjct: 705 GKEVMPELNRLREIGEESLESVFYAGQGRSSHPSQVSYT 743
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219360|ref|NP_173120.1| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] gi|332191372|gb|AEE29493.1| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 930 bits (2403), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/759 (61%), Positives = 582/759 (76%), Gaps = 29/759 (3%)
Query: 1 MWQPKGNGVKKTGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSV 60
MW PK + KK NG +A+A+DKDKSSQ+A+KW +NL RGQT+ LIHV +
Sbjct: 1 MWLPKADATKKGTRNGSVAIAIDKDKSSQNAIKWTLENLATRGQTLALIHVLPK------ 54
Query: 61 SSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYV 120
SQS + T H++Q +KQ +DLF++F CYC+RK+I C DV+LEDVD VKAI EYV
Sbjct: 55 -SQSSLDIEEGIT--HKQQMEKQTKDLFVSFHCYCSRKEIHCLDVVLEDVDKVKAIVEYV 111
Query: 121 SFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPF 180
+ +AIE+LVLGAPSR+ F+R+FK D+P+SVSKAAPDFCN+YV+SKGKISS RNASR AP+
Sbjct: 112 TVSAIENLVLGAPSRNSFMRRFKTDLPTSVSKAAPDFCNVYVISKGKISSLRNASRLAPY 171
Query: 181 TSPLLDQLQSQNDISDTQSRYSMNL----RDRTSFKPRMSFEESAKSP-----ARGRGFD 231
+L ++ I+ + + N + R S ++ K P G D
Sbjct: 172 HPSVLSEVDDHETIAIERKHKTANTPALPKGRRSIDSDVTRLGLPKPPHGHMKLMGDFSD 231
Query: 232 RKS---FMDSSESDT-DISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSFRL 287
+S F+ +S+ ++ D+SF+SSGRPS D S S Y+ + R SR+STSSE S+GS RL
Sbjct: 232 SESEFSFISASQQESSDLSFISSGRPSVDRS-SFTYDLPESARTSRMSTSSEQSIGSHRL 290
Query: 288 GLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACKEA 347
G+++ D S SS+S +SG TSCS SSQ+L++VEA+M+RL+LELKQTMDMYS+AC+EA
Sbjct: 291 GIKFTDLSYLNGSSSVSDESGRTSCSFSSQSLNDVEAQMKRLRLELKQTMDMYSSACREA 350
Query: 348 LVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEA 407
L A+ +A ELQ+ R +EERRLEE + EETA+S+ E ERA+ K A+EAAEAA R+AE+EA
Sbjct: 351 LTARNEATELQKLRTEEERRLEELKMTEETAMSIVENERAKAKTALEAAEAANRLAEVEA 410
Query: 408 QRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPV 467
+RR+ AEM LKESD S +RYR+Y++++IEE T F ESRK+GEGGYGPV
Sbjct: 411 KRRVHAEMKVLKESDSFSRHSI------VRYRKYSVQEIEEGTANFAESRKVGEGGYGPV 464
Query: 468 YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLA 527
++ +LDHT VAVKVLRPDAAQGRSQF +E+EVLSCIRHPNMVLLLGACPEYGI+VYEY+A
Sbjct: 465 FRGHLDHTSVAVKVLRPDAAQGRSQFHKEVEVLSCIRHPNMVLLLGACPEYGILVYEYMA 524
Query: 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587
GSLDDR+FRRGNTPP+SWQ RFRIAAEIATGLLFLHQTKPEP+VHRDLKPGN+LLDHNY
Sbjct: 525 RGSLDDRLFRRGNTPPISWQLRFRIAAEIATGLLFLHQTKPEPIVHRDLKPGNVLLDHNY 584
Query: 588 VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQ 647
VSKISDVGLARLVPAVAENVTQY +TS AGTFCYIDPEYQQTGMLGVKSDVYSLGI+LLQ
Sbjct: 585 VSKISDVGLARLVPAVAENVTQYRVTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQ 644
Query: 648 LITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707
L+TAKQPMGL ++VE++IE GTL +MLDP V DWP EE L AKL+LQC+ELRRKDRPDL
Sbjct: 645 LLTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDWPLEEALSLAKLSLQCAELRRKDRPDL 704
Query: 708 GKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMT 746
GK V+PEL+RLRE+ +ES+ ++ G S S S T
Sbjct: 705 GKEVMPELSRLREIGEESLDSVYYAGQGRSSHPSQVSYT 743
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476012|ref|XP_003631778.1| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2402), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/780 (63%), Positives = 601/780 (77%), Gaps = 38/780 (4%)
Query: 1 MWQPKGNGVKKTGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSV 60
MW +GN KK GGN L+AVA+DKDK SQ ALKWA DN+LNRGQTVVLIHV +
Sbjct: 1 MWLGRGNTEKKEGGNPLVAVAIDKDKGSQSALKWAIDNILNRGQTVVLIHVKLK------ 54
Query: 61 SSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYV 120
Q + S T + D ++LFL FRC+CTRKDI+C DV+LED D+VKA+ EYV
Sbjct: 55 ----QSHSHSYPTGDEVAKLDHYTKELFLPFRCFCTRKDIQCKDVILEDTDVVKALIEYV 110
Query: 121 SFAAIEDLVLGAPSRHGFIRKFKA-DVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAP 179
S +AIE LV+GAP++ GF+R+FKA D+P S++K APDFC +YV+SKGKISS R+ASR+AP
Sbjct: 111 SHSAIEVLVVGAPAKGGFLRRFKAIDIPGSITKGAPDFCTVYVISKGKISSTRSASRAAP 170
Query: 180 FTSPLLDQLQSQNDI----SDTQSRYSMNLR----DRTSF-------KPRMSFE--ESAK 222
SPL +Q+ +Q I SD ++ + R D S PR S + E K
Sbjct: 171 AISPLRNQIMNQGSIRPDPSDLPIPHAPSSRAISDDPISAVEKPPVEPPRSSHDDFEHIK 230
Query: 223 SP-ARG-RGFDRKSFMDSSESDTDISFVSSGRPSSDHS-PSMHYEFVDVGR-NSRISTSS 278
SP RG RG + +S+ + S D+DISFVSSGRPS+D P + +D+ R N R+S SS
Sbjct: 231 SPFTRGARGPNGRSYGEISLPDSDISFVSSGRPSTDRMFPPFYDSNIDIIRSNPRLSNSS 290
Query: 279 E---HSLGSFRLGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQ 335
+ + S ++G + + SP + +ISQ++ TS S SQ+ ++VEAEMRRLKLELKQ
Sbjct: 291 DMDNQTFESSQMGRKSMEIGSPPEFLAISQENDRTSWS--SQSAEDVEAEMRRLKLELKQ 348
Query: 336 TMDMYSTACKEALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEA 395
TMDMYSTACKEAL AKQKA ELQRW+L+EE+RLEEAR AEE AL++AE+E+A+ +AA+E
Sbjct: 349 TMDMYSTACKEALSAKQKARELQRWKLEEEQRLEEARLAEEAALAIAEREKAKSRAAIEH 408
Query: 396 AEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTE 455
AEAA+RIAELEAQ+R++AEM +KE++E K +L+ D+RYR+YTIE+IE AT+FF+E
Sbjct: 409 AEAAQRIAELEAQKRINAEMKAIKEAEEKKKVLDSLAQTDVRYRKYTIEEIESATEFFSE 468
Query: 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
SRKIGEGGYGPVYKC LDHT VA+KVLRPDAAQGRSQFQ+E+EVLSCIRHPNMVLLLGAC
Sbjct: 469 SRKIGEGGYGPVYKCNLDHTQVAIKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGAC 528
Query: 516 PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRD 575
PEYG +VYEY+ANGSL+DR+FRRG++PPLSWQ RFRIAAEI TGLLFLHQTKPEPLVHRD
Sbjct: 529 PEYGCLVYEYMANGSLEDRLFRRGDSPPLSWQLRFRIAAEIGTGLLFLHQTKPEPLVHRD 588
Query: 576 LKPGNILLDHNYVSKISDVGLARLV-PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGV 634
LKP NILLD NYVSKISDVGLARLV P+VA+NVTQY +TSTAGTFCYIDPEYQQTGMLG+
Sbjct: 589 LKPANILLDRNYVSKISDVGLARLVPPSVADNVTQYRMTSTAGTFCYIDPEYQQTGMLGI 648
Query: 635 KSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLAL 694
KSDVYSLGI+LLQ+ITAK PMGLTH VER+IE T EMLDP V DWP EE L FAK+AL
Sbjct: 649 KSDVYSLGIMLLQIITAKPPMGLTHLVERAIEKDTFEEMLDPVVPDWPLEEALSFAKIAL 708
Query: 695 QCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMTMQDVLSDP 754
QC+ELRRKDRPDLGK VLPELNRLREL++E + T GGS S+ + +DV SDP
Sbjct: 709 QCAELRRKDRPDLGKAVLPELNRLRELSEEHLDPTMMGGSQYHSTNHSQVSFRRDVASDP 768
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297842679|ref|XP_002889221.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297335062|gb|EFH65480.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 924 bits (2387), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/752 (63%), Positives = 590/752 (78%), Gaps = 31/752 (4%)
Query: 1 MWQPKGNGVKKTGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSV 60
MW PK NG KK G+G +AVA+DKDK SQHALKW DNL +RGQT+ LIHV R+ SS
Sbjct: 1 MWLPKANGAKKETGSGSVAVAIDKDKGSQHALKWTIDNLASRGQTISLIHVLSRSHSSS- 59
Query: 61 SSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYV 120
D T ++Q +K +DLF++F CYC+RK+I C D+LLED D V+AITEYV
Sbjct: 60 -------DLEEGTPQQRQQSEKIAKDLFVSFHCYCSRKEINCRDILLEDADKVRAITEYV 112
Query: 121 SFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPF 180
S +AIE+LV+G+ SR+GF+R+FK D+P++VSK+APDFCN+YV+SKGKI+S RNASR AP+
Sbjct: 113 SSSAIENLVVGSASRNGFMRRFKTDLPTTVSKSAPDFCNVYVISKGKIASVRNASRPAPY 172
Query: 181 TSPL----LDQLQSQNDISDTQSRYSMNLRDRTSFKPRMSFE-ESAKSPARGRG-----F 230
+ + +D + N T +PR S E ++ +SP R +
Sbjct: 173 QNSMQHCEIDNHHPHTPDKAPKHHDHSNSAGSTPSRPRKSVEVDATRSPLVKRKPYGDLY 232
Query: 231 DRKSFMD----SSESDTDISFVSSGRPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSFR 286
D S + SS D+DISF+SSGRPS + S S +F + R SR+STSSE S+GS R
Sbjct: 233 DSDSDLSFISPSSHRDSDISFISSGRPSVERS-SFSLDFPESARTSRMSTSSEQSIGSHR 291
Query: 287 LGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACKE 346
LG++++D P + S+ S++SG TS S SSQ+LD+VEAEM+RL+LELKQTMDMYSTACKE
Sbjct: 292 LGIKFSDPGFPNESSTFSEESGRTS-SYSSQSLDDVEAEMKRLRLELKQTMDMYSTACKE 350
Query: 347 ALVAKQKALELQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELE 406
AL A+Q+A ELQ+ R +EERRLEEA+ +EE A+S+ EKERA+ KAA+EAAEAAKR+AE+E
Sbjct: 351 ALSARQQATELQKLRTEEERRLEEAKSSEEAAMSIVEKERAKAKAALEAAEAAKRLAEVE 410
Query: 407 AQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGP 466
A+RRL+AEM LKESD + S + +RYR+YT+E+IEEAT F ES+K+GEGGYGP
Sbjct: 411 AKRRLTAEMKTLKESD-------SFSRRFVRYRKYTVEEIEEATSNFAESQKVGEGGYGP 463
Query: 467 VYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYL 526
V++ +LDHT VAVKVLRPDAAQGRSQFQ+E+EVLSCIRHPNMVLLLGACPE+GI+VYEY+
Sbjct: 464 VFRGFLDHTSVAVKVLRPDAAQGRSQFQKEVEVLSCIRHPNMVLLLGACPEFGILVYEYM 523
Query: 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586
A GSL+DR+F RGNTPP++WQ RFRIAAEIATGLLFLHQTKPEP+VHRDLKPGN+LLD+N
Sbjct: 524 AKGSLEDRLFMRGNTPPITWQLRFRIAAEIATGLLFLHQTKPEPIVHRDLKPGNVLLDYN 583
Query: 587 YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 646
YVSKISDVGLARLVPAVAENVTQY +TS AGTFCYIDPEYQQTGMLGVKSDVYSLGI+LL
Sbjct: 584 YVSKISDVGLARLVPAVAENVTQYRVTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLL 643
Query: 647 QLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706
Q++TAKQPMGL ++VE++IE GTL +MLDP V DWP EE L AKL+LQC+ELRRKDRPD
Sbjct: 644 QILTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDWPMEEALSLAKLSLQCAELRRKDRPD 703
Query: 707 LGKVVLPELNRLRELADESMGQTFFGGSLGPS 738
LGK +LPELNRLRE+ +ES+ F+ GS G S
Sbjct: 704 LGKEILPELNRLREIGEESLESVFYAGSQGKS 735
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9954729|gb|AAG09082.1|AC026237_3 Similar to protein kinases [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2384), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/785 (60%), Positives = 581/785 (74%), Gaps = 55/785 (7%)
Query: 1 MWQPKGNGVKKTGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSV 60
MW PK + KK NG +A+A+DKDKSSQ+A+KW +NL RGQT+ LIHV +
Sbjct: 1 MWLPKADATKKGTRNGSVAIAIDKDKSSQNAIKWTLENLATRGQTLALIHVLPK------ 54
Query: 61 SSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYV 120
SQS + T H++Q +KQ +DLF++F CYC+RK+I C DV+LEDVD VKAI EYV
Sbjct: 55 -SQSSLDIEEGIT--HKQQMEKQTKDLFVSFHCYCSRKEIHCLDVVLEDVDKVKAIVEYV 111
Query: 121 SFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPF 180
+ +AIE+LVLGAPSR+ F+R+FK D+P+SVSKAAPDFCN+YV+SKGKISS RNASR AP+
Sbjct: 112 TVSAIENLVLGAPSRNSFMRRFKTDLPTSVSKAAPDFCNVYVISKGKISSLRNASRLAPY 171
Query: 181 TSPLLDQLQSQNDISDTQSRYSMNL-----------RDRTSFKPRM--SFEESAKSPARG 227
+L ++ I+ + + N D T F +F S
Sbjct: 172 HPSVLSEVDDHETIAIERKHKTANTPALPKGRRSIDSDVTRFSSVSIENFRISYVYNFLN 231
Query: 228 RGFD-------------------------RKSFMDSSESD-TDISFVSSGRPSSDHSPSM 261
GFD SF+ +S+ + +D+SF+SSGRPS D S S
Sbjct: 232 LGFDFCRLGLPKPPHGHMKLMGDFSDSESEFSFISASQQESSDLSFISSGRPSVDRS-SF 290
Query: 262 HYEFVDVGRNSRISTSSEHSLGSFRLGLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDE 321
Y+ + R SR+STSSE S+GS RLG+++ D S SS+S +SG TSCS SSQ+L++
Sbjct: 291 TYDLPESARTSRMSTSSEQSIGSHRLGIKFTDLSYLNGSSSVSDESGRTSCSFSSQSLND 350
Query: 322 VEAEMRRLKLELKQTMDMYSTACKEALVAKQKALELQRWRLDEERRLEEARFAEETALSL 381
VEA+M+RL+LELKQTMDMYS+AC+EAL A+ +A ELQ+ R +EERRLEE + EETA+S+
Sbjct: 351 VEAQMKRLRLELKQTMDMYSSACREALTARNEATELQKLRTEEERRLEELKMTEETAMSI 410
Query: 382 AEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRY 441
E ERA+ K A+EAAEAA R+AE+EA+RR+ AEM LKESD S +RYR+Y
Sbjct: 411 VENERAKAKTALEAAEAANRLAEVEAKRRVHAEMKVLKESDSFSRHSI------VRYRKY 464
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLS 501
++++IEE T F ESRK+GEGGYGPV++ +LDHT VAVKVLRPDAAQGRSQF +E+EVLS
Sbjct: 465 SVQEIEEGTANFAESRKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFHKEVEVLS 524
Query: 502 CIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLL 561
CIRHPNMVLLLGACPEYGI+VYEY+A GSLDDR+FRRGNTPP+SWQ RFRIAAEIATGLL
Sbjct: 525 CIRHPNMVLLLGACPEYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAAEIATGLL 584
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
FLHQTKPEP+VHRDLKPGN+LLDHNYVSKISDVGLARLVPAVAENVTQY +TS AGTFCY
Sbjct: 585 FLHQTKPEPIVHRDLKPGNVLLDHNYVSKISDVGLARLVPAVAENVTQYRVTSAAGTFCY 644
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681
IDPEYQQTGMLGVKSDVYSLGI+LLQL+TAKQPMGL ++VE++IE GTL +MLDP V DW
Sbjct: 645 IDPEYQQTGMLGVKSDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDW 704
Query: 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFFGGSLGPSSKS 741
P EE L AKL+LQC+ELRRKDRPDLGK V+PEL+RLRE+ +ES+ ++ G S S
Sbjct: 705 PLEEALSLAKLSLQCAELRRKDRPDLGKEVMPELSRLREIGEESLDSVYYAGQGRSSHPS 764
Query: 742 NASMT 746
S T
Sbjct: 765 QVSYT 769
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.933 | 0.963 | 0.554 | 3.3e-214 | |
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.698 | 0.692 | 0.581 | 5.3e-208 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.924 | 0.946 | 0.531 | 1.7e-192 | |
| TAIR|locus:2087610 | 780 | AT3G20200 [Arabidopsis thalian | 0.451 | 0.452 | 0.653 | 8.9e-182 | |
| TAIR|locus:2182613 | 731 | AT5G35380 [Arabidopsis thalian | 0.430 | 0.461 | 0.706 | 5.6e-180 | |
| TAIR|locus:2180677 | 703 | AT5G26150 [Arabidopsis thalian | 0.411 | 0.458 | 0.687 | 3.2e-149 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.406 | 0.453 | 0.708 | 2.9e-148 | |
| TAIR|locus:2007908 | 728 | AT1G17540 [Arabidopsis thalian | 0.437 | 0.469 | 0.594 | 4.4e-145 | |
| TAIR|locus:2030245 | 697 | AT1G72760 [Arabidopsis thalian | 0.400 | 0.449 | 0.648 | 8e-144 | |
| TAIR|locus:2063601 | 700 | AT2G07020 [Arabidopsis thalian | 0.693 | 0.774 | 0.496 | 1.1e-128 |
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2070 (733.7 bits), Expect = 3.3e-214, P = 3.3e-214
Identities = 421/759 (55%), Positives = 525/759 (69%)
Query: 1 MWQPXXXXXXXXXXXXLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTXXXXX 60
MW P +A+A+DKDKSSQ+A+KW +NL RGQT+ LIHV ++
Sbjct: 1 MWLPKADATKKGTRNGSVAIAIDKDKSSQNAIKWTLENLATRGQTLALIHVLPKSQSSLD 60
Query: 61 XXXXXXYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYV 120
+ T H++Q +KQ +DLF++F CYC+RK+I C DV+LEDVD VKAI EYV
Sbjct: 61 I------EEGIT---HKQQMEKQTKDLFVSFHCYCSRKEIHCLDVVLEDVDKVKAIVEYV 111
Query: 121 SFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPF 180
+ +AIE+LVLGAPSR+ F+R+FK D+P+SVSKAAPDFCN+YV+SKGKISS RNASR AP+
Sbjct: 112 TVSAIENLVLGAPSRNSFMRRFKTDLPTSVSKAAPDFCNVYVISKGKISSLRNASRLAPY 171
Query: 181 TSPLLDQLQSQNDISDTQSRYSMNL----RDRTSFKPRMSFEESAKSP-----ARGRGFD 231
+L ++ I+ + + N + R S ++ K P G D
Sbjct: 172 HPSVLSEVDDHETIAIERKHKTANTPALPKGRRSIDSDVTRLGLPKPPHGHMKLMGDFSD 231
Query: 232 RKS---FMDSSESDT-DISFVXXXXXXXXXXXXMHYEFVDVGRNSRISTSSEHSLGSFRL 287
+S F+ +S+ ++ D+SF+ Y+ + R SR+STSSE S+GS RL
Sbjct: 232 SESEFSFISASQQESSDLSFISSGRPSVDRSSFT-YDLPESARTSRMSTSSEQSIGSHRL 290
Query: 288 GLRYNDRSSPYDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACKEA 347
G+++ D S SS+S +SG TSCS SSQ+L++VEA+M+RL+LELKQTMDMYS+AC+EA
Sbjct: 291 GIKFTDLSYLNGSSSVSDESGRTSCSFSSQSLNDVEAQMKRLRLELKQTMDMYSSACREA 350
Query: 348 LVAKQKAXXXXXXXXXXXXXXXXXXXXXXXXXSLXXXXXXXXXXXXXXXXXXXXXXXXXX 407
L A+ +A S+
Sbjct: 351 LTARNEATELQKLRTEEERRLEELKMTEETAMSIVENERAKAKTALEAAEAANRLAEVEA 410
Query: 408 QRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPV 467
+RR+ AEM LKESD S +RYR+Y++++IEE T F ESRK+GEGGYGPV
Sbjct: 411 KRRVHAEMKVLKESDSFSRHSI------VRYRKYSVQEIEEGTANFAESRKVGEGGYGPV 464
Query: 468 YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLA 527
++ +LDHT VAVKVLRPDAAQGRSQF +E+EVLSCIRHPNMVLLLGACPEYGI+VYEY+A
Sbjct: 465 FRGHLDHTSVAVKVLRPDAAQGRSQFHKEVEVLSCIRHPNMVLLLGACPEYGILVYEYMA 524
Query: 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587
GSLDDR+FRRGNTPP+SWQ RFRIAAEIATGLLFLHQTKPEP+VHRDLKPGN+LLDHNY
Sbjct: 525 RGSLDDRLFRRGNTPPISWQLRFRIAAEIATGLLFLHQTKPEPIVHRDLKPGNVLLDHNY 584
Query: 588 VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQ 647
VSKISDVGLARLVPAVAENVTQY +TS AGTFCYIDPEYQQTGMLGVKSDVYSLGI+LLQ
Sbjct: 585 VSKISDVGLARLVPAVAENVTQYRVTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQ 644
Query: 648 LITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707
L+TAKQPMGL ++VE++IE GTL +MLDP V DWP EE L AKL+LQC+ELRRKDRPDL
Sbjct: 645 LLTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDWPLEEALSLAKLSLQCAELRRKDRPDL 704
Query: 708 GKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNASMT 746
GK V+PEL+RLRE+ +ES+ ++ G S S S T
Sbjct: 705 GKEVMPELSRLREIGEESLDSVYYAGQGRSSHPSQVSYT 743
|
|
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1540 (547.2 bits), Expect = 5.3e-208, Sum P(2) = 5.3e-208
Identities = 324/557 (58%), Positives = 386/557 (69%)
Query: 196 DTQSRYSMNLRDRTSFKPRMSFEESAKSPARGRGFDRKSFMDSSESDTDISFVXXXXXXX 255
+ Q R SM + R S + ES +SP RG R S+ D + ++DISF+
Sbjct: 228 EDQQRRSMEDQQRRSIDDQ---SESFRSPFTRRGNGR-SYGDLTVPESDISFISSGRPSI 283
Query: 256 XXXXXMHYEFVDVGRNS-RISTSSEHSLGS-FRLGLRYNDRSSPYDLSSISQDSGATSCS 313
Y+ D R R+S S+ S Y RS D++S + D + S
Sbjct: 284 DRIFPSLYDNNDPSRTPPRLSNFSDMDYSSSLDQSSNYGRRS--VDMNSPT-DFESERFS 340
Query: 314 CSSQNLDEVEAEMRRLKLELKQTMDMYSTACKEALVAKQKAXXXXXXXXXXXXXXXXXXX 373
+SQ++D+VEAEMRRLKLELKQTM+MYSTACKEAL AKQKA
Sbjct: 341 SASQSIDDVEAEMRRLKLELKQTMEMYSTACKEALTAKQKATELQRWKLEEERKLEEARN 400
Query: 374 XXXXXXSLXXXXXXXXXXXXXXXXXXXXXXXXXXQRRLSAEMNRLKESDEVKIASSNLST 433
++ ++R++AEM LKES+E A + L+
Sbjct: 401 AEEAALAIAEKEKAKSKAAMEAAEAAQRIAELEAKKRVNAEMKALKESEEKTKALTALAN 460
Query: 434 KDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQF 493
D+RYR+Y+IEDIE AT+FF E KIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQF
Sbjct: 461 SDVRYRKYSIEDIELATEFFAEKYKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQF 520
Query: 494 QREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIA 553
Q+E+EVLSCIRHPNMVLLLGACPE G +VYE++ANGSL+DR+FR GN+PPLSWQ RFRIA
Sbjct: 521 QQEVEVLSCIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRLGNSPPLSWQMRFRIA 580
Query: 554 AEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP-AVAENVTQYHL 612
AEI TGLLFLHQ KPEPLVHRDLKPGNILLD N+VSKISDVGLARLVP VA+ VTQY +
Sbjct: 581 AEIGTGLLFLHQAKPEPLVHRDLKPGNILLDRNFVSKISDVGLARLVPPTVADTVTQYRM 640
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGE 672
TSTAGTFCYIDPEYQQTGMLGVKSD+YSLGI+ LQLITAK PMGLTH+VER++E GTL +
Sbjct: 641 TSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITAKPPMGLTHYVERALEKGTLVD 700
Query: 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFFG 732
+LDP V+DWP E+T FAKLAL+C+ELRRKDRPDL KV+LPELNRLR LADES G
Sbjct: 701 LLDPVVSDWPMEDTEEFAKLALKCAELRRKDRPDLAKVILPELNRLRTLADESSHSVVVG 760
Query: 733 GSLGPS-SKSNASMTMQ 748
S PS + S +S+ ++
Sbjct: 761 NSPLPSPTGSQSSLKLE 777
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1865 (661.6 bits), Expect = 1.7e-192, P = 1.7e-192
Identities = 398/749 (53%), Positives = 498/749 (66%)
Query: 17 LIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTXXXXXXXXXXXYDASATT--N 74
L+AVA+D+DK+SQ ALKWA DNLL +GQTVVL+HV R ++S T+ N
Sbjct: 17 LVAVAIDRDKNSQGALKWAVDNLLQKGQTVVLVHVKPRASSLSTNPSINS-NSSKTSQIN 75
Query: 75 PHQK----QPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVL 130
+P+ + LFL FRC C+RKDI+C DVLLE+ D+ +A+ EY + IE LV+
Sbjct: 76 GDSSLVCGEPEGSYKQLFLPFRCLCSRKDIQCKDVLLEESDVARALVEYANQVMIEVLVV 135
Query: 131 GAPSRHGFIRKFKA-DVPSSVSKAAPDFCNIYVVSKGKISSKRNASRSAPFTSPLLDQLQ 189
G+ S+ GF+R K D+P +++K APDFC +Y ++KGK+S+K+ ASR+AP SPL QLQ
Sbjct: 136 GSSSKGGFLRFNKPIDIPGAITKTAPDFCTVYAITKGKLSTKKTASRAAPSVSPLRIQLQ 195
Query: 190 SQNDISDTQSRYSM--NLR-DRTSFKP--RMSFEESAKS---PARGRGFDRKSFMDSSES 241
QN + S N R +R SF+ R S ++ + S P RG +S+ + S
Sbjct: 196 -QNGLKPHPPLPSATTNTRAERQSFESQHRRSLDDQSDSFRPPYNKRGLTGRSYGELSIP 254
Query: 242 DTDISFVXXXXXXXXXXXXMHYEFVDVGRNS-RISTSSEHSLGSFR---LGLRYNDRSSP 297
D++ISF Y+ D R R+S S+ SF G R D SSP
Sbjct: 255 DSEISFNSSGRPSIERNSPSLYDNSDPNRTPPRLSNFSDVDYCSFESMTFGRRSMDLSSP 314
Query: 298 YDLSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACKEALVAKQKAXXX 357
S+ S ++ S +SQ D+VEAEMRRLKLELKQTM+MYSTACKEAL AK KA
Sbjct: 315 TAFSTGSFEN--ERFSSASQGGDDVEAEMRRLKLELKQTMEMYSTACKEALTAKHKATEL 372
Query: 358 XXXXXXXXXXXXXXXXXXXXXXSLXXXXXXXXXXXXXXXXXXXXXXXXXXQRRLSAEMNR 417
++ ++R+ AE
Sbjct: 373 QRWKLAEERKFEEAKLAEEAALAIAEKEKAKSKAAMEAAEAAQRIADIESRKRVDAETKA 432
Query: 418 LKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV 477
LKES E + + N KD+RYR+Y+IE+IE+AT+FF + KIGEG YGPVYKCYLDHTPV
Sbjct: 433 LKES-EARTKAVNALAKDVRYRKYSIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPV 491
Query: 478 AVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFR 537
AVK LRPDAAQGRSQFQ+E+EVL IRHPNMVLLLGACPE G +VYE++ANGSL+DR+FR
Sbjct: 492 AVKALRPDAAQGRSQFQKEVEVLCSIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFR 551
Query: 538 RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597
+G++P LSWQ RFRIAAEI T LLFLHQTKPEPLVHRDLKP NILLD N+VSK++DVGLA
Sbjct: 552 QGDSPALSWQTRFRIAAEIGTVLLFLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLA 611
Query: 598 RLVP-AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMG 656
RLVP +VA VTQYH+TSTAGTFCYIDPEYQQTGMLGVKSD+YSLGI+ LQLIT K PMG
Sbjct: 612 RLVPPSVANTVTQYHMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMG 671
Query: 657 LTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716
LTH+VER++E G L ++LDP V+DWP E+T FAKLAL+C+E+RRKDRPDL KV+LPELN
Sbjct: 672 LTHYVERALEKGNLKDLLDPAVSDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELN 731
Query: 717 RLRELADESMGQTFFGGSLGPS-SKSNAS 744
RLR LA+ES S GP+ ++S S
Sbjct: 732 RLRVLAEESTQAAVVINSSGPTPTESQTS 760
|
|
| TAIR|locus:2087610 AT3G20200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1217 (433.5 bits), Expect = 8.9e-182, Sum P(2) = 8.9e-182
Identities = 232/355 (65%), Positives = 279/355 (78%)
Query: 427 ASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA 486
A+ + S LRYRRY I +IEEAT F ++ KIGEGGYGPVYK YLDHTPVA+K L+ DA
Sbjct: 427 AAGSFSDSSLRYRRYVIGEIEEATNSFDKANKIGEGGYGPVYKGYLDHTPVAIKALKADA 486
Query: 487 AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSW 546
QGRSQFQRE+EVLSCIRHP+MVLL+GACPEYG++VYEY+A GSL DR+++ GNTPPLSW
Sbjct: 487 VQGRSQFQREVEVLSCIRHPHMVLLIGACPEYGVLVYEYMAKGSLADRLYKYGNTPPLSW 546
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606
+ RFRIAAE+ATGLLFLHQTKPEP+VHRDLKPGNIL+D NYVSKI DVGLA+LVPAVAEN
Sbjct: 547 ELRFRIAAEVATGLLFLHQTKPEPIVHRDLKPGNILIDQNYVSKIGDVGLAKLVPAVAEN 606
Query: 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE 666
VTQ H++STAGTFCYIDPEYQQTGMLGVKSDVYS GILLL+L+TAK+P GL + VE+++E
Sbjct: 607 VTQCHVSSTAGTFCYIDPEYQQTGMLGVKSDVYSFGILLLELLTAKRPTGLAYTVEQAME 666
Query: 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESM 726
G +MLDP V +WP EE + AK+AL+C++LRRKDRPDLGK VLPELN+LR AD +M
Sbjct: 667 QGKFKDMLDPAVPNWPVEEAMSLAKIALKCAQLRRKDRPDLGKEVLPELNKLRARADTNM 726
Query: 727 GQTFFGGSLGPSSKSNASMTMQDVLSDPQPWNXXXXXXXXXXXXHLEKPSEQPEE 781
F S G + +++ +++ V D EK S+Q EE
Sbjct: 727 EWMMFNLSRGRLTPNHSQVSLPPV--DELSVCSDKSYTHSSTVSDTEKNSDQNEE 779
|
|
| TAIR|locus:2182613 AT5G35380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1248 (444.4 bits), Expect = 5.6e-180, Sum P(2) = 5.6e-180
Identities = 246/348 (70%), Positives = 289/348 (83%)
Query: 411 LSAEMNRLKES-DEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYK 469
L AE + E+ DE K A S+L RYR+YTIE+IEEAT+ F+ SRK+GEGGYGPVYK
Sbjct: 376 LEAEKRKHIETVDEKKRAVSSL-----RYRKYTIEEIEEATEDFSPSRKVGEGGYGPVYK 430
Query: 470 CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANG 529
LD+T VA+KVLRPDAAQGRSQFQRE+EVL+C+RHPNMVLLLGACPEYG +VYEY+ANG
Sbjct: 431 GTLDYTKVAIKVLRPDAAQGRSQFQREVEVLTCMRHPNMVLLLGACPEYGCLVYEYMANG 490
Query: 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589
SLDD +FRRGN+P LSWQ RFRIA+EIATGL FLHQ KPEPLVHRDLKPGNILLD ++VS
Sbjct: 491 SLDDCLFRRGNSPILSWQLRFRIASEIATGLHFLHQMKPEPLVHRDLKPGNILLDQHFVS 550
Query: 590 KISDVGLARLVP-AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQL 648
KISDVGLARLVP +VA+ TQY +TSTAGTF YIDPEYQQTGMLG KSD+YS GI+LLQ+
Sbjct: 551 KISDVGLARLVPPSVADTATQYRMTSTAGTFFYIDPEYQQTGMLGTKSDIYSFGIMLLQI 610
Query: 649 ITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLG 708
+TAK PMGLTH VE++IE GT EMLDP V DWPFEE L AKLALQC++LRRKDRPDLG
Sbjct: 611 LTAKPPMGLTHHVEKAIEKGTFAEMLDPAVPDWPFEEALAAAKLALQCAKLRRKDRPDLG 670
Query: 709 KVVLPELNRLRELADESMGQTFFG-GSLGPSSKSNASMTMQDVLSDPQ 755
+VLPEL +LR+LA+ES+ FG P S ++ ++Q+++SDPQ
Sbjct: 671 NIVLPELKKLRDLAEESIK---FGVRQPSPIRSSGSATSIQEIISDPQ 715
|
|
| TAIR|locus:2180677 AT5G26150 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1167 (415.9 bits), Expect = 3.2e-149, Sum P(2) = 3.2e-149
Identities = 222/323 (68%), Positives = 261/323 (80%)
Query: 408 QRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPV 467
QRR AEM + E + A S L+ D+RYR+Y+IE+IEEAT+ F RKIGEGGYGPV
Sbjct: 377 QRRKQAEMKAVSEEKDKDRAVSALAHNDVRYRKYSIEEIEEATERFANHRKIGEGGYGPV 436
Query: 468 YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLA 527
Y LDHTPVA+KVLRPDAAQG+ QFQ+E+EVL IRHP+MVLLLGACPEYG +VYE++
Sbjct: 437 YNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMVLLLGACPEYGCLVYEFME 496
Query: 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587
NGSL+DR+FR GN+PPLSW++RF IAAEIAT L FLHQ KPEPLVHRDLKP NILLD NY
Sbjct: 497 NGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPEPLVHRDLKPANILLDKNY 556
Query: 588 VSKISDVGLARLVPA-VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 646
VSKISDVGLARLVPA +A++VTQ+H+TS AGTFCYIDPEYQQTGML KSDVYSLGILLL
Sbjct: 557 VSKISDVGLARLVPASIADSVTQFHMTSAAGTFCYIDPEYQQTGMLTTKSDVYSLGILLL 616
Query: 647 QLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706
Q+IT + PMGL H V R+I GT EMLDP V DWP +E FA LAL+C+ELR++DRPD
Sbjct: 617 QIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQSFATLALKCAELRKRDRPD 676
Query: 707 LGKVVLPELNRLRELADESMGQT 729
LGK V+P L RL+ ++ +T
Sbjct: 677 LGKEVVPHLIRLKNFGNDGDERT 699
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1192 (424.7 bits), Expect = 2.9e-148, Sum P(2) = 2.9e-148
Identities = 226/319 (70%), Positives = 264/319 (82%)
Query: 408 QRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPV 467
QRR AEM +ES E A S L D+RYR+Y+I++IE AT+ F +RKIGEGGYGPV
Sbjct: 377 QRRKQAEMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFANNRKIGEGGYGPV 436
Query: 468 YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLA 527
Y LDHTPVA+KVLRPDAAQG+ QFQ+E+EVLS IRHP+MVLLLGACPEYG +VYE++
Sbjct: 437 YHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGCLVYEFMD 496
Query: 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587
NGSL+DR+FRRGN+PPLSW++RF+IAAEIAT L FLHQ KPEPLVHRDLKP NILLD NY
Sbjct: 497 NGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPANILLDKNY 556
Query: 588 VSKISDVGLARLVPA-VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 646
VSKISDVGLARLVPA VA VTQYH+TS AGTFCYIDPEYQQTG L KSD++SLGI+LL
Sbjct: 557 VSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIFSLGIMLL 616
Query: 647 QLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706
Q+ITAK PMGL H V R+I+ GT +MLDP V DWP EE L FAKL L+C+ELR++DRPD
Sbjct: 617 QIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLRCAELRKRDRPD 676
Query: 707 LGKVVLPELNRLRELADES 725
LGK ++PEL RLR L ++
Sbjct: 677 LGKEIVPELLRLRNLGKDN 695
|
|
| TAIR|locus:2007908 AT1G17540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 4.4e-145, Sum P(3) = 4.4e-145
Identities = 210/353 (59%), Positives = 268/353 (75%)
Query: 411 LSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKC 470
+ + RL E + + N++ + YRRY+I D+E AT F+++ KIGEGGYGPVYK
Sbjct: 369 IETQKRRLVEM-QARFKEQNMADS-ISYRRYSIRDVEGATDGFSDALKIGEGGYGPVYKA 426
Query: 471 YLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGS 530
L++T VA+K+L+ D +QG QF +EIEVLSC+RHPNMV+LLGACPEYG +VYEY+ NG+
Sbjct: 427 VLENTSVAIKLLKSDVSQGLKQFNQEIEVLSCMRHPNMVILLGACPEYGCLVYEYMENGT 486
Query: 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSK 590
L+DR+F + NTPPLSW+ RFRIAAEIATGLLFLHQ KPEPLVHRDLKP NIL+D ++ SK
Sbjct: 487 LEDRLFCKDNTPPLSWRARFRIAAEIATGLLFLHQAKPEPLVHRDLKPANILIDRHFTSK 546
Query: 591 ISDVGLARLVPA-VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLI 649
ISDVGLARLVPA VA++ + YH+T+ AGTFCYIDPEYQQTGMLGVKSD+YS G++LLQ+I
Sbjct: 547 ISDVGLARLVPAAVADSFSNYHMTAAAGTFCYIDPEYQQTGMLGVKSDLYSFGVVLLQII 606
Query: 650 TAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGK 709
TA MGL+H VE++IE L E+LDP ++DWP EET+ A+LALQC ELR+KDRPDL
Sbjct: 607 TAMPAMGLSHRVEKAIEKKKLREVLDPKISDWPEEETMVLAQLALQCCELRKKDRPDLAS 666
Query: 710 VVLPELNRLRELADE-----SMGQTFF---GGSLGPSSKSNASMTMQDVLSDP 754
V+LP L++LRE A E + +TF +L P S ++ T D +P
Sbjct: 667 VLLPALSKLREFATEDHEVHNSDRTFHVSRAHNLVPLSPISSCQTEDDAWENP 719
|
|
| TAIR|locus:2030245 AT1G72760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 8.0e-144, Sum P(3) = 8.0e-144
Identities = 205/316 (64%), Positives = 253/316 (80%)
Query: 410 RLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYK 469
++ ++ RL E + + + T + YRRY+I+D+E+AT F+++ KIGEGGYGPVYK
Sbjct: 341 KMESQKRRLLEM-QANLDKQMMFTT-VSYRRYSIKDVEDATYGFSDALKIGEGGYGPVYK 398
Query: 470 CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANG 529
LD+T VA+K+L+ +G QFQ+EIEVLS +RHPNMV+LLGACPEYG +VYEY+ NG
Sbjct: 399 AVLDYTSVAIKILKSGITEGLKQFQQEIEVLSSMRHPNMVILLGACPEYGCLVYEYMENG 458
Query: 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589
+L+DR+F + NTPPLSW+ RFRIA+EIATGLLFLHQ KPEPLVHRDLKP NILLD +
Sbjct: 459 TLEDRLFCKNNTPPLSWRARFRIASEIATGLLFLHQAKPEPLVHRDLKPANILLDKHLTC 518
Query: 590 KISDVGLARLVP-AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQL 648
KISDVGLARLVP AVA+ + YH+TS AGTFCYIDPEYQQTGMLGVKSD+YS G++LLQ+
Sbjct: 519 KISDVGLARLVPPAVADTYSNYHMTSAAGTFCYIDPEYQQTGMLGVKSDLYSFGVVLLQI 578
Query: 649 ITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLG 708
ITA+ MGL H VE ++EN L E+LDPTV++WP EETL AKLALQC ELR+KDRPDL
Sbjct: 579 ITAQPAMGLGHKVEMAVENNNLREILDPTVSEWPEEETLELAKLALQCCELRKKDRPDLA 638
Query: 709 KVVLPELNRLRELADE 724
V+LP LNRL+E A E
Sbjct: 639 LVLLPALNRLKEFATE 654
|
|
| TAIR|locus:2063601 AT2G07020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1263 (449.7 bits), Expect = 1.1e-128, P = 1.1e-128
Identities = 280/564 (49%), Positives = 352/564 (62%)
Query: 171 KRNASRSAPFTSPLLDQLQSQ---NDISDTQSRYSMNLRDRTSFKPRMSFEESAKSPARG 227
K ++ RSA + P L ++ Q + + +S + R + E KSP
Sbjct: 150 KISSVRSATSSPPPLCTIRPQLPARSSNANNNNFSPRAQRRLQSVQSIQDEIEIKSPYLR 209
Query: 228 RGFDRKSFMDSSESDTDISFVXXXXXXXXXXXXMHYEFVDVGRNSRISTSSEHSLGSFRL 287
+ +D+ ++ + SD+D+SFV M + F D R++ ++SS S
Sbjct: 210 KEYDQGTYQ-ALVSDSDLSFVSSDRPS------MDW-FED-NRSNYATSSSSSEKQSI-- 258
Query: 288 GLRYNDRSSPYD-LSSISQDSGATSCSCSSQNLDEVEAEMRRLKLELKQTMDMYSTACKE 346
D S Y S+ SQ+SG S S S + D+VE+EMRRLKLELK TMDMY++ACKE
Sbjct: 259 -----DLCSSYSAFSTSSQESGRLS-SLSMYSQDDVESEMRRLKLELKYTMDMYNSACKE 312
Query: 347 ALVAKQKAXXXXXXXXXXXXXXXXXXXXXXXXXSLXXXXXXXXXXXXXXXXXXXXXXXXX 406
A+ AK+ ++
Sbjct: 313 AIAAKKTTIELHKWKEERKHKLEEAILAKEAAMAIAENEKAKSRAAMEALEAAHRMAETE 372
Query: 407 XQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGP 466
Q+R E L+E + A L + YR+YTIE+IE+ T F++S KIGEG YG
Sbjct: 373 AQKRKQIETAALREVEHENKAMHALPHSNRMYRKYTIEEIEQGTTKFSDSHKIGEGSYGT 432
Query: 467 VYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYL 526
VYK LD+TPVA+KV+RPDA QGRSQFQ+E+EVL+CIRHPNMVLLLGAC EYG +VYEY+
Sbjct: 433 VYKGTLDYTPVAIKVVRPDATQGRSQFQQEVEVLTCIRHPNMVLLLGACAEYGCLVYEYM 492
Query: 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586
+NGSLDD + RRGN+P LSWQ RFRIAAEIAT L FLHQ KPEPLVHRDLKP NILLD +
Sbjct: 493 SNGSLDDCLLRRGNSPVLSWQLRFRIAAEIATSLNFLHQLKPEPLVHRDLKPANILLDQH 552
Query: 587 YVSKISDVGLARLVPAVAENV-TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
VSKISDVGLARLVP +++ T Y +TSTAGT CYIDPEYQQTGMLG KSD+YS GI+L
Sbjct: 553 MVSKISDVGLARLVPPTIDDIATHYRMTSTAGTLCYIDPEYQQTGMLGTKSDIYSFGIVL 612
Query: 646 LQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705
LQ++TAK PMGLT+ VE++IE G ++LDP VTDWP EE L AK+ LQC+ELRRKDRP
Sbjct: 613 LQILTAKTPMGLTNQVEKAIEEGNFAKILDPLVTDWPIEEALILAKIGLQCAELRRKDRP 672
Query: 706 DLGKVVLPELNRLRELADESMGQT 729
DLG VVLP L RL LA+E+M T
Sbjct: 673 DLGTVVLPGLKRLMNLAEENMSIT 696
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh1_pm.C_scaffold_1001429 | annotation not avaliable (757 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 782 | |||
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 8e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 4e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| pfam13868 | 349 | pfam13868, Trichoplein, Tumour suppressor, Mitosta | 0.001 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 0.001 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| COG2268 | 548 | COG2268, COG2268, Uncharacterized protein conserve | 0.004 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 0.004 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 8e-59
Identities = 76/151 (50%), Positives = 107/151 (70%), Gaps = 6/151 (3%)
Query: 17 LIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPH 76
+AVAVDKDK S++ALKWA DNL +GQT+VL+HV ++S+ S S + ++ +
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPP--ITSIPSSSGKLEVASA---Y 55
Query: 77 QKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRH 136
+++ DK+ ++L L +RC+C+RK ++C DV+LED D+ KAI EYV+ I LV+GA S +
Sbjct: 56 KQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDN 115
Query: 137 GFIRKFK-ADVPSSVSKAAPDFCNIYVVSKG 166
F KFK +DV SSV K APDFC +YVVSKG
Sbjct: 116 HFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-47
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 459 IGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGAC 515
+GEGG+G VY VA+K+++ + + + REIE+L + HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 516 --PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ +V EY GSL D + N LS + RI +I GL +LH ++H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 574 RDLKPGNILLDH-NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-YQQTGM 631
RDLKP NILLD N K++D GL++L+ + L + GT Y+ PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL-----TSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 632 LGVKSDVYSLGILLLQLITAKQ 653
KSD++SLG++L +L K
Sbjct: 171 YSEKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 74/236 (31%), Positives = 110/236 (46%), Gaps = 22/236 (9%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLG 513
K+GEG +G VY VA+KV++ + R + REI++L ++HPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 514 AC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ +V EY G L D + +RG LS + +I + L +LH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLHSKG---I 118
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
VHRDLKP NILLD + K++D GLAR + LT+ GT Y+ PE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLD------PGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 632 LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETL 687
G D++SLG++L +L+T K P F ++ P P E +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGKPKPPFPPPEWDI 223
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 80/209 (38%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNM 508
+ RK+G G +G VYK T VAVK+L+ + + +REI +L + HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 509 VLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
V L+ A ++ +V EY G L D + R G PLS + +IA +I GL +LH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS- 116
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE- 625
++HRDLKP NILLD N V KI+D GLA+ + + LT+ GT Y+ PE
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKL-----LKSSSSLTTFVGTPWYMAPEV 169
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
G K DV+SLG++L +L+T K P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 89/265 (33%), Positives = 121/265 (45%), Gaps = 31/265 (11%)
Query: 454 TESRKIGEGGYGPVYKCYLDHTP------VAVKVLRPDA-AQGRSQFQREIEVLSCIRHP 506
T +K+GEG +G VYK L VAVK L+ DA Q +F RE ++ + HP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 507 NMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
N+V LLG C E IV EY+ G L + R N P LS A +IA G+ +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLS--YLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ +HRDL N L+ N V KISD GL+R + + Y ++ P
Sbjct: 120 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL----YDDDYYRKRGGKLPIRWMAP 172
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLIT-AKQP---MGLTHFVERSIENGTLGEMLDPTVTD 680
E + G KSDV+S G+LL ++ T +QP M +E ++N G L
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY-LKN---GYRLPQ---- 224
Query: 681 WPFEETLGFAKLALQCSELRRKDRP 705
P L LQC +DRP
Sbjct: 225 -PPNCPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 4e-43
Identities = 78/227 (34%), Positives = 114/227 (50%), Gaps = 26/227 (11%)
Query: 457 RKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMV 509
+K+GEG +G VYK L T VAVK L+ A+ + R +F E ++ + HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 510 LLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
LLG C + IV EY+ G L D F R + L+ + ++A +IA G+ +L
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTF--CYIDPE 625
VHRDL N L+ N V KISD GL+R + Y+ G ++ PE
Sbjct: 123 ---FVHRDLAARNCLVTENLVVKISDFGLSRDIYE-----DDYYRKRGGGKLPIKWMAPE 174
Query: 626 YQQTGMLGVKSDVYSLGILLLQLIT-AKQP---MGLTHFVERSIENG 668
+ G KSDV+S G+LL ++ T +QP M +E +E+G
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL-LEDG 220
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 77/216 (35%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 457 RKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVL 510
+K+GEG +G VYK L T VAVK L+ DA + R F +E V+ + HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 511 LLGACPEYG--IIVYEYLANGSLDD------RIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
LLG C E +V EY+ G L D +F LS + A +IA G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
L + VHRDL N L+ + V KISD GL+R V Y+ T G I
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV-----YDDDYYRKKTGGKL-PI 171
Query: 623 D---PEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
PE + G+ KSDV+S G+LL ++ T P
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 86/265 (32%), Positives = 122/265 (46%), Gaps = 30/265 (11%)
Query: 454 TESRKIGEGGYGPVYKCYLD------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHP 506
T +K+GEG +G VYK L VAVK L+ DA Q +F RE ++ + HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 507 NMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
N+V LLG C E +IV EY+ G L D + + LS A +IA G+ +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE 120
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ +HRDL N L+ N V KISD GL+R + + Y + ++ P
Sbjct: 121 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL----YDDDYYKVKGGKLPIRWMAP 173
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLIT-AKQP---MGLTHFVERSIENGTLGEMLDPTVTD 680
E + G KSDV+S G+LL ++ T ++P M +E ++ G L
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY-LKK---GYRLPK---- 225
Query: 681 WPFEETLGFAKLALQCSELRRKDRP 705
P KL LQC +DRP
Sbjct: 226 -PPNCPPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 72/248 (29%), Positives = 115/248 (46%), Gaps = 18/248 (7%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
F KIG+GG+G VYK VA+KV++ ++ + + + EI++L +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 511 LLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
G+ + IV E+ + GSL D + + L+ Q + E+ GL +LH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRD+K NILL + K+ D GL+ +L A N + GT ++ PE
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-------TMVGTPYWMAPEVI 169
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETL 687
K+D++SLGI ++L K P ++ + T G W +E
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWS-DEFK 228
Query: 688 GFAKLALQ 695
F K LQ
Sbjct: 229 DFLKKCLQ 236
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-34
Identities = 89/343 (25%), Positives = 137/343 (39%), Gaps = 23/343 (6%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRS---QFQREIEVLSCIRHPNMV 509
+ RK+GEG +G VY D VA+KVL +F REI++L+ + HP +
Sbjct: 2 YRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 510 ---LLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
+V EY+ GSL+D + + G PLS + I A+I + L +LH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS- 119
Query: 567 KPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVPAVAENVTQYHLTSTA-GTFCYIDP 624
+ ++HRD+KP NILLD + V K+ D GLA+L+P + L ST+ GT Y+ P
Sbjct: 120 --KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 625 EY---QQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF------VERSIENGTLGEMLD 675
E SD++SLGI L +L+T P + I +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFFGGSL 735
P P + + L + K+R + +L +L + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 736 GPSSKSNASMTMQDV--LSDPQPWNSESLKSQSGSSSHLEKPS 776
P S + L+ S+ S S L
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNG 340
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 9e-34
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLR--PDAAQGRSQFQREIEVLSCIRHPNM 508
+T +G G +G VY T +AVK + D+ + +REI +LS ++HPN+
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 509 VLLLGAC--PEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFL 563
V G+ E I EY++ GSL + + G P R +I GL +L
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE----PVIRKYTRQILEGLAYL 117
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
H +VHRD+K NIL+D + V K++D G A+ + + T S GT ++
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR---LGDIETGEGTGSVRGTPYWMA 171
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE + G +D++SLG ++++ T K P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 73/251 (29%), Positives = 114/251 (45%), Gaps = 42/251 (16%)
Query: 452 FFTESRKIGEGGYGPVYKCYLDHTP------VAVKVLRPDA-AQGRSQFQREIEVLSCIR 504
+++GEG +G V C D VAVK L Q RS F+REIE+L +
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 505 HPNMVLLLGACPEYGI----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
H N+V G C + G ++ EYL +GSL R + + + ++ ++ +++I G+
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG--- 617
+L + +HRDL NIL++ + KISD GLA+++P + Y+ G
Sbjct: 123 DYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD----YYYVKEPGESP 175
Query: 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT------------------AKQPMGLTH 659
F Y PE +T SDV+S G+ L +L T A+ M +T
Sbjct: 176 IFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234
Query: 660 FVERSIENGTL 670
+E E L
Sbjct: 235 LLELLKEGERL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 72/202 (35%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 457 RKIGEGGYGPVYK-CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
RK+G G +G V+ + T VAVK L+P F +E +++ +RH +V L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P Y IV EY++ GSL D + G L Q +AA+IA G+ +L
Sbjct: 71 SEEEPIY--IVTEYMSKGSLLD-FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---Y 124
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPA---VAENVTQYHLTSTAGTFCYIDPEYQQ 628
+HRDL NIL+ N V KI+D GLARL+ A ++ + TA PE
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA-------PEAAN 177
Query: 629 TGMLGVKSDVYSLGILLLQLIT 650
G +KSDV+S GILL +++T
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 458 KIGEGGYGPVYKCY--LDHTPVAVKVLR-PDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
+G+G G VYK A+K + + R Q RE++ L P +V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 515 CPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
+ G IV EY+ GSL D + + G P IA +I GL +LH + ++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHTKRH--II 122
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML 632
HRD+KP N+L++ KI+D G + V EN T GT Y+ PE Q
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFG----ISKVLENTLDQCNTFV-GTVTYMSPERIQGESY 177
Query: 633 GVKSDVYSLGILLLQLITAKQP 654
+D++SLG+ LL+ K P
Sbjct: 178 SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 453 FTESRKIGEGGYGPVYK-CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
FT RK+G G +G V++ + + VA+K+L+ D + FQ+E++ L +RH +++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 512 LGAC----PEYGIIVYEYLANGSLDDRIFRR---GNTPPLSWQQRFRIAAEIATGLLFLH 564
C P Y I+ E + GSL F R G P++ +A ++A G+ +L
Sbjct: 68 FAVCSVGEPVY--IITELMEKGSL--LAFLRSPEGQVLPVA--SLIDMACQVAEGMAYLE 121
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ +HRDL NIL+ + V K++D GLARL + E+V Y + + + P
Sbjct: 122 EQN---SIHRDLAARNILVGEDLVCKVADFGLARL---IKEDV--YLSSDKKIPYKWTAP 173
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQ 653
E G KSDV+S GILL ++ T Q
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 456 SRKIGEGGYGPVYKCY-LD-HTPVAVKVLRPDAAQGRS--QFQREIEVLSCIRHPNMVLL 511
KIG G +G VY LD +AVK +R ++ + E++VL ++HPN+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 512 LGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G E I EY + G+L++ + G + + ++ GL +LH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVY--TLQLLEGLAYLHSHG-- 119
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH--LTSTAGTFCYIDPEYQ 627
+VHRD+KP NI LDHN V K+ D G A + N T + S AGT Y+ PE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVK---LKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 628 QTGML---GVKSDVYSLGILLLQLITAKQP 654
G G +D++SLG ++L++ T K+P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 3e-26
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 457 RKIGEGGYGPVY--KCYLDHTPVAVKV--LRPDAAQGRSQFQREIEVLSCIRHPNMVLLL 512
++IG+G +G VY + D +K L + + R E+++L + HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII--- 62
Query: 513 GACPE------YGIIVYEYLANGSLDDRIFRRGNT-PPLSWQQRFRIAAEIATGLLFLHQ 565
E IV EY G L +I ++ P +Q ++ L +LH
Sbjct: 63 -KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
K ++HRD+KP NI L N + K+ D G+++++ + T + GT Y+ PE
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKTVVGTPYYLSPE 173
Query: 626 ------YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
Y KSD++SLG +L +L T K P
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 28/205 (13%)
Query: 457 RKIGEGGYGPVYK-CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
RK+G G +G V++ + + TPVAVK L+P F E +++ +RHP ++ L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P Y IV E + GSL + + L Q +AA++A+G+ +L +
Sbjct: 71 TLEEPIY--IVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEA---QNY 124
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV------TQYHLTSTAGTFCYIDPE 625
+HRDL N+L+ N + K++D GLAR+ + E++ ++ + TA PE
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARV---IKEDIYEAREGAKFPIKWTA-------PE 174
Query: 626 YQQTGMLGVKSDVYSLGILLLQLIT 650
+KSDV+S GILL +++T
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 78/246 (31%), Positives = 117/246 (47%), Gaps = 37/246 (15%)
Query: 457 RKIGEGGYGPVYK--CYL-----DHTPVAVKVLR-PDAAQGRSQFQREIEVLSCIRHPNM 508
R++GEG +G V+ CY D VAVK L+ + R F+RE E+L+ +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 509 VLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTP-------------PLSWQQRFRIA 553
V G C E I+V+EY+ +G L+ F R + P L+ Q +IA
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNK--FLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 554 AEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLT 613
+IA+G+++L VHRDL N L+ ++ V KI D G++R V T Y+
Sbjct: 129 VQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT-----TDYYRV 180
Query: 614 --STAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTL 670
T ++ PE +SDV+S G++L ++ T KQP E IE T
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEVIECITQ 239
Query: 671 GEMLDP 676
G +L
Sbjct: 240 GRLLQR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 30/210 (14%)
Query: 457 RKIGEGGYGPVYKCYLDHTP----VAVKVLR--PDAAQGRSQFQREIEVLSCIRHPNMVL 510
++G G G V K H P +AVK +R + A + Q RE+++L P +V
Sbjct: 7 GELGAGNSGVVSKVL--HRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVG 63
Query: 511 LLGACPEYG--IIVYEYLANGSLDD---RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
GA G I EY+ GSLD + R L +IA + GL +LH+
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCYIDP 624
++HRD+KP NIL++ K+ D G++ +LV ++A+ + GT Y+ P
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--------TFVGTSSYMAP 168
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E Q VKSD++SLG+ L++L T + P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVL--RPDAAQGRSQF-QREIEVLSCI-RHPNMVL 510
+ IGEG + V T A+K+L R + + ++ + E EVL+ + HP ++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 511 LLG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L E V EY NG L I + G+ L + AAEI L +LH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLHSKG- 122
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV-----------TQYHLTSTAG 617
++HRDLKP NILLD + KI+D G A+++ +
Sbjct: 123 --IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 618 TFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+F Y+ PE G SD+++LG ++ Q++T K P
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 83/268 (30%), Positives = 127/268 (47%), Gaps = 37/268 (13%)
Query: 457 RKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGA 514
KIG+G +G VYK L +T VAVK R + +F +E E+L HPN+V L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 515 C----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
C P Y IV E + GSL F R L+ ++ +++ + A G+ +L
Sbjct: 61 CVQKQPIY--IVMELVPGGSLLT--FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--- 113
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLAR----LVPAVAENVTQYHLTSTAGTFCYIDPEY 626
+HRDL N L+ N V KISD G++R + V++ + Q + TA PE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA-------PEA 166
Query: 627 QQTGMLGVKSDVYSLGILLLQLIT-AKQPM-GLTHFVERS-IENGTLGEMLDPTVT-DWP 682
G +SDV+S GILL + + P G+++ R IE+G M P + +
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG--YRMPAPQLCPEEI 224
Query: 683 FEETLGFAKLALQCSELRRKDRPDLGKV 710
+ +L LQC ++RP ++
Sbjct: 225 Y-------RLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 81/265 (30%), Positives = 120/265 (45%), Gaps = 42/265 (15%)
Query: 459 IGEGGYGPVYKCYLDHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACP 516
IG+G +G V VAVK L+ D AAQ F E V++ +RHPN+V LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 517 EYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
+ IV EY+A GSL D + RG ++ Q+ A ++ G+ +L + VHR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 575 DLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YIDPEYQQTGML 632
DL N+L+ + V+K+SD GLA+ + Q +G + PE +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQ-----DSGKLPVKWTAPEALREKKF 176
Query: 633 GVKSDVYSLGILLLQLIT-AKQP---MGLTHFVERSIENGTLGEMLD---PTVTDWPFEE 685
KSDV+S GILL ++ + + P + L V +E G E + P V
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH-VEKGYRMEAPEGCPPEVY------ 229
Query: 686 TLGFAKLALQCSELRRKDRPDLGKV 710
K+ C EL RP ++
Sbjct: 230 -----KVMKDCWELDPAKRPTFKQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 457 RKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNM 508
R++G+G +G VY+ T VA+K + +A+ R +F E V+ ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 509 VLLLGAC----PEYGIIVYEYLANGSL---------DDRIFRRGNTPPLSWQQRFRIAAE 555
V LLG P +V E +A G L + P L Q+ ++AAE
Sbjct: 72 VRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL--QKFIQMAAE 127
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
IA G+ +L K VHRDL N ++ + KI D G+ R + T Y+
Sbjct: 128 IADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGG 179
Query: 616 AGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTH 659
G ++ PE + G+ KSDV+S G++L ++ T A+QP GL++
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRP--DAAQGRSQFQREIEVLSCIRHPNM 508
+ IG G +G VYK T VA+K + + +EI++L ++HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 509 VLLLGACP--EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
V +G+ + I+ EY NGSL I + G P ++ GL +LH+
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHE- 117
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
+ ++HRD+K NIL + V K++D G+A + V+++ S GT ++ PE
Sbjct: 118 --QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-----DASVVGTPYWMAPEV 170
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ SD++SLG +++L+T P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA- 514
+IG G YG VYK T VA+KV++ + Q+EI +L RHPN+V G+
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 515 -CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ IV EY GSL D I++ PLS Q + E GL +LH+T +H
Sbjct: 70 LRRDKLWIVMEYCGGGSLQD-IYQVTRG-PLSELQIAYVCRETLKGLAYLHETG---KIH 124
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLG 633
RD+K NILL + K++D G++ + A T S GT ++ PE G
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 634 ---VKSDVYSLGILLLQLITAKQPMGLTH 659
K D+++LGI ++L + PM H
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 72/236 (30%), Positives = 116/236 (49%), Gaps = 41/236 (17%)
Query: 457 RKIGEGGYGPVYKC-------YLDHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNM 508
R IG+G +G V++ Y T VAVK+L+ +A A ++ FQRE +++ HPN+
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 509 VLLLGACPEYG--IIVYEYLANGSLDDRIFRR-------------------GNTPPLSWQ 547
V LLG C +++EY+A G L++ + R N PLS
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
++ IA ++A G+ +L + K VHRDL N L+ N V KI+D GL+R + +
Sbjct: 131 EQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS----- 182
Query: 608 TQYHLTST--AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTH 659
Y+ S A ++ PE +SDV++ G++L ++ + QP G+ H
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 30/220 (13%)
Query: 457 RKIGEGGYGPVY--KCY-----LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
R++GEG +G V+ +CY D VAVK L+ + R F RE E+L+ ++H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 510 LLLGACPEYG--IIVYEYLANGSLD--------DRIFRRGNTPP--LSWQQRFRIAAEIA 557
G C E I+V+EY+ +G L+ D + P L+ Q IA +IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--T 615
G+++L + VHRDL N L+ N + KI D G++R V + T Y+ T
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-----TDYYRVGGHT 182
Query: 616 AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
++ PE +SDV+SLG++L ++ T KQP
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 457 RKIGEGGYGPVYK-CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+K+G G +G V+ + +T VAVK L+P S F E +++ +RH +V L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVV 70
Query: 516 PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
E I IV EY++ GSL D + G L +AA++A G+ ++ + +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126
Query: 575 DLKPGNILLDHNYVSKISDVGLARLV---PAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
DL+ NIL+ V KI+D GLARL+ A ++ + TA PE G
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA-------PEAALYGR 179
Query: 632 LGVKSDVYSLGILLLQLIT 650
+KSDV+S GILL +L+T
Sbjct: 180 FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 5e-22
Identities = 79/252 (31%), Positives = 113/252 (44%), Gaps = 45/252 (17%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQ----REIEVLSCIRHPNMVLL 511
K+GEG YG VYK T VA+K +R D REI +L ++HPN+V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 512 LGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
L +V+EY D + + PLS I ++ GL + H +
Sbjct: 64 LDVIHTERKLYLVFEYCDM---DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR-- 118
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDLKP NIL++ + V K++D GLAR A + Y T T Y PE
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLAR---AFGIPLRTY--THEVVTLWYRAPEI--- 169
Query: 630 GMLGVKS-----DVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD----PTVTD 680
+LG K D++S+G + ++IT +P+ F S E L ++ PT
Sbjct: 170 -LLGSKHYSTAVDIWSVGCIFAEMIT-GKPL----FPGDS-EIDQLFKIFQILGTPTEES 222
Query: 681 WPFEETLGFAKL 692
WP G KL
Sbjct: 223 WP-----GVTKL 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 76/261 (29%), Positives = 121/261 (46%), Gaps = 36/261 (13%)
Query: 458 KIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
K+G G YG VY+ VAVK L+ D + +F +E V+ I+HPN+V LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P Y I+ E++ G+L D + R N ++ +A +I++ + +L +
Sbjct: 72 TREPPFY--IITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID---PEYQQ 628
+HRDL N L+ N++ K++D GL+RL +T T+ AG I PE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL-------MTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 629 TGMLGVKSDVYSLGILLLQLIT---AKQP-MGLTHFVERSIENGTLGEMLDPTVTDWPFE 684
+KSDV++ G+LL ++ T + P + L+ V +E G E +
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPPK---- 233
Query: 685 ETLGFAKLALQCSELRRKDRP 705
+L C + DRP
Sbjct: 234 ----VYELMRACWQWNPSDRP 250
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
+ + KIGEG G VYK T VA+K +R Q + EI ++ +HPN
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 508 MVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V + + +V EY+ GSL D I N ++ Q + E+ GL +LH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFCYIDP 624
++HRD+K NILL + K++D G A+L + S GT ++ P
Sbjct: 135 QN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS------KRNSVVGTPYWMAP 185
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLI 649
E + G K D++SLGI+ +++
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 457 RKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+K+G G +G V+ Y + HT VA+K L+ + F E ++ ++HP +V L
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 516 PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
+ I I+ EY+ NGSL D + L+ + +AA+IA G+ F+ + +HR
Sbjct: 71 TQEPIYIITEYMENGSLVD-FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHR 126
Query: 575 DLKPGNILLDHNYVSKISDVGLARLVPA---VAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
DL+ NIL+ KI+D GLARL+ A ++ + TA PE G
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA-------PEAINYGT 179
Query: 632 LGVKSDVYSLGILLLQLIT 650
+KSDV+S GILL +++T
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 453 FTESRKIGEGGYGPVYKC--YLDHTPVAVKV--LRPDAAQGRSQFQREIEVLSCIRHPNM 508
F +K+G+G YG VYK D+ A+K L + + R EI +L+ + HPN+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 509 V-----LLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTP-PLSWQQRFRIAAEIATGL 560
+ L G C IV EY G L I +R + Q+ +RI ++ GL
Sbjct: 62 ISYKEAFLDGNKLC-----IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
LH+ K ++HRDLK NILL N + KI D+G++++ + + + GT
Sbjct: 117 QALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV-------LKKNMAKTQIGTPH 166
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
Y+ PE + KSD++SLG LL ++ T P
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 68/198 (34%), Positives = 104/198 (52%), Gaps = 17/198 (8%)
Query: 458 KIGEGGYGPVYK-CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP 516
K+G+G +G V+ + T VA+K L+P + F +E +++ +RH +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 517 EYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRD 575
E I IV E++ GSL D + G+ L Q +AA+IA G+ ++ + +HRD
Sbjct: 72 EEPIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 576 LKPGNILLDHNYVSKISDVGLARLVPA---VAENVTQYHLTSTAGTFCYIDPEYQQTGML 632
L+ NIL+ N V KI+D GLARL+ A ++ + TA PE G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA-------PEAALYGRF 180
Query: 633 GVKSDVYSLGILLLQLIT 650
+KSDV+S GILL +L+T
Sbjct: 181 TIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 35/268 (13%)
Query: 459 IGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLL 512
IG G +G V + L VA+K L+ + + R F E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 513 GACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
G + +I+ EY+ NGSLD F R N + Q + IA+G+ +L +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDK--FLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG---TFCYIDPEYQ 627
VHRDL NIL++ N V K+SD GL+R + T T G + PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTAPEAI 180
Query: 628 QTGMLGVKSDVYSLGILLLQLIT-AKQPMG--LTHFVERSIENG-TLGEMLDPTVTDWPF 683
SDV+S GI++ ++++ ++P V +++E+G L P D P
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-----PPPMDCP- 234
Query: 684 EETLGFAKLALQCSELRRKDRPDLGKVV 711
+L L C + R +RP ++V
Sbjct: 235 ---SALYQLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 71/199 (35%), Positives = 105/199 (52%), Gaps = 19/199 (9%)
Query: 458 KIGEGGYGPVYK-CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP 516
K+G+G +G V+ + T VA+K L+P + F +E +V+ +RH +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 517 EYGI-IVYEYLANGSLDDRIFRRGNTPP-LSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
E I IV EY++ GSL D F +G L Q +AA+IA+G+ ++ + VHR
Sbjct: 72 EEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 575 DLKPGNILLDHNYVSKISDVGLARLVPA---VAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
DL+ NIL+ N V K++D GLARL+ A ++ + TA PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA-------PEAALYGR 179
Query: 632 LGVKSDVYSLGILLLQLIT 650
+KSDV+S GILL +L T
Sbjct: 180 FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVKVL--RPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
+GEG YG V KC T VA+K D + RE++VL +RH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 514 ACPEYG--IIVYEYLANGSLDDRIFRRGNTPP-----LSWQQRFRIAAEIATGLLFLHQT 566
A G +V+EY+ L+ G PP WQ + + + H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHSH 119
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
++HRD+KP NIL+ + V K+ D G AR + A + LT T Y PE
Sbjct: 120 N---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS----PLTDYVATRWYRAPEL 172
Query: 627 Q-QTGMLGVKSDVYSLGILLLQLIT 650
G DV+++G ++ +L+
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 32/172 (18%)
Query: 456 SRKIGEGGYGPVYKCYLDHTP------------------VAVKVLRPDAAQ-GRSQFQRE 496
K+GEG +G V+ C D VAVKVLRPDA+ R F +E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 497 IEVLSCIRHPNMVLLLGACP--EYGIIVYEYLANGSLDD----RIFRRG----NTPPLSW 546
+++LS + PN+ LLG C ++ EY+ NG L+ + N+ LS+
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
+A +IA+G+ +L VHRDL N L+ NY KI+D G++R
Sbjct: 130 STLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 34/229 (14%)
Query: 444 EDIEEATQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAA-QGRSQFQR 495
E A +F E +GEG +G VYK L T VA+K L+ +A + + +F++
Sbjct: 1 EIPLSAVRFLEE---LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ 57
Query: 496 EIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRR-------------GN 540
E E++S ++HPN+V LLG C + +++EYLA+G L + + R
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 541 TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600
L IA +IA G+ +L VHRDL N L+ KISD GL+R +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 601 PAVAENVTQYHLTSTAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQL 648
+ Y + S + ++ PE G +SD++S G++L ++
Sbjct: 175 ----YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 37/225 (16%)
Query: 457 RKIGEGGYGPVY--KCY-----LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
R++GEG +G V+ +CY D VAVK L+ R FQRE E+L+ ++H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 510 LLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTP---------------PLSWQQRFRI 552
G C + I+V+EY+ +G L+ F R + P L Q I
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
A++IA+G+++L + VHRDL N L+ N + KI D G++R V + T Y+
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS-----TDYYR 180
Query: 613 TS--TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
T ++ PE +SDV+S G++L ++ T KQP
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVK-VLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
E ++GEG G V KC L +T A+K + + Q RE+E+ + P +V
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 510 LLLGAC-----PEYGIIVYEYLANGSLD---DRIFRRG---NTPPLSWQQRFRIAAEIAT 558
GA GI + EY GSLD ++ +RG L +IA +
Sbjct: 63 KYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLK 116
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
GL +LH K ++HRD+KP NILL K+ D G V+ + S AGT
Sbjct: 117 GLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFG-----------VSGELVNSLAGT 162
Query: 619 FC----YIDPEYQQTGMLGVKSDVYSLGILLLQL 648
F Y+ PE Q + SDV+SLG+ LL++
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 31/169 (18%)
Query: 458 KIGEGGYGPVYKCY--------------LDHTP--VAVKVLRPDAAQ-GRSQFQREIEVL 500
K+GEG +G V+ C D P VAVK+LR D + R+ F +EI+++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 501 SCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRR---------GNTPPLSWQQR 549
S +++PN++ LLG C ++ EY+ NG L+ + +R N P +S
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 550 FRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
+A +IA+G+ +L VHRDL N L+ ++Y KI+D G++R
Sbjct: 132 LYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 78/282 (27%), Positives = 117/282 (41%), Gaps = 46/282 (16%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVK--VLRPDAAQGRSQFQREIEVLSCIRHPNM 508
+ +IGEG +G V+K T VA+K LR +Q REI+ L +HP +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 509 VLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
V LL P ++V EY+ L + + PL Q + G+ ++H
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
++HRDLKP N+L+ + V KI+D GLARL E Y + T Y PE
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFS--EEEPRLY--SHQVATRWYRAPEL 171
Query: 627 ---QQTGMLGVKSDVYSLGILLLQLITAKQPM--GLTHFVERSIENGTLGEMLDPTVTDW 681
+ GV D++++G + +L+ P+ G + +I TLG P W
Sbjct: 172 LYGARKYDPGV--DLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGT---PNEETW 225
Query: 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN--RLREL 721
P +L PD K+ PE L E+
Sbjct: 226 PGLTSL-----------------PDYNKITFPESKPIPLEEI 250
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 36/223 (16%)
Query: 458 KIGEGGYGPVY--KCY-----LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
++GEG +G V+ +C+ D VAVK L+ + R FQRE E+L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 511 LLGACPEYG--IIVYEYLANGSLDDRIFRRGNTP--------------PLSWQQRFRIAA 554
G C E ++V+EY+ +G L+ F R + P L+ Q IA+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
+IA+G+++L VHRDL N L+ V KI D G++R + + T Y+
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-----TDYYRVG 181
Query: 615 --TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
T ++ PE +SD++S G++L ++ T KQP
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMV 509
Q T IGEG +G V + VAVK ++ D AQ F E V++ + H N+V
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLV 62
Query: 510 LLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
LLG G+ IV E ++ G+L + + RG +S Q + + ++A G+ +L K
Sbjct: 63 RLLGVILHNGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKK- 120
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
LVHRDL NIL+ + V+K+SD GLAR+ +N ++ + TA PE +
Sbjct: 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-SKLPVKWTA-------PEALK 170
Query: 629 TGMLGVKSDVYSLGILLLQLIT-AKQP 654
KSDV+S G+LL ++ + + P
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 457 RKIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRSQFQ----REIEVLSCIRHPNMVL 510
+IGEG YG VYK VA+K +R + + F REI++L +RHPN+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 511 LLGACPEYGI----IVYEYLA---NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
L G +V+EY+ G LD + + Q ++ GL +L
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK------FTESQIKCYMKQLLEGLQYL 116
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
H ++HRD+K NIL++++ V K++D GLAR T+ T Y
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY----TKRNSADYTNRVITLWYRP 169
Query: 624 PEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPM 655
PE +LG D++S+G +L +L K
Sbjct: 170 PEL----LLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 459 IGEGGYGPVYKCYLDHT--PVAVKVLR-----PDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+G+G +G VY CY T +AVK + P+ + + + EI++L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 512 LGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G E I EY+ GS+ D++ G L+ + +I G+ +LH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM-- 124
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
+VHRD+K NIL D K+ D G ++ + + + T + S GT ++ PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT--GMKSVTGTPYWMSPEVISG 181
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
G K+DV+S+G +++++T K P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 459 IGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLG 513
+G+G +G V T A+KVL+ R + + E +LS I HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 514 A--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
A E +V EY G L + + G + RF AAEI L +LH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARF-YAAEIVLALEYLHS---LGI 114
Query: 572 VHRDLKPGNILLD-HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEY 626
++RDLKP NILLD ++ K++D GLA+ + S TFC Y+ PE
Sbjct: 115 IYRDLKPENILLDADGHI-KLTDFGLAKEL---------SSEGSRTNTFCGTPEYLAPEV 164
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQP 654
G D +SLG+LL +++T K P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVK--VLRP---DAAQGRSQ-FQREIEVLSCIR 504
+T+ +G+G YG VY C L + +AVK L AA+ + Q E+++L ++
Sbjct: 2 WTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 505 HPNMVLLLGACPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
H N+V LG C + I E++ GS+ + R G P + + +I G+ +
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC---KYTKQILDGVAY 117
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH-LTSTAGTFCY 621
LH +VHRD+K N++L N + K+ D G AR + V + T + L S GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
+ PE G KSD++S+G + ++ T K P+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 80/257 (31%), Positives = 119/257 (46%), Gaps = 27/257 (10%)
Query: 459 IGEGGYGPVYKCY--LDHTPVAVKV--LRPDAAQGR---SQFQREIEVLSCIRHPNMVLL 511
+G G +G VY+ D AVK L D G+ Q ++EI +LS ++HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 512 LGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
LG E I E + GSL + + G+ P + R +I GL +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLHDRN-- 122
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY-QQ 628
VHRD+K NIL+D N V K++D G+A+ V V S G+ ++ PE Q
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAKQV------VEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 629 TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688
G G+ +D++SLG +L++ T K P V + G E+ P + D +E
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPIPDHLSDEAKD 233
Query: 689 FAKLALQCSELRRKDRP 705
F L+C + RP
Sbjct: 234 F---ILKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 30/258 (11%)
Query: 457 RKIGEGGYGPVY-KCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+K+G G +G V+ Y HT VAVK ++P + F E V+ ++H +V L
Sbjct: 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 516 PEYGI-IVYEYLANGSLDDRI-FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ I I+ E++A GSL D + G+ PL + +A+IA G+ F+ Q +H
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPA---VAENVTQYHLTSTAGTFCYIDPEYQQTG 630
RDL+ NIL+ + V KI+D GLAR++ A ++ + TA PE G
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA-------PEAINFG 178
Query: 631 MLGVKSDVYSLGILLLQLIT-AKQPM-GLTHF-VERSIENGTLGEMLDPTVTDWPFEETL 687
+KSDV+S GILL++++T + P G+++ V R++E G M P + P E
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--RM--PRPENCPEE--- 231
Query: 688 GFAKLALQCSELRRKDRP 705
+ ++C + R ++RP
Sbjct: 232 -LYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 41/280 (14%)
Query: 454 TESRKIGEGGYGPVYKCY-LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLL 512
T ++IG G +G V+ Y L+ VA+K +R + A F E +V+ + HP +V L
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 513 GACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
G C E I V+E++ +G L D + R S + + ++ G+ +L +
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT---FCYIDPEYQ 627
++HRDL N L+ N V K+SD G+ R V QY TS+ GT + PE
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-----DQY--TSSTGTKFPVKWSSPEVF 173
Query: 628 QTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEMLDPTVTDW----P 682
KSDV+S G+L+ ++ + K P EN + E+++ + P
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPY----------ENRSNSEVVETINAGFRLYKP 223
Query: 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELA 722
+ +L C + R +DRP + L +LA
Sbjct: 224 RLASQSVYELMQHCWKERPEDRPSFSLL-------LHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 451 QFFTESRKIGEGGYGPVYKC-YLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM 508
+ F K+GEG YG VYK + + VA+KV+ + + +EI +L P +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYI 60
Query: 509 VLLLGACPEYG--------IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
V YG IV EY GS+ D + T L+ ++ I + GL
Sbjct: 61 V------KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGL 112
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
+LH K +HRD+K GNILL+ +K++D G V + T + GT
Sbjct: 113 EYLHSNK---KIHRDIKAGNILLNEEGQAKLADFG----VSGQLTD-TMAKRNTVIGTPF 164
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
++ PE Q K+D++SLGI +++ K P
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 459 IGEGGYGPVYKCYLDHTP-------VAVKVLRPDAA-QGRSQFQREIEVLSCI-RHPNMV 509
+GEG +G V K VAVK+L+ DA + S E+E++ I +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 510 LLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPP---------------LSWQQRFRI 552
LLG C + G +V EY A+G+L R F R PP L+ +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNL--RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
A ++A G+ FL K +HRDL N+L+ ++V KI+D GLAR + + Y+
Sbjct: 138 AYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHIDYYR 189
Query: 613 TSTAGTFCY--IDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
+T G + PE + +SDV+S G+LL ++ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 458 KIGEGGYGPVYK-----CYLDHTPVAVKVLRPDAAQGRSQ-FQREIEVLSCIRHPNMVLL 511
K+G+G +G V + PVAVK L+ D F +E ++ + H N++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 512 LGACPEYGII-------VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
YG++ V E GSL DR+ R+ A +IA G+ +L
Sbjct: 62 ------YGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN-VTQYHLTSTAGTFCYID 623
+ +HRDL NILL + KI D GL R +P ++ V + HL F +
Sbjct: 115 SKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCA 168
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE +T SDV+ G+ L ++ T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 30/271 (11%)
Query: 454 TESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPN 507
T+ + IG G +G V++ L VA+K L+P + R F E ++ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 508 MVLLLGACPEY--GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
++ L G ++ +I+ EY+ NG+LD + R + S Q + IA G+ +L
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDK--YLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YID 623
VHRDL NIL++ N K+SD GL+R V E+ + T++ G +
Sbjct: 126 MN---YVHRDLAARNILVNSNLECKVSDFGLSR----VLEDDPEGTYTTSGGKIPIRWTA 178
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMG--LTHFVERSIENGTLGEMLDPTVTD 680
PE SDV+S GI++ ++++ ++P H V ++I +G P D
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG----FRLPAPMD 234
Query: 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
P +L LQC + R RP +V
Sbjct: 235 CPS----AVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQ--REIEVLSCIRHPNM 508
+ + KIGEG YG VYK L VA+K ++ REI++L + HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 509 VLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
+ LL G +V+E++ D + L ++ GL F H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
++HRDLKP N+L++ V K++D GLAR T T Y PE
Sbjct: 118 G---ILHRDLKPENLLINTEGVLKLADFGLARSF-----GSPVRPYTHYVVTRWYRAPEL 169
Query: 627 QQT-GMLGVKSDVYSLGILLLQLIT 650
D++S+G + +L++
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 453 FTESRKIGEGGYGPVYK--CYLDHTPVA---VKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
F +KIG+G + VYK C LD VA V++ A+ R +EI++L + HPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRI--FRRGNTPPLSWQQRFRIAAEIATGLLFL 563
++ L + E IV E G L I F++ + + ++ ++ + L +
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLCSALEHM 122
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
H + ++HRD+KP N+ + V K+ D+GL R + T H S GT Y+
Sbjct: 123 HSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAH--SLVGTPYYMS 174
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE KSD++SLG LL ++ + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 451 QFFTESRKIGEGGYGPV-YKCY---LDHTP--VAVKVLRPD-AAQGRSQFQREIEVLSCI 503
++ + R +GEG +G V CY D T VAVK L+ + Q S +++EI +L +
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 504 RHPNMVLLLGACPEYG----IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
H N+V G C E G ++ EY+ GSL D + + L+ Q A +I G
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEG 119
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG-- 617
+ +LH +HRDL N+LLD++ + KI D GLA+ VP E Y+ G
Sbjct: 120 MAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE----YYRVREDGDS 172
Query: 618 -TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
F Y E + SDV+S G+ L +L+T
Sbjct: 173 PVFWYA-VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 454 TESRKI---GEGGYGPVYKCYL------DHTPVAVKVLRPDAAQGRSQ-FQREIEVLSCI 503
TE KI G G +G VYK PVA+KVLR + + ++ E V++ +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 504 RHPNMVLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
HP++V LLG C + ++ + + G L D + R + + Q +IA G+ +
Sbjct: 67 DHPHVVRLLGICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
L + + LVHRDL N+L+ KI+D GLA+L+ + +YH ++
Sbjct: 125 LEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV---DEKEYHAEGGKVPIKWM 178
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLIT 650
E + KSDV+S G+ + +L+T
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 19/198 (9%)
Query: 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVL 510
+++G G +G V K VAVK L+ + A G+ +F RE V++ + HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 511 LLGACPEYGII-VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
L+G C ++ V E G L + +R P ++ +A ++A G+ +L
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH-- 115
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YIDPEYQ 627
VHRDL N+LL + + +KISD G++R + A ++ Y+ +TAG + + PE
Sbjct: 116 -FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD----YYRATTAGRWPLKWYAPECI 170
Query: 628 QTGMLGVKSDVYSLGILL 645
G KSDV+S G+ L
Sbjct: 171 NYGKFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 457 RKIGEGGYGPVYKCYLDHTPV----AVKVL---RPDAAQGRSQFQREIEVLSCIRHPNMV 509
+IG G G VYK + H P A+KV+ D R Q REIE+L + HPN+V
Sbjct: 80 NRIGSGAGGTVYK--VIHRPTGRLYALKVIYGNHEDTV--RRQICREIEILRDVNHPNVV 135
Query: 510 LLLGACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAEIATGLLFLHQ 565
G I + E++ GSL+ ++F +A +I +G+ +LH+
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHI---------ADEQFLADVARQILSGIAYLHR 186
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
+VHRD+KP N+L++ KI+D G++R++ T S+ GT Y+ PE
Sbjct: 187 RH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSVGTIAYMSPE 238
Query: 626 YQQT----GML-GVKSDVYSLGILLLQLITAKQPMGL 657
T G G D++SLG+ +L+ + P G+
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLL 512
R +G G +G V+ C D V +K + + R Q E +VL + HPN++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 513 GACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
E +IV EY G+L + I +R N S I LL LH +
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTKL 121
Query: 571 LVHRDLKPGNILLD-HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDLK NILLD H V KI D G+++++ ++ + GT CYI PE +
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKIL------SSKSKAYTVVGTPCYISPELCEG 175
Query: 630 GMLGVKSDVYSLGILLLQLITAKQ 653
KSD+++LG +L +L + K+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 43/277 (15%)
Query: 459 IGEGGYGPVYKCYL-------DHTPVAVKVLRP-DAAQGRSQFQREIEVLSCIRHPNMVL 510
+G G +G V+ T V VK L+ +S+F+RE+++ + H N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 511 LLGAC----PEYGIIVYEYLANGSLDD--RIFRRG----NTPPLSWQQRFRIAAEIATGL 560
LLG C P Y ++ EY G L R + PPLS +Q+ + +IA G+
Sbjct: 73 LLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
L + VHRDL N L+ K+S + L++ V N Y L +
Sbjct: 131 DHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDV----YNSEYYKLRNALIPLR 183
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP---MGLTHFVERSIENGTLGEMLDP 676
++ PE Q KSDV+S G+L+ ++ T + P + + R ++ G L
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-LQAGKL------ 236
Query: 677 TVTDWPFEETL--GFAKLALQCSELRRKDRPDLGKVV 711
+ P E KL +C + KDRP ++V
Sbjct: 237 ---ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 60/238 (25%), Positives = 93/238 (39%), Gaps = 32/238 (13%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--------VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM 508
R IG+G +G V T K + + + E +L + HP +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR---NVLNERRILQELNHPFL 62
Query: 509 VLLLGACP--EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQ-RFRIAAEIATGLLFLHQ 565
V L + E +V + L G L + ++ S +Q +F EI L +LH
Sbjct: 63 VNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKF-WICEIVLALEYLHS 118
Query: 566 TKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
++HRD+KP NILLD +V I+D +A V TST+GT Y+ P
Sbjct: 119 KG---IIHRDIKPDNILLDEQGHV-HITDFNIATKVT------PDTLTTSTSGTPGYMAP 168
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682
E V D +SLG+ + + K+P R+I + + V
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPY---RGHSRTIRDQIRAKQETADVLYPA 223
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 459 IGEGGYGPVYKCYLDHTP--------VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
+G+G +G V C D P VAVK L+ A+ F+REIE+L ++H N+V
Sbjct: 12 LGKGNFGSVELCRYD--PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 511 LLGACPEYGI----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
G C G +V EYL GSL D + + + L ++ A++I G+ +L
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG---TFCYID 623
+ VHRDL NIL++ KI D GL +++P E Y+ G F Y
Sbjct: 128 R---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE----YYKVREPGESPIFWYA- 179
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE V SDV+S G++L +L T
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 457 RKIGEGGYGPV-YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+++G G +G V + VA+K++R + A F E +V+ + HPN+V L G C
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 516 PEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ IV EY+ANG L + + R L + + +++ + +L +H
Sbjct: 69 TKQRPIFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID---PEYQQTG 630
RDL N L+ + V K+SD GLAR V QY TS+ GT + PE
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD-----DQY--TSSQGTKFPVKWAPPEVFDYS 176
Query: 631 MLGVKSDVYSLGILLLQLIT 650
KSDV+S G+L+ ++ +
Sbjct: 177 RFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 457 RKIGEGGYGPVY--KCYLDHTPVAVKV--LRPDAAQGRSQFQREIEVLSCIRHPNMVLLL 512
+KIGEG +G +Y K D +K L + + ++E+ +L+ ++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 513 GACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+ E G IV EY G L RI R+ S Q +I+ GL +H K
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVL-FSEDQILSWFVQISLGLKHIHDRK--- 121
Query: 571 LVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRD+K NI L N V+K+ D G+AR + N + + GT Y+ PE Q
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-----NDSMELAYTCVGTPYYLSPEICQN 176
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
K+D++SLG +L +L T K P
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 22/202 (10%)
Query: 457 RKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+K+G G +G V+ Y ++ T VAVK L+P ++ F E ++ ++H +V L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVV 70
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P Y I+ EY+A GSL D + + + +A+IA G+ ++ +
Sbjct: 71 TKEEPIY--IITEYMAKGSLLD-FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---Y 124
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPA---VAENVTQYHLTSTAGTFCYIDPEYQQ 628
+HRDL+ N+L+ + + KI+D GLAR++ A ++ + TA PE
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA-------PEAIN 177
Query: 629 TGMLGVKSDVYSLGILLLQLIT 650
G +KSDV+S GILL +++T
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 51/279 (18%)
Query: 459 IGEGGYGPVYKCYL----DHTPVAVKVLRPDAAQG-RSQFQREIEVLSCI-RHPNMVLLL 512
IGEG +G V + + A+K+L+ A++ F E+EVL + HPN++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 513 GACPEYGI--IVYEYLANGSL-----------DDRIFRR--GNTPPLSWQQRFRIAAEIA 557
GAC G I EY G+L D F + G L+ QQ + A+++A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
TG+ +L + + +HRDL N+L+ N SKI+D GL+R E V ++ T G
Sbjct: 130 TGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR-----GEEV---YVKKTMG 178
Query: 618 TFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT---------------AKQPMGLTHF 660
++ E + KSDV+S G+LL ++++ K P G
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 661 VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSEL 699
R+ ++ + E++ D P+E FA++++Q S +
Sbjct: 239 KPRNCDD-EVYELMRQCWRDRPYERP-PFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 40/178 (22%)
Query: 458 KIGEGGYGPVYKCYLDHTP------------------VAVKVLRPDAAQ-GRSQFQREIE 498
K+GEG +G V+ C + + VAVK+LRPDA + R+ F +E++
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 499 VLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLD----------------DRIFRRGN 540
+LS ++ PN++ LLG C + ++ EY+ NG L+ D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 541 TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
P +S+ +A +IA+G+ +L VHRDL N L+ N KI+D G++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 458 KIGEGGYGPVYKCY--LDHTPVAVKV--LRPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
KIG+G +G V+K D A+K L + R + E VL+ + ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 514 ACPEYGI--IVYEYLANGSLDDRI-FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+ + G IV EY NG L + +RG PL Q +R +I GL LH K
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGR--PLPEDQVWRFFIQILLGLAHLHSKK--- 121
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQQT 629
++HRD+K N+ LD KI D+G+A+L+ + +T GT Y+ PE +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS------DNTNFANTIVGTPYYLSPELCED 175
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
KSDV++LG++L + T K P
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 457 RKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLL 511
+G G G V K + H P +A KV+ A R Q RE++++ R P +V
Sbjct: 11 SDLGAGNGGSVSK--VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 512 LGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
GA + E++ GSLD RI+++G P+ + +IA + GL +L+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD-RIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--H 123
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
++HRD+KP NIL++ K+ D G++ L+ ++A+ + GT Y+ PE Q
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--------TFVGTSTYMSPERIQ 175
Query: 629 TGMLGVKSDVYSLGILLLQLITAKQP 654
G VKSDV+SLGI +++L K P
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 458 KIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRSQF-QREIEVLSCIRHPNMVLLLGA 514
IG G VY C ++ VA+K + + Q ++E++ +S HPN+V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 515 CPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA---EIATGLLFLHQTKPE 569
+V YL+ GSL D I + P IA E+ GL +LH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLD-IMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG-- 122
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST--AGTFCYIDPE-- 625
+HRD+K GNILL + KI+D G++ ++A+ + GT C++ PE
Sbjct: 123 -QIHRDIKAGNILLGEDGSVKIADFGVS---ASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
Q G K+D++S GI ++L T P
Sbjct: 179 EQVHGY-DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 459 IGEGGYGPVYKCYLDHTP---VAVKV--LRPDAAQGRSQFQR--------EIEVLSCIRH 505
IG+G YG VY L+ T +AVK L A Q+ EIE L + H
Sbjct: 9 IGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 506 PNMVLLLG--ACPEYGIIVYEYLANGSLDDRIFRRGN-TPPLSWQQRFRIAAEIATGLLF 562
N+V LG EY I EY+ GS+ + G L RF ++ GL +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV---RF-FTEQVLEGLAY 123
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
LH + ++HRDLK N+L+D + + KISD G+++ + +N S G+ ++
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWM 177
Query: 623 DPEYQQTGMLG--VKSDVYSLGILLLQLITAKQPMG 656
PE + G K D++SLG ++L++ ++P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQ---REIEVLSCIRHPNMVLL 511
+ +G G +G V + A+K+L Q + E +L IRHP +V L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 512 LGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G+ +V EY+ G L R+ P + + AA++ L +LH
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFY--AAQVVLALEYLHSLD-- 121
Query: 570 PLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
+V+RDLKP N+LLD + Y+ KI+D G A+ V + T + GT Y+ PE
Sbjct: 122 -IVYRDLKPENLLLDSDGYI-KITDFGFAKRV----KGRTY----TLCGTPEYLAPEIIL 171
Query: 629 TGMLGVKSDVYSLGILLLQLIT------AKQPMGL 657
+ G D ++LGIL+ +++ P+ +
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-17
Identities = 40/146 (27%), Positives = 60/146 (41%), Gaps = 17/146 (11%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
I VAVD + S+ AL+WAA G +VL+HV V ++
Sbjct: 2 ILVAVDGSEESERALRWAARLARRLGAELVLLHV--------------VDPPPSSAAELA 47
Query: 78 KQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHG 137
+ +++ R L R +K V+LE D +AI E + +V+G+ R G
Sbjct: 48 ELLEEEARALLEALREALAEAGVKVETVVLEG-DPAEAILEAAEELGADLIVMGSRGRSG 106
Query: 138 FIRKFKADVPSSVSKAAPDFCNIYVV 163
R V V + AP C + VV
Sbjct: 107 LRRLLLGSVAERVLRHAP--CPVLVV 130
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 78/268 (29%), Positives = 120/268 (44%), Gaps = 30/268 (11%)
Query: 457 RKIGEGGYGPVYKCYLD-----HTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVL 510
+ IG G +G V L PVA+K L+ + R F E ++ HPN++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 511 LLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L G + +IV EY+ NGSLD F R + + Q + IA+G+ +L
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG- 126
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YIDPEY 626
VHRDL NIL++ N V K+SD GL+R V E+ + T+ G + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSR----VLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 627 QQTGMLGVKSDVYSLGILLLQLIT-AKQPMG--LTHFVERSIENGTLGEMLDPTVTDWPF 683
SDV+S GI++ ++++ ++P V ++IE G P D P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG----YRLPAPMDCP- 235
Query: 684 EETLGFAKLALQCSELRRKDRPDLGKVV 711
+L L C + R +RP ++V
Sbjct: 236 ---AALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 36/270 (13%)
Query: 459 IGEGGYGPVYKCYLDH-----TPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLL 512
IG G +G V + L VA+K L+ + R F E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 513 G----ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
G + P +I+ E++ NG+LD F R N + Q + IA G+ +L +
Sbjct: 72 GVVTKSRPV--MIITEFMENGALDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN- 126
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG---TFCYIDPE 625
VHRDL NIL++ N V K+SD GL+R + ++ + TS+ G + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW---- 681
SDV+S GI++ ++++ + ER + + ++++ D+
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMSNQDVINAIEQDYRLPP 232
Query: 682 PFEETLGFAKLALQCSELRRKDRPDLGKVV 711
P + +L L C + R RP G++V
Sbjct: 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 69/197 (35%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 459 IGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGAC- 515
+G+G +G V+K L D TPVAVK + D Q + +F E +L HPN+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 516 ---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
P Y IV E + G D F R L +Q + A + A G+ +L +
Sbjct: 63 QRQPIY--IVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG----TFCYIDPEYQQ 628
HRDL N L+ N V KISD G++R E+ Y S++G + PE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIY---SSSGLKQIPIKWTAPEALN 167
Query: 629 TGMLGVKSDVYSLGILL 645
G +SDV+S GILL
Sbjct: 168 YGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 84/289 (29%), Positives = 133/289 (46%), Gaps = 48/289 (16%)
Query: 459 IGEGGYGPVYKCYLD----HTPVAVKVLRPDAAQG-RSQFQREIEVLSCI-RHPNMVLLL 512
IGEG +G V K + A+K ++ A++ F E+EVL + HPN++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 513 GACPEYGII--VYEYLANGSLDD--RIFRRGNTPP-----------LSWQQRFRIAAEIA 557
GAC G + EY +G+L D R R T P LS QQ AA++A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
G+ +L Q + +HRDL NIL+ NYV+KI+D GL+R + ++ T G
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 183
Query: 618 TFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD 675
++ E + SDV+S G+LL ++++ +G T + T E+ +
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYC-----GMTCAELYE 234
Query: 676 PTVTDWPFEETLG----FAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720
+ E+ L L QC + +RP ++++ LNR+ E
Sbjct: 235 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV-SLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 51/279 (18%)
Query: 459 IGEGGYGPVYKCYLDHTPV----AVKVLRPDAAQG-RSQFQREIEVLSCI-RHPNMVLLL 512
IGEG +G V K + + A+K ++ A++ F E+EVL + HPN++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 513 GACPEYGI--IVYEYLANGSL-----------DDRIFRR--GNTPPLSWQQRFRIAAEIA 557
GAC G + EY +G+L D F LS QQ AA++A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
G+ +L Q + +HRDL NIL+ NYV+KI+D GL+R + V ++ T G
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR-----GQEV---YVKKTMG 171
Query: 618 TFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT---------------AKQPMGLTHF 660
++ E + SDV+S G+LL ++++ K P G
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231
Query: 661 VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSEL 699
+ ++ + +++ + P+E FA++ + + +
Sbjct: 232 KPLNCDD-EVYDLMRQCWREKPYERP-SFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 457 RKIGEGGYGPVYK-CYLDHTP----VAVKVL-RPDAAQGRSQFQREIEVLSCIRHPNMVL 510
R IG+G +G VY +D AVK L R + QF +E ++ HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 511 LLGAC-PEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
LLG C P G ++V Y+ +G L + I + P + F + ++A G+ +L K
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASKK 118
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
VHRDL N +LD ++ K++D GLAR + H T ++ E
Sbjct: 119 ---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH-TGAKLPVKWMALESL 174
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
QT KSDV+S G+LL +L+T P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 63/194 (32%), Positives = 95/194 (48%), Gaps = 19/194 (9%)
Query: 459 IGEGGYGPVYKCYLDHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPE 517
IG+G +G V VAVK ++ DA AQ F E V++ +RH N+V LLG E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 518 YG---IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
IV EY+A GSL D + RG + L + + ++ + +L VHR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 575 DLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGV 634
DL N+L+ + V+K+SD GL + + ++ + + TA PE +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTA-------PEALREKKFST 178
Query: 635 KSDVYSLGILLLQL 648
KSDV+S GILL ++
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQGR-SQFQREIEVLSCIRH 505
+ IG G YG VY+ H P VA+K++ D S QRE+ +LS +R
Sbjct: 1 SLYQRLELIGRGAYGAVYRGK--HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ 58
Query: 506 ---PNMVLLLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
PN+ G+ P II+ EY GS+ R + P++ + I E+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIM-EYAEGGSV--RTLMKAG--PIAEKYISVIIREVLVA 113
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTF 619
L ++H+ ++HRD+K NIL+ + K+ D G+A L+ N ++ GT
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRSTFVGTP 165
Query: 620 CYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPM 655
++ PE G K+D++SLGI + ++ T P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAAQGRS-QFQREIEVLSCI 503
+F R +GEG +G V C D VAVK L+P++ ++EIE+L +
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 63
Query: 504 RHPNMVLLLGACPEYG----IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
H N+V G C E G ++ E+L +GSL + + R N ++ +Q+ + A +I G
Sbjct: 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKG 121
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT-QYHLTSTAGT 618
+ +L + VHRDL N+L++ + KI D GL + + E T + L S
Sbjct: 122 MDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--V 176
Query: 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
F Y PE + SDV+S G+ L +L+T
Sbjct: 177 FWYA-PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 459 IGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQ---------FQREIEVLSCIRHPN 507
IG G +G VY +AVK + + S+ REI +L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 508 MVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V LG+ ++ I EY+ GS+ + G + R +I GL +LH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV-TQYHLTSTAGTFCYIDP 624
++HRD+K NIL+D+ KISD G+++ + A + + T S G+ ++ P
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E + K+D++SLG L+++++T K P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 81/270 (30%), Positives = 114/270 (42%), Gaps = 42/270 (15%)
Query: 458 KIGEGGYGPVYKCYL--DHTPVAVKVLR----PDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+IG G +G V+ L D+TPVAVK R PD +++F +E +L HPN+V L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRL 58
Query: 512 LGAC----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
+G C P Y IV E + G D F R P L ++ ++ A G+ +L +
Sbjct: 59 IGVCTQKQPIY--IVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYL---E 111
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARL----VPAVAENVTQYHLTSTAGTFCYID 623
+ +HRDL N L+ V KISD G++R V A + Q + TA
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTA------- 164
Query: 624 PEYQQTGMLGVKSDVYSLGILL---LQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTD 680
PE G +SDV+S GILL L +IE G + P +
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG--VRLPCPELC- 221
Query: 681 WPFEETLGFAKLALQCSELRRKDRPDLGKV 710
P +L +C E RP V
Sbjct: 222 -PDA----VYRLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 453 FTESRKIGEGGYGPVYK--CYLDHTPVAVK---VLRPDAAQGRSQFQREIEVLSCIRHPN 507
F +KIG G + VY+ C LD PVA+K + A+ R+ +EI++L + HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 508 MVLLLGACPEYGI--IVYEYLANGSLDDRI--FRRGN--TPPLSWQQRFRIAAEIATGLL 561
++ + E IV E G L I F++ P + + F ++ + L
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF---VQLCSALE 120
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
+H + ++HRD+KP N+ + V K+ D+GL R + T H S GT Y
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAH--SLVGTPYY 172
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ PE KSD++SLG LL ++ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 453 FTESRKIGEGGYGPVYKC-------------YLDHTP-----VAVKVLRPDAAQ-GRSQF 493
T K+GEG +G V+ C LD + VAVK+LR DA + R+ F
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 494 QREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFR--------RGNTPP 543
+EI+++S ++ PN++ LL C ++ EY+ NG L+ + R + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
+S+ +A +IA+G+ +L VHRDL N L+ NY KI+D G++R
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSR----- 178
Query: 604 AENVTQ---YHLTSTAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
N+ Y + A ++ E G SDV++ G+ L +++T + +
Sbjct: 179 --NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
Query: 660 FV-ERSIEN 667
E+ IEN
Sbjct: 237 LSDEQVIEN 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
+G+GG+G V C + T A K L R +G E ++L + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 514 A--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
A + +V + G L I+ G P + AA+I GL LHQ +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
V+RDLKP N+LLD + +ISD+GLA + + AGT Y+ PE Q +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGRAGTPGYMAPEVLQGEV 170
Query: 632 LGVKSDVYSLGILLLQLITAKQP 654
D ++LG L ++I + P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 457 RKIGEGGYGPVYKCY---LDHT----PVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPN 507
+ +G G +G V + L + VAVK+L+P A + R E++++S + H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V LLGAC G +++ EY G L + RR L+ + + ++A G+ FL
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVAKGMAFL-- 157
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC---YI 622
+ +HRDL N+LL H + KI D GLAR + N + Y ++
Sbjct: 158 -ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI----MNDSNY--VVKGNARLPVKWM 210
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE + +SDV+S GILL ++ +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVKVL--RPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
+GEG YG V KC T VA+K D + REI +L +RH N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 514 ACPE----YGIIVYEYLANGSLDD-RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
Y +V+E++ + LDD + G L + + +I G+ F H
Sbjct: 68 VFRRKKRLY--LVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHSHN- 120
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--TAGTFCYIDPEY 626
++HRD+KP NIL+ + V K+ D G AR + A E T Y T A D +Y
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKY 178
Query: 627 QQTGMLGVKSDVYSLGILLLQLITA 651
G D++++G L+ +++T
Sbjct: 179 ------GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 495 REIEVLSCIRHPNMVLLLGACPE---YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFR 551
+EI +++ + HP+++ +LGA E + + V E++A GS+ + + G
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYG---AFKEAVIIN 107
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVTQY 610
++ GL +LH+ + ++HRD+K N+L+D +I+D G A + A ++
Sbjct: 108 YTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164
Query: 611 HLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT----HF-----V 661
GT ++ PE + G DV+S+G +++++ TAK P H +
Sbjct: 165 Q-GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223
Query: 662 ERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705
+ ++ E L P + D + L+C EL+ +DRP
Sbjct: 224 ASATTAPSIPEHLSPGLRD-----------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQF-QREIEVLSCIRHPN 507
+ FT IG+G +G VYK T VA+KV+ + A+ + Q+EI+ LS R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 508 MVLLLGACPE-YGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ G+ + + I+ EY GS D + + G L I E+ GL +LH+
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPG---KLDETYIAFILREVLLGLEYLHE 116
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-------AGT 618
E +HRD+K NILL K++D G++ LTST GT
Sbjct: 117 ---EGKIHRDIKAANILLSEEGDVKLADFGVSG------------QLTSTMSKRNTFVGT 161
Query: 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
++ PE + K+D++SLGI ++L + P+
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 66/235 (28%), Positives = 95/235 (40%), Gaps = 56/235 (23%)
Query: 452 FFTESRKIGEGGYGPVYKCYL----DHTPVAVKVLRPDAAQ--GRSQFQ-REIEVLSCIR 504
+ IG G YG VYK D A+K + D Q G SQ REI +L ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 505 HPNMVLLLGACPE-----------------YGIIVYEYLANG-SLDDRIFRRGNTPPLSW 546
H N+V L+ E + II + A S+ + + L W
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS-----LLW 115
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARLVPA 602
Q I G+ +LH ++HRDLKP NIL+ V KI D+GLARL
Sbjct: 116 Q--------ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-- 162
Query: 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
A L T Y PE +LG + D++++G + +L+T +
Sbjct: 163 NAPLKPLADLDPVVVTIWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 73/225 (32%), Positives = 108/225 (48%), Gaps = 44/225 (19%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQGRSQFQREI--EVLSCIRH- 505
++G G YG V K + H P +AVK +R A SQ Q+ + ++ +R
Sbjct: 3 LEVIEELGRGAYGVVDK--MRHVPTGTIMAVKRIR---ATVNSQEQKRLLMDLDISMRSV 57
Query: 506 --PNMVLLLGACPEYG--IIVYEYLANGSLDD---RIFRRGNTPP---LSWQQRFRIAAE 555
P V GA G I E + + SLD +++ +G T P L +IA
Sbjct: 58 DCPYTVTFYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVS 111
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTS 614
I L +LH ++HRD+KP N+L++ N K+ D G++ LV +VA+ T
Sbjct: 112 IVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-------TI 162
Query: 615 TAGTFCY-----IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
AG Y I+PE Q G VKSDV+SLGI +++L T + P
Sbjct: 163 DAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 453 FTESRKIGEGGYGPVYK--CYLDHTPVAVK---VLRPDAAQGRSQFQREIEVLSCIRHPN 507
F +KIG G + VY+ C LD PVA+K + A+ R +EI++L + HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 508 MVLLLGACPEYGI--IVYEYLANGSLDDRI--FRRGN--TPPLSWQQRFRIAAEIATGLL 561
++ L + E IV E G L I F++ P + + F ++ + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF---VQLCSAVE 120
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
+H + ++HRD+KP N+ + V K+ D+GL R + T H S GT Y
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAH--SLVGTPYY 172
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ PE KSD++SLG LL ++ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 459 IGEGGYGPVYKCYL--------DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMV 509
+G G +G VY+ VAVK LR A Q + +F +E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 510 LLLGAC----PEYGIIVYEYLANGSL-----DDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
LLG C P+Y I+ E + G L D R+ R G P L+ ++ I ++A G
Sbjct: 63 KLLGVCLLNEPQY--IIMELMEGGDLLSYLRDARVERFG-PPLLTLKELLDICLDVAKGC 119
Query: 561 LFLHQTKPEPLVHRDLKPGNILL-----DHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
++L Q +HRDL N L+ D + V KI D GLAR + + Y+
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-----SDYYRKEG 171
Query: 616 AGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
G ++ PE G +SDV+S G+L+ +++T +QP
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGR-SQFQREIEVLSCIRHPN 507
+ FT+ +IG+G +G VYK + T VA+K++ + A+ Q+EI VLS P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ G+ + I+ EYL GS D + + G PL I EI GL +LH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG---PLEETYIATILREILKGLDYLHS 119
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
E +HRD+K N+LL K++D G+A + TQ + GT ++ PE
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-----TQIKRNTFVGTPFWMAPE 171
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
+ K+D++SLGI ++L + P H
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
+++G G YG VYK HT AVK+++ + S Q+EI ++ +H N+V G+
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 515 --CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
E I EY GSL D I+ T PLS Q + E GL +LH +
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHV--TGPLSELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE---YQQT 629
HRD+K NILL N K++D G+A + A T S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 630 GMLGVKSDVYSLGILLLQLITAKQPM 655
G D++++GI ++L + PM
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 47/217 (21%)
Query: 458 KIGEGGYGPVYKC--YLDHTPVAVKVLRPDAA-QG-RSQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG VYK L VA+K +R + +G S REI +L + HPN+V LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 514 ACPE----YGIIVYEYLANGSLD-----DRIFRRGNTPPL----SWQQRFRIAAEIATGL 560
Y +V+E+L LD D G PPL +Q + G+
Sbjct: 66 VVHSENKLY--LVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQGI 112
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
+ H + ++HRDLKP N+L+D K++D GLAR A V Y T T
Sbjct: 113 AYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR---AFGVPVRTY--THEVVTLW 164
Query: 621 YIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
Y PE +LG + D++S+G + +++ +
Sbjct: 165 YRAPEI----LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-15
Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 19/191 (9%)
Query: 477 VAVKVLRPDAAQG---RSQFQREIEVLSCIRHPNMVLLL--GACPEYGII-VYEYLANGS 530
VA+K+LR DA + R++F+RE + + + HPN+V LL G P + V+EY+ +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNY 587
L + + G L + R+ ++ L H + +VHRDLKP NI++
Sbjct: 66 LREVLAADG---ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119
Query: 588 VSKISDVGLARLVPAVAENVTQYHLTSTA---GTFCYIDPEYQQTGMLGVKSDVYSLGIL 644
+K+ D G+ L+P V + LT T GT Y PE + + SD+Y+ G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVA-TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 645 LLQLITAKQPM 655
L+ +T ++ +
Sbjct: 179 FLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGR-SQFQREIEVLSCIRHPN 507
+ FT+ KIG+G +G V+K + T VA+K++ + A+ Q+EI VLS P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ G+ + I+ EYL GS D + PL Q I EI GL +LH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 119
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
K +HRD+K N+LL + K++D G+A + TQ + GT ++ PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-----TQIKRNTFVGTPFWMAPE 171
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
+ K+D++SLGI ++L + P H
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 459 IGEGGYGPVYKCYLDHTP----VAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLG 513
+G G G VYK Y H +AVKV+ D + + Q E+E+L P ++ G
Sbjct: 9 LGHGNGGTVYKAY--HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 514 AC-PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
A E I I E++ GSLD ++R+ L RIA + GL +L K +
Sbjct: 67 AFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---I 116
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLAR-LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG 630
+HRD+KP N+L++ K+ D G++ LV ++A + GT Y+ PE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--------KTYVGTNAYMAPERISGE 168
Query: 631 MLGVKSDVYSLGILLLQLITAKQP 654
G+ SDV+SLGI ++L + P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 69/224 (30%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 457 RKIGEGGYGPVYKCY---LDH------TPVAVKVLRPDAAQGR-SQFQREIEVLSCI-RH 505
+ +GEG +G V LD T VAVK+L+ DA + S E+E++ I +H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 506 PNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPP---------------LSWQQ 548
N++ LLGAC + G ++ EY + G+L R + R PP LS++
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNL--REYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
A ++A G+ +L K +HRDL N+L+ + V KI+D GLAR + +
Sbjct: 142 LVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----- 193
Query: 609 QYHLTSTAGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
Y+ +T G ++ PE + +SDV+S G+LL ++ T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 36/270 (13%)
Query: 448 EATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVK-VLRP--DAAQGRSQFQREIEVLSC 502
E T + + + +G G +G V L VA+K +++P + + RE+++L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKH 65
Query: 503 IRHPNMVLL--LGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ--QRFRIAAEIAT 558
+RH N++ L + P I Y L + R + PL Q Q F +I
Sbjct: 66 LRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYF--LYQILR 119
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
GL ++H +VHRDLKP NIL++ N KI D GLAR + +T T
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR--------IQDPQMTGYVST 168
Query: 619 FCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPM--GLTHFVERSIENGTLGEMLD 675
Y PE T V+ D++S G + +++ K P+ G H + SI LG D
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPD 227
Query: 676 PTVTDWPFEETLGFAKLALQCSELRRKDRP 705
+ E TL F + S +R+ P
Sbjct: 228 DVINTICSENTLRFVQ-----SLPKREPVP 252
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 42/226 (18%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCIR----HPNMVLLL 512
IGEG YG VYK T VA+K++ + + + E +L R HPN+
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNIL---RKYSNHPNIATFY 69
Query: 513 GA-------CPEYGI-IVYEYLANGSLDD---RIFRRGNTPPLSWQQRFRIA---AEIAT 558
GA + + +V E GS+ D + ++G W IA E
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLR 124
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
GL +LH+ K ++HRD+K NILL N K+ D G++ + + T + GT
Sbjct: 125 GLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-----TLGRRNTFIGT 176
Query: 619 FCYIDPE-----YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
++ PE Q +SDV+SLGI ++L K P+ H
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGR-SQFQREIEVLSCIRHPN 507
+ FT+ +IG+G +G V+K + T VA+K++ + A+ Q+EI VLS P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ G+ + I+ EYL GS D + R G P Q + EI GL +LH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAG---PFDEFQIATMLKEILKGLDYLHS 119
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
K +HRD+K N+LL K++D G+A + TQ + GT ++ PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-----TQIKRNTFVGTPFWMAPE 171
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
Q K+D++SLGI ++L + P H
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 25/170 (14%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRP---DAAQGRSQFQREIEVLSCIRHPNMVLL 511
+ IG G YG V VA+K + D + REI++L +RH N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGL 64
Query: 512 L-----GACPEYG--IIVYEYLANGSLD-DRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
L + ++ IV E + D ++ + PL+ +I GL +L
Sbjct: 65 LDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYL 119
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV---PAVAENVTQY 610
H ++HRDLKP NIL++ N KI D GLAR V +T+Y
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 31/217 (14%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQG--RSQFQREIEVLSCIRHPNM 508
+T+ KIGEG YG VYK T VA+K +R ++ + S REI +L ++HPN+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 509 VLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA---EIATGLLFL 563
V L + +++E+L S+D + + + P + + + +I G+LF
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
H + ++HRDLKP N+L+D+ V K++D GLAR A V Y T T Y
Sbjct: 118 HSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR---AFGIPVRVY--THEVVTLWYRA 169
Query: 624 PEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPM 655
PE +LG D++S+G + ++ T K+P+
Sbjct: 170 PEV----LLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 61/221 (27%), Positives = 88/221 (39%), Gaps = 54/221 (24%)
Query: 459 IGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLG 513
I +G YG V+ T A+KV++ ++Q + E ++LS + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 514 ACPEYGII-------VYEYLANG----------SLDDRIFRRGNTPPLSWQQRFRIAAEI 556
Y V EYL G SLD+ + R AEI
Sbjct: 60 ----YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI-------------YIAEI 102
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS-- 614
L +LH ++HRDLKP NIL+D N K++D GL++ V V +
Sbjct: 103 VLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKED 158
Query: 615 --TAGTFCYIDPEY---QQTGMLGVKSDVYSLGILLLQLIT 650
GT YI PE Q D +SLG +L + +
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSK---TVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 43/214 (20%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVL----RPDAAQG--RSQFQREIEVLSCIRHPNM 508
+K+GEG Y VYK VA+K + R +A G + REI++L ++HPN+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHPNI 64
Query: 509 VLLLGACPEYGII--VYEYLANGSL----DDR--IFRRGNTPPLSWQQRFRIAAEIATGL 560
+ LL I V+E++ L D+ + + GL
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM--------TLRGL 115
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
+LH ++HRDLKP N+L+ + V K++D GLAR + +T T
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVVTRW 167
Query: 621 YIDPEYQQTGMLGVKS-----DVYSLGILLLQLI 649
Y PE + G + D++S+G + +L+
Sbjct: 168 YRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 459 IGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC- 515
+G+G +G VYK T + A K+++ ++ + F EI++LS +HPN+V L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 516 --PEYGIIVYEYLANGSLDDRI--FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ I++ E+ G+LD + RG T P Q R+ + ++ L FLH K +
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEP---QIRY-VCRQMLEALNFLHSHK---V 124
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
+HRDLK GNILL + K++D G V A ++ Q T GT ++ PE
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFG----VSAKNKSTLQKRDTFI-GTPYWMAPEVVACET 179
Query: 632 L-----GVKSDVYSLGILLLQLITAKQP 654
K+D++SLGI L++L + P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 453 FTESRKIGEGGYGPVYKCYL---------DHTPVAVKVLRPDAAQGR-SQFQREIEVLSC 502
T + +GEG +G V + VAVK+L+ DA + S E+E++
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 76
Query: 503 I-RHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPP---------------L 544
I +H N++ LLGAC + G ++ EY + G+L R + R PP +
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNL--REYLRARRPPGMEYSYDIARVPDEQM 134
Query: 545 SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604
+++ ++A G+ +L K +HRDL N+L+ N V KI+D GLAR V
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDV---- 187
Query: 605 ENVTQYHLTSTAGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
N Y+ +T G ++ PE + +SDV+S G+L+ ++ T
Sbjct: 188 -NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQF---QREIEVLSCIRHPNMVLL 511
+ +G+G +G V L T AVKVL+ D E VL+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 512 LGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L +C + V EY+ G L I R G + RF AAEI GL FLH+
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD--EPRARF-YAAEIVLGLQFLHERG- 116
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQ 627
+++RDLK N+LLD KI+D G+ + E + TST GT YI PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCK------EGILGGVTTSTFCGTPDYIAPEIL 168
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
G D ++LG+LL +++ + P
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEV 499
TI + + + +T KIG+G G VY T VA+K + + EI V
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 500 LSCIRHPNMVLLLGA---CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA-- 554
+ +HPN+V L + E +V EYLA GSL D + + +IAA
Sbjct: 70 MRENKHPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVC 121
Query: 555 -EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHL 612
E L FLH + ++HRD+K NILL + K++D G A++ P Q
Sbjct: 122 RECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKR 172
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
++ GT ++ PE G K D++SLGI+ ++++ + P
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 459 IGEGGYGPVYKCYLDH-------TPVAVKVLRPDAAQGR-SQFQREIEVLSCIRHPNMVL 510
+GEG +G V K T VAVK+L+ +A+ E +L + HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 511 LLGACPEYG--IIVYEYLANGSLDDRIFRR-------------GNTP----------PLS 545
L GAC + G +++ EY GSL R F R GN L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSL--RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 546 WQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
A +I+ G+ +L + K LVHRDL N+L+ KISD GL+R V E
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR---DVYE 179
Query: 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
+ + ++ E + +SDV+S G+LL +++T
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 457 RKIGEGGYGPV-YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+++G G +G V Y + VA+K+++ + + +F E +V+ + H +V L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 516 P-EYGI-IVYEYLANGSLDD--RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ I IV EY++NG L + R + P Q + ++ G+ +L +
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQP----SQLLEMCKDVCEGMAYLESKQ---F 121
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT---FCYIDPEYQQ 628
+HRDL N L+D K+SD GL+R V +Y TS+ G+ + PE
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLD-----DEY--TSSVGSKFPVRWSPPEVLL 174
Query: 629 TGMLGVKSDVYSLGILLLQLIT-AKQP 654
KSDV++ G+L+ ++ + K P
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 459 IGEGGYGPVYKCY-------LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+G+G +G VY CY L V P+ ++ S + EI++L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 512 LGACPEYG----IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
G + I EY+ GS+ D++ G L+ + +I G+ +LH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM 126
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
+VHRD+K NIL D K+ D G ++ + + + T + S GT ++ PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG--IRSVTGTPYWMSPEVI 181
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
G K+DV+SLG +++++T K P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 449 ATQFFTESRKIGEGGYGPVYKCYL-----DHTP-VAVKVLRP-DAAQGRSQFQREIEVLS 501
A +F E +GE +G +YK +L DH VA+K L+ + Q +FQ+E +++
Sbjct: 6 AVRFMEE---LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMA 62
Query: 502 CIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGN--------------TPPLS 545
+ HPN+V LLG + +++EYL G L + + R L
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 546 WQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
IA +IA G+ +L VH+DL NIL+ KISD+GL+R + +
Sbjct: 123 HGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179
Query: 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
Q + ++ PE G SD++S G++L ++ +
Sbjct: 180 YRVQ---PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 459 IGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQ---FQREIEVLSCIRHPNMVLLLG 513
+G GG+G V + A+K ++ Q E E+L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 514 AC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+Y ++ EY G L + RG + RF A + +LH +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARF-YIACVVLAFEYLHNRG---I 114
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQ 627
++RDLKP N+LLD N K+ D G A+ ++ + TFC Y+ PE
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK----KLKSGQKTW------TFCGTPEYVAPEII 164
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQPMG 656
D +SLGILL +L+T + P G
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 459 IGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP 516
+G+G YG VY T V A+K + ++ EI + S ++H N+V LG+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 517 EYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI--AAEIATGLLFLHQTKPEPLV 572
E G I E + GSL + R PL ++ I +I GL +LH + +V
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IV 130
Query: 573 HRDLKPGNILLD-HNYVSKISDVG----LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
HRD+K N+L++ ++ V KISD G LA + P E T GT Y+ PE
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFT--------GTLQYMAPEVI 181
Query: 628 QTGM--LGVKSDVYSLGILLLQLITAKQP 654
G G +D++SLG ++++ T K P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 457 RKIGEGGYGP--VYKCYLDHTPVAVKVLRPDAAQG--RSQFQREIEVLSCIRHPNMVLLL 512
+KIGEG +G + K D +K + R + ++E+ VLS ++HPN+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 513 GACPEYG--IIVYEYLANGSLDDRI-FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
+ E G IV +Y G L +I +RG Q +I L +H K
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK-- 121
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA-GTFCYIDPEYQQ 628
++HRD+K NI L + K+ D G+AR++ + E L T GT Y+ PE +
Sbjct: 122 -ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE------LARTCIGTPYYLSPEICE 174
Query: 629 TGMLGVKSDVYSLGILLLQLITAKQ 653
KSD+++LG +L ++ T K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 48/282 (17%)
Query: 457 RKIGEGGYGPVYKCYLDHT-------PVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNM 508
R +G G +G VY+ VAVK L + Q S F E ++S H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 509 VLLLGAC----PEYGIIVYEYLANGSLDDRIFRRGNTP------PLSWQQRFRIAAEIAT 558
V L+G P + I+ E +A G L F R N P L+ + A ++A
Sbjct: 72 VRLIGVSFERLPRF--ILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGLARLVPAVAENVTQYHLTST 615
G +L + +HRD+ N LL V+KI+D G+AR + Y+
Sbjct: 128 GCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR-----ASYYRKGG 179
Query: 616 AGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS----IENGT 669
++ PE G+ K+DV+S G+LL ++ + +G + R+ +E T
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS----LGYMPYPGRTNQEVMEFVT 235
Query: 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
G LDP P ++ C + +DRP+ ++
Sbjct: 236 GGGRLDP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
++IG G YG VYK +T A+KV++ + + + Q+EI ++ +H N+V G+
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 515 CPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
I E+ GSL D I+ T PLS Q ++ E GL +LH +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHV--TGPLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE---YQQT 629
HRD+K NILL N K++D G++ + A T S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 630 GMLGVKSDVYSLGILLLQLITAKQPM 655
G D++++GI ++L + PM
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 458 KIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRSQFQ--REIEVLSCIRHPNMVLLL- 512
+IGEG YG VY+ VA+K +R D + REI +L +RHPN+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 513 ---GACPEYGIIVYEY----LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
G + +V EY LA+ LD+ P S Q + ++ GL +LH+
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLAS-LLDN------MPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
++HRDLK N+LL KI+D GLAR A+ +T T Y PE
Sbjct: 127 ---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-----PMTPKVVTLWYRAPE 178
Query: 626 YQQTGMLGVKS-----DVYSLGILLLQLITAK 652
+LG + D++++G +L +L+ K
Sbjct: 179 L----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPN 507
F + R +G+GG+G V C + T A K L R +G S E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 508 MVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V L A + +V + G L I+ GN P ++ AAEI GL LH+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR 120
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
E V+RDLKP NILLD +ISD+GLA +P + GT Y+ PE
Sbjct: 121 ---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES------IRGRVGTVGYMAPE 171
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ D + LG L+ ++I + P
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 457 RKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQ---REIEVLSCIR-HPNMVL 510
R +G+G +G V + AVKVL+ D + E +LS R HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 511 LLGAC---PEYGIIVYEYLANGSLDDRI--FRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
L C P+ V E++ G L I RR + + RF AAEI + L+FLH
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARF-YAAEITSALMFLHD 114
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDP 624
+ +++RDLK N+LLDH K++D G+ + E + TST GT YI P
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGIFNGKTTSTFCGTPDYIAP 165
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E Q + G D +++G+LL +++ P
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 453 FTESRKIGEGGYGPVYKCYL---------DHTPVAVKVLRPDAA-QGRSQFQREIEVLSC 502
T + +GEG +G V VAVK+L+ DA + S E+E++
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 503 I-RHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPP---------------L 544
I +H N++ LLGAC + G ++ EY + G+L R + R PP L
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNL--REYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 545 SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604
+++ A ++A G+ +L K +HRDL N+L+ + V KI+D GLAR V +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNI- 187
Query: 605 ENVTQYHLTSTAGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
Y+ +T G ++ PE + +SDV+S G+LL ++ T
Sbjct: 188 ----DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 40/224 (17%)
Query: 457 RKIGEGGYGPVYKC--------YLDHT-PVAVKVLRPDAA-QGRSQFQREIEVLSCI-RH 505
+ +GEG +G V + D T VAVK+L+ +A + + E+E++ I +H
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 506 PNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPP---------------LSWQQ 548
N++ LLG C + G ++ EY A G+L R F R PP LS++
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNL--REFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
A ++A G+ +L + +HRDL N+L+ + V KI+D GLAR V +
Sbjct: 136 LVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDI----- 187
Query: 609 QYHLTSTAGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
Y+ ++ G ++ PE + +SDV+S GIL+ ++ T
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDA-AQG-RSQFQREIEVLSCIRHPNM 508
F + KIGEG YG VYK T VA+K +R D +G S REI +L + HPN+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 509 VLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTP---PLSWQQRFRIAAEIATGLLFL 563
V LL +V+E+L D + F + PL + + ++ GL F
Sbjct: 62 VKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYLF--QLLQGLAFC 116
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
H + ++HRDLKP N+L++ K++D GLAR A V Y T T Y
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY--THEVVTLWYRA 168
Query: 624 PEYQQTGMLGVK-----SDVYSLGILLLQLITAK 652
PE +LG K D++SLG + +++T +
Sbjct: 169 PEI----LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 457 RKIGEGGYGPVY-KCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+++G G +G V+ + VA+K + + A F E +V+ + HP +V L G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P Y IV E++ NG L + + R LS + ++ G+ +L +
Sbjct: 69 TQQKPLY--IVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---F 121
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YIDPEYQQT 629
+HRDL N L+ V K+SD G+ R V + + +S+ F + PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYV------LDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 630 GMLGVKSDVYSLGILLLQLIT-AKQP 654
KSDV+S G+L+ ++ T K P
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 458 KIGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
++G+G +G VYK T A KV+ + + + EIE+L+ HP +V LLGA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 516 PEYG--IIVYEYLANGSLDDRIFR--RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
G I+ E+ G++D + RG T P Q I ++ L +LH K +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP----QIQVICRQMLEALQYLHSMK---I 131
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV-TQYHLTSTAGTFCYIDPEYQQTG 630
+HRDLK GN+LL + K++D G++ A+NV T S GT ++ PE
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 631 ML-----GVKSDVYSLGILLLQLITAKQP 654
+ K+D++SLGI L+++ + P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGR-SQFQREIEVLSCIRHPNMV 509
F + K+GEG Y VYK T VA+K + DA +G S REI ++ ++H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 510 LLLGACPEYGII--------VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLL 561
L + +I V+EY+ + L + G L ++ G+
Sbjct: 62 RL------HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
F H+ + ++HRDLKP N+L++ K++D GLAR A V + ++ T Y
Sbjct: 115 FCHENR---VLHRDLKPQNLLINKRGELKLADFGLAR---AFGIPVNTF--SNEVVTLWY 166
Query: 622 IDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
P+ +LG ++ D++S+G ++ ++IT +
Sbjct: 167 RAPDV----LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 459 IGEGGYGPVYKCYLDHT--PVAVKVLR-----PDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+G+G +G VY CY T +AVK ++ P+ ++ + + EI++L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 512 LGAC---PEYGIIVY-EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
G E + ++ E++ GS+ D++ G L+ + +I G+ +LH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM 126
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
+VHRD+K NIL D K+ D G ++ + + + T + S GT ++ PE
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG--MKSVTGTPYWMSPEVI 181
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
G K+D++S+G +++++T K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 457 RKIGEGGYGP--VYKCYLDHTPVAVKV--LRPDAAQGRSQFQREIEVLSCIRHPNMVLLL 512
R +G+G +G +Y+ D + V K L + + R EI +LS ++HPN++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 513 GACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA--EIATGLLFLHQTKP 568
+ +I EY G+L D+I R+ +++ + +I + + ++H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQIVSAVSYIHK--- 119
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
++HRD+K NI L + K+ D G+++++ + GT Y+ PE Q
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-----GSEYSMAETVVGTPYYMSPELCQ 174
Query: 629 TGMLGVKSDVYSLGILLLQLITAKQ 653
KSD+++LG +L +L+T K+
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 72/224 (32%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ---REIEVLS 501
++ + FT+ R+IG G +G VY T VA+K + Q ++Q +E+ L
Sbjct: 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 502 CIRHPNMVLLLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA---E 555
+RHPN + G C +V EY GS D + + PL Q IAA
Sbjct: 71 QLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDIL--EVHKKPL---QEVEIAAICHG 123
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV-PAVAENVTQYHLTS 614
GL +LH + +HRD+K GNILL K++D G A LV PA S
Sbjct: 124 ALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----------NS 170
Query: 615 TAGTFCYIDPEY---QQTGMLGVKSDVYSLGILLLQLITAKQPM 655
GT ++ PE G K DV+SLGI ++L K P+
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-13
Identities = 79/314 (25%), Positives = 131/314 (41%), Gaps = 43/314 (13%)
Query: 408 QRRLSAEMNRLKESD---EVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGY 464
+ R + E+ R++ D E++ S +S + TI DI + E I G
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKVS------KSITINDILSSL---KEENVISRGKK 703
Query: 465 GPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIV 522
G YK ++ + + S EI + ++HPN+V L+G C + ++
Sbjct: 704 GASYKGKSIKN--GMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761
Query: 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582
+EY+ +L + + R LSW++R +IA IA L FLH +V +L P I+
Sbjct: 762 HEYIEGKNLSE-VLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815
Query: 583 LDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLG 642
+D + RL S+A Y+ PE ++T + KSD+Y G
Sbjct: 816 IDGKDEPHL------RLSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFG 865
Query: 643 ILLLQLITAKQPMGLTHFVERSI--------ENGTLGEMLDPTV---TDWPFEETLGFAK 691
++L++L+T K P V SI + L +DP++ E +
Sbjct: 866 LILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN 925
Query: 692 LALQCSELRRKDRP 705
LAL C+ RP
Sbjct: 926 LALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 454 TESRKIGEGGYGPVYK-CYLDHT----PVAVKVLRPDAAQGRSQ-FQREIEVLSCIRHPN 507
T R IGEG +G VY+ Y+ VAVK + + + F +E ++ HP+
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 508 MVLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
+V L+G E + IV E G L R + + N L + +++T L +L
Sbjct: 69 IVKLIGVITENPVWIVMELAPLGEL--RSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
+ VHRD+ N+L+ K+ D GL+R + E+ + Y + ++ PE
Sbjct: 127 R---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL----EDESYYKASKGKLPIKWMAPES 179
Query: 627 QQTGMLGVKSDVYSLGILLLQ-LITAKQPMGLTHFVERS-----IENG 668
SDV+ G+ + + L+ +P V+ + IENG
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPF---QGVKNNDVIGRIENG 224
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 457 RKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNM 508
R++G+G +G VY+ T VAVK + A+ + R +F E V+ ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 509 VLLLGACP--EYGIIVYEYLANGSLDD--RIFR-----RGNTPPLSWQQRFRIAAEIATG 559
V LLG + ++V E +A+G L R R PP + Q+ ++AAEIA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTF 619
+ +L+ K VHRDL N ++ H++ KI D G+ R + T Y+ G
Sbjct: 132 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-----TDYYRKGGKGLL 183
Query: 620 --CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
++ PE + G+ SD++S G++L ++ + A+QP
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAA-QGRSQFQREIE 498
E A + T SR++G+G +G VY+ T VA+K + A+ + R +F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 499 VLSCIRHPNMVLLLGACPE--YGIIVYEYLANGSLDD--RIFRR------GNTPPLSWQQ 548
V+ ++V LLG + +++ E + G L R R PP S ++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP-SLKK 120
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
++A EIA G+ +L+ K VHRDL N ++ ++ KI D G+ R + T
Sbjct: 121 MIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----T 172
Query: 609 QYHLTSTAGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTH-FVER 663
Y+ G ++ PE + G+ SDV+S G++L ++ T A+QP G+++ V R
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
Query: 664 SIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
+ G L + D D FE L C + K RP +++
Sbjct: 233 FVMEGGLLDKPD-NCPDMLFE-------LMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVK--VLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG V+KC T VA+K V D + REI +L ++HPN+V L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 514 ACPEYGI--IVYEYLANGSLD--DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
+V+EY + L+ ++ N + +I + + F H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHKHN-- 120
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQY 610
+HRD+KP NIL+ K+ D G AR++ ++ T Y
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 33/230 (14%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVL-RP--DAAQGRSQ 492
YR+ + + E + +G G YG V + T VA+K L RP A +
Sbjct: 2 YRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT 61
Query: 493 FQREIEVLSCIRHPNMVLLLGA-CPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQR 549
+ RE+ +L + H N++ LL P + ++ YL + + LS
Sbjct: 62 Y-RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 550 FRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609
+ +I GL ++H ++HRDLKP NI ++ + KI D GLAR + +T
Sbjct: 121 QFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTG 174
Query: 610 YHLTSTAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQLITAK 652
Y T Y PE Y QT D++S+G ++ +L+T K
Sbjct: 175 Y-----VATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 49/229 (21%)
Query: 459 IGEGGYGPVYKCY--LDHTPVAVKVLR----PDAAQGRSQF----------QREIEVLSC 502
+GEG YG V K Y L VA+K ++ + Q RE+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 503 IRHPNMVLLLGACPEYGII--VYEYLANG---SLDDRIFRRGNTPPLSWQQRFRIAAEIA 557
I+H N++ L+ E I V + +A+ +D +I L+ Q I +I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-------LTESQVKCILLQIL 129
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR------LVPAVAENVT--- 608
GL LH+ +HRDL P NI ++ + KI+D GLAR ++++ T
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
+ +TS T Y PE ++G + D++S+G + +L+T K
Sbjct: 187 REEMTSKVVTLWYRAPEL----LMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 457 RKIGEGGYGPV--YKCYLDHTPVAVKVL--RPDAAQGRSQFQREIEVLSCIRHPNMVLLL 512
R +G+G YG V + D +K L R + + R ++E ++LS ++HPN+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 513 -----GACPEYGIIVYEYLANGSLDDRIF-RRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
Y IV + G L ++ ++G P + Q +IA L +LH+
Sbjct: 66 ESWEGEDGLLY--IVMGFCEGGDLYHKLKEQKGKLLPEN--QVVEWFVQIAMALQYLHE- 120
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPE 625
+ ++HRDLK N+ L + K+ D+G+AR V EN Q + ST GT Y+ PE
Sbjct: 121 --KHILHRDLKTQNVFLTRTNIIKVGDLGIAR----VLEN--QCDMASTLIGTPYYMSPE 172
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQPMG---LTHFVERSIENGTLGEMLDPTVTDWP 682
KSDV++LG + ++ T K + V R IE G L M P
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPM--------P 223
Query: 683 FEETLGFAKLALQCSELRRKDRPDLGKVV 711
+ + +L R + RP + ++
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 457 RKIGEGGYGPVYKCYLDHTP-----VAVKVLRPDAAQGRSQ-----FQREIEVLSCIRHP 506
+ +G+GGYG V++ A+KVL+ A R+Q + E +L ++HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLK-KATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 507 NMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
+V L+ A G ++ EYL+ G L + R G + F ++ EI+ L LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF--MEDTACFYLS-EISLALEHLH 117
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYID 623
Q + +++RDLKP NILLD K++D GL + E++ + +T T GT Y+
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCK------ESIHEGTVTHTFCGTIEYMA 168
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE G D +SLG L+ ++T P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKC--YLDHTPVAVKVLRPDAAQGRSQFQREIEV 499
TI I + + +T KIG+G G V+ VA+K + + EI V
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 500 LSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIA 557
+ +++PN+V L + + +V EYLA GSL D + + Q + E
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECL 125
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTA 616
L FLH + ++HRD+K N+LL + K++D G A++ P Q ++
Sbjct: 126 QALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE------QSKRSTMV 176
Query: 617 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
GT ++ PE G K D++SLGI+ ++++ + P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 458 KIGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
++G+G +G VYK T V A KV+ + + + EI++L+ HPN+V LL A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 516 P-EYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
E + I+ E+ A G++D + PL+ Q + + L +LH+ K ++H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENV-TQYHLTSTAGTFCYIDPEY-----Q 627
RDLK GNIL + K++D G++ A+N T S GT ++ PE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS------AKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
+ K+DV+SLGI L+++ + P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 457 RKIGEGGYG-PVYKCY-LDHTPVAVKVLR-PDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
R +GEG +G + + A+K +R P ++ ++E +L+ ++HPN+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 514 ACPEYG--IIVYEYLANGSLDDRI-FRRGNTPP----LSWQQRFRIAAEIATGLLFLHQT 566
+ G IV EY G L +I +RG P L W ++ G+ +H+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK 119
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
+ ++HRD+K NI L N K+ D G ARL+ + Y GT Y+ PE
Sbjct: 120 R---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-----VGTPYYVPPEI 171
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ KSD++SLG +L +L T K P
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 69/256 (26%), Positives = 118/256 (46%), Gaps = 51/256 (19%)
Query: 458 KIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQ----REIEVLSCIRHPNMV-- 509
+I EG YG VY + VA+K L+ + + + F REI +L ++HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKME--KEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 510 --LLLGACPEYGIIVYEYLAN---GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
+++G+ + +V EY+ + ++ P + + ++ +G+ LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMET------MKQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
++HRDLK N+LL++ + KI D GLAR + + T T Y P
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-----PYTQLVVTLWYRAP 175
Query: 625 EYQQTGMLGVKS-----DVYSLGILLLQLITAKQPMGLTHFVERS-IE--NGTLGEMLDP 676
E +LG K D++S+G + +L+T K+P+ F +S I+ N + P
Sbjct: 176 EL----LLGAKEYSTAIDMWSVGCIFAELLT-KKPL----FPGKSEIDQLNKIFKLLGTP 226
Query: 677 TVTDWPFEETLGFAKL 692
T WP GF++L
Sbjct: 227 TEKIWP-----GFSEL 237
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 459 IGEGGYGPVYKCYLDHT--PVAVKVL--RPDAAQGRSQ---FQREIEVLSCIRHPNMVLL 511
+G G +G VY CY T +AVK + PD+ + + + EI++L +RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 512 LGACPEYG----IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
G + I EY+ GS+ D++ G L+ R +I G+ +LH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM 126
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
+VHRD+K NIL D K+ D G ++ + + + T + S GT ++ PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG--IKSVTGTPYWMSPEVI 181
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
G K+DV+S+ +++++T K P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQG-RSQFQREIEVLSCIRHPN 507
F + ++G G G V+K + H P +A K++ + R+Q RE++VL P
Sbjct: 7 FEKISELGAGNGGVVFK--VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V GA G I E++ GSLD + + G P Q +++ + GL +L +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE 121
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCYIDP 624
++HRD+KP NIL++ K+ D G++ +L+ ++A S GT Y+ P
Sbjct: 122 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--------NSFVGTRSYMSP 171
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
E Q V+SD++S+G+ L+++ + P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 69/209 (33%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPN 507
F + R +G+GG+G V C + T A K L R +G S E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 508 MVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V L A + +V + G L I+ G + F AAEI GL LHQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQ 120
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
E +V+RDLKP NILLD + +ISD+GLA VP E T + GT Y+ PE
Sbjct: 121 ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQT---IKGRVGTVGYMAPE 171
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ D ++LG LL ++I + P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 458 KIGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGR-SQFQREIEVLSCIRHPNMVLLLGA 514
++G+G YG VYK T V A+K +R + + + +Q E+++L P +V GA
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 515 CPEYGIIVY--EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL---HQTKPE 569
G + EY+ GSLD T + RI + GL FL H
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---- 123
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCYIDPEY-- 626
++HRD+KP N+L++ N K+ D G++ LV ++A+ + G Y+ PE
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--------TNIGCQSYMAPERIK 174
Query: 627 ----QQTGMLGVKSDVYSLGILLLQLITAKQP 654
Q V+SDV+SLG+ +L++ + P
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 27/160 (16%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP---VAVKVLRPDAAQGRSQFQ--------REIEVLS 501
+ +++G+G +G VY + VA+K ++ +F RE++ L
Sbjct: 1 YKVIKQLGDGTFGSVYLA-RNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLR 52
Query: 502 CI-RHPNMVLLLGACPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIAT 558
+ HPN+V L E V+EY+ G+L + R P S I +I
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQILQ 110
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
GL +H+ HRDLKP N+L+ V KI+D GLAR
Sbjct: 111 GLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 76/259 (29%), Positives = 112/259 (43%), Gaps = 57/259 (22%)
Query: 453 FTESRKIGEGGYGPVYKC--YLDHTPVAVKVLR-PDAAQGRSQFQ-REIEVLSCIR---H 505
+ E +IGEG YG VYK VA+K +R P + +G REI +L + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 506 PNMVLLLGAC--PEYG-----IIVYEY----LANGSLDDRIFRRGNTPPLSWQQRFRIAA 554
PN+V LL C P +V+E+ LA + P L + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLA------TYLSKCPKPGLPPETIKDLMR 114
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
++ G+ FLH + +VHRDLKP NIL+ + KI+D GLAR + + LTS
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR----IYSF--EMALTS 165
Query: 615 TAGTFCYIDPE--YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENG-TLG 671
T Y PE Q + V D++S+G + +L F R + G +
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPV--DMWSVGCIFAEL-----------FRRRPLFRGTSEA 212
Query: 672 EMLD--------PTVTDWP 682
+ LD P+ +WP
Sbjct: 213 DQLDKIFDVIGLPSEEEWP 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 454 TESRKI---GEGGYGPVYKCYLD------HTPVAVKVLRPDAAQGRSQFQR---EIEVLS 501
TE RK+ G G +G V+K PVA+K ++ + GR FQ + +
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMG 64
Query: 502 CIRHPNMVLLLGACPEYGI-IVYEYLANGSLDDRIF-RRGNTPP---LSWQQRFRIAAEI 556
+ H +V LLG CP + +V + GSL D + R + P L+W +I
Sbjct: 65 SLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQI 118
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA 616
A G+ +L + + +VHR+L NILL + + +I+D G+A L+ + +Y +
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP---DDKKYFYSEHK 172
Query: 617 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
++ E G +SDV+S G+ + ++++
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 67/209 (32%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPN 507
F R +G+GG+G V C + T A K L R +G + E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 508 MVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V L A + +V + G L I+ GN P ++ AAEI GL LH+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR 120
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
E +V+RDLKP NILLD +ISD+GLA +P E T + GT Y+ PE
Sbjct: 121 ---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP---EGET---IRGRVGTVGYMAPE 171
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ D + LG L+ ++I K P
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ---REIEVLS 501
E+ + FT+ R+IG G +G VY T VA+K + Q ++Q +E++ L
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
I+HPN + G +V EY GS D + + PL + I G
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQG 137
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV-PAVAENVTQYHLTSTAGT 618
L +LH ++HRD+K GNILL K++D G A + PA S GT
Sbjct: 138 LAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----------NSFVGT 184
Query: 619 FCYIDPEY---QQTGMLGVKSDVYSLGILLLQLITAKQPM 655
++ PE G K DV+SLGI ++L K P+
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 43/235 (18%)
Query: 445 DIEEATQFFTESRKIGEGGYGPVYKCYLDHTP-------VAVKVLRPDAAQG--RSQFQR 495
+I +T F E ++GE +G VYK +L T VA+K L+ D A+G R +F+
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKH 57
Query: 496 EIEVLSCIRHPNMVLLLGACPEYGII--VYEYLANGSL-----------------DDRIF 536
E + S ++HPN+V LLG + + ++ Y ++ L DD+
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 537 RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596
+ P I +IA G+ FL +VH+DL N+L+ KISD+GL
Sbjct: 118 KSTLEPA----DFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 597 ARLVPAVAENVTQYHLTSTAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
R V A Y L + ++ PE G + SD++S G++L ++ +
Sbjct: 171 FREVYA----ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 6e-12
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEV 499
+I + + + +T KIG+G G VY T VA+K + + EI V
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 500 LSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIA 557
+ ++PN+V L + + +V EYLA GSL D + + Q + E
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 125
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTA 616
L FLH + ++HRD+K NILL + K++D G A++ P Q ++
Sbjct: 126 QALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMV 176
Query: 617 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
GT ++ PE G K D++SLGI+ ++++ + P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 458 KIGEGGYGPVYKCYL--DHTPVAVKVL--RPDAAQGRSQFQREIEVLSCIRHPNMV---- 509
IG+G +G V K D + K + + + Q E+ +L ++HPN+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 510 --LLLGACPEYGIIVYEYLANGSLDDRIFR-RGNTPPLSWQQRFRIAAEIATGLLFLH-Q 565
+ Y IV EY G L I + + + + +RI ++ L H +
Sbjct: 67 RIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 566 TKPEPLV-HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ P V HRDLKP NI LD N K+ D GLA+++ + GT Y+ P
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-----GHDSSFAKTYVGTPYYMSP 179
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E KSD++SLG L+ +L P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPN 507
F R +G+GG+G V C + T A K L R +G + E +L + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSR 60
Query: 508 MVLLLGACPEYG---IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
V+ L E +V + G L I+ GN P Q+ AAE+ GL L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQ 119
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ E +V+RDLKP NILLD +ISD+GLA +P E T + GT Y+ P
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGET---VRGRVGTVGYMAP 170
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E D + LG L+ ++I + P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 7e-12
Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 18/228 (7%)
Query: 432 STKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG 489
S +++ + +I + + + +T KIG+G G VY T VA++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 490 RSQFQREIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
+ EI V+ ++PN+V L + + +V EYLA GSL D + +
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEG 116
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAEN 606
Q + E L FLH + ++HRD+K NILL + K++D G A++ P
Sbjct: 117 QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169
Query: 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
Q ++ GT ++ PE G K D++SLGI+ +++I + P
Sbjct: 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYLD------HTPVAVKVLR-PDAAQGRSQFQREIEVLSCIRH 505
F + + +G G +G VYK PVA+K LR + + + E V++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 506 PNMVLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
P++ LLG C + ++ + + G L D + R + + Q +IA G+ +L
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ + LVHRDL N+L+ KI+D GLA+L+ A + +YH ++
Sbjct: 127 ERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---DEKEYHAEGGKVPIKWMAL 180
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLIT 650
E + +SDV+S G+ + +L+T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 454 TESRKI---GEGGYGPVYKCYLD------HTPVAVKVLRPDAA-QGRSQFQREIEVLSCI 503
TE +K+ G G +G VYK PVA+KVLR + + + + E V++ +
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66
Query: 504 RHPNMVLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
P + LLG C + +V + + G L D + R N + Q +IA G+ +
Sbjct: 67 GSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSY 124
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
L + + LVHRDL N+L+ KI+D GLARL+ + T+YH ++
Sbjct: 125 LEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI---DETEYHADGGKVPIKWM 178
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLIT 650
E +SDV+S G+ + +L+T
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 459 IGEGGYGPVYKCY------LDHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLL 511
+G G +G VYK PVA+K+L + +F E +++ + HP++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 512 LGACPEYGI-IVYEYLANGSLDDRIFRR----GNTPPLSWQQRFRIAAEIATGLLFLHQT 566
LG C I +V + + +G L D + G+ L+W +IA G+++L +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER 128
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
+ LVHRDL N+L+ KI+D GLARL+ + +Y+ ++ E
Sbjct: 129 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG---DEKEYNADGGKMPIKWMALEC 182
Query: 627 QQTGMLGVKSDVYSLGILLLQLIT 650
+SDV+S G+ + +L+T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 35/218 (16%)
Query: 459 IGEGGYGPVYKCYLDHTP---VAVK-------VLRPDAAQGRSQFQREIEVLSCI----R 504
+G G +G VYK + +A+K D + + ++ I R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 505 HPNMVLLLGACPE----YGIIVYEYLANGSLDDRIF----RRGNTPPLSWQQRFRIAAEI 556
HPN+V E Y IV + + L + ++ ++ + I ++
Sbjct: 68 HPNIVRYYKTFLENDRLY--IVMDLIEGAPLGEHFNSLKEKKQRFTE---ERIWNIFVQM 122
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA 616
L +LH+ K +VHRDL P NI+L + I+D GLA+ + + LTS
Sbjct: 123 VLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK------QKQPESKLTSVV 174
Query: 617 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
GT Y PE + G K+DV++ G +L Q+ T + P
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 447 EEATQFFTESRKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQ---REIEVLS 501
++ + F++ R+IG G +G VY + + VA+K + Q ++Q +E+ L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
+RHPN + G +V EY GS D + + PL + + G
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQG 127
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV-PAVAENVTQYHLTSTAGT 618
L +LH ++HRD+K GNILL + K+ D G A ++ PA GT
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----------NXFVGT 174
Query: 619 FCYIDPEY---QQTGMLGVKSDVYSLGILLLQLITAKQPM 655
++ PE G K DV+SLGI ++L K P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
KIGEG G V T VAVK + Q R E+ ++ +HPN+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 511 LLGACPEYGI-----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ + Y + +V E+L G+L D I ++ +Q + + L FLH
Sbjct: 81 MYSS---YLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSFLHA 133
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
++HRD+K +ILL + K+SD G V++ V + S GT ++ PE
Sbjct: 134 QG---VIHRDIKSDSILLTSDGRVKLSDFGFC---AQVSKEVPRRK--SLVGTPYWMAPE 185
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
G + D++SLGI++++++ + P
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 74/249 (29%), Positives = 107/249 (42%), Gaps = 37/249 (14%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ--REIEVLSCIR---HPNMVL 510
+IG G YG VYK H+ VA+K +R + RE+ +L + HPN+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 511 LLGACPEYGI-------IVYEYLANGSLDDRIFRRGNTPP-LSWQQRFRIAAEIATGLLF 562
L+ C +V+E++ D R + PP L + + + GL F
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
LH +VHRDLKP NIL+ K++D GLAR+ Q LT T Y
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC------QMALTPVVVTLWYR 174
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD----PTV 678
PE D++S+G + ++ K P+ F S E LG++ D P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK-PL----FCGNS-EADQLGKIFDLIGLPPE 228
Query: 679 TDWPFEETL 687
DWP + TL
Sbjct: 229 DDWPRDVTL 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGR-----SQFQREIEVLSCIRHPNMVLL 511
+G+G +G V L T A+KVL+ D + ++ I L+ +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 512 LGA--CPEYGIIVYEYLANGSLDDRI--FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
+ V EY+ G L +I R+ + P + RF AAE+ L+FLH+
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP----RSRF-YAAEVTLALMFLHR-- 114
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEY 626
+++RDLK NILLD K++D G+ + E + T+T GT YI PE
Sbjct: 115 -HGVIYRDLKLDNILLDAEGHCKLADFGMCK------EGILNGVTTTTFCGTPDYIAPEI 167
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQP 654
Q G D ++LG+L+ +++ + P
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 459 IGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQ----REIEVLSCIRHPNMVLLLGA 514
+GEG YG V KC T V + + ++ + + RE+++L ++ N+V L A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 515 CPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
G +V+EY+ L+ PP ++ + I + +H +V
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE------KVRSYIYQLIKAIHWCHKNDIV 122
Query: 573 HRDLKPGNILLDHNYVSKISDVGLAR-LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
HRD+KP N+L+ HN V K+ D G AR L N T+Y T Y PE
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY-----VATRWYRSPELLLGAP 177
Query: 632 LGVKSDVYSLGILLLQLITAKQPM 655
G D++S+G +L +L + QP+
Sbjct: 178 YGKAVDMWSVGCILGEL-SDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQG-RSQFQREIEVLSCIRHPN 507
F ++G G G V K + H P +A K++ + R+Q RE++VL P
Sbjct: 7 FERISELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V GA G I E++ GSLD ++ + P + IA + GL +L +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSIA--VLRGLAYLRE 121
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCYIDP 624
++HRD+KP NIL++ K+ D G++ +L+ ++A S GT Y+ P
Sbjct: 122 K--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--------NSFVGTRSYMSP 171
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
E Q V+SD++S+G+ L++L + P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQG-RSQFQREIEVLSCIRHPN 507
F + ++G G G V K H P +A K++ + R+Q RE++VL P
Sbjct: 3 FEKLGELGAGNGGVVTKVL--HRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL-- 563
+V GA G I E++ GSLD + + G P +I+ + GL +L
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---NILGKISIAVLRGLTYLRE 117
Query: 564 -HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCY 621
H+ ++HRD+KP NIL++ K+ D G++ +L+ ++A S GT Y
Sbjct: 118 KHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--------NSFVGTRSY 164
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
+ PE Q V+SD++SLG+ L+++ + P+
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 32/166 (19%)
Query: 453 FTESRKIGEGGYGPVYK--CYLDHTPVAVK-VLRPDAAQGRSQF----QREIEVLSCIRH 505
+ K+GEG +G VYK VA+K +L + G F REI++L ++H
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKH 66
Query: 506 PNMVLLLGACPEY--------GII--VYEYLA---NGSLDDRIFRRGNTPPLSWQQRFRI 552
PN+V L+ E G + V Y+ +G L++ + L+ Q
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------LTESQIKCY 120
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
++ G+ +LH+ ++HRD+K NIL+D+ + KI+D GLAR
Sbjct: 121 MLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 458 KIGEGGYGPVYKCYLD----HTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLL 511
++G G +G V K VAVK+L+ D + + RE V+ + +P +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 512 LGACP-EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+G C E ++V E G L+ + + + ++ + + +++ G+ +L +T
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETN--- 115
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YIDPEYQQ 628
VHRDL N+LL + +KISD GL++ + A EN Y+ T G + + PE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DEN---YYKAKTHGKWPVKWYAPECMN 171
Query: 629 TGMLGVKSDVYSLGILL 645
KSDV+S G+L+
Sbjct: 172 YYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ---REIEVLS 501
++ + F +IG G +G VY HT VAVK + Q ++Q +E++ L
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
++HPN + G +V EY GS D + + PL + I G
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQG 133
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV-PAVAENVTQYHLTSTAGT 618
L +LH ++HRD+K GNILL K++D G A PA S GT
Sbjct: 134 LAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----------NSFVGT 180
Query: 619 FCYIDPEY---QQTGMLGVKSDVYSLGILLLQLITAKQPM 655
++ PE G K DV+SLGI ++L K P+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-11
Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 58/267 (21%)
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQREIEV 499
E+A +++ SR +G G G V K D P AVKV+ + + + + EV
Sbjct: 24 EATAKEQAKKYWI-SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEV 82
Query: 500 ---LSC----------------IRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGN 540
L+C R+P VL++ +V +Y G L I R
Sbjct: 83 CCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA-------LVLDYANAGDLRQEIKSRAK 135
Query: 541 TPPLSWQQRFRIAAEIATGLLFL------HQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594
T R E GLLF+ H + ++HRD+K NILL N + K+ D
Sbjct: 136 TN--------RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187
Query: 595 GLARLVPA-VAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLI 649
G +++ A V+++V + TFC Y+ PE + K+D++SLG+LL +L+
Sbjct: 188 GFSKMYAATVSDDVGR--------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239
Query: 650 TAKQPMGLTHFVERSIENGTLGEMLDP 676
T K+P + E + + TL DP
Sbjct: 240 TLKRPFDGENMEE--VMHKTLAGRYDP 264
|
Length = 496 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 457 RKIGEGGYGPVYK----CYLDHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLL 511
+IG G +G V + V VK LR A + F +E++ + HPN++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 512 LGACPEYG--IIVYEYLANGSL-----DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
LG C E ++V E+ G L +R Q R+A E+A+GLL+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ---RMACEVASGLLWLH 117
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YI 622
Q +H DL N L + KI D GL A+ + Y++T ++
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGL-----ALEQYPEDYYITKDCHAVPLRWL 169
Query: 623 DPEY---QQTGMLGVK----SDVYSLGILLLQLIT-AKQP 654
PE + +L S+++SLG+ + +L T A QP
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQGRSQFQ-REIEVLSCIRHPN 507
+ IGEG YG V C H P VA+K + P Q Q REI++L +H N
Sbjct: 7 YQNLSYIGEGAYGMV--CSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 508 MVLLLGACPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
++ +L + Y+ ++ +++ T LS +I GL ++H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHS 124
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
++HRDLKP N+LL+ N KI D GLAR+ ++ LT T Y PE
Sbjct: 125 AN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF--LTEYVATRWYRAPE 179
Query: 626 YQQTGMLGVKS-----DVYSLGILLLQLITAK 652
ML K D++S+G +L ++++ +
Sbjct: 180 I----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRH---PNMVL 510
IG GG+G VY C T A+K L R QG + E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 511 LLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
+ A P+ + + + G L + + G S ++ A EI GL +H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHN--- 115
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
+V+RDLKP NILLD + +ISD+GLA + ++ ++ GT Y+ PE Q
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLAC-------DFSKKKPHASVGTHGYMAPEVLQ 168
Query: 629 TGM-LGVKSDVYSLGILLLQLITAKQP 654
G +D +SLG +L +L+ P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 50/222 (22%)
Query: 459 IGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
IG G +G V K + H P +AVK +R + Q + +++ +R +
Sbjct: 12 IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSSD------- 61
Query: 515 CPE----YGIIVYE-------YLANGSLDD---RIFRRGNTPPLSWQQRF--RIAAEIAT 558
CP YG + E L + SLD ++ I +IA
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLK-------SVIPEEILGKIAV 114
Query: 559 GLL-FLHQTKPE-PLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQYHLTST 615
+ L+ K E ++HRD+KP NILLD N K+ D G++ +LV ++A+ T
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-------TRD 167
Query: 616 AGTFCYIDPEYQQTGMLG---VKSDVYSLGILLLQLITAKQP 654
AG Y+ PE V+SDV+SLGI L ++ T K P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 31/279 (11%)
Query: 453 FTESRKIGEGGYGPVYKCYL---DHTP--VAVKVLRPDAAQGR--SQFQREIEVLSCIRH 505
+ +GEG +G V + L D + VAVK ++ D +F E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 506 PNMVLLLGAC--------PEYGIIVYEYLANGSLDDRIFRR---GNTPPLSWQQRFRIAA 554
PN++ L+G C +++ ++ +G L + G L Q +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
+IA G+ +L +HRDL N +L + ++D GL++ + + + Q +
Sbjct: 121 DIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYS-GDYYRQGRIAK 176
Query: 615 TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEML 674
+ I E + KSDV++ G+ + ++ T G T + +EN + + L
Sbjct: 177 MPVKWIAI--ESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYP--GVENHEIYDYL 228
Query: 675 -DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712
P + L C KDRP K+
Sbjct: 229 RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 25/233 (10%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRH---PNMVL 510
IG GG+G VY C T A+K L R QG + E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 511 LLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
+ A P+ + + + G L + + G S + AAEI GL +H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHN--- 115
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
+V+RDLKP NILLD + +ISD+GLA + ++ ++ GT Y+ PE Q
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLAC-------DFSKKKPHASVGTHGYMAPEVLQ 168
Query: 629 TGMLGVKS-DVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTD 680
G+ S D +SLG +L +L+ P H + E + + + D
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 38/269 (14%)
Query: 458 KIGEGGYG----PVYKCYLDHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLL 512
++G G +G VYK VA+KVL+ + + R + RE E++ + +P +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 513 GAC-PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
G C E ++V E + G L+ + + + +S + +++ G+ +L
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLEGKN---F 116
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--YIDPEYQQT 629
VHRDL N+LL + + +KISD GL++ + A Y+ +AG + + PE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGA----DDSYYKARSAGKWPLKWYAPECINF 172
Query: 630 GMLGVKSDVYSLGILLLQLIT--------AKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681
+SDV+S GI + + + K P ++ F+E+ G+ L D
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQ-------GKRL-----DC 219
Query: 682 PFEETLGFAKLALQCSELRRKDRPDLGKV 710
P E L C + +DRP+ KV
Sbjct: 220 PAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 58/225 (25%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVKVLR-PDAAQG-RSQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG V+K T VA+K +R D +G S REI +L ++H N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL-- 64
Query: 514 ACPEYGI--------IVYEYL----------ANGSLDDRIFRRGNTPPLSWQQRFRIAAE 555
Y + +V+EY NG +D I + +
Sbjct: 65 ----YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS-------------FMFQ 107
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
+ GL F H ++HRDLKP N+L++ N K++D GLAR A V Y ++
Sbjct: 108 LLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCY--SAE 159
Query: 616 AGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPM 655
T Y P+ + G K D++S G + +L A +P+
Sbjct: 160 VVTLWYRPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 16/142 (11%)
Query: 475 TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLD 532
V +KVL D + F ++S + H ++V L G C E I+V EY+ G LD
Sbjct: 31 VSVVLKVLGSDHRDSLA-FFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLD 88
Query: 533 DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL-----DHNY 587
+ R N L W + +A ++A+ L +L K LVH ++ NIL+ + Y
Sbjct: 89 VFLHREKNNVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGY 143
Query: 588 V--SKISDVGLARLVPAVAENV 607
V K+SD G+ V + E V
Sbjct: 144 VPFIKLSDPGIPITVLSREERV 165
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 13/138 (9%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLL 511
+ +G+G G V+ L T A+KVL R++ +R E E+L+ + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 512 LG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQ-RFRIAAEIATGLLFLHQTKP 568
Y +V +Y G L R+ +R LS + RF AAE+ L +LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARF-YAAEVLLALEYLHL--- 121
Query: 569 EPLVHRDLKPGNILLDHN 586
+V+RDLKP NILL +
Sbjct: 122 LGIVYRDLKPENILLHES 139
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAA-QG-RSQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG VYK T +A+K +R + +G S REI +L ++H N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 514 A--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAEIATGLLFLHQTKPE 569
+ +V+EYL LD + ++P + R +I G+ + H +
Sbjct: 69 VVHSEKRLYLVFEYL---DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHSHR-- 122
Query: 570 PLVHRDLKPGNILLDHNYVS-KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
++HRDLKP N+L+D + K++D GLAR A V + T T Y PE
Sbjct: 123 -VLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEVVTLWYRAPEI-- 174
Query: 629 TGMLGVKS-----DVYSLGILLLQLITAK 652
+LG + D++S+G + +++ K
Sbjct: 175 --LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 32/161 (19%)
Query: 458 KIGEGGYGPVYK--CYLDHTPVAVK-VLRPDAAQGRSQFQ----REIEVLSCIRHPNMVL 510
KIG+G +G V+K VA+K VL + +G F REI++L ++H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 511 LLGAC-----PEYG-----IIVYEYLAN---GSLDDRIFRRGNTPPLSWQQRFRIAAEIA 557
L+ C P +V+E+ + G L ++ + + + ++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK------FTLSEIKKVMKMLL 129
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
GL ++H+ K ++HRD+K NIL+ + + K++D GLAR
Sbjct: 130 NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ------REIEVLSCIRHPNMVL 510
+G G +G V T A+K L+ R + + R E + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 511 LLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L AC ++ V EY A G L I + P + F AA + GL +LH+ K
Sbjct: 67 LF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVF-YAACVVLGLQYLHENK 121
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
+V+RDLK N+LLD KI+D GL + E + TS TFC PE+
Sbjct: 122 ---IVYRDLKLDNLLLDTEGFVKIADFGLCK------EGMGFGDRTS---TFCGT-PEFL 168
Query: 628 QTGMLGVKS-----DVYSLGILLLQLITAKQP 654
+L S D + LG+L+ +++ + P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLG 513
+G+GG+G V C + T A K L + R ++ E +L+ + H ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 514 ACPEYGI---IVYEYLANGSLDDRIFR-RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
+ +V + G L I+ P + A+I +GL LHQ +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
+++RDLKP N+LLD++ +ISD+GLA + Y AGT ++ PE Q
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY-----AGTPGFMAPELLQG 171
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
D ++LG+ L ++I A+ P
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 14/109 (12%)
Query: 551 RIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA-RLVPAVAENVTQ 609
++ I L +L + ++HRD+KP NILLD + K+ D G++ RLV + A+
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---- 171
Query: 610 YHLTSTAGTFCYIDPEY----QQTGMLGVKSDVYSLGILLLQLITAKQP 654
T +AG Y+ PE +++DV+SLGI L++L T + P
Sbjct: 172 ---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 64/207 (30%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ---REIEVLSCI-RHPNMVL 510
+ +G+G +G V+ L T A+K L+ D + E VLS HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 511 LLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L E V EYL G L +F + + AAEI GL FLH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS--- 114
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQ 627
+ +V+RDLK NILLD + KI+D G+ + EN+ T T GT YI PE
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
D +S G+LL +++ + P
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 453 FTESRKIGEGGYGPV----YKCYLDHTPVAVK----VLRPDAAQGRSQFQREIEVLSCIR 504
+ +++G+G YG V + VA+K V R+ RE+++L R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFR 59
Query: 505 -HPNMVLLLG-----ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIAT 558
H N+ L + +YE L L +I R G PL+ +I
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLH-QIIRSGQ--PLTDAHFQSFIYQILC 116
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
GL ++H ++HRDLKPGN+L++ + KI D GLAR +T T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVAT 172
Query: 619 FCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPM 655
Y PE ML +S DV+S+G +L +L+ K P+
Sbjct: 173 RWYRAPEI----MLSFQSYTKAIDVWSVGCILAELLGRK-PV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 58/178 (32%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 459 IGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQREIE-----VLSCIRHPNMVLL 511
IG+G +G V K D AVKVL+ A + + Q+ I +L ++HP +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 512 LGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQTKP 568
+ + V +Y+ G L + R + P + R R AAEIA+ L +LH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSLN- 116
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPE 625
+++RDLKP NILLD ++D GL + E + TST GT Y+ PE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK------EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 48/142 (33%), Positives = 67/142 (47%), Gaps = 19/142 (13%)
Query: 517 EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDL 576
E+ V EYL G L I G + RF AAEI GL FLH+ +++RDL
Sbjct: 69 EHLFFVMEYLNGGDLMFHIQSSGRFD--EARARF-YAAEIICGLQFLHKKG---IIYRDL 122
Query: 577 KPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGML 632
K N+LLD + KI+D G+ + EN+ A TFC YI PE +
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCK------ENMN---GEGKASTFCGTPDYIAPEILKGQKY 173
Query: 633 GVKSDVYSLGILLLQLITAKQP 654
D +S G+LL +++ + P
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
+G+GG+G V + +T A K L R G E E+L + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 514 A--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
A + +V + G L I+ G L ++ +A+I G+L LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---I 116
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
V+RD+KP N+LLD ++SD+GLA + + +TQ AGT Y+ PE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKD-GKTITQ-----RAGTNGYMAPEILKEEP 170
Query: 632 LGVKSDVYSLGILLLQLITAKQP 654
D +++G + +++ + P
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 457 RKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQF-----QREIEVLSCIRHPNMV 509
+ I +G +G VY K A+KVL+ ++Q +R I ++ P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVA 60
Query: 510 LLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L + +Y +V EYL G I G P W +++ AE+ G+ LHQ
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP-EDWAKQY--IAEVVLGVEDLHQ-- 115
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRD+KP N+L+D K++D GL+R GT Y+ PE
Sbjct: 116 -RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG---------LENKKFVGTPDYLAPET- 164
Query: 628 QTGMLGV----KSDVYSLGILLLQLITAKQP 654
+LGV SD +SLG ++ + + P
Sbjct: 165 ---ILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 461 EGGYGPVYKCYLDHT------PVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLG 513
EG +G ++ L V VK ++ A++ + +E +L + H N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 514 ACPEYG---IIVYEYLANGSL-----DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
C E G ++Y Y+ G+L R+ N LS QQ +A +IA G+ +LH+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR-LVPAVAENVTQYHLTSTAGTFCYIDP 624
++H+D+ N ++D KI+D L+R L P YH C D
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPM------DYH--------CLGDN 178
Query: 625 EYQQTGMLGVK----------SDVYSLGILLLQLIT-AKQP 654
E + + ++ SDV+S G+LL +L+T + P
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 50/234 (21%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLD---HTPVAVKVLRPDAAQGRSQFQR 495
R+Y I +K+G+G YG V+K +D VA+K + DA + + QR
Sbjct: 7 RKYEIL------------QKLGKGAYGIVWKA-IDRRTKEVVALKKIF-DAFRNATDAQR 52
Query: 496 ---EIEVLSCIR-HPNMVLLLGACPE------YGIIVYEYLANGSLDD--RIFRRGNTPP 543
EI L + HPN+V LL Y +V+EY+ D + R
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIY--LVFEYMET----DLHAVIRANILED 106
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
+ +R+ I ++ L ++H ++HRDLKP NILL+ + K++D GLAR + +
Sbjct: 107 V--HKRY-IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
EN LT T Y PE +LG D++S+G +L +++ K
Sbjct: 161 EENPENPVLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 457 RKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVL 510
R +G G +G + + L PVA+ LR + R F E L H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 511 LLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L G +IV EY++NG+LD F R + L Q + +A+G+ +L +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG- 127
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
VH+ L +L++ + V KIS G RL +E + Y S + PE Q
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQ 181
Query: 629 TGMLGVKSDVYSLGILLLQLIT 650
SDV+S GI++ ++++
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 457 RKIGEGGYGPVYKC-----YLDHTPVAVKVLRPDAAQGRSQFQR----EIEVLSCIRH-P 506
R +G G YG V+ + A+KVL+ +++ E +VL +R P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 507 NMVLLLGACPEYGI-------IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI-AAEIAT 558
+V L Y ++ +Y+ G L +++R + + R+ AEI
Sbjct: 66 FLVTL-----HYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----ESEVRVYIAEIVL 116
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
L LHQ +++RD+K NILLD ++D GL++ +AE + + S GT
Sbjct: 117 ALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAY--SFCGT 169
Query: 619 FCYIDPEYQQTGMLGVKS--DVYSLGILLLQLITAKQP 654
Y+ PE + G G D +SLG+L +L+T P
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 42/204 (20%), Positives = 82/204 (40%), Gaps = 34/204 (16%)
Query: 467 VYKCYLDHTPVAVKVLRPDAAQGR---SQFQREIEVLSCIRHPNMVLLLGACPE------ 517
+YK ++ V ++ + + + EI+ L I N++ + G +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 518 YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLK 577
++ EY G L + + + + LS++ + +A + GL L++ +P +++L
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 578 PGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLG---- 633
+ L+ NY KI GL E + Y + ML
Sbjct: 151 SVSFLVTENYKLKIICHGL--------EKILSSPPFKNVNFMVYFSYK-----MLNDIFS 197
Query: 634 ---VKSDVYSLGILLLQLITAKQP 654
+K D+YSLG++L ++ T K P
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 41/110 (37%), Positives = 58/110 (52%), Gaps = 24/110 (21%)
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
AAEIA GL FLH + +++RDLK N++LD KI+D G+ + EN+
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFG--- 154
Query: 613 TSTAGTFC----YIDPE---YQQTGMLGVKS-DVYSLGILLLQLITAKQP 654
T TFC YI PE YQ G KS D ++ G+LL +++ + P
Sbjct: 155 GKTTRTFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 80/279 (28%), Positives = 123/279 (44%), Gaps = 43/279 (15%)
Query: 458 KIGEGGYGPVYKCY-LDHTP--VAVKVLRPDAAQGRSQFQ--REIEVL---SCIRHPNMV 509
+IGEG YG V+K L + VA+K +R + RE+ VL HPN+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 510 LLLGACP------EYGI-IVYEYLANG--SLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
L C E + +V+E++ + D++ G P + + + ++ GL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKD---MMFQLLRGL 123
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
FLH + +VHRDLKP NIL+ + K++D GLAR+ Q LTS T
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTLW 174
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD----P 676
Y PE D++S+G + ++ K + V++ LG++LD P
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ------LGKILDVIGLP 228
Query: 677 TVTDWPFEETL---GFAKLALQCSELRRKDRPDLGKVVL 712
DWP + L F + Q E D +LGK +L
Sbjct: 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 267
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 68/223 (30%), Positives = 101/223 (45%), Gaps = 46/223 (20%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ----REIEVLSCIRHPNMVLL- 511
IGEG YG VYK T VA+K +R D + F REI++L + H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLD--NEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 512 ---------LGACPEYG--IIVYEYLAN---GSLDDRIFRRGNTPPLSWQQRFRIAAEIA 557
L + G +V+EY+ + G L+ + S ++
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH------FSEDHIKSFMKQLL 126
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
GL + H+ +HRD+K NILL++ K++D GLARL +E Y T+
Sbjct: 127 EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY--NSEESRPY--TNKVI 179
Query: 618 TFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPM 655
T Y PE +LG + DV+S G +L +L T K+P+
Sbjct: 180 TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 23/221 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQF---QREIEVL-SCIRHPNMVL 510
R IG G Y V L T A+KV++ + Q E V + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 511 LLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L +C V E+++ G L + R+ P RF +AEI+ L FLH+
Sbjct: 61 L-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP--EEHARF-YSAEISLALNFLHE-- 114
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEY 626
+++RDLK N+LLD K++D G+ + E + TST GT YI PE
Sbjct: 115 -RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK------EGIRPGDTTSTFCGTPNYIAPEI 167
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN 667
+ G D ++LG+L+ +++ + P + + +N
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 459 IGEGGYGPVYKCY--LDHTPVAVKVLR-PDAAQGRS--QFQREIEVLSCIRHPNMVLLLG 513
+G G +G V+ + A+KV+ P+ + + E VL + HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 514 ACPE--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ + ++ EY+ G L + G S A+EI L +LH + +
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSKE---I 122
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQ 627
V+RDLKP NILLD K++D G A+ L T C Y+ PE
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAK------------KLRDRTWTLCGTPEYLAPEVI 170
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
Q+ D ++LGIL+ +++ P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 33/146 (22%), Positives = 55/146 (37%), Gaps = 12/146 (8%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
I VAVD + S+ AL+WA + RG ++L+HV + S +
Sbjct: 5 ILVAVDGSEESERALEWALELAKRRGAELILLHVIDPEPSGAAS----EALEEEEEEELE 60
Query: 78 KQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHG 137
++ + +V++ D +AI E + +V+G+ R G
Sbjct: 61 EEEAEAEALAAA------AEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSRGRSG 114
Query: 138 FIRKFKADVPSSVSKAAPDFCNIYVV 163
R V V + AP C + VV
Sbjct: 115 LRRLLLGSVAEKVLRHAP--CPVLVV 138
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 25/153 (16%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ--REIEVLSCIRHPNMVLLLG 513
K+GEG Y VYK T VA+K +R + +G + F RE +L ++H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTL-- 68
Query: 514 ACPEYGII--------VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ II V+EYL + L + G + + F ++ GL + HQ
Sbjct: 69 ----HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLF--QLLRGLAYCHQ 121
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
+ ++HRDLKP N+L+ K++D GLAR
Sbjct: 122 RR---VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVA---VKVLR--------PDAAQGRSQFQREIEVLSCIRH 505
+++G+G +G VY D VA +KVL+ P+ Q +E ++LS + H
Sbjct: 6 QRLGKGSFGTVY-LVKDKKAVAEERLKVLKEIPVGELNPNET---VQANQEAQLLSKLDH 61
Query: 506 PNMVLLLGACPEYG--IIVYEYLANGSLDDRIFR-RGNTPPLSWQQRFRIAAEIATGLLF 562
P +V + E I+ EY LD ++ + LS Q ++ G+ +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
+HQ + ++HRDLK NI L +N + KI D G++RL+ + T + GT Y+
Sbjct: 122 MHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF-----TGTPYYM 172
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQL 648
PE + KSD++SLG +L ++
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ---REIEVLSCIRHPNMVLLLG 513
+G+G +G V T A+K+L+ D + E VL+ P + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 514 AC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+C + V EY+ G L I + G Q AAEI+ GL FLH+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHR---RG 121
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQQT 629
+++RDLK N++LD KI+D G+ + E++ T T GT YI PE
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
G D ++ G+LL +++ + P
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA- 514
KIGEG G V H+ VAVK++ Q R E+ ++ +H N+V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 515 -CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
E ++ E+L G+L D + + L+ +Q + + L +LH + ++H
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLG 633
RD+K +ILL + K+SD G ++++V + S GT ++ PE G
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRK--SLVGTPYWMAPEVISRTPYG 195
Query: 634 VKSDVYSLGILLLQLITAKQP 654
+ D++SLGI++++++ + P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 70/242 (28%), Positives = 114/242 (47%), Gaps = 41/242 (16%)
Query: 458 KIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRS-QFQREIEVLSCIRHPNMVLLLGA 514
K+GEG Y V+K L VA+K +R + +G RE+ +L ++H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 515 C-PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
E + +V+EYL + L + GN + + F ++ GL + H+ K ++
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCHKRK---IL 125
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML 632
HRDLKP N+L++ K++D GLAR A++V ++ T Y P+ +L
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEVVTLWYRPPDV----LL 176
Query: 633 GVKS-----DVYSLGILLLQLITAKQPM--GLT-----HFVERSIENGTLGEMLDPTVTD 680
G D++ +G +L ++ T + PM G T H + R + GT PT
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLL--GT------PTEET 227
Query: 681 WP 682
WP
Sbjct: 228 WP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 453 FTESRKIGEGGYGPV----YKCYLDHTPVAVKVLRPDAAQGRSQFQR---EIEVLSCIRH 505
F R +G G +G V YK D PVA+K + Q E ++L+ I H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 506 PNMVLLLGACPE--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFR------IAAEIA 557
P V L G+ + Y +V E++ G F R N +RF AA+I
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRN-------KRFPNDVGCFYAAQIV 141
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
+L +V+RDLKP N+LLD + K++D G A++V + Y L G
Sbjct: 142 LIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTL---CG 190
Query: 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
T YI PE G +D ++LGI + +++ P
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 34/269 (12%)
Query: 457 RKIGEGGYGPVYKCYLDHT----PVAVKVLRPDAAQGRSQFQREIEVLSCIR---HPNMV 509
+ +GEG +G V + L+ VAVK ++ A RS+ + + C++ HPN++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI-AICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 510 LLLGACPEYG--------IIVYEYLANGSLDDRIF--RRGNTPP-LSWQQRFRIAAEIAT 558
L+G C + +++ ++ +G L + R G+ P L Q + +IA+
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
G+ +L +HRDL N +L+ N ++D GL++ + N Y A
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKI----YNGDYYRQGRIAKM 176
Query: 619 -FCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDP- 676
+I E + KSDV+S G+ + ++ T Q T + +EN + + L
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ----TPY--PGVENSEIYDYLRQG 230
Query: 677 TVTDWPFEETLGFAKLALQCSELRRKDRP 705
P + G L C L KDRP
Sbjct: 231 NRLKQPPDCLDGLYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 31/148 (20%)
Query: 517 EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI------AAEIATGLLFLHQTKPEP 570
E+ V E+L G L I +G RF + AAEI GL FLH +
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHS---KG 116
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEY 626
+++RDLK N++LD + KI+D G+ + ENV + A TFC YI PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCK------ENVFG---DNRASTFCGTPDYIAPEI 167
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQP 654
Q D +S G+LL +++ + P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 459 IGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQ---FQREIEVLSCIRHPNMVLLLG 513
IG G +G V+ T A+KVLR R+Q + E ++L+ P +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 514 ACP--EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ E+ +V EY+ G L + + R+ P RF IA E+ L +H+
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETA-RFYIA-ELVLALDSVHKLG---F 122
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLA------------------------RLVPAVAENV 607
+HRD+KP NIL+D + K++D GL LV
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLI 649
+ ST GT YI PE + G++ D +SLG++L +++
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 41/242 (16%)
Query: 458 KIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRS-QFQREIEVLSCIRHPNMVLL--L 512
K+GEG Y VYK L VA+K +R + +G RE+ +L ++H N+V L +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 513 GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
+ +V+EYL + L + GN+ + + F ++ GL + H+ K ++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLF--QLLRGLNYCHRRK---VL 126
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML 632
HRDLKP N+L++ K++D GLAR A+++ ++ T Y P+ +L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYSNEVVTLWYRPPDI----LL 177
Query: 633 G-----VKSDVYSLGILLLQLITAKQPM--GLT-----HFVERSIENGTLGEMLDPTVTD 680
G + D++ +G + ++ T + P+ G T HF+ R + GT PT
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRIL--GT------PTEET 228
Query: 681 WP 682
WP
Sbjct: 229 WP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 44/138 (31%), Positives = 69/138 (50%), Gaps = 13/138 (9%)
Query: 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGN 580
+V EY+ G L + R+ P RF AAEI L FLH+ +++RDLK N
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLP--EEHARF-YAAEICIALNFLHE---RGIIYRDLKLDN 126
Query: 581 ILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQQTGMLGVKSDVY 639
+LLD + K++D G+ + E + TST GT YI PE + G D +
Sbjct: 127 VLLDADGHIKLTDYGMCK------EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180
Query: 640 SLGILLLQLITAKQPMGL 657
+LG+L+ +++ + P +
Sbjct: 181 ALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 37/280 (13%)
Query: 457 RKIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRSQFQ--REIEVLSCIRHPNMVLL- 511
K+GEG Y VYK ++ VA+KV+ +G F RE +L ++H N+VLL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLH 69
Query: 512 -LGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+ E V+EY+ I G P + + ++ GL ++H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL---FMFQLLRGLAYIHGQH--- 123
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG 630
++HRDLKP N+L+ + K++D GLAR A+++ +S T Y P+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR-----AKSIPSQTYSSEVVTLWYRPPDV---- 174
Query: 631 MLGVKS-----DVYSLGILLLQLITAKQPM--GLTHFVERSIENGTLGEMLDPTVTDWPF 683
+LG D++ G + ++++ QP G++ E+ + T+ + PT WP
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKIWTV--LGVPTEDTWP- 230
Query: 684 EETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELAD 723
G +KL E +P +VV L+R + D
Sbjct: 231 ----GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAED 266
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 53/172 (30%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLL 511
R IG G +G V+ D VA+K + P+ Q +R E+++L +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 512 LGACPEYGIIVYEY------LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
L I +E L L I PLS +I GL +LH
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL------VPAVAENVTQYH 611
++HRD+KPGN+L++ N V KI D GLAR+ E VTQY+
Sbjct: 122 AG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ---REIEVLSCIRHPNMV-LLL 512
+G G +G V T A+K L+ Q Q +E +L + HP +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 513 GACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
E + + E++ G L + + G P + +F AE+ +LH +
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFP--NDVAKF-YHAELVLAFEYLHSKD---I 139
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
++RDLKP N+LLD+ K++D G A+ VP + L GT Y+ PE Q+
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTL---CGTPEYLAPEVIQSKG 191
Query: 632 LGVKSDVYSLGILLLQLITAKQP 654
G D +++G+LL + I P
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 459 IGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGAC 515
IG+G YG V+K + + AVK+L P + + E +L + HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 516 PEYGI-------IVYEYLANGSLDDRI---FRRG---NTPPLSWQQRFRIAAEIATGLLF 562
+ + +V E GS+ D + +RG P +++ I E GL
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGLQH 139
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
LH K +HRD+K NILL K+ D G++ + + T+ ++ GT ++
Sbjct: 140 LHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-----TRLRRNTSVGTPFWM 191
Query: 623 DPEY-----QQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
PE Q + DV+SLGI ++L P+ H
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 53/155 (34%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 457 RKIGEGGYGPVY--KCYLDHTP--VAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLL 511
++IG G +G V + +TP V VK LR A+ Q + +F E + ++H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 512 LGACPEYG--IIVYEYLANGSLDD--RIFRRGN--TP-PLSWQQRFRIAAEIATGLLFLH 564
LG C E ++V E+ G L R R+ TP P + Q R+A EIA GLL LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ---RMACEIALGLLHLH 117
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599
+ +H DL N LL + KI D GL+
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 33/141 (23%), Positives = 57/141 (40%), Gaps = 16/141 (11%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM----VLLL 512
+ + G VY +K+ + +RE+ +L + + VL
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLAS 61
Query: 513 GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
G + ++ E++ +LD +S +++ IA ++A L LHQ L
Sbjct: 62 GESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 573 HRDLKPGNILLDHNYVSKISD 593
H DL PGNIL+D + I D
Sbjct: 112 HGDLHPGNILVDDGKILGIID 132
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 453 FTESRKIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRSQFQ--REIEVLSCIRHPNM 508
+ + K+GEG Y VYK ++ VA+KV+R +G + F RE +L ++H N+
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANI 65
Query: 509 VLL--LGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
VLL + E +V+EY+ G P + + ++ GL ++HQ
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL---FLFQLLRGLSYIHQR 122
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
++HRDLKP N+L+ K++D GLAR A++V + ++ T Y P+
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLAR-----AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 627 QQTGMLGVKS-----DVYSLGILLLQLI 649
+LG D++ +G + +++I
Sbjct: 175 ----LLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 459 IGEGGYGPVY--KCYLDHTPVAVKVLRPDA-----AQGRSQFQREIEVLSCIRHPNMVLL 511
IG+G +G V K D + AVKVL+ Q +R + +L ++HP +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 512 LGA--CPEYGIIVYEYLANGSL-----DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
+ E V +Y+ G L +R F + RF AAE+A+ + +LH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-------RARF-YAAEVASAIGYLH 113
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYID 623
+++RDLKP NILLD ++D GL + E V TST GT Y+
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCK------EGVEPEETTSTFCGTPEYLA 164
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE + D + LG +L +++ P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQ---REIEVLSCIRHPNMVLLLG 513
+G+G +G V T A+K+L+ D + E VL+ P + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 514 ACPEYG---IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFR------IAAEIATGLLFLH 564
+C + V EY+ G L +I + G RF+ AAEIA GL FLH
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLH 118
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYID 623
+ +++RDLK N++LD KI+D G+ + EN+ T T GT YI
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENMWDGVTTKTFCGTPDYIA 169
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE G D ++ G+LL +++ + P
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA- 514
KIGEG G V HT VAVK + Q R E+ ++ H N+V + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 515 -CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ +V E+L G+L D + ++ +Q + + L +LH + ++H
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHN---QGVIH 141
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLG 633
RD+K +ILL + K+SD G V++ V + S GT ++ PE G
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC---AQVSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 634 VKSDVYSLGILLLQLITAKQP 654
+ D++SLGI+++++I + P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 459 IGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQREIE-----VLSCIRHPNMVLL 511
IG+G +G V K LD AVKVL+ R + Q+ I +L ++HP +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 512 LGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQTKP 568
+ E V +++ G L + R + P + R R AAEIA+ L +LH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSIN- 116
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQ 627
+V+RDLKP NILLD ++D GL + E + Q T+T GT Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
+ D + LG +L +++ P
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 65/232 (28%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRP--DAAQGRSQFQR 495
RY I+++ IG+G YG V HT VA+K + + ++ R
Sbjct: 1 RYKIQEV------------IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR 48
Query: 496 EIEVLSCIRHPNMV----LLLGACP-EYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQ- 547
EI++L +RHP++V ++L E+ +V+E L L I + P Q
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQF 107
Query: 548 ---QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604
Q R L ++H + HRDLKP NIL + + KI D GLAR A
Sbjct: 108 FLYQLLR-------ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR--VAFN 155
Query: 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS----DVYSLGILLLQLITAK 652
+ T T T Y PE G K D++S+G + +++T K
Sbjct: 156 DTPTAIFWTDYVATRWYRAPEL--CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 453 FTESRKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQG---RSQFQREIEVLSCIRHPN 507
F ++G+GGYG V+ K VA+K ++ E ++L+ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 508 MVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQ-RFRIAAEIATGLLFLH 564
+V LL A EY + EY+ G D R N LS RF +A E+ + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGG--DFRTLL-NNLGVLSEDHARFYMA-EMFEAVDALH 118
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ +HRDLKP N L+D + K++D GL+ VT + S G+ Y+ P
Sbjct: 119 ELG---YIHRDLKPENFLIDASGHIKLTDFGLS------KGIVTYAN--SVVGSPDYMAP 167
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E + D +SLG +L + + P
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 453 FTESRKIGEGGYGPVYKCYLDH-----TPVAVKVLRPD--AAQGRSQFQREIEVLSCIRH 505
FT R +G+G +G V + L VAVK+L+ D ++ +F RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 506 PNMVLLLGACPE--------YGIIVYEYLANGSLDDRIF--RRGNTP-PLSWQQRFRIAA 554
PN++ L+G +++ ++ +G L + R G P L Q R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
+IA+G+ +L +HRDL N +L+ N ++D GL++ + + Y+
Sbjct: 121 DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYS-----GDYYRQG 172
Query: 615 TAGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQ 653
A ++ E + SDV++ G+ + +++T Q
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-08
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 51/236 (21%)
Query: 457 RKIGEGGYGPVYKCYLDHTP-----VAVKVLRPDAAQG---RSQFQREIEVLSCIRHPNM 508
R IG+GG G VY L + P VA+K +R D ++ + +F RE ++ + + HP +
Sbjct: 8 RLIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 509 VLLLGACPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQR---------------FR 551
V + C + + Y Y+ +L + + WQ+
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLK-SLLKS------VWQKESLSKELAEKTSVGAFLS 117
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL----------VP 601
I +I + ++H + ++HRDLKP NILL I D G A +
Sbjct: 118 IFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 602 AVAENVTQYHLT---STAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
N+ +T GT Y+ PE +D+Y+LG++L Q++T P
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA- 514
KIGEG G V + + VAVK + Q R E+ ++ +H N+V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 515 -CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ +V E+L G+L D + ++ +Q + + L LH + ++H
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLG 633
RD+K +ILL H+ K+SD G V++ V + S GT ++ PE G
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC---AQVSKEVPRR--KSLVGTPYWMAPELISRLPYG 194
Query: 634 VKSDVYSLGILLLQLITAKQP 654
+ D++SLGI++++++ + P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGA- 514
+G G YG VYK T A+KV+ + + ++EI +L H N+ GA
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 515 -------CPEYGIIVYEYLANGSLDDRIFR-RGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
+ +V E+ GS+ D I +GNT W I EI GL LHQ
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
K ++HRD+K N+LL N K+ D G+ A+L V T GT ++ PE
Sbjct: 131 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT------FIGTPYWMAPE 181
Query: 626 Y-----QQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
KSD++SLGI +++ P+ H
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 34/192 (17%)
Query: 478 AVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSL- 531
A+K+L+ + + + E VL RHP + L + + V EY+ G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF 83
Query: 532 ----DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587
+R+F T RF AEI + L +LH K +V+RDLK N++LD +
Sbjct: 84 FHLSRERVFSEDRT-------RF-YGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDG 132
Query: 588 VSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGI 643
KI+D GL + E +T +T TFC Y+ PE + G D + LG+
Sbjct: 133 HIKITDFGLCK------EGITD---AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 644 LLLQLITAKQPM 655
++ +++ + P
Sbjct: 184 VMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 457 RKIGEGGYGPVYKCYLDHTP---VAVKVLRPDA----AQGRSQFQREIEVLSCIRHPNMV 509
IG G YG V +D VA+K + P A + RE+++L +H N++
Sbjct: 11 ENIGSGAYGVVCSA-IDTRSGKKVAIKKI-PHAFDVPTLAKRTL-RELKILRHFKHDNII 67
Query: 510 LL---LGACPEYGIIVYEY--LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
+ L VY L L I PL+ + ++ GL ++H
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH 124
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
++HRDLKP N+L++ + +I D G+AR + + + +Y +T T Y P
Sbjct: 125 SAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL-SSSPTEHKYFMTEYVATRWYRAP 180
Query: 625 EYQQTGMLGV-----KSDVYSLGILLLQLITAKQ 653
E +L + D++S+G + +++ +Q
Sbjct: 181 EL----LLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 64/248 (25%), Positives = 112/248 (45%), Gaps = 56/248 (22%)
Query: 457 RKIGEGGYGPVY--KCYLDH--TPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLL 511
++IG G +G V + Y D V VK L+ +A+ + +++F ++ + ++HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 512 LGACPEY--GIIVYEYLANGSLDDRI----FRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
LG C E ++V+EY G L + + R N+ L Q R+A EIA G+ +H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK 117
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLA--------------RLVP---AVAENVT 608
+H DL N L + K+ D G+ + VP E V
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 609 QYH---LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLI-TAKQPMGLTHFVERS 664
++H +T+ +QT S+V++LG+ L +L A QP +H +R
Sbjct: 175 EFHGGLITA------------EQTK----PSNVWALGVTLWELFENAAQPY--SHLSDRE 216
Query: 665 IENGTLGE 672
+ N + +
Sbjct: 217 VLNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 31/163 (19%)
Query: 512 LGACPEYGII--------------VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIA 557
L AC +GI+ + EY + G L+ +I +R L F+ E
Sbjct: 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR-----LKEHLPFQ---EYE 170
Query: 558 TGLLF------LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
GLLF L + ++HRDLK NI L + K+ D G ++ +++V+
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSLDV 227
Query: 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+S GT Y+ PE + K+D++SLG++L +L+T +P
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 11/146 (7%)
Query: 458 KIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRS-QFQREIEVLSCIRHPNMVLL--L 512
K+GEG Y V+K L VA+K +R + +G RE+ +L ++H N+V L +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 513 GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
+ +V+EYL + L + GN + + F +I GL + H+ K ++
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLY--QILRGLAYCHRRK---VL 126
Query: 573 HRDLKPGNILLDHNYVSKISDVGLAR 598
HRDLKP N+L++ K++D GLAR
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 13/136 (9%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
T+ F R+ G YG ++K T V +KVL F ++S + H ++V
Sbjct: 9 TKIFKGIRR-EVGDYGELHK-----TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 510 LLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L G C + I+V EY+ GSLD + + N +SW + +A ++A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 568 PEPLVHRDLKPGNILL 583
L H ++ N+LL
Sbjct: 121 ---LTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 459 IGEGGYGPV--YKCYLDHTPVAVKVLRPDAAQGRSQ---FQREIEVLSCIRHPNMVLLLG 513
IG G +G V + A+K+L RS F E ++++ P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 514 ACPE--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
A + Y +V EY+ G L + P W + + AE+ L +H L
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFY--TAEVVLALDAIHSMG---L 163
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-- 629
+HRD+KP N+LLD + K++D G + + + GT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKM----DETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 630 --GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD 675
G G + D +S+G+ L +++ P V GT +++D
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVL-RPDAAQGRSQFQ-REIEVLSCIRHPNM 508
+ + + IG G G V + + VAVK L RP Q ++ RE+ +L C+ H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 509 VLLLGA-CPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ LL P+ + ++ YL +D + + + L ++ + ++ G+ LH
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCGIKHLHS 141
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
++HRDLKP NI++ + KI D GLAR T + +T T Y PE
Sbjct: 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------CTNFMMTPYVVTRYYRAPE 192
Query: 626 YQQTGMLGVK----SDVYSLGILLLQLI 649
+LG+ D++S+G ++ +L+
Sbjct: 193 V----ILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 48/219 (21%)
Query: 459 IGEGGYGPVYKCYLDHTPVAVKVLRPDAAQ---------------GRSQFQREIEVLSCI 503
+G+G +G V+ + K+ PDA Q R + + E ++L+ +
Sbjct: 4 LGQGSFGKVF--------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV 55
Query: 504 RHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFR------IAAE 555
HP +V L A G ++ ++L G L F R LS + F AE
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTR-----LSKEVMFTEEDVKFYLAE 106
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
+A L LH +++RDLKP NILLD K++D GL++ ++ Y S
Sbjct: 107 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAY---SF 158
Query: 616 AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
GT Y+ PE +D +S G+L+ +++T P
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLG 513
+G+G +G V T A+K+L+ + + + E VL RHP + L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 514 ACPE--YGIIVYEYLANGSL-----DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
+ V EY G L +R+F RF AEI + L +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RF-YGAEIVSALGYLHSC 114
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPE 625
+V+RDLK N++LD + KI+D GL + E ++ T GT Y+ PE
Sbjct: 115 D---VVYRDLKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPE 165
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ G D + LG+++ +++ + P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC- 515
IG G +G V + HT A+K+L R++ +C R VL+ G C
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE-------TACFREERNVLVNGDCQ 61
Query: 516 -----------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
Y +V +Y G L + + + P RF IA E+ + +H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYIA-EMVLAIHSIH 119
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
Q VHRD+KP N+LLD N +++D G + + Q + GT YI P
Sbjct: 120 QLH---YVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSV--AVGTPDYISP 172
Query: 625 EYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE 662
E Q G G + D +SLG+ + +++ + P VE
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 458 KIGEGGYGPVYKCYLDHTP--VAVK--VLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG VYK +T VA+K L D REI +L + ++ L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 514 ACPEYGI---------IVYEYLANGSLDDRI--FRRGNTPPLSWQQRFRIAAEIATGLLF 562
E+ +V+EYL + L + RG PL + ++ G+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
H+ ++HRDLKP N+L+D + KI+D+GL R A + V Y T T Y
Sbjct: 126 CHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR---AFSIPVKSY--THEIVTLWY 177
Query: 622 IDPEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPM 655
PE +LG D++S+G + ++ KQP+
Sbjct: 178 RAPEV----LLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 459 IGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQREIE----VLSCIRHPNMVLLL 512
IG+G +G V + + AVKVL+ A + + + + +L ++HP +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 513 GA--CPEYGIIVYEYLANGSL-----DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ + V +Y+ G L +R F L + RF AAEIA+ L +LH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCF-------LEPRARF-YAAEIASALGYLHS 114
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDP 624
+V+RDLKP NILLD ++D GL + EN+ TST GT Y+ P
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGTTSTFCGTPEYLAP 165
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E D + LG +L +++ P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 35/231 (15%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY-LDH---TPVAVKVL-RPDAAQ-GRS 491
YR+ + I E + + +++G G YG V C LD VA+K L RP ++
Sbjct: 2 YRQEVNKTIWEVPDRYRDLKQVGSGAYGTV--CSALDRRTGAKVAIKKLYRPFQSELFAK 59
Query: 492 QFQREIEVLSCIRHPNMVLLLGA-CPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQ 548
+ RE+ +L ++H N++ LL P+ + + YL + + + LS +
Sbjct: 60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR 119
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
+ ++ GL ++H ++HRDLKPGN+ ++ + KI D GLAR T
Sbjct: 120 IQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ--------T 168
Query: 609 QYHLTSTAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQLITAK 652
+T T Y PE Y QT D++S+G ++ +++T K
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQT------VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQF---QREIEVLSCIRHPNMVLL 511
R IG G Y V L T A+KV++ + Q E V + ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 512 LGACPEYG---IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L +C + V EY+ G L + R+ P RF +AEI+ L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARF-YSAEISLALNYLHE--- 114
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQ 627
+++RDLK N+LLD K++D G+ + E + TST GT YI PE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQPMGL 657
+ G D ++LG+L+ +++ + P +
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 47/247 (19%)
Query: 443 IEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVL 500
+E + + T + IG+G YG VYK D + AVK+L P + + + E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72
Query: 501 SCI-RHPNMVLLLGACPEYGI-------------IVYEYLANGSLDDRI---FRRGNTPP 543
+ HPN+V YG+ +V E GS+ + + G
Sbjct: 73 QSLPNHPNVVKF------YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG---- 122
Query: 544 LSWQQRFR---IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600
QR I+ + LL L ++HRD+K NILL K+ D G++ +
Sbjct: 123 ----QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
Query: 601 PAVAENVTQYHLTSTAGTFCYIDPEY-----QQTGMLGVKSDVYSLGILLLQLITAKQPM 655
+ T+ ++ GT ++ PE Q + DV+SLGI ++L P+
Sbjct: 179 TS-----TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
Query: 656 GLTHFVE 662
H V+
Sbjct: 234 FDMHPVK 240
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 36/192 (18%)
Query: 478 AVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL- 531
A+K+LR + + + E VL RHP + L A + V EY G L
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83
Query: 532 ----DDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586
+R+F ++R R AEI + L +LH +V+RD+K N++LD +
Sbjct: 84 FHLSRERVFT---------EERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKD 131
Query: 587 YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLG 642
KI+D GL + E ++ +T TFC Y+ PE + G D + LG
Sbjct: 132 GHIKITDFGLCK------EGISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 643 ILLLQLITAKQP 654
+++ +++ + P
Sbjct: 183 VVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 43/164 (26%), Positives = 68/164 (41%), Gaps = 30/164 (18%)
Query: 496 EIEVLSCIRHPNMVLLLG-------AC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLS 545
E +L + HP+++ + C P Y +Y YL + PL
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK-----------RSRPLP 155
Query: 546 WQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
Q I +I GL +LH + ++HRD+K NI ++ I D+G A+ P VA
Sbjct: 156 IDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAP 211
Query: 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLI 649
AGT PE K+D++S GI+L +++
Sbjct: 212 A-----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 457 RKIGEGGYGPV---YKCYLDHTPVAVKVLRPDAAQGRSQFQ-REIEVLSCIRHPNMVLLL 512
+ IG G G V Y LD K+ RP Q ++ RE+ ++ C+ H N++ LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 513 GA-CPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
P+ + ++ YL +D + + L ++ + ++ G+ LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG-- 139
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDLKP NI++ + KI D GLAR T + +T T Y PE
Sbjct: 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAG------TSFMMTPYVVTRYYRAPEV--- 189
Query: 630 GMLGV----KSDVYSLGILLLQLITAK 652
+LG+ D++S+G ++ +++ K
Sbjct: 190 -ILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 32/172 (18%)
Query: 495 REIEVLSCIRHPNMVLLLGACPEYG-------IIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
REI++L + H N++ + P IVYE L + L +I R ++ LS
Sbjct: 53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE-LMDTDLH-QIIR--SSQTLSDD 108
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
++ GL ++H ++HRDLKP N+LL+ N KI D GLAR + +
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165
Query: 608 TQYHLTSTAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQLITAK 652
T+Y +T Y PE Y DV+S+G + +L+ K
Sbjct: 166 TEYVVTRW-----YRAPELLLNCSEY------TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 29/128 (22%), Positives = 42/128 (32%), Gaps = 31/128 (24%)
Query: 468 YKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL--LGACP-------EY 518
Y+ + + V++ RE E N L G P E
Sbjct: 15 YRVEVANKKYVVRIPGNGT---ELLINRENEAE------NSKLAAEAGIGPKLYYFDPET 65
Query: 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV--HRDL 576
G+++ E++ L F +IA + LH + LV H DL
Sbjct: 66 GVLITEFIEGSELLTEDFSDPEN-------LEKIAKLLKK----LHSSPLPDLVPCHNDL 114
Query: 577 KPGNILLD 584
PGN LLD
Sbjct: 115 LPGNFLLD 122
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 33/223 (14%)
Query: 452 FFTESRKIGEGGYGPVYKCYL----DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
F E K+G G YG VYK D A+K + + REI +L ++HPN
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC--REIALLRELKHPN 59
Query: 508 MVLL----LGACPEYGIIVYEYLANGSLDDRIFRRG---NTPPLSWQQRF--RIAAEIAT 558
++ L L ++++Y + F R N P+ + + +I
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
G+ +LH ++HRDLKP NIL+ KI+D+G ARL + + + L
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD--LDP 174
Query: 615 TAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
TF Y PE +LG + D++++G + +L+T++
Sbjct: 175 VVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 8/109 (7%)
Query: 543 PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602
PL R ++++A G+ FL + +HRD+ N+LL V+KI D GLAR +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-- 262
Query: 603 VAENVTQYHLTSTAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
N + Y + A ++ PE + V+SDV+S GILL ++ +
Sbjct: 263 --MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVL-RP-DAAQGRSQF 493
YR+ + I E + + +G G YG V + T VAVK L RP + +
Sbjct: 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 63
Query: 494 QREIEVLSCIRHPNMVLLLG------ACPEYG-IIVYEYLANGSLDDRIFRRGNTPPLSW 546
RE+ +L ++H N++ LL + E+ + + +L L++ + L+
Sbjct: 64 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTD 119
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606
+ +I GL ++H ++HRDLKP N+ ++ + KI D GLAR
Sbjct: 120 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH------- 169
Query: 607 VTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAK 652
T +T T Y PE M D++S+G ++ +L+T +
Sbjct: 170 -TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 33/230 (14%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVL-RP--DAAQGRSQ 492
YR+ + + E + + +G G YG V Y VAVK L RP R
Sbjct: 2 YRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT 61
Query: 493 FQREIEVLSCIRHPNMVLLLGA-CPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQR 549
+ RE+ +L ++H N++ LL P I + YL + + LS +
Sbjct: 62 Y-RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120
Query: 550 FRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609
+ ++ GL ++H ++HRDLKP N+ ++ + +I D GLAR
Sbjct: 121 QFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ--------AD 169
Query: 610 YHLTSTAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQLITAK 652
+T T Y PE Y QT D++S+G ++ +L+ K
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLG 513
IG+G +G V + T A+K +R RS+ E VL+ + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 514 A--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ PE +V ++ G L + R G + RF A E+ L LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFD--LSRARFYTA-ELLCALENLHKFN---V 114
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQ 627
++RDLKP NILLD+ + D GL +L N+ TFC Y+ PE
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL------NMKD---DDKTNTFCGTPEYLAPELL 165
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
D ++LG+LL +++T P
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 20/188 (10%)
Query: 478 AVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLD 532
A+KV++ A + S F+ E ++LS P + L A + +V EY G L
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 533 DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592
+ R +F +A E+ + +HQ VHRD+KP N+L+D K++
Sbjct: 90 S-LLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLA 144
Query: 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT------GMLGVKSDVYSLGILLL 646
D G A + A + GT YI PE T G GV+ D +SLG++
Sbjct: 145 DFGSAARLTANKMVNS----KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200
Query: 647 QLITAKQP 654
++I + P
Sbjct: 201 EMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 50/182 (27%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 501 SCIRHPNMVLLLGAC------------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQ 548
+C R VL+ G +V +Y G L + + + P
Sbjct: 46 ACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MA 104
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG-LARLVP--AVAE 605
RF +A E+ + +HQ VHRD+KP N+LLD N +++D G RL+ V
Sbjct: 105 RFYLA-EMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 606 NVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHF 660
NV GT YI PE Q G G + D +SLG+ + +++ + P
Sbjct: 161 NV-------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 661 VE 662
VE
Sbjct: 214 VE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 459 IGEGGYGPVYKCYLDHTP-----VAVKVLRPDAAQGRSQFQR----EIEVLSCIRH-PNM 508
+G G YG V+ A+KVL+ A +++ E VL +R P +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 509 VLLLGACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQ 565
V L A + + +Y++ G + +++R N + R + EI L LH+
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIILALEHLHK 123
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
+V+RD+K NILLD ++D GL++ + + T S GT Y+ PE
Sbjct: 124 LG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT----YSFCGTIEYMAPE 176
Query: 626 Y--QQTGMLGVKSDVYSLGILLLQLITAKQPMGL 657
+ G G D +SLGIL+ +L+T P L
Sbjct: 177 IIRGKGGH-GKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 16/137 (11%)
Query: 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGN 580
+V +Y++ G L + + G + +F IA E+ L LH+ +V+RDLKP N
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFS--EDRAKFYIA-ELVLALEHLHKYD---IVYRDLKPEN 126
Query: 581 ILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPE--YQQTGMLGVKSD 637
ILLD + D GL++ N+T T+T GT Y+ PE + G D
Sbjct: 127 ILLDATGHIALCDFGLSK------ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVD 179
Query: 638 VYSLGILLLQLITAKQP 654
+SLG+L+ ++ P
Sbjct: 180 FWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 452 FFTESRKIGEGGYGPVYKCYL----DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
F E K+G G YG VYK D A+K + + REI +L ++HPN
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC--REIALLRELKHPN 59
Query: 508 MVLL----LGACPEYGIIVYEYLANGSLDDRIFRRG---NTPPLSWQQRF--RIAAEIAT 558
++ L L ++++Y + F R N P+ + + +I
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILL-----DHNYVSKISDVGLARLVPAVAENVTQYHLT 613
G+ +LH ++HRDLKP NIL+ + V KI+D+G ARL + + + L
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLAD--LD 173
Query: 614 STAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
TF Y PE +LG + D++++G + +L+T++
Sbjct: 174 PVVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLG 513
+G+G +G V T A+K+L+ + + + E VL RHP + L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 514 ACPEYG--IIVYEYLANGSL-----DDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQ 565
+ + V EY G L +R+F + R R AEI + L +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFS---------EDRARFYGAEIVSALDYLHS 113
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----Y 621
K +V+RDLK N++LD + KI+D GL + E + +T TFC Y
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKD---GATMKTFCGTPEY 162
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ PE + G D + LG+++ +++ + P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 24/182 (13%)
Query: 477 VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYLANGSLDDR 534
V +KVL P F ++ + H ++VLL G C I+V E++ G LD
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD-- 92
Query: 535 IFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS----- 589
+F + L+ +F++A ++A+ L +L LVH ++ NILL +
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP 149
Query: 590 --KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLL 646
K+SD G+ V + E V + +I PE + + L + +D +S G L
Sbjct: 150 FIKLSDPGIPITVLSRQECVER---------IPWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 647 QL 648
++
Sbjct: 201 EI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 36/125 (28%), Positives = 53/125 (42%), Gaps = 40/125 (32%)
Query: 543 PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602
PL+ + + ++A G+ FL K +HRDL NILL N V KI D GLAR +
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI-- 223
Query: 603 VAENVTQYHLTSTAGTFCYIDPEYQQTG-----------------MLGVKSDVYSLGILL 645
Y DP+Y + G + +SDV+S G+LL
Sbjct: 224 ------------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 265
Query: 646 LQLIT 650
++ +
Sbjct: 266 WEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 67/256 (26%), Positives = 107/256 (41%), Gaps = 41/256 (16%)
Query: 434 KDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV----AVKVLRPDAAQG 489
+ + R ED F + IG G +G V + H A+K+L
Sbjct: 33 EKITKLRMKAED-------FDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIK 83
Query: 490 RSQ---FQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTP-P 543
RS F E ++++ +V L A +Y +V EY+ G D + N P
Sbjct: 84 RSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIP 140
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
W RF A E+ L +H +HRD+KP N+LLD + K++D G + A
Sbjct: 141 EKWA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQT----GMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
+ GT YI PE ++ G G + D +S+G+ L +++ +G T
Sbjct: 196 G----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-----VGDTP 246
Query: 660 FVERSIENGTLGEMLD 675
F S+ GT +++D
Sbjct: 247 FYADSL-VGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 22/223 (9%)
Query: 443 IEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQ---FQREI 497
I D+ + + + IG G +G V T A+K+L RS F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 498 EVLSCIRHPNMVLLLGACPE--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAE 555
++++ P +V L A + Y +V EY+ G L + P W + + AE
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFY--TAE 150
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
+ L +H +HRD+KP N+LLD + K++D G + +
Sbjct: 151 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM----NKEGMVRCDTA 203
Query: 616 AGTFCYIDPEYQQT----GMLGVKSDVYSLGILLLQLITAKQP 654
GT YI PE ++ G G + D +S+G+ L +++ P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 30/219 (13%)
Query: 459 IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGAC 515
+G G YG VYK T A+KV+ + + + EI +L H N+ GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 516 PEYG--------IIVYEYLANGSLDDRIFR-RGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
+ +V E+ GS+ D + +GN W I EI GL LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
K ++HRD+K N+LL N K+ D G+ A+L V T GT ++ PE
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT------FIGTPYWMAPE 191
Query: 626 Y-----QQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
+SD++SLGI +++ P+ H
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 50/239 (20%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQ---FQREIEVLSCIRHPN 507
F + IG G +G V T A+K LR + Q + E ++L+ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 508 MVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQ-RFRIAAEIATGLLFLH 564
+V L + Y ++ EYL G + + ++ +T + ++ RF IA E + +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-DT--FTEEETRFYIA-ETILAIDSIH 118
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA-----RLVPAVAENVTQYHLT------ 613
+ +HRD+KP N+LLD K+SD GL ++ +
Sbjct: 119 KLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 614 ----------------------STAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQLI 649
ST GT YI PE + QTG + D +SLG+++ +++
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 10/169 (5%)
Query: 543 PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602
PL+ + + ++A G+ FL K +HRDL NILL N V KI D GLAR +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE 662
+ V + S ++ PE + +SDV+S G+LL ++ + +G + +
Sbjct: 227 DPDYVRK---GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPG 279
Query: 663 RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
I + D T P T ++ L C + K+RP +V
Sbjct: 280 VQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 36/231 (15%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVL-RPDAAQ--GRSQ 492
YR + + E + +T +++G G YG V T VA+K L RP ++ +
Sbjct: 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA 61
Query: 493 FQREIEVLSCIRHPNMVLLLG---ACPEYGIIVYEYLANGSLDDRIFR-RGNTPPLSWQQ 548
+ RE+ +L ++H N++ LL + YL + + + G+ PLS +
Sbjct: 62 Y-RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--PLSEDK 118
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
+ ++ GL ++H ++HRDLKPGN+ ++ + KI D GLAR A AE
Sbjct: 119 VQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--HADAE--- 170
Query: 609 QYHLTSTAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQLITAK 652
+T T Y PE Y QT D++S+G ++ +++T K
Sbjct: 171 ---MTGYVVTRWYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 30/241 (12%)
Query: 457 RKIGE----GGYGPVYKCYLDHTPVAVKVLRPDAAQGR--SQFQREIEVLSCIRHPNMVL 510
IG+ + K +T VAVK + D+ Q+EI ++HPN +L
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN-IL 62
Query: 511 LLGACPEYG---IIVYEYLANGSLDDRI---FRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
+V +A GS +D + F G P L+ + ++ L ++H
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILK---DVLNALDYIH 118
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQY----HLTSTAGTFC 620
+ +HR +K +ILL + +S GL V + Q S+
Sbjct: 119 S---KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 621 YIDPEYQQTGMLG--VKSDVYSLGILLLQLITAKQPMGLTHFVERSIE--NGTLGEMLDP 676
++ PE Q + G KSD+YS+GI +L P + +E GT+ +LD
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233
Query: 677 T 677
+
Sbjct: 234 S 234
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 457 RKIGEGGYGPV---YKCYLDHTPVAVKVLRPDAAQGRSQFQ-REIEVLSCIRHPNMVLLL 512
+ IG G G V Y L+ K+ RP Q ++ RE+ ++ C+ H N++ LL
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 513 GA-CPEYGIIVYE--YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
P+ + ++ Y+ +D + + L ++ + ++ G+ LH
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG-- 146
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDLKP NI++ + KI D GLAR T + +T T Y PE
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAG------TSFMMTPYVVTRYYRAPEV-IL 198
Query: 630 GMLGVKS--DVYSLGILLLQLITAK 652
GM G K D++S+G ++ ++I
Sbjct: 199 GM-GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
++A G+ FL +HRDL NILL H ++KI D GLAR + N + Y +
Sbjct: 222 QVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI----RNDSNYVVKG 274
Query: 615 TAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
A ++ PE + +SDV+S GILL ++ +
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 46/214 (21%)
Query: 458 KIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRSQFQ--------REIEVLSCIR-HP 506
KIGEG + V K A+K ++ F+ REI+ L + HP
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHP 58
Query: 507 NMVLLLGACPEYGIIVYEYLANGSL-------DDRIFR--RGNTPPLSWQQRFRIAAEIA 557
N++ L+ ++++ G L D ++ +G PL ++ ++
Sbjct: 59 NILRLIE-------VLFDRK-TGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLL 110
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
L +H+ + HRD+KP NIL+ + + K++D G R + T+Y
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGI-YSKPPYTEY-----IS 160
Query: 618 TFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLIT 650
T Y PE T G G K D++++G + ++++
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 54/182 (29%), Positives = 75/182 (41%), Gaps = 33/182 (18%)
Query: 479 VKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLG--ACPEYGIIVYEYLANGSLDDRIF 536
+K LR + R R + C+ PNMV L + +V ++ G L I
Sbjct: 23 LKGLRKSSEYSRE---RLTIIPHCV--PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77
Query: 537 RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH------NYVSK 590
+ N P + R AAE+ L LH+ E +V RDL P NILLD Y S+
Sbjct: 78 KFLNIPE---ECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSR 131
Query: 591 ISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
S+V + AV EN+ Y PE D +SLG +L +L+T
Sbjct: 132 WSEVEDSCDGEAV-ENM-------------YCAPEVGGISEETEACDWWSLGAILFELLT 177
Query: 651 AK 652
K
Sbjct: 178 GK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 65/224 (29%)
Query: 457 RKIGEGGYGPVYKCYLDHTP--VAVKVL-RPDAAQGRSQFQ---------REIEVLSCIR 504
+ IG G G V Y T VA+K L RP FQ RE+ ++ +
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP--------FQNVTHAKRAYRELVLMKLVN 73
Query: 505 HPNMVLLLGA-CPEYGI-------IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEI 556
H N++ LL P+ + +V E L + +L I + +S+ + ++
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQMDLDHERMSY-----LLYQM 127
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR-------LVPAVAENVTQ 609
G+ LH ++HRDLKP NI++ + KI D GLAR + P V VT+
Sbjct: 128 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTR 181
Query: 610 YHLTSTAGTFCYIDPEYQQTGMLGV----KSDVYSLGILLLQLI 649
Y Y PE +LG+ D++S+G ++ ++I
Sbjct: 182 Y----------YRAPEV----ILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 13/119 (10%)
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
RF +A E+ + +HQ VHRD+KP NIL+D N +++D G + + +
Sbjct: 105 RFYLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTV 158
Query: 609 QYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE 662
Q + GT YI PE Q G G + D +SLG+ + +++ + P VE
Sbjct: 159 QSSV--AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 49/190 (25%), Positives = 73/190 (38%), Gaps = 52/190 (27%)
Query: 543 PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602
L+ + + ++A G+ FL K +HRDL NILL N V KI D GLAR +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI-- 229
Query: 603 VAENVTQYHLTSTAGTFCYIDPEYQQTG-----------------MLGVKSDVYSLGILL 645
Y DP+Y + G + ++SDV+S G+LL
Sbjct: 230 ------------------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271
Query: 646 LQLIT-AKQPMGLTHFVE---RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRR 701
++ + P E R ++ GT M P T +T+ L C
Sbjct: 272 WEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTM------LDCWHGEP 323
Query: 702 KDRPDLGKVV 711
RP ++V
Sbjct: 324 SQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 6/118 (5%)
Query: 533 DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592
R +P LS+ + ++A G+ FL VHRDL N+L+ + KI
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKIC 281
Query: 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
D GLAR + + +++ ST ++ PE + SDV+S GILL ++ T
Sbjct: 282 DFGLARDIMRDSNYISK---GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 459 IGEGGYGPVY-----------KCYLDHTPVAVKVLRP----DAAQGRSQFQREIEVLSCI 503
+G G YG V+ K Y A+KVL+ A+ + E +VL I
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLY------AMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 504 RHPNMVLLLGACPEYGI---IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
R ++ L + ++ +Y+ G L + +R Q+ + EI L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLAL 118
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
LH+ +++RD+K NILLD N ++D GL++ E Y S GT
Sbjct: 119 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAY---SFCGTIE 171
Query: 621 YIDPEYQQTGMLGVKS--DVYSLGILLLQLITAKQP 654
Y+ P+ + G G D +S+G+L+ +L+T P
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
++A G+ FL VHRDL N+LL + KI D GLAR + + V++ S
Sbjct: 245 QVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GS 298
Query: 615 TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
T ++ PE + SDV+S GILL ++ +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 55/226 (24%), Positives = 82/226 (36%), Gaps = 71/226 (31%)
Query: 453 FTESRKIGEGGYGPVYKCYLDH---TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
+ + R +G G G V+ +D VAVK + Q REI+++ + H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 510 LLLGACPEYGIIVYEYLANGSLDD-------------------------RIFRRGNTPPL 544
VYE L D + +G PL
Sbjct: 66 K-----------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PL 111
Query: 545 SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVPAV 603
S + ++ GL ++H ++HRDLKP N+ ++ + V KI D GLAR+V
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIV--- 165
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQTGML--GVKSDVYSLGILLLQ 647
DP Y G L G+ + Y LLL
Sbjct: 166 -------------------DPHYSHKGYLSEGLVTKWYRSPRLLLS 192
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 65/271 (23%), Positives = 112/271 (41%), Gaps = 36/271 (13%)
Query: 453 FTESRKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQR---EIEVLSCIRHPN 507
F + I G YG VY + A+K + R+Q Q+ E ++L+ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 508 MVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V + + + +V EY+ G + G P + F AE L +LH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYF---AETVLALEYLHN 119
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL-VPAVAENVTQYHLTSTA-------- 616
+VHRDLKP N+L+ K++D GL+++ + ++ N+ + H+
Sbjct: 120 YG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 617 -GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD 675
GT YI PE G D +++GI+L + + +G F + E E+
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL-----VGCVPFFGDTPE-----ELFG 226
Query: 676 PTVTD---WPFEETLGFAKLALQCSELRRKD 703
++D WP + A S L R++
Sbjct: 227 QVISDDIEWPEGDEALPADAQDLISRLLRQN 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 37/208 (17%)
Query: 462 GGYGPVYKCY----LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA--- 514
G G V+ C V VK A G REI++L I H ++ L+ A
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRW 157
Query: 515 ----C---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
C P+Y ++ Y+ DR PL +Q I + L +LH
Sbjct: 158 KSTVCMVMPKYKCDLFTYV------DRS------GPLPLEQAITIQRRLLEALAYLHG-- 203
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRD+K NI LD + + D G A + A + Y +GT PE
Sbjct: 204 -RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY---GWSGTLETNSPELL 259
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQPM 655
K+D++S G++L ++ +
Sbjct: 260 ALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 40/170 (23%), Positives = 65/170 (38%), Gaps = 29/170 (17%)
Query: 496 EIEVLSCIRHPNMVLLLGA-------C---PEYGIIVYEYLANGSLDDRIFRRGNTPPLS 545
E +L I HP+++ L G C P Y +Y YLA + N
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA---------KRNIAICD 183
Query: 546 WQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
I + + +LH+ + ++HRD+K NI ++H + D G A
Sbjct: 184 I---LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA----CFPV 233
Query: 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
++ AGT PE G D++S GI+L ++ T +
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 33/205 (16%)
Query: 477 VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC---PEYGIIVYEYLANGSLDD 533
V +KVL P F ++S + H ++ + G C E I+V E++ +G LD
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSE-NIMVEEFVEHGPLDV 105
Query: 534 RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS---- 589
+ + P++W + +A ++A+ L +L LVH ++ NILL ++
Sbjct: 106 CLRKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTS 160
Query: 590 ---KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-YQQTGMLGVKSDVYSLGILL 645
K+SD G++ + E V + +I PE L +D +S G L
Sbjct: 161 PFIKLSDPGVSFTALSREERVER---------IPWIAPECVPGGNSLSTAADKWSFGTTL 211
Query: 646 LQL-------ITAKQPMGLTHFVER 663
L++ + + P F E+
Sbjct: 212 LEICFDGEVPLKERTPSEKERFYEK 236
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|206039 pfam13868, Trichoplein, Tumour suppressor, Mitostatin | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 28/103 (27%), Positives = 40/103 (38%)
Query: 317 QNLDEVEAEMRRLKLELKQTMDMYSTACKEALVAKQKALELQRWRLDEERRLEEARFAEE 376
Q L E K E Q A +E ++ KQ E E+RR++ E
Sbjct: 233 QELQRAREEQIEEKEERLQEERAEEEAERERMLEKQAEDEELEQENAEKRRMKRLEHRRE 292
Query: 377 TALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLK 419
+ EKE R E E +R+ E EA+R+ E R +
Sbjct: 293 LEQQIEEKEERRAAEREEELEEGERLREEEAERQARIEEERQR 335
|
Trichoplein or mitostatin, was first defined as a meiosis-specific nuclear structural protein. It has since been linked with mitochondrial movement. It is associated with the mitochondrial outer membrane, and over-expression leads to reduction in mitochondrial motility whereas lack of it enhances mitochondrial movement. The activity appears to be mediated through binding the mitochondria to the actin intermediate filaments (IFs). Length = 349 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 2/80 (2%)
Query: 350 AKQKALELQRWRLDEERRL--EEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEA 407
KQ+A E R + E+R + A+ AE+ A EK++ +A + A AK AE EA
Sbjct: 81 EKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKAEAEA 140
Query: 408 QRRLSAEMNRLKESDEVKIA 427
+++ E + E + A
Sbjct: 141 EKKAKEEAKKQAEEEAKAKA 160
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 30/120 (25%), Positives = 52/120 (43%), Gaps = 11/120 (9%)
Query: 317 QNLDEVEAEMRRLKLELKQTMDMYSTACKEALVAKQKALELQRWRLDEERR--------- 367
Q AE +R K E +Q ++ E + K LE +R E+++
Sbjct: 70 QQKSAKRAEEQRKKKEQQQAEELQQKQAAEQ--ERLKQLEKERLAAQEQKKQAEEAAKQA 127
Query: 368 LEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIA 427
+ + AEE A A +A+ +A + A AA + A EA+++ AE + ++ K A
Sbjct: 128 ALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAKKAAAEAKKKAEAEAAKKAAAEAKKKA 187
|
Length = 387 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGR---SQFQRE 496
+IE+ F + I G +G VY + AVKV++ + Q Q E
Sbjct: 2 SIEE-------FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE 54
Query: 497 IEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDD--RIFRRGNTPPLSWQQRFRI 552
+ L+ + P +V L + +V EYL G + I+ + I
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE----MAVKYI 110
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599
+ E+A L +LH+ ++HRDLKP N+L+ + K++D GL+++
Sbjct: 111 S-EVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 11/96 (11%)
Query: 457 RKIGEGGYGPVYKCY---LDHT----PVAVKVLRPDAAQGRSQ-FQREIEVLSCI-RHPN 507
R +G G +G V + L H+ VAVK+L+ A Q E++++S + H N
Sbjct: 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNT 541
+V LLGAC + G I+ EY G L D + R +T
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHT 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|225177 COG2268, COG2268, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 18/68 (26%), Positives = 27/68 (39%), Gaps = 5/68 (7%)
Query: 345 KEALVAKQKALELQRWRLDEERR--LEEARFAEETALSLAEKERARCKAAVEAAEAAKRI 402
+ ALVA +A E ++ + EA + AE R + KA AEA + +
Sbjct: 387 QAALVAAAEAAEQEQVEIAVRAEAAKAEAEAQAAEIKAEAEAIREKGKA---EAEAKRAL 443
Query: 403 AELEAQRR 410
AE
Sbjct: 444 AEAIQVLG 451
|
Length = 548 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 13/92 (14%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP 506
EE +++ +G VY VA+KV R D+ R ++E ++L
Sbjct: 18 EEGKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILE----- 70
Query: 507 NMVLLLGACPE---YG--IIVYEYLANGSLDD 533
++ G PE YG I EY+ L
Sbjct: 71 -ILAGEGVTPEVYFYGEDFIRMEYIDGRPLGK 101
|
Length = 201 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.77 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.77 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.6 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.01 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.16 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 98.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.72 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.64 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.06 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.98 | |
| PLN02236 | 344 | choline kinase | 96.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.67 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=446.65 Aligned_cols=274 Identities=44% Similarity=0.795 Sum_probs=236.9
Q ss_pred ccccccHHHHHHHhccccccceeeeeCcEeEEEEEECC-eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccc
Q 040785 437 RYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515 (782)
Q Consensus 437 ~~~~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 515 (782)
..+.|++.++..+|++|...+.||+||||.||+|...+ +.||||.+.....+...+|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46789999999999999999999999999999999955 89999988775443134599999999999999999999999
Q ss_pred cCc---cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 516 PEY---GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 516 ~~~---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
.+. .+||||||++|+|.+.|+..... +++|..|++|+.++|.||+|||...+.+||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 644 49999999999999999876554 79999999999999999999999988899999999999999999999999
Q ss_pred ccccccccccccccccccccccc-cCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCC---------hHHHH
Q 040785 593 DVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGL---------THFVE 662 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~---------~~~~~ 662 (782)
|||||+..+.. ....... .||.+|+||||...+.++.|+|||||||+|+||+||+.|.+. ..+..
T Consensus 220 DFGLa~~~~~~-----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 220 DFGLAKLGPEG-----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred CccCcccCCcc-----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999765421 1111122 899999999999999999999999999999999999988863 33455
Q ss_pred HHHHhCcccccCCCCCC--CCCh-hHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 663 RSIENGTLGEMLDPTVT--DWPF-EETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 663 ~~~~~~~~~~~ld~~~~--~~p~-~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
..+..+.+.+++||.+. .++. .....+..++.+|++.+|++||+|.+|+ ..|+.
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv-~~L~~ 351 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV-KELEG 351 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH-HHHHh
Confidence 77888899999999985 4443 4667799999999999999999999986 34433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=402.91 Aligned_cols=253 Identities=35% Similarity=0.542 Sum_probs=208.4
Q ss_pred ccccceeeeeCcEeEEEEEECCee-EEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCc---cEEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTP-VAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEY---GIIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~-vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---~~lV~Ey~ 526 (782)
+...+.||.|+||+||+|.+.++. ||||++...... ..+.|.+|+.+|.+++|||||.|+|+|.+. .++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999999998 999999765322 256899999999999999999999999775 48999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~~ 605 (782)
++|+|.++++.. ....+++..++.|+.|||.||.|||+.++ ||||||||+||||+.++ ++||+|||+++....
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~--- 196 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI--- 196 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc---
Confidence 999999999875 33469999999999999999999999996 99999999999999998 999999999986532
Q ss_pred cccccccccccCCcccCChhhhh--cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQ--TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
+....+...||+.|||||++. ...|+.|+|||||||+||||+||+.||......... .+.......|.+ |.
T Consensus 197 --~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~--~~v~~~~~Rp~~---p~ 269 (362)
T KOG0192|consen 197 --SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA--SAVVVGGLRPPI---PK 269 (362)
T ss_pred --ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhcCCCCCC---Cc
Confidence 113445578999999999999 568999999999999999999999999877653221 111122223332 33
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+..+..|+.+||+.+|..||++.+++. .|..+.
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~-~l~~~~ 304 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS-RLESIM 304 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHH-HHHHHH
Confidence 35667999999999999999999998883 444443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=383.94 Aligned_cols=244 Identities=29% Similarity=0.436 Sum_probs=204.0
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc---EEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG---IIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~---~lV~Ey~ 526 (782)
.+.++.||+|..|+||++.+ +++.+|+|++..+. ....+++.+|++|+..++||+||.+||+|...+ +|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 34467899999999999999 47789999996543 345788999999999999999999999995443 7999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++|+|++++...+ .+++.....|+.+|++||.|||. .+ ||||||||+|||++..|.+||||||.++.+-
T Consensus 161 DgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lv---- 230 (364)
T KOG0581|consen 161 DGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILV---- 230 (364)
T ss_pred CCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhh----
Confidence 9999999886553 48999999999999999999996 77 9999999999999999999999999998762
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh-----HHHHHHHHhCcccccCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT-----HFVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~~~ld~~~~~ 680 (782)
.....+.+||..|||||.+.++.|+.++||||||++++||.+|+.||... .+.+. +..+++...+.
T Consensus 231 ---nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------l~~Iv~~ppP~ 301 (364)
T KOG0581|consen 231 ---NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------LCAIVDEPPPR 301 (364)
T ss_pred ---hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------HHHHhcCCCCC
Confidence 22446789999999999999999999999999999999999999999653 22221 11222222233
Q ss_pred CChh-HHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 681 WPFE-ETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 681 ~p~~-~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.|.. .+.+|..|+..||+.+|.+||++.+++.+.+
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 4443 6677999999999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=396.17 Aligned_cols=248 Identities=28% Similarity=0.405 Sum_probs=210.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.+|...+.||+|||+.||.+++ .|..||+|++.+.. ...++.+.+||+|.+.|.|||||+++++|++.. |||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588999999999999999998 67899999997632 234667899999999999999999999998765 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|+|++++|..++.++ .++++.+++.++.||+.||.|||+++ |||||||..||||+++.++||+|||||..+...
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988644 36999999999999999999999999 999999999999999999999999999987432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
..+..+.||||.|+|||++....++..+||||+|||||-||.|++||.....-+.. ..-...+- ..|.
T Consensus 172 -----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-~~Ik~~~Y------~~P~ 239 (592)
T KOG0575|consen 172 -----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-NKIKLNEY------SMPS 239 (592)
T ss_pred -----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-HHHHhcCc------cccc
Confidence 23456789999999999999999999999999999999999999999866544322 11111111 1234
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
....+..+||.++|+.+|.+||+++++|.+...
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 555668999999999999999999999965544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=379.55 Aligned_cols=244 Identities=32% Similarity=0.461 Sum_probs=199.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
..|...+.||.|+||+||+|++ +++.||||.+... .....+.+..|+.||+.++|||||.|++++.... |||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 4588889999999999999998 5679999999766 4455677889999999999999999999986544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC------Cceeeecccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN------YVSKISDVGLAR 598 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~------~~~kL~DFGla~ 598 (782)
||.||+|.+++++++ .+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999998876 4899999999999999999999999 9999999999999764 468999999999
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCC
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDP 676 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~ 676 (782)
.+.. .....+.||++.|||||+++.+.|+.|+|+||+|+|+|+|++|+.||......+-. ++.++ .
T Consensus 164 ~L~~------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~--~---- 231 (429)
T KOG0595|consen 164 FLQP------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN--E---- 231 (429)
T ss_pred hCCc------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc--c----
Confidence 8752 23345679999999999999999999999999999999999999999755544322 22222 1
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.++..+......+.+|+...+..+|.+|-++.+-+.
T Consensus 232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 232 IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred ccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 111122223333567777778888888877766553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=365.05 Aligned_cols=247 Identities=29% Similarity=0.439 Sum_probs=207.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecc-cccCcc---EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLG-ACPEYG---IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g-~~~~~~---~lV~ 523 (782)
.|.++++||+|.||.||++.. ++..||.|.++... ...++....|+.+|++|+|||||++++ .|.+.. +|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 388999999999999999987 78899999998553 344677889999999999999999998 454433 7999
Q ss_pred EeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 524 EYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPE-PLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
|||.+|+|...+... .....+++..+++++.|++.||..+|+.-++ .|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999988754 3345699999999999999999999994332 38999999999999999999999999999885
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
. ......+.+|||.||+||.+...+|+.||||||+||++|||+.-++||.+.++.. ..|+.|.+ +
T Consensus 180 s-----~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~--------~ 246 (375)
T KOG0591|consen 180 S-----KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY--------P 246 (375)
T ss_pred c-----hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--------C
Confidence 4 2233456799999999999999999999999999999999999999998776543 44555533 2
Q ss_pred CCC-hhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 680 DWP-FEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 680 ~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..| ...+.++..||..|+..||+.||+...+|
T Consensus 247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred CCcHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence 233 45677899999999999999999964444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=375.87 Aligned_cols=235 Identities=28% Similarity=0.329 Sum_probs=198.4
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.|++++.||+|+||+||.++. +++.+|+|++++.. ....+....|..||..++||+||.|+..|++.. |||+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 499999999999999999987 56789999998752 223567889999999999999999999997765 99999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+.||.|...|.+.+. |++..+..++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+||||++..-..
T Consensus 106 ~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred ccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 9999999999977653 899999999999999999999999 999999999999999999999999999854221
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.....+.|||+.|||||++....|+..+|+|||||++||||+|.+||...+... ..+..+. +...|
T Consensus 179 ----~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------~~~~p 246 (357)
T KOG0598|consen 179 ----GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------LPLPP 246 (357)
T ss_pred ----CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------CCCCC
Confidence 112234799999999999999999999999999999999999999997665432 2233332 12222
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 040785 683 FEETLGFAKLALQCSELRRKDRP 705 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RP 705 (782)
.....+..+++.+.+..+|++|-
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhc
Confidence 33445689999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=380.05 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=204.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-------hHHHHHHHHHHHHhcCCCCeeeecccccC--c
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-------GRSQFQREIEVLSCIRHPNMVLLLGACPE--Y 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~ 518 (782)
.+.|.+.+.||.|+||.|-+|.. +++.||||++++.... ....+.+|++||++|.|||||+++++|.. +
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45688899999999999999987 6779999999764211 12235799999999999999999999954 4
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC---Cceeeeccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN---YVSKISDVG 595 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~---~~~kL~DFG 595 (782)
.|+||||+.||+|.+.+-.++. +.+..-..++.|++.||.|||++| |+||||||+||||..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 4999999999999999977653 677778889999999999999999 9999999999999765 889999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCC---CCCchhHHHHHHHHHHHHhCCCCCCCh--HH-HHHHHHhCc
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQLITAKQPMGLT--HF-VERSIENGT 669 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~Pf~~~--~~-~~~~~~~~~ 669 (782)
+|+... ....+.+.|||+.|.|||++.+.. +..++|+||+|||||-+|+|.+||... .. ....+..|.
T Consensus 325 lAK~~g------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 325 LAKVSG------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR 398 (475)
T ss_pred hhhccc------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence 999763 345667899999999999988765 345889999999999999999999633 22 445566665
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+... +........+..+||.+||..||++||++.++|.+.
T Consensus 399 y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 399 YAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred cccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 4332 111245666789999999999999999999988543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=374.83 Aligned_cols=241 Identities=32% Similarity=0.475 Sum_probs=202.3
Q ss_pred ccccceeeeeCcEeEEEEEECCe-eEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHT-PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~-~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
+...+.||+|-||.||.|.++++ .||+|.++... ...+.|.+|++||++|+|+|||+|+|+|.... |||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 55678999999999999999776 99999998763 34578999999999999999999999997754 9999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.++|... ....+...+.+.++.|||+|++||++++ +|||||-..||||+++..+||+|||||+.+... .
T Consensus 287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-----~ 357 (468)
T KOG0197|consen 287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-----E 357 (468)
T ss_pred cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC-----c
Confidence 999999763 3345888999999999999999999999 999999999999999999999999999955321 1
Q ss_pred c-ccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhH
Q 040785 610 Y-HLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 610 ~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
+ ......-...|.|||.+..+.++.|||||||||+||||+| |+.||......+ ..++.|- ....|..+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--------Rlp~P~~C 429 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--------RLPRPEGC 429 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--------cCCCCCCC
Confidence 2 1122233568999999999999999999999999999999 999987655433 3444442 12345667
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
|..+.+++..||+.+|++||+++.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 77899999999999999999997443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=373.16 Aligned_cols=248 Identities=28% Similarity=0.347 Sum_probs=205.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 523 (782)
+|...+.||+|+|++||+|+. .++.+|||++.+.. ....+.+.+|-++|.+| .||.|++||..|.+.. |+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 388889999999999999998 57799999997642 22244578899999999 8999999999997765 9999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.++|.+.+ .|++..+..++.+|+.||+|||++| ||||||||+|||||.|+++||+|||.|+.++..
T Consensus 154 e~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999998775 3899999999999999999999999 999999999999999999999999999988543
Q ss_pred ccc--------ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCC
Q 040785 604 AEN--------VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD 675 (782)
Q Consensus 604 ~~~--------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld 675 (782)
... .......+.+||..|.+||++..+..++.+|||+||||||+|+.|.+||...+....-...-.+ +
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l----~ 303 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL----D 303 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh----c
Confidence 221 1112235689999999999999999999999999999999999999999766543211111111 1
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
-.+|+..+....+|+.+.|..+|.+|++..++-.
T Consensus 304 ---y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 304 ---YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1345555567899999999999999999977753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=365.61 Aligned_cols=244 Identities=24% Similarity=0.283 Sum_probs=196.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhH---HHHHHHHHHHHhcCCCCeeeecccccCc--cEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGR---SQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~ 523 (782)
++|+.+..||+|+||.||+|+. +|..+|+|++++.....+ ..+..|.+||....+|+||+||..|.+. .||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 4599999999999999999987 677999999988755443 4567899999999999999999999764 49999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+|||++..+|.+.+ .|++..+..++.+++.|+..||+.| ||||||||+|+|||..|++||+||||+.-+...
T Consensus 221 EylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999997665 4999999999999999999999999 999999999999999999999999999643110
Q ss_pred ----------------c--cc--cc----------------------ccccccccCCcccCChhhhhcCCCCCchhHHHH
Q 040785 604 ----------------A--EN--VT----------------------QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSL 641 (782)
Q Consensus 604 ----------------~--~~--~~----------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSl 641 (782)
. .. .. .......+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 00 00 000124689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 642 GILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 642 Gvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
|||+||||.|.+||......+ ..+......-. -|. ......+..+||.+||. ||.+|-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-fP~----~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-FPE----EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-CCC----cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999997655433 22222221110 111 01233568999999999 9999987
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=346.68 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=199.0
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.|+.+.++|+|+||+||+|++ +|+.||||.+.... ....+-..+||.+|++|+|||+|.|+.+|.... +||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 488889999999999999998 67799999996542 334556789999999999999999999996654 999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
|+..-|. .|.+..+ .++...+..|++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+...
T Consensus 83 ~dhTvL~-eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 83 CDHTVLH-ELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred cchHHHH-HHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 9875444 4555443 3888999999999999999999999 999999999999999999999999999987532
Q ss_pred cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH------------------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE------------------ 666 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~------------------ 666 (782)
....|..+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|-+...++...-
T Consensus 155 ---gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 155 ---GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred ---cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 233456778999999998776 6799999999999999999999999965444332211
Q ss_pred hCcccccCCCCCCCC------ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 667 NGTLGEMLDPTVTDW------PFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+..+..+.-|..... .+....-+.+|+..|++.||.+|++-++++.+.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 111111111211110 112233578999999999999999999998554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=362.01 Aligned_cols=253 Identities=29% Similarity=0.414 Sum_probs=206.6
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccc--ccCc--cEEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA--CPEY--GIIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~--~~lV~Ey 525 (782)
+|...+.||+|+||.||++... +...|||.+........+.+.+|+.+|++++|||||+++|. ..+. .++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4777889999999999999984 58999999876543336678999999999999999999996 3343 5899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~ 604 (782)
+++|+|.+++.+.+. .|++..+.+++.||++||.|||+++ ||||||||+||||+. ++.+||+|||+++.....
T Consensus 98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~- 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK- 171 (313)
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc-
Confidence 999999999977664 5999999999999999999999999 999999999999999 799999999999876431
Q ss_pred ccccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCCCC-hHHHHHHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPMGL-THFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
...........||+.|||||++.++. ...++|||||||+++||+||.+||.. .......+..+.-. ..+.+|
T Consensus 172 -~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~P~ip 245 (313)
T KOG0198|consen 172 -GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SLPEIP 245 (313)
T ss_pred -cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CCCCCC
Confidence 11122334578999999999998654 34599999999999999999999975 23333333333221 233556
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
...+....+|+.+|+..+|+.||++.++|.+.+.
T Consensus 246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 6677789999999999999999999999865443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.80 Aligned_cols=229 Identities=28% Similarity=0.387 Sum_probs=197.3
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhh---HHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQG---RSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
|+.++.||.|+||+|.+++. .+..+|+|++.+...-. .+...+|..+|+.+.||++++|++.|.+.. |+||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 88899999999999999998 56689999998764333 344678999999999999999999997765 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++||.|..+|++.+ .|++..++.++.||+.||+|||+++ |++|||||+|||||.+|.+||+|||+|+.+..
T Consensus 126 v~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 126 VPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred cCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999997665 4999999999999999999999999 99999999999999999999999999998742
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 683 (782)
...+.|||+.|+|||++....|+..+|+|||||++|||+.|.+||....... ..|-.|. -.+|.
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~---------v~fP~ 262 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK---------VKFPS 262 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc---------ccCCc
Confidence 1346799999999999999999999999999999999999999997665532 1122222 13455
Q ss_pred hHHHHHHHHHHHhhccCcCCC
Q 040785 684 EETLGFAKLALQCSELRRKDR 704 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~R 704 (782)
.....+.+|+.+.|+.|-..|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 556678999999999999888
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=360.08 Aligned_cols=251 Identities=29% Similarity=0.355 Sum_probs=202.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV 522 (782)
+.|+.+++||+|.||.||+|++ ++..||+|.++.+.. .......+||.||++|.||||++|.+...+. .|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3488889999999999999998 567899999987653 2344567999999999999999999987554 2999
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
+|||+. +|.-++...+ -.|++.++..++.||+.||.|+|+++ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999987 7777664433 24999999999999999999999999 99999999999999999999999999998743
Q ss_pred ccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCcccccCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGTLGEMLDPT 677 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~~~ld~~ 677 (782)
. ....+|..+-|++|.|||++.+. .|+..+|+||.||||.||++|++.|.....+++... -|...+-..+
T Consensus 271 ~----~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~- 345 (560)
T KOG0600|consen 271 S----GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP- 345 (560)
T ss_pred C----CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-
Confidence 2 22336778899999999987776 599999999999999999999999987766654432 2333333333
Q ss_pred CCCCC-------------------hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 VTDWP-------------------FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 ~~~~p-------------------~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+.| ...+....+|+..+|.+||.+|.++.++|.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 112345679999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=362.03 Aligned_cols=245 Identities=26% Similarity=0.382 Sum_probs=207.8
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|.+.+.||+|+||+||+|+.+ ...||+|.+.+. .....+.+.+|++|++.++|||||.++++|+... ++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45788889999999999999874 558999999765 3344667899999999999999999999997655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+.| +|..+|...+ .++++.+..|+.+++.||.|||+++ |+|||+||.||||+.+|++|+||||+|+....
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9977 9999996654 3999999999999999999999999 99999999999999999999999999997632
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChh
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.....+.+.||+.|||||++.++.|+..+|+||+|||+|||.+|++||.......- .+.+......||..
T Consensus 153 ---~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L-------v~~I~~d~v~~p~~ 222 (808)
T KOG0597|consen 153 ---NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL-------VKSILKDPVKPPST 222 (808)
T ss_pred ---CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH-------HHHHhcCCCCCccc
Confidence 33456778999999999999999999999999999999999999999954433221 11111222457778
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
....|.+|+...+..||..|-+..+++-+.
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 888899999999999999999998887543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=361.70 Aligned_cols=246 Identities=27% Similarity=0.375 Sum_probs=204.8
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC----ch-hhHHHHHHHHHHHHhcC-CCCeeeecccccCc--
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD----AA-QGRSQFQREIEVLSCIR-HPNMVLLLGACPEY-- 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~----~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~-- 518 (782)
..+.|...+.||+|+||.|++|.+ ++..||||++... .. ...+.+.+|+.+++.++ ||||++++.++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345799999999999999999987 6789999987653 11 23456779999999999 99999999998543
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeeccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLA 597 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla 597 (782)
.++||||+.||+|.+.+...+ ++.+.++..++.|++.|++|||+++ |+||||||+|||||.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 489999999999999997743 4888999999999999999999999 9999999999999999 99999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCC-CC-CchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCccccc
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM-LG-VKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEM 673 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s-~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ 673 (782)
.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||...+..... +..+.
T Consensus 169 ~~~~-----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~---- 239 (370)
T KOG0583|consen 169 AISP-----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE---- 239 (370)
T ss_pred cccC-----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC----
Confidence 8653 1334556789999999999999877 74 8999999999999999999999875543322 22221
Q ss_pred CCCCCCCCChhH-HHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 674 LDPTVTDWPFEE-TLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 674 ld~~~~~~p~~~-~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
-..|... ..++..|+.+|+..+|..|+++.+++.+.
T Consensus 240 -----~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 240 -----FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred -----ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 1223333 66799999999999999999999998433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=359.83 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=200.0
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY-- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~-- 518 (782)
.++|.+.++||+|+||.||+|.+ .++.||||+++... ......+.+|+.+|..+ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45689999999999999999974 23579999997543 23346789999999999 899999999988643
Q ss_pred -cEEEEEeCCCCChhHHHhhcCC---------------------------------------------------------
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGN--------------------------------------------------------- 540 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 540 (782)
.++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 3899999999999998865321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCC
Q 040785 541 --TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618 (782)
Q Consensus 541 --~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt 618 (782)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .........++
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~~ 239 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRKGSARLP 239 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCc---chhcccCCCCC
Confidence 135888999999999999999999999 9999999999999999999999999998653211 11122334567
Q ss_pred cccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH---HHHHHHhCcccccCCCCCCCCChhHHHHHHHHHH
Q 040785 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF---VERSIENGTLGEMLDPTVTDWPFEETLGFAKLAL 694 (782)
Q Consensus 619 ~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~ 694 (782)
..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+.. ...|...+..+.+|+.
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~ 311 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR--------MRAPENATPEIYRIML 311 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC--------CCCCCCCCHHHHHHHH
Confidence 88999999999999999999999999999997 9999965432 1222222211 1112334556899999
Q ss_pred HhhccCcCCCCChHHhhhHHHHHH
Q 040785 695 QCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 695 ~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+||..+|.+||++.+++. .|+.+
T Consensus 312 ~cl~~dp~~RPs~~el~~-~l~~~ 334 (338)
T cd05102 312 ACWQGDPKERPTFSALVE-ILGDL 334 (338)
T ss_pred HHccCChhhCcCHHHHHH-HHHHH
Confidence 999999999999998873 44443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=363.85 Aligned_cols=236 Identities=29% Similarity=0.445 Sum_probs=199.1
Q ss_pred cccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 454 TESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
..++.||.|+-|.||+|++.+..||||.++. .-..+|.-|++|+||||+.|.|+|.... |||||||..|.|
T Consensus 127 sELeWlGSGaQGAVF~Grl~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhhccCcccceeeeeccCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3467899999999999999999999998753 2245788899999999999999997655 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+.|.... ++.......|..+||.|+.|||.++ |||||||.-||||..+..+||+|||.++..... ..
T Consensus 200 ~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~------ST 267 (904)
T KOG4721|consen 200 YEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK------ST 267 (904)
T ss_pred HHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh------hh
Confidence 99995443 4777888999999999999999999 999999999999999999999999999876432 23
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAK 691 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~ 691 (782)
+-.++||..|||||++.+.+.+.|+|||||||||||||||..||...+....++.-|. ..|. ...|..++..|.-
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--NsL~---LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NSLH---LPVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--Cccc---ccCcccCchHHHH
Confidence 3467999999999999999999999999999999999999999975554333322222 2111 2346677888999
Q ss_pred HHHHhhccCcCCCCChHHhhhH
Q 040785 692 LALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 692 li~~cl~~~P~~RPs~~~vl~~ 713 (782)
|+.+||+-.|+.||++.+++++
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHH
Confidence 9999999999999999999853
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=347.39 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=206.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey 525 (782)
+.|+....||.|..++||+|+. .+..||||++..+... ....+.+|+..|+.++||||+.++..|... .++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4599999999999999999998 6789999999876433 357899999999999999999999988543 4899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
|.+||+.+++...-. ..|.+..+..|+++++.||.|||.+| .||||||+.||||+.+|.|||+|||.+-.+...+.
T Consensus 106 Ma~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999876533 34999999999999999999999999 99999999999999999999999998776644332
Q ss_pred cccccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh--CcccccCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN--GTLGEMLDPTVTDW 681 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~ld~~~~~~ 681 (782)
. ......+..||++|||||+++. ..|+.|+|||||||+.+||.+|..||......+-.+.. +.....+ ....
T Consensus 182 R-~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---t~~~ 257 (516)
T KOG0582|consen 182 R-QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---TSGL 257 (516)
T ss_pred e-eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---cccC
Confidence 2 2222267899999999998554 35999999999999999999999999866655533322 2111111 1111
Q ss_pred Ch----hHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 682 PF----EETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 682 p~----~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+. .....|.+++..||..||+.||++++++.+.
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 11 2344799999999999999999999988443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.33 Aligned_cols=264 Identities=28% Similarity=0.453 Sum_probs=209.1
Q ss_pred HHHHHHhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-E
Q 040785 444 EDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-I 520 (782)
Q Consensus 444 ~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~ 520 (782)
+++++..+.+.+...||.|.||+||+|.+ +..||||+++.+. ....+.|++|+.+|++.+|-||+.+.|+|.... .
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w-hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW-HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccc-ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 33444445577889999999999999988 4579999998653 335678999999999999999999999996655 7
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
||..+|.|.+|+.+|+-... .|...+.+.|+.|||+|+.|||.++ |||||||..||||.+++.|||+||||+..-
T Consensus 464 IiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 89999999999999976543 3888999999999999999999999 999999999999999999999999999754
Q ss_pred ccccccccccccccccCCcccCChhhhhcC---CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH-HhCcccccCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTG---MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI-ENGTLGEMLDP 676 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~ld~ 676 (782)
.... .........|...|||||+++.+ +|++.+||||||||+|||+||..||. ....+..+ ..|.-. +-|
T Consensus 539 ~~w~---g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~--l~p 612 (678)
T KOG0193|consen 539 TRWS---GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGY--LMP 612 (678)
T ss_pred eeec---cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccc--cCc
Confidence 2221 11222345688899999987644 58999999999999999999999998 33333322 222221 122
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+.......+.++.+|+..||..++++||.+.+++...+..++
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 3333335667789999999999999999999999864444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=359.38 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=207.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccccc--CccEEEEEeCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP--EYGIIVYEYLA 527 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 527 (782)
.|....+||+|+.|.||.+.. ++..||||.+.......++.+.+|+.+|+..+|+|||.++..|. +..++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 477778999999999999987 56689999998776666777899999999999999999998874 44599999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
||+|.|.+... .+++.++..|+.+++.||.|||.++ |||||||.+||||+.+|.+||+|||+|..+..
T Consensus 354 ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~----- 421 (550)
T KOG0578|consen 354 GGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE----- 421 (550)
T ss_pred CCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc-----
Confidence 99999988443 3899999999999999999999999 99999999999999999999999999987632
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHH
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETL 687 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 687 (782)
.+...++.+||+.|||||++....|++|+||||||++++||+-|.+||-..+.........+ .-.|.+ ..+.....
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~---ng~P~l-k~~~klS~ 497 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPKL-KNPEKLSP 497 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---cCCCCc-CCccccCH
Confidence 23355678999999999999999999999999999999999999999954444332221111 011222 23455667
Q ss_pred HHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 688 GFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 688 ~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.|.+|+.+||..|+.+||++.++|.+.+
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 8999999999999999999999985543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=350.19 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=203.7
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-hHHHHHHHHHHHHhcC-CCCeeeecccccCcc---EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIR-HPNMVLLLGACPEYG---IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~---~lV 522 (782)
.++|...++||.|+||.||+|.. .+..||||.++..... ....=.||+..|++|. |||||+|..++.++. ++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45799999999999999999987 6778999998765322 2223468999999998 999999999996655 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
||||+ .+|+.++..+ ..+|++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||||+.+.+
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99995 4899988766 457999999999999999999999999 99999999999999999999999999997743
Q ss_pred ccccccccccccccCCcccCChhhh-hcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCcccccCC--
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGTLGEMLD-- 675 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~~~ld-- 675 (782)
....|..+.|.+|.|||++ +.+.|+.+.|+||+|||++|+.+-++-|-+....++... .|+..+--+
T Consensus 163 ------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 163 ------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 3345667889999999965 567799999999999999999999999976655443322 122111111
Q ss_pred ------------CC-----CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 676 ------------PT-----VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 676 ------------~~-----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
|. +...-+....++++|+.+||..||.+||++.+.+.+..
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 11 11111235567999999999999999999999985433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=324.52 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=208.4
Q ss_pred cccccHHHHHHHhccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeec
Q 040785 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLL 512 (782)
Q Consensus 438 ~~~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~ 512 (782)
.+.+++++ |++.+.||+|-||.||+|+.+ +-.||+|++.+.. .....++.+|++|-+.|+||||+++|
T Consensus 16 ~~~~~l~d-------feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 16 TKTWTLDD-------FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred ccccchhh-------ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhh
Confidence 35666655 899999999999999999984 4579999996542 23356789999999999999999999
Q ss_pred ccccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCcee
Q 040785 513 GACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSK 590 (782)
Q Consensus 513 g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~k 590 (782)
++|.+.. ||++||.++|+|...|.... ...+++.....++.|+|.||.|+|..+ ||||||||+|+|++..+.+|
T Consensus 89 ~~fhd~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 89 GYFHDSKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred hheeccceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCee
Confidence 9997765 99999999999999997433 235888999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcc
Q 040785 591 ISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTL 670 (782)
Q Consensus 591 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 670 (782)
|+|||++-..+ .....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||......+......
T Consensus 165 iAdfGwsV~~p-------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~-- 235 (281)
T KOG0580|consen 165 IADFGWSVHAP-------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR-- 235 (281)
T ss_pred ccCCCceeecC-------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--
Confidence 99999987543 233456899999999999999999999999999999999999999996554322111111
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 671 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......|...+...+++|.+|+..+|.+|..+.+++.
T Consensus 236 -----k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 236 -----KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -----HccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1112334566677999999999999999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=360.87 Aligned_cols=238 Identities=25% Similarity=0.306 Sum_probs=196.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc--cEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY--GIIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~--~~lV 522 (782)
++|..+++||+|.||+|+++.+ ++..+|||+++++. .++.+....|..|+... +||.+++|+.+|... .|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 4599999999999999999998 45589999998863 34456778899988877 599999999999654 4999
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+.||++..+. ....|++..+..++.+|+.||.|||+++ |||||||.+|||||.+|++||+||||++..-.
T Consensus 448 mey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999954333 2234999999999999999999999999 99999999999999999999999999985321
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.....++.|||+.|||||++.+..|+..+|+|||||+|||||.|..||...+.-+ ..+.-... + .-+|
T Consensus 521 -----~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~FdsI~~d---~---~~yP 588 (694)
T KOG0694|consen 521 -----QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDSIVND---E---VRYP 588 (694)
T ss_pred -----CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhcC---C---CCCC
Confidence 2234567899999999999999999999999999999999999999997554321 11111111 1 2356
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
...+.+.+.++.++|..+|+.|--+
T Consensus 589 ~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CcccHHHHHHHHHHhccCcccccCC
Confidence 6677789999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=320.30 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=199.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-h-HHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-G-RSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.+|...++||+|.||.||+|++ +++.||||.++..... + .....+||..|+.++||||+.|+++|+... .||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577888999999999999998 6779999999765322 1 235679999999999999999999997654 79999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
||+. +|+..+..+. ..|+..++..++.+++.||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 8988885544 45899999999999999999999999 9999999999999999999999999999885432
Q ss_pred ccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH----HhCcccccCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI----ENGTLGEMLDPTVT 679 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~----~~~~~~~~ld~~~~ 679 (782)
. ..+..+-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+....++.. --|+...-..|.+.
T Consensus 156 ~-----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 R-----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c-----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2 22334779999999976654 69999999999999999999988776554443321 12333333333322
Q ss_pred CCC-----------------hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWP-----------------FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p-----------------~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..| +....+..+|+..++..||.+|+++.+.+.
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 221 223445789999999999999999999884
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.83 Aligned_cols=242 Identities=21% Similarity=0.308 Sum_probs=196.4
Q ss_pred ccceeeeeCcEeEEEEEECCeeEEEEEecCCchhh---HHHHHHHHHHHHhcCCCCeeeecccccC------ccEEEEEe
Q 040785 455 ESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQG---RSQFQREIEVLSCIRHPNMVLLLGACPE------YGIIVYEY 525 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~lV~Ey 525 (782)
....||+|++|.||+|.++++.||||+++...... .+.|.+|+.+|.+++||||++++|+|.+ ..++||||
T Consensus 24 ~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 24 TSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 34679999999999999999999999997653222 4678899999999999999999999855 23899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
+++|+|.+++.... .+++.....++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP- 176 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc-
Confidence 99999999986543 488999999999999999999985 6 889999999999999999999999999865321
Q ss_pred ccccccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..+.. .+ .
T Consensus 177 -------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~----~~---~ 242 (283)
T PHA02988 177 -------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN----SL---K 242 (283)
T ss_pred -------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC----CC---C
Confidence 123468899999999876 679999999999999999999999997554322 11111111 11 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.|...+..+.+|+.+||+.+|++||++.+++ ..|..+
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell-~~l~~~ 279 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEIL-YNLSLY 279 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHH-HHHHHH
Confidence 2334556799999999999999999999887 355544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=343.78 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=195.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
|...+.||+|+||.||+|.+ +++.||||.+..... .....+.+|+.+|..+.||||+.++++|.+.. ++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77889999999999999987 578999999865422 22345789999999999999999999886544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+.+..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 999999988765432 35899999999999999999999999 999999999999999999999999999765321
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.... ......++.
T Consensus 156 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 226 (285)
T cd05631 156 ----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-----KEDQEEYSE 226 (285)
T ss_pred ----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-----hcccccCCc
Confidence 1123457999999999999999999999999999999999999999754321 11111110 011112333
Q ss_pred hHHHHHHHHHHHhhccCcCCCCC-----hHHhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPD-----LGKVV 711 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs-----~~~vl 711 (782)
..+..+.+|+.+||..+|.+||+ +++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~ 259 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK 259 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh
Confidence 44557899999999999999997 55555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.72 Aligned_cols=255 Identities=28% Similarity=0.450 Sum_probs=195.6
Q ss_pred ccccccceeeeeCcEeEEEEEEC------------------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeee
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD------------------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLL 511 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~------------------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 511 (782)
++|...++||+|+||.||+|.+. +..||+|++.... ......|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 45888899999999999999752 2369999997653 3345679999999999999999999
Q ss_pred cccccCcc--EEEEEeCCCCChhHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 040785 512 LGACPEYG--IIVYEYLANGSLDDRIFRRG----------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573 (782)
Q Consensus 512 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH 573 (782)
+++|.+.. |+||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99986544 89999999999999886432 1234788999999999999999999999 999
Q ss_pred cCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh--C
Q 040785 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT--A 651 (782)
Q Consensus 574 rDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G 651 (782)
|||||+|||++.++.+||+|||+++.+.... .........++..|+|||++..+.++.++|||||||++|+|++ |
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD---YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc---eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999998653211 1112233456889999999998999999999999999999987 5
Q ss_pred CCCCCChHHHHHHHHhC-cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 652 KQPMGLTHFVERSIENG-TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 652 ~~Pf~~~~~~~~~~~~~-~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..||............. .+...........++..+..+.+|+.+||..+|.+||++.+++
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 67886433221110000 0000000111112334456799999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=348.80 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=202.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.|+....||+|+||.||+|.+ .++.||+|++..+. ......+++|+.+|..++++||..+||.+-... +++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 377778999999999999998 56689999998763 445788999999999999999999999885544 7999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
.||++.+.|... ..+.+..+..|+.+++.||.|||..+ .||||||+.|||+..+|.+||+|||.+-.+..
T Consensus 94 ~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~---- 163 (467)
T KOG0201|consen 94 GGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN---- 163 (467)
T ss_pred cCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec----
Confidence 999999988433 23578888889999999999999999 99999999999999999999999999876532
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
+.....+.+||+.|||||+++...|+.|+||||||++.+||++|.+||...+...-.. .+.+-..|. +.....
T Consensus 164 -~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf---lIpk~~PP~---L~~~~S 236 (467)
T KOG0201|consen 164 -TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF---LIPKSAPPR---LDGDFS 236 (467)
T ss_pred -hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE---eccCCCCCc---cccccC
Confidence 2333467899999999999998899999999999999999999999997666522110 011111122 222455
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..|.+|+..||+.+|+.||++.+++.+
T Consensus 237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 679999999999999999999998744
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=356.21 Aligned_cols=241 Identities=26% Similarity=0.400 Sum_probs=207.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
-|...+.||.|+.|.|-+|.+ +|+.+|||++.+.. ......+.+||-||+.+.|||+++||+++.+.. |||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 477889999999999999998 78899999996642 222456889999999999999999999997654 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|.|++++.+++ +|++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+..
T Consensus 93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--- 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--- 163 (786)
T ss_pred ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc---
Confidence 999999999998876 4899999999999999999999999 9999999999999999999999999998642
Q ss_pred ccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTDW 681 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~ 681 (782)
......+.||.+.|.+||++.+.+| +.++||||.|||||.||||+.||+..+...-. +..|. -+.
T Consensus 164 ---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---------f~M 231 (786)
T KOG0588|consen 164 ---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---------FEM 231 (786)
T ss_pred ---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---------ccC
Confidence 3344567899999999999999987 68999999999999999999999866543322 22332 244
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
|...+.+..+|+.+|+..||..|.++.+|+.+
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 56677789999999999999999999999853
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=341.18 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=197.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--------------hHHHHHHHHHHHHhcCCCCeeeecc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--------------GRSQFQREIEVLSCIRHPNMVLLLG 513 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--------------~~~~~~~Ei~iL~~l~HpnIv~l~g 513 (782)
-+.|++...||+|.||.|-+|+. +++.||||++.+.... ..+...+||.||++|+|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 35699999999999999999998 6789999999653111 1356889999999999999999999
Q ss_pred cccC----ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 514 ACPE----YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 514 ~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
+..+ ..|||+|||..|.+.+.- ...+.|++.+++.|+.++..||.|||.+| ||||||||+|+||+.+|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 8754 349999999999876422 22233999999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCC----CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM----LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI 665 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~ 665 (782)
||+|||.+..++..............+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||......+..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~- 328 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF- 328 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH-
Confidence 999999998764332222223334579999999999876643 467899999999999999999999655443321
Q ss_pred HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 666 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
++-.-..+. .+.. +++...+.+||.++|..||+.|.++.++.++
T Consensus 329 ~KIvn~pL~---fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 329 DKIVNDPLE---FPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHhcCccc---CCCc-ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 111111111 1121 2456679999999999999999999888643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.11 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=196.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...+.||+|+||.||+|.. +++.||||++.... ......+.+|+.+|..++||||+++++++.+.. |+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 588899999999999999998 47789999996532 123456889999999999999999999886654 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 82 YVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 999999999886543 4889999999999999999999999 99999999999999999999999999986521
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ..+|
T Consensus 154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------~~~~ 218 (291)
T cd05612 154 ------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---------LEFP 218 (291)
T ss_pred ------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------cCCC
Confidence 1123579999999999998889999999999999999999999997654322 1122221 1233
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCC-----hHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPD-----LGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs-----~~~vl~ 712 (782)
......+.+|+.+||+.||.+||+ +.+++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 334556899999999999999996 666553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=327.84 Aligned_cols=250 Identities=26% Similarity=0.293 Sum_probs=203.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhh--HHHHHHHHHHHHhcCCCCeeeecccc----cCccEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQG--RSQFQREIEVLSCIRHPNMVLLLGAC----PEYGIIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lV~ 523 (782)
.|+.+++|++|+||.||+|.+ +++.||+|.++.+.... .-.-.+||.+|.+++|||||.+-.+. -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 388999999999999999998 56689999998753221 12347999999999999999986554 44559999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|||+. +|..++.... .+|...++..++.|++.||.|||.+. |+||||||+|+|++..|.+||+|||||+.+...
T Consensus 157 e~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99977 8888887665 46999999999999999999999999 999999999999999999999999999987532
Q ss_pred cccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH----HHhCcccccCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS----IENGTLGEMLDPTV 678 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~~~~~ld~~~ 678 (782)
...++..+-|.+|.|||.+.+. .|++.+|+||+|||+.||+++++-|.+....++. ..-|+..+-+.|.+
T Consensus 231 -----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 231 -----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred -----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 3345677889999999987765 5999999999999999999999999765443322 23466666666655
Q ss_pred CCCChh---------------------HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFE---------------------ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~---------------------~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...|.. ....-.+|+..++..||.+|-++.+.|.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 443311 1234678999999999999999998874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.85 Aligned_cols=238 Identities=23% Similarity=0.316 Sum_probs=196.3
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|..++||||+++++++.+.. |+|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 488999999999999999998 46789999997542 123456889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+.+...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 99 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred CCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999886543 4889999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ...|
T Consensus 172 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---------~~~p 235 (329)
T PTZ00263 172 -------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---------LKFP 235 (329)
T ss_pred -------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------cCCC
Confidence 123579999999999999999999999999999999999999996554322 2222221 1122
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCC-----hHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPD-----LGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs-----~~~vl~ 712 (782)
...+..+.+|+.+||+.||.+||+ +.+++.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 334456899999999999999997 455553
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=334.44 Aligned_cols=240 Identities=30% Similarity=0.453 Sum_probs=207.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
..+|++.+.||+|.||.|-+++. .++.||||.++++. .++.-.+.+||+||+.|+||||+.+|.+|.... .||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45688889999999999999986 68899999998763 344556789999999999999999999997655 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||..+|.|+|++.+++ .|++.++..++.||..|+.|+|.++ ++|||||.+|||||.|+++||+||||+.++.
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 99999999999998775 3999999999999999999999999 9999999999999999999999999998874
Q ss_pred ccccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~ 679 (782)
.....+++||++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||++.++- -..+..|.+.+--.
T Consensus 205 -----~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~---- 275 (668)
T KOG0611|consen 205 -----DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET---- 275 (668)
T ss_pred -----cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC----
Confidence 2345677899999999999998887 68999999999999999999999876553 34556666554222
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+....-||+.||-.+|++|.++.++.
T Consensus 276 ------PSdA~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 276 ------PSDASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred ------CchHHHHHHHHHhcCcccchhHHHHh
Confidence 22467899999999999999998875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=365.91 Aligned_cols=251 Identities=34% Similarity=0.526 Sum_probs=208.6
Q ss_pred cccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
+....+.||+|.||+||+|... .+.||||.++..... .+.+|++|+++|..|+|||||+|+|+|.+.. |+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3556788999999999999862 347999999887655 6889999999999999999999999997655 99
Q ss_pred EEEeCCCCChhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCcee
Q 040785 522 VYEYLANGSLDDRIFRRGN-----------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSK 590 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~k 590 (782)
|+|||..|+|.++|..... .++|+..+.+.|+.|||.|+.||-++. +|||||-..|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 9999999999999975421 234899999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccccccccccccc-cccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHH
Q 040785 591 ISDVGLARLVPAVAENVTQYHLT-STAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIE 666 (782)
Q Consensus 591 L~DFGla~~~~~~~~~~~~~~~~-~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~ 666 (782)
|+||||++.+-.. ..|+.. ...-..+||+||.+..++|+++||||||||+|||+++ |+.||..... +-..+.
T Consensus 644 IsDfGLsRdiYss----DYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 644 ISDFGLSRDIYSS----DYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred ecccccchhhhhh----hhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999976321 233322 3344679999999999999999999999999999998 9999864432 334455
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.|.+ ...|..+|..+..|+..||+.+|++||++.++= ..|...
T Consensus 720 ~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~-~~L~~~ 762 (774)
T KOG1026|consen 720 AGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH-SRLQAW 762 (774)
T ss_pred cCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH-HHHHHH
Confidence 5543 345677788899999999999999999998885 244433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.18 Aligned_cols=236 Identities=24% Similarity=0.289 Sum_probs=192.8
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
+.||+|+||.||+|.. +++.||||+++... ......+.+|+.+|..++||||+.++++|.... |+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 56789999997542 223456788999999999999999999886554 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.... ..
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-----~~ 149 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-----DG 149 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----CC
Confidence 9998886543 5899999999999999999999999 99999999999999999999999999875321 11
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEETL 687 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~ 687 (782)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+. ..+|...+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLSP 220 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCCCH
Confidence 12234679999999999999999999999999999999999999996544322 1111111 123344556
Q ss_pred HHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 688 GFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 688 ~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
.+.+|+.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 799999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.55 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=200.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.++..++||||+++++++.+.. |+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 588999999999999999998 46799999997542 223456889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999986543 4889999999999999999999999 99999999999999999999999999976532
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccC-CCCCCCCCh
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEML-DPTVTDWPF 683 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l-d~~~~~~p~ 683 (782)
......||+.|+|||++.+..++.++|||||||++|||++|..||......+...........+ .|.......
T Consensus 154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 227 (333)
T cd05600 154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227 (333)
T ss_pred ------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccc
Confidence 2234679999999999999999999999999999999999999997654432211111111111 111111112
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+..+.+|+.+||..+|.+||++.+++.+
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 335568999999999999999999998854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=362.31 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=203.1
Q ss_pred cccccceeeeeCcEeEEEEEE--C-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--D-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.|...+.||+|+||.||+|.. + +..||+|.+..........+.+|+.+|..++||||++++++|.... ||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 388899999999999999987 3 5678999876655555567889999999999999999999986544 8999999
Q ss_pred CCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++|+|.+.+... ....++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~- 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV- 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-
Confidence 999999988643 33346899999999999999999999999 9999999999999999999999999998663211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 683 (782)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+..+.. ...|.
T Consensus 224 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~--------~~~~~ 293 (478)
T PTZ00267 224 --SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY--------DPFPC 293 (478)
T ss_pred --ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCCc
Confidence 11123446799999999999999999999999999999999999999975543221 1111211 11233
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
..+..+.+|+.+||..+|+.||++.+++...+
T Consensus 294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~ 325 (478)
T PTZ00267 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEF 325 (478)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence 34456999999999999999999999985443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=344.10 Aligned_cols=236 Identities=24% Similarity=0.290 Sum_probs=191.6
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
+.||+|+||.||++.. ++..||+|+++... ......+.+|+.++..++||||+.++++|.... |+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 57789999997542 223456778999999999999999999886544 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-----~~ 149 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-----DG 149 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC-----CC
Confidence 9988885543 4899999999999999999999999 99999999999999999999999999875321 11
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEETL 687 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~~ 687 (782)
.......||+.|+|||++.++.++.++|||||||++|+|++|+.||........ .+.... ..+|...+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRFPRTLSP 220 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCCH
Confidence 122345799999999999999999999999999999999999999965443221 111111 122334456
Q ss_pred HHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 688 GFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 688 ~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
.+.+|+.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 789999999999999998 6766663
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=341.60 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=199.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|+..+.||+|+||.||++.+ .+..+|+|++.... ......+.+|+++|..++||||+++++++.... ++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 4689999999999999999998 46689999997653 233567999999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 85 MDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 99999999886543 4889999999999999999999853 299999999999999999999999999876522
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcc-------cc----
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTL-------GE---- 672 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~-------~~---- 672 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. .+..... ..
T Consensus 157 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 157 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 112345799999999999988999999999999999999999999965433221 1100000 00
Q ss_pred ---------------------------cCCCCCCCCC-hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 673 ---------------------------MLDPTVTDWP-FEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 673 ---------------------------~ld~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
+........+ ...+.++.+|+.+||..+|++||++.+++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000000 123456899999999999999999999986544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=339.41 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=197.3
Q ss_pred cccccceeeeeCcEeEEEEEE--CCe----eEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHT----PVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 523 (782)
.|+..+.||+|+||.||+|.+ ++. .||||+++... ......|.+|+.+++.++||||++++|+|.... ++|+
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~ 87 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 87 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeee
Confidence 489999999999999999986 333 48999987543 334567899999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+.+.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 88 QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 9999999999887543 34889999999999999999999999 999999999999999999999999999876422
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
. .........++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+..+.. ..
T Consensus 163 ~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~ 231 (316)
T cd05108 163 E---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--------LP 231 (316)
T ss_pred C---cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC--------CC
Confidence 1 1111222345678999999999999999999999999999998 999997543322 22222210 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+...+..+.+++.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 232 QPPICTIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12334456899999999999999999998884
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=341.89 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=192.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC-------ccE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------YGI 520 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~ 520 (782)
+|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.+|+.++||||+++++++.. ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999987 5678999998643 12234568899999999999999999998732 238
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+. ++|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888875443 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccccccccccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--------------
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS-------------- 664 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~-------------- 664 (782)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.........
T Consensus 154 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccC--ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 22111 1122244679999999998876 67899999999999999999999999644322110
Q ss_pred ---HHhCccccc---CCC----CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 665 ---IENGTLGEM---LDP----TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 665 ---~~~~~~~~~---ld~----~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+........ +.. ......+..+..+.+++.+||..+|++||++.+++.+
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 000 0000011233457899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=348.35 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=196.9
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 519 (782)
.++|...+.||+|+||.||+|.+ .+..||||+++... ....+.+.+|+.+|..+ +||||++++++|.+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999974 24479999997543 23456788999999999 8999999999996654
Q ss_pred -EEEEEeCCCCChhHHHhhcCC----------------------------------------------------------
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN---------------------------------------------------------- 540 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 540 (782)
++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 899999999999998865321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 541 --------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 541 --------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 268 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS-- 268 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc--
Confidence 124789999999999999999999999 9999999999999999999999999998653221
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH---HHHHHHhCcccccCCCCCCCCC
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF---VERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.........++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+.. + ..|
T Consensus 269 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----~---~~~ 339 (375)
T cd05104 269 -NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-----M---LSP 339 (375)
T ss_pred -cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-----C---CCC
Confidence 1111223345678999999999999999999999999999998 8999964322 1222222211 1 112
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+.++.+|+.+||+.+|++||++.+++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 223456999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=333.92 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=195.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.++..++||||++++++|.... |+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3588999999999999999998 46689999987542 223456889999999999999999999986544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|++++.+..+. ... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~-~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLE-EMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHH-hcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99988776543 222 34899999999999999999999999 9999999999999999999999999998763211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCc-----------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGT----------- 669 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~----------- 669 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|++||........... .+.
T Consensus 155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 155 ----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 1122345789999999999988999999999999999999999999975432221110 000
Q ss_pred ---ccccCCCCCC-------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 ---LGEMLDPTVT-------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ---~~~~ld~~~~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......+... .+....+..+.+|+.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000001000 011123456999999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.18 Aligned_cols=238 Identities=24% Similarity=0.277 Sum_probs=192.6
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
+.||+|+||.||++.. +++.||||++.... ......+.+|+.+|+.++||||+.+++++.... |+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 56799999997542 233456889999999999999999999886544 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.+.+.... .+++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..... .
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-----~ 149 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-----A 149 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-----c
Confidence 9998885543 4899999999999999999999999 999999999999999999999999998753211 1
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGF 689 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 689 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... ....+|...+..+
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~~~~------~~~~~p~~~~~~~ 222 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILM------EDIKFPRTLSADA 222 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HHhcc------CCccCCCCCCHHH
Confidence 1223457999999999999999999999999999999999999999655432211 11000 1112334455678
Q ss_pred HHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 690 AKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 690 ~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
.+|+.+||..+|++|| ++.+++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 9999999999999997 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.50 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=204.6
Q ss_pred HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc----
Q 040785 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY---- 518 (782)
Q Consensus 447 ~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---- 518 (782)
....++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|..++|+||+.+++.+...
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33456899999999999999999987 6789999998654 233456788999999999999999988765321
Q ss_pred ------cEEEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 519 ------GIIVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 519 ------~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
.++||||+++|+|.+.+... .....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 26899999999999988654 23356999999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCc
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGT 669 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~ 669 (782)
+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......... +..+.
T Consensus 185 ~DFGls~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 185 GDFGFSKMYAATV---SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred EecccCeeccccc---cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 9999998653211 111223467999999999999999999999999999999999999999765443211 11111
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+ ..|...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 262 ----~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 ----YD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----CC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 2234455679999999999999999999998754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=339.36 Aligned_cols=236 Identities=23% Similarity=0.258 Sum_probs=190.0
Q ss_pred eeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
||+|+||.||+|.+ ++..||+|++.... ......+.+|+.+|..++||||++++++|.+.. |+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999998 46689999986532 233456789999999999999999999886544 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+.+...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-----~~~ 149 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-----DDK 149 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC-----CCc
Confidence 99886543 4899999999999999999999999 999999999999999999999999999754211 112
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAK 691 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~ 691 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .. ....+|...+..+.+
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~~ 222 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQ-----EPLRFPDGFDRDAKD 222 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--Hc-----CCCCCCCcCCHHHHH
Confidence 23457999999999999999999999999999999999999999654432211110 00 011233444566899
Q ss_pred HHHHhhccCcCCCCC---hHHhhh
Q 040785 692 LALQCSELRRKDRPD---LGKVVL 712 (782)
Q Consensus 692 li~~cl~~~P~~RPs---~~~vl~ 712 (782)
|+.+||..+|.+||+ +.+++.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHc
Confidence 999999999999986 455553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=344.42 Aligned_cols=237 Identities=25% Similarity=0.327 Sum_probs=195.0
Q ss_pred cccccceeeeeCcEeEEEEEEC---CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD---HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~---~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
+|...+.||+|+||.||+|.+. ...||+|++.... ......+.+|+.++..++||||++++++|.+.. |+||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 4899999999999999999863 2579999986432 223456889999999999999999999987654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 111 Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999886543 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
......||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+..+. ..+
T Consensus 184 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------~~~ 247 (340)
T PTZ00426 184 -------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------IYF 247 (340)
T ss_pred -------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------CCC
Confidence 1124579999999999998889999999999999999999999997654322 1222221 112
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCC-----ChHHhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRP-----DLGKVV 711 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl 711 (782)
|...+..+.+++.+||+.+|.+|+ ++.+++
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 333445689999999999999996 565554
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=343.92 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=195.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.|..++.||+|+||+||+|.+ ++..||||++.... ......+.+|+.+|..++||||++++++|.+.. |+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999988 56689999997542 223456889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999886543 4889999999999999999999999 9999999999999999999999999986431100
Q ss_pred cc------------------------------------------ccccccccccCCcccCChhhhhcCCCCCchhHHHHH
Q 040785 605 EN------------------------------------------VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLG 642 (782)
Q Consensus 605 ~~------------------------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlG 642 (782)
.. .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 000011235799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHH--hhccCcCCCCChHHhhhHH
Q 040785 643 ILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQ--CSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 643 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~--cl~~~P~~RPs~~~vl~~~ 714 (782)
|++|||++|..||.................. ...+. ......++.+|+.+ |+..+|..||++.+++.+.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENT--LHIPP-QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccc--cCCCC-CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 9999999999999765443322211110000 01111 11234567888887 5556666799999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.28 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=197.4
Q ss_pred ccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~-- 519 (782)
++|...+.||+|+||.||+|... +..||||+++... ......+.+|+.+++.+ +||||++++++|.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 45889999999999999999852 2479999997543 33356788999999999 8999999999986654
Q ss_pred EEEEEeCCCCChhHHHhhcCC-----------------------------------------------------------
Q 040785 520 IIVYEYLANGSLDDRIFRRGN----------------------------------------------------------- 540 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 540 (782)
|+||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 899999999999998864311
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccccccc
Q 040785 541 --------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612 (782)
Q Consensus 541 --------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 612 (782)
..++++.++..|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+.... .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~---~~~~~ 271 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS---NYVVK 271 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCc---ceeec
Confidence 124788999999999999999999999 9999999999999999999999999997653211 11112
Q ss_pred ccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH---HHHHhCcccccCCCCCCCCChhHHHH
Q 040785 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE---RSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 613 ~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~---~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ..+..+ ..+. .|...+..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~ 343 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-----YQMS---RPDFAPPE 343 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-----cCcc---CCCCCCHH
Confidence 23345678999999998999999999999999999997 999996443211 111111 1111 12223456
Q ss_pred HHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 689 FAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
+.+++.+||+.+|.+||++.+++. .|..
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~-~l~~ 371 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ-LIQR 371 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH-HHHH
Confidence 999999999999999999998873 4443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=346.86 Aligned_cols=254 Identities=22% Similarity=0.265 Sum_probs=197.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|+..+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|..++||||++++++|.+.. |+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3588999999999999999998 56789999997532 223456789999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999886543 4899999999999999999999999 999999999999999999999999998764221
Q ss_pred cccc---------------------------------cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh
Q 040785 604 AENV---------------------------------TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650 (782)
Q Consensus 604 ~~~~---------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt 650 (782)
.... ........+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0001123479999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC---hHHhhhHH
Q 040785 651 AKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD---LGKVVLPE 714 (782)
Q Consensus 651 G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs---~~~vl~~~ 714 (782)
|..||..................+ ..+. ....+..+.+|+.+|+. +|.+|++ +.+++.+.
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETL--QFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcc--CCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 999997654433221111111100 0111 11234468899999996 9999998 88887543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.07 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=199.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|++.++||.|+||.||++.+ ++..+|+|++.... ......+.+|+++|..++||||++++++|.+.. |+||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 5689999999999999999998 46689999987642 233567899999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
+++|+|.+++...+ .+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 85 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999886543 488999999999999999999975 6 999999999999999999999999998755221
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH-----hCccccc------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE-----NGTLGEM------ 673 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~-----~~~~~~~------ 673 (782)
......||..|+|||++.+..++.++|||||||++|+|++|+.||........... .+.....
T Consensus 158 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred ------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 12235789999999999988899999999999999999999999975433211100 0000000
Q ss_pred ---------------------------CCCCCCCCCh-hHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 674 ---------------------------LDPTVTDWPF-EETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 674 ---------------------------ld~~~~~~p~-~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
........+. ..+.++.+|+.+||+.+|++||++.+++.+.+-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 0000000000 1234688999999999999999999998765543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=344.09 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=200.2
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|.+.+.||+|+||.||+|.+. +..||||+++.... .....+..|+.++..++||||+++++++.+.. |+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5889999999999999999984 78999999975421 23456889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 99999999998765 35899999999999999999999999 9999999999999999999999999998663221
Q ss_pred c------------------------cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH
Q 040785 605 E------------------------NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF 660 (782)
Q Consensus 605 ~------------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~ 660 (782)
. ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 0 0001122345799999999999999999999999999999999999999976553
Q ss_pred HHHHHHhCcccc-cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC-hHHhhhH
Q 040785 661 VERSIENGTLGE-MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD-LGKVVLP 713 (782)
Q Consensus 661 ~~~~~~~~~~~~-~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs-~~~vl~~ 713 (782)
............ ...|... ..+..+.+|+.+|+. +|.+||+ +.+++.+
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKESLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCcccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 322111111001 1111111 135568999999997 9999999 9888854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.16 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=195.4
Q ss_pred ccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
+.|.+.+.||+|+||.||+|.+. +..||+|.++.... .....|.+|+.++..++||||++++|++.... ++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45888999999999999999762 45899999976532 33457899999999999999999999986544 999
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999886543 35899999999999999999999999 99999999999999999999999998765321
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
. .........++..|+|||++.++.++.++|||||||++|||++ |..||....... ..+..+.. .
T Consensus 160 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--------~ 227 (266)
T cd05064 160 E----AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--------L 227 (266)
T ss_pred c----chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------C
Confidence 1 1111112345678999999999999999999999999999775 999996543322 12222211 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..|...+..+.+++.+||+.+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~ 259 (266)
T cd05064 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQIH 259 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 12334556699999999999999999998887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.63 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=192.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|.+.+.||+|+||.||+|.. +++.||||++..... .....+.+|+.+++.++||||+.+++++.+.. |+||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 5699999999999999999998 577899999975432 22345788999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--- 155 (303)
T cd07869 85 VH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV--- 155 (303)
T ss_pred CC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC---
Confidence 95 67877775543 34888999999999999999999999 99999999999999999999999999875421
Q ss_pred cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH-----hCccccc------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE-----NGTLGEM------ 673 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~-----~~~~~~~------ 673 (782)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+. .+.....
T Consensus 156 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 156 --PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 1112234578999999998765 4589999999999999999999999975432211111 0110000
Q ss_pred ----CCCC-CCC-CCh---------hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 ----LDPT-VTD-WPF---------EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 ----ld~~-~~~-~p~---------~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+. ... .+. .....+.+|+.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000 000 11245789999999999999999998884
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.97 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=210.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc---EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG---IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~---~lV~ 523 (782)
++|..++.||+|+||.++++.+ +++.+++|.+.... ...+....+|+.++++++|||||.+.+.|.+.+ ||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4688899999999999999887 56789999987653 233456789999999999999999999997665 7999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
+|++||+|.+.+.+.+ ..-|+++.+..++.|++.||.|||++. |+|||||+.|||++.++.+||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997765 345999999999999999999999988 999999999999999999999999999987432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
. ....+..||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+...-..... .....| .|.
T Consensus 160 ~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~--~~~~~P----lp~ 228 (426)
T KOG0589|consen 160 D-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN--RGLYSP----LPS 228 (426)
T ss_pred h-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh--hccCCC----CCc
Confidence 1 23456789999999999999999999999999999999999999998776654332221 111233 345
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
....++..++..|+..+|+.||++.++|..
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 566679999999999999999999999854
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.77 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=193.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.|...++||.|+||.||+|.. ++..||+|+++.... .....+.+|+.+++.++||||+++++++.... ++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 3588899999999999999987 567899999875432 23456789999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++ +|.+.+...+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-- 156 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-- 156 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC--
Confidence 975 8988876543 34789999999999999999999999 999999999999999999999999999754221
Q ss_pred cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCc-----------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGT----------- 669 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~----------- 669 (782)
........||+.|+|||++.+ ..++.++|||||||++|+|++|++||......+.. .. .+.
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 157 ---TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred ---CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 112234578999999998765 56899999999999999999999999654332211 00 000
Q ss_pred ---ccccCCCCCCC-----CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 ---LGEMLDPTVTD-----WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ---~~~~ld~~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+...+.+.... .......++.+|+.+||..+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111100 01123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.63 Aligned_cols=237 Identities=25% Similarity=0.301 Sum_probs=189.3
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHH---HhcCCCCeeeecccccCcc--EEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVL---SCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL---~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
|.+.+.||+|+||.||+|.+ +++.||||+++... ....+.+.+|+.++ ..++||||+++++++.... |+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999987 56789999997542 22234566776665 5668999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|...+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887743 24899999999999999999999999 99999999999999999999999999875321
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~ 680 (782)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+..+. ..
T Consensus 154 -----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------~~ 219 (324)
T cd05589 154 -----FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE---------VR 219 (324)
T ss_pred -----CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 11122346799999999999999999999999999999999999999975543221 111111 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
.|...+..+.+++.+||+.+|.+||+..+.
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 249 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEK 249 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCC
Confidence 233445668999999999999999965443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.35 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=191.7
Q ss_pred cccccceeeeeCcEeEEEEEE---CCeeEEEEEecCCchh--hHHHHHHHHHHHHhc---CCCCeeeeccccc-------
Q 040785 452 FFTESRKIGEGGYGPVYKCYL---DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCI---RHPNMVLLLGACP------- 516 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~------- 516 (782)
+|.+.+.||+|+||.||+|.+ .++.||||+++..... ....+.+|+.++..+ .||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 588899999999999999987 3568999998754221 234566788887766 6999999999873
Q ss_pred CccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 517 EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 517 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
...++||||++ ++|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 12389999996 689888865432 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHHhCc-c--
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIENGT-L-- 670 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~-~-- 670 (782)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||........ .+.... .
T Consensus 157 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred eEeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 9765321 222345789999999999888999999999999999999999999975433221 111100 0
Q ss_pred ----------cccCCCCCC----CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 671 ----------GEMLDPTVT----DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 671 ----------~~~ld~~~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+.+... ...+..+..+.+|+.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 011223456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.54 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=195.3
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.|++.+.||+|+||.||+|.. +++.||||++..... .....+.+|+++|..++||||+++++.|.+.. |+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 588999999999999999987 467899999965321 22456889999999999999999999986555 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999986543 4888999999999999999999999 9999999999999999999999999985331000
Q ss_pred c--------------------------------------cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHH
Q 040785 605 E--------------------------------------NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 646 (782)
Q Consensus 605 ~--------------------------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ 646 (782)
. ..........+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00000112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCC---ChHHhhhHH
Q 040785 647 QLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP---DLGKVVLPE 714 (782)
Q Consensus 647 elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP---s~~~vl~~~ 714 (782)
||++|+.||......+...........+. ... ....+..+.+++.+|+ .+|.+|+ ++.+++.+.
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~-~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLH--IPS-QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCcccc--CCC-CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 99999999976554332221111111110 111 1223445788888876 4999999 888887543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.99 Aligned_cols=236 Identities=28% Similarity=0.372 Sum_probs=190.9
Q ss_pred ceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc----hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA----AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.||+|+||.||++.. .++.||||+++... ......+.+|+.+|..++||||++++++|.... |+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 45689999997532 122345788999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+.+.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-- 153 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC--
Confidence 99999999886543 4788899999999999999999999 999999999999999999999999998753211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 683 (782)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+. ...|.
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~---------~~~~~ 221 (323)
T cd05584 154 ---GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK---------LNLPP 221 (323)
T ss_pred ---CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CCCCC
Confidence 1122345799999999999988899999999999999999999999976543321 111111 12233
Q ss_pred hHHHHHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
..+..+.+|+.+||+.+|++|| ++.+++.
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 4456689999999999999999 6666553
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=353.59 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=204.0
Q ss_pred HhccccccceeeeeCcEeEEEEEE-CC-eeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeeccccc-----Cc--
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL-DH-TPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACP-----EY-- 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~-~~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~-----~~-- 518 (782)
...++++.+.|.+|||+.||++.+ .+ ..||+|++-..+....+.+.+||++|+.|. |||||.+++.+. .+
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345688899999999999999998 34 799999998777888899999999999996 999999999431 12
Q ss_pred --cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 --GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.+|.||||.||.|-|++..+.... |++.++++|+.++++|+.+||... .||||||||-+||||+.+|..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 168999999999999998765544 999999999999999999999997 5799999999999999999999999999
Q ss_pred ccccccccccccc--c--ccccccCCcccCChhhh---hcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCc
Q 040785 597 ARLVPAVAENVTQ--Y--HLTSTAGTFCYIDPEYQ---QTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGT 669 (782)
Q Consensus 597 a~~~~~~~~~~~~--~--~~~~~~Gt~~Y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 669 (782)
|...-........ + ..-...-|+.|.|||++ .+..+++|+|||+|||+||-|+....||+..... +|-.|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--aIlng~ 270 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--AILNGN 270 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--eEEecc
Confidence 8754111100000 0 00112358899999964 5667999999999999999999999999644211 122222
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
+. ++.. +.....|.+||..||+.+|.+||++.+|+. ++.++.
T Consensus 271 Y~------~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~-~~~~l~ 312 (738)
T KOG1989|consen 271 YS------FPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLE-EIFELA 312 (738)
T ss_pred cc------CCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHH-HHHHHh
Confidence 21 1222 356677999999999999999999999984 444443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.59 Aligned_cols=246 Identities=27% Similarity=0.352 Sum_probs=196.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~E 524 (782)
+|+..+.||+|+||.||++.. +++.||||++..... .....+.+|+.+++.++||||+.+++.+.+. .|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 378889999999999999987 577999999965422 2234577899999999999999999988654 489999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+.+..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 9999999988865432 45899999999999999999999999 999999999999999999999999998765321
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+... +.......+
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~ 225 (285)
T cd05605 156 -----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-----VKEDQEEYS 225 (285)
T ss_pred -----CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-----hhhcccccC
Confidence 11234578999999999998899999999999999999999999997543211 111111 111112233
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
...+..+.+|+.+||..||.+|| ++.+++.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 44556789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.16 Aligned_cols=247 Identities=29% Similarity=0.458 Sum_probs=198.9
Q ss_pred cccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
.|...+.||+|+||.||+|...+ ..||+|.++... ......|.+|+.++..++||||+++++++.... |+
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 48889999999999999998733 469999987543 233567899999999999999999999986543 89
Q ss_pred EEEeCCCCChhHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc
Q 040785 522 VYEYLANGSLDDRIFRRGNT-------------PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV 588 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~ 588 (782)
+|||+++|+|.+++...... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 99999999999998754221 35889999999999999999999999 999999999999999999
Q ss_pred eeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHH
Q 040785 589 SKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSI 665 (782)
Q Consensus 589 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~ 665 (782)
+||+|||+++...... .........+++.|+|||++.++.++.++|||||||++|||++ |..||......+ ..+
T Consensus 163 ~~L~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSAD---YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred EEECCCcceeeccccc---cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999997652211 1112234467889999999988999999999999999999998 999996543322 222
Q ss_pred HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+. ....|...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 240 RSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred HcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2221 11223455667999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.50 Aligned_cols=237 Identities=25% Similarity=0.282 Sum_probs=187.9
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ ++..||||+++... ......+..|..++..+ +||||+++++++.... |+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 45679999997542 22334566777777654 8999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~----- 149 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----- 149 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-----
Confidence 99998886543 4899999999999999999999999 999999999999999999999999999754211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ......|...+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~-------~~~~~~~~~~~~~ 222 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-------NDRPHFPRWISKE 222 (316)
T ss_pred CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCCCCCCCCHH
Confidence 122234679999999999998899999999999999999999999997554322111100 0111223344556
Q ss_pred HHHHHHHhhccCcCCCCChHHhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+.+|+.+||..+|.+||++.+.+
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHH
Confidence 89999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.42 Aligned_cols=246 Identities=25% Similarity=0.304 Sum_probs=198.4
Q ss_pred cccccceeeeeCcEeEEEEEECC--eeEEEEEecCCchhh---HHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDH--TPVAVKVLRPDAAQG---RSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~--~~vAvK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~E 524 (782)
.|..++.||.|.-|+||++.+.+ ..+|+|++.+..... ....+.|-+||+.+.||.++.||..|... .|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 47788999999999999999965 689999998764433 44567899999999999999999999654 499999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc-
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV- 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~- 603 (782)
||+||+|..++++. ....|++..+..++.+|+.||+|||-+| ||+|||||+||||.++|++.|+||.|+......
T Consensus 158 yCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999876554 5567999999999999999999999999 999999999999999999999999987543110
Q ss_pred --c------------------------------c------------------cccccccccccCCcccCChhhhhcCCCC
Q 040785 604 --A------------------------------E------------------NVTQYHLTSTAGTFCYIDPEYQQTGMLG 633 (782)
Q Consensus 604 --~------------------------------~------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s 633 (782)
. . ..+..+....+||..|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0011223356899999999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 634 VKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 634 ~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
.++|||+|||+|||||.|..||.+.+.-+..... +.+ ++..++.| .....+.+||.+.|..||++|-.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~~--~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VGQ--PLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hcC--CCcCCCCC-cchhHHHHHHHHHhccChhhhhc
Confidence 9999999999999999999999766543322111 111 12333333 55667999999999999999998
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.31 Aligned_cols=240 Identities=27% Similarity=0.422 Sum_probs=188.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
|...++||+|+||.||+|.+ +++.||||++.... ......|.+|+++|+.++||||+++++++.+.. ++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 56678899999999999988 47799999996543 233567899999999999999999999986654 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+.. .+.+..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~---- 221 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT---- 221 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc----
Confidence 99986532 2567788899999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~ 680 (782)
........||..|+|||++.. ...+.++|||||||++|||++|+.||...... .......... ....
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~ 295 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-----QPPE 295 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-----CCCC
Confidence 111234579999999998743 23456899999999999999999999632211 1111110000 0112
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+...+..+.+|+.+||+.+|++||++.+++.
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23344557999999999999999999999884
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.38 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=192.5
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|+..+.||+|+||+||+|.. +++.||||++.... ......+.+|+.++..++||||+++++.+.+.. |+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 588999999999999999987 46789999997532 223456788999999999999999999987654 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 82 FLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999986543 4899999999999999999999999 9999999999999999999999999997653211
Q ss_pred ccc------------------------------cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCC
Q 040785 605 ENV------------------------------TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654 (782)
Q Consensus 605 ~~~------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P 654 (782)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 00011245799999999999999999999999999999999999999
Q ss_pred CCChHHHHHH--HHhCcccccCCCCCCCCChhHHHHHHHHHHHhhc--cCcCCCCChHHhhhH
Q 040785 655 MGLTHFVERS--IENGTLGEMLDPTVTDWPFEETLGFAKLALQCSE--LRRKDRPDLGKVVLP 713 (782)
Q Consensus 655 f~~~~~~~~~--~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~--~~P~~RPs~~~vl~~ 713 (782)
|......... +......-.+ | .. ......+.+++.+++. .++..||++.+++.+
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~-p---~~-~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLIF-P---PE-VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHHHHHHHcCcCcccC-C---Cc-CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9755433221 1111111111 1 11 1123457777776443 233456899988754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=345.00 Aligned_cols=253 Identities=23% Similarity=0.255 Sum_probs=194.4
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|.+.+.||+|+||.||++.. +++.||||++.... ......+.+|++++..++||||++++++|.+.. |+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 588899999999999999987 57789999986532 223456889999999999999999999987654 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 82 FLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999886543 4889999999999999999999999 9999999999999999999999999996431100
Q ss_pred cc-----------cc-------------------------------ccccccccCCcccCChhhhhcCCCCCchhHHHHH
Q 040785 605 EN-----------VT-------------------------------QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLG 642 (782)
Q Consensus 605 ~~-----------~~-------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlG 642 (782)
.. .. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00 0001125799999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCC---CChHHhhhHH
Q 040785 643 ILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDR---PDLGKVVLPE 714 (782)
Q Consensus 643 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~R---Ps~~~vl~~~ 714 (782)
|++|||++|..||..................+ ..++ .......+.+|+.+|+. +|.+| |++.+++.+.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETL--YFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc--CCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 99999999999997544322211111111100 1111 11234568899999997 67665 5888887543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=361.95 Aligned_cols=245 Identities=32% Similarity=0.489 Sum_probs=203.4
Q ss_pred cccccceeeeeCcEeEEEEEEC---Ce----eEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD---HT----PVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~---~~----~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
.....+.||+|.||.||.|... +. .||||.++.. ..+...+|.+|..+|+.+.|||||+++|+|.+.. +|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3556788999999999999972 22 4999999765 4556788999999999999999999999997755 89
Q ss_pred EEEeCCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 522 VYEYLANGSLDDRIFRRG----NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
++|||.+|+|..+|.... ....|+..+.+.++.+||+|+.||++++ +|||||...|+||+....+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999997651 1345899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccc-cCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH---HHHhCcccc
Q 040785 598 RLVPAVAENVTQYHLTST-AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER---SIENGTLGE 672 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~---~~~~~~~~~ 672 (782)
+.+... ..+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+- ....|.
T Consensus 850 rDiy~~----~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR--- 922 (1025)
T KOG1095|consen 850 RDIYDK----DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR--- 922 (1025)
T ss_pred Hhhhhc----hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc---
Confidence 954221 22222222 23458999999999999999999999999999999 9999987665443 233332
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.|..++..+.+++.+||+.+|++||++..++.
T Consensus 923 ------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 ------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2335677778999999999999999999999884
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=341.34 Aligned_cols=230 Identities=25% Similarity=0.337 Sum_probs=186.5
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ ++..||||+++... ......+..|+.++..+ +||||+.++++|.+.. |+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999998 56789999997542 22345688999999988 7999999999986554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-----~ 149 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-----P 149 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc-----C
Confidence 99988875543 4899999999999999999999999 99999999999999999999999999874311 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-----------HHHHHHhCcccccCCCC
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF-----------VERSIENGTLGEMLDPT 677 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-----------~~~~~~~~~~~~~ld~~ 677 (782)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 220 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------- 220 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC---------
Confidence 1122346799999999999999999999999999999999999999953211 11111111
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
....|...+..+.+++.+||+.+|.+||+
T Consensus 221 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 221 QIRIPRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 11223344556899999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=326.44 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=197.9
Q ss_pred HhccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG- 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 519 (782)
.+++|+..+.||+|+||.||+|.+. ++.||||++.... ......|.+|+.+++.++||||++++++|.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999863 3469999986532 234556889999999999999999999987554
Q ss_pred -EEEEEeCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN-------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 899999999999998865321 234688899999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhC
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENG 668 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~ 668 (782)
+|||+++...... .........+++.|+|||++.++.++.++|||||||++|||++ |..||....... ..+..+
T Consensus 161 ~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 161 GDFGMTRDIYETD---YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred CCCCCccccCCcc---eeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999987653211 1111122356788999999998899999999999999999999 789986543322 111111
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. ...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 238 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 238 GL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred Cc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1222334456999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=343.99 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=198.9
Q ss_pred hccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCCeeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~- 519 (782)
.+.|.+.++||+|+||.||+|.+. ...||||++..... ...+.|.+|+.+|..+. ||||++++++|.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 456889999999999999999862 23699999976432 33567899999999996 999999999997654
Q ss_pred -EEEEEeCCCCChhHHHhhcCC----------------------------------------------------------
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN---------------------------------------------------------- 540 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 540 (782)
||||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 899999999999998865311
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC
Q 040785 541 -----------------------------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH 585 (782)
Q Consensus 541 -----------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~ 585 (782)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 134888999999999999999999999 999999999999999
Q ss_pred CCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--
Q 040785 586 NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE-- 662 (782)
Q Consensus 586 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~-- 662 (782)
++.+||+|||+++.+.... .........++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDS---NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred CCEEEEEeCCcceeccccc---cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 9999999999998653211 1112233457788999999988899999999999999999997 999986432211
Q ss_pred -HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 663 -RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 663 -~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
..+..+. . ...+...+..+.+++.+||..+|++||++.+++ ..|.+
T Consensus 350 ~~~~~~~~-----~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~-~~l~~ 396 (400)
T cd05105 350 YNKIKSGY-----R---MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS-DIVES 396 (400)
T ss_pred HHHHhcCC-----C---CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH-HHHHH
Confidence 1122211 1 112334456799999999999999999998876 34444
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=336.31 Aligned_cols=237 Identities=25% Similarity=0.298 Sum_probs=190.6
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCC-CeeeecccccCc--cEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHP-NMVLLLGACPEY--GIIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~Hp-nIv~l~g~~~~~--~~lV~ 523 (782)
+|...+.||+|+||.||+|... ++.||||++.... ......+..|+.++..+.|+ +|+.+++++.+. .|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3788999999999999999984 4589999997542 23345678899999999765 577888877543 48999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF- 153 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC-
Confidence 9999999998886543 4889999999999999999999999 99999999999999999999999999874311
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~ 681 (782)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+.... ..+
T Consensus 154 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~~ 220 (324)
T cd05587 154 ----GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VSY 220 (324)
T ss_pred ----CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------CCC
Confidence 11122345799999999999999999999999999999999999999975543221 111111 122
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLG 708 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~ 708 (782)
|...+..+.+++.+||..+|.+||+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 334455689999999999999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.77 Aligned_cols=252 Identities=20% Similarity=0.272 Sum_probs=193.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.|..+++||+|+||.||+|.. ++..||||++.... ......+.+|+.+|+.+.||||+++++.|.+.. |+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999998 56789999997542 223456889999999999999999999996554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999886543 4889999999999999999999999 9999999999999999999999999985331000
Q ss_pred cc------------------------------------------ccccccccccCCcccCChhhhhcCCCCCchhHHHHH
Q 040785 605 EN------------------------------------------VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLG 642 (782)
Q Consensus 605 ~~------------------------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlG 642 (782)
.. .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC---hHHhhhH
Q 040785 643 ILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD---LGKVVLP 713 (782)
Q Consensus 643 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs---~~~vl~~ 713 (782)
|++|||++|+.||.................. ...+. .......+.+++.+++ .+|.+|++ +.+++.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTS--LHIPP-QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCC--cCCCC-cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999999765543322221111110 01111 1123445778888776 49999997 7666643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.32 Aligned_cols=237 Identities=24% Similarity=0.279 Sum_probs=191.0
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.++..++||||+.+++++.... |+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 56789999997542 223456788999999999999999999886544 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
+|.+.+.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~----- 149 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD----- 149 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-----
Confidence 9998875543 48999999999999999999997 67 999999999999999999999999998753211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ...|...+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~---------~~~p~~~~ 220 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLS 220 (325)
T ss_pred CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCC
Confidence 112234579999999999999999999999999999999999999996544322 1111111 12233345
Q ss_pred HHHHHHHHHhhccCcCCCC-----ChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRP-----DLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RP-----s~~~vl~~ 713 (782)
..+.+|+.+||+.+|++|+ ++.+++.+
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 5689999999999999997 77777643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=321.05 Aligned_cols=243 Identities=25% Similarity=0.399 Sum_probs=196.0
Q ss_pred cccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
.|+..+.||+|+||.||++.+. +..+|+|.+.... .....|.+|+.+|+.++||||++++++|.+.. ++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4788899999999999999884 4589999886542 33467889999999999999999999986554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05114 84 GCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---- 154 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc----
Confidence 99999886543 24899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||........ .+..+. .. ..|...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~--~~------~~~~~~ 226 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--RL------YRPKLA 226 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--CC------CCCCCC
Confidence 111123345678999999988889999999999999999999 9999975543322 122221 11 112223
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..+.+++.+||..+|++||++.+++.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 456899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.31 Aligned_cols=236 Identities=25% Similarity=0.307 Sum_probs=191.2
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 523 (782)
+|...+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ .||+|+.+++++.+.. |+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3788899999999999999884 5689999997542 22234567788888877 5899999999886544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW- 153 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC-
Confidence 9999999998886543 4889999999999999999999999 99999999999999999999999999875421
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+. ..+
T Consensus 154 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------~~~ 220 (323)
T cd05616 154 ----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VAY 220 (323)
T ss_pred ----CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCC
Confidence 1112234679999999999999999999999999999999999999997554322 1111111 123
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
|...+..+.+++.+||+.+|.+|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 34455678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.32 Aligned_cols=245 Identities=26% Similarity=0.333 Sum_probs=191.5
Q ss_pred cccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--
Q 040785 452 FFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA----AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~-- 519 (782)
+|++.+.||+|+||.||++.. .++.||+|++.... ......+..|+.+|..+ .||||+.+++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 378899999999999999876 46789999996532 12245678899999999 5999999999886554
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 89999999999999886543 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDP 676 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~ 676 (782)
+.... ........||+.|+|||++.+. .++.++|||||||++|||++|..||...... ...+..... ..++
T Consensus 155 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~ 228 (332)
T cd05614 155 FLSEE----KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDP 228 (332)
T ss_pred ccccC----CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCC
Confidence 52211 1122345799999999988765 4789999999999999999999999532110 011111000 0111
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCC-----ChHHhh
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRP-----DLGKVV 711 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl 711 (782)
..+...+..+.+++.+||+.+|++|| ++.+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 265 (332)
T cd05614 229 ---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265 (332)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHH
Confidence 22334455689999999999999999 555555
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.39 Aligned_cols=249 Identities=24% Similarity=0.285 Sum_probs=197.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...+.||+|+||.||++.. +++.||||+++.... .....+..|+.++..++||||+.+++++.+.. |+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 588899999999999999987 577899999975422 23456889999999999999999999886544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 82 YQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999886653 25899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccccccCCcccCChhhhh------cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQ------TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTV 678 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 678 (782)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||............-.....+ ..
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~ 230 (330)
T cd05601 157 ----MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL--KF 230 (330)
T ss_pred ----ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--CC
Confidence 11223357999999999886 4568899999999999999999999996544332211110111111 01
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+. ....+..+.+|+..|+. +|.+||++.+++.+
T Consensus 231 ~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 PE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11 11234568999999998 99999999988754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.98 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=189.0
Q ss_pred eeeeCcEeEEEEEE--CCeeEEEEEecCCchh---hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ---GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
||+|+||+||++.+ +++.||+|.+...... ....+..|+.+++.++||||+.+++++.... |+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999987 5678999998654222 2356778999999999999999999886544 899999999999
Q ss_pred hHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccccc
Q 040785 532 DDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQY 610 (782)
Q Consensus 532 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 610 (782)
.+.+.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-----~ 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-----S 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC-----c
Confidence 88775432 3346899999999999999999999999 9999999999999999999999999997653211 1
Q ss_pred ccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 611 HLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 611 ~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+....+ .. ....+...+..
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~ 227 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL----ND-SVTYPDKFSPA 227 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc----cc-CCCCcccCCHH
Confidence 123457999999999999999999999999999999999999999643211 111111111 11 11233445567
Q ss_pred HHHHHHHhhccCcCCCCChHH
Q 040785 689 FAKLALQCSELRRKDRPDLGK 709 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~ 709 (782)
+.+++.+||+.+|++||++.+
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCC
Confidence 999999999999999996544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.69 Aligned_cols=236 Identities=25% Similarity=0.321 Sum_probs=189.8
Q ss_pred ceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+. ++.||||++.... ......+..|+.++..+ +||||+.+++++.... |+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999984 5689999997542 22345677899999876 7999999999986554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~-----~ 149 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL-----N 149 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc-----C
Confidence 99998886543 4889999999999999999999999 99999999999999999999999999875421 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+..+. ...|...+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~---------~~~p~~~~ 220 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD---------VLYPVWLS 220 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCCC
Confidence 1122345799999999999999999999999999999999999999976543221 111111 11222344
Q ss_pred HHHHHHHHHhhccCcCCCC-------ChHHhhh
Q 040785 687 LGFAKLALQCSELRRKDRP-------DLGKVVL 712 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RP-------s~~~vl~ 712 (782)
..+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 5689999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.70 Aligned_cols=231 Identities=26% Similarity=0.337 Sum_probs=187.8
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ +++.||||++.... ......+..|+.++..+ .||||+++++++.... |+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 46789999997542 22345677899998876 6999999999986554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-----~ 149 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-----N 149 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-----C
Confidence 99998886543 4899999999999999999999999 99999999999999999999999999875321 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ...|...+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------VVYPTWLS 220 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCC
Confidence 112234579999999999998899999999999999999999999997654322 1121111 11223345
Q ss_pred HHHHHHHHHhhccCcCCCCCh
Q 040785 687 LGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~ 707 (782)
..+.+|+.+||+.+|.+||+.
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCC
Confidence 568999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.52 Aligned_cols=234 Identities=25% Similarity=0.317 Sum_probs=190.7
Q ss_pred ceeeeeCcEeEEEEEE-----CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
+.||+|+||.||++.. .++.||+|++..... .....+.+|+++|.+++||||++++++|.+.. |+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 467899999975422 22345778999999999999999999986554 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---- 151 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---- 151 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC----
Confidence 999999886543 4899999999999999999999999 999999999999999999999999998764221
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCCCChhH
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +..+. ...|...
T Consensus 152 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------~~~p~~~ 221 (318)
T cd05582 152 -EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------LGMPQFL 221 (318)
T ss_pred -CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------CCCCCCC
Confidence 11223457999999999999888999999999999999999999999755433221 11111 1223344
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
+..+.+|+.+||+.+|++||++.+.
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~~ 246 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGPD 246 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCC
Confidence 5668999999999999999996553
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.93 Aligned_cols=243 Identities=36% Similarity=0.582 Sum_probs=190.0
Q ss_pred ccceeeeeCcEeEEEEEEC------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 455 ESRKIGEGGYGPVYKCYLD------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~~------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
..+.||.|.||.||+|.+. +..|+||+++... ......|.+|++++++++||||++++|+|.... ++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 5689999996643 334778999999999999999999999997433 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~- 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS- 157 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS-
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-
Confidence 99999999998762 235899999999999999999999999 9999999999999999999999999998652111
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.........+...|+|||++....++.++||||||+++|||++ |+.||....... ..+..+.. ...+
T Consensus 158 --~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------~~~~ 227 (259)
T PF07714_consen 158 --KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------LPIP 227 (259)
T ss_dssp --SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------TTSB
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ceec
Confidence 1122233457788999999999999999999999999999999 789996543322 22233322 1122
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+++..||+.+|++||++.+++.
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 334556899999999999999999998873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=328.06 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=193.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC-------ccEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------YGIIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~lV 522 (782)
.|...+++|.|+||.||.|.. .+..||||..-.+. +.-.+|++||+.+.|||||+|..+|.. +..||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 478889999999999999998 45689999985442 233589999999999999999988732 12689
Q ss_pred EEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeecccccccc
Q 040785 523 YEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLV 600 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla~~~ 600 (782)
|||||. +|.+.+... .....++.-.+.-+.+||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999977 888877642 22345777788889999999999999999 9999999999999976 89999999999987
Q ss_pred ccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH-------------
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE------------- 666 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~------------- 666 (782)
..... ..+...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+...+.+..+
T Consensus 177 ~~~ep------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEP------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCC------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 43222 2344568899999976655 599999999999999999999999976544332221
Q ss_pred ---hCcccccCCCCCCC------CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 667 ---NGTLGEMLDPTVTD------WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 667 ---~~~~~~~ld~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+....+.-.|.+.. +....+.+..+|+.+++..+|..|.+..+++.+.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 11111222222211 2234566799999999999999999999998654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.74 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=202.5
Q ss_pred ccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
++|.+.+.||+|+||.||++.. ++..+|+|.+..........+.+|++++.+++||||++++++|.... ++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4588899999999999999975 23468999987665555678999999999999999999999986544 89
Q ss_pred EEEeCCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 522 VYEYLANGSLDDRIFRRG----------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999886443 1234899999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhC
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENG 668 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~ 668 (782)
+|||+++...... .........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+
T Consensus 162 ~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 162 GDFGMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred ccCCccccccCCc---eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998653211 1112233456788999999998889999999999999999998 999996543322 222222
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
... ..+...+..+.+|+.+||+.+|.+||++.+++ ..|+.+.
T Consensus 239 ~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~-~~l~~~~ 280 (288)
T cd05093 239 RVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH-SLLQNLA 280 (288)
T ss_pred CcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHH-HHHHHHH
Confidence 211 11222345699999999999999999998886 3555554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=335.32 Aligned_cols=231 Identities=25% Similarity=0.337 Sum_probs=186.0
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ +++.||+|+++... ......+..|+.++..+ +||||+++++++.... |+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 46689999997542 23345678899998876 7999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|...+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~----- 149 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----- 149 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-----
Confidence 99988875543 4899999999999999999999999 999999999999999999999999998753211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH-----------HHHHHHHhCcccccCCCC
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH-----------FVERSIENGTLGEMLDPT 677 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~-----------~~~~~~~~~~~~~~ld~~ 677 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 220 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 220 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---------
Confidence 112234679999999999999999999999999999999999999995211 111111111
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
....|......+.+|+.+||+.+|++||+.
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 112334455668999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.94 Aligned_cols=247 Identities=30% Similarity=0.454 Sum_probs=198.3
Q ss_pred ccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--E
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~ 520 (782)
+.|.+.+.||+|+||.||+|... +..||||++...... ....|.+|+++|..++||||+++++++.... +
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 34788899999999999999762 357999999765433 4578999999999999999999999986544 8
Q ss_pred EEEEeCCCCChhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 521 IVYEYLANGSLDDRIFRRGN-----------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
+||||+++|+|.+++...+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999975432 245889999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIE 666 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~ 666 (782)
||+|||++....... .........+++.|+|||++.++.++.++|||||||++|+|++ |..||....... ..+.
T Consensus 162 kl~d~g~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred EECCcccceecccCc---ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999997542211 1111233456789999999999999999999999999999998 999985433222 1222
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+.. ...+...+..+.+++.+||..+|.+||++.+++
T Consensus 239 ~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 239 QGRL--------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred cCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 2221 111223445689999999999999999998887
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.10 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=202.1
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEec--CCchhhHHHHHHHHHHHHhcCCCCeeeecccccC-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLR--PDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~--~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 517 (782)
....|...+.||+|+||.|..+.+ ++..||||.+. .......+...+|+.+|+.++|+||+.+++.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345577789999999999999988 67799999987 3445556778899999999999999999998843
Q ss_pred ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 518 YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 518 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
..|+|+|+| ..+|...+.... .|+...+..++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 128999999 568888774433 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhh-cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCccc-
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGTLG- 671 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~- 671 (782)
+..... .....+|..+-|.+|.|||+.. ...|+..+||||.||||.||++|++-|-+.+.+++.-. .|+..
T Consensus 173 R~~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 173 RYLDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred eecccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 987432 2345567788999999999655 45699999999999999999999999976665443210 01110
Q ss_pred ------------ccCC--CCCCCCC-----hhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 672 ------------EMLD--PTVTDWP-----FEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 672 ------------~~ld--~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
..+. |..+..| +...+...+|+.+||..||.+|++.++.|.+.
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 0000 1111111 23445688999999999999999999998543
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=332.81 Aligned_cols=236 Identities=26% Similarity=0.306 Sum_probs=188.1
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ ++..||||+++... ......+..|..++..+ +||||+++++++.+.. |+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999998 56689999997542 12345567788888764 8999999999986554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-----~ 149 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-----G 149 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc-----C
Confidence 99998886543 4889999999999999999999999 99999999999999999999999999874311 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....... ..+ ..|......
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~~~~---~~~---~~~~~~~~~ 222 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFESIRV---DTP---HYPRWITKE 222 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh---CCC---CCCCCCCHH
Confidence 112345679999999999999999999999999999999999999997544322 1111110 011 223334556
Q ss_pred HHHHHHHhhccCcCCCCChHHh
Q 040785 689 FAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~v 710 (782)
+.+|+.+||+.+|.+||++.+.
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~ 244 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGN 244 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHH
Confidence 8999999999999999998543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.68 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=197.4
Q ss_pred cccccceeeeeCcEeEEEEEE--CCe----eEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHT----PVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 523 (782)
.|...+.||+|+||.||+|.+ ++. .+++|.+..... .....+..|+.++..+.||||+++++++.... ++++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~ 87 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT 87 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence 378889999999999999987 343 478888754322 23456788888999999999999999986544 7999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 88 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 88 QLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999986543 34899999999999999999999999 999999999999999999999999999876322
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~ 680 (782)
. .........|+..|+|||++.++.++.++|||||||++|||++ |..||...... ...+..+....
T Consensus 163 ~---~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (279)
T cd05111 163 D---KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA-------- 231 (279)
T ss_pred C---cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC--------
Confidence 1 1122234567789999999998999999999999999999998 99999654332 23333322111
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+...+..+..++.+||..+|..||++.+++. .|..+
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~-~l~~~ 268 (279)
T cd05111 232 QPQICTIDVYMVMVKCWMIDENVRPTFKELAN-EFTRM 268 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH-HHHHH
Confidence 11123345788999999999999999998863 44443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.17 Aligned_cols=244 Identities=26% Similarity=0.428 Sum_probs=196.5
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
+.|+..++||+|+||.||+|.. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+.. +++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4589999999999999999987 45689999987543 33568999999999999999999998886544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 157 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--- 157 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc---
Confidence 999999886543 235889999999999999999999999 9999999999999999999999999998753211
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
........++..|+|||++..+.++.++|||||||++|+|++ |..||...... ...+..+. ..+.. ..
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~----~~ 228 (261)
T cd05072 158 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY----RMPRM----EN 228 (261)
T ss_pred -eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----CCCCC----CC
Confidence 111123346778999999988889999999999999999998 99999643322 12222221 11111 22
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+..+.+++.+||..+|++||++.+++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~ 255 (261)
T cd05072 229 CPDELYDIMKTCWKEKAEERPTFDYLQ 255 (261)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 345689999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.41 Aligned_cols=253 Identities=29% Similarity=0.441 Sum_probs=202.3
Q ss_pred cccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
+|...+.||+|+||.||+|... ...+++|.+........+.+.+|+.++++++||||+++++++.... ++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4778899999999999999752 3468999987666555678999999999999999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 523 YEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 999999999999865431 234899999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIE 666 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~ 666 (782)
+|+|||++....... .........|+..|+|||++.+..++.++|||||||++|+|+| |..||....... ..+.
T Consensus 163 ~l~dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 163 KIGDFGMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred EECCCCcccccCCCc---eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999997653211 1112234567889999999998899999999999999999999 999985443221 2222
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+... ..+...+..+.+++.+||+.+|.+||++.+++ ..|..+.
T Consensus 240 ~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~-~~l~~~~ 283 (291)
T cd05094 240 QGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY-KILHALG 283 (291)
T ss_pred CCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHH-HHHHHHH
Confidence 22211 12223445689999999999999999998887 3555553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=332.36 Aligned_cols=233 Identities=28% Similarity=0.333 Sum_probs=187.1
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ ++..||||+++... ......+..|..++..+ +||||+++++++.+.. ++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 45689999997642 22344567788888764 8999999999986554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.... .+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~ 149 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML-----G 149 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC-----C
Confidence 99999886532 4889999999999999999999999 99999999999999999999999999875321 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+ .+. .|....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~---~~~~~~ 220 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NPC---YPRWLT 220 (316)
T ss_pred CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCC---CCccCC
Confidence 1122345799999999999998999999999999999999999999975543221 11111 111 222344
Q ss_pred HHHHHHHHHhhccCcCCCCChHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGK 709 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~ 709 (782)
..+.+|+.+||+.+|++||++.+
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~ 243 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKG 243 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChH
Confidence 56899999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=342.17 Aligned_cols=245 Identities=20% Similarity=0.309 Sum_probs=189.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
..|.+.+.||+|+||.||+|.+ .++.||||... ...+.+|+++|+.++||||++++++|.... |+||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 3588999999999999999998 56789999753 235789999999999999999999885444 8999998
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
. ++|..++.... .+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 166 ~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--- 235 (391)
T PHA03212 166 K-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--- 235 (391)
T ss_pred C-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc---
Confidence 5 68888775443 4889999999999999999999999 999999999999999999999999999754211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH----------HHHHHHH-hCcccc---
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH----------FVERSIE-NGTLGE--- 672 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~----------~~~~~~~-~~~~~~--- 672 (782)
.........||+.|+|||++.+..++.++|||||||++|||++|..||.... .....+. .|....
T Consensus 236 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 -NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1122334689999999999999999999999999999999999998863211 0111110 010000
Q ss_pred ------------------cCCCC-CCCCC--hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 673 ------------------MLDPT-VTDWP--FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 673 ------------------~ld~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+. ...|. ...+..+.+|+.+||+.+|++||++.+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00111 123457899999999999999999999884
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.06 Aligned_cols=233 Identities=26% Similarity=0.303 Sum_probs=185.8
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHH-HHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIE-VLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ +++.||||++..... .....+..|.. +++.++||||+++++.+.+.. |+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999998 577899999975421 22334555655 457789999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-----~ 149 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-----H 149 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc-----C
Confidence 99999886543 4889999999999999999999999 99999999999999999999999999875321 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+. ...+...+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---------LRLKPNIS 220 (323)
T ss_pred CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCCC
Confidence 1122345799999999999999999999999999999999999999975543221 111111 11222345
Q ss_pred HHHHHHHHHhhccCcCCCCChHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGK 709 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~ 709 (782)
..+.+++.+||+.+|.+||++..
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCC
Confidence 56899999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.03 Aligned_cols=239 Identities=24% Similarity=0.331 Sum_probs=188.6
Q ss_pred eeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
||+|+||.||++.. ++..||+|.+..... .....+..|++++..++||||+++++++.... |+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999987 578999999864321 12344567999999999999999999886544 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+.+..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------~~ 150 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------KT 150 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC------ce
Confidence 988865433 34889999999999999999999999 999999999999999999999999998765321 11
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH--HHHHHHhCcccccCCCCCCCCChhHHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF--VERSIENGTLGEMLDPTVTDWPFEETLGF 689 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 689 (782)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+........+... ....+..+
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 226 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE----HQNFTEES 226 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc----cccCCHHH
Confidence 2345789999999999998999999999999999999999999964321 11111111111111111 11234568
Q ss_pred HHHHHHhhccCcCCCCChHHhh
Q 040785 690 AKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 690 ~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+|+.+||+.+|++||++.+++
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHhccCHhhCCCCccch
Confidence 9999999999999999997766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=334.84 Aligned_cols=253 Identities=29% Similarity=0.424 Sum_probs=197.9
Q ss_pred ccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc---
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY--- 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~--- 518 (782)
++|.+.+.||.|+||.||+|... ++.||+|+++... ......+.+|+.++.++ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46889999999999999999752 3579999987543 22345678899999999 899999999988533
Q ss_pred cEEEEEeCCCCChhHHHhhcCC----------------------------------------------------------
Q 040785 519 GIIVYEYLANGSLDDRIFRRGN---------------------------------------------------------- 540 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 540 (782)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 3789999999999998864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcc
Q 040785 541 TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620 (782)
Q Consensus 541 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~ 620 (782)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.... .........++..
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~---~~~~~~~~~~~~~ 240 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRKGDARLPLK 240 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCc---chhhccCCCCCcc
Confidence 125899999999999999999999999 9999999999999999999999999998763211 1112233456778
Q ss_pred cCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH---HHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHh
Q 040785 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF---VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQC 696 (782)
Q Consensus 621 Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~c 696 (782)
|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+... ..+......+.+++.+|
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--------RAPEYATPEIYSIMLDC 312 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--------CCCccCCHHHHHHHHHH
Confidence 999999999999999999999999999998 9999964321 12222222111 11223345689999999
Q ss_pred hccCcCCCCChHHhhhHHHHHH
Q 040785 697 SELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 697 l~~~P~~RPs~~~vl~~~l~~l 718 (782)
|+.+|++||++.+++. .|..+
T Consensus 313 l~~~p~~RPs~~ell~-~l~~~ 333 (337)
T cd05054 313 WHNNPEDRPTFSELVE-ILGDL 333 (337)
T ss_pred ccCChhhCcCHHHHHH-HHHHH
Confidence 9999999999998873 44443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.12 Aligned_cols=244 Identities=29% Similarity=0.394 Sum_probs=200.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|...+.||+|+||.||+|.. +++.|++|.+... .......+.+|+++++.++||||+++++++.+.. ++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 377889999999999999988 5778999998643 2344667899999999999999999999986654 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 99999999887642 345899999999999999999999999 9999999999999999999999999988663211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~p~ 683 (782)
.......|+..|+|||++.++.++.++|||||||++++|++|+.||......... +..+. ....+.
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (256)
T cd08529 156 ----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--------FPPVSQ 223 (256)
T ss_pred ----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------CCCCcc
Confidence 1123346889999999999999999999999999999999999999765532211 11111 111222
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 34456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=347.42 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=190.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC----------c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE----------Y 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----------~ 518 (782)
..|...+.||+|+||.||+|.+ .+..||||++.... ....+|+.+|+.++||||+++++++.. .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 4588999999999999999988 56789999885432 234579999999999999999886521 1
Q ss_pred cEEEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeecccc
Q 040785 519 GIIVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGL 596 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGl 596 (782)
.++||||+++ +|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 2689999975 676665432 23346899999999999999999999999 99999999999998664 799999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---H-hCc--
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---E-NGT-- 669 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~-~~~-- 669 (782)
|+.+... .......||+.|+|||++.+. .|+.++|||||||++|||++|.+||.......... . .+.
T Consensus 218 a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 218 AKNLLAG------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred chhccCC------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9865321 122345789999999987654 68999999999999999999999997543322111 0 110
Q ss_pred ----------ccccCCCCCC------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 670 ----------LGEMLDPTVT------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 670 ----------~~~~ld~~~~------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
+..+--+... .+|...+.++.+|+.+||..+|.+||++.+++.+.+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0010001110 122234567899999999999999999999986554
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.01 Aligned_cols=243 Identities=27% Similarity=0.355 Sum_probs=193.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
|+..+.||+|+||+||+|.+ +++.||+|.+..... .....+.+|+++|+.++|+||+.+++++.... |+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999988 567899999865421 22345788999999999999999998875543 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+.+...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-- 155 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--
Confidence 999999988865432 35999999999999999999999999 999999999999999999999999998754321
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ..+... ... ....++.
T Consensus 156 ----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-~~~----~~~~~~~ 226 (285)
T cd05632 156 ----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-VLE----TEEVYSA 226 (285)
T ss_pred ----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-hhc----cccccCc
Confidence 11234579999999999988899999999999999999999999997543321 111111 111 0112223
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
..+..+.+|+..||..+|++||+..+.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 344568999999999999999994433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.71 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=193.2
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 517 (782)
..++|...+.||+|+||.||++.+ .+..||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346799999999999999999987 5678999999653 22335568899999999999999999998742
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..|+||||+.+ +|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 23899999975 56555532 3788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHh-Cc---
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IEN-GT--- 669 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~~--- 669 (782)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... +.. +.
T Consensus 170 a~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 170 ARTACT------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred cccccc------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 975421 12234457899999999999989999999999999999999999999754321110 000 00
Q ss_pred ---------cccc--CCCC---------CCCC--------ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 670 ---------LGEM--LDPT---------VTDW--------PFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 670 ---------~~~~--ld~~---------~~~~--------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.... -.+. ..+| .......+.+|+.+||..+|++||++.+++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000 0000 0011 111234588999999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.35 Aligned_cols=249 Identities=27% Similarity=0.349 Sum_probs=196.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
++|.+.+.||+|+||.||+|.. ++..||+|++..........+.+|+.++..++||||+++++++.... ++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4588999999999999999997 56789999997654444567889999999999999999999886544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.... ++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 9999999886543 4899999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
........|+..|+|||.+. ...++.++|||||||++|+|++|+.||............. ...+.+.....+.
T Consensus 160 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 235 (267)
T cd06646 160 --IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--KSNFQPPKLKDKT 235 (267)
T ss_pred --ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--cCCCCCCCCcccc
Confidence 11122356889999999874 3457889999999999999999999985433222111100 0011111111112
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+|+.+||..+|++||++++++.
T Consensus 236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 236 KWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 23456899999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=359.11 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=202.9
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.++||+|+||.||+|.+ .++.||||++.... ....+.|.+|+.+++.++||||+++++++.+.. |+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4689999999999999999988 46789999997542 223467899999999999999999999986654 8999
Q ss_pred EeCCCCChhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 524 EYLANGSLDDRIFRRG--------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
||++||+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1123667788999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccc-------------ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH
Q 040785 596 LARLVPAVAEN-------------VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE 662 (782)
Q Consensus 596 la~~~~~~~~~-------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~ 662 (782)
+++........ ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99866211100 00011223579999999999999999999999999999999999999996543222
Q ss_pred HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 663 RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 663 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.... .. +..|.........+..+.+++.+|+..+|++||+..+.+...|....
T Consensus 239 i~~~-~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ISYR-DV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhh-hh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 11 11111100012344568999999999999999988888776766653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.78 Aligned_cols=247 Identities=27% Similarity=0.434 Sum_probs=198.5
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
.|...+.||+|+||.||+|.+ .++.||+|++..+. .....+.+|++++..++||||++++++|.... ++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 378889999999999999987 46789999987543 34567899999999999999999999986544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~--- 158 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--- 158 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce---
Confidence 999999886543 235899999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
........++..|+|||++.+..++.++|||||||++|||++ |..||......+ ..+..+ .. ...+..
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~~---~~~~~~ 229 (263)
T cd05052 159 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-----YR---MERPEG 229 (263)
T ss_pred -eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CC---CCCCCC
Confidence 111112334668999999998999999999999999999998 999996543322 112211 11 122334
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
.+..+.+++.+||..+|++||++.+++. .|+
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~-~l~ 260 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQ-AFE 260 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHH-HHH
Confidence 4567999999999999999999998873 443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=339.38 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=195.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|...+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.++..++||||+.+++++.+.. |+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 4589999999999999999988 46789999996432 123345788999999999999999999886654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 123 Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 123 EYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999988543 3788899999999999999999999 999999999999999999999999999765321
Q ss_pred cccccccccccccCCcccCChhhhhcC----CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPT 677 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~ 677 (782)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||......... +..+.. .+ .
T Consensus 196 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~---~ 267 (370)
T cd05596 196 ----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-SL---T 267 (370)
T ss_pred ----CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-cC---C
Confidence 11122346799999999987653 4789999999999999999999999765543221 111110 01 1
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCC--CCChHHhhhH
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKD--RPDLGKVVLP 713 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~--RPs~~~vl~~ 713 (782)
.+. ....+..+.+|+.+||..+|.+ ||++.+++.+
T Consensus 268 ~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111 1124567899999999999987 9999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.14 Aligned_cols=236 Identities=27% Similarity=0.330 Sum_probs=190.4
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ ++..||||+++... ......+.+|+.++..+ +||||+++++++.+.. |+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999998 45689999997542 22345677899999888 6999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-----~ 149 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-----G 149 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc-----C
Confidence 99998886543 4899999999999999999999999 99999999999999999999999999874311 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.... ...|...+
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE---------VRYPRWLS 220 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------CCCCCcCC
Confidence 112234579999999999999999999999999999999999999997544322 1111111 11233345
Q ss_pred HHHHHHHHHhhccCcCCCCCh-----HHhhh
Q 040785 687 LGFAKLALQCSELRRKDRPDL-----GKVVL 712 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~-----~~vl~ 712 (782)
..+.+|+.+||..+|.+||++ .+++.
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 568999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.17 Aligned_cols=246 Identities=28% Similarity=0.480 Sum_probs=197.4
Q ss_pred ccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
++|+..+.||+|+||.||+|.+. ...||||.+.... ......|.+|+.++..++||||+++++++.+.. ++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 45889999999999999999873 3479999987643 333567899999999999999999999886554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++++|.+++..... .+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999865432 5899999999999999999999999 99999999999999999999999999987641
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
.. .........+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ..+..+. ..+
T Consensus 159 ~~---~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~--- 228 (266)
T cd05033 159 SE---ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY----RLP--- 228 (266)
T ss_pred cc---cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----CCC---
Confidence 11 1111122345678999999998899999999999999999998 999995433221 2222211 111
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+...+..+.+++.+||+.+|++||++.+++.
T Consensus 229 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 229 -PPMDCPSALYQLMLDCWQKDRNERPTFSQIVS 260 (266)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12334556899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.64 Aligned_cols=236 Identities=24% Similarity=0.298 Sum_probs=185.6
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHH-HHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIE-VLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ ++..||+|++..... .....+..|+. +++.++||||++++++|.+.. |+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 567899999965321 22334555654 578899999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|...+.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 149 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----- 149 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-----
Confidence 99988875543 4888999999999999999999999 999999999999999999999999998753111
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
........||+.|+|||++.+..++.++|||||||++|||++|..||...+.... .... ... ....|......
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i-~~~-----~~~~~~~~~~~ 222 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNI-LHK-----PLQLPGGKTVA 222 (321)
T ss_pred CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHH-hcC-----CCCCCCCCCHH
Confidence 1122345799999999999988999999999999999999999999975543221 1110 000 11233344556
Q ss_pred HHHHHHHhhccCcCCCCChHHh
Q 040785 689 FAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~v 710 (782)
+.+++.+||+.+|.+||+....
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~ 244 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKAD 244 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCC
Confidence 8999999999999999987533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.90 Aligned_cols=245 Identities=29% Similarity=0.483 Sum_probs=201.0
Q ss_pred hccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
...|...++||.|+||.||+|.+ .+..+++|++..........+..|+.+++.++||||+++++++.+.. ++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34588899999999999999998 56789999998766555678999999999999999999999886544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--- 157 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED--- 157 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc---
Confidence 9999999986543 345899999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 683 (782)
........++..|+|||++..+.++.++||||||+++|+|++ |+.||......+ ..+..+ .. ...+.
T Consensus 158 --~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~---~~~~~ 227 (261)
T cd05148 158 --VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-----YR---MPCPA 227 (261)
T ss_pred --cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-----Cc---CCCCC
Confidence 111223456778999999988889999999999999999998 899996543222 111111 11 11233
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+..+.+++.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~ 255 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALR 255 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 4456689999999999999999998887
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.76 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=195.4
Q ss_pred cccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV 522 (782)
.|+..+.||+|+||.||+|.. .+..|++|.+.... ......|.+|+.+++.++||||+++++++... .|+|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 478889999999999999985 34579999997532 33446789999999999999999999987554 3899
Q ss_pred EEeCCCCChhHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc
Q 040785 523 YEYLANGSLDDRIFRRGN--------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV 588 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~ 588 (782)
|||+++|+|.+++..... ...+++.++..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 999999999998854321 234789999999999999999999999 999999999999999999
Q ss_pred eeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHH
Q 040785 589 SKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSI 665 (782)
Q Consensus 589 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~ 665 (782)
+||+|||+++...... .........++..|+|||++.++.++.++|||||||++|||++ |..||...... ...+
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSAD---YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred EEeccccccccccCCc---ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999998653211 1111233456788999999988889999999999999999998 99999653321 1222
Q ss_pred HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 666 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+.. ...+...+..+.+++.+||+.+|.+||++.+++
T Consensus 240 ~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 277 (283)
T cd05090 240 RKRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277 (283)
T ss_pred HcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 22211 112233455689999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.43 Aligned_cols=238 Identities=25% Similarity=0.307 Sum_probs=190.7
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcC-CCCeeeecccccCc--cEEEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIR-HPNMVLLLGACPEY--GIIVYE 524 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~lV~E 524 (782)
|...+.||+|+||.||+|.. ++..||||++.... ......+..|+.++..+. ||+|+.+++++.+. .|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 77789999999999999987 56789999997542 223456778999998885 56777888887544 389999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+.+...+ .+++.++..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 82 YVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 999999999886543 4899999999999999999999999 999999999999999999999999998754211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ..+|
T Consensus 155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~~p 221 (323)
T cd05615 155 ----GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VSYP 221 (323)
T ss_pred ----CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCC
Confidence 112234579999999999999899999999999999999999999997554321 1111111 1223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
...+..+.+++.+||+.+|.+|++..+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPE 249 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCC
Confidence 3445568999999999999999986543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.79 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=191.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhc---CCCCeeeecccccCc------
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCI---RHPNMVLLLGACPEY------ 518 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~~------ 518 (782)
+|.+.+.||+|+||.||+|.+ +++.||+|.++..... ....+.+|+.++..+ .||||++++++|...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 378889999999999999998 5678999998754222 223566788887766 699999999987431
Q ss_pred -cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
.++||||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 3899999974 8888776543 245899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH---HHHHh-Cc----
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIEN-GT---- 669 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~---~~~~~-~~---- 669 (782)
+..... .......||..|+|||++.+..++.++|||||||++|+|++|++||....... ..+.. +.
T Consensus 156 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQ------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCc------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 865321 12234578999999999998899999999999999999999999996443221 11110 00
Q ss_pred -cc-------ccCCCC----CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 -LG-------EMLDPT----VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 -~~-------~~ld~~----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. ..+.+. .....+..+..+.+++.+||..||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 00111234456889999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.73 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=198.0
Q ss_pred HHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccC-------
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPE------- 517 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------- 517 (782)
.+++.|...+.||+|+||.||+|.. .++.||+|++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3566789999999999999999987 56789999986543 3345788999999998 79999999998843
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 2389999999999999886533 235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 671 (782)
+...... ........|+..|+|||++. +..++.++|||||||++|+|++|..||..............
T Consensus 158 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-- 230 (272)
T cd06637 158 SAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-- 230 (272)
T ss_pred ceecccc-----cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--
Confidence 9765321 11223467899999999876 34588899999999999999999999965443332221111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+.. .+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 231 -~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -NPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CCCCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 001111 11223456899999999999999999998874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.97 Aligned_cols=255 Identities=29% Similarity=0.414 Sum_probs=195.3
Q ss_pred ccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GII 521 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~l 521 (782)
|...+.||+|+||+||++.. ++..||+|+++.... .....|.+|+++|+.++||||++++++|... .++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988753 456899999976532 3456788999999999999999999987532 389
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999988543 3899999999999999999999999 9999999999999999999999999998663
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-HHHHHHh-------Cccccc
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF-VERSIEN-------GTLGEM 673 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-~~~~~~~-------~~~~~~ 673 (782)
.... .........++..|+|||++....++.++|||||||++|+|++|..||..... ....+.. ..+.+.
T Consensus 159 ~~~~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 159 EGHE--YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred Ccch--hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 2111 00111223456779999999888899999999999999999999999864321 1111100 001111
Q ss_pred CCCCC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 674 LDPTV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 674 ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
++... ...+...+..+.+++.+||+.+|++||++.+++. .|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~-~l~~ 280 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP-ILKE 280 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH-HHHH
Confidence 11111 1123344567999999999999999999998873 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.25 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=192.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|+..+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.. |+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4589999999999999999998 46689999986421 223456789999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 123 Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 123 EYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999988543 3788999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccccCCcccCChhhhhcC----CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPT 677 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~ 677 (782)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... +.....
T Consensus 196 ----~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~------- 264 (370)
T cd05621 196 ----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN------- 264 (370)
T ss_pred ----CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------
Confidence 11122456799999999988754 3789999999999999999999999755433211 111110
Q ss_pred CCCCCh--hHHHHHHHHHHHhhccCcCC--CCChHHhhhH
Q 040785 678 VTDWPF--EETLGFAKLALQCSELRRKD--RPDLGKVVLP 713 (782)
Q Consensus 678 ~~~~p~--~~~~~l~~li~~cl~~~P~~--RPs~~~vl~~ 713 (782)
...+|. ..+..+.+++..|+..++.+ ||++.+++.+
T Consensus 265 ~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011121 23456889999999755543 8899888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=332.88 Aligned_cols=235 Identities=26% Similarity=0.299 Sum_probs=186.2
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHH-HHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIE-VLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.. +++.||||++.... ......+..|.. +++.++||||+++++++.... |+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 57799999996542 122345566665 467789999999999886543 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|...+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----- 149 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----- 149 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-----
Confidence 99998886443 4899999999999999999999999 999999999999999999999999998753211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+.+ ..++...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 220 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---------VLRPGAS 220 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------cCCCCCC
Confidence 1122346799999999999999999999999999999999999999975543221 1111110 1122344
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhh
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+.+++.+|++.+|.+||++.+.+
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCH
Confidence 5688999999999999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.85 Aligned_cols=231 Identities=25% Similarity=0.340 Sum_probs=186.5
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.. .++.||+|++.... ......+.+|+.++.++ +||||+.+++++.+.. |+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 46789999997642 22345688999999888 6999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|...+...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-----~ 149 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-----P 149 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC-----C
Confidence 99998876543 4899999999999999999999999 99999999999999999999999999875311 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH---------HHHHHHHhCcccccCCCCCC
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH---------FVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---------~~~~~~~~~~~~~~ld~~~~ 679 (782)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+... ..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~ 220 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------PI 220 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------CC
Confidence 112234679999999999999999999999999999999999999995311 111111111 11
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
..|...+..+.+++.+||..+|++||+.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2233445568999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.76 Aligned_cols=313 Identities=23% Similarity=0.262 Sum_probs=225.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhchhhHhhhcccCCcCccccccccHHHH
Q 040785 367 RLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDI 446 (782)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~e~e~~~~~~~e~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~ 446 (782)
++++....|.++.+....+|+++..++++.. .+..+++. -.++... .++..... .....+.....+.+.+-
T Consensus 86 cLQWTTVIERTF~ves~~eRq~W~~AIq~vs--n~l~q~e~-----~~tn~~p-~~~~d~~~-~s~s~d~~~e~m~i~~t 156 (516)
T KOG0690|consen 86 CLQWTTVIERTFYVESAEERQEWIEAIQAVS--NRLKQEEL-----MDTNGNP-EGEMDVNM-GSPSDDFGSEEMSIAET 156 (516)
T ss_pred eeeeeeeeeeeeecCCHHHHHHHHHHHHHHh--hhhhhhhh-----cccCCCc-cccccccC-CCCCccccceeeeeccc
Confidence 4666678888888888999999988887653 11111110 0000000 00000000 00000111111111100
Q ss_pred -------HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeeccc
Q 040785 447 -------EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGA 514 (782)
Q Consensus 447 -------~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~ 514 (782)
....++|..+++||+|.||.|.+|+. .++.+|||+++++.- .....-..|-.+|...+||.+..|-..
T Consensus 157 ~~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 157 EEAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred ccccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 11234589999999999999999987 677999999987632 333445679999999999999999888
Q ss_pred ccCc--cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 515 CPEY--GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 515 ~~~~--~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
|..+ .|+||||..||.|.-.|.+.. .|++.....+-.+|+.||.|||+++ ||+||||.+|+|||.+|++||+
T Consensus 237 FQt~drlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 237 FQTQDRLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred hccCceEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEee
Confidence 8654 499999999999998886543 4888888999999999999999999 9999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGE 672 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 672 (782)
||||++---. ....+.+.|||+.|+|||++....|+..+|+|.+||++|||++|+.||...+.- ++-+
T Consensus 311 DFGLCKE~I~-----~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFe 378 (516)
T KOG0690|consen 311 DFGLCKEEIK-----YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFE 378 (516)
T ss_pred ecccchhccc-----ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-------HHHH
Confidence 9999985321 223456789999999999999999999999999999999999999999654331 1111
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
++-..-..+|.....+...|+...|..+|.+|-.
T Consensus 379 LIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 379 LILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred HHHhhhccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 1111122345555667889999999999999964
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.92 Aligned_cols=252 Identities=23% Similarity=0.222 Sum_probs=192.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|.+.+.||+|+||.||++.. +++.||||++.... ......|.+|+.++..++||||+.++++|.+.. |+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 588999999999999999998 46789999996521 223456889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred cCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999886533 34889999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccccccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
........||+.|+|||++.. +.++.++|||||||++|+|++|+.||......+...........+ .+.
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~ 230 (331)
T cd05597 157 ----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF--QFP 230 (331)
T ss_pred ----CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc--cCC
Confidence 111223469999999998863 457889999999999999999999997654333211110001101 011
Q ss_pred CCChhHHHHHHHHHHHhhccCc--CCCCChHHhhhHH
Q 040785 680 DWPFEETLGFAKLALQCSELRR--KDRPDLGKVVLPE 714 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P--~~RPs~~~vl~~~ 714 (782)
......+..+.+|+.+|+...+ ..||++.+++.+.
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 1112244568888988775533 3478998888553
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.69 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=191.9
Q ss_pred eeeeeCcEeEEEEEE----CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCCCC
Q 040785 458 KIGEGGYGPVYKCYL----DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLANGS 530 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~----~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~gs 530 (782)
.||+|+||.||+|.+ ++..+|+|+++... ....+.|.+|+.++..+.||||+++++++.... ++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999975 45689999986543 233567899999999999999999999986544 89999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccccc
Q 040785 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQY 610 (782)
Q Consensus 531 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 610 (782)
|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||.|||++.++.+||+|||+++........ ..
T Consensus 82 L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~--~~ 153 (257)
T cd05116 82 LNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY--YK 153 (257)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe--ee
Confidence 999886543 4899999999999999999999999 999999999999999999999999999866322110 11
Q ss_pred ccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChhHHH
Q 040785 611 HLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFEETL 687 (782)
Q Consensus 611 ~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~~ 687 (782)
......++..|+|||.+..+.++.++|||||||++|||++ |..||...... ...+..+.. ...|...+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--------~~~~~~~~~ 225 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--------MECPQRCPP 225 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--------CCCCCCCCH
Confidence 1122345678999999988889999999999999999998 99999754322 222333221 122334556
Q ss_pred HHHHHHHHhhccCcCCCCChHHhhh
Q 040785 688 GFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 688 ~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.+++.+||+.+|++||++.+|+.
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHH
Confidence 7999999999999999999988873
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=337.74 Aligned_cols=243 Identities=28% Similarity=0.420 Sum_probs=199.8
Q ss_pred ceeeeeCcEeEEEEEECCe--eEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCccE--EEEEeCCCCChh
Q 040785 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGI--IVYEYLANGSLD 532 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~~--~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~--lV~Ey~~~gsL~ 532 (782)
-+||+|.||+||-|++.++ ..|||-+........+-+..||.+-++|+|.|||+++|.|.++++ |.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3589999999999998555 678998876666667778999999999999999999999998884 789999999999
Q ss_pred HHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCceeeeccccccccccccccccc
Q 040785 533 DRIFRRGNTPPL--SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 533 ~~l~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
++|...-. |+ .+.+.-.+..||++||.|||.+. |||||||-+|||++ -.|.+||+|||.++.+....
T Consensus 661 sLLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin----- 730 (1226)
T KOG4279|consen 661 SLLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN----- 730 (1226)
T ss_pred HHHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC-----
Confidence 98865532 35 78888899999999999999999 99999999999995 67999999999998774321
Q ss_pred cccccccCCcccCChhhhhcCC--CCCchhHHHHHHHHHHHHhCCCCCCChHH-HHHHHHhCcccccCCCCCCCCChhHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQLITAKQPMGLTHF-VERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
...-+..||..|||||++..|. |+..+|||||||++.||.||++||-.... ....+.-|-+ ..-+..|.+..
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy-----KvHP~iPeels 805 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY-----KVHPPIPEELS 805 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce-----ecCCCCcHHHH
Confidence 1223567999999999988775 99999999999999999999999942222 1222222322 22345577788
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.+...||++|+..+|.+||++.++|...
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 8899999999999999999999988543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.99 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=197.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
.|++.+.||.|+||.||+|.+ .+..+++|.+..........+.+|+++++.++||||++++++|.... ++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 367888999999999999998 45678999987665556678899999999999999999999886544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|...+.+.. .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---- 156 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 156 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc----
Confidence 999988776533 35899999999999999999999999 999999999999999999999999998764221
Q ss_pred cccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
........||+.|+|||++. +..++.++|||||||++|+|++|++||............... ..+.. ..+
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~-~~~ 231 (282)
T cd06643 157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTL-AQP 231 (282)
T ss_pred -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc---CCCCC-CCc
Confidence 11223456899999999874 345788999999999999999999999755443322221110 01111 112
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2334568999999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.41 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=199.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.. +++.||||.+... .......|.+|+.+++.++||||+++++++.+.. ++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688899999999999999987 6789999987642 2233456889999999999999999999886543 8999
Q ss_pred EeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345889999999999999999999999 99999999999999999999999999987642
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-HHHHHHhCcccccCCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF-VERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~ld~~~~~~ 681 (782)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....... +.....+.. .
T Consensus 159 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~--~ 229 (267)
T cd08228 159 KT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK--IEQCDYPPL--P 229 (267)
T ss_pred hh-----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH--HhcCCCCCC--C
Confidence 21 112234688999999999888899999999999999999999999954321 1111111 111111111 1
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+...+..+.+++.+||..+|.+||++.+++. .++.+
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~-~~~~~ 265 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ-IAKQM 265 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHH-HHHHh
Confidence 1234456999999999999999999998873 44443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.27 Aligned_cols=247 Identities=27% Similarity=0.382 Sum_probs=196.1
Q ss_pred cccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
.|...+.||+|+||.||+|.+. +..||||+++..... ....|.+|+.++..++||||+++++++.+.. ++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3777889999999999999863 357999999755322 3466889999999999999999999986544 89
Q ss_pred EEEeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc
Q 040785 522 VYEYLANGSLDDRIFRRG-------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV 588 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~ 588 (782)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999885321 1234888999999999999999999999 999999999999999999
Q ss_pred eeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHH
Q 040785 589 SKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSI 665 (782)
Q Consensus 589 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~ 665 (782)
+||+|||+++...... .........+++.|+|||++.++.++.++|||||||++|||++ |..||....... ..+
T Consensus 163 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAAD---YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred eEecccccccccccch---heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999988653211 1111233456789999999988899999999999999999998 888986543221 112
Q ss_pred HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+. ....+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 240 RNRQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HcCC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2221 12233445566899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.50 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=200.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~ 526 (782)
.+|...+.||.|+||.||+|.. .+..|++|.+..........+.+|+.+++.++||||+++++.|... .|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3588889999999999999987 5679999999766555567789999999999999999999988544 48999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++... .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--- 169 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc---
Confidence 999999988432 3789999999999999999999999 999999999999999999999999998754321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||............... . .+.. ..+...+
T Consensus 170 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~--~~~~-~~~~~~~ 243 (296)
T cd06654 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G--TPEL-QNPEKLS 243 (296)
T ss_pred --ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-C--CCCC-CCccccC
Confidence 11123357899999999998888999999999999999999999999755443222111110 0 1111 1223344
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+.+++.+||..+|++||++.+++..
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 568999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.64 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=193.6
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 517 (782)
..++|...+.||+|+||.||++.+ .+..||||.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456799999999999999999987 56789999997532 2334567899999999999999999998742
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 23899999965 56665532 3788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHh-C----
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IEN-G---- 668 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~---- 668 (782)
++.... ........||..|+|||++.+..++.++|||||||++|+|++|+.||......... +.. +
T Consensus 166 ~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 166 ARTAGT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred cccCCC------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 986532 11223457899999999999889999999999999999999999999754432111 000 0
Q ss_pred ------------------cccccC---------CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 669 ------------------TLGEML---------DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 669 ------------------~~~~~l---------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
....+. .+.....+......+.+|+.+||..+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 000011112234568899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.40 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=202.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+.|++-+.||+|.|+.||++.+ +++.+|+|+++.. ...+.+.+.+|+.|-+.|+||||++|...+.+.+ |||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4578888999999999999987 6778999988543 2335677899999999999999999999886655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~DFGla~~~~ 601 (782)
+|.|++|..-+-.+ ..+++..+-.++.||++||.|+|.++ |||||+||.|+||. ..--+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999997666554 24788888899999999999999999 99999999999993 44568999999998764
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT--HFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~--~~~~~~~~~~~~~~~ld~~~~ 679 (782)
........+|||.|||||++...+|+..+|||+.|||||-||.|++||... +-.-..+..|.+ |-.-+
T Consensus 165 ------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y----d~~~~ 234 (355)
T KOG0033|consen 165 ------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY----DYPSP 234 (355)
T ss_pred ------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc----CCCCc
Confidence 234456789999999999999999999999999999999999999999652 223334444443 22222
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.| +...++..+|+.+||..||.+|.+..+.|.+.
T Consensus 235 ~w-~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 235 EW-DTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred cc-CcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 34 34556789999999999999999999987443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=335.74 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=193.4
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------cEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------GII 521 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~~l 521 (782)
|++.+.||+|+||.||++.+ +++.||||.+... .....+.+.+|+.+|+.++||||+.+++++... .|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 78889999999999999997 6789999998643 223456788999999999999999999988542 389
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 82 VTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred Eeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 999996 5787777443 35899999999999999999999999 9999999999999999999999999998653
Q ss_pred cccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----C--------
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----G-------- 668 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~-------- 668 (782)
.. .....+...||+.|+|||++.+. .++.++|||||||++|||++|+.||...+........ |
T Consensus 155 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 155 PD----ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred cC----ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 21 11223345689999999988764 4799999999999999999999999654332211000 0
Q ss_pred ---------cccccCCC-C---CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 669 ---------TLGEMLDP-T---VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 669 ---------~~~~~ld~-~---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.......+ . ...........+.+|+.+||+.||++||++.+++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00000000 0 0011122345688999999999999999999998644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.67 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=191.9
Q ss_pred cccceeeeeCcEeEEEEEECCe----eEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC--------cc
Q 040785 454 TESRKIGEGGYGPVYKCYLDHT----PVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--------YG 519 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~~~~----~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~~ 519 (782)
.+.+.||+|+||.||+|.+... .||+|.++.. .......|.+|+.++..++||||++++++|.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987432 5899988654 23445678999999999999999999997632 23
Q ss_pred EEEEEeCCCCChhHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 520 IIVYEYLANGSLDDRIFRR---GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
+++|||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 7999999999999887532 12245899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCccccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEM 673 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ 673 (782)
++....... ........+++.|++||++.+..++.++|||||||++|+|++ |..||....... ..+..+..
T Consensus 159 ~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 232 (272)
T cd05075 159 SKKIYNGDY---YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--- 232 (272)
T ss_pred ccccCcccc---eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 987632111 011122346778999999998899999999999999999999 899996543221 22222211
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 233 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 233 -----LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1112234456899999999999999999988873
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.69 Aligned_cols=246 Identities=23% Similarity=0.362 Sum_probs=194.1
Q ss_pred ccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC--------
Q 040785 453 FTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------- 517 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------- 517 (782)
|.+.+.||+|+||.||+|... +..||||.++... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 566789999999999999873 2569999987542 2335678999999999999999999998732
Q ss_pred ccEEEEEeCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecc
Q 040785 518 YGIIVYEYLANGSLDDRIFRRG---NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594 (782)
Q Consensus 518 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DF 594 (782)
..+++|||+++|+|...+.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 1389999999999998885432 2235899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCccc
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLG 671 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~ 671 (782)
|+++...... .........++..|+|||++.+..++.++|||||||++|||++ |..||......+ ..+..+.
T Consensus 158 g~~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 232 (273)
T cd05035 158 GLSKKIYSGD---YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-- 232 (273)
T ss_pred cceeeccccc---cccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--
Confidence 9998653221 1111122345678999999988889999999999999999999 999996543322 1111111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....|...+..+.+++.+||+.+|.+||++.+++.
T Consensus 233 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 233 ------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred ------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11223345567999999999999999999988873
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=316.06 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=197.6
Q ss_pred hccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.+.|...+.||+|+||.||+|.+ .++.||||.++... ...+.|.+|+.++++++||||+++++++.... ++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35588899999999999999987 45689999997653 33567899999999999999999999886554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI-- 157 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc--
Confidence 9999999986543 345899999999999999999999999 9999999999999999999999999998763211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 683 (782)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ..+..+. .. ..+.
T Consensus 158 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~~ 227 (261)
T cd05068 158 --YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-----RM---PCPP 227 (261)
T ss_pred --ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----CC---CCCC
Confidence 001111223457999999988899999999999999999999 999996543322 1111111 00 1123
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+++.+|++.+|.+||++.+++.
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 34456999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=318.55 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=198.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCe----eEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHT----PVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
+.|...++||.|+||+||+|.+ ++. .||+|+++... ......+.+|+.++..+.||||+.++++|.... +++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 3588899999999999999986 333 48999987543 334567889999999999999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+.+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999886543 35899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
.. .........+++.|+|||+..+..++.++|||||||++|||++ |..||..... ....+..+...
T Consensus 162 ~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 230 (279)
T cd05109 162 DE---TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-------- 230 (279)
T ss_pred cc---ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--------
Confidence 21 1111222345678999999988899999999999999999998 9999965332 11222222111
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+...+..+.+++.+||..+|+.||++.+++ ..|..+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~-~~l~~~ 268 (279)
T cd05109 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRM 268 (279)
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHH-HHHHHh
Confidence 11223445689999999999999999999987 344443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=315.24 Aligned_cols=244 Identities=30% Similarity=0.471 Sum_probs=196.8
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLAN 528 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 528 (782)
++|.+.++||+|+||.||+|.. .+..+|+|.+..... ....|.+|+.++++++||||+++++++.+.. +++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 3588899999999999999987 456899999976433 3467999999999999999999999885544 999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||++++++.++|+|||++..+....
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~---- 156 (260)
T cd05070 85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---- 156 (260)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc----
Confidence 99999886543 235899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. .+..+ . ....+...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~---~~~~~~~~ 228 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-----Y---RMPCPQDC 228 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----C---CCCCCCcC
Confidence 111112345678999999988889999999999999999999 9999965443221 11111 0 11223344
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+..+.+|+.+|+..+|++||++.+++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHH
Confidence 56799999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.22 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=200.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-----hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-----QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
++|...+.||.|+||.||+|.. ++..||+|.+..... .....+.+|++++++++||||+++++++.+.. ++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4588899999999999999987 567999999865321 12356889999999999999999999986554 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++++|.+.+...+ .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999886543 4889999999999999999999999 9999999999999999999999999997653
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
.... .........|+..|+|||++.+..++.++|||||||++|+|++|+.||............... +.....
T Consensus 156 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~ 228 (263)
T cd06625 156 TICS--SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-----PTNPQL 228 (263)
T ss_pred cccc--ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----CCCCCC
Confidence 2111 111112356889999999999888999999999999999999999999755443322221111 111223
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 229 PSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 3345556899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.49 Aligned_cols=235 Identities=26% Similarity=0.283 Sum_probs=185.5
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHH-HHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIE-VLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+ ++..||+|++..... .....+..|.. +++.++||||+++++++.+.. |+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999998 456899999975321 12233444544 567789999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~----- 149 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----- 149 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-----
Confidence 99999886543 4788889999999999999999999 999999999999999999999999998753211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+.... ...+...+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------LQLKPNIT 220 (325)
T ss_pred CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------cCCCCCCC
Confidence 1122346799999999999999999999999999999999999999975543321 111111 11223344
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhh
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+.+++.+||+.+|.+||+..+.+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCH
Confidence 5689999999999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.58 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=194.9
Q ss_pred ccccccceeeeeCcEeEEEEEECC----------------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH----------------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLG 513 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~----------------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g 513 (782)
++|.+.+.||+|+||.||+|...+ ..||+|.++... ......|.+|+++|.+++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 458888999999999999987632 248999997653 334567999999999999999999999
Q ss_pred cccCcc--EEEEEeCCCCChhHHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEE
Q 040785 514 ACPEYG--IIVYEYLANGSLDDRIFRRG---------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582 (782)
Q Consensus 514 ~~~~~~--~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 582 (782)
++.... ++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 986544 89999999999999886432 1134789999999999999999999999 999999999999
Q ss_pred EcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh--CCCCCCChHH
Q 040785 583 LDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT--AKQPMGLTHF 660 (782)
Q Consensus 583 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~Pf~~~~~ 660 (782)
++.++.+||+|||++....... .........++..|+|||++.++.++.++|||||||++|+|++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD---YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EcCCCcEEecccccccccccCc---ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999997653211 1111223456778999999998999999999999999999998 6778865432
Q ss_pred HHHHHHhCc-ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 661 VERSIENGT-LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 661 ~~~~~~~~~-~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
......... +...........+...+..+.+|+.+||..+|.+||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 211100000 000000111111223445799999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.85 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=195.5
Q ss_pred cccccceeeeeCcEeEEEEEECC-eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
.|...+.||+|+||.||+|.+.+ ..+|||.+.... .....|.+|+.++..++||||++++++|.+.. ++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 47888999999999999998754 469999987543 23467899999999999999999999986544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---- 154 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc----
Confidence 999998865432 5899999999999999999999999 9999999999999999999999999988653211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........++..|+|||++.++.++.++|||||||++|+|++ |..||....... ..+..+.. + ..+...
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----~---~~~~~~ 226 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-----L---YRPHLA 226 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-----C---CCCCCC
Confidence 111122346678999999988889999999999999999998 999997543321 11222111 1 112223
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 456899999999999999999988873
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.09 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=195.4
Q ss_pred ccccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC----ccE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE----YGI 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 520 (782)
..|.+.+.||+|+||.||+|.. .+..||||.+........+.|.+|+++|..++||||+++++++.. ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3588889999999999999974 356899999987666666789999999999999999999997632 238
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999986543 24899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH-HHHHHhCcc--------c
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV-ERSIENGTL--------G 671 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~--------~ 671 (782)
...... ........++..|+|||++.++.++.++|||||||++|||++|..|+...... ......... .
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 159 PQDKEY--YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cCCCcc--eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 432110 00111223455699999998889999999999999999999998776433211 000000000 0
Q ss_pred ccCCC-CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDP-TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+.. .....+...+..+.+|+.+||..+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000 001112334456999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=320.03 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=195.0
Q ss_pred ccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 453 FTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
|.+.+.||+|+||.||+|.... ..+++|.+.... ......+.+|+.++..+.||||+++++.|.... ++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 6778899999999999998632 468999887543 233567899999999999999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceE
Q 040785 523 YEYLANGSLDDRIFRRG---------------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNI 581 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NI 581 (782)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence 99999999999886421 1235889999999999999999999999 99999999999
Q ss_pred EEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH
Q 040785 582 LLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF 660 (782)
Q Consensus 582 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~ 660 (782)
|+++++.+||+|||+++...... .........++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEED---SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEcCCCcEEeccccccccccCcc---chhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999998653211 1111223356778999999988889999999999999999998 9999965433
Q ss_pred HH--HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 661 VE--RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 661 ~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. ..+..+. .. ..+...+..+.+++..||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~-----~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLKTGY-----RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhCCC-----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 22 1122111 11 112334457999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=332.96 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=193.3
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 517 (782)
..++|...+.||+|+||.||++.+ .++.||||++.... ......+.+|+.+++.++||||+.+++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 346799999999999999999987 56789999996532 2334567899999999999999999988742
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 13899999965 67666632 3788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHHh-Cc---
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIEN-GT--- 669 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~~-~~--- 669 (782)
++.... ........||..|+|||++.+..++.++|||||||++|+|++|+.||........ .+.. +.
T Consensus 173 a~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred ccccCC------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 986532 1122345789999999999999999999999999999999999999965433211 1100 00
Q ss_pred -------------------c---------cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 670 -------------------L---------GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 670 -------------------~---------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+ ...+-+............+.+|+.+|+..||.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000000001111123468899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=319.87 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=201.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|.+.+.||.|+||.||+|.+ ++..+|+|++..........|.+|+++++.++||||+++++.+.... |+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 34688999999999999999988 46789999998766666678999999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999999886543 35899999999999999999999999 999999999999999999999999998754221
Q ss_pred cccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 680 (782)
........||+.|+|||++. +..++.++|||||||++|+|++|+.||.............. ...+.+ .
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~-~ 229 (280)
T cd06611 157 ---LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEPPTL-D 229 (280)
T ss_pred ---ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCCCCc-C
Confidence 11223456899999999875 34477899999999999999999999976544332221111 001111 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.+...+..+.+++.+||+.+|.+||++.+++.+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 1223345689999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.92 Aligned_cols=252 Identities=22% Similarity=0.240 Sum_probs=192.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||++.+ .+..||+|++.... ......+..|+.++..+.||||+.+++++.+.. |+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688999999999999999988 45689999986531 222345788999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999987643 24889999999999999999999999 999999999999999999999999999765321
Q ss_pred cccccccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTV 678 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 678 (782)
. ........||+.|+|||++.+ +.++.++|||||||++|+|++|+.||......+.....-.... ...+
T Consensus 156 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~ 229 (331)
T cd05624 156 G----TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE--RFQF 229 (331)
T ss_pred C----ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC--cccC
Confidence 1 111223579999999998875 5688999999999999999999999975544332111100000 0111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCC--CCChHHhhhH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKD--RPDLGKVVLP 713 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~--RPs~~~vl~~ 713 (782)
+......+..+.+++.+|+...+++ |+++.+++.+
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111223456889999998865544 4577777643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.32 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=203.6
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhh-------HHHHHHHHHHHHhcCCCCeeeeccccc---
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQG-------RSQFQREIEVLSCIRHPNMVLLLGACP--- 516 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~l~g~~~--- 516 (782)
..++|-.+++||+|||+.||++.+ ..+.||||+-..+.... .+...+|..|-+.|.||.||++|++|.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 355788899999999999999987 67799999976442221 234568999999999999999999984
Q ss_pred CccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeeec
Q 040785 517 EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISD 593 (782)
Q Consensus 517 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~D 593 (782)
+..|-|+|||+|.+|+-+|.... -+++.++..|+.||+.||.||.... .||||-||||.||||- ..|.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 44599999999999998885543 4899999999999999999999987 4799999999999994 457899999
Q ss_pred ccccccccccccc-ccccc-cccccCCcccCChhhhhcC----CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh
Q 040785 594 VGLARLVPAVAEN-VTQYH-LTSTAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN 667 (782)
Q Consensus 594 FGla~~~~~~~~~-~~~~~-~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~ 667 (782)
|||++.+.....+ ..... ....+||.+|++||.|.-+ +++.|+||||+|||+|++|.|+.||+....-...+..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999988554332 22222 3346899999999987654 4789999999999999999999999977666666655
Q ss_pred CcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 668 GTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 668 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.++...-.-.++.- +-...+...||++||+..-++|.+.-++.
T Consensus 697 NTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 NTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 55432211111111 23445688999999999999999886664
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.85 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=207.8
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh---hHHHHHHHHHHHHhcC-CCCeeeecccccCcc--E
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ---GRSQFQREIEVLSCIR-HPNMVLLLGACPEYG--I 520 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~ 520 (782)
....|...+.||.|.||.||+|.. +++.+|+|++.+.... ....+.+|+.||+.+. |||||.++++|.+.. +
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 345688899999999999999998 5778999999765432 3468999999999998 999999999997665 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC----CCceeeecccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH----NYVSKISDVGL 596 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~----~~~~kL~DFGl 596 (782)
+|||++.||.|.+.+... . +++..+..++.|++.++.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999877 2 999999999999999999999999 999999999999953 35799999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEML 674 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l 674 (782)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...... ...+..+.+
T Consensus 186 a~~~~~------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---- 255 (382)
T KOG0032|consen 186 AKFIKP------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---- 255 (382)
T ss_pred ceEccC------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC----
Confidence 997742 34456789999999999999999999999999999999999999999765532 233444443
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+-....| ......+.+++..|+..||..|+++.++|.
T Consensus 256 ~f~~~~w-~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 DFTSEPW-DDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCCc-cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2222233 344667999999999999999999999885
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.52 Aligned_cols=246 Identities=28% Similarity=0.370 Sum_probs=194.2
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
|+..+.||+|+||.||++.+ +++.||||.+..... .....+.+|+.++..++|+||+.+++.+.+.. |+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67788999999999999998 567899999865421 22345778999999999999999999886544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+.+..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 155 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC--
Confidence 999999998865432 35899999999999999999999999 999999999999999999999999998765321
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||...... ...... .+.......+.
T Consensus 156 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~ 226 (285)
T cd05630 156 ----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----LVKEVQEEYSE 226 (285)
T ss_pred ----ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-----hhhhhhhhcCc
Confidence 1123457999999999999999999999999999999999999999743210 001100 00000011223
Q ss_pred hHHHHHHHHHHHhhccCcCCCCC-----hHHhhhH
Q 040785 684 EETLGFAKLALQCSELRRKDRPD-----LGKVVLP 713 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs-----~~~vl~~ 713 (782)
..+..+.+|+.+||+.+|.+||+ +.+++.+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 34456899999999999999999 6666643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.03 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=196.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
++|...+.||+|+||.||+|.+ +++.||+|+++.........+.+|+.++..++||||+++++.+.... ++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3588889999999999999987 57789999997765555567889999999999999999999885544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++...+ .+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999886543 4899999999999999999999999 999999999999999999999999998765321
Q ss_pred ccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH--HhCcccccCCCCCCCC
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--ENGTLGEMLDPTVTDW 681 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~ld~~~~~~ 681 (782)
........||..|+|||++. .+.++.++|||||||++|+|++|..||.......... ....+. .+.. ..
T Consensus 160 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~-~~ 233 (267)
T cd06645 160 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---PPKL-KD 233 (267)
T ss_pred --ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---CCcc-cc
Confidence 11123457899999999874 4568899999999999999999999985433222111 111111 1111 11
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+..+.+++.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1123345899999999999999999988874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.72 Aligned_cols=238 Identities=29% Similarity=0.418 Sum_probs=195.6
Q ss_pred cccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccccc-C--ccEEEEEeCCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP-E--YGIIVYEYLAN 528 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~--~~~lV~Ey~~~ 528 (782)
.|...+.||+|+||.||++...++.||+|.++... ..+.|.+|+.+++.++|||++++++++. + ..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 48888999999999999999999999999987543 2457899999999999999999999753 2 23899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----- 155 (256)
T cd05082 85 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 155 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc-----
Confidence 999998865433 35889999999999999999999999 999999999999999999999999998754221
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ..+..+. .+ ..+...
T Consensus 156 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~~ 224 (256)
T cd05082 156 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----KM---DAPDGC 224 (256)
T ss_pred ---CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----CC---CCCCCC
Confidence 122345678999999998889999999999999999998 999996543322 2222221 11 122334
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+..+.+++.+||+.+|++||++.+++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~ 250 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLR 250 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 55689999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.82 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=192.9
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.|...+.||+|+||.||+|.+ .+..||+|.++.... .....+.+|+.++..++||||+++++++.... ++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 3588899999999999999987 566899999875432 22346788999999999999999999986443 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++ +|.+.+...+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 157 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP-- 157 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC--
Confidence 975 7887775543 34789999999999999999999999 999999999999999999999999999754221
Q ss_pred cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHH-hCccc---------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIE-NGTLG--------- 671 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~-~~~~~--------- 671 (782)
........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||......+. ... .+...
T Consensus 158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 158 ---TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ---ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 111233568999999998765 4689999999999999999999999965432211 100 00000
Q ss_pred --ccCC---CCC-----CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 672 --EMLD---PTV-----TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 672 --~~ld---~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
...+ +.. .......+..+.+|+.+||+.+|++||++.+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000 000 001112345688999999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=321.42 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=195.6
Q ss_pred ccccccceeeeeCcEeEEEEEEC--Ce--eEEEEEecCC-chhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HT--PVAVKVLRPD-AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~--~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|++.+.||+|+||.||+|... +. .+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+.. ++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 35888899999999999999873 22 4788888643 233456789999999999 7999999999986654 899
Q ss_pred EEeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 523 YEYLANGSLDDRIFRRG-------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
|||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1135889999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIE 666 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~ 666 (782)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... ..+.
T Consensus 159 kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~ 232 (297)
T cd05089 159 KIADFGLSRGEEVY------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232 (297)
T ss_pred EECCcCCCccccce------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 99999998643210 11111233567999999988889999999999999999997 999996544322 1111
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+. . ...+...+..+.+|+.+||..+|.+||++.+++. .|..+.
T Consensus 233 ~~~-----~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~-~l~~~~ 276 (297)
T cd05089 233 QGY-----R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV-QLSRML 276 (297)
T ss_pred cCC-----C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHH
Confidence 111 1 1122334456899999999999999999999874 344443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=319.94 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=198.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+.|++.++||.|+||.||+|.+ .+..+++|++..........+.+|+.+++.++||||+++++.|.... |+||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4588899999999999999988 46789999998766666778999999999999999999999875444 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|..++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 9999988775543 34899999999999999999999999 999999999999999999999999998754211
Q ss_pred ccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCC
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
........|+..|+|||++. ...++.++|||||||++|+|++|..||.............. ...+.. ..
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~-~~ 237 (292)
T cd06644 164 --LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTL-SQ 237 (292)
T ss_pred --ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCccC-CC
Confidence 11123456889999999874 34578899999999999999999999975543322211111 111111 11
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+...+..+.+++.+||..+|++||++.+++.
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 2234456899999999999999999998874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=335.51 Aligned_cols=254 Identities=29% Similarity=0.439 Sum_probs=200.0
Q ss_pred HhccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCCeeeecccccCcc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~ 519 (782)
..++|.+.++||+|+||.||+|.+. +..||||+++... ......+.+|+.+|.++. ||||++++|+|....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999863 2479999997643 223456889999999997 999999999997654
Q ss_pred --EEEEEeCCCCChhHHHhhcCC---------------------------------------------------------
Q 040785 520 --IIVYEYLANGSLDDRIFRRGN--------------------------------------------------------- 540 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 540 (782)
++||||+++|+|.+++.+...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 899999999999999975421
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEE
Q 040785 541 --------------------------------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582 (782)
Q Consensus 541 --------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 582 (782)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 134788889999999999999999998 999999999999
Q ss_pred EcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH
Q 040785 583 LDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV 661 (782)
Q Consensus 583 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~ 661 (782)
++.++.+||+|||+++.+.... .........|+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDS---NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EeCCCEEEEEecCcceeccccc---ccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999998653211 1111223457889999999988889999999999999999998 89999644322
Q ss_pred H---HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 662 E---RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 662 ~---~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
+ ..+..+. .+ ..|...+..+.+|+.+||..+|..||++.+++. .|+.
T Consensus 349 ~~~~~~~~~~~-----~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~-~L~~ 398 (401)
T cd05107 349 EQFYNAIKRGY-----RM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH-LVGD 398 (401)
T ss_pred HHHHHHHHcCC-----CC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHH
Confidence 2 1122221 11 123334567999999999999999999998873 4444
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=317.96 Aligned_cols=249 Identities=29% Similarity=0.408 Sum_probs=198.5
Q ss_pred hccccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... ......+.+|+.+|..++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3468889999999999999998742 579999987543 233557889999999999999999999986544
Q ss_pred EEEEEeCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 520 IIVYEYLANGSLDDRIFRRGN-------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999865422 234789999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGT 669 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~ 669 (782)
|||+++.+.... .........+|..|+|||++.++.++.++|||||||++|||++ |..||....... ..+..+.
T Consensus 162 dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 162 DFGMTRDIYETD---YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred CcccchhhccCc---ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 999998653211 1111233457889999999988899999999999999999998 999996433221 1122111
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....|...+..+.+++.+||..+|++||++.+++.
T Consensus 239 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 --------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11223334567999999999999999999988873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=318.11 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=196.0
Q ss_pred hccccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--c
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--G 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~ 519 (782)
+++|.+.+.||+|+||.||+|.+.+ ..|++|.+.... ......|.+|+.+++.++||||+++++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568999999999999999998843 578999886543 23345689999999999999999999987554 3
Q ss_pred EEEEEeCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC---ceeee
Q 040785 520 IIVYEYLANGSLDDRIFRRGN----TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY---VSKIS 592 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~---~~kL~ 592 (782)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 899999999999999876532 135899999999999999999999999 99999999999998654 68999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGT 669 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~ 669 (782)
|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+
T Consensus 162 dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~- 237 (277)
T cd05036 162 DFGMARDIYRASY---YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG- 237 (277)
T ss_pred cCccccccCCccc---eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999986622110 011112234568999999999999999999999999999997 999996543222 111111
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....|...+..+.+++.+||+.+|++||++.+++.
T Consensus 238 -------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 238 -------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111223445567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=358.69 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=196.9
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC----ccE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE----YGI 520 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 520 (782)
..+.|.+.+.||+|+||.||+|.+ .+..||+|++.... ......|..|+.+|..|+|||||+++++|.+ ..|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 446799999999999999999998 45689999987542 2345678999999999999999999998732 238
Q ss_pred EEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCceEEEcC----------
Q 040785 521 IVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKP----EPLVHRDLKPGNILLDH---------- 585 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~iiHrDLKp~NILld~---------- 585 (782)
|||||+++|+|.++|... .....+++..++.|+.||+.||.|||+.++ .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999988653 222459999999999999999999998542 34999999999999964
Q ss_pred -------CCceeeeccccccccccccccccccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 040785 586 -------NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLITAKQPMG 656 (782)
Q Consensus 586 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~Pf~ 656 (782)
.+.+||+|||++..+... .......||+.|+|||++.+ ..++.++||||||||||+|++|..||.
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIE------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccCCCCceEEccCCcccccccc------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 345899999999865321 11234579999999998864 458999999999999999999999996
Q ss_pred ChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 657 LTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 657 ~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
........+..... ...... ...+..+.+||..||..+|.+||++.++|..
T Consensus 245 ~~~~~~qli~~lk~--~p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 245 KANNFSQLISELKR--GPDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cCCcHHHHHHHHhc--CCCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 54433322221110 001111 1234568999999999999999999999853
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.60 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=192.5
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.|+..+.||+|+||.||++.. ++..||||+++... ......+.+|+.++..++||||+++++.+.+.. |+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 588899999999999999988 56789999997532 223456788999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999886543 4899999999999999999999999 9999999999999999999999999987552210
Q ss_pred ccc------------------------------cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCC
Q 040785 605 ENV------------------------------TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654 (782)
Q Consensus 605 ~~~------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P 654 (782)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 000 00011245799999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC---hHHhh
Q 040785 655 MGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD---LGKVV 711 (782)
Q Consensus 655 f~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs---~~~vl 711 (782)
|..................+ ..+.. ......+.+|+.+|+. +|.+|++ +.+++
T Consensus 236 f~~~~~~~~~~~i~~~~~~~--~~p~~-~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 236 FCSETPQETYRKVMNWKETL--VFPPE-VPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCHHHHHHHHHcCCCce--ecCCC-CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 97554433211111100000 01110 1134457888888774 9999996 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=321.49 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.+|+..+.||.|+||.||+|.+ ++..|++|.+..........+.+|+.+++.++||||+.++++|.... ++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588899999999999999986 67799999987654455677889999999999999999999986544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++... .+++.++..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 169 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-- 169 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence 999999987432 4899999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......|+..|+|||.+.+..++.++|||||||++|+|++|+.||................ .+. ...+...+
T Consensus 170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~---~~~-~~~~~~~~ 242 (296)
T cd06655 170 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TPE-LQNPEKLS 242 (296)
T ss_pred ---ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---Ccc-cCCcccCC
Confidence 11233568999999999988889999999999999999999999997665443322111100 011 11223344
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
..+.+|+.+||..+|.+||++.+++.+.+-+
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 5688999999999999999999998655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.11 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=198.7
Q ss_pred HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 447 ~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
+.+++++.....||+|+||.||+|.+ ++..|++|.+........+.+.+|+.+++.++||||+++++++.... ++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34566677778999999999999987 45689999987766666778999999999999999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeeccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARLVP 601 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~~~ 601 (782)
|||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999875432111278888999999999999999999 999999999999976 6799999999987653
Q ss_pred cccccccccccccccCCcccCChhhhhcCC--CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
.. ........|+..|+|||++.... ++.++|||||||++|+|++|+.||.............. ......
T Consensus 161 ~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~ 231 (268)
T cd06624 161 GI-----NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----MFKIHP 231 (268)
T ss_pred cC-----CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh----hhccCC
Confidence 21 11122346889999999986654 78999999999999999999999964322111111000 001112
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..|......+.+|+.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 234445567899999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=317.83 Aligned_cols=244 Identities=31% Similarity=0.440 Sum_probs=196.1
Q ss_pred ccccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLAN 528 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 528 (782)
++|.+.++||+|+||.||+|.+. ...||+|++.... .....|.+|+++++.++||||+++++.+.+.. ++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 45899999999999999999874 3479999997543 23467899999999999999999999875444 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~--- 157 (262)
T cd05071 85 GSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--- 157 (262)
T ss_pred CcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc---
Confidence 99999986542 235789999999999999999999999 99999999999999999999999999976532111
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
.......++..|+|||+..++.++.++|||||||++|+|++ |..||....... ..+..+. ....+...
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~ 228 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCPPEC 228 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC--------CCCCcccc
Confidence 11123456778999999988899999999999999999999 888996543221 1111111 01112344
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+..+.+++.+|++.+|++||++.+++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~ 254 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQ 254 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHH
Confidence 56789999999999999999998887
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.27 Aligned_cols=243 Identities=27% Similarity=0.407 Sum_probs=194.6
Q ss_pred cccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
.|+..+.||+|+||.||+|.+. +..+|+|++..... ....|.+|+++++.++||||+++++++.+.. ++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3778889999999999999874 45799999865422 3456889999999999999999999886554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++..... .+++..+..|+.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~---- 154 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---- 154 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc----
Confidence 999998865442 5899999999999999999999999 9999999999999999999999999997653211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHH--HHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERS--IENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........++..|+|||++.+..++.++|||||||++|+|++ |..||......... +..+ ..+ ..+...
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~---~~~~~~ 226 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-----YRL---YRPKLA 226 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-----CcC---CCCCCC
Confidence 111112234568999999998899999999999999999999 89999654332211 1111 111 122334
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..+.+++.+||..+|++||++.+++.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 557999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=315.14 Aligned_cols=253 Identities=26% Similarity=0.327 Sum_probs=198.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCC-eeeecccccC--------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPN-MVLLLGACPE-------- 517 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~-------- 517 (782)
..|..+++||+|+||+||+|+. ++..||+|.++.+... ......+|+.+|..|+|+| |+.|++++..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3477788899999999999997 6779999999876442 3445689999999999999 9999999843
Q ss_pred ccEEEEEeCCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 YGIIVYEYLANGSLDDRIFRRGNT-PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..++|+||+.. +|..++...... ..++...+..++.||+.||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 23799999954 888888665422 34777889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~ 671 (782)
|+.+.- .....+..++|.+|.|||++.+. .|++..||||+|||++||+++++-|......+.... -|+..
T Consensus 167 Ara~~i-----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSI-----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcC-----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 985521 23335677899999999998877 699999999999999999999999965544333221 23333
Q ss_pred ccCCCCCC----------CCC------hhH---HHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVT----------DWP------FEE---TLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~----------~~p------~~~---~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+...|.+. .|+ ... .....+++.+|++.+|..|.++...|.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 22223221 121 011 135789999999999999999988874
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=314.46 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=199.1
Q ss_pred ccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCc------hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDA------AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
|...+.||.|+||.||+|.. ++..+|||.+.... ......+.+|+++|+.++||||++++++|.+.. ++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 77788999999999999987 67789999986432 112356889999999999999999999986654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++.+.. ++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999986543 4789999999999999999999999 999999999999999999999999998865321
Q ss_pred cccc-cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 604 AENV-TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 604 ~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.... .........|+..|+|||++.+..++.++|||||||++|+|++|..||..................+ + ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~---~~~ 231 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-P---RLP 231 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-C---CCC
Confidence 1110 1112234568999999999998889999999999999999999999997554433322222111111 1 122
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 334556899999999999999999998874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.16 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=202.2
Q ss_pred cHHHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeeccccc--
Q 040785 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACP-- 516 (782)
Q Consensus 442 ~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~-- 516 (782)
.++.+..+.++|++.+.||+|+||.||++.+ .++.+|+|++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3445556778899999999999999999988 56789999986532 2235688999999999 6999999999873
Q ss_pred -----CccEEEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCcee
Q 040785 517 -----EYGIIVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSK 590 (782)
Q Consensus 517 -----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~k 590 (782)
...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 1238999999999999887542 22345889999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccccccccccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH
Q 040785 591 ISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI 665 (782)
Q Consensus 591 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~ 665 (782)
|+|||+++..... ........|++.|+|||++.. ..++.++|||||||++|+|++|+.||..........
T Consensus 165 l~dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 165 LVDFGVSAQLTST-----RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred EccCCceeecccC-----CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 9999998765321 112234579999999998753 457899999999999999999999997655443322
Q ss_pred HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 666 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..... ..+.. ..+...+..+.+|+.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~---~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 KIPRN---PPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hcccc---CCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 21111 11111 1122233468999999999999999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.56 Aligned_cols=252 Identities=30% Similarity=0.452 Sum_probs=199.6
Q ss_pred hccccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 519 (782)
.++|+..+.||+|+||.||++...+ ..+|+|.+.... ......+.+|++++..+ +||||++++++|....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4568899999999999999998632 479999987642 23345688999999999 8999999999986654
Q ss_pred -EEEEEeCCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC
Q 040785 520 -IIVYEYLANGSLDDRIFRR-------------GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH 585 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~ 585 (782)
+++|||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 8999999999999998653 22346899999999999999999999999 999999999999999
Q ss_pred CCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--
Q 040785 586 NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE-- 662 (782)
Q Consensus 586 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~-- 662 (782)
++.+||+|||+++.+.... .........++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHID---YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred CCeEEeCcccccccccccc---ceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999998663211 1111122345678999999988899999999999999999997 999996543322
Q ss_pred HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 663 RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 663 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
..+..+. ....+...+..+.+|+.+||..+|.+||++.+++. .|.
T Consensus 245 ~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~-~l~ 289 (293)
T cd05053 245 KLLKEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE-DLD 289 (293)
T ss_pred HHHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH-HHH
Confidence 2222211 11223344567999999999999999999999884 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.72 Aligned_cols=240 Identities=29% Similarity=0.425 Sum_probs=190.4
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
+.||+|+||.||+|.+ +++.||+|.+.... ......|.+|+++++.++||||++++++|.... ++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999987 67889999886542 334567899999999999999999999986554 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~ 152 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV---YAST 152 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc---cccc
Confidence 99886543 35899999999999999999999999 9999999999999999999999999987542110 0000
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
.....++..|+|||++.++.++.++|||||||++|+|++ |..||...... ...+..+. . ...+...+..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~ 224 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-----R---LPCPELCPDA 224 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-----C---CCCcccCCHH
Confidence 111233567999999999999999999999999999998 99999643322 12222111 1 1223334557
Q ss_pred HHHHHHHhhccCcCCCCChHHhhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+|+.+||..+|++||++.+++.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.59 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=196.8
Q ss_pred cccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
+|...++||+|+||.||++.. ++..+|+|.+..........|.+|++++..++||||+++++++.+.. +++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 477788999999999999964 34579999987665566678999999999999999999999886544 899
Q ss_pred EEeCCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCcee
Q 040785 523 YEYLANGSLDDRIFRRGN------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSK 590 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~k 590 (782)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence 999999999999875432 134889999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHh
Q 040785 591 ISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIEN 667 (782)
Q Consensus 591 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~ 667 (782)
|+|||++....... .........+++.|+|||++.+..++.++|||||||++|+|++ |.+||........ .+..
T Consensus 163 L~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 163 IGDFGMSRDIYSTD---YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred ECCCCceeEcCCCc---eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999997653211 1111223346788999999998999999999999999999998 9999954433221 1112
Q ss_pred CcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 668 GTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 668 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+.. ...+...+..+.+|+.+||..+|.+||++.+++
T Consensus 240 ~~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~ 275 (280)
T cd05092 240 GRE--------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIH 275 (280)
T ss_pred Ccc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 111 111223445689999999999999999998887
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=347.12 Aligned_cols=251 Identities=24% Similarity=0.281 Sum_probs=188.6
Q ss_pred HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCC------CeeeecccccCc
Q 040785 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP------NMVLLLGACPEY 518 (782)
Q Consensus 447 ~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hp------nIv~l~g~~~~~ 518 (782)
...+++|.+.++||+|+||+||+|.+ .+..||||+++... .....+..|+.++..++|. +++.++++|...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 34567899999999999999999987 56789999996532 2234566788888777654 588888887543
Q ss_pred ---cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCC-------
Q 040785 519 ---GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNY------- 587 (782)
Q Consensus 519 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~------- 587 (782)
.|+||+++ +++|.+++.+.+ .+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 38999988 778888886543 48999999999999999999997 58 99999999999998765
Q ss_pred ---------ceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh
Q 040785 588 ---------VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT 658 (782)
Q Consensus 588 ---------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~ 658 (782)
.+||+|||++.... ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~--------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER--------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccCCCCceEEECCCCccccCc--------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999886431 1224568999999999999999999999999999999999999999654
Q ss_pred HHHHHH--HH--hCccc-------------------ccCCCCCCC---------CC---hhHHHHHHHHHHHhhccCcCC
Q 040785 659 HFVERS--IE--NGTLG-------------------EMLDPTVTD---------WP---FEETLGFAKLALQCSELRRKD 703 (782)
Q Consensus 659 ~~~~~~--~~--~~~~~-------------------~~ld~~~~~---------~p---~~~~~~l~~li~~cl~~~P~~ 703 (782)
...+.. +. .|.+. ..+.+.... .+ ......+.+||.+||..||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 322111 00 01000 000010000 00 011234789999999999999
Q ss_pred CCChHHhhhH
Q 040785 704 RPDLGKVVLP 713 (782)
Q Consensus 704 RPs~~~vl~~ 713 (782)
||++.++|.+
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999853
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.98 Aligned_cols=239 Identities=26% Similarity=0.419 Sum_probs=190.5
Q ss_pred eeeeeCcEeEEEEEEC----CeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCCCCh
Q 040785 458 KIGEGGYGPVYKCYLD----HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLANGSL 531 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~gsL 531 (782)
.||+|+||.||+|.+. +..||+|++..... ...+.|.+|+.++++++||||++++++|.... ++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999763 34699999976532 33467899999999999999999999986544 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........ ....
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~ 154 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKA 154 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc--ceec
Confidence 99886443 35899999999999999999999999 99999999999999999999999999986532111 1111
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+.. ...+...+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 226 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR--------LDCPAECPPE 226 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------CCCCCCCCHH
Confidence 122334678999999988889999999999999999996 999996543322 22222211 1223344567
Q ss_pred HHHHHHHhhccCcCCCCChHHhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+.+++.+||..+|++||++.++.
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~ 249 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVE 249 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHH
Confidence 99999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.83 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=196.4
Q ss_pred HhccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG- 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 519 (782)
..++|++.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999753 3479999886543 223446788999999999999999999886544
Q ss_pred -EEEEEeCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN-------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
|+||||+++|+|.+++..... .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999975321 244677888999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCcc
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTL 670 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 670 (782)
+|||+++...... .........++..|+|||++.++.++.++|||||||++|||++ |..||........ ...
T Consensus 161 ~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~-~~~--- 233 (288)
T cd05061 161 GDFGMTRDIYETD---YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-LKF--- 233 (288)
T ss_pred CcCCccccccccc---cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH---
Confidence 9999998653211 1111122345778999999998899999999999999999998 7889965443221 110
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 671 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+.+......+...+..+.+++.+||+.+|++||++.+++
T Consensus 234 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 272 (288)
T cd05061 234 --VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272 (288)
T ss_pred --HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 011111122333456799999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.34 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=193.2
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
..++|.+.+.||+|+||.||+|.+ ++..||+|++.... ......+.+|+.++..++||||+++++++.+.. |+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 346799999999999999999998 46689999986421 223455788999999999999999999986554 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999988543 3788899999999999999999999 9999999999999999999999999998653
Q ss_pred cccccccccccccccCCcccCChhhhhcC----CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLD 675 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld 675 (782)
.. .........||+.|+|||++... .++.++|||||||++|||++|..||......... +.... ..
T Consensus 194 ~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~-- 265 (371)
T cd05622 194 KE----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NS-- 265 (371)
T ss_pred cC----CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--Cc--
Confidence 21 11122356799999999988653 3789999999999999999999999765543211 11111 00
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCC--CCChHHhhhH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKD--RPDLGKVVLP 713 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPs~~~vl~~ 713 (782)
...+. +...+..+.+++..|+...+.+ ||++.+++.+
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 01111 1234556889999999844433 7788877743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=320.06 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=197.8
Q ss_pred ccccccceeeeeCcEeEEEEEECC------------------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeee
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH------------------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLL 511 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~------------------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 511 (782)
..|.+.+.||+|+||.||+|.+.. ..||+|.+.... ......|.+|++++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 458889999999999999998632 358999987653 2346678999999999999999999
Q ss_pred cccccCcc--EEEEEeCCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceE
Q 040785 512 LGACPEYG--IIVYEYLANGSLDDRIFRRGN--------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNI 581 (782)
Q Consensus 512 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NI 581 (782)
+++|.... ++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 99986543 899999999999999876431 225899999999999999999999999 99999999999
Q ss_pred EEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh--CCCCCCChH
Q 040785 582 LLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT--AKQPMGLTH 659 (782)
Q Consensus 582 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~Pf~~~~ 659 (782)
|++.++.++|+|||+++...... .........++..|+|||++.++.++.++|||||||++|+|++ |..||....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSD---YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eecCCCceEEccccceeecccCc---ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999987653211 1112234456789999999988899999999999999999998 778886543
Q ss_pred HHHHHHHhCcc-cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 660 FVERSIENGTL-GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 660 ~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
........... ...-.......+...+..+.+++.+||..+|.+||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 22211111100 00000111112333446799999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.38 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=193.4
Q ss_pred ccccccceeeeeCcEeEEEEEEC--Ce--eEEEEEecCC-chhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HT--PVAVKVLRPD-AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~--~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|++.+.||+|+||.||+|.+. +. .+++|.+... .......|.+|++++.++ +||||++++++|.+.. ++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 35888899999999999999873 33 4677777543 233456788999999999 8999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 523 YEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999875431 235899999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhC
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENG 668 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 668 (782)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|+| |..||........ ....
T Consensus 164 kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKL 236 (303)
T ss_pred EeCccccCcccchh------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-HHHH
Confidence 99999998643110 11112234678999999988889999999999999999998 9999964433221 1111
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
. ... ....+...+..+.+|+.+||..+|++||++.+++..
T Consensus 237 ~--~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 P--QGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred h--cCC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 000 111122334568999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=322.00 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=200.2
Q ss_pred hccccccceeeeeCcEeEEEEEECC---------eeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH---------TPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 518 (782)
.+.|.+.+.||+|+||.||++.+.+ ..+|+|.+.... ......+.+|++++..+ +||||++++++|.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3569999999999999999997522 369999997652 33456788999999999 799999999998655
Q ss_pred c--EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
. ++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 4 899999999999999976432 124899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE 662 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~ 662 (782)
+.++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred cCCCcEEECCCcccccccccc---hhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999987653211 0011112234568999999988899999999999999999998 889986544321
Q ss_pred --HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 663 --RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 663 --~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+..+. ....+...+..+.+|+.+||..+|.+||++.+++. .|..+.
T Consensus 251 ~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~-~l~~~~ 300 (307)
T cd05098 251 LFKLLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRIL 300 (307)
T ss_pred HHHHHHcCC--------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH-HHHHHH
Confidence 1122211 11223344567899999999999999999998874 555544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.37 Aligned_cols=250 Identities=29% Similarity=0.380 Sum_probs=202.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
++|...+.||.|+||.||+|.. +++.+++|++........+.+.+|+.+++.++||||+++++++.+.. |++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4688999999999999999987 46789999998765556678999999999999999999999886544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.... ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999886542 34899999999999999999999999 9999999999999999999999999997653211
Q ss_pred ccccccccccCCcccCChhhhhcC---CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTG---MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.......|+..|+|||++.+. .++.++|||||||++|+|++|..||.............. .. +.+.....+.
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~~ 230 (262)
T cd06613 156 ---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SN-FPPPKLKDKE 230 (262)
T ss_pred ---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cc-CCCccccchh
Confidence 122345688899999998776 789999999999999999999999976543332221111 10 1111111223
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 44567999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=314.28 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=198.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh---------hHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ---------GRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
|.....||.|+||.||+|.+ .++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 67778999999999999987 5678999988654221 1256889999999999999999999986544
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.++|+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 89999999999999886543 4889999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccc-cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCC
Q 040785 600 VPAVAENV-TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTV 678 (782)
Q Consensus 600 ~~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 678 (782)
........ .........|+..|+|||++.++.++.++|||||||++|+|++|+.||.............. ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-- 230 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NASP-- 230 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---cCCC--
Confidence 64211110 11112234688999999999888899999999999999999999999976544333222111 1111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 -EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 223344566899999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.45 Aligned_cols=252 Identities=26% Similarity=0.299 Sum_probs=194.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.|+..+.||.|+||.||+|.. ++..||||.+..... .....+.+|+.++..++||||+++++++.+.. |+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 378889999999999999988 567899999865422 22456889999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++ ++|.+.+........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 97 688888765544456899999999999999999999999 999999999999999999999999998754221
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Ccccc--------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTLGE-------- 672 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~~-------- 672 (782)
........|++.|+|||++.+. .++.++|||||||++|+|+||++||............ +....
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 ---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1112334678999999987654 4789999999999999999999999754332211110 00000
Q ss_pred ----------cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 673 ----------MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 673 ----------~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.............+.++.+++.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000011123456789999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.81 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=201.1
Q ss_pred hccccccceeeeeCcEeEEEEEEC------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccC---cc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YG 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~ 519 (782)
.++|...+.||+|+||.||+|.+. +..|++|.+.... ......+.+|+.++..+.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 456888999999999999999974 4689999987542 3345678899999999999999999998754 34
Q ss_pred EEEEEeCCCCChhHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNT-----PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DF 594 (782)
+++++|+++|+|.+++...... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998664322 46899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHH--HHhCccc
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERS--IENGTLG 671 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~--~~~~~~~ 671 (782)
|+++.+.... .........++..|+|||++.+..++.++|||||||++||+++ |+.||......... +..+.
T Consensus 162 g~~~~~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-- 236 (280)
T cd05043 162 ALSRDLFPMD---YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-- 236 (280)
T ss_pred CCcccccCCc---eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC--
Confidence 9998653211 1111123456778999999988889999999999999999999 99999754332211 11111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.. ..+...+..+.+++.+||..+|++||++.+++ ..|..+
T Consensus 237 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~-~~l~~~ 276 (280)
T cd05043 237 ---RL---AQPINCPDELFAVMACCWALDPEERPSFSQLV-QCLTDF 276 (280)
T ss_pred ---CC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH-HHHHHH
Confidence 11 11223345689999999999999999998887 355444
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=312.54 Aligned_cols=245 Identities=26% Similarity=0.382 Sum_probs=195.6
Q ss_pred ceeeeeCcEeEEEEEECC---e--eEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYLDH---T--PVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~---~--~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~g 529 (782)
+.||+|+||.||+|.+.. + .||||.+..... ...+.|.+|+.++++++||||+++++.+.+.. ++||||+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 368999999999998732 2 699999987655 55678999999999999999999999887633 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.+.+..... ..+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.+...... .
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~ 154 (257)
T cd05040 81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--Y 154 (257)
T ss_pred cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc--e
Confidence 99999876543 45899999999999999999999999 999999999999999999999999999876432111 1
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||......+......... .....+...+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 229 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-----ERLERPEACPQD 229 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----CcCCCCccCCHH
Confidence 11123467889999999998899999999999999999999 999996443322111111100 011122334567
Q ss_pred HHHHHHHhhccCcCCCCChHHhhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 230 IYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHCCCCcccCCCHHHHHH
Confidence 999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.35 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=197.4
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+|+..+.||+|+||.||++.+ .+..||+|.+... .......+.+|++++.+++||||+++++++.... ++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 478889999999999999998 4779999988654 2233567889999999999999999999886544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++++|..++........+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999998888654333468999999999999999999996 47 99999999999999999999999999876521
Q ss_pred cccccccccccCCcccCChhhhhcC------CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG------MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
.......|+..|+|||++.+. .++.++|||||||++|+|++|+.||.......... .+..+.+....
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~ 228 (286)
T cd06622 156 ----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---QLSAIVDGDPP 228 (286)
T ss_pred ----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---HHHHHhhcCCC
Confidence 112234688899999987544 35889999999999999999999996433221110 00111111122
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
..+...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 33444566789999999999999999999988543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=312.40 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=198.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+|.+.+.||.|+||.||++.. ++..+|+|.++.. .....+.+.+|+.+++.++||||+++++.+.+.. |+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 377889999999999999987 5678999998643 2334567889999999999999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+.+.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--- 153 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--- 153 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc---
Confidence 9999998875432 345889999999999999999999999 999999999999999999999999999765321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCCCChh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~p~~ 684 (782)
........|++.|+|||++.+..++.++||||||+++|+|++|..||......... +..+... ..+..
T Consensus 154 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 223 (255)
T cd08219 154 --GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--------PLPSH 223 (255)
T ss_pred --ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------CCCcc
Confidence 11123456899999999998888999999999999999999999999765543322 2222211 11223
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+.+|+.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 3456899999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.33 Aligned_cols=244 Identities=29% Similarity=0.455 Sum_probs=197.5
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLAN 528 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 528 (782)
+.|.+.++||.|+||.||+|.. +++.||+|.+..... ....|.+|+.+++.++||||+++++++.... +++|||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 4588999999999999999987 567899999876432 3467899999999999999999999875443 999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+++.... ...+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---- 156 (260)
T cd05067 85 GSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE---- 156 (260)
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC----
Confidence 99999886543 345899999999999999999999999 9999999999999999999999999997653211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........++..|+|||++..+.++.++|||||||++|+|++ |+.||....... ..+..+. .. ..+...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~~ 228 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-----RM---PRPDNC 228 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-----CC---CCCCCC
Confidence 111123356778999999998999999999999999999999 999996443322 1121111 11 112223
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+..+.+++.+||+.+|++||++.+++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLR 254 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHH
Confidence 45699999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.54 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=195.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+|.+.+.||+|+||.||++.+ ++..+|+|.+.... ......+.+|++++..++||||++++++|.+.. |+||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 588999999999999999988 45678999987542 233456889999999999999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++++|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 82 DGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999998654 348899999999999999999998 46 999999999999999999999999998755221
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCccc-ccCCC--------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLG-EMLDP-------- 676 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~ld~-------- 676 (782)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||................ ....+
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 -----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred -----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence 1233578999999999888889999999999999999999999995433211110000000 00000
Q ss_pred ---------------------CCCCCC-hhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 677 ---------------------TVTDWP-FEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 677 ---------------------~~~~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
..+..| ...+..+.+|+.+||..+|++||++.+++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000001 11345689999999999999999999998544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.72 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=199.6
Q ss_pred ccccccceeeeeCcEeEEEEEECC-----eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH-----TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 523 (782)
++|...+.||+|+||.||+|.+.. ..|+||...... ....+.|.+|+.+++.+.||||++++++|.+.. ++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 347888999999999999998732 369999987654 445668999999999999999999999886554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999986543 24899999999999999999999999 999999999999999999999999999865322
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHH--HHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERS--IENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~ 680 (782)
.....+...++..|+|||++....++.++|||||||++|+|++ |..||......... +..+. .. .
T Consensus 161 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----~~---~ 228 (270)
T cd05056 161 ----SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-----RL---P 228 (270)
T ss_pred ----cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----cC---C
Confidence 1111223345678999999888889999999999999999996 99999655433221 21211 01 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+...+..+.+++.+|+..+|.+||++.+++ ..|..+
T Consensus 229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~-~~l~~~ 265 (270)
T cd05056 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELK-AQLSDI 265 (270)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH-HHHHHH
Confidence 2234455799999999999999999998876 344444
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.69 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=194.7
Q ss_pred cccccceeeeeCcEeEEEEEEC--C---eeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--H---TPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~---~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.|...+.||+|+||.||+|.+. + ..||||++... .......|..|+.+++.+.||||+++++++.+.. ++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4788899999999999999873 2 35999998764 2334568999999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999886543 34899999999999999999999999 999999999999999999999999998866322
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
.............++..|+|||++.++.++.++|||||||++|||++ |..||....... ..+... .. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-----~~---~~ 231 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-----YR---LP 231 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-----Cc---CC
Confidence 11111111111122457999999999999999999999999999886 999996543322 111111 00 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.+.+..+.+++.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12344556899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.12 Aligned_cols=241 Identities=30% Similarity=0.463 Sum_probs=198.9
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.|...+.||.|+||.||+|...++.||||.+..... ..+.+.+|+.++..++||||+++++++.+.. ++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3588889999999999999999999999999976644 4678999999999999999999999986433 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----- 155 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----- 155 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc-----
Confidence 999998865542 35899999999999999999999999 999999999999999999999999999865211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
.....++..|+|||++.++.++.++||||||+++|+|++ |..||....... ..+..+. .+ ..+...
T Consensus 156 ---~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~~ 224 (256)
T cd05039 156 ---QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-----RM---EAPEGC 224 (256)
T ss_pred ---cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----CC---CCccCC
Confidence 112345678999999988899999999999999999997 999996554322 1111111 11 112334
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..+.+++.+||..+|++||++.+++.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 456899999999999999999988873
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=317.72 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=198.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.|+..+.||.|+||.||+|.+ .+..||+|.+.... ......+.+|+.+++.++||||++++++|.... |+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 377788999999999999987 56789999987543 334567899999999999999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+.+.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 99999988743 34889999999999999999999999 9999999999999999999999999997653211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||........... +. .......+...+
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~~---~~~~~~~~~~~~ 226 (277)
T cd06642 156 ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---IP---KNSPPTLEGQYS 226 (277)
T ss_pred ---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---hh---cCCCCCCCcccC
Confidence 112234688999999999988899999999999999999999999964432221111 00 111112233445
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
..+.+++.+||..+|.+||++.+++.+.+
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 67899999999999999999999996543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.53 Aligned_cols=242 Identities=35% Similarity=0.517 Sum_probs=197.9
Q ss_pred ceeeeeCcEeEEEEEEC-----CeeEEEEEecCCchhh-HHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|... +..|++|++....... ...+.+|+.++..++||||+++++++.... ++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999984 6689999998764433 678899999999999999999999986644 899999999
Q ss_pred CChhHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 529 GSLDDRIFRRGN------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 529 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999876521 256999999999999999999999999 99999999999999999999999999987643
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
... ........++..|+|||.+....++.++|||||||++|+|++ |..||....... ..+..+ ...
T Consensus 158 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~ 226 (262)
T cd00192 158 DDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------YRL 226 (262)
T ss_pred ccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------CCC
Confidence 211 122234567889999999988899999999999999999999 699997654322 111111 111
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+...+..+.+++.+||..+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence 223444567999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.65 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=191.6
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccC-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPE------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 517 (782)
..++|...+.||.|+||.||+|.+ ++..||||++..... .....+.+|+.+|+.++||||++++++|..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456799999999999999999987 566899999875422 234567799999999999999999988742
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 137899987 7889877642 24899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---H-hCcc-
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---E-NGTL- 670 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~-~~~~- 670 (782)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... . .+..
T Consensus 165 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred ceecCC--------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 986521 1234578999999998876 568999999999999999999999996543322110 0 0000
Q ss_pred cccC-----------CCCCCCCCh--------hHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 671 GEML-----------DPTVTDWPF--------EETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 671 ~~~l-----------d~~~~~~p~--------~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+ ...+...+. .....+.+|+.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000011111 122347899999999999999999998853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.50 Aligned_cols=248 Identities=31% Similarity=0.486 Sum_probs=199.6
Q ss_pred cccccceeeeeCcEeEEEEEEC---C---eeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD---H---TPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GI 520 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~---~---~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~ 520 (782)
+-...++||+|+||.||+|.+. + ..||||..+.. ....+..|.+|+++|+.++|||||+|||++... .+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 3444589999999999999872 2 23899998852 345678899999999999999999999998544 49
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
||||+|+||+|.++|.+.+. .++..++..++.+.|.||+|||+++ +|||||-..|+|++.++.+||+||||++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999987764 4899999999999999999999999 999999999999999999999999998754
Q ss_pred ccccccccccccc--cccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHH-HhCcccccC
Q 040785 601 PAVAENVTQYHLT--STAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSI-ENGTLGEML 674 (782)
Q Consensus 601 ~~~~~~~~~~~~~--~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~-~~~~~~~~l 674 (782)
. .+... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||....... ..+ ..+..
T Consensus 313 ~-------~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r---- 381 (474)
T KOG0194|consen 313 S-------QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR---- 381 (474)
T ss_pred c-------ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc----
Confidence 2 11111 1124568999999999999999999999999999999 889997655432 222 22221
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
...|...+..+..++.+||..+|++||+|.++. ..+..+..
T Consensus 382 ----~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~-~~l~~~~~ 422 (474)
T KOG0194|consen 382 ----MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK-KKLEALEK 422 (474)
T ss_pred ----CCCCCCCHHHHHHHHHHhccCChhhccCHHHHH-HHHHHHHh
Confidence 122335566788999999999999999998887 35555443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.45 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=200.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.+|...+.||.|+||.||+|.. ++..||+|.+..........+.+|+.+++.++||||++++++|.... |+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4588899999999999999987 57899999997655555667889999999999999999999986544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.+. .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--- 168 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 168 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC---
Confidence 999999988542 3789999999999999999999999 999999999999999999999999998765321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........|++.|+|||++.+..++.++|||||||++|+|++|..||............... -.+. ...+...+
T Consensus 169 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~---~~~~-~~~~~~~~ 242 (297)
T cd06656 169 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---GTPE-LQNPERLS 242 (297)
T ss_pred --ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC---CCCC-CCCccccC
Confidence 11123456889999999999888999999999999999999999999654432221111100 0011 11233344
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+.+|+.+||..+|.+||++.+++.+
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 568899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.32 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=200.6
Q ss_pred hccccccceeeeeCcEeEEEEEEC---------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 518 (782)
.++|.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+ +||||++++++|...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 345888999999999999999741 2369999987542 33456789999999999 899999999998655
Q ss_pred c--EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
. ++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 4 899999999999999876421 235888999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE 662 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~ 662 (782)
+.++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred cCCCcEEECCCccceeccccc---ccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999998663221 1111223456778999999988889999999999999999998 888886443322
Q ss_pred --HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 663 --RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 663 --~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
..+..+. ....+...+..+.+|+.+||..+|.+||++.+++. .|.++..
T Consensus 248 ~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~-~l~~~~~ 298 (304)
T cd05101 248 LFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE-DLDRILT 298 (304)
T ss_pred HHHHHHcCC--------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH-HHHHHHH
Confidence 1122111 01122344566999999999999999999988874 5555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.92 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=200.5
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+.|+..+.||.|+||.||+|... +..+++|.+..... ...+.+|+++++.++||||+++++.+.+.. |+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 45888999999999999999984 67899999876532 678999999999999999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 9999999886543 35899999999999999999999999 9999999999999999999999999998663211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||............... ..+. ...+....
T Consensus 154 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~ 226 (256)
T cd06612 154 ---AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPT-LSDPEKWS 226 (256)
T ss_pred ---cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCCC-CCchhhcC
Confidence 1123345889999999999889999999999999999999999999755443322221110 0111 11122344
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 56899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.40 Aligned_cols=244 Identities=30% Similarity=0.431 Sum_probs=196.1
Q ss_pred ccccccceeeeeCcEeEEEEEECC-eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLAN 528 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 528 (782)
++|.+...||+|+||.||+|.+.+ ..+|+|.+.... .....|.+|+.+++.++|||++.+++++.... ++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 358888999999999999998844 479999886543 23467889999999999999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~---- 156 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---- 156 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc----
Confidence 99999886543 235899999999999999999999999 9999999999999999999999999997653211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........++..|+|||+..++.++.++|||||||++|+|++ |..||........ .+..+ ..+ ..+...
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~---~~~~~~ 228 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-----YRM---PCPQGC 228 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCC---CCCccc
Confidence 111122346778999999988899999999999999999999 9999965433221 11111 111 122344
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+..+.+++.+||..+|.+||++.+++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~ 254 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQ 254 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHH
Confidence 56799999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.20 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=196.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...+.||.|+||.||+|.. ++..++||.+.... ......|.+|+.+++.+.||||++++++|.+.. +++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 578889999999999999996 67899999886432 223467889999999999999999999886543 89999
Q ss_pred eCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886432 2345899999999999999999999999 999999999999999999999999998765321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
. .......|+..|+|||++.+..++.++||||||+++|+|++|..||............ .+.....+.. .+.
T Consensus 160 ~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~--~~~ 231 (267)
T cd08229 160 T-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEQCDYPPL--PSD 231 (267)
T ss_pred C-----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-hhhcCCCCCC--Ccc
Confidence 1 1122356899999999998888999999999999999999999999543221111100 0111111111 112
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+..+.+++.+||..+|.+||++.+++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~Rpt~~~i~ 259 (267)
T cd08229 232 HYSEELRQLVNMCINPDPEKRPDITYVY 259 (267)
T ss_pred cccHHHHHHHHHhcCCCcccCCCHHHHH
Confidence 3455799999999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.65 Aligned_cols=233 Identities=24% Similarity=0.409 Sum_probs=184.3
Q ss_pred ceeeeeCcEeEEEEEEC--------------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cE
Q 040785 457 RKIGEGGYGPVYKCYLD--------------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GI 520 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~--------------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~ 520 (782)
+.||+|+||.||+|... ...|++|++..........|..|+.++..++||||++++++|... .+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999999852 125899998766555556788999999999999999999998654 48
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc-------eeeec
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV-------SKISD 593 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~-------~kL~D 593 (782)
+||||+++|+|..++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999988775443 34899999999999999999999999 999999999999987664 89999
Q ss_pred cccccccccccccccccccccccCCcccCChhhhh-cCCCCCchhHHHHHHHHHHHH-hCCCCCCChHHHHHH-HHhCcc
Q 040785 594 VGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQLI-TAKQPMGLTHFVERS-IENGTL 670 (782)
Q Consensus 594 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwSlGvil~ell-tG~~Pf~~~~~~~~~-~~~~~~ 670 (782)
||++..... .....|+..|+|||++. +..++.++|||||||++|+|+ +|..||......+.. +..+..
T Consensus 156 ~g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (262)
T cd05077 156 PGIPITVLS---------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226 (262)
T ss_pred CCCCccccC---------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc
Confidence 999875421 12345788999999876 466899999999999999998 588998654332211 111111
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 671 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. .......+.+|+.+||+.+|.+||++.+++.
T Consensus 227 -~~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 227 -ML--------VTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred -cC--------CCCChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 1112346899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=327.49 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=196.1
Q ss_pred ccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc---
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY--- 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~--- 518 (782)
++|.+.+.||+|+||.||+|.+ .++.||||+++... ......+.+|+.+|.++ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688999999999999999974 35689999997643 23345688999999999 689999999988542
Q ss_pred cEEEEEeCCCCChhHHHhhcCC----------------------------------------------------------
Q 040785 519 GIIVYEYLANGSLDDRIFRRGN---------------------------------------------------------- 540 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 540 (782)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 3899999999999998864321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccccccccc
Q 040785 541 ------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS 614 (782)
Q Consensus 541 ------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 614 (782)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.... .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~ 240 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRKGD 240 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCc---chhhcCC
Confidence 124788899999999999999999999 9999999999999999999999999998652211 1112223
Q ss_pred ccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH---HHHHHHhCcccccCCCCCCCCChhHHHHHH
Q 040785 615 TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF---VERSIENGTLGEMLDPTVTDWPFEETLGFA 690 (782)
Q Consensus 615 ~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 690 (782)
..++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+.. +.. |...+..+.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~---~~~~~~~~~ 312 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----MRA---PDYTTPEMY 312 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-----CCC---CCCCCHHHH
Confidence 446778999999988899999999999999999997 9999964322 1222222221 111 112334689
Q ss_pred HHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 691 KLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 691 ~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
+++..||+.+|.+||++.+++. .|..
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~-~l~~ 338 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVE-HLGN 338 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHH-HHHH
Confidence 9999999999999999999874 4443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=319.76 Aligned_cols=245 Identities=27% Similarity=0.373 Sum_probs=191.5
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.|...+.||+|+||.||+|.+ ++..||+|++..+. ......|.+|++++.++.||||++++++|.... ++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 477889999999999999987 56789999986542 333467889999999999999999999986543 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---- 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---- 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc----
Confidence 999986532 3788899999999999999999999 99999999999999999999999999976521
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH-HHhCcccccCCCCCCCCC-hh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS-IENGTLGEMLDPTVTDWP-FE 684 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~ld~~~~~~p-~~ 684 (782)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||......... ........+.+......+ ..
T Consensus 148 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (279)
T cd06619 148 ---SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224 (279)
T ss_pred ---ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCc
Confidence 1123457899999999998888999999999999999999999999532110000 000000000011111111 12
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+..+.+++.+||+.+|+.||++.+++.+
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 34468999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.75 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=195.9
Q ss_pred hccccccceeeeeCcEeEEEEEEC--C---eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--H---TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~---~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
.++|+..+.||+|+||.||+|.+. + ..+|+|.+.... ......+.+|++++..++||||+++++++.... ++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346888999999999999999873 2 269999987652 334567899999999999999999999986554 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++++|.+++.... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999886543 35899999999999999999999999 9999999999999999999999999987653
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 678 (782)
.... ..........+..|+|||++.++.++.++|||||||++|||++ |..||....... ..+..+ ...+
T Consensus 159 ~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~----~~~~-- 230 (268)
T cd05063 159 DDPE--GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG----FRLP-- 230 (268)
T ss_pred cccc--cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC----CCCC--
Confidence 2111 1111112233567999999988889999999999999999997 999995433221 222211 1111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+...+..+.+++.+||..+|++||++.+++.
T Consensus 231 --~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 --APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12234556899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.81 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=197.9
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|...+.||.|+||.||+|.. +++.||+|.++.. .......+.+|++++++++|+||+.+++++.+.. ++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4688899999999999999998 5789999988642 2223567899999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
||+++|+|.+++... .....+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 22345899999999999999999999999 99999999999999999999999999876532
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH----HHHHHhCcccccCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV----ERSIENGTLGEMLDPTV 678 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~~~~~ld~~~ 678 (782)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+..
T Consensus 159 ~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 225 (267)
T cd08224 159 KT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-------- 225 (267)
T ss_pred CC-----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--------
Confidence 11 1122346889999999998888999999999999999999999999543211 111111211
Q ss_pred CCCCh-hHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 679 TDWPF-EETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 679 ~~~p~-~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
...|. ..+..+.+++.+||..+|++||++.+++
T Consensus 226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il 259 (267)
T cd08224 226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259 (267)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 11122 3445689999999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=304.67 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=205.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--------hhHHHHHHHHHHHHhc-CCCCeeeecccccCc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--------QGRSQFQREIEVLSCI-RHPNMVLLLGACPEY 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 518 (782)
.+.|...+.||.|..++|.++.+ ++..+|+|++..... ..++.-.+|+.||+++ .||+|+.|.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 34577788899999999999987 566899999854311 1234456899999998 699999999999776
Q ss_pred c--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
. ++|+|.|+.|.|.|+|... -.+++....+|+.|+..|+.|||.++ ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 5 7899999999999999554 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc------CCCCCchhHHHHHHHHHHHHhCCCCCCChHH--HHHHHHhC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT------GMLGVKSDVYSLGILLLQLITAKQPMGLTHF--VERSIENG 668 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~Pf~~~~~--~~~~~~~~ 668 (782)
++.++. .......|||++|+|||.+.. ..|+..+|+|++|||||.||.|.+||-.... .-..+..|
T Consensus 170 a~~l~~------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 170 ACQLEP------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred eeccCC------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 998753 334567899999999997653 3588899999999999999999999954332 34566777
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
++.- .-+.| .+......+||.+||+.||..|.+..++|.+.+.
T Consensus 244 kyqF----~speW-adis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 244 KYQF----RSPEW-ADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred cccc----CCcch-hhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 6542 12233 3455668999999999999999999999976654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.79 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=195.0
Q ss_pred ccccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----G 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 519 (782)
..|.+.+.||+|+||.||++.+ .+..||+|.++... ......+.+|+.+++.+.||||++++++|.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578899999999999999974 35689999987553 33356789999999999999999999988653 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999886543 24899999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--------------H---
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--------------E--- 662 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--------------~--- 662 (782)
+...... ........|+..|+|||++.+..++.++|||||||++|+|++|+.|+...... .
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 159 IETDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccCccc--eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 6322111 11122355778899999998888999999999999999999988765321110 0
Q ss_pred HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 663 RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 663 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+. ....+...+..+.+|+.+||+.+|++||++.+++.
T Consensus 237 ~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 237 RVLEEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0011111 01112334567999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.31 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=197.2
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 519 (782)
.++|...+.||+|+||.||++.. .+..||||+++... ......+.+|+.+++++ +||||++++++|....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45699999999999999999975 22379999987543 23346789999999999 7999999999986554
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
++||||+++|+|.+++..... ..+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 899999999999998865432 34899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH---HHHHhCcccccC
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE---RSIENGTLGEML 674 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~---~~~~~~~~~~~l 674 (782)
.+.... .........++..|+|||++.++.++.++|||||||++|+|++ |..||....... ..+..+.
T Consensus 190 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~----- 261 (302)
T cd05055 190 DIMNDS---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY----- 261 (302)
T ss_pred cccCCC---ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC-----
Confidence 653221 1111223356788999999998999999999999999999998 999986543221 2222221
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+ ..+...+..+.+++.+||..+|++||++.+++.
T Consensus 262 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01 112233456999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.01 Aligned_cols=249 Identities=31% Similarity=0.479 Sum_probs=197.0
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|...+.||+|+||.||++.+ .++.||+|++.... ......|.+|+.++..+.||||++++++|.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 35688999999999999999986 34689999987643 234567999999999999999999999986544
Q ss_pred EEEEEeCCCCChhHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCce
Q 040785 520 IIVYEYLANGSLDDRIFRRG-------------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGN 580 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~N 580 (782)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986432 1234788999999999999999999999 9999999999
Q ss_pred EEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH
Q 040785 581 ILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH 659 (782)
Q Consensus 581 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~ 659 (782)
||++.++.++|+|||++..+..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY---YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecCCCceEECccccceecccCcc---ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999875522110 011122345677999999988899999999999999999998 888985433
Q ss_pred HHH--HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 660 FVE--RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 660 ~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+ ..+..+.. ...+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 222 22222221 1123344567999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.04 Aligned_cols=239 Identities=29% Similarity=0.460 Sum_probs=191.6
Q ss_pred ceeeeeCcEeEEEEEEC--C---eeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYLD--H---TPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~--~---~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~g 529 (782)
++||+|+||.||+|.+. + ..+|+|.+..... .....+.+|+.+++.+.||||+++++++.... ++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999762 2 5799999976543 24567899999999999999999999886544 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.+++.... .+++..+..++.|++.||.|||..+ |+|+||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~--~~ 152 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD--YY 152 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc--cc
Confidence 9999986554 5899999999999999999999999 99999999999999999999999999986632211 01
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..+..+.. ...+...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 224 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER--------LPRPEECP 224 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--------CCCCCCCC
Confidence 11112234568999999998899999999999999999998 999997544322 22222211 11233445
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhh
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+.+++.+||..+|.+||++.+++
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~ 249 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELE 249 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHH
Confidence 5689999999999999999998887
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.61 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=197.9
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-----AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----G 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 519 (782)
.+|...+.||+|+||.||+|.+ ++..||||.+.... ......+.+|+.++..++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 3588899999999999999987 46789999886431 22345788999999999999999999988542 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 78999999999999886543 3788899999999999999999999 99999999999999999999999999886
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
...... .........|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..+..+
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~~ 228 (265)
T cd06652 156 LQTICL--SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----TQPTNP 228 (265)
T ss_pred cccccc--cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-----cCCCCC
Confidence 532111 1111233468999999999988889999999999999999999999997554333322111 111222
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..|......+.+++.+|+. +|++||++++++.+
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 3345555678899999994 99999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.87 Aligned_cols=256 Identities=28% Similarity=0.425 Sum_probs=194.7
Q ss_pred ccccccceeeeeCcEeEEEEEEC------------------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeee
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD------------------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLL 511 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~------------------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 511 (782)
++|++.++||+|+||.||++... ...||+|++.... ......|.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45888999999999999998642 2368999997543 3345689999999999999999999
Q ss_pred cccccCcc--EEEEEeCCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceE
Q 040785 512 LGACPEYG--IIVYEYLANGSLDDRIFRRGN--------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNI 581 (782)
Q Consensus 512 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NI 581 (782)
++++.... ++||||+++|+|.+++..... ...+++.++..++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99985443 899999999999998875421 124788899999999999999999999 99999999999
Q ss_pred EEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh--CCCCCCChH
Q 040785 582 LLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT--AKQPMGLTH 659 (782)
Q Consensus 582 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~Pf~~~~ 659 (782)
|++.++.++|+|||+++.+.... .....+...+++.|++||+...+.++.++|||||||++|||++ |..||....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGD---YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEcCCCCEEeccCcccccccCCc---ceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999998653211 1111122345678999999888899999999999999999998 778886433
Q ss_pred HHHHHHHhCcc-cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 660 FVERSIENGTL-GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 660 ~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+.....+.. ...........+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22211100000 000000001112234466999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.20 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=203.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccccc-------CccE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP-------EYGI 520 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-------~~~~ 520 (782)
.++|.+.+.||+|||+.||++.. ++..+|+|.+......+.+...+|++..++++|||++++++++. ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46789999999999999999986 67789999998877777888999999999999999999998862 2249
Q ss_pred EEEEeCCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNT-PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+++|...|+|.+.+.+.... ..+++.+++.|+.+|++||.+||...| |++||||||+|||+.+.+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999766433 369999999999999999999999985 799999999999999999999999999986
Q ss_pred ccccccc----ccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh-Cccc
Q 040785 600 VPAVAEN----VTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN-GTLG 671 (782)
Q Consensus 600 ~~~~~~~----~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~~~ 671 (782)
.+-.... ..-........|..|.|||.|. +...+.++|||||||+||.|+.|..||.. .... |.+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~------~~~~GgSla 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER------IYQQGGSLA 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH------HhhcCCeEE
Confidence 5322111 1112233446788999999775 44578999999999999999999999942 2222 2222
Q ss_pred ccCCCCCCCCC--hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWP--FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
--+...--.+| ...+..+.+++..|++.||.+||++.+++.
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11111011122 125667999999999999999999998874
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.36 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=206.6
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
|.++.+||+|+||.||++.+ .|..+|||.+..+ .+.+++.+|+.||.++..|++|++||.+..+. ++|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 88899999999999999987 6778999998654 45688999999999999999999999875544 999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|++.|++.-+. .+|++.++..|+...+.||+|||... -||||||..||||+.+|+.||+|||.|-.+.. +
T Consensus 113 GSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-----T 182 (502)
T KOG0574|consen 113 GSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-----T 182 (502)
T ss_pred CcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-----h
Confidence 99999987654 46999999999999999999999998 89999999999999999999999999976532 2
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
.....+..||+.|||||++..-.|+.++||||||++..||..|++||...|.....+..-+ ...|.+ .-|..-..+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---~PPPTF-~KPE~WS~~ 258 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---KPPPTF-KKPEEWSSE 258 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---CCCCCC-CChHhhhhH
Confidence 2334567899999999999999999999999999999999999999988887654332211 011111 224455667
Q ss_pred HHHHHHHhhccCcCCCCChHHhhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
|.+|+..||-..|++|-++-+++.
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhh
Confidence 999999999999999999888763
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=313.39 Aligned_cols=247 Identities=32% Similarity=0.469 Sum_probs=194.7
Q ss_pred ccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHH--HHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRS--QFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~--~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
|+..+.||+|+||+||++... +..||+|++......... ...+|+.++..++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999994 457999999876443322 3456999999999999999999985443 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---- 150 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE---- 150 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS----
T ss_pred cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc----
Confidence 999999999733 34899999999999999999999999 99999999999999999999999999875311
Q ss_pred ccccccccccCCcccCChhhhh-cCCCCCchhHHHHHHHHHHHHhCCCCCCChHH--HHHHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQLITAKQPMGLTHF--VERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.........||..|+|||++. +..++.++||||||+++|+|++|..||..... ....+............ ....
T Consensus 151 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 227 (260)
T PF00069_consen 151 -NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS--QQSR 227 (260)
T ss_dssp -TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--TSHT
T ss_pred -cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--cccc
Confidence 122334567899999999988 78899999999999999999999999986521 11111111100000000 0001
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+.+++.+||+.+|++||++.+++.
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11367999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.30 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=199.0
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC-c--cEEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE-Y--GIIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~--~~lV~E 524 (782)
.|++.+.||+|+||.||++.. ++..||+|.+.... ....+.+.+|+++++.++|||++.+++.+.. . .|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 378899999999999999987 46689999986532 2345568899999999999999999988753 2 379999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|.+.+.... ...+++.++..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999886542 345899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p 682 (782)
.......|++.|+|||++.+..++.++|||||||++++|++|+.||........ .+..+.+ ...+
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~~~~ 223 (257)
T cd08223 157 -----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------PPMP 223 (257)
T ss_pred -----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------CCCc
Confidence 122345689999999999999999999999999999999999999975543221 1222221 1223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+++.+|+..+|++||++.+++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 344567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.18 Aligned_cols=239 Identities=31% Similarity=0.445 Sum_probs=196.3
Q ss_pred cccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCCCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLANGS 530 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~gs 530 (782)
.|.+.+.||+|+||.||+|...+..||+|.++... ....+.+|+.++..++||||+++++++.... ++||||+++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 48889999999999999999899999999987543 3467899999999999999999999886554 89999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccccc
Q 040785 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQY 610 (782)
Q Consensus 531 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 610 (782)
|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 85 L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~------- 153 (254)
T cd05083 85 LVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG------- 153 (254)
T ss_pred HHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-------
Confidence 9999865532 35889999999999999999999999 999999999999999999999999998754211
Q ss_pred ccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHHH
Q 040785 611 HLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEETL 687 (782)
Q Consensus 611 ~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~ 687 (782)
......+..|+|||++.++.++.++|||||||++|+|++ |+.||....... ..+..+.. . ..+...+.
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~ 224 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---M-----EPPEGCPA 224 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---C-----CCCCcCCH
Confidence 112234568999999988899999999999999999998 999996554322 22222210 1 11223445
Q ss_pred HHHHHHHHhhccCcCCCCChHHhhh
Q 040785 688 GFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 688 ~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.+++.+||+.+|+.||++.+++.
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.61 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=195.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-----AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GI 520 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~ 520 (782)
+|...+.||+|+||.||+|.. .+..|++|.+.... ......+.+|+.+++.++||||+.+++++.+. .+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 588899999999999999987 56789999986432 12345688999999999999999999987542 37
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
++|||+++++|.+.+...+ .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999886543 4889999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 680 (782)
..... .........|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. . +..+.
T Consensus 157 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~--~---~~~~~ 229 (266)
T cd06651 157 QTICM--SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--Q---PTNPQ 229 (266)
T ss_pred ccccc--cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--C---CCCCC
Confidence 32111 11111234688999999999888899999999999999999999999976544333322111 1 11122
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.|......+..++ .||..+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 3334445577777 7888999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.92 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=198.6
Q ss_pred ccccccceeeeeCcEeEEEEEEC---------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 519 (782)
++|.+.+.||+|+||.||+|... ...+|+|.++... ......+.+|+.++..+ +||||++++++|.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45888999999999999999752 3469999987542 23456788999999999 6999999999986544
Q ss_pred --EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 520 --IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
++||||+++|+|.+++..... ...+++.++..++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 899999999999999865421 235899999999999999999999999 99999999999999
Q ss_pred CCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH-
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE- 662 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~- 662 (782)
.++.+||+|||+++....... ........++..|+|||++.++.++.++|||||||++|+|++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDY---YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred CCCcEEEcccccccccccccc---ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999986532110 011112234567999999988899999999999999999999 899996543221
Q ss_pred -HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 663 -RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 663 -~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+..+. ....+...+..+.+++.+||..+|.+||++.+++ ..|..+.
T Consensus 246 ~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll-~~l~~~~ 294 (314)
T cd05099 246 FKLLREGH--------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV-EALDKVL 294 (314)
T ss_pred HHHHHcCC--------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH-HHHHHHH
Confidence 2222221 1122334455788999999999999999998887 3555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.22 Aligned_cols=239 Identities=28% Similarity=0.428 Sum_probs=191.1
Q ss_pred ceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCChh
Q 040785 457 RKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLD 532 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~ 532 (782)
++||.|+||.||+|.. +++.+|+|++...... ....|.+|++++..++||||++++++|.... ++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999987 5678999998765432 3446889999999999999999999986544 8999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccccccc
Q 040785 533 DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612 (782)
Q Consensus 533 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 612 (782)
+++.... ..+.+..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~----~~~~ 151 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI----YSSS 151 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc----cccC
Confidence 9886543 34889999999999999999999999 9999999999999999999999999987542211 1111
Q ss_pred ccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHHHHH
Q 040785 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEETLGF 689 (782)
Q Consensus 613 ~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l 689 (782)
....++..|+|||++.++.++.++|||||||++|+|++ |..||....... ..+..+. . ...+...+..+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~ 223 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----R---MSCPQKCPDDV 223 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----C---CCCCCCCCHHH
Confidence 12344678999999998999999999999999999998 999996543322 1122211 1 11223345679
Q ss_pred HHHHHHhhccCcCCCCChHHhhh
Q 040785 690 AKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 690 ~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+++.+|+..+|++||++.+++.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.54 Aligned_cols=247 Identities=29% Similarity=0.476 Sum_probs=195.3
Q ss_pred ccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
.+|.+.+.||+|+||.||+|.+. ...+|+|.++... ......|.+|+.++..++||||+++++++.+.. |+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45888999999999999999862 2369999987543 233567899999999999999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++++|.+++.... ..+++.++..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986543 34899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
... .........++..|+|||++.++.++.++|||||||++|++++ |..||....... ..+..+. . .
T Consensus 159 ~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-----~---~ 228 (267)
T cd05066 159 DPE--AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-----R---L 228 (267)
T ss_pred ccc--eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-----c---C
Confidence 111 1111122334668999999998899999999999999999886 999996443221 1122211 0 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+...+..+.+++.+|++.+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 112234456899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.76 Aligned_cols=245 Identities=26% Similarity=0.361 Sum_probs=199.0
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+|...+.||.|+||.||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.. ++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 578889999999999999987 56789999987543 333467889999999999999999999886544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++... ++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 999999988543 5899999999999999999999999 9999999999999999999999999998764221
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+........ .....+.+... ..+
T Consensus 153 ---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~--~~~ 224 (274)
T cd06609 153 ---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---PKNNPPSLEGN--KFS 224 (274)
T ss_pred ---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---hhcCCCCCccc--ccC
Confidence 1223456888999999999888999999999999999999999999755432221110 01111221111 144
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+.+++.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 568999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.44 Aligned_cols=246 Identities=26% Similarity=0.364 Sum_probs=200.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.|+..+.||.|+||.||+|.+ .+..||||++.... ......+.+|+.+++.+.||||++++++|.+.. |+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 478889999999999999987 56789999987542 344567899999999999999999999987554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.. .++++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 99999998853 24889999999999999999999999 9999999999999999999999999997653211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......++..|+|||++.+..++.++|||||||++|+|++|..||............ .. ......+...+
T Consensus 156 ---~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~---~~~~~~~~~~~ 226 (277)
T cd06640 156 ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---PK---NNPPTLTGEFS 226 (277)
T ss_pred ---cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---hc---CCCCCCchhhh
Confidence 1122346888999999998888999999999999999999999999754432211100 00 11122334566
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 77999999999999999999999986544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.69 Aligned_cols=246 Identities=26% Similarity=0.330 Sum_probs=186.0
Q ss_pred ceeeeeCcEeEEEEEEC----CeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYLD----HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
+.||+|+||.||+|... ...+|+|.++.... .....|.+|+.+++.++||||++++++|.+.. ++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999863 24689999876532 33457889999999999999999999986544 8999999999
Q ss_pred ChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 530 SLDDRIFRRGN--TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 530 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~--- 154 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED--- 154 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc---
Confidence 99999875432 234677888899999999999999999 9999999999999999999999999997542211
Q ss_pred cccccccccCCcccCChhhhhcC-------CCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHH--HhCcccccCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTG-------MLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSI--ENGTLGEMLDPT 677 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~-------~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~--~~~~~~~~ld~~ 677 (782)
.........|+..|+|||++... .++.++|||||||++|||++ |..||......+... ..+......++.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 11112234678899999987532 35789999999999999996 999996543322111 111111111222
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+..+.+++..|+ .+|++||++.+++.
T Consensus 235 ---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 ---LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 12223445889999999 68999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=327.26 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=209.8
Q ss_pred HHHHHhccccccceeeeeCcEeEEEEEEC----Ce--eEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccC
Q 040785 445 DIEEATQFFTESRKIGEGGYGPVYKCYLD----HT--PVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPE 517 (782)
Q Consensus 445 ~~~~~t~~f~~~~~LG~G~fg~Vy~~~~~----~~--~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~ 517 (782)
+++.........++||.|-||.||+|.+. |. .||||..+.+. ..+.+.|..|.-+|+.++|||||+|+|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 33334445666789999999999999873 22 59999998753 4457789999999999999999999999988
Q ss_pred cc-EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 YG-IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 ~~-~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.. +||||.++-|.|..+|..++.. |+......++.||+.||.|||+.. +|||||-..|||+.....+||+||||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred cceeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 77 8999999999999999887654 788888999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCcccccCC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEMLD 675 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld 675 (782)
++++... ..|..+...-..-|||||-+....++.++|||-|||++||+++ |..||......+ .+..+-.
T Consensus 538 SR~~ed~----~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------VI~~iEn 607 (974)
T KOG4257|consen 538 SRYLEDD----AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------VIGHIEN 607 (974)
T ss_pred hhhcccc----chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------eEEEecC
Confidence 9998542 3444444455678999999999999999999999999999987 999996443211 1222222
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......|+.+++.+..|+.+||..+|.+||.+.++..
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 2334567888888999999999999999999988763
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.97 Aligned_cols=251 Identities=22% Similarity=0.233 Sum_probs=192.3
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...++||+|+||.||++.+. +..+|+|++.... ......|..|+.++..++||||+.+++++.+.. |+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5888999999999999999984 5689999986421 122345788999999999999999999886544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 y~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred ccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999997643 24899999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
........||+.|+|||++. .+.++.++|||||||++|||++|+.||............-. .......+
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~~~p 230 (332)
T cd05623 157 ----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN--HKERFQFP 230 (332)
T ss_pred ----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC--CCccccCC
Confidence 11223457999999999886 34689999999999999999999999976544332211100 00001111
Q ss_pred CCChhHHHHHHHHHHHhhccCcCC--CCChHHhhhH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKD--RPDLGKVVLP 713 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~--RPs~~~vl~~ 713 (782)
..+...+..+.+|+.+|+..++.+ ||++.+++.+
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 112234556889999988654443 6788888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.50 Aligned_cols=193 Identities=27% Similarity=0.389 Sum_probs=156.8
Q ss_pred cceeeeeCcEeEEEEEE----CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEEEeCC
Q 040785 456 SRKIGEGGYGPVYKCYL----DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVYEYLA 527 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~----~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~Ey~~ 527 (782)
.++||+|+||.||+|.. .+..||+|.+.... ....+.+|+.+|+.++||||+++++++... .|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 46899999999999986 34679999986542 234578999999999999999999987432 389999985
Q ss_pred CCChhHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE----cCCCceeeeccccc
Q 040785 528 NGSLDDRIFRRG------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLA 597 (782)
Q Consensus 528 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----d~~~~~kL~DFGla 597 (782)
++|.+.+.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877764321 1235899999999999999999999999 9999999999999 45679999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMG 656 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~ 656 (782)
+.+..... .........||+.|+|||++.+. .++.++|||||||++|+|++|++||.
T Consensus 160 ~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCc--cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 87642211 11123356789999999988764 58999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.19 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=207.2
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVY 523 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~ 523 (782)
...|...+.||+|-|.+|-++++ +|..||||++.+...+ ....+.+|+..|+.++|||||+||.+.... .|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45688889999999999999986 8999999999765333 345688999999999999999999998554 49999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE-cCCCceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL-DHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl-d~~~~~kL~DFGla~~~~~ 602 (782)
|+=++|+|+|++.+...+ +.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ .+-|.+||+|||++..+.
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 999999999999876543 899999999999999999999999 9999999999876 567899999999997663
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCC-CchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLG-VKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
.....++.||++.|-|||++.+..|+ +++||||||||||.|++|++||...+..+ ++.-++|=. -..
T Consensus 171 -----PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------TLTmImDCK-Ytv 238 (864)
T KOG4717|consen 171 -----PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------TLTMIMDCK-YTV 238 (864)
T ss_pred -----CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh------hhhhhhccc-ccC
Confidence 23455678999999999999998885 68999999999999999999996554333 333333322 234
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
|.....++.+||..||..+|++|.++++++
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 778888999999999999999999999886
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.07 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=193.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.|...+.||.|+||.||+|.+ ++..||+|.+..... .....+.+|+.+++.++||||+++++++.... ++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 3588899999999999999987 467899999875432 22346778999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++ ++|...+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 157 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 157 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC--
Confidence 97 58888876543 34889999999999999999999999 999999999999999999999999998754211
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH--h--C-----cccccC-
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE--N--G-----TLGEML- 674 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~--~--~-----~~~~~l- 674 (782)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||......+.... . + ....++
T Consensus 158 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 158 ---TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred ---CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 1112234678999999987654 578999999999999999999999965433211100 0 0 000000
Q ss_pred -----CCCCCC--------CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 675 -----DPTVTD--------WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 675 -----d~~~~~--------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
....+. .....+..+.+|+.+||+.+|++||++.+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000011 1122345688999999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.72 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=183.6
Q ss_pred eeeeeCcEeEEEEEE-C---CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCC
Q 040785 458 KIGEGGYGPVYKCYL-D---HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGS 530 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~-~---~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 530 (782)
.||+|+||.||+|.. . ...+++|.+.... ......|.+|+.+++.++||||+++++.|.+.. ++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999975 2 3468888876443 233456889999999999999999999986554 89999999999
Q ss_pred hhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 531 LDDRIFRRGN--TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 531 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|.+++..... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999876432 233567888999999999999999999 99999999999999999999999999875422110
Q ss_pred ccccccccCCcccCChhhhhc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH---HHHHhCcccccCCCC
Q 040785 609 QYHLTSTAGTFCYIDPEYQQT-------GMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE---RSIENGTLGEMLDPT 677 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~---~~~~~~~~~~~ld~~ 677 (782)
........++..|+|||++.. ..++.++|||||||++|||++ |..||....... ..+..+. .....+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~- 233 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKLPKP- 233 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-ccCCCC-
Confidence 011123456778999998653 356889999999999999999 888986443221 1111111 111112
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+...+..+.+++..|+ .+|++||++.+++
T Consensus 234 --~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~ 264 (269)
T cd05042 234 --QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVH 264 (269)
T ss_pred --cccccCCHHHHHHHHHHh-cCcccccCHHHHH
Confidence 223344556788899998 5999999998887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.32 Aligned_cols=246 Identities=27% Similarity=0.380 Sum_probs=187.9
Q ss_pred ceeeeeCcEeEEEEEEC-----CeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccC-c--cEEEEEeCC
Q 040785 457 RKIGEGGYGPVYKCYLD-----HTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-Y--GIIVYEYLA 527 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~--~~lV~Ey~~ 527 (782)
+.||+|+||.||+|.+. ...||||.+... .......+.+|+.+++.++||||++++++|.. . .++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999862 347999998543 23345678899999999999999999997642 2 389999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~- 154 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY- 154 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce-
Confidence 9999999865432 3677888999999999999999999 999999999999999999999999999755321100
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.........++..|+|||++.+..++.++|||||||++|||++ |.+||........ .+..+. ....+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 226 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--------RLLQPEY 226 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--------CCCCCCc
Confidence 0111123456778999999988899999999999999999999 5666754332221 111111 1111222
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
.+..+.+++.+||..+|++||++.+++. .|+.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~-~l~~ 258 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVS-RIEQ 258 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH-HHHH
Confidence 3456899999999999999999998873 4443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.99 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=203.5
Q ss_pred ccHHHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccC
Q 040785 441 YTIEDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPE 517 (782)
Q Consensus 441 ~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~ 517 (782)
+...++..++++|...+.||.|+||.||++.. +++.+|+|++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566667788999999999999999999988 56789999986542 2245678899999998 89999999998742
Q ss_pred -------ccEEEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 518 -------YGIIVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 518 -------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 248999999999999987642 22345899999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCC-----CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM-----LGVKSDVYSLGILLLQLITAKQPMGLTHFVERS 664 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~ 664 (782)
||+|||++....... .......|+..|+|||++..+. ++.++|||||||++|+|++|+.||.........
T Consensus 168 kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 168 KLVDFGVSAQLTSTR-----LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred EEeecccchhccccc-----ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 999999988653211 1123356899999999876543 688999999999999999999999765443322
Q ss_pred HH--hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 665 IE--NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 665 ~~--~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.. .+....+. .+......+.+++.+||+.+|++||++.+++.+
T Consensus 243 ~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIPRNPPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHhcCCCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 21 11111111 122233468999999999999999999998853
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.77 Aligned_cols=244 Identities=22% Similarity=0.294 Sum_probs=195.3
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
|.....||.|+||.||++.. +++.||+|++..........+.+|+.++..++||||++++++|.... ++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456799999999999987 57899999997654445667889999999999999999999885443 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~----- 170 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 170 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc-----
Confidence 999987643 24889999999999999999999999 999999999999999999999999998755321
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
........|+..|+|||++.+..++.++|||||||++|+|++|+.||............... ..+.. ..+...+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~ 246 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPKL-KNAHKISPV 246 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCCCc-cccCCCCHH
Confidence 11123456899999999999888999999999999999999999999655433322111100 01111 111223446
Q ss_pred HHHHHHHhhccCcCCCCChHHhhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+++.+||+.+|.+||++.+++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhh
Confidence 899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.93 Aligned_cols=240 Identities=28% Similarity=0.407 Sum_probs=194.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~E 524 (782)
.|+.++.||.|+||.||.+++ +...||||.+.-. +......+..|+..|.+++|||+|.+-|+|... .+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 488889999999999999998 5568999998654 334467789999999999999999999998543 489999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
||- |+-.|++.-.. .++.+.++..|..+.+.||.|||+.+ .||||||..||||++.|.|||+|||.|....
T Consensus 107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 994 56666664333 35889999999999999999999999 9999999999999999999999999997652
Q ss_pred ccccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
...+++|||.|||||++. .|.|+-++|||||||+.+||.-.++|+-..+......-. .+.-.|.+.
T Consensus 178 ------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNesPtLq-- 246 (948)
T KOG0577|consen 178 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTLQ-- 246 (948)
T ss_pred ------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcCCCCCC--
Confidence 224578999999999765 567999999999999999999999997544433222111 111123332
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+-...|..|+..||+.-|.+||+.++++
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 134455699999999999999999998765
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.25 Aligned_cols=246 Identities=23% Similarity=0.307 Sum_probs=196.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
.|.....||.|+||.||++.. ++..||||.+........+.+.+|+.++..++||||+++++.+.... ++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 355567799999999999987 56789999987655555677899999999999999999999875444 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+++|.+++... .+++.++..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999877432 3889999999999999999999999 9999999999999999999999999987553211
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHH
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETL 687 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 687 (782)
.......|+..|+|||++.+..++.++|||||||++|||++|..||........... +...+.+.+.. ....+.
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~ 246 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRVKD-SHKVSS 246 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCcccc-ccccCH
Confidence 112235689999999999888899999999999999999999999965443221111 01111121111 122344
Q ss_pred HHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 688 GFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 688 ~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+.+++.+||..+|.+||++.+++.+
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 68899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=336.17 Aligned_cols=248 Identities=21% Similarity=0.271 Sum_probs=190.5
Q ss_pred ccccccceeeeeCcEeEEEEEEC----CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD----HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
..|.+.+.||+|+||.||+|... +..||+|.+... ..+.+|+++|+.++||||+++++++.... |+|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 45899999999999999999763 357999988543 34568999999999999999999886543 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+. ++|.+++... ..+++.+++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+....
T Consensus 167 ~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 985 6888877332 35899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH------HHHHHHHh-Cc--------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH------FVERSIEN-GT-------- 669 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~------~~~~~~~~-~~-------- 669 (782)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.. +.
T Consensus 240 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 240 ---DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ---ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 1112234679999999999999999999999999999999999999995321 11111110 00
Q ss_pred -----------ccccCCCCC--CCC--ChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 670 -----------LGEMLDPTV--TDW--PFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 670 -----------~~~~ld~~~--~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+.....+.. +.. ....+..+.+|+.+||..+|++||++.+++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000 01123468899999999999999999999854
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.71 Aligned_cols=231 Identities=24% Similarity=0.359 Sum_probs=181.7
Q ss_pred eeeeeCcEeEEEEEEC--------------------------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeee
Q 040785 458 KIGEGGYGPVYKCYLD--------------------------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL 511 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~~--------------------------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 511 (782)
.||+|+||.||+|... ...|++|++..........|..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999741 13589999876554445678899999999999999999
Q ss_pred cccccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC--
Q 040785 512 LGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-- 587 (782)
Q Consensus 512 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-- 587 (782)
+++|.+.. ++||||+++|+|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99996544 89999999999998886533 34889999999999999999999998 99999999999997654
Q ss_pred -----ceeeeccccccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHH-hCCCCCCChHH
Q 040785 588 -----VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLI-TAKQPMGLTHF 660 (782)
Q Consensus 588 -----~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~ell-tG~~Pf~~~~~ 660 (782)
.+||+|||++..... .....++..|+|||++.+ ..++.++|||||||++|||+ +|..||.....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~---------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS---------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCccceeeecCCcccccccc---------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 479999998764321 122357888999998865 56899999999999999985 79999964332
Q ss_pred HH--HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 661 VE--RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 661 ~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. ..+... . ..|......+.+++.+||+.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~-------~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 228 SEKERFYEKK-------H---RLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HHHHHHHHhc-------c---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 21 111110 0 111122245899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.11 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=200.2
Q ss_pred cHHHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccC-
Q 040785 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPE- 517 (782)
Q Consensus 442 ~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~- 517 (782)
++.++....+.|+..+.||.|+||.||+|.+ .+..+|+|++.... .....+..|+.++.++ +||||++++++|..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444555667899999999999999999998 56789999986543 3345688999999998 69999999998832
Q ss_pred -------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCcee
Q 040785 518 -------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSK 590 (782)
Q Consensus 518 -------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~k 590 (782)
..|++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 2389999999999999886543 234888899999999999999999999 99999999999999999999
Q ss_pred eeccccccccccccccccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH
Q 040785 591 ISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI 665 (782)
Q Consensus 591 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~ 665 (782)
|+|||++...... ........|++.|+|||.+. ...++.++|||||||++|+|++|..||..........
T Consensus 162 l~dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 162 LVDFGVSAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred EeeCcchhhhhcc-----ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 9999998765321 11223457899999999875 3468889999999999999999999996544333222
Q ss_pred HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.... ...+.. .+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 237 ~~~~---~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LIPR---NPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hHhh---CCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1111 001111 11123456999999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.10 Aligned_cols=239 Identities=31% Similarity=0.490 Sum_probs=187.6
Q ss_pred ceeeeeCcEeEEEEEECC--e--eEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYLDH--T--PVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~--~--~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||+|+||.||+|.+.+ . .+++|.++... ......+.+|++++.++ +||||++++++|.... ++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998733 2 47888887432 33456788999999999 7999999999986654 899999999
Q ss_pred CChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 529 GSLDDRIFRRG-------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 529 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986542 1234889999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccc
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGE 672 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~ 672 (782)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... ..+..+.
T Consensus 158 l~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--- 228 (270)
T cd05047 158 LSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--- 228 (270)
T ss_pred Cccccchh------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---
Confidence 98633210 11112234667999999988889999999999999999997 999996443221 1111111
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+...+..+.+++.+||..+|.+||++.+++.
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 -----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 01112233456899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.11 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=195.9
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.|++.+.||+|+||.||++... ++.||+|++.... ......+.+|++++..++||||+++++++.... ++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45888899999999999999984 7789999986543 234567899999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
+++++|.+++...+ ++++..+..++.+++.||.|||+ .+ |+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999998875533 58999999999999999999997 46 999999999999999999999999998754211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH-------HHHHHhCcccccCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV-------ERSIENGTLGEMLDPT 677 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~-------~~~~~~~~~~~~ld~~ 677 (782)
......||..|+|||++.++.++.++|||||||++|+|++|+.||...... ....+ .+..+....
T Consensus 158 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (284)
T cd06620 158 ------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD--LLQQIVQEP 229 (284)
T ss_pred ------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH--HHHHHhhcc
Confidence 112357899999999998889999999999999999999999999643221 00000 001111111
Q ss_pred CCCCCh-hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 VTDWPF-EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 ~~~~p~-~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+. ..+..+.+|+.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111 24456899999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=320.10 Aligned_cols=253 Identities=29% Similarity=0.445 Sum_probs=198.1
Q ss_pred ccccccceeeeeCcEeEEEEEEC---------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 519 (782)
.+|.+.+.||+|+||.||+|... ...||+|+++... ......+.+|+.++.++ +||||++++++|....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35888999999999999999752 1268999887542 33456789999999999 7999999999986554
Q ss_pred --EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 520 --IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
+++|||+++|+|.+++.+... ...+++.++..++.|++.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 899999999999999875421 234889999999999999999999999 99999999999999
Q ss_pred CCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER 663 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~ 663 (782)
.++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred CCCcEEECCcccceeccccc---ccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999998653211 0111122344578999999999999999999999999999998 8999865433221
Q ss_pred --HHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 664 --SIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 664 --~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+..+. ....+...+..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 246 ~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~-~l~~~ 293 (334)
T cd05100 246 FKLLKEGH--------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE-DLDRV 293 (334)
T ss_pred HHHHHcCC--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH-HHHHH
Confidence 121111 11122334456899999999999999999998874 44444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.96 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=203.4
Q ss_pred hccccccceeeeeCcEeEEEEEECC-eeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccC--ccEEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPE--YGIIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey 525 (782)
.+...+.++||+|-||.|.+|...+ ..||||.+++++.. .+..|.+|+.+|.+|+|||||.|+|+|.. ..|+|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3446677899999999999999976 89999999987554 45899999999999999999999999953 34999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
|++|+|..+|...... .+.-....+|+.||+.||+||.+.+ +|||||.+.|+|+|.++++||+|||+++-+-..
T Consensus 617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg-- 690 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG-- 690 (807)
T ss_pred HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC--
Confidence 9999999999776422 1344556779999999999999999 999999999999999999999999999955321
Q ss_pred cccccc-cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh--CCCCCCChHHHHHHHH-hCcccc-cCCCCCCC
Q 040785 606 NVTQYH-LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT--AKQPMGLTHFVERSIE-NGTLGE-MLDPTVTD 680 (782)
Q Consensus 606 ~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~Pf~~~~~~~~~~~-~~~~~~-~ld~~~~~ 680 (782)
..++ .+..+-.++|||||.+..+++++++|||+||+++||+++ ...||+....-. .++ .+.+.. --...+..
T Consensus 691 --~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 691 --DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-VVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred --CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-HHHhhhhhcCCCCcceecc
Confidence 1121 223455689999999999999999999999999999765 778986443211 111 111111 11112234
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.|.-++..+.+++++||..+-.+||+++++.+..+
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 56677888999999999999999999999986443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.41 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=196.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCe----eEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCc-cEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHT----PVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEY-GIIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-~~lV~ 523 (782)
.|...+.||+|+||.||+|.+ ++. .||+|.+..... .....+.+|+.++..+.||||++++|+|... .++++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~ 87 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT 87 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeee
Confidence 478889999999999999987 333 579998876432 2344688999999999999999999998544 47999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+.+.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 88 QLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred hhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 9999999999886543 24889999999999999999999999 999999999999999999999999999876322
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~ 680 (782)
. .........++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+.. . .
T Consensus 163 ~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------~-~ 231 (303)
T cd05110 163 E---KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-------L-P 231 (303)
T ss_pred c---cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-------C-C
Confidence 1 1112223456788999999988889999999999999999997 9999964322 2222222211 0 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+...+..+.+++..||..+|++||++.+++. .|..+
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~-~l~~~ 268 (303)
T cd05110 232 QPPICTIDVYMVMVKCWMIDADSRPKFKELAA-EFSRM 268 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 12223456899999999999999999998874 44443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.37 Aligned_cols=233 Identities=27% Similarity=0.429 Sum_probs=185.3
Q ss_pred ceeeeeCcEeEEEEEECCe------------eEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC-ccEEEE
Q 040785 457 RKIGEGGYGPVYKCYLDHT------------PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-YGIIVY 523 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~~------------~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~lV~ 523 (782)
+.||+|+||.||+|.+..+ .+++|++...... ...|.+|+.+|+.++||||++++++|.. ..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 3699999999999998433 3888887655433 5788999999999999999999998864 348999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-------ceeeecccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-------VSKISDVGL 596 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-------~~kL~DFGl 596 (782)
||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999998876543 5899999999999999999999999 99999999999999888 799999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCccccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEM 673 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 673 (782)
+..... .....++..|+|||++... .++.++|||||||++|+|++ |..||..............
T Consensus 155 a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~---- 221 (259)
T cd05037 155 PITVLS---------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---- 221 (259)
T ss_pred cccccc---------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----
Confidence 986422 1224567789999998876 78999999999999999999 6888865432211111100
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. ..+......+.+++.+||..+|.+||++.+++.
T Consensus 222 --~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 --QH--RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --CC--CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 011111256899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.53 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=205.0
Q ss_pred ccccccceeeeeCcEeEEEEEECCe--eEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccc--cCccEEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~--~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 526 (782)
+.|.++..||.|+||.||++....+ ..|.|++........+.|.-||+||..+.||+||.|++.| ....++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3477888899999999999987554 4678998877778889999999999999999999999865 33348999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
.||-++.++...+ .+|.+.++..+++|++.||.|||+.+ |||||||..|||+.-+|.++|+|||.+....
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~----- 181 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK----- 181 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-----
Confidence 9999998887765 35999999999999999999999999 9999999999999999999999999875432
Q ss_pred ccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCC
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
.+.....++.||++|||||+.+ ..+|+.++|||||||+|+||..+.+|....+...-.+...+- -.|.+. .
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTLl-q 257 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLL-Q 257 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCccc-C
Confidence 1333456789999999999754 567999999999999999999999998766655544433221 112221 2
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
|..-...|.+|+.+||..+|+.||+.++++.+
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 33445569999999999999999999999844
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=305.54 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=199.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|+..+.||.|+||.||.+.. ++..+++|.+... .......+.+|+.++++++||||+++++++.+.. +++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488899999999999998887 5678999988653 2334567889999999999999999999986655 789999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~- 155 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY- 155 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc-
Confidence 99999999886553 345899999999999999999999999 9999999999999999999999999998663221
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~p~ 683 (782)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||......+.. +..+.+. ..+.
T Consensus 156 ----~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 223 (256)
T cd08221 156 ----SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--------PVVS 223 (256)
T ss_pred ----ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------CCcc
Confidence 1223456899999999998888999999999999999999999999765433221 1222221 1123
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 34456899999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.58 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=199.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC--c--cEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--Y--GIIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~--~~lV~ 523 (782)
+|+..+.||.|+||.||++.+ ++..||+|++... .....+.+..|+++++.++||||+++++++.. . .+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 377889999999999999987 5678999998653 23345678899999999999999999987742 2 28999
Q ss_pred EeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 524 EYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLH-----QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH-----~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
||+++++|.+++... ....++++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988654 22346899999999999999999999 767 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCC
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLD 675 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld 675 (782)
....... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ..+..+.
T Consensus 158 ~~~~~~~-----~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------ 226 (265)
T cd08217 158 KILGHDS-----SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK------ 226 (265)
T ss_pred ccccCCc-----ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC------
Confidence 8763221 11233568999999999998889999999999999999999999997654221 1122221
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
....+...+..+.+++.+|+..+|.+||++.+++.+
T Consensus 227 --~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 --FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 223344455679999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=305.81 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=198.4
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-----AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
|...+.||+|+||.||+|.. ++..|++|.+.... ....+.+.+|+.+++.++||||+++++++.+.. ++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 66778999999999999987 57799999986532 224567899999999999999999999986544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999886543 4889999999999999999999999 999999999999999999999999998765321
Q ss_pred cccccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||+...........+.... ....+
T Consensus 156 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~ 224 (258)
T cd06632 156 S------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LPPIP 224 (258)
T ss_pred c------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CCCcC
Confidence 1 123456899999999887776 89999999999999999999999976554333333222111 11223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 334566899999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.81 Aligned_cols=256 Identities=21% Similarity=0.233 Sum_probs=190.7
Q ss_pred ccceeeee--CcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 455 ESRKIGEG--GYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 455 ~~~~LG~G--~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
...+||+| +|++||++.. ++..||||++.... ......+.+|+.+++.++||||++++++|.... |+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7899999987 56789999997542 223456788999999999999999999985544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999998865432 34899999999999999999999999 999999999999999999999999875443211110
Q ss_pred c--cccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH--HhCcccccCCCC---
Q 040785 607 V--TQYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--ENGTLGEMLDPT--- 677 (782)
Q Consensus 607 ~--~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~ld~~--- 677 (782)
. .........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ..+.+...++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0 0011123457788999999876 458999999999999999999999996432211111 111111111100
Q ss_pred ----------------C------------------CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 678 ----------------V------------------TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 678 ----------------~------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
. ..........+.+|+.+||+.||++||++.+++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0 001112345688999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.03 Aligned_cols=194 Identities=27% Similarity=0.385 Sum_probs=156.4
Q ss_pred cceeeeeCcEeEEEEEEC----CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC----ccEEEEEeCC
Q 040785 456 SRKIGEGGYGPVYKCYLD----HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE----YGIIVYEYLA 527 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~lV~Ey~~ 527 (782)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+|+.++||||++++++|.. ..++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999863 3579999986542 23457899999999999999999998732 2389999986
Q ss_pred CCChhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE----cCCCceeeeccccc
Q 040785 528 NGSLDDRIFRR------GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLA 597 (782)
Q Consensus 528 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----d~~~~~kL~DFGla 597 (782)
+ +|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 777766422 12235899999999999999999999999 9999999999999 56789999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGL 657 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~ 657 (782)
+.+..... .........||+.|+|||++.+. .++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcc--cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 87632211 11122345789999999988764 589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=327.71 Aligned_cols=230 Identities=24% Similarity=0.274 Sum_probs=180.5
Q ss_pred eeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhc---CCCCeeeecccccCcc--EEEEEeCCC
Q 040785 459 IGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCI---RHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 459 LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
||+|+||.||+|.+ .+..||||++..... .....+..|..++..+ .||||+.+++.+.+.. |+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 577999999864321 2233455677777765 6999999999886544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+.+...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----- 149 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD----- 149 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-----
Confidence 99998886543 4899999999999999999999999 999999999999999999999999998754211
Q ss_pred ccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ..+..+.. .++. ...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------~~~~--~~~ 221 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV------RFPK--NVL 221 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC------CCCC--ccC
Confidence 1122346799999999988765 48999999999999999999999997654322 12222211 1111 123
Q ss_pred HHHHHHHHHHhhccCcCCCCCh
Q 040785 686 TLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~ 707 (782)
+..+.+|+.+||..+|.+||+.
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCC
Confidence 4468899999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=307.01 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=201.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|+..+.||.|+||.||+|.. ++..+++|++.... ......+.+|+.+|+.++||||+.+++.+.... ++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3588899999999999999987 56689999986542 234677899999999999999999999875444 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999876543345899999999999999999999999 99999999999999999999999999987643221
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC--
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP-- 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p-- 682 (782)
.. ........|+..|+|||++... .++.++|||||||++|+|++|+.||............... ..+......
T Consensus 158 ~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (267)
T cd06610 158 RT-RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADY 233 (267)
T ss_pred cc-ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccc
Confidence 11 0122345689999999998877 7899999999999999999999999755433222111110 111111111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+++.+||..+|+.||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 234456899999999999999999998874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=306.75 Aligned_cols=245 Identities=28% Similarity=0.443 Sum_probs=196.8
Q ss_pred hccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLA 527 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~ 527 (782)
.+.|...++||+|+||.||++.+ .+..+++|.+.... .....|.+|+.+++.++|+||+++++++.+.. +++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 34688999999999999999987 45679999887543 34567899999999999999999999886644 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--- 156 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE--- 156 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC---
Confidence 999999986643 335889999999999999999999998 9999999999999999999999999997653211
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
........++..|+|||++..+.++.++|||||||++|+|++ |..||...... ...+..+... ..+..
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 227 (260)
T cd05073 157 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------PRPEN 227 (260)
T ss_pred -cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------CCccc
Confidence 111122345678999999998889999999999999999999 99999654322 2222222110 11223
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+..+.+++.+||+.+|++||++.+++
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 445689999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.51 Aligned_cols=247 Identities=30% Similarity=0.394 Sum_probs=196.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~E 524 (782)
+|...+.||.|+||.||+|.+ .++.+|+|.+..... .....+.+|+++++.++||||++++++|.+. .|+|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 588899999999999999998 567899999875432 3456789999999999999999999988432 389999
Q ss_pred eCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|+++++|.+++... .....+++..+..|+.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999887542 23345899999999999999999999999 999999999999999999999999998754211
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-----HH--HHHHhCcccccCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF-----VE--RSIENGTLGEMLDP 676 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-----~~--~~~~~~~~~~~ld~ 676 (782)
......++..|+|||.+.+..++.++|||||||++|+|++|..||..... .+ ..+..... +
T Consensus 159 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~ 226 (287)
T cd06621 159 -------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-----P 226 (287)
T ss_pred -------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-----h
Confidence 11234578899999999989999999999999999999999999975411 11 11111111 1
Q ss_pred CCCCCC---hhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 677 TVTDWP---FEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 677 ~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+...+ ...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111111 1234568999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.96 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=198.1
Q ss_pred cccccceeeeeCcEeEEEEEEC--C----eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--H----TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~----~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 523 (782)
.|...+.||+|+||.||+|.+. + ..+|+|.+.... ......+.+|+.++..++||||++++++|.... ++||
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 87 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLIT 87 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEE
Confidence 4788899999999999999862 2 258999887653 334567889999999999999999999986543 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+.+..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred ecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999865432 4899999999999999999999998 999999999999999999999999999876422
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
. .........++..|+|||.+..+.++.++|||||||++|||++ |..||......+ ..+..+.. ..
T Consensus 163 ~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 231 (279)
T cd05057 163 E---KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER--------LP 231 (279)
T ss_pred c---cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC--------CC
Confidence 1 1111122334678999999988899999999999999999998 999997654322 22222110 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.|...+..+.+++.+||..+|..||++.+++ ..|..+
T Consensus 232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~-~~l~~~ 268 (279)
T cd05057 232 QPPICTIDVYMVLVKCWMIDAESRPTFKELI-NEFSKM 268 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHH-HHHHHH
Confidence 1223345688999999999999999998876 344444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=307.59 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=199.5
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|+..+.||.|+||.||++.. ++..||+|.+... .......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 378899999999999999987 5678999998643 2233467899999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+.+..... ..+++.++..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999998865432 34789999999999999999999999 9999999999999999999999999997653211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhH
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
.......|++.|+|||++.++.++.++|||||||++++|++|+.||............ +.......+...
T Consensus 156 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 225 (256)
T cd08218 156 ----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI------IRGSYPPVSSHY 225 (256)
T ss_pred ----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH------hcCCCCCCcccC
Confidence 1122346888999999998888999999999999999999999999655433221111 011111223344
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+..+.+++.+||+.+|.+||++.+++.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 5569999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.26 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=198.3
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCc-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY------- 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~------- 518 (782)
.+++|+..+.||.|+||.||+|.. .+..+++|++..... ....|.+|+.+++++ .||||++++++|.+.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 467899999999999999999998 456899999876543 346789999999999 699999999998432
Q ss_pred -cEEEEEeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 389999999999999886532 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 671 (782)
+....... .......|+..|+|||++.. ..++.++|||||||+||+|++|..||...+.........
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--- 231 (275)
T cd06608 160 SAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP--- 231 (275)
T ss_pred ceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh---
Confidence 87653211 12234568999999998754 346789999999999999999999997544332221110
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+.. ..+...+..+.+|+.+||..+|++||++.+++.
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0001111 112224456899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.79 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=200.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~ 526 (782)
++|...+.||.|+||.||+|.. ++..|++|.+..........+.+|+.+++.++||||+.+++.|... .++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4688899999999999999986 5678999998755444556789999999999999999999998544 48999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 999999988543 3789999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......|++.|+|||++..+.++.++|||||||++|+|++|+.||............+... .+... .+...+
T Consensus 170 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~~~-~~~~~~ 242 (293)
T cd06647 170 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TPELQ-NPEKLS 242 (293)
T ss_pred ---cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC---CCCCC-CccccC
Confidence 12233468899999999988889999999999999999999999997554332211111100 01111 122334
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
..+.+++.+||..+|.+||++.+++.+.+
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 56899999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.58 Aligned_cols=243 Identities=28% Similarity=0.459 Sum_probs=194.4
Q ss_pred cccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
.|+..+.||.|+||.||+|.+. +..+|+|.+..... ....|.+|+++++.+.||||+++++++.... ++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4778899999999999999874 77899999865432 3457899999999999999999999986544 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 99999886543 24889999999999999999999999 9999999999999999999999999987552211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........++..|+|||++.++.++.++|||||||++|+|++ |..||........ .+..+ .....+ ...
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~------~~~ 226 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG--FRLYKP------RLA 226 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC--CCCCCC------CCC
Confidence 011122345678999999988899999999999999999998 9999975543221 11111 111112 123
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..+.+|+.+||+.+|++||++.+++.
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 356899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=333.79 Aligned_cols=248 Identities=20% Similarity=0.236 Sum_probs=189.8
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
...|.+.+.||+|+||.||+|.+. +..||||.... ..+.+|+++|++++|||||++++++.... |+||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346889999999999999999984 56899996432 34678999999999999999999885544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+. ++|.+++.... ..+++.+++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~- 314 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW- 314 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc-
Confidence 94 68888775543 25999999999999999999999999 9999999999999999999999999998663211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCC-Ch---------HHHHHHHHhCcccc-cC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMG-LT---------HFVERSIENGTLGE-ML 674 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~-~~---------~~~~~~~~~~~~~~-~l 674 (782)
.........||+.|+|||++.+..++.++|||||||+||||++|..|+- .. ......+....+.. .+
T Consensus 315 --~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 315 --STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred --ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 1111234579999999999999999999999999999999999886542 11 11222222221110 00
Q ss_pred C--------------------C--CCCCCCh--hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 D--------------------P--TVTDWPF--EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 d--------------------~--~~~~~p~--~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
. + ....|.. .....+.+|+.+||..||++||++.++|.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 0 0011111 12235889999999999999999999984
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.16 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=197.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc------hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA------AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
+|+..+.||+|+||.||+|.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.. ++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 377889999999999999987 67789999986532 113467889999999999999999999987655 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeecccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLV 600 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~ 600 (782)
||||+++++|.+++.+.. ++++..+..++.||+.||.|||+.+ |+|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999886543 5889999999999999999999999 99999999999998775 6999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH---HHHHHHhCcccccCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF---VERSIENGTLGEMLDPT 677 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~ld~~ 677 (782)
....... ........||..|+|||++.+..++.++|||||||++|+|++|..||..... .......... ..
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~ 228 (268)
T cd06630 155 AAKGTGA-GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA-----TT 228 (268)
T ss_pred ccccccC-CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-----CC
Confidence 4321111 1112234688999999999888899999999999999999999999964322 1111111110 01
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+...+..+.+++.+|+..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 12334445567999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.36 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=196.2
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh----------hHHHHHHHHHHHHhcCCCCeeeecccccCcc-
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ----------GRSQFQREIEVLSCIRHPNMVLLLGACPEYG- 519 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~----------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 519 (782)
|...+.||.|+||.||+|.. ++..+|||.++..... ..+.+..|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 67788999999999999986 5778999988642111 1245788999999999999999999986544
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 8999999999999988655 35899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCC--CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCC
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDP 676 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 676 (782)
...... .........|+..|+|||++.... ++.++||||||+++|+|++|..||..........+..... ..+
T Consensus 157 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~ 231 (272)
T cd06629 157 KSDDIY---DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--SAP 231 (272)
T ss_pred cccccc---cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--cCC
Confidence 643211 111223456899999999887655 8899999999999999999999997554443333221110 111
Q ss_pred CC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 677 TV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 677 ~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. .......+..+.+++.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11 1111234567999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=309.14 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=196.4
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcC---CCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIR---HPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~--~lV~ 523 (782)
.|+..+.||.|+||.||+|.+ ++..||+|++.... ......+.+|+.+++.++ |||+++++++|.+.. |+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999997 57789999987542 334567889999999997 999999999886554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999987442 5899999999999999999999999 999999999999999999999999999876322
Q ss_pred cccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
. .......|+..|+|||++.++ .++.++|||||||++|+|++|..||............. ....+.+..
T Consensus 155 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~~~-- 224 (277)
T cd06917 155 S-----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---KSKPPRLED-- 224 (277)
T ss_pred c-----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---cCCCCCCCc--
Confidence 1 122345689999999988765 46899999999999999999999997654433221111 111111111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 114456899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=310.42 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=193.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|+....||+|+||.||+|.+ ++..||+|++.... ....+.+.+|+.+++.++||||+.++++|.... ++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 3588889999999999999998 47789999986432 223456889999999999999999999986544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99998887765432 24899999999999999999999999 9999999999999999999999999998763221
Q ss_pred ccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Ccc---------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTL--------- 670 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~--------- 670 (782)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+..... +..
T Consensus 155 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 155 D-----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred c-----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 1 1223467889999998876 45789999999999999999999999654432221110 000
Q ss_pred -----cccCCCCCCC------CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 671 -----GEMLDPTVTD------WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 671 -----~~~ld~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+.... +....+..+.+|+.+||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 00123456889999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=305.10 Aligned_cols=246 Identities=27% Similarity=0.427 Sum_probs=197.3
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|...+.||+|+||.||++.. .+..+|||.+.... ......+.+|+++|+.++||||+.+++.+.... ++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999987 56789999986542 234567899999999999999999999875443 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla~~~~~~~ 604 (782)
+++++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999986643 235899999999999999999999999 9999999999999754 568999999998663211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChh
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.............. ......+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 224 (256)
T cd08220 157 ------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS------GTFAPISDR 224 (256)
T ss_pred ------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh------cCCCCCCCC
Confidence 11234688999999999888899999999999999999999999976543322211110 111112223
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+..+.+++.+||..+|.+||++.+++.+
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 44568999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=307.27 Aligned_cols=243 Identities=28% Similarity=0.412 Sum_probs=190.7
Q ss_pred ceeeeeCcEeEEEEEECC--------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 457 RKIGEGGYGPVYKCYLDH--------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~--------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.||.|+||.||+|.... ..+|||.+.... ......|.+|+.+++.++||||++++++|.... ++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998732 468999886543 234567899999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-----ceeeecccc
Q 040785 526 LANGSLDDRIFRRG----NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-----VSKISDVGL 596 (782)
Q Consensus 526 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-----~~kL~DFGl 596 (782)
+++|+|.+++.... ....+++.++..++.|++.||.|||+.+ ++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234889999999999999999999999 99999999999999877 899999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCcccccCC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEMLD 675 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld 675 (782)
++...... .........++..|+|||++.++.++.++|||||||++|+|++ |..||..............
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------ 228 (269)
T cd05044 158 ARDIYKSD---YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA------ 228 (269)
T ss_pred cccccccc---ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc------
Confidence 97653211 1111123356788999999999999999999999999999998 9999964433221111000
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
......+...+..+.+++.+||..+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 264 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 011122334456789999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.75 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=194.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|+..+.||+|+||.||+|.+ .+..||+|++..... ...+.+.+|+++++.++||||++++++|.... |+||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 588899999999999999998 467899999865322 23456889999999999999999999996554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.++.... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 82 VDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred CCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 9999888765432 23899999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Cccc---------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTLG--------- 671 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~--------- 671 (782)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|++||......+..... +.+.
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 ----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred ----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 12233568899999998875 45788999999999999999999999644332211110 0000
Q ss_pred -----ccCCCCCC------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 -----EMLDPTVT------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 -----~~ld~~~~------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+... ...+..+..+.+|+.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00011110 011233456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.89 Aligned_cols=234 Identities=23% Similarity=0.347 Sum_probs=184.6
Q ss_pred ceeeeeCcEeEEEEEEC---------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC--ccEEEEEe
Q 040785 457 RKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--YGIIVYEY 525 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey 525 (782)
+.||.|+||.||+|... ...+++|.+........+.|..|+.++..+.||||+++++++.. ..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999863 23488888866544455678899999999999999999999864 34899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc--------eeeeccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV--------SKISDVGLA 597 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~--------~kL~DFGla 597 (782)
+++|+|.+++...+. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999876543 4889999999999999999999999 999999999999987765 699999988
Q ss_pred cccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhC-CCCCCChHHHHHHHHhCcccccCC
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITA-KQPMGLTHFVERSIENGTLGEMLD 675 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~ld 675 (782)
..... .....|++.|+|||++.+. .++.++|||||||++|+|++| ..||..............
T Consensus 156 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------ 220 (258)
T cd05078 156 ITVLP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------ 220 (258)
T ss_pred cccCC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------
Confidence 65421 1234678899999988764 579999999999999999998 466654433221111110
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....|......+.+|+.+||+.+|++||++.+++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01122233356899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.74 Aligned_cols=245 Identities=32% Similarity=0.473 Sum_probs=196.4
Q ss_pred hccccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEeC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYL 526 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~ 526 (782)
.++|.+.+.||.|+||.||+|.+. +..||||.+.... .....+.+|+.+++.++||||+++++++... .++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 456899999999999999999874 4679999987643 3356799999999999999999999998653 38999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-- 157 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh--
Confidence 9999999886543 235899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 683 (782)
........++..|+|||.+.+..++.++|||||||++|+|++ |+.||....... ..+..+. . ...+.
T Consensus 158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~ 227 (261)
T cd05034 158 --YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-----R---MPRPP 227 (261)
T ss_pred --hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----C---CCCCC
Confidence 111112234678999999998889999999999999999998 999996543221 1111110 0 11122
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+..+.+++.+|+..+|++||++.+++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 3345689999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.15 Aligned_cols=246 Identities=27% Similarity=0.391 Sum_probs=201.3
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+|...+.||.|+||.||+|.+ ++..|+||++..... .....+.+|+.++..++||||+++++++.... ++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 588889999999999999998 477899999977643 44678999999999999999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~- 154 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL- 154 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC-
Confidence 999999998654 358999999999999999999999 99 9999999999999999999999999998663211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH--HHHHHHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH--FVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ........-. .......+.
T Consensus 155 ----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 225 (264)
T cd06623 155 ----DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-----DGPPPSLPA 225 (264)
T ss_pred ----CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-----cCCCCCCCc
Confidence 11124568899999999999999999999999999999999999996553 1111111111 111112223
Q ss_pred h-HHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 684 E-ETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 684 ~-~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
. .+..+.+++.+||..+|++||++.+++..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 3 45679999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.60 Aligned_cols=248 Identities=29% Similarity=0.443 Sum_probs=197.0
Q ss_pred ccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCc--cE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEY--GI 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~ 520 (782)
++|.....||.|+||.||+|... ...|++|.+...... ....+.+|+.++.+++||||++++++|.+. .|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45888999999999999999862 346999998654333 456799999999999999999999998664 49
Q ss_pred EEEEeCCCCChhHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecc
Q 040785 521 IVYEYLANGSLDDRIFRRGNT------PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DF 594 (782)
+||||+++|+|.+++...... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998755422 25899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCccc
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLG 671 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~ 671 (782)
|++...... .........++..|+|||.+.++.++.++|||||||++|+|++ |..||...... ...+..+.+.
T Consensus 162 ~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd05046 162 SLSKDVYNS----EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237 (275)
T ss_pred ccccccCcc----cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC
Confidence 998754211 1122233456788999999888889999999999999999999 88899643221 1112222211
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
. + .+...+..+.+++.+||..+|.+||++.+++.
T Consensus 238 ~---~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 238 L---P----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred C---C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1 1 12233456999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=344.30 Aligned_cols=245 Identities=24% Similarity=0.280 Sum_probs=199.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+++.||+|+||.|.++++ +++.||+|++++-.. .....|..|.+||..-..++|++|+.+|.+.. |+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 4589999999999999999998 456899999976322 22356889999999999999999999997755 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|||+||+|..++.+.. .+++..+..++.+|..||.-||+.| +|||||||+|||||..|++||+|||.|-.+...
T Consensus 155 dY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999886655 5999999999999999999999999 999999999999999999999999998776432
Q ss_pred cccccccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTV 678 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 678 (782)
+.......+|||.|++||+++. +.|++.+|+||+||++||||.|..||.....++..-..-.... .
T Consensus 229 ----G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~-----~ 299 (1317)
T KOG0612|consen 229 ----GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE-----S 299 (1317)
T ss_pred ----CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh-----h
Confidence 2334556799999999998763 5699999999999999999999999977766654322211111 1
Q ss_pred CCCC--hhHHHHHHHHHHHhhccCcCCCCC---hHHhh
Q 040785 679 TDWP--FEETLGFAKLALQCSELRRKDRPD---LGKVV 711 (782)
Q Consensus 679 ~~~p--~~~~~~l~~li~~cl~~~P~~RPs---~~~vl 711 (782)
-.+| .+.+....+||.+.+. +|+.|-. ++++-
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 2333 3456678899988775 6777776 66554
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.58 Aligned_cols=186 Identities=24% Similarity=0.360 Sum_probs=157.8
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
.|.+.+.||+|+||.||+|... +..||+|+.... .+..|+.+++.++||||++++++|.... |+||||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 5889999999999999999984 458999985432 2356999999999999999999986544 89999995
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
++|.+++.... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++....
T Consensus 141 -~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 209 (357)
T PHA03209 141 -SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV----- 209 (357)
T ss_pred -CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc-----
Confidence 68888775543 35899999999999999999999999 99999999999999999999999999975321
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf 655 (782)
........||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 11223457999999999999999999999999999999999865544
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.63 Aligned_cols=251 Identities=25% Similarity=0.270 Sum_probs=197.4
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh---hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ---GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...+.||+|+||.||+|.. .+..||||.+...... ....+..|++++..+.||||+++++.+.+.. |+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 588899999999999999998 4679999999765322 4567889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999988643 2346899999999999999999999999 9999999999999999999999999987553211
Q ss_pred ccc------------------------cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH
Q 040785 605 ENV------------------------TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF 660 (782)
Q Consensus 605 ~~~------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~ 660 (782)
... .........||..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 00111234689999999999988899999999999999999999999975543
Q ss_pred HHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC----hHHhh
Q 040785 661 VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD----LGKVV 711 (782)
Q Consensus 661 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~~vl 711 (782)
......... .. ..... ....+..+.+++.+||..+|++||+ +.+++
T Consensus 238 ~~~~~~~~~-~~---~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 238 DETFSNILK-KE---VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHHHHHHhc-CC---ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 322211110 00 01111 1114567999999999999999999 55555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.50 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=197.3
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.|...+.||.|+||.||+|.. ++..||||++.... ......|.+|+.++..++||||++++++|.+.. ++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 378889999999999999987 56789999986432 233467889999999999999999999986544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+...
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--- 154 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--- 154 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc---
Confidence 99999988743 24889999999999999999999999 999999999999999999999999998765321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........|+..|+|||++.+..++.++|||||||++|+|++|..||............. .......+...+
T Consensus 155 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~ 226 (277)
T cd06641 155 --QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------KNNPPTLEGNYS 226 (277)
T ss_pred --hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------cCCCCCCCcccC
Confidence 111223468899999999988889999999999999999999999997544322111110 001112223345
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+.+++.+||..+|..||++.+++.+
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 668999999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=308.90 Aligned_cols=245 Identities=27% Similarity=0.374 Sum_probs=197.5
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+|+..+.||.|+||.||++.+. +..+++|.+.... ......+.+|+++++.++||||+++++.|.... ++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4777889999999999999984 6789999987653 344567899999999999999999999886544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 9999999886543 458999999999999999999999 88 9999999999999999999999999987652211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH----HHHHHHHhCcccccCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH----FVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~----~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||.... .....+... +.......
T Consensus 156 ------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 224 (265)
T cd06605 156 ------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-----VNEPPPRL 224 (265)
T ss_pred ------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-----hcCCCCCC
Confidence 111678899999999988899999999999999999999999996541 111111110 01111112
Q ss_pred Chh-HHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 682 PFE-ETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 682 p~~-~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+.. .+..+.+++.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 222 45569999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.81 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=197.6
Q ss_pred cccccceeeeeCcEeEEEEEEC------CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccC----ccE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPE----YGI 520 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~------~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 520 (782)
.|...+.||+|+||.||+|.+. +..+|||++...... ....|.+|+++++.+.||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4677889999999999999863 568999999765443 46789999999999999999999998865 348
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999865442 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH--------HhCcccc
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--------ENGTLGE 672 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--------~~~~~~~ 672 (782)
..... .........++..|++||++.+..++.++||||||+++|+|++|..||.........+ ....+..
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 160 PEDKD--YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccCCc--ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 42111 1111112345677999999988899999999999999999999999985432110000 0000000
Q ss_pred cCCC-CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 673 MLDP-TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 673 ~ld~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
.+.. .....+...+..+.+++.+||..+|++||++.+++. .|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~-~l~~ 282 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL-IVDR 282 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH-HHhh
Confidence 0000 001112233456999999999999999999998873 4443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.73 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=192.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-----hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-----GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
+|...+.||.|+||.||+|.+ +++.||||.+...... ....+..|+++++.++||||+++++++.+.. ++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 377788999999999999987 5679999999765322 2345678999999999999999999987644 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999886543 35899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHHh-Cc--------
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIEN-GT-------- 669 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~~-~~-------- 669 (782)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||........ .... +.
T Consensus 155 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PN-----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CC-----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 21 12233457889999998755 4578999999999999999999888854332211 1100 00
Q ss_pred ---ccccCC------CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 ---LGEMLD------PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ---~~~~ld------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...... ..........+..+.+++.+||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000 0000011223456889999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.32 Aligned_cols=243 Identities=35% Similarity=0.523 Sum_probs=195.8
Q ss_pred ccccceeeeeCcEeEEEEEECC------eeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYLDH------TPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~------~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
|++.+.||.|+||.||++.+.. ..||+|++...... ....+..|+.++..++||||+++++++.+.. +++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999854 67999999766443 5678999999999999999999999987644 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998865432 12899999999999999999999999 999999999999999999999999999866322
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
. ........+++.|+|||.+.+..++.++||||||+++++|++ |.+||....... ..+..+.. ..
T Consensus 157 ~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 224 (258)
T smart00219 157 D----YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------LP 224 (258)
T ss_pred c----ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------CC
Confidence 1 111112337889999999988889999999999999999998 889986433221 22222221 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+...+..+.+++.+|+..+|++||++.+++
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll 255 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELV 255 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHH
Confidence 1223455699999999999999999999886
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.09 Aligned_cols=247 Identities=28% Similarity=0.457 Sum_probs=204.3
Q ss_pred cccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
...+.++||.|.||.||+|+++ ...||||.|+.... ..+..|..|+.||-++.||||++|-|+..... +||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999982 33799999987644 34678999999999999999999999987655 7899
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|||++|+|+.+|..+.. .|++-+..-++++||.|+.||-+++ +|||||-..|||++.+..+|++||||++.+...
T Consensus 710 EyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999977653 3899999999999999999999999 999999999999999999999999999987443
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH--FVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~ld~~~~~ 680 (782)
.. ..+....-.-..+|.|||.+...+++.+||||||||+|||.++ |..||-... .+-..+++|- . ..
T Consensus 785 ~~--~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy-------R-LP 854 (996)
T KOG0196|consen 785 PE--AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY-------R-LP 854 (996)
T ss_pred CC--ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc-------C-CC
Confidence 21 1121111122468999999999999999999999999999776 999984332 2334455542 1 12
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
-|.+++..|.+|++.||+++..+||.+.++|..
T Consensus 855 pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 367788889999999999999999999999953
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.34 Aligned_cols=244 Identities=29% Similarity=0.408 Sum_probs=198.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeeccccc--CccEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACP--EYGIIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 522 (782)
.+.|..-++||+||||.||-++. +|+.+|.|.+.+.. ........+|-.||.++..|.||.|-.+|. +..|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45688889999999999998876 67789999885432 223345678999999999999999988885 445999
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
+..|+||+|.-.|...++ +.|++..+..++.+|+.||.+||..+ ||+|||||+|||||++|++.|+|+|||..++.
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999988877665 67999999999999999999999999 99999999999999999999999999987753
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-H-HHHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF-V-ERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-~-~~~~~~~~~~~~ld~~~~~ 680 (782)
.......+||.+|||||++.++.|+...|+|||||+||||+.|+.||..... + +..++.-++.. .-.
T Consensus 340 ------g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-----~~e 408 (591)
T KOG0986|consen 340 ------GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-----PEE 408 (591)
T ss_pred ------CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----hhh
Confidence 2233456899999999999999999999999999999999999999953221 1 11222222111 123
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLG 708 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~ 708 (782)
++...+.+...|....|+.||.+|-.-.
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 4455566788999999999999998654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.58 Aligned_cols=251 Identities=26% Similarity=0.321 Sum_probs=192.4
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|+..+.||.|+||.||+|.+ ++..||||.+..... .....+.+|++++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999987 577899999875432 22356889999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 95 68888776543 245899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---Hh-CcccccCC-----
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---EN-GTLGEMLD----- 675 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~~-~~~~~~ld----- 675 (782)
.......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||.......... .. +.....+.
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 ----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 1123345788999999876544 6889999999999999999999996543322111 10 10000000
Q ss_pred -------------CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 676 -------------PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 676 -------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.............+.+++.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000111123345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.35 Aligned_cols=250 Identities=25% Similarity=0.288 Sum_probs=189.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|+..+.||.|+||.||+|.+ ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+.. ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 378889999999999999998 577899999865422 12346788999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 152 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP-- 152 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC--
Confidence 97 57877765433 34899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----h-Cc--------cc
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----N-GT--------LG 671 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~-~~--------~~ 671 (782)
........+++.|+|||++.+.. ++.++|||||||++|+|+||..||.........+. . +. +.
T Consensus 153 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred ---CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence 11123346789999999887654 79999999999999999999988632211111100 0 00 00
Q ss_pred ccCCC-CCCC---------CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDP-TVTD---------WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~-~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+. .... ..+.....+.+|+.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0000 01123456889999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.28 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=195.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+|+..++||.|+||.||+|.+ ++..||||+++..... ....+.+|+.+++.++||||++++++|.+.. ++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 488899999999999999998 5778999999765332 2456778999999999999999999986543 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++ +|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--- 153 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP--- 153 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC---
Confidence 85 88888766554456899999999999999999999999 999999999999999999999999999765321
Q ss_pred ccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHhC-----------ccc
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IENG-----------TLG 671 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~~-----------~~~ 671 (782)
........+|..|++||++.+. .++.++|||||||++|+|++|+.||......+.. .... ...
T Consensus 154 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 154 --VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred --ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 1112334678899999987654 5789999999999999999999999754432211 1000 000
Q ss_pred ccCCCCCC--------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVT--------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..... ...+..+..+.+++.+|++.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 011123456889999999999999999998874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.52 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=188.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHH-HHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEV-LSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~i-L~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|++.+.||+|+||.||++.+ +++.||||+++... ......+..|+.+ ++.+.||||+++++++.... |+||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 588899999999999999998 57899999987643 2233456667765 55668999999999986544 899999
Q ss_pred CCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 526 LANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 526 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
++ |+|.+++... .....+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 96 6888777543 2335699999999999999999999997 7 999999999999999999999999999865321
Q ss_pred cccccccccccccCCcccCChhhhhc----CCCCCchhHHHHHHHHHHHHhCCCCCCChHH-HHHHHHhCcccccCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQT----GMLGVKSDVYSLGILLLQLITAKQPMGLTHF-VERSIENGTLGEMLDPTV 678 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~ld~~~ 678 (782)
...+...|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..... ....... . ....+..
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~-~~~~~~~ 228 (283)
T cd06617 158 ------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV--V-EEPSPQL 228 (283)
T ss_pred ------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH--H-hcCCCCC
Confidence 11223468899999998754 4468899999999999999999999964211 1111100 0 0011111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.. ...+..+.+++.+||..+|.+||++.+++.+
T Consensus 229 ~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 PA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred Cc--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1234568999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.78 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=196.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEeCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYLAN 528 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~~~ 528 (782)
|...+.||.|+||.||++.. .+..+++|.+........+.+.+|+.+++.+.||||+++++++... .|+|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 55567999999999999987 5678999998765555566789999999999999999999987543 4899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+.+.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---- 169 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---- 169 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC----
Confidence 999998865 24889999999999999999999999 9999999999999999999999999887553211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ .....+.. ..+...+..
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~ 244 (285)
T cd06648 170 -PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---RDNLPPKL-KNLHKVSPR 244 (285)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH---HhcCCCCC-cccccCCHH
Confidence 1122356899999999998888999999999999999999999999654433221111 01111111 112224456
Q ss_pred HHHHHHHhhccCcCCCCChHHhhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+++.+||..+|++||++.+++.
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHcc
Confidence 999999999999999999998884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.17 Aligned_cols=240 Identities=30% Similarity=0.423 Sum_probs=191.2
Q ss_pred ceeeeeCcEeEEEEEEC-CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCChh
Q 040785 457 RKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLD 532 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~ 532 (782)
++||.|+||.||++.+. ++.|++|.+...... ....|.+|+++++.+.||||+.+++++.+.. ++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999884 789999998765333 4567999999999999999999999986554 8999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccccccc
Q 040785 533 DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612 (782)
Q Consensus 533 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 612 (782)
+++.... ..+++..+..++.+++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~ 152 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY---TVSD 152 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc---eecc
Confidence 9886543 24889999999999999999999999 99999999999999999999999999976531110 0011
Q ss_pred ccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChhHHHHH
Q 040785 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEETLGF 689 (782)
Q Consensus 613 ~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l 689 (782)
....++..|+|||++.++.++.++|||||||++|+|++ |..||....... ..+..+. .. ..+...+..+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~ 224 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-----RM---PAPQLCPEEI 224 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-----CC---CCCccCCHHH
Confidence 12234667999999988899999999999999999999 899986543221 1111110 00 1123345579
Q ss_pred HHHHHHhhccCcCCCCChHHhhh
Q 040785 690 AKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 690 ~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+++.+||..+|.+||++.+++.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999988873
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.95 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=203.9
Q ss_pred cccceeeeeCcEeEEEEEEC---C--eeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeC
Q 040785 454 TESRKIGEGGYGPVYKCYLD---H--TPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYL 526 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~~---~--~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~ 526 (782)
...++||+|+||.|++|.|+ + -.||||+++.+... ....|.+|+.+|.+|+|||+++|||+..+.. .+|+|++
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELa 192 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELA 192 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhc
Confidence 44678999999999999983 3 37999999887544 5788999999999999999999999997654 7999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
+.|+|.++|.+ .....|.......++.|||.||.||.+++ +|||||-..||||-....+||+||||.+-+...
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n--- 265 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN--- 265 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC---
Confidence 99999999987 44567888999999999999999999999 999999999999999999999999999977432
Q ss_pred cccccccc-ccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCC
Q 040785 607 VTQYHLTS-TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 607 ~~~~~~~~-~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p 682 (782)
...|.++. ..-.+.|+|||.+....++.++|||+|||+||||+| |..||-+..-... .++.+ .....|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------erLpRP 337 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------ERLPRP 337 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--------ccCCCC
Confidence 23344332 234568999999999999999999999999999998 8899965443222 22211 223446
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..++.++.+++..||..+|.+||++..+..
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 778889999999999999999999998864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.94 Aligned_cols=231 Identities=26% Similarity=0.364 Sum_probs=191.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...+.||.|+||.||++.+ .+..||+|++.... ......+.+|+++|+++.||||+++++++.+.. ++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 588899999999999999988 56789999986532 223456889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999986653 4889999999999999999999999 999999999999999999999999998865321
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ..+..+. ...|
T Consensus 155 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~ 218 (290)
T cd05580 155 -------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK---------VRFP 218 (290)
T ss_pred -------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------ccCC
Confidence 233568999999999988889999999999999999999999997654322 1111111 1122
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 040785 683 FEETLGFAKLALQCSELRRKDRP 705 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RP 705 (782)
...+..+.+++.+||..+|.+||
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHcc
Confidence 33345689999999999999999
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.66 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=197.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|...+.||+|+||.||+|.. ++..|++|+++..... ....+..|+.+++.++||||+++++++.... ++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999987 5678999999765442 5678899999999999999999999885544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++... ..+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999988653 24788999999999999999999999 99999999999999999999999999987643221
Q ss_pred cccccccccccCCcccCChhhhhcCC---CCCchhHHHHHHHHHHHHhCCCCCCChHH-HHHHHHhCcccccCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQLITAKQPMGLTHF-VERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~ld~~~~~~ 681 (782)
... .......|+..|+|||++.... ++.++||||||+++|+|++|+.||..... ......... ...+.++.+
T Consensus 155 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (264)
T cd06626 155 TMG-EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPDS 230 (264)
T ss_pred ccc-ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCcc
Confidence 111 1012356889999999988766 89999999999999999999999964421 111111111 111222221
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+++.+||+.+|.+||++.+++.
T Consensus 231 -~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 231 -LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 122456889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.23 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=201.5
Q ss_pred HhccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++.|+..+.||.|+||.||+|.+. +..|++|++..... ....+.+|++++..++||||++++++|.... ++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3556888899999999999999984 77899999976544 4567889999999999999999999885444 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997654 35899999999999999999999999 9999999999999999999999999987553211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChh
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.......|+..|++||++.+..++.++|||||||++|+|++|..||............... .. +.. ..+..
T Consensus 171 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~-~~~-~~~~~ 241 (286)
T cd06614 171 -----SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GI-PPL-KNPEK 241 (286)
T ss_pred -----hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CC-CCC-cchhh
Confidence 1112345788999999998888999999999999999999999999765543322221110 00 111 11122
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+.+++.+||+.+|..||++.+++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 3456899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.88 Aligned_cols=249 Identities=22% Similarity=0.261 Sum_probs=193.3
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...+.||+|+||.||++.. .++.|++|.+..... .....+.+|++++..++||||+++++.+.... ++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999988 456899999876532 23456889999999999999999999886655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999985543 4899999999999999999999999 9999999999999999999999999987421100
Q ss_pred ----------ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccC
Q 040785 605 ----------ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEML 674 (782)
Q Consensus 605 ----------~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l 674 (782)
............|+..|+|||++.+..++.++|||||||++|+|++|..||......+ ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccC
Confidence 0001111223468889999999988889999999999999999999999996443221 11111111111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHh
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
.+.. +...+..+.+++.+||+.+|++||+...+
T Consensus 235 ~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 235 WPEG---DEALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred CCCc---cccCCHHHHHHHHHHhccChhhccCccCH
Confidence 1111 11334568999999999999999996433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=297.16 Aligned_cols=245 Identities=28% Similarity=0.432 Sum_probs=200.5
Q ss_pred ccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
|...+.||.|+||.||++... +..+++|++..........+.+|+++++.++||||+.+++++.... ++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 778899999999999999984 7789999998765545678999999999999999999999885543 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++.... ..+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999886543 35899999999999999999999998 99999999999999999999999999986632211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
.....|+..|++||++....++.++||||||+++|+|++|+.||............... ..+.. ..+...+..
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~ 226 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN---GPPGL-RNPEKWSDE 226 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---CCCCc-CcccccCHH
Confidence 23456889999999998888999999999999999999999999765333322222110 00111 111222456
Q ss_pred HHHHHHHhhccCcCCCCChHHhhh
Q 040785 689 FAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+++.+||..+|++||++.+++.
T Consensus 227 ~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 227 FKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999998874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.30 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=195.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|.+.+.||.|+||.||+|.+ +++.|+||++.... ......+.+|+.+++.++||||+++++++.... ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 378889999999999999997 57799999987643 223467899999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+ +++|.+.+.... .++++.++..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 45999999999999999999999999 99999999999999999999999999986632211
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHH---HHHHh-Ccc----------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIEN-GTL---------- 670 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~---~~~~~-~~~---------- 670 (782)
.......|+..|+|||++.+. .++.++|||||||++|+|++|.+||....... ..+.. +..
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 112345789999999987654 46899999999999999999988886443211 11110 000
Q ss_pred ----cccCCCCC-----CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 671 ----GEMLDPTV-----TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 671 ----~~~ld~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+..+.. .....+.+..+.+|+.+||..+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 01112334678999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.48 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=191.3
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++.|...+.||+|+||.||+|.. ++..||+|++...... ....+.+|+.+++.++|+||+++++++.+.. |+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999987 5779999998654322 2346788999999999999999999986544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP- 156 (291)
T ss_pred ccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC-
Confidence 996 67776664432 34788889999999999999999999 999999999999999999999999998754221
Q ss_pred ccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh-----Cccc-------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN-----GTLG------- 671 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~-----~~~~------- 671 (782)
........+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+.. +...
T Consensus 157 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 ----SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred ----CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 1112334678999999987654 5788999999999999999999999654332111111 0000
Q ss_pred --------ccCCCCCCC-----C-ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 --------EMLDPTVTD-----W-PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 --------~~ld~~~~~-----~-p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......... + ....+..+.+++.+|+..+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0 0012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.95 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=190.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.|...+.||.|+||.||+|.. +++.||||.+...... ....+.+|+++++.++||||+++++++.+.. ++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 4588899999999999999987 5678999998754322 2345778999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++ +|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 156 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP-- 156 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC--
Confidence 975 89888765432 5899999999999999999999999 999999999999999999999999998754211
Q ss_pred cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH----Hh-CcccccC-----
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI----EN-GTLGEML----- 674 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~----~~-~~~~~~l----- 674 (782)
........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+ .. +......
T Consensus 157 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 ---SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred ---CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 111123357889999998765 458999999999999999999999996443111110 00 0000000
Q ss_pred ---------CCCCCC------CC-hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 ---------DPTVTD------WP-FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 ---------d~~~~~------~p-~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.... .+ ......+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 00 011145789999999999999999998874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.56 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=197.5
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|...+.||.|+||.||+|.. ++..+|+|.+.... ......+.+|+.+++.++||||+++++.+.... ++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478889999999999999998 56789999986542 123457889999999999999999999986654 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~ 604 (782)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999998865432 35899999999999999999999999 99999999999998875 56999999987653211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChh
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.......|++.|+|||++.+..++.++|||||||++++|++|..||............. ...+.+ .+..
T Consensus 157 -----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~----~~~~ 225 (257)
T cd08225 157 -----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--QGYFAP----ISPN 225 (257)
T ss_pred -----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh--cccCCC----CCCC
Confidence 11123468999999999988889999999999999999999999997554433222111 111111 1223
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+.+++.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 3456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.67 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=183.7
Q ss_pred eeeeeCcEeEEEEEE-CC---eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCC
Q 040785 458 KIGEGGYGPVYKCYL-DH---TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGS 530 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~-~~---~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 530 (782)
.||+|+||.||+|.. ++ ..+++|.+.... ......|.+|+.+++.++||||+++++.|.+.. |+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975 22 246677776543 334568999999999999999999999987544 89999999999
Q ss_pred hhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 531 LDDRIFRRGN-TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 531 L~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
|.+++.+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~---~~ 155 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED---YI 155 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch---hh
Confidence 9999876432 234677788899999999999999999 9999999999999999999999999986431110 00
Q ss_pred cccccccCCcccCChhhhhc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH---HHHHhCcccccCCCCC
Q 040785 610 YHLTSTAGTFCYIDPEYQQT-------GMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE---RSIENGTLGEMLDPTV 678 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~---~~~~~~~~~~~ld~~~ 678 (782)
.......|+..|+|||++.. ..++.++|||||||++|||++ |..||......+ ..+ .+......+|.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI-KDQQVKLFKPQL 234 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hhcccccCCCcc
Confidence 11224568899999998743 235789999999999999997 577885433322 222 222223333333
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
. ......+.+++..|| .+|++||++.+++
T Consensus 235 ~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~ 263 (268)
T cd05086 235 E---LPYSERWYEVLQFCW-LSPEKRATAEEVH 263 (268)
T ss_pred C---CCCcHHHHHHHHHHh-hCcccCCCHHHHH
Confidence 2 234456888999999 6899999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.46 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=192.8
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
|+..+.||.|++|.||+|.+ +++.||+|++..... .....+.+|+++++.++||||+++++++.+.. |++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999987 678999999875432 22356889999999999999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
+ ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--- 152 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP--- 152 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC---
Confidence 5 689888865432 35899999999999999999999998 999999999999999999999999999755221
Q ss_pred ccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Ccc-----------
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTL----------- 670 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~----------- 670 (782)
........++..|+|||++.+. .++.++|||||||++|+|++|+.||............ +..
T Consensus 153 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 153 --VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 1112234578899999987654 5789999999999999999999999654432211110 000
Q ss_pred -------cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 671 -------GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 671 -------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+.........+..+.+++.+|++.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000001111112233456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.56 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=195.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|+..+.||.|+||.||+|.+ ++..||||.++... ......+.+|+++++.++||||++++++|.... ++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 588899999999999999988 46689999986532 223567899999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++++.+..++... ..+++.++..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9987776554332 24899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Cccc---------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTLG--------- 671 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~--------- 671 (782)
.......|+..|+|||++.+. .++.++||||||+++|+|++|++||............ +.+.
T Consensus 156 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 156 ----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 122345688999999998888 7899999999999999999999999754333221110 0000
Q ss_pred -------ccCCCCCC-----CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 -------EMLDPTVT-----DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 -------~~ld~~~~-----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
........ .++...+..+.+|+.+||..+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 112223567999999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=302.20 Aligned_cols=246 Identities=23% Similarity=0.381 Sum_probs=192.6
Q ss_pred ccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 453 FTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
|.+.+.||+|+||.||+|.+ .+..||||++..+. ....+.+.+|+.+|+.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 55678899999999999986 24689999987542 33456788999999999999999999987421
Q ss_pred -cEEEEEeCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRG---NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DF 594 (782)
.+++++|+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 268899999999988775321 2234789999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCccc
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLG 671 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~ 671 (782)
|+++...... .........+++.|++||.+....++.++|||||||++|+|++ |++||....... ..+..+..
T Consensus 158 g~~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 233 (273)
T cd05074 158 GLSKKIYSGD---YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR- 233 (273)
T ss_pred cccccccCCc---ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 9998653211 1111123345678999999998889999999999999999999 899996554322 11211110
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 234 -------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 234 -------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122334457999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.89 Aligned_cols=252 Identities=26% Similarity=0.308 Sum_probs=191.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCCeeeecccccCc--cEEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIR-HPNMVLLLGACPEY--GIIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~lV~Ey 525 (782)
+|...+.||+|+||.||++.+ +++.||+|.+.... ......+.+|+.++.++. ||||+++++++... .+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 356678899999999999998 56789999987543 234567889999999996 99999999987544 3899999
Q ss_pred CCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 526 LANGSLDDRIFR--RGNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 526 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
+.. +|.++... ......+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55554321 11224589999999999999999999975 7 99999999999999999999999999976532
Q ss_pred ccccccccccccccCCcccCChhhhhcC---CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTG---MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
. .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+.... ....+.+.
T Consensus 161 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~ 232 (288)
T cd06616 161 S------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV--KGDPPILS 232 (288)
T ss_pred C------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc--CCCCCcCC
Confidence 1 111334689999999988776 689999999999999999999999964432111111110 00111111
Q ss_pred -CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 680 -DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 680 -~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
..+...+..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 111235567999999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.56 Aligned_cols=242 Identities=24% Similarity=0.268 Sum_probs=197.0
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|...+.||.|+||.||+|.+. +..||+|++.... ....+.+.+|++++++++||||+.+++++.+.. ++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999984 7799999997542 234567899999999999999999999886544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+.+++|.+.+... .++++..+..|+.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988654 35899999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH--HHHHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF--VERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p 682 (782)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ......... ......|
T Consensus 155 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~ 222 (258)
T cd05578 155 ------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE------TADVLYP 222 (258)
T ss_pred ------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc------cccccCc
Confidence 12345688899999999888899999999999999999999999975432 111111111 0111223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCCh--HHhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDL--GKVV 711 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~--~~vl 711 (782)
...+..+.+++.+||..+|.+||++ .+++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 3445679999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.13 Aligned_cols=243 Identities=29% Similarity=0.400 Sum_probs=192.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
..|...+.||+|+||.||+|.. .+..||+|++.... ......+.+|+++++.++||||++++++|.+.. ++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3488889999999999999987 57799999986432 233456889999999999999999999986543 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||++ |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC-
Confidence 9997 57777665433 34899999999999999999999999 99999999999999999999999999875421
Q ss_pred cccccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 680 (782)
.....|+..|+|||++. .+.++.++||||||+++|+|++|..||.............. ...+...
T Consensus 168 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~- 235 (307)
T cd06607 168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPTLS- 235 (307)
T ss_pred --------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCCCCCC-
Confidence 12346888999999864 45688999999999999999999999975544332221110 0011111
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 -SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 12234568999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=300.68 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=194.4
Q ss_pred cccccceeeeeCcEeEEEEEEC---CeeEEEEEecCCc----------hhhHHHHHHHHHHHHh-cCCCCeeeecccccC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD---HTPVAVKVLRPDA----------AQGRSQFQREIEVLSC-IRHPNMVLLLGACPE 517 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~---~~~vAvK~l~~~~----------~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~ 517 (782)
.|++.+.||+|+||.||+|.+. +..+|+|.+.... ......+.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3778889999999999999984 4689999885421 2234457789988875 799999999999866
Q ss_pred cc--EEEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeec
Q 040785 518 YG--IIVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISD 593 (782)
Q Consensus 518 ~~--~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~D 593 (782)
.. ++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ |+|+||||.|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 54 8999999999999987542 223458999999999999999999996 56 99999999999999999999999
Q ss_pred cccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCccc
Q 040785 594 VGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLG 671 (782)
Q Consensus 594 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~ 671 (782)
||++....... ......|+..|++||++.++.++.++||||||+++|+|++|+.||......... +..+..
T Consensus 158 fg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~- 230 (269)
T cd08528 158 FGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY- 230 (269)
T ss_pred ccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC-
Confidence 99998653211 234457899999999999888999999999999999999999999765443221 111111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+... ...+..+.+++.+||..+|++||++.++..
T Consensus 231 ---~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 231 ---EPLPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred ---CcCCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 11111 123356899999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=314.80 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=194.5
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 517 (782)
..+.|...+.||+|+||.||+|.+ +++.||||++... .......+.+|+.++.+++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 346799999999999999999987 5779999998643 22334567789999999999999999998742
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..|+||||+. ++|.+.+... +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2389999996 5787776432 788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHH-hCc---
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIE-NGT--- 669 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~-~~~--- 669 (782)
++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.... .+. .+.
T Consensus 165 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCC------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9865321 112345688999999999999999999999999999999999999964432110 000 000
Q ss_pred ------------------------ccccCC----CCCC-CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 670 ------------------------LGEMLD----PTVT-DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 670 ------------------------~~~~ld----~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
+...+. +... ..+...+..+.+++.+||..+|++||++.++|.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 000000 0000 001123456889999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=299.49 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=198.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCCeeeecccccCc----c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD-----AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----G 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 519 (782)
.+|.+.+.||+|+||.||+|.+ ++..||+|.+... .......+.+|+++++.++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3588899999999999999987 5678999987532 123345788999999999999999999988542 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++|+||+++++|.+.+...+ .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999886543 3789999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
...... .........|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. .+...
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~ 228 (264)
T cd06653 156 IQTICM--SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTKP 228 (264)
T ss_pred cccccc--cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-----CCCCC
Confidence 532111 11112335689999999999888899999999999999999999999976544433322211 11112
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..|......+.+++.+||. +|..||+..+++.
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 2344555679999999999 5799999987764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=317.30 Aligned_cols=242 Identities=29% Similarity=0.469 Sum_probs=202.7
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.......++||-|-||.||.|.+. .-.||||.++.+. ...++|..|+.+|+.++|||+|+|+|+|.... |||.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 334566789999999999999994 3479999998764 44789999999999999999999999996554 999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
|..|+|.++|.+.+. ..++--..+.++.||..|+.||..++ +|||||-..|.|+.++..+||+||||++++..+
T Consensus 345 M~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-- 418 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-- 418 (1157)
T ss_pred ccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCC--
Confidence 999999999977654 34666677899999999999999999 999999999999999999999999999987432
Q ss_pred cccccccccccC---CcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 606 NVTQYHLTSTAG---TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 606 ~~~~~~~~~~~G---t~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
..+..+| .+-|.|||-+....++.|+|||+|||+|||+.| |-.||-..+. +-..+++|-- -
T Consensus 419 -----TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR--------M 485 (1157)
T KOG4278|consen 419 -----TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR--------M 485 (1157)
T ss_pred -----ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--------c
Confidence 2222333 567999999999999999999999999999998 8889866554 3344555421 2
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+.|..++....+|++.||+.+|.+||+++++-
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 34566777899999999999999999998875
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=314.28 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=192.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------c
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------G 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~ 519 (782)
+++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999987 57789999986532 22345678899999999999999999876432 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||+.+ +|.+.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 77776632 24899999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---H---h---Cc
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---E---N---GT 669 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~---~---~~ 669 (782)
....... ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+...... + . ..
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccc--cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 5322111 112234578999999998654 468999999999999999999999996543321110 0 0 00
Q ss_pred ccccCC----------CCCCC-----CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 670 LGEMLD----------PTVTD-----WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 670 ~~~~ld----------~~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+..+.+ +.... ..+.....+.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00000 011234568899999999999999999998853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.20 Aligned_cols=253 Identities=24% Similarity=0.272 Sum_probs=191.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcC-CCCeeeecccccC--c-----c
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIR-HPNMVLLLGACPE--Y-----G 519 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~-----~ 519 (782)
+|+..+.||.|+||.||+|.+ +++.||||.+..... .....+.+|+.+++.+. ||||+++++++.. . .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 588899999999999999998 577899999865422 12356888999999995 6999999998743 2 3
Q ss_pred EEEEEeCCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeecccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGN--TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGL 596 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGl 596 (782)
|+||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 899999985 78887765432 346899999999999999999999999 999999999999998 89999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Cccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~ 671 (782)
+..+... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||............ +...
T Consensus 158 ~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 158 GRAFSIP-----VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred ceecCCC-----ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 8765221 111223457889999998765 45799999999999999999999999654333221110 0000
Q ss_pred ccCCCC---------CCC--------CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 672 EMLDPT---------VTD--------WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 672 ~~ld~~---------~~~--------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
....+. ... ..+..+..+.+||.+||..+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 000 011244568999999999999999999998853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.96 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=190.7
Q ss_pred ccccceeeeeCcEeEEEEEE----CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL----DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GII 521 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~----~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~l 521 (782)
|...+.||+|+||.||+|.. .+..||+|.+.... ......+.+|+.++..++||||++++++|.+. .++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 77889999999999999998 35789999997632 23345678899999999999999999998655 389
Q ss_pred EEEeCCCCChhHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC----CCceeeeccc
Q 040785 522 VYEYLANGSLDDRIFRRG--NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH----NYVSKISDVG 595 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~----~~~~kL~DFG 595 (782)
||||+++ +|.+.+.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 6666664322 2236899999999999999999999999 999999999999999 9999999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHH------------
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVE------------ 662 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~------------ 662 (782)
++..+..... .........+|+.|+|||++.+. .++.++|||||||++|+|++|++||.......
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 158 LARLFNAPLK--PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccccCCCcc--cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 9987632211 11222345789999999987664 58999999999999999999999996332110
Q ss_pred HHHH---------------hCcccccCC-CCCCCCC-----------hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 663 RSIE---------------NGTLGEMLD-PTVTDWP-----------FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 663 ~~~~---------------~~~~~~~ld-~~~~~~p-----------~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+. ...+....+ ......+ ......+.+++.+||..+|++||++.+++.
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 000000000 0000011 023346889999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.24 Aligned_cols=252 Identities=23% Similarity=0.266 Sum_probs=192.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccC----ccEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPE----YGIIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~lV 522 (782)
++|+..+.||.|+||.||+|.+ +++.+++|.++..... ....+.+|+.++.+++||||+.+++++.. ..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 3588899999999999999998 4678999999754322 23356789999999999999999998753 34999
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 489888865432 5899999999999999999999999 99999999999999999999999999986632
Q ss_pred ccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHh-----------
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IEN----------- 667 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~----------- 667 (782)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||......... ...
T Consensus 159 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 159 PL-----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred Cc-----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 11 112334678899999988654 4689999999999999999999999654322110 000
Q ss_pred ---------CcccccCCCCC-CCCChh-HHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 668 ---------GTLGEMLDPTV-TDWPFE-ETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 668 ---------~~~~~~ld~~~-~~~p~~-~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..........+ ..++.. ....+.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000 111111 35568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=307.20 Aligned_cols=258 Identities=21% Similarity=0.235 Sum_probs=194.9
Q ss_pred cccceeeeeCcEeEEEEEECCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 454 TESRKIGEGGYGPVYKCYLDHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
.+.+.+|.|+++.||++..+++.||||++... .......+.+|+++++.++||||+++++++.+.. +++|||+++|
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34455667777777777778899999999764 2344567999999999999999999999886544 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc--c
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN--V 607 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~--~ 607 (782)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+......... .
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99998875432 34889999999999999999999999 999999999999999999999999998755322111 0
Q ss_pred cccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh--CcccccCC--------
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN--GTLGEMLD-------- 675 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~ld-------- 675 (782)
.........++..|+|||++... .++.++|||||||++|+|++|..||..........+. +.....++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 11112345678899999988763 5889999999999999999999999755433322211 11111111
Q ss_pred ------------CCC-----CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 676 ------------PTV-----TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 676 ------------~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
+.. ...+......+.+|+.+||..+|++||++.+++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000 0011223456889999999999999999999985444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.56 Aligned_cols=236 Identities=27% Similarity=0.377 Sum_probs=188.3
Q ss_pred eeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
||+|+||+||+|.. +++.||+|++.... ......+..|+++|+.++||||+.+++.+.... |+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999987 57789999986532 223446778999999999999999999885443 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+++..... ..+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------~~~ 150 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKK 150 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc------CCc
Confidence 998876543 35899999999999999999999999 99999999999999999999999999876532 111
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH--HHHHHHhCcccccCCCCCCCCChhHHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF--VERSIENGTLGEMLDPTVTDWPFEETLGF 689 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 689 (782)
.....|+..|+|||++.++.++.++|||||||++|+|++|+.||..... ....+...... .....+...+..+
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 225 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----MAVEYPDKFSPEA 225 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----ccccCCccCCHHH
Confidence 2234678899999999888899999999999999999999999965432 11112222111 1112233345568
Q ss_pred HHHHHHhhccCcCCCCChHH
Q 040785 690 AKLALQCSELRRKDRPDLGK 709 (782)
Q Consensus 690 ~~li~~cl~~~P~~RPs~~~ 709 (782)
.+++.+||+.+|.+||++.+
T Consensus 226 ~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHccCChhHccCCCc
Confidence 99999999999999996555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.18 Aligned_cols=248 Identities=24% Similarity=0.302 Sum_probs=193.4
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCC--chhhHHHHHHHHHHHHhc-CCCCeeeecccccCc--cEEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY--GIIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~--~~lV~E 524 (782)
..|+++++||.||.+.||++.. +.+.+|+|.+... +.+....|.+|+..|.+| .|.+||+||+|--.. .|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 3489999999999999999988 4567788776543 345577899999999999 499999999986433 489999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|= ..+|-.+|.+..... ..| .+..+..|++.|+.++|+.| |||-||||.|+|+- .|.+||+|||+|..+...
T Consensus 441 ~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D- 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD- 512 (677)
T ss_pred cc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc-
Confidence 75 458988887665432 334 67788999999999999999 99999999999995 468999999999987543
Q ss_pred ccccccccccccCCcccCChhhhhcCC-----------CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCccccc
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGM-----------LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEM 673 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----------~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 673 (782)
.+.......+||+.||+||.+.... ++.++||||||||||+|+.|++||+...... .++..+
T Consensus 513 --TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~-----aKl~aI 585 (677)
T KOG0596|consen 513 --TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI-----AKLHAI 585 (677)
T ss_pred --ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----HHHHhh
Confidence 2445556789999999999876432 5689999999999999999999997544322 233444
Q ss_pred CCCCCC-CCChhH-HHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 674 LDPTVT-DWPFEE-TLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 674 ld~~~~-~~p~~~-~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+|... .+|... ..++.+++..||.+||.+||+..++|.+
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 555321 222111 1128999999999999999999999844
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=304.33 Aligned_cols=253 Identities=24% Similarity=0.295 Sum_probs=191.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|+..+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+++++.++||||+++++++.+.. |+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 3588899999999999999987 567899999865422 22456889999999999999999999986544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~~~~~ 603 (782)
|++ ++|.+.+..... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578777754432 34688888999999999999999999 999999999999985 567999999999765321
Q ss_pred cccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Ccc-cccCC--
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTL-GEMLD-- 675 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~-~~~ld-- 675 (782)
....+...|++.|+|||++.+. .++.++|||||||++|+|+||++||............ +.. ....+
T Consensus 157 -----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 -----VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred -----ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 1112334678999999987664 5789999999999999999999999654332211110 000 00000
Q ss_pred -------CCCCC--------CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 676 -------PTVTD--------WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 676 -------~~~~~--------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..... ..+..+..+.+++.+|++.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 112234568899999999999999999999853
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.55 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=201.8
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~ 523 (782)
+|...+.||+|+||.||+|... ++.|++|++..... ...+.+.+|+.++++++||||+++++.+.+. .++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3777899999999999999984 77899999876542 3467789999999999999999999998655 38999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999886544 5899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH-HHHHHHHhCcccccCCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH-FVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~-~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
... .......++..|++||++.+..++.++||||||+++++|++|..||.... .......... .......|
T Consensus 155 ~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 226 (260)
T cd06606 155 ETG---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----SGEPPEIP 226 (260)
T ss_pred ccc---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----cCCCcCCC
Confidence 110 01234568899999999988889999999999999999999999997654 1111111110 01112233
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+..+.+++.+|+..+|.+||++.+++.+
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 4445679999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=304.65 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=194.3
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEeCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYLAN 528 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~~~ 528 (782)
|....+||+|+||.||++.. ++..||||.+..........+.+|+.+++.++||||+++++.+... .++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 33446799999999999987 5779999998655445566789999999999999999999988544 4899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---- 170 (292)
T cd06657 102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 170 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc----
Confidence 9999877432 4789999999999999999999999 9999999999999999999999999987553211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+ +.+.... ....+
T Consensus 171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~ 243 (292)
T cd06657 171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-----LPPKLKN-LHKVS 243 (292)
T ss_pred -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-----CCcccCC-cccCC
Confidence 112235688999999998888899999999999999999999999975443321 11111 1111111 12234
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+.+++.+||..+|.+||++.+++.+
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 458899999999999999999998853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.95 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=200.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|+..+.||.|+||.||++.. .+..|++|.+..... .....+.+|++++++++|||++++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 377889999999999999987 467899999976643 34567999999999999999999999886544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988654 35899999999999999999999999 99999999999999999999999999987632211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhH
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
......|+..|+|||+..+..++.++||||||+++|+|++|..||.............. ......+...
T Consensus 155 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~ 223 (254)
T cd06627 155 -----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPLPEGI 223 (254)
T ss_pred -----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------cCCCCCCCCC
Confidence 12335689999999998888889999999999999999999999975544332222211 1111223344
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..+.+++.+||..+|++||++.+++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 567899999999999999999998874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.72 Aligned_cols=253 Identities=24% Similarity=0.286 Sum_probs=194.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
.+.|.+.+.||+|+||.||+|.+ +++.||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35689999999999999999997 5679999998653 222345677899999999999999999987432
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.|+||||+. ++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 389999995 6888877543 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH------------
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI------------ 665 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~------------ 665 (782)
...... .......||..|+|||++.. ..++.++|||||||++|+|++|+.||.........-
T Consensus 157 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 653211 12234467899999998765 468999999999999999999999996543221100
Q ss_pred -----HhCc-------ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 666 -----ENGT-------LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 666 -----~~~~-------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.... .....++.........+..+.+++.+||+.+|++||++.+++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 0000 000001111111223456689999999999999999999998543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=312.21 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=194.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC------ccE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE------YGI 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~ 520 (782)
++|+..+.||.|+||.||+|.. ++..||+|++.... ......+.+|+.+|..++||||++++++|.. ..+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5799999999999999999987 57799999987542 2234567889999999999999999988742 238
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+. |+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68888775432 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH----HhCc------
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI----ENGT------ 669 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~----~~~~------ 669 (782)
...... .........|+..|+|||++.. ..++.++|||||||++|+|++|+.||.......... ..|.
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTE-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcC-CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 322111 1112234578999999998765 458999999999999999999999996543221110 0000
Q ss_pred -------ccccCC--CCCCC-----CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 670 -------LGEMLD--PTVTD-----WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 670 -------~~~~ld--~~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+....+ +.... .....+..+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 00001 112235669999999999999999999998853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=320.32 Aligned_cols=240 Identities=23% Similarity=0.406 Sum_probs=187.9
Q ss_pred ceeeeeCcEeEEEEEECCe--eEE---EEEecC-CchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc----EEEEEeC
Q 040785 457 RKIGEGGYGPVYKCYLDHT--PVA---VKVLRP-DAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG----IIVYEYL 526 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~~--~vA---vK~l~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----~lV~Ey~ 526 (782)
..||+|+|-+||+|.+..+ .|| ||+-.. ......+.|..|+.+|+.|+|||||++|.++.+.. .+|.|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 4699999999999998554 343 222111 12344678999999999999999999999985433 6899999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~~ 605 (782)
..|+|..++.+.+. +....+..|+.||+.||.|||++.| ||||||||.+||+|+. -|.|||+|+|||+...
T Consensus 126 TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r---- 197 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR---- 197 (632)
T ss_pred cCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhh----
Confidence 99999999876653 6778999999999999999999985 7999999999999975 4899999999998763
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~~~~~~~ld~~~~~~p 682 (782)
..+.....|||.|||||++. ..|+..+||||||++|+||+|+..||.--...... +-.|....- +....
T Consensus 198 ---~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s----l~kV~ 269 (632)
T KOG0584|consen 198 ---KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA----LSKVK 269 (632)
T ss_pred ---ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH----hhccC
Confidence 33445689999999999876 78999999999999999999999999633222222 122221111 11111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
.+++.+||.+|+.. ..+||++.++|.+.+.
T Consensus 270 ---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff 299 (632)
T KOG0584|consen 270 ---DPEVREFIEKCLAT-KSERLSAKELLKDPFF 299 (632)
T ss_pred ---CHHHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence 23589999999999 9999999999865543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=301.70 Aligned_cols=247 Identities=22% Similarity=0.273 Sum_probs=187.4
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCCeeeecccccCc----cEEEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIR-HPNMVLLLGACPEY----GIIVYE 524 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~----~~lV~E 524 (782)
|...+.||+|+||.||+|.. +++.||+|+++.... .......+|+.++.++. ||||++++++|.+. .++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999987 577899999875422 22234457999999885 99999999998654 389999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|++ |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~- 152 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK- 152 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC-
Confidence 997 57877775533 35899999999999999999999999 999999999999999 99999999999865321
Q ss_pred ccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Cc----------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GT---------- 669 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~---------- 669 (782)
.......++..|+|||++.. +.++.++|||||||++|||++|..||...+..+..... +.
T Consensus 153 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 -----PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred -----CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 11123467899999997654 55789999999999999999999999654432211000 00
Q ss_pred ---ccccCCCC-CC----CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 ---LGEMLDPT-VT----DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ---~~~~ld~~-~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......+. .. ......+..+.+|+.+||..+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 00 011234567999999999999999999998874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.83 Aligned_cols=243 Identities=29% Similarity=0.442 Sum_probs=199.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|++.+.||.|+||.||++.. ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999987 56689999987542 233556789999999999999999998886544 899999
Q ss_pred CCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
+++++|.+++.+.. ....+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999886632 2345899999999999999999999999 999999999999999999999999999876322
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p 682 (782)
......|+..|++||++.+..++.++|+||||+++|+|++|+.||........ .+..+. ....+
T Consensus 157 ------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 222 (256)
T cd08530 157 ------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--------YPPIP 222 (256)
T ss_pred ------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------CCCCc
Confidence 11234688999999999988899999999999999999999999976554321 122221 11222
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+++.+|+..+|.+||++.+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 344566999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=335.29 Aligned_cols=253 Identities=31% Similarity=0.422 Sum_probs=193.0
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeeccccc---------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACP--------- 516 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------- 516 (782)
....|+.+..||+||||.||+++. +|+.+|||.+.... ......+.+|+.+|++|+|||||++|..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 345689999999999999999987 89999999997654 223456789999999999999998764210
Q ss_pred --------------------------------------------------------------------------------
Q 040785 517 -------------------------------------------------------------------------------- 516 (782)
Q Consensus 517 -------------------------------------------------------------------------------- 516 (782)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C---------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040785 517 -----------------------E---------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564 (782)
Q Consensus 517 -----------------------~---------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH 564 (782)
+ ..||-||||+..+|.+++.++.... .-...++++++|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 0 0167889999988888886664321 35678999999999999999
Q ss_pred hcCCCCeeecCCCCceEEEcCCCceeeeccccccccc----cc---------cccccccccccccCCcccCChhhhhcCC
Q 040785 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP----AV---------AENVTQYHLTSTAGTFCYIDPEYQQTGM 631 (782)
Q Consensus 565 ~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~----~~---------~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 631 (782)
++| ||||||||.||+||.++.|||+|||+|+... .. .........|..+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998721 00 0011122456789999999999987655
Q ss_pred ---CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCC
Q 040785 632 ---LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705 (782)
Q Consensus 632 ---~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP 705 (782)
|+.|+|+|||||||+||+. ||+..-..-..+ ..|.+.. ..++.......-+.+|.++++.||.+||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~-----~~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPE-----PADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCC-----CcccccccchHHHHHHHHHhcCCCccCC
Confidence 9999999999999999985 576543332222 2232221 1233334444568999999999999999
Q ss_pred ChHHhhhHH
Q 040785 706 DLGKVVLPE 714 (782)
Q Consensus 706 s~~~vl~~~ 714 (782)
++.++|-.+
T Consensus 864 tA~eLL~s~ 872 (1351)
T KOG1035|consen 864 TATELLNSE 872 (1351)
T ss_pred CHHHHhhcc
Confidence 999987433
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=311.63 Aligned_cols=257 Identities=26% Similarity=0.331 Sum_probs=194.6
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhc-CCCCeeeecccccCc----c
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY----G 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~----~ 519 (782)
..++|+..+.||.|+||.||+|.+ .++.+|||.+... .......+.+|+.++.++ +||||++++++|... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 345688999999999999999987 5678999988542 223345677899999999 999999999987532 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||++ ++|...+... .+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 5888877543 4889999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHHh-Cc-----
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIEN-GT----- 669 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~~-~~----- 669 (782)
.................||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643221111122334568999999997654 4578999999999999999999999964332211 0000 00
Q ss_pred --------ccccCC-------CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 670 --------LGEMLD-------PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 670 --------~~~~ld-------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+++ ..........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 00011112245678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.78 Aligned_cols=239 Identities=29% Similarity=0.395 Sum_probs=190.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
|...+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.+++.++|||+++++++|.+.. ++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77889999999999999987 56789999986432 223456889999999999999999999986543 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++ |+|.+.+.... .++++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 97 47777665433 34899999999999999999999999 99999999999999999999999999875421
Q ss_pred cccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH--HhCcccccCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--ENGTLGEMLDPTVTD 680 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~ld~~~~~ 680 (782)
.....|++.|+|||++. .+.++.++|||||||++|+|++|..||.......... ..+.. +. .
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~--~ 244 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PT--L 244 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-----CC--C
Confidence 12346889999999874 4568999999999999999999999986543322111 11110 10 0
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 112234468999999999999999999998853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.48 Aligned_cols=253 Identities=25% Similarity=0.286 Sum_probs=195.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-C-----CCeeeeccccc--Ccc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-H-----PNMVLLLGACP--EYG 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~g~~~--~~~ 519 (782)
..+|.+.+.||+|+||.|.+|++ ++..||||+++... .-..+-..|+.||..|+ | -|+|+++++|. .+.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 33789999999999999999998 56789999998653 33456678999999996 3 47999999984 455
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC--Cceeeeccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN--YVSKISDVGLA 597 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~--~~~kL~DFGla 597 (782)
|||+|.+ .-+|.++|..++. .+|+...+..|+.||+.||.+||..+ |||+||||+||||.+- ..+||+|||.+
T Consensus 264 ciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999998 5599999866554 45999999999999999999999999 9999999999999643 37999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH-------------
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS------------- 664 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~------------- 664 (782)
..... .. ...+-+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.+.++..
T Consensus 339 c~~~q-------~v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 339 CFESQ-------RV-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccCC-------cc-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 87532 11 2456788999999999999999999999999999999998877543322111
Q ss_pred -HHhC------------ccc-------------------------ccCCC-CCCCC----ChhHHHHHHHHHHHhhccCc
Q 040785 665 -IENG------------TLG-------------------------EMLDP-TVTDW----PFEETLGFAKLALQCSELRR 701 (782)
Q Consensus 665 -~~~~------------~~~-------------------------~~ld~-~~~~~----p~~~~~~l~~li~~cl~~~P 701 (782)
++.+ .+. ...-| ....+ +......|.+|+.+|++.||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 1100 000 00001 11111 11344569999999999999
Q ss_pred CCCCChHHhhhHHHH
Q 040785 702 KDRPDLGKVVLPELN 716 (782)
Q Consensus 702 ~~RPs~~~vl~~~l~ 716 (782)
..|++..+.+.+.+-
T Consensus 491 ~~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 491 AERITPAQALNHPFL 505 (586)
T ss_pred hhcCCHHHHhcCccc
Confidence 999999999865443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.87 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=199.0
Q ss_pred cccccHHHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecc
Q 040785 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLG 513 (782)
Q Consensus 438 ~~~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g 513 (782)
++.....++...+++|...+.||+|+||.||+|.+ ++..||+|++.... ......+.+|+.++.+++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 45556677778889999999999999999999986 57789999987532 223456788999999999999999998
Q ss_pred cccC--------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC
Q 040785 514 ACPE--------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH 585 (782)
Q Consensus 514 ~~~~--------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~ 585 (782)
++.. ..|++++++ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 8742 136777776 78998877432 3899999999999999999999999 999999999999999
Q ss_pred CCceeeeccccccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH-
Q 040785 586 NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER- 663 (782)
Q Consensus 586 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~- 663 (782)
++.+||+|||++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 156 ~~~~kl~dfg~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 156 DCELKILDFGLARHTDD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred CCCEEEecccccccccc--------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999875421 1233568899999998766 5688999999999999999999999954332111
Q ss_pred --HHH-hCc--------------------ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 664 --SIE-NGT--------------------LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 664 --~~~-~~~--------------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
... .+. +.........+........+.+|+.+|++.+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100 000 00000000011111234468899999999999999999988854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.03 Aligned_cols=252 Identities=18% Similarity=0.198 Sum_probs=178.4
Q ss_pred ccccccceeeeeCcEeEEEEEECC-----eeEEEEEecCCchhhH-----------HHHHHHHHHHHhcCCCCeeeeccc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH-----TPVAVKVLRPDAAQGR-----------SQFQREIEVLSCIRHPNMVLLLGA 514 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~~~~~-----------~~~~~Ei~iL~~l~HpnIv~l~g~ 514 (782)
+.|.+.++||+|+||.||+|.+.+ ..+|+|+......... .....+...+..+.|+||+.++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568899999999999999999743 3567776543221110 011233344556789999999987
Q ss_pred ccCc------cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc
Q 040785 515 CPEY------GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV 588 (782)
Q Consensus 515 ~~~~------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~ 588 (782)
+... .+++++++. .++.+.+... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 6432 267777764 3566555332 23678889999999999999999999 999999999999999999
Q ss_pred eeeecccccccccccccccc--ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH-
Q 040785 589 SKISDVGLARLVPAVAENVT--QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI- 665 (782)
Q Consensus 589 ~kL~DFGla~~~~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~- 665 (782)
++|+|||+|+.+........ ........||+.|+|||++.+..++.++|||||||++|||++|..||.........+
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987632211111 111223479999999999999999999999999999999999999996442111000
Q ss_pred --HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 666 --ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 666 --~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+.+..+..+.. .+...+..+.+++..|+..+|++||++.+++
T Consensus 245 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 245 AAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred HhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 0000111111110 0122345699999999999999999998886
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.16 Aligned_cols=247 Identities=26% Similarity=0.439 Sum_probs=201.0
Q ss_pred cccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+|...+.||.|+||.||++.+. +..|++|++..... .....+.+|+++++.++|||++++++.+.... ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999984 77999999976532 45667899999999999999999998875544 899999
Q ss_pred CCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
+++++|.+.+.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 2356999999999999999999999999 9999999999999999999999999998653221
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChh
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.......|++.|+|||++....++.++||||||+++++|++|..||............ ... .....+..
T Consensus 158 -----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~----~~~~~~~~ 226 (258)
T cd08215 158 -----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKG----QYPPIPSQ 226 (258)
T ss_pred -----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH--hcC----CCCCCCCC
Confidence 1223357899999999998888999999999999999999999999755432211111 111 11122334
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+.+++.+||..+|++||++.+++.
T Consensus 227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 227 YSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.25 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=190.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCc--------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------- 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------- 518 (782)
++|...+.||+|+||.||+|.. ++..||||.+..... .....+.+|+.++++++||||++++++|...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4599999999999999999998 577999999864322 1233567899999999999999999987432
Q ss_pred --cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 --GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.++||||+. ++|.+.+.... ..+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 289999996 47877775433 24899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHh--Cccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIEN--GTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~--~~~~ 671 (782)
+.......... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||........ .+.. +.+.
T Consensus 166 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred cccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98663221111 1122334678899999987654 478899999999999999999999965432211 0000 1111
Q ss_pred ccCCCCC-----------CC----------CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTV-----------TD----------WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~-----------~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+.+.. .. ++......+.+|+.+||..+|.+||++.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 00 00011235679999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.01 Aligned_cols=236 Identities=25% Similarity=0.294 Sum_probs=189.8
Q ss_pred eeeeCcEeEEEEEEC--CeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYLD--HTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
||.|+||.||+|.+. ++.|++|++..... ...+.+.+|+.+++.++||||+++++.+.+.. ++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999985 78999999975422 23467899999999999999999999886544 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------~ 148 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------K 148 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------c
Confidence 99986543 4889999999999999999999999 9999999999999999999999999998663211 1
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH--HHHHHHHhCcccccCCCCCCCCChhHHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH--FVERSIENGTLGEMLDPTVTDWPFEETLGF 689 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 689 (782)
.....|+..|++||++....++.++|+||||+++|+|++|..||.... .......... .......|...+..+
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 223 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-----GNGKLEFPNYIDKAA 223 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc-----cCCCCCCCcccCHHH
Confidence 223468899999999988889999999999999999999999997554 2211111000 011122333345679
Q ss_pred HHHHHHhhccCcCCCCChHHhh
Q 040785 690 AKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 690 ~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+++.+||..+|++||++.+..
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred HHHHHHHccCChhhCcCCcccC
Confidence 9999999999999999954433
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.55 Aligned_cols=241 Identities=26% Similarity=0.423 Sum_probs=202.7
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeeccccc--CccEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACP--EYGIIVY 523 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 523 (782)
+..|.+...||+|.|+.|.++.+ +++.||||++.+... ..+..+.+|+++|..|.|||||+++.+.. ...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45699999999999999999998 788999999987632 33456889999999999999999999875 4459999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||..+|.++++|.+.+. ..+..+..++.|+..|++|||+++ |||||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence 99999999999987664 455788899999999999999999 99999999999999999999999999988742
Q ss_pred cccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCC----
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTV---- 678 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~---- 678 (782)
.....+.+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+..... +++.+
T Consensus 208 -----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------Lr~rvl~gk 271 (596)
T KOG0586|consen 208 -----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------LRPRVLRGK 271 (596)
T ss_pred -----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------ccchheeee
Confidence 234457899999999999998876 789999999999999999999996544321 11111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
-..|.-...++.+++.++|-++|..|+++.++..+
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 12244455678999999999999999999988643
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.04 Aligned_cols=251 Identities=29% Similarity=0.324 Sum_probs=191.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV 522 (782)
++|...+.||.|+||.||+|.+ ++..||+|+++..... ....+.+|+.++.+++||||+++++++.+. .++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 4699999999999999999998 5779999998654221 123466899999999999999999987432 3899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+.+ +|.+.+.... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 87 MEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999964 7888776543 35899999999999999999999999 99999999999999999999999999986632
Q ss_pred ccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCcccccCCC-
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGTLGEMLDP- 676 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~~~~~ld~- 676 (782)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||......... .. .+.......+
T Consensus 161 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 161 PA-----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cc-----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 11 11223456888999998765 45899999999999999999999999654433211 11 0000000000
Q ss_pred ----------CCCCCC--------hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 677 ----------TVTDWP--------FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 677 ----------~~~~~p--------~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+ ......+.+++.+||..||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 112456789999999999999999998885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.87 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=193.4
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------ 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 518 (782)
..++|...+.||+|+||.||+|.. ++..||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 466799999999999999999987 57789999986432 22345688999999999999999999987532
Q ss_pred --cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 --GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 27999999 7788877743 24899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Cc--
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GT-- 669 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~-- 669 (782)
+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||............ +.
T Consensus 165 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 165 ARQTDS--------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccc--------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 976522 1123467899999998876 45889999999999999999999999754432211110 00
Q ss_pred ------------------ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 670 ------------------LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 670 ------------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+.......+..........+.+++.+|++.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000011112334468899999999999999999998854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.51 Aligned_cols=235 Identities=26% Similarity=0.307 Sum_probs=192.3
Q ss_pred cccccceeeeeCcEeEEEEEECCe--eEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccC--ccEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPE--YGIIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~~--~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~--~~~lV~ 523 (782)
+|..+.+||+|+||.|.++...++ .+|||+++++. .++.+--..|-.+|... +-|.+++|+.+|.. ..|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 488899999999999999988655 79999998763 22233345677777766 57889999988854 459999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+.||+|...+++.+. |.+..+..++.+||-||-|||+++ ||+||||.+|||||.+|++||+|||+++.-
T Consensus 430 EyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--- 500 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN--- 500 (683)
T ss_pred EEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc---
Confidence 99999999998877664 778889999999999999999999 999999999999999999999999999842
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
........+.+||+.|+|||++...+|+..+|+|||||+|||||.|++||...+.-+ ..|.+.+ ..+
T Consensus 501 --i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------vsy 569 (683)
T KOG0696|consen 501 --IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------VSY 569 (683)
T ss_pred --ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---------CcC
Confidence 112233456899999999999999999999999999999999999999998665432 3332222 134
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
|...+.+...++...+...|..|-.
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cccccHHHHHHHHHHhhcCCccccC
Confidence 5566677888999999999998864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.15 Aligned_cols=236 Identities=28% Similarity=0.344 Sum_probs=179.8
Q ss_pred eeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHh---cCCCCeeeecccccCc--cEEEEEeCC
Q 040785 458 KIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSC---IRHPNMVLLLGACPEY--GIIVYEYLA 527 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~---l~HpnIv~l~g~~~~~--~~lV~Ey~~ 527 (782)
.||+|+||.||++.. +++.+|+|.+..... .....+.+|..++.. ..||||+.+++++... .++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 567999999865421 122334455544443 4799999999888543 389999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 999998886543 4899999999999999999999999 999999999999999999999999998754211
Q ss_pred cccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHH-HHHHHhCcccccCCCCCCCCChhH
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFV-ERSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
......||..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ...+...... ... ..+...
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~---~~~~~~ 222 (279)
T cd05633 151 ---KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNV---ELPDSF 222 (279)
T ss_pred ---CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc--CCc---CCcccc
Confidence 1123468999999998864 45899999999999999999999999633211 1111111111 111 223344
Q ss_pred HHHHHHHHHHhhccCcCCCCC-----hHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPD-----LGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs-----~~~vl 711 (782)
+..+.+++.+||..+|.+||+ +.+++
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 253 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVK 253 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 567899999999999999995 65555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.40 Aligned_cols=195 Identities=30% Similarity=0.492 Sum_probs=170.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--------cEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--------GII 521 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--------~~l 521 (782)
+...+.||+||||.||+|+. .|..||||.++... ...++...+|++||++|+|||||+++++-.+. ..+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34456799999999999996 68899999998753 33466788999999999999999999875332 279
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc--CCC--ceeeeccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD--HNY--VSKISDVGLA 597 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld--~~~--~~kL~DFGla 597 (782)
|||||.+|||+..|.+..+...|++.+.+.++.+++.||.|||.++ ||||||||.||++- .+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988877788999999999999999999999999 99999999999993 333 4699999999
Q ss_pred cccccccccccccccccccCCcccCChhhhh-cCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQLITAKQPMG 656 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~Pf~ 656 (782)
+-++. +...++..||..|++||++. .+.|+..+|.|||||++|+++||..||-
T Consensus 172 rel~d------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDD------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCC------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 97743 23567889999999999888 4889999999999999999999999994
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.18 Aligned_cols=254 Identities=26% Similarity=0.285 Sum_probs=193.3
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccC-------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPE------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 517 (782)
..+.|++.+.||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456799999999999999999998 467899999975432 223467789999999999999999998753
Q ss_pred -----ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 518 -----YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 518 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
..++|+||+++ +|...+... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 34899999976 676666543 235899999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHh--
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IEN-- 667 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~-- 667 (782)
|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|++||......... +..
T Consensus 159 dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred cccccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999987632211 11122356788999998764 35789999999999999999999999754433211 100
Q ss_pred Cccccc-------------CCC------CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 668 GTLGEM-------------LDP------TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 668 ~~~~~~-------------ld~------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..... .++ .........+..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 000 000011123556899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.26 Aligned_cols=240 Identities=26% Similarity=0.306 Sum_probs=190.9
Q ss_pred eeeeCcEeEEEEEEC--CeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYLD--HTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
||.|+||.||++.+. +..+++|++..... .....+.+|++++.+++||||+++++.+.... |+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 78999999976533 34567889999999999999999999886544 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc---cc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN---VT 608 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~---~~ 608 (782)
.+++.+.+ .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99886644 4899999999999999999999999 999999999999999999999999998764221100 00
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhH--H
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEE--T 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~--~ 686 (782)
........++..|++||+.....++.++||||||+++|+|++|..||.............. .. ..++... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~------~~~~~~~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GK------IEWPEDVEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CC------cCCCccccCC
Confidence 1122345688899999999888899999999999999999999999975543322111110 00 1122222 5
Q ss_pred HHHHHHHHHhhccCcCCCCCh---HHhh
Q 040785 687 LGFAKLALQCSELRRKDRPDL---GKVV 711 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~---~~vl 711 (782)
..+.+++.+||+.+|.+||++ .+++
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 568999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.19 Aligned_cols=250 Identities=27% Similarity=0.347 Sum_probs=191.8
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVYE 524 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~E 524 (782)
|.+.+.||.|+||.||+|.. .++.+|+|++.... ......+.+|+.+++.++|||++++++++.+. .++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56788999999999999988 45789999998653 22345688999999999999999999998655 489999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++ +|.+.+.... ..+++..++.++.||+.||.|||+.+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888775543 35899999999999999999999999 9999999999999999999999999998663321
Q ss_pred ccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHh-Cccc--------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IEN-GTLG-------- 671 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~~~~-------- 671 (782)
. ...+...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ... +...
T Consensus 155 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 S----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 1 11233467889999997654 45789999999999999999999999654432211 110 0000
Q ss_pred cc-----CCCCC------CCCChh-HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EM-----LDPTV------TDWPFE-ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~-----ld~~~------~~~p~~-~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+ ..+.. .+.... ++..+.+++.+||..+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 00000 000011 2556899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.88 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=189.1
Q ss_pred eeeee--CcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 458 KIGEG--GYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 458 ~LG~G--~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
.||+| +||+||++.+ .++.||||++.... ....+.+.+|+.+++.++||||++++++|.... ++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999988 67899999987542 233467889999999999999999999996544 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc-
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT- 608 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~- 608 (782)
+|.+++.+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+...........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998866532 34899999999999999999999999 99999999999999999999999987643321111000
Q ss_pred -ccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh--Cccc------------
Q 040785 609 -QYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN--GTLG------------ 671 (782)
Q Consensus 609 -~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~~~------------ 671 (782)
........++..|+|||++.++ .++.++|||||||++|+|++|+.||............ +...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0001112456779999998764 4789999999999999999999999654322211110 0000
Q ss_pred -------------------------ccCCCCC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 672 -------------------------EMLDPTV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 672 -------------------------~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.+..... ...+......+.+|+.+||..+|++||++.+++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000000 0111234567899999999999999999999986554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=330.20 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=182.4
Q ss_pred HhccccccceeeeeCcEeEEEEEECC---eeEEEE------------------EecCCchhhHHHHHHHHHHHHhcCCCC
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDH---TPVAVK------------------VLRPDAAQGRSQFQREIEVLSCIRHPN 507 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~---~~vAvK------------------~l~~~~~~~~~~~~~Ei~iL~~l~Hpn 507 (782)
..+.|.+.+.||+|+||.||+|.... ..+++| .+.. .......+.+|+.+|..++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45679999999999999999987521 112222 1111 1223456889999999999999
Q ss_pred eeeecccccCcc--EEEEEeCCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGN--TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 508 Iv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
|+++++++.... |+|++++. ++|.+++..... ........+..|+.||+.||.|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999985543 89999984 577776654321 122345677889999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCC-CCCCh--HH
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQ-PMGLT--HF 660 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-Pf~~~--~~ 660 (782)
+.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||+||||++|.. ||+.. ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred CCCCCEEEEeCCCceecCccc----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 999999999999998763211 112234679999999999999999999999999999999999875 44321 11
Q ss_pred ---HHHHHHh-Ccc-cccCCC-----------CCC----CCC-----hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 661 ---VERSIEN-GTL-GEMLDP-----------TVT----DWP-----FEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 661 ---~~~~~~~-~~~-~~~ld~-----------~~~----~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
....+.. +.. .++.++ ... ..+ ...+..+.+++.+||..||.+||++.++|.+.+
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 1111110 000 000000 000 000 012235778899999999999999999985443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.79 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=189.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
.++|...+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36799999999999999999987 57799999986532 22235678999999999999999999987532
Q ss_pred -cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
.++|+||+.. +|...+ + ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---G--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH---c--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 2899999964 666544 1 24899999999999999999999999 999999999999999999999999998
Q ss_pred cccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHhC-----
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IENG----- 668 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~~----- 668 (782)
+.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......... +...
T Consensus 165 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA--------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC--------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 75421 1123467889999998876 46899999999999999999999999755432211 1100
Q ss_pred ------------cc----cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 669 ------------TL----GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 669 ------------~~----~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.. ............+..+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000000011234458899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=297.33 Aligned_cols=249 Identities=25% Similarity=0.315 Sum_probs=194.2
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
|...+.||.|++|.||+|.. ++..+++|.+...... ....+.+|+.+|+.++||||+++++++.... ++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999987 5778999998754322 3567889999999999999999999986544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++ +|...+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 8888776543 35899999999999999999999999 9999999999999999999999999997663221
Q ss_pred ccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Ccc-----cccC--
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTL-----GEML-- 674 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~-----~~~l-- 674 (782)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..... +.. ....
T Consensus 153 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 ---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 112234688899999988776 7899999999999999999999999655443221110 000 0000
Q ss_pred ------------CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 ------------DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 ------------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...........+..+.+++.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000111234557899999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=300.24 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=190.7
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~E 524 (782)
+.|...+.||.|+||.||+|.+. ++.||||.++... ......+..|+.++..+. ||||+.++++|.+.. |+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 34888999999999999999985 7899999997542 233456777888777775 999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|+. ++|.+.+.... ..+++..+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 47777665433 268999999999999999999997 47 999999999999999999999999998765321
Q ss_pred cccccccccccccCCcccCChhhhhcCC----CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGM----LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
. ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||.........+... +... .+...
T Consensus 169 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~-~~~~~ 240 (296)
T cd06618 169 K------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-LQEE-PPSLP 240 (296)
T ss_pred C------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-hcCC-CCCCC
Confidence 1 112345788999999886553 8899999999999999999999996532211111110 0000 01111
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.....+..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 241 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 241 -PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 11123456999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.85 Aligned_cols=248 Identities=27% Similarity=0.347 Sum_probs=199.1
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcC-CCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~ 523 (782)
+|...+.||.|+||.||+|.. ++..||+|++.... ......+.+|++++.++. ||||+++++++.... ++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 588899999999999999998 57799999987532 223456889999999998 999999999986544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+.+.+.. .+++..++.|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 82 EYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999886543 5999999999999999999999999 999999999999999999999999999866322
Q ss_pred cccc---------------cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhC
Q 040785 604 AENV---------------TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENG 668 (782)
Q Consensus 604 ~~~~---------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 668 (782)
.... .........|+..|+|||++....++.++||||||+++++|++|+.||.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 1100 0122234568899999999988889999999999999999999999997654322111110
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCCh----HHhhh
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDL----GKVVL 712 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~----~~vl~ 712 (782)
.....+|...+..+.+|+.+||+.+|.+||++ .+++.
T Consensus 236 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 -------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01112233445569999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.66 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=190.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccC--------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPE-------- 517 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------- 517 (782)
.++|.+.++||.|+||.||+|.+ +++.+|||++...... ....+.+|+++++.++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 45799999999999999999998 4678999998654222 23457789999999999999999987632
Q ss_pred --ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 518 --YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 518 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
..++||||+.+ +|...+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 12899999965 6766665432 35999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccc------cccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HH
Q 040785 596 LARLVPAVAENV------TQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SI 665 (782)
Q Consensus 596 la~~~~~~~~~~------~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~ 665 (782)
++.......... .....+...|++.|+|||++.+. .++.++|||||||++|+|++|++||........ .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998653221110 11122345678999999987654 589999999999999999999999965443221 11
Q ss_pred Hh-Ccc-----------cccCC-CCCCCCC-------hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 EN-GTL-----------GEMLD-PTVTDWP-------FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~-~~~-----------~~~ld-~~~~~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. +.. ....+ ......+ ......+.+++.+||+.+|.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00 000 00000 0000111 112246889999999999999999988874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=295.37 Aligned_cols=239 Identities=19% Similarity=0.276 Sum_probs=184.0
Q ss_pred HHhcccccccee--eeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--E
Q 040785 448 EATQFFTESRKI--GEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 448 ~~t~~f~~~~~L--G~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~ 520 (782)
...+.|.+.+.+ |.|+||.||++.. ++..+|+|++....... .|+.+...+ +||||+++++.|.... |
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334556676666 9999999999987 56789999986532111 133333223 6999999999985444 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeeccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARL 599 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~ 599 (782)
+||||+++|+|.+++.... .+++.++..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999886543 5899999999999999999999999 99999999999999988 999999999876
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH---HHHHhCcccccCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIENGTLGEMLDP 676 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~ld~ 676 (782)
.... ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... ..+... .. .
T Consensus 160 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----~ 225 (267)
T PHA03390 160 IGTP---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-QQ----K 225 (267)
T ss_pred cCCC---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-hc----c
Confidence 5311 12468899999999998899999999999999999999999996432111 111111 01 1
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCC-hHHhhh
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPD-LGKVVL 712 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs-~~~vl~ 712 (782)
....+...+..+.+|+.+||+.+|.+||+ +.+++.
T Consensus 226 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11122244556999999999999999996 577763
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=290.13 Aligned_cols=242 Identities=25% Similarity=0.391 Sum_probs=194.6
Q ss_pred cccccc-ceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc------E
Q 040785 451 QFFTES-RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG------I 520 (782)
Q Consensus 451 ~~f~~~-~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~------~ 520 (782)
++|++. .+||-|-.|.|..|.+ ++..+|+|++... ....+|+++--.. .|||||.++++|.... .
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 345543 6799999999999988 5668999998543 3456777765444 6999999999985432 5
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeeeccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLA 597 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~DFGla 597 (782)
+|||+|+||.|..++..++. .+|++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||+|
T Consensus 136 iVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 79999999999999987765 46999999999999999999999999 99999999999995 4568999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH------HHHHHHhCccc
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF------VERSIENGTLG 671 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~------~~~~~~~~~~~ 671 (782)
+.-. ....+.+.+-|+.|.|||++...+|+..+|+||+||++|-||+|.+||...+. ....|..|.+.
T Consensus 212 K~t~------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 212 KETQ------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cccC------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 8532 23455677899999999999999999999999999999999999999964432 23444444321
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+-+ ++| ...+....++|+.+|+.+|.+|-++.+++.
T Consensus 286 -FP~---pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 286 -FPE---PEW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -CCC---hhH-hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111 123 345667899999999999999999988873
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.36 Aligned_cols=239 Identities=24% Similarity=0.298 Sum_probs=187.8
Q ss_pred cccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCch----hhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--
Q 040785 452 FFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDAA----QGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~-- 519 (782)
+|++.+.||.|+||.||++.. ++..||+|++..... ...+.+.+|+.+|..+ +||||+.+++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999986 567899999975322 2245678999999999 5999999998886554
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 89999999999999886543 4889999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHhCCCCCCChHH---HHHHHHhCcccccC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLITAKQPMGLTHF---VERSIENGTLGEML 674 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l 674 (782)
..... ........|+..|+|||++..+ .++.++||||||+++|+|++|..||..... ....... +
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------~ 224 (290)
T cd05613 155 FHEDE----VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR------I 224 (290)
T ss_pred ccccc----ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH------h
Confidence 53211 1112245689999999987653 478899999999999999999999963221 1111111 0
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
......++......+.+++.+||..+|.+||+
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 01111233445566899999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.22 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=192.8
Q ss_pred cccccceeeeeCcEeEEEEEECC--eeEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDH--TPVAVKVLRPDA-----AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~--~~vAvK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
+|.+.+.||+|+||.||++.+.. ..+++|+++... ......+..|+.+++.++||||+++++++.+.. ++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 37788999999999999998743 356666665321 122345778999999999999999999986544 899
Q ss_pred EEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 523 YEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
|||+++++|.+.+... .....+++..+..++.|++.||.|||+.+ |+|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988653 23346999999999999999999999999 999999999999975 569999999987653
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||............ ........
T Consensus 157 ~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 225 (260)
T cd08222 157 GSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VEGPTPSL 225 (260)
T ss_pred CCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcCCCCCC
Confidence 211 1122346888999999998888999999999999999999999999755443322111 01111223
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+...+..+.+++.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 3445567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=291.64 Aligned_cols=232 Identities=23% Similarity=0.242 Sum_probs=181.7
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh---hHHHHHHHHHHH-HhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ---GRSQFQREIEVL-SCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ei~iL-~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+.||.|+||.||+|.. .++.||||++...... ....+..|..++ ....||||+++++++.... |+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999988 5679999998654321 123345565554 4458999999999986543 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999886543 4889999999999999999999999 99999999999999999999999999875421
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||........ .+..+... ..+ ..+...+
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~ 221 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPE---EVKEFCS 221 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCC---cccccCC
Confidence 2234688999999999888899999999999999999999999975543221 11111111 001 1112344
Q ss_pred HHHHHHHHHhhccCcCCCCChH
Q 040785 687 LGFAKLALQCSELRRKDRPDLG 708 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~ 708 (782)
..+.+++.+||..+|++||++.
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCC
Confidence 5689999999999999999664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.47 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=190.9
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCCeeeecccccCcc--EEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
|.+.+.||.|+||.||+|.. .+..|+||.+..... .......+|+..+.+++ ||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 56778999999999999998 467899999865422 22334567999999999 999999999986644 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+++ |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--- 152 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--- 152 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC---
Confidence 889988886554 245899999999999999999999999 999999999999999999999999999765321
Q ss_pred ccccccccccCCcccCChhhhh-cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhC----c-----------c
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENG----T-----------L 670 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~----~-----------~ 670 (782)
.......|+..|+|||++. ...++.++||||||+++++|++|++||............. . +
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 153 ---PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ---CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 1123356889999999774 4457899999999999999999999996543322111000 0 0
Q ss_pred cccCCCC--------CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 671 GEMLDPT--------VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 671 ~~~ld~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+.. +.......+..+.+++.+||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 01111122456899999999999999999998874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=307.61 Aligned_cols=253 Identities=22% Similarity=0.267 Sum_probs=191.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc----------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY---------- 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---------- 518 (782)
.+|...+.||.|+||.||+|.. ++..||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5689999999999999999988 4678999998765555567788999999999999999999876432
Q ss_pred ------cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCceee
Q 040785 519 ------GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKI 591 (782)
Q Consensus 519 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~kL 591 (782)
.|+||||+. ++|.+.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 379999997 588877643 24889999999999999999999999 99999999999997 5568899
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcc
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTL 670 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 670 (782)
+|||+++........ ........|+..|+|||++.. ..++.++|||||||++|+|++|+.||...............
T Consensus 157 ~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred CCcccceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999765321110 111123467889999997654 45889999999999999999999999654332211110000
Q ss_pred c----------------ccCC--CCCCCC-----ChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 671 G----------------EMLD--PTVTDW-----PFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 671 ~----------------~~ld--~~~~~~-----p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
. .... ...... .......+.+|+.+||..+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 0000 000001 11234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.51 Aligned_cols=236 Identities=28% Similarity=0.349 Sum_probs=180.8
Q ss_pred eeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHH---HHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 458 KIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEV---LSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~i---L~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
.||+|+||.||++.+ .++.||+|++..... .....+..|..+ +....||||+.+++++.+.. |+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 467999999865421 112234444443 44457999999999886544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 99999887543 35899999999999999999999999 999999999999999999999999998755221
Q ss_pred cccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHH-HHHHhCcccccCCCCCCCCChhH
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVE-RSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
......|+..|+|||++.++ .++.++|||||||++|+|++|+.||....... ..+..... ... ..+|...
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~---~~~~~~~ 222 (278)
T cd05606 151 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMA---VELPDSF 222 (278)
T ss_pred ---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--ccC---CCCCCcC
Confidence 11234789999999998755 58999999999999999999999996542111 11111111 011 1233334
Q ss_pred HHHHHHHHHHhhccCcCCCC-----ChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRP-----DLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RP-----s~~~vl 711 (782)
+..+.+++.+|+..+|.+|| ++.+++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 56799999999999999999 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=300.67 Aligned_cols=241 Identities=28% Similarity=0.381 Sum_probs=189.9
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
|...+.||+|+||.||+|.. .+..|++|++.... ......+.+|+++++.++|||++.+++++.+.. |+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 67778899999999999987 57789999986432 223456889999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+. |+|.+.+.... .++++.++..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 57777775443 35899999999999999999999999 9999999999999999999999999986431
Q ss_pred cccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
......|+..|+|||++. .+.++.++|||||||++|+|++|..||............... . .+... .
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~--~ 242 (313)
T cd06633 173 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D--SPTLQ--S 242 (313)
T ss_pred -----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-C--CCCCC--c
Confidence 112356889999999874 456889999999999999999999999654433222111110 0 01111 1
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223458999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=345.80 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=194.2
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
...|...+.||+|+||.||+|.. ++..||||.+..... ....|++++++++|||||+++|+|.+.. |+||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577888999999999999986 577999999864322 2235688999999999999999996544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++. .++|..+..|+.|++.||.|||.....+|+||||||+|||++.++.+++. ||......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 99999999984 28899999999999999999996544459999999999999999988876 66654321
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh--------HHHHHHHHhCcccccCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT--------HFVERSIENGTLGEMLDPT 677 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~--------~~~~~~~~~~~~~~~ld~~ 677 (782)
......||+.|+|||++.+..++.++|||||||++|||+||+.||... .+.............+|+.
T Consensus 834 -----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 834 -----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 112236889999999999999999999999999999999999998532 1122222223334445554
Q ss_pred CCC---CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 678 VTD---WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 678 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+.. .+..+...+.+++.+||+.+|++||++.+++. .|..+
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~-~L~~~ 951 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK-TLESA 951 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH-HHHHh
Confidence 422 23455567889999999999999999999873 44443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.10 Aligned_cols=253 Identities=27% Similarity=0.323 Sum_probs=196.0
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------cE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------GI 520 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~~ 520 (782)
+|.+.+.||.|+||.||+|.. .+..||||.+.... ....+.+.+|+.+++.++||||+.+++++... .|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 478889999999999999997 46789999987643 33456789999999999999999999998543 38
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||++ ++|.+.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 47888775433 6999999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCcccc---
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGTLGE--- 672 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~~~~--- 672 (782)
...... ........||..|+|||++.+. .++.++||||||+++|+|++|++||......+.. .. .+....
T Consensus 154 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 432110 1122345689999999998887 7899999999999999999999999755432211 00 000000
Q ss_pred ----------cCC---C----CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 673 ----------MLD---P----TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 673 ----------~ld---~----~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+. . .........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 0 0000112234568999999999999999999998843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.38 Aligned_cols=239 Identities=27% Similarity=0.403 Sum_probs=189.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.|...+.||+|+||.||+|.. ++..+|+|.+... .......+.+|+++++.++|||++++++++.... ++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 377788999999999999997 5668999998642 2233456889999999999999999999875543 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+. |+|.+.+.... .++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 996 57877665433 34899999999999999999999999 99999999999999999999999999875421
Q ss_pred ccccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH--HhCcccccCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--ENGTLGEMLDPTVT 679 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~ld~~~~ 679 (782)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||.......... ..+.. +...
T Consensus 168 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~ 235 (308)
T cd06634 168 -------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PALQ 235 (308)
T ss_pred -------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----CCcC
Confidence 12346889999999875 3567889999999999999999999986543322111 11111 1111
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 236 --~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred --cccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 1233456899999999999999999998874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=304.16 Aligned_cols=255 Identities=25% Similarity=0.296 Sum_probs=189.7
Q ss_pred ccccc-cceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhh--------------HHHHHHHHHHHHhcCCCCeeeecc
Q 040785 451 QFFTE-SRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQG--------------RSQFQREIEVLSCIRHPNMVLLLG 513 (782)
Q Consensus 451 ~~f~~-~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~--------------~~~~~~Ei~iL~~l~HpnIv~l~g 513 (782)
++|.. .+.||.|+||.||+|.+ .++.||||++....... ...+.+|+++++.++||||+.+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34553 46799999999999987 57789999986542221 124678999999999999999999
Q ss_pred cccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 514 ACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 514 ~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
++.... |+||||+. |+|.+.+... ..+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 985443 89999996 6888887543 24889999999999999999999999 999999999999999999999
Q ss_pred ecccccccccccccc---------ccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHH
Q 040785 592 SDVGLARLVPAVAEN---------VTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFV 661 (782)
Q Consensus 592 ~DFGla~~~~~~~~~---------~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~ 661 (782)
+|||++......... ..........+++.|+|||++.+. .++.++|||||||++|+|++|.+||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999865311000 011122334578899999988764 4789999999999999999999999755432
Q ss_pred HHHH---H-hCccccc-------------CC----CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 662 ERSI---E-NGTLGEM-------------LD----PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 662 ~~~~---~-~~~~~~~-------------ld----~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.... . .+..... .. +.........+..+.+++.+||..+|++||++.+++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2111 0 0000000 00 0000001123456889999999999999999999984
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=304.28 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=191.9
Q ss_pred HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC---cc
Q 040785 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YG 519 (782)
Q Consensus 447 ~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~ 519 (782)
..++++|+..+.||.|+||.||++.. ++..||||++.... ....+.+.+|++++..++||||++++++|.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678899999999999999999987 56789999886432 2234678899999999999999999998743 34
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||+ +++|.+++.. .++++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 5688877742 24788889999999999999999999 99999999999999999999999999875
Q ss_pred cccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH---------
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE--------- 666 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~--------- 666 (782)
... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+
T Consensus 158 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 158 QDP--------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred cCC--------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 421 1123467889999998765 56899999999999999999999999644321110 00
Q ss_pred -----hCcccccCC--CCCCCCC-----hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 667 -----NGTLGEMLD--PTVTDWP-----FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 667 -----~~~~~~~ld--~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.....+. +.....| ...+..+.+++.+||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0000111 123456899999999999999999998874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.34 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=190.0
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCCeeeecccccC--c-----
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCI---RHPNMVLLLGACPE--Y----- 518 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~--~----- 518 (782)
|++.+.||.|+||.||+|.+ +++.||+|+++.... .....+.+|+.++.++ .||||++++++|.. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 56788999999999999998 367999999975322 1234566788887766 59999999999843 2
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.+++|||+++ +|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 4799999974 78887765432 35899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHHhCcc-----
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIENGTL----- 670 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~~----- 670 (782)
..... .......++..|+|||++.+..++.++|||||||++|+|++|.+||......+. .......
T Consensus 156 ~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFE------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCC------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 65321 111234578899999999988999999999999999999999999975443221 1111000
Q ss_pred ------------cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 671 ------------GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 671 ------------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..................+.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000111233456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=283.46 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=188.1
Q ss_pred cccceeeeeCcEeEEEEEEC--CeeEEEEEecCC-chhhHHHHHHHHHHHHhcC-CCCeeeecccccCcc--EEEEEeCC
Q 040785 454 TESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPD-AAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
..+..||.|+.|.|+++++. +...|||.+... +....+.+...++++.... .|+||+.+|+|-.+. ++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34567999999999999984 578999999764 4555677888888887764 899999999996554 67788773
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
.-++.+|.+-. .++++.-+-++..-++.||.||..++ .|||||+||+|||||+.|++||||||++-.+-..
T Consensus 175 -~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---- 245 (391)
T KOG0983|consen 175 -TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---- 245 (391)
T ss_pred -HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc----
Confidence 34445444333 35899989999999999999999876 4999999999999999999999999998766322
Q ss_pred cccccccccCCcccCChhhhhc---CCCCCchhHHHHHHHHHHHHhCCCCCCChH--H-HHHHHHhCcccccCCCCCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQLITAKQPMGLTH--F-VERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~--~-~~~~~~~~~~~~~ld~~~~~~ 681 (782)
...+..+|.+.|||||.+.- ..|+.++|||||||+++||.||+.||.+-+ + +-..+-+ . ..|.++.-
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~----ePP~L~~~ 318 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-E----EPPLLPGH 318 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-c----CCCCCCcc
Confidence 22345689999999997754 358999999999999999999999997532 2 1111111 1 11222211
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
......|.+|+..||..|+++||.+.+++.+.+
T Consensus 319 -~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 319 -MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred -cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 114556999999999999999999999985543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.61 Aligned_cols=258 Identities=24% Similarity=0.286 Sum_probs=195.3
Q ss_pred cccccceeeeeCcEeEEEEEEC------CeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCc---cE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEY---GI 520 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~------~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---~~ 520 (782)
.|+....||+|.||.||++.-. ...+|||.++-... .......+|+.+++.++||||+.|..+|-.. .+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 4899999999999999999642 22689999875422 1234567999999999999999999988552 28
Q ss_pred EEEEeCCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC----Cceeeecc
Q 040785 521 IVYEYLANGSLDDRIFR--RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN----YVSKISDV 594 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~----~~~kL~DF 594 (782)
|++||.+. +|+.++.- ......++...+..|++||+.|+.|||++. |+||||||+|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999977 78877753 233356899999999999999999999999 9999999999999877 89999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChH------------HH
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTH------------FV 661 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~------------~~ 661 (782)
|+++.+...-. +-+.....+-|++|.|||.+.+. .|+++.||||.|||+.||||-.+-|.... .+
T Consensus 181 GlaR~~~~plk--pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 181 GLARLFNNPLK--PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cHHHHhhcccc--ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99998843221 22334456789999999987776 59999999999999999999888774221 11
Q ss_pred HHHH-HhCcccccCCCCCCCCChh--------------------------HHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 662 ERSI-ENGTLGEMLDPTVTDWPFE--------------------------ETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 662 ~~~~-~~~~~~~~ld~~~~~~p~~--------------------------~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.+.+ --|...+...|.+..+|.. -+....+|+.++|+.||-.|.+..+.+.+.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111 1233333333433333321 011256899999999999999999987544
Q ss_pred H
Q 040785 715 L 715 (782)
Q Consensus 715 l 715 (782)
.
T Consensus 339 y 339 (438)
T KOG0666|consen 339 Y 339 (438)
T ss_pred c
Confidence 3
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.47 Aligned_cols=249 Identities=27% Similarity=0.356 Sum_probs=193.5
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
|+..+.||.|+||.||+|.. +++.||+|++.... ......+..|+.+++.++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 55678899999999999998 46799999997653 223456788999999999999999999986544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
+ ++|.+++.+.. ..+++..+..++.+++.||.|||+.+ |+||||+|+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-- 152 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-- 152 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc--
Confidence 7 58999887653 35899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCc------------cccc
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGT------------LGEM 673 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------------~~~~ 673 (782)
.......++..|+|||++.+. .++.++|||||||++|||++|++||.............. ...+
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 153 ---RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ---cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 112234567889999988776 789999999999999999999999976543322110000 0000
Q ss_pred --CCCCCCCC--------ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 --LDPTVTDW--------PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 --ld~~~~~~--------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.....+ .+..+..+.+++.+||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 01111111 0112456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=296.22 Aligned_cols=244 Identities=26% Similarity=0.331 Sum_probs=190.1
Q ss_pred ccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--E
Q 040785 453 FTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA----AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~ 520 (782)
|...+.||+|+||.||++.. +++.||||+++... ......+.+|+.++.++ .||||+.+++.+.... +
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 77889999999999999875 45689999987532 12245688999999999 5999999998886544 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+++|+|.+.+.... .+++..+..++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||+++.+
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999886542 4889999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCCcccCChhhhhcCC--CCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDP 676 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~ 676 (782)
.... ........|+..|+|||++.+.. .+.++||||||+++|+|++|..||...... ...+.......
T Consensus 156 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 227 (288)
T cd05583 156 LAEE----EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS---- 227 (288)
T ss_pred cccc----ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc----
Confidence 3211 11122356899999999887665 788999999999999999999999632211 11111111111
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
....+...+..+.+++.+||+.+|+.||++.++.
T Consensus 228 -~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~ 261 (288)
T cd05583 228 -KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGAD 261 (288)
T ss_pred -CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHH
Confidence 1122233445689999999999999999976553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.53 Aligned_cols=204 Identities=24% Similarity=0.337 Sum_probs=170.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHH---HHHHHHHHHHhcCCCCeeeecccccCc--cEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRS---QFQREIEVLSCIRHPNMVLLLGACPEY--GIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~---~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~ 523 (782)
.-|..++.||-|+||.|.+++. +...+|+|.|++.+...+. .++.|.+||.....+.||+||..|.+. .|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3478889999999999999987 4447999999875443333 467899999999999999999999664 48999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc--
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP-- 601 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~-- 601 (782)
+|++||++..+|.+.+ .|.+..+..++.++.+|+++.|.+| +|||||||+|||||.+|++||+|||||.-+.
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999998876 4889999999999999999999999 9999999999999999999999999996331
Q ss_pred -c-----cccc-----------------------------ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHH
Q 040785 602 -A-----VAEN-----------------------------VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 646 (782)
Q Consensus 602 -~-----~~~~-----------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ 646 (782)
. .+.. ......-..+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 0000 0001112457999999999999999999999999999999
Q ss_pred HHHhCCCCCCChHH
Q 040785 647 QLITAKQPMGLTHF 660 (782)
Q Consensus 647 elltG~~Pf~~~~~ 660 (782)
||+.|++||-....
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999954433
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=300.09 Aligned_cols=256 Identities=22% Similarity=0.266 Sum_probs=190.7
Q ss_pred cccccceeeeeCcEeEEEEEEC----CeeEEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCCeeeecccccC------c
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD----HTPVAVKVLRPDA--AQGRSQFQREIEVLSCI-RHPNMVLLLGACPE------Y 518 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------~ 518 (782)
+|...+.||+|+||.||++... +..||||.+.... ....+.+.+|+.++.++ .||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3778899999999999999984 5589999986432 22345678899999999 59999999986421 2
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.+++++|+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 378888885 6888887543 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH---HHHHh-Cc----
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIEN-GT---- 669 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~---~~~~~-~~---- 669 (782)
.+...... .........||..|+|||++.+ ..++.++|||||||++|+|++|.+||....... ..+.. +.
T Consensus 154 ~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 154 GFSENPGE-NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eccccccc-ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 66432111 1112234578999999998765 468999999999999999999999997543211 00000 00
Q ss_pred ----------------ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 670 ----------------LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 670 ----------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
........+..........+.+|+.+||+.+|++||++.+++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 0000000001111123456899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=334.79 Aligned_cols=252 Identities=27% Similarity=0.322 Sum_probs=198.0
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeeccccc--CccEEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACP--EYGIIV 522 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 522 (782)
.+-++.....||.|.||.||-|.. +|...|+|-++... ......+.+|+.+|..+.|||+|++||+-. +..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677788999999999999987 66788999886543 233456789999999999999999999853 444899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
||||.+|+|.+.+.... ..++.....+..|++.||.|||+.| ||||||||+||||+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999885443 2566666778899999999999999 99999999999999999999999999998754
Q ss_pred ccccccccccccccCCcccCChhhhhcCC---CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
...+.. .......||+.|||||++.+.. ..-+.||||+|||++||+||+.||...+.-+.....-... ..+
T Consensus 1387 ~~~~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g-----h~P 1460 (1509)
T KOG4645|consen 1387 NAQTMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG-----HKP 1460 (1509)
T ss_pred chhcCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-----CCC
Confidence 332222 2344678999999999887644 5678999999999999999999996443322222111111 113
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..|.....+-.+|+.+||+.||+.|.++.+++.
T Consensus 1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 345556677889999999999999988877764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=304.18 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=191.8
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------ 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 518 (782)
..++|...+.||.|+||.||+|.. ++..||||++.... ......+.+|+.+++.++||||+.+++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456799999999999999999998 46789999986532 22345677899999999999999999876421
Q ss_pred --cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 --GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 48999998 6799888753 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---Hh-Cccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---EN-GTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~~-~~~~ 671 (782)
+..... ......+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.......... .. +...
T Consensus 165 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred cccccc--------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 976521 12334678899999987653 67899999999999999999999996443322111 10 0000
Q ss_pred ----------------ccC----CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 ----------------EML----DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ----------------~~l----d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+ .+.........+..+.+++.+||..+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 00000001122456899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=323.82 Aligned_cols=142 Identities=28% Similarity=0.418 Sum_probs=125.8
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~ 523 (782)
++|.+.++||+|+||.||+|.+. ++.||||+++... ......+..|+.++..++||||+++++++... .||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46889999999999999999984 7899999997532 22346788999999999999999999888544 48999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
||+.+++|.+++...+ .+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999886543 4889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.84 Aligned_cols=245 Identities=26% Similarity=0.387 Sum_probs=197.0
Q ss_pred ceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
+.||+|+|+.|--|.. ++..+|||++.+.....+..+.+|++++..+ .|+||++|+.+|.+.. |||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 5799999999998875 7889999999988777888999999999998 5999999999997654 999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC---ceeeecccccccccc--cccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY---VSKISDVGLARLVPA--VAEN 606 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~---~~kL~DFGla~~~~~--~~~~ 606 (782)
...++++. .|++.++.+++.+|+.||.|||.+| |.||||||+|||-.... -+|||||.|+.-+.. ....
T Consensus 164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99998765 3899999999999999999999999 99999999999996544 479999998765421 1112
Q ss_pred ccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChH-----------------HHHHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTH-----------------FVERS 664 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~-----------------~~~~~ 664 (782)
.......+.+|+..|||||++. ...|+.++|.||||||||-||+|.+||.+.. ..-..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 2334456778999999999642 2358999999999999999999999995321 11123
Q ss_pred HHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 665 IENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 665 ~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
|.+|.+. +.| .+| .....+..+++...+-.++.+|-++.+++-
T Consensus 318 IQEGkYe-FPd---kdW-ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYE-FPD---KDW-AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCc-CCh---hhh-HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3444432 111 122 345666889999999999999999998885
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=280.54 Aligned_cols=232 Identities=29% Similarity=0.333 Sum_probs=188.7
Q ss_pred eeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 531 (782)
||.|+||.||++.. .++.+++|++..... .....+..|+.+++.++||||+++++.+.... |+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999998 467999999876432 23457889999999999999999999986554 899999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccc
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 611 (782)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~ 149 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-----SR 149 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-----Cc
Confidence 99886543 4899999999999999999999999 9999999999999999999999999987653211 12
Q ss_pred cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHH
Q 040785 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAK 691 (782)
Q Consensus 612 ~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~ 691 (782)
.....|+..|++||.+.+...+.++|+||||+++|+|++|..||........ ..... . .....+...+..+.+
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~-~-----~~~~~~~~~~~~l~~ 222 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YEKIL-K-----DPLRFPEFLSPEARD 222 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHh-c-----CCCCCCCCCCHHHHH
Confidence 2345688999999999888889999999999999999999999965543211 11110 0 011223333566899
Q ss_pred HHHHhhccCcCCCCChH
Q 040785 692 LALQCSELRRKDRPDLG 708 (782)
Q Consensus 692 li~~cl~~~P~~RPs~~ 708 (782)
++.+||..+|++||++.
T Consensus 223 ~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 223 LISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHhcCCHhhCCCcc
Confidence 99999999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=284.67 Aligned_cols=247 Identities=26% Similarity=0.318 Sum_probs=189.7
Q ss_pred cccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCC
Q 040785 454 TESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
+.+..||.|+||+|++-.+ .++..|||.++.... ...++|..|.++..+- ..||||++||++...+ ++.||+|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3456799999999999988 577899999987644 4567889999877665 6999999999986554 78999984
Q ss_pred CCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 528 NGSLDDRIFRR--GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 528 ~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
.||+.+...- -....+++.-.-.|..-+..||.||...- .||||||||+|||||..|.+||||||++-.+.
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---- 219 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---- 219 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH----
Confidence 4665433211 12235888888889999999999998653 39999999999999999999999999987552
Q ss_pred cccccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---HhCcccccCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---ENGTLGEMLDPTVTD 680 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~~~~~~~~ld~~~~~ 680 (782)
.....+..+|...|||||.+... .|+.+|||||||++|||+.||..|+...+.+-..+ ..|....++.+ .
T Consensus 220 --~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~---~ 294 (361)
T KOG1006|consen 220 --DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD---K 294 (361)
T ss_pred --HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc---c
Confidence 22334556899999999976543 48999999999999999999999997655443333 23332222111 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+....+..+|..|+..+..+||.+.++..
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 12345667999999999999999999988874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.19 Aligned_cols=235 Identities=22% Similarity=0.290 Sum_probs=199.3
Q ss_pred ccccceeeeeCcEeEEEEEECCee--EEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~--vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+..+..||-||||.|=++...+.. +|+|++++.. ....+.+..|-+||..++.|.||+||-.|.+.. |+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 445567999999999999886554 8999987642 223455778999999999999999999997765 789999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
|-||.|+..|..++. |....+..|+..+.+|++|||.++ ||+|||||+|.|||.+|-+||.|||+|+.+...
T Consensus 502 ClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 502 CLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred hcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 999999999977653 888889999999999999999999 999999999999999999999999999987532
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 683 (782)
....+.|||+.|.|||++.+...+..+|.||||+++||||+|.+||...+.... .+-.|. ..-.||.
T Consensus 574 ----~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------d~i~~Pr 642 (732)
T KOG0614|consen 574 ----RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------DKIEFPR 642 (732)
T ss_pred ----CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------hhhhccc
Confidence 234568999999999999999999999999999999999999999988876542 233331 1125667
Q ss_pred hHHHHHHHHHHHhhccCcCCCCC
Q 040785 684 EETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs 706 (782)
..+....+|+.+.+..+|.+|-.
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhc
Confidence 77778899999999999999987
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=310.94 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=208.6
Q ss_pred HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccc-------c
Q 040785 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGAC-------P 516 (782)
Q Consensus 447 ~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~-------~ 516 (782)
...++-|++.+.||.|.||.||++.. +++.+|||++..+.. ..+++..|.+||+.+ .|||++.+||+| .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34466799999999999999999976 788999999987643 346788899999887 699999999987 2
Q ss_pred CccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 517 EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 517 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
+..+||||||.+||..|++.... +..+.|..+..|+.+++.||.+||.+. +||||||-.||||+.++.+||+|||+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeee
Confidence 33499999999999999887665 567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 671 (782)
+..+.. +.....+..||++|||||++.. ..|+..+|+||||++.+||--|.+|+...|.+...+....
T Consensus 170 SaQlds-----T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR-- 242 (953)
T KOG0587|consen 170 SAQLDS-----TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-- 242 (953)
T ss_pred eeeeec-----ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC--
Confidence 876533 3344556789999999997653 3478899999999999999999999998888776543221
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...|.+. .|..-...|.+||..||..+...||++.++|.
T Consensus 243 -NPPPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 243 -NPPPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -CCCcccc-chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1112221 23344567999999999999999999998873
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=276.79 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=196.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccC-----c---
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPE-----Y--- 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-----~--- 518 (782)
+.|....+||+|.||.||+++. .++.||+|++-.+... -.....+|+.+|..|+|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3477788999999999999987 4667888876432211 12345799999999999999999998832 1
Q ss_pred --cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 --GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.|+||.+|+. +|.-+|.... ..|+..++.+++.++..||.|+|.+. |+|||+||+|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 3899999976 7777774332 34889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH----HHHhCccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVER----SIENGTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~~~ 671 (782)
++.+.... +......+..+-|++|.+||.+.+. .|+++.|||..|||+.||+||.+-|........ ..--|.+.
T Consensus 171 ar~fs~~~-n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 171 ARAFSTSK-NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ccceeccc-ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 98774322 2233446677889999999976654 699999999999999999999988864432221 11234455
Q ss_pred ccCCCCCCCCChh------------------------HHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 672 EMLDPTVTDWPFE------------------------ETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 672 ~~ld~~~~~~p~~------------------------~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.-..|.+...|.. -.....+|+.+++..||..|++..+++-+.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 4445544333211 112567999999999999999999987433
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=301.76 Aligned_cols=243 Identities=25% Similarity=0.415 Sum_probs=203.0
Q ss_pred ccccceeeeeCcEeEEEEEE--CC----eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DH----TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYE 524 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~----~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~E 524 (782)
....++||.|+||+||+|.+ ++ -+||||++.... ......|..|+-+|.+|+|||+++|+|+|.... .||.+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 34568899999999999988 33 279999997653 344678999999999999999999999997655 78999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
||+.|+|.|+++.... .+..+..+.|..|||+||.|||.+. ++||||-..|||+..-.++||.|||+++......
T Consensus 778 ~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999976543 4888999999999999999999999 9999999999999999999999999999885433
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~ 681 (782)
..+......-.+-|||-|.+....|+.++|||||||++|||+| |..|+..... ....++.|. ....
T Consensus 853 ---~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--------RLsq 921 (1177)
T KOG1025|consen 853 ---KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--------RLSQ 921 (1177)
T ss_pred ---ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--------cCCC
Confidence 3344334444678999999999999999999999999999998 9999865533 233344432 2345
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
|+..+.++..++.+||-.|+..||.++++.
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 777888999999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.19 Aligned_cols=220 Identities=24% Similarity=0.181 Sum_probs=175.1
Q ss_pred eCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCChhHHHhh
Q 040785 462 GGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFR 537 (782)
Q Consensus 462 G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~ 537 (782)
|.||.||++.+ +++.||+|.+.... .+.+|...+....||||+++++++.+.. ++||||+++|+|.+.+.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999998 66789999997643 2345555566667999999999886544 899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccC
Q 040785 538 RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617 (782)
Q Consensus 538 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~G 617 (782)
.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....+
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------~~~~~~ 144 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------CDGEAV 144 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--------cccCCc
Confidence 43 4899999999999999999999999 999999999999999999999999987654211 123356
Q ss_pred CcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhh
Q 040785 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCS 697 (782)
Q Consensus 618 t~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl 697 (782)
+..|+|||+..++.++.++|||||||++|+|++|+.||...... +. .... ...|...+..+.+++.+|+
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~~-----~~~~---~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---IN-----THTT---LNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---cc-----cccc---cCCcccCCHHHHHHHHHHc
Confidence 77899999988888999999999999999999999887432110 00 0000 1123334566899999999
Q ss_pred ccCcCCCCChHHhh
Q 040785 698 ELRRKDRPDLGKVV 711 (782)
Q Consensus 698 ~~~P~~RPs~~~vl 711 (782)
+.+|.+||++.+..
T Consensus 214 ~~dp~~R~~~~~~~ 227 (237)
T cd05576 214 QFNPTERLGAGVAG 227 (237)
T ss_pred cCCHHHhcCCCccc
Confidence 99999999975443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=287.83 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=187.7
Q ss_pred ccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHh--cCCCCeeeecccccC------ccEEEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSC--IRHPNMVLLLGACPE------YGIIVYE 524 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~------~~~lV~E 524 (782)
.....+||+|.||.||+|.++++.||||++. .+..+.|++|-+|.+. ++|+||++++++-.. ..+||++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3446789999999999999999999999996 3556789999999876 589999999987532 2379999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC------CCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP------EPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
|-+.|+|.++|..+ .++|....+|+.-+++||+|||.--| .+|+|||||..||||.+|++..|+|||||.
T Consensus 289 fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999554 48999999999999999999997543 369999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCC-CC-----CchhHHHHHHHHHHHHhCCCCC--------CChHH----
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM-LG-----VKSDVYSLGILLLQLITAKQPM--------GLTHF---- 660 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s-----~ksDVwSlGvil~elltG~~Pf--------~~~~~---- 660 (782)
.+.... .....-..+||.+|||||++.+.. +. .+.||||+|.|||||++...-+ ..+..
T Consensus 365 ~~~p~~---~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 365 RLEPGK---PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred EecCCC---CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 875322 111222378999999999886643 22 3689999999999999865433 11110
Q ss_pred ---HHHHHHhCcccccCCCCCCC-CCh-hHHHHHHHHHHHhhccCcCCCCChHHh
Q 040785 661 ---VERSIENGTLGEMLDPTVTD-WPF-EETLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 661 ---~~~~~~~~~~~~~ld~~~~~-~p~-~~~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
.-.....-.+.+...|.+++ |-. .....+.+.+..||..||+.|-++.=+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 00111112222333444432 222 233458899999999999999998433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=293.21 Aligned_cols=240 Identities=25% Similarity=0.366 Sum_probs=197.5
Q ss_pred cceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC--ccEEEEEeCCCC
Q 040785 456 SRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--YGIIVYEYLANG 529 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~g 529 (782)
.+.||.|-||+||-|.+ +|+.||||++.+. ......++.+|+.||..+.||.||.|-..|+. ..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999987 6889999999764 22334678999999999999999999988854 448999999654
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC---Cceeeecccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN---YVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~---~~~kL~DFGla~~~~~~~~~ 606 (782)
-| +.+..... ..|++.....++.||+.||.|||.++ |+|.||||+||||... -.+||||||+|+.+...
T Consensus 649 ML-EMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--- 720 (888)
T KOG4236|consen 649 ML-EMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--- 720 (888)
T ss_pred HH-HHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence 44 44444332 24899988999999999999999999 9999999999999543 37899999999988532
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
....+.+||+.|+|||++.+..|...-|+||.|||+|--|+|..||+........+.+..+..- | ..| .+..
T Consensus 721 ---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyP--p--~PW-~eis 792 (888)
T KOG4236|consen 721 ---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYP--P--NPW-SEIS 792 (888)
T ss_pred ---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccC--C--Cch-hhcC
Confidence 2345689999999999999999999999999999999999999999877777777766554331 1 123 3455
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhh
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
....+||...|+..-+.|.+..+.+
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhc
Confidence 6688999999999999999988876
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=310.01 Aligned_cols=251 Identities=31% Similarity=0.471 Sum_probs=201.2
Q ss_pred ccccccceeeeeCcEeEEEEEEC---------CeeEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCCeeeecccccCcc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDAA-QGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 519 (782)
++..+.+.||+|.||.|++|... ...||||.++.... ...+.+..|+++|+.+ +||||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455669999999999999852 34799999986543 3567899999999998 5999999999997744
Q ss_pred --EEEEEeCCCCChhHHHhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 520 --IIVYEYLANGSLDDRIFRRG-----NT--------PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
++|+||+..|+|.++|.... .. ..++..+.+.++.|||.|++||++.. +|||||-..|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 89999999999999997665 00 23889999999999999999999999 99999999999999
Q ss_pred CCCceeeeccccccccccccccccccccccccC--CcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH--
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAG--TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH-- 659 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~G--t~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~-- 659 (782)
.+..+||+|||+|+..... ..+......| ...|||||.+....|+.++|||||||+||||+| |..||....
T Consensus 453 ~~~~~kIaDFGlar~~~~~----~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNK----DYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCC----CceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 9999999999999965322 2232222333 335999999999999999999999999999998 889997522
Q ss_pred -HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 660 -FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 660 -~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
.+...+..|. ....|..+..++.+++..||+.+|++||++.+++. .+..
T Consensus 529 ~~l~~~l~~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~-~~~~ 578 (609)
T KOG0200|consen 529 EELLEFLKEGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE-FFEK 578 (609)
T ss_pred HHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH-HHHH
Confidence 1222333432 22345666778999999999999999999999984 3433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=297.79 Aligned_cols=237 Identities=24% Similarity=0.286 Sum_probs=191.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++.|.....||.|+|+.|-.+.+ ++...++|++.... .+-.+|+.++... .||||+++.+.|.+.. ++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 55688888899999999999988 56789999996552 2345678777666 6999999999997765 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE-cCCCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL-DHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl-d~~~~~kL~DFGla~~~~~~ 603 (782)
++.++-|.+.+.... ....++..|+.+|+.|+.|||..| ||||||||+|||+ +..++++|+|||.++..+..
T Consensus 397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998888876543 222778889999999999999999 9999999999999 68999999999999876432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH---HHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV---ERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~ld~~~~~ 680 (782)
+.+.+-|..|.|||++....|+..+||||||++||+||+|+.||.....- ...+..+.+
T Consensus 470 --------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~---------- 531 (612)
T KOG0603|consen 470 --------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF---------- 531 (612)
T ss_pred --------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc----------
Confidence 33456789999999999999999999999999999999999999533221 111222221
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
....+....+|+.+||+.+|.+||++.++..+.+.
T Consensus 532 -s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 -SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 13455568999999999999999999998764443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=281.72 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=191.3
Q ss_pred hccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHh--cCCCCeeeeccccc-Cc-----cEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSC--IRHPNMVLLLGACP-EY-----GII 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~-~~-----~~l 521 (782)
.......+.||+|.||.||+|.+.|..||||++... +...+.+|.+|.+. |+|+||+.++++-. ++ .+|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 345677899999999999999999999999999643 33568899999987 49999999998742 22 289
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-----TKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
|.+|-+.|||.|+|.+. .++....++++.-+|.||++||- +|.+.|.|||||+.|||+.+++.+-|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999663 48889999999999999999994 3445699999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCC------CCchhHHHHHHHHHHHHhC----------CCCCCChHH
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML------GVKSDVYSLGILLLQLITA----------KQPMGLTHF 660 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~------s~ksDVwSlGvil~elltG----------~~Pf~~~~~ 660 (782)
|-...... +.-.......+||.+|||||++....- -..+||||||.|+||++.. ++||...-.
T Consensus 363 Av~h~~~t-~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 363 AVRHDSDT-DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eEEecccC-CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 98765443 223344456799999999998765431 1368999999999998843 356642211
Q ss_pred HH---HHHHhCcccccCCCCCCC-CCh-hHHHHHHHHHHHhhccCcCCCCCh
Q 040785 661 VE---RSIENGTLGEMLDPTVTD-WPF-EETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 661 ~~---~~~~~~~~~~~ld~~~~~-~p~-~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
.+ ....+-.-.+.+.|.++. |.. +....+.+++..||..+|.-|-++
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 11 111222223344555543 333 334459999999999999999886
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=277.30 Aligned_cols=239 Identities=25% Similarity=0.327 Sum_probs=187.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.|..++.||+|+|..|.++++ +.+.+|+|++++. ...+..-++.|-.+.... +||.+|-|+.+|.... ++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 488899999999999999998 4568999999865 233455567788877765 7999999999997654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||++||+|.-.+++.. .|+++.+..+..+|+.||.|||++| ||+||||.+|||||..|++||+|+|+++.--.
T Consensus 331 eyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~- 403 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG- 403 (593)
T ss_pred EEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC-
Confidence 9999999976665433 4899999999999999999999999 99999999999999999999999999985311
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH------HHHHHHhCcccccCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF------VERSIENGTLGEMLDPT 677 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~------~~~~~~~~~~~~~ld~~ 677 (782)
......+.+||+.|+|||++.+..|+..+|+|+|||+++||+.|+.||+.... .+..+-.-.+..-+
T Consensus 404 ----~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--- 476 (593)
T KOG0695|consen 404 ----PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--- 476 (593)
T ss_pred ----CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc---
Confidence 22233568999999999999999999999999999999999999999963221 11111110111100
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
..|...+.....++...|+.||.+|-.
T Consensus 477 --riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 --RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 112233344677888899999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=247.75 Aligned_cols=249 Identities=25% Similarity=0.286 Sum_probs=188.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.|...++||+|.||+||+|+. ++..||+|.++.+.. .......+||-+|+.++|.|||++++...... -+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 366778999999999999987 566899999976533 23566789999999999999999999875443 799999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
|.. +|..+....+ ..+..+.+..++.|+++||.|+|+++ +.||||||+|+||+.+|.+||+|||+++.+.-
T Consensus 83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi--- 153 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--- 153 (292)
T ss_pred hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC---
Confidence 954 7777665443 34888899999999999999999999 99999999999999999999999999997632
Q ss_pred cccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHH----HHhCcccccCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERS----IENGTLGEMLDPTVT 679 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~----~~~~~~~~~ld~~~~ 679 (782)
........+-|.+|.+|.++.+.+ |++..|+||.|||+.|+.. |++-|...+..++. ..-|...+--.|++.
T Consensus 154 --pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 154 --PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred --ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 112233456799999999877665 8999999999999999987 55555443322221 223555554445443
Q ss_pred CCCh--------------hHH----HHHHHHHHHhhccCcCCCCChHHhh
Q 040785 680 DWPF--------------EET----LGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 680 ~~p~--------------~~~----~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..|. ... ..=.+++.+.+.-+|..|.+++..+
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 3221 011 1235778888888899998887665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=262.79 Aligned_cols=235 Identities=29% Similarity=0.374 Sum_probs=188.2
Q ss_pred CcEeEEEEEEC--CeeEEEEEecCCchhh-HHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEeCCCCChhHHHhh
Q 040785 463 GYGPVYKCYLD--HTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYLANGSLDDRIFR 537 (782)
Q Consensus 463 ~fg~Vy~~~~~--~~~vAvK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~~~gsL~~~l~~ 537 (782)
+||.||+|... +..+++|++....... ...+.+|++++++++|+||+++++++... .+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999984 5789999998765444 67899999999999999999999998653 4899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccC
Q 040785 538 RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617 (782)
Q Consensus 538 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~G 617 (782)
.. .+++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ......|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~ 148 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTTFVG 148 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc------ccccccC
Confidence 43 2889999999999999999999999 9999999999999999999999999998764221 2334568
Q ss_pred CcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhh
Q 040785 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCS 697 (782)
Q Consensus 618 t~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl 697 (782)
+..|++||.+....++.++||||||+++++|++|..||............... ...... ......+..+.+++.+|+
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~i~~~l 225 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-PKPPFP--PPEWKISPEAKDLIRKLL 225 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc-cCCCCc--cccccCCHHHHHHHHHHc
Confidence 88999999998888999999999999999999999999662222221111110 000000 000004456999999999
Q ss_pred ccCcCCCCChHHhhh
Q 040785 698 ELRRKDRPDLGKVVL 712 (782)
Q Consensus 698 ~~~P~~RPs~~~vl~ 712 (782)
..+|++||++.+++.
T Consensus 226 ~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 226 VKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCchhccCHHHHhh
Confidence 999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=278.02 Aligned_cols=252 Identities=27% Similarity=0.318 Sum_probs=192.7
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC--CCC----eeeecccccCcc-
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR--HPN----MVLLLGACPEYG- 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~--Hpn----Iv~l~g~~~~~~- 519 (782)
.+++|.+..++|+|.||.|-.+.+ .+..||||+++.-. .-++.-.-|+++|.++. .|+ +|.+.++|.-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 377899999999999999999998 45689999997532 23455677999999993 333 778888886555
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-------------
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH------------- 585 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~------------- 585 (782)
|||+|.+ |-|+.++|..++. .+++..++..|+.|++.++.|||+.+ ++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 8999988 6799999965544 56999999999999999999999999 999999999999931
Q ss_pred -------CCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh
Q 040785 586 -------NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT 658 (782)
Q Consensus 586 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~ 658 (782)
+..++|+|||.|+... ......+.|..|.|||++.+-.++.++||||+||||+||.||..-|...
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~--------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH--------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred ceeccCCCcceEEEecCCcceec--------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3458999999998642 2225678899999999999999999999999999999999999988533
Q ss_pred HHH------HHHH-----------------HhCccc-----------ccCCCCCC-----CCChhHHHHHHHHHHHhhcc
Q 040785 659 HFV------ERSI-----------------ENGTLG-----------EMLDPTVT-----DWPFEETLGFAKLALQCSEL 699 (782)
Q Consensus 659 ~~~------~~~~-----------------~~~~~~-----------~~ld~~~~-----~~p~~~~~~l~~li~~cl~~ 699 (782)
... +..+ ..|.+. ..+++..+ .....+...|.+|+.++|..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 211 1110 011100 00111000 00123445699999999999
Q ss_pred CcCCCCChHHhhhHH
Q 040785 700 RRKDRPDLGKVVLPE 714 (782)
Q Consensus 700 ~P~~RPs~~~vl~~~ 714 (782)
||.+|+++.+++.+.
T Consensus 393 DP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 393 DPARRITLREALSHP 407 (415)
T ss_pred CccccccHHHHhcCH
Confidence 999999999998543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=299.07 Aligned_cols=252 Identities=21% Similarity=0.208 Sum_probs=165.6
Q ss_pred hccccccceeeeeCcEeEEEEEEC------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccc--------c
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA--------C 515 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~--------~ 515 (782)
.++|...++||+|+||.||+|.+. +..||||.+...... +.+..| .+....+.++..++.. .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 456999999999999999999983 568999988643221 111111 1122222233322221 1
Q ss_pred cCccEEEEEeCCCCChhHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040785 516 PEYGIIVYEYLANGSLDDRIFRRGNT-----------------PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKP 578 (782)
Q Consensus 516 ~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp 578 (782)
....++||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 22348999999999999988643211 01123345679999999999999999 99999999
Q ss_pred ceEEEcC-CCceeeeccccccccccccccccccccccccCCcccCChhhhhcC----------------------CCCCc
Q 040785 579 GNILLDH-NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG----------------------MLGVK 635 (782)
Q Consensus 579 ~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----------------------~~s~k 635 (782)
+||||+. ++.+||+|||+|+.+... ..+......||+.|+|||.+... .++.+
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~----~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVG----INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccc----cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999985 689999999999865321 12233456889999999965422 23456
Q ss_pred hhHHHHHHHHHHHHhCCCCCCChHH-HHHHHHhCcc-----cccCCCCCC-C------CChhHHHHHHHHHHHhhccCcC
Q 040785 636 SDVYSLGILLLQLITAKQPMGLTHF-VERSIENGTL-----GEMLDPTVT-D------WPFEETLGFAKLALQCSELRRK 702 (782)
Q Consensus 636 sDVwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~-----~~~ld~~~~-~------~p~~~~~~l~~li~~cl~~~P~ 702 (782)
+|||||||+||||+++..|+..... ....+..... ...+.+... + ..........+|+.+||+.||+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 7999999999999998877653221 1111111110 001111100 0 0001112345899999999999
Q ss_pred CCCChHHhhh
Q 040785 703 DRPDLGKVVL 712 (782)
Q Consensus 703 ~RPs~~~vl~ 712 (782)
+||++.+++.
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999884
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=290.36 Aligned_cols=256 Identities=20% Similarity=0.223 Sum_probs=179.3
Q ss_pred hccccccceeeeeCcEeEEEEEE------------------CCeeEEEEEecCCchhhHHHH--------------HHHH
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL------------------DHTPVAVKVLRPDAAQGRSQF--------------QREI 497 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~------------------~~~~vAvK~l~~~~~~~~~~~--------------~~Ei 497 (782)
.++|.+.++||+|+||.||+|.+ .++.||||.+..........| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45799999999999999999964 235799999876533323333 3467
Q ss_pred HHHHhcCCCCe-----eeecccccC----------ccEEEEEeCCCCChhHHHhhcCC---------------------C
Q 040785 498 EVLSCIRHPNM-----VLLLGACPE----------YGIIVYEYLANGSLDDRIFRRGN---------------------T 541 (782)
Q Consensus 498 ~iL~~l~HpnI-----v~l~g~~~~----------~~~lV~Ey~~~gsL~~~l~~~~~---------------------~ 541 (782)
.++.+++|.++ +.++++|.. ..+|||||+++|+|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 567777642 23899999999999998864311 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCccc
Q 040785 542 PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621 (782)
Q Consensus 542 ~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y 621 (782)
..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ........+|+.|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----~~~~~~g~~tp~Y 376 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----NFNPLYGMLDPRY 376 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC----ccCccccCCCcce
Confidence 13567888999999999999999999 9999999999999999999999999997553211 1111223458899
Q ss_pred CChhhhhcCC--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCChHHHHHHHHhC--ccc-----
Q 040785 622 IDPEYQQTGM--------------------L--GVKSDVYSLGILLLQLITAKQ-PMGLTHFVERSIENG--TLG----- 671 (782)
Q Consensus 622 ~aPE~~~~~~--------------------~--s~ksDVwSlGvil~elltG~~-Pf~~~~~~~~~~~~~--~~~----- 671 (782)
+|||.+.... | ..+.||||+|||+|+|++|.. ||.........+... ...
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999775432 1 235799999999999999986 775433222211110 000
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCc---CCCCChHHhhhH
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRR---KDRPDLGKVVLP 713 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P---~~RPs~~~vl~~ 713 (782)
......+..+ ........+|+.++|..+| .+|+++.++|.+
T Consensus 457 ~~~~~~~~~~-d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFSLL-DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCcccc-cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0001111111 1234558899999999766 689999999853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=298.13 Aligned_cols=247 Identities=28% Similarity=0.342 Sum_probs=193.0
Q ss_pred cccccceeeeeCcE-eEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeCC
Q 040785 452 FFTESRKIGEGGYG-PVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 452 ~f~~~~~LG~G~fg-~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
.|...+.+|.|+-| .||+|.+.++.||||.+-... ....++||..|+.- .|||||++|+.-.+.. ||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 46667789999876 689999999999999986432 23568999999887 6999999998766554 8999999
Q ss_pred CCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---C--Cceeeeccccccccc
Q 040785 528 NGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---N--YVSKISDVGLARLVP 601 (782)
Q Consensus 528 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~--~~~kL~DFGla~~~~ 601 (782)
..+|.|++... ........-..+.++.|++.||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 55999999663 11111111345678999999999999999 999999999999975 3 478999999999886
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhC-CCCCCChHHHHHHHHhCcccccCCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA-KQPMGLTHFVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 680 (782)
.... ...+.....||-+|+|||++....-+..+||||||||+|+.++| .+||+.....+..|-.|...-..-....+
T Consensus 663 ~~~s--S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 663 GGKS--SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CCcc--hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCch
Confidence 4332 22335678899999999999998888899999999999999986 99999776665555555433221111111
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+ ...+||.+|++.+|..||++.+|+.+
T Consensus 741 ~------eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 741 C------EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred H------HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 67899999999999999999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=249.21 Aligned_cols=197 Identities=28% Similarity=0.386 Sum_probs=160.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC-chhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+.......||+|+||.|=+-++ +|+..|+|.+... ..+..++..+|+++..+. ..|.+|++||...+.+ ++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4455567899999999988877 7889999999764 334566788999987765 7999999999876655 89999
Q ss_pred eCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
.|. .||..+..+- ..+..+++.-+-+|+.-+..||.|||++-. |||||+||+||||+.+|.+||||||++-++...
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 984 4776544322 334568999999999999999999998742 999999999999999999999999999876321
Q ss_pred cccccccccccccCCcccCChhhhhc----CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQT----GMLGVKSDVYSLGILLLQLITAKQPMG 656 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~s~ksDVwSlGvil~elltG~~Pf~ 656 (782)
...+..+|...|||||.+.. ..|+.++||||||++++||.+++.||.
T Consensus 203 ------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 203 ------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred ------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 12233578889999997643 368999999999999999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=242.88 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=189.7
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccCcc----EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG----IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~----~lV 522 (782)
.++|++.+++|+|.|+.||.|.. ++..++||++++ -..+.+.+|+.||..|+ ||||+.|++...+.. .||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45699999999999999999985 677999999985 34567899999999996 999999999986543 799
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeeccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVP 601 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla~~~~ 601 (782)
+||+.+.+...+. +.|+...+..++.+++.||.|+|++| |+|||+||.|++||.. ..++|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998776544 34777889999999999999999999 9999999999999854 579999999998874
Q ss_pred cccccccccccccccCCcccCChhhhh-cCCCCCchhHHHHHHHHHHHHhCCCCCCCh-----HHHHHHHH---------
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQLITAKQPMGLT-----HFVERSIE--------- 666 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~Pf~~~-----~~~~~~~~--------- 666 (782)
.. ......+.+..|--||.+- ...|+..-|+|||||+|..|+..+.||-.. ..+..+--
T Consensus 185 p~------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 185 PG------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred CC------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 22 1222345677888999655 456899999999999999999999999321 11111100
Q ss_pred hCcccccCCCCCCC---------CC--------hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 667 NGTLGEMLDPTVTD---------WP--------FEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 667 ~~~~~~~ld~~~~~---------~p--------~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
-+++.-.+||...+ |. .-..++..+|+.+.|..|-++||++.+.+.+.+
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY 324 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence 01111113332211 11 012356889999999999999999998886544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=256.48 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=200.7
Q ss_pred HHhccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccCcc
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPEYG 519 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~ 519 (782)
....++....++-+|.||.||.|.+. .+.|-+|.++....+ ....|..|.-.|..+.|||+..+.|++.+..
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 33445667778899999999999662 224677877655332 3556888998999999999999999985543
Q ss_pred ---EEEEEeCCCCChhHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 520 ---IIVYEYLANGSLDDRIF-----RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 520 ---~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
+..|.++.-|+|..+|. .....+.++..+...++.|++.|+.|||..+ |||.||-..|.+||+...+||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEe
Confidence 88999999999999998 3334456778888999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhC
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENG 668 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~ 668 (782)
+|=.|++.+-...... .-........||+||.+.+..|+..+|||||||+||||+| |+.|+...+..+. .+.+|
T Consensus 438 tDsaLSRDLFP~DYhc---LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHC---LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccchhccccCcccccc---cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 9999998763221110 1112245668999999999999999999999999999998 9999987766553 33343
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
. ....|.+++.++..++..||...|++||++++++.
T Consensus 515 y--------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 Y--------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred c--------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 2 12346778888999999999999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=275.79 Aligned_cols=250 Identities=28% Similarity=0.350 Sum_probs=205.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC--ccEEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--YGIIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey 525 (782)
.++|..+..+|.|+||.||++++ .+...|||+++.....+...+++|+-+++.++|||||.++|.+.. ..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 34688899999999999999998 677999999999888888889999999999999999999999854 45999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
|.+|+|.+..+- +.++++.++..+.++.+.||.|||+.+ -+|||||-.|||+++.|.+|++|||.+-.+..
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--- 164 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh---
Confidence 999999997643 346999999999999999999999999 89999999999999999999999999865532
Q ss_pred cccccccccccCCcccCChhhh---hcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQ---QTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
+-....+..||+.|||||+. ..+.|...+|||++|++..|+---++|....+......--.+ ..++|.-..-+
T Consensus 165 --ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--S~~qpp~lkDk 240 (829)
T KOG0576|consen 165 --TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--SGFQPPTLKDK 240 (829)
T ss_pred --hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--cCCCCCcccCC
Confidence 23344578999999999954 567899999999999999999999999876665543322111 11222211112
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..-...|.+|+..|+..+|+.||+.+.+|.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 222345999999999999999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=256.10 Aligned_cols=128 Identities=30% Similarity=0.424 Sum_probs=107.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-----CC---CeeeecccccCcc-
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-----HP---NMVLLLGACPEYG- 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-----Hp---nIv~l~g~~~~~~- 519 (782)
.+|.+.++||+|-|++||+|++ ..+.||+|+.+.. ..-.+....||.+|++++ |+ +||+|++.|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5789999999999999999998 5678999999753 233456678999999984 33 5999999995433
Q ss_pred -----EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 520 -----IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 520 -----~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
|+|+|++ |-+|..+|.+... ..++...+..|++||+.||.|||..+ +|||.||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999999 7788888866544 45999999999999999999999876 49999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=234.89 Aligned_cols=205 Identities=35% Similarity=0.556 Sum_probs=177.9
Q ss_pred eeeeCcEeEEEEEEC--CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccC--ccEEEEEeCCCCChhH
Q 040785 459 IGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPE--YGIIVYEYLANGSLDD 533 (782)
Q Consensus 459 LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~ 533 (782)
||.|++|.||++... +..+++|++...... ....+.+|+.++..+.|++|+++++++.. ..+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999996 789999999865432 34679999999999999999999999876 4489999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeecccccccccccccccccccc
Q 040785 534 RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARLVPAVAENVTQYHL 612 (782)
Q Consensus 534 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 612 (782)
++.... ..+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----~~ 150 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----LL 150 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----hh
Confidence 886543 34889999999999999999999999 999999999999999 89999999999986532110 12
Q ss_pred ccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHH
Q 040785 613 TSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAK 691 (782)
Q Consensus 613 ~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~ 691 (782)
....+...|++||.+... .++.+.|+|+||+++++| ..+.+
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~~ 192 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELKD 192 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHHH
Confidence 335678899999998887 789999999999999999 35899
Q ss_pred HHHHhhccCcCCCCChHHhh
Q 040785 692 LALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 692 li~~cl~~~P~~RPs~~~vl 711 (782)
++..|+..+|.+||++.+++
T Consensus 193 ~l~~~l~~~p~~R~~~~~l~ 212 (215)
T cd00180 193 LIRKMLQKDPEKRPSAKEIL 212 (215)
T ss_pred HHHHHhhCCcccCcCHHHHh
Confidence 99999999999999998886
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=250.92 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=186.7
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC-------ccEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------YGII 521 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~l 521 (782)
.+..+.||-|+||+||.+++ +++.||+|.+..- ....-+.+.+|+.+|..++|.|++..++.... ..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45678999999999999998 7889999987432 22335678899999999999999999887532 2267
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
+.|.| ..+|..++... .+|+-..+.-++.||++||.|||+.+ |.||||||.|+|++.|..+||||||||+...
T Consensus 135 ~TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 77877 44777766433 35888889999999999999999999 9999999999999999999999999999763
Q ss_pred cccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH----------------
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---------------- 664 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---------------- 664 (782)
.. ....++..+-|-.|.|||++++. .|+...||||.|||+.|||..+.-|.....++..
T Consensus 208 ~d----~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 208 QR----DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred hh----hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 22 23445566778899999999876 4999999999999999999988888543332211
Q ss_pred -HHhCcccccCCCCC--CCC--------ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 665 -IENGTLGEMLDPTV--TDW--------PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 665 -~~~~~~~~~ld~~~--~~~--------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+|.-..++.... ++. +.........+..+++..+|+.|.+..+.+.
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 11222222222111 111 1222334667778889999999998877763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=264.62 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=200.6
Q ss_pred ccccccHHHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC------CCCe
Q 040785 437 RYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR------HPNM 508 (782)
Q Consensus 437 ~~~~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~------HpnI 508 (782)
.|.++.+-++ ...+|.+....|+|-|++|.+|.+ .+..||||+++.+.. ..+.=++|++||.+|. --|+
T Consensus 420 GYYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 420 GYYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ceEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 3555555554 457899999999999999999998 566999999987532 2344568999999994 3468
Q ss_pred eeecccccC--ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC
Q 040785 509 VLLLGACPE--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586 (782)
Q Consensus 509 v~l~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~ 586 (782)
++|+..|.. +.|||+|-+ ..+|.+.|.+.+..-.|....+..++.|+..||..|..++ |+|.||||+|||++++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 888877743 459999988 5589999998888888999999999999999999999999 9999999999999876
Q ss_pred -CceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-----
Q 040785 587 -YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF----- 660 (782)
Q Consensus 587 -~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~----- 660 (782)
..+||||||.|..+.. ...+...-+..|.|||++.+-.|+...|+||.||+||||.||+.-|.+...
T Consensus 573 k~iLKLCDfGSA~~~~e-------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASE-------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred cceeeeccCcccccccc-------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 4679999999987632 122333446689999999999999999999999999999999998853211
Q ss_pred ---------HHHHHHhCccc---------------------------ccCCCC---------CCCCChh---HHHHHHHH
Q 040785 661 ---------VERSIENGTLG---------------------------EMLDPT---------VTDWPFE---ETLGFAKL 692 (782)
Q Consensus 661 ---------~~~~~~~~~~~---------------------------~~ld~~---------~~~~p~~---~~~~l~~l 692 (782)
....+..|.+. ..+.|. ...+|.+ ....|.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 11122222111 111110 0112322 33468899
Q ss_pred HHHhhccCcCCCCChHHhhhH
Q 040785 693 ALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 693 i~~cl~~~P~~RPs~~~vl~~ 713 (782)
+.+|+.+||+.|-+..+.|.+
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999988753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=244.11 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=190.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC--------c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--------Y 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~ 518 (782)
.+|..+..+|.|.- .|-.+.+ .+++||+|.+... .....+...+|..++..+.|+||+.++.+|.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45777888999988 5555655 6889999987543 22334567899999999999999999999843 2
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.|+|||||. .+|...++-. +.-..+..|+.|+++|+.|||+.+ |+||||||+||++..++.+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 289999994 5888777632 556778899999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH-------------
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI------------- 665 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~------------- 665 (782)
... ....++..+.|..|.|||++.+..|...+||||+||++.||++|..-|.+.+...+..
T Consensus 167 ~e~------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 167 TED------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred ccC------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 542 3367788899999999999998889999999999999999999999886443221110
Q ss_pred -----Hh-------------CcccccCC----CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 666 -----EN-------------GTLGEMLD----PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 666 -----~~-------------~~~~~~ld----~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.. -.+.+.+. +...+.+.-....+.+++.+||-.+|++|-+..++|.+..
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 00 01111111 1111111122334778999999999999999999885443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=234.49 Aligned_cols=200 Identities=35% Similarity=0.549 Sum_probs=169.3
Q ss_pred ccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccccC--ccEEEEEeCC
Q 040785 453 FTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGACPE--YGIIVYEYLA 527 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 527 (782)
|...+.||.|+||.||++... +..+++|.+...... ....+.+|++.+..++|+|++++++++.. ..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456788999999999999984 578999999876544 56789999999999999999999998864 3489999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+++|.+++..... .+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-- 153 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-- 153 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence 9999998865432 1789999999999999999999998 99999999999999999999999999987643210
Q ss_pred cccccccccCCcccCChhhh-hcCCCCCchhHHHHHHHHHHHHhCCCCCCC-hHHH
Q 040785 608 TQYHLTSTAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQLITAKQPMGL-THFV 661 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~Pf~~-~~~~ 661 (782)
.......++..|++||.+ ....++.++|||+||+++++|++|+.||.. ....
T Consensus 154 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 154 --ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred --ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 022345678899999988 666788899999999999999999999965 4444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=261.69 Aligned_cols=192 Identities=26% Similarity=0.374 Sum_probs=161.8
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--------hHHHHHHHHHHHHhcC---CCCeeeecccccCc
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--------GRSQFQREIEVLSCIR---HPNMVLLLGACPEY 518 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--------~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~ 518 (782)
.|+.+..+|.|+||.|++|.+ +...|+||.+.+..-. ....+-.||.||..|+ |+||++++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 489999999999999999998 4458999998764211 1223557999999997 99999999999876
Q ss_pred c--EEEEEeC-CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 519 G--IIVYEYL-ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 519 ~--~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
. ||+||-- ++-+|.+++... +.+++.++..|+.||+.|+.+||+.+ |||||||-+||.++.+|.+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 6 6777743 344888888543 45899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCC
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMG 656 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~ 656 (782)
.|.+... -......||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 716 saa~~ks-------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKS-------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcC-------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987632 22345789999999999998886 678999999999999999988884
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=233.98 Aligned_cols=236 Identities=22% Similarity=0.320 Sum_probs=174.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeeccc-ccCc--cEEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGA-CPEY--GIIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~-~~~~--~~lV~E 524 (782)
+.|.+.+.||+|.||.+-++.+ ..+.+++|.+.... ....+|.+|..---.| .|.||+.-|.. |... .++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3589999999999999999999 45689999986543 3467899998765555 58999988865 4333 368999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc--CCCceeeecccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD--HNYVSKISDVGLARLVPA 602 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld--~~~~~kL~DFGla~~~~~ 602 (782)
|+|.|+|...+... .+.+....+++.|++.||.|||+.+ +||||||.+||||- +...+||||||+.+....
T Consensus 103 ~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998877443 3788888999999999999999999 99999999999993 445899999999875432
Q ss_pred ccccccccccccccCCcccCChhhhhcC---C--CCCchhHHHHHHHHHHHHhCCCCCCChH-----HHH-HHHHhCccc
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTG---M--LGVKSDVYSLGILLLQLITAKQPMGLTH-----FVE-RSIENGTLG 671 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~--~s~ksDVwSlGvil~elltG~~Pf~~~~-----~~~-~~~~~~~~~ 671 (782)
. .....-+..|.+||..... . ..+.+|||.|||++|.+|||.+||.... +.+ ..+..+.
T Consensus 176 t--------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk-- 245 (378)
T KOG1345|consen 176 T--------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK-- 245 (378)
T ss_pred e--------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc--
Confidence 1 1122345679999965432 2 4778999999999999999999996221 121 2223332
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
.+.++..-......+..+..+-+..+|++|=-.
T Consensus 246 ---~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki 278 (378)
T KOG1345|consen 246 ---NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKI 278 (378)
T ss_pred ---CccCchhhcccCHHHHHHHHHhcCCcccccchh
Confidence 223332222233456777788888889888333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=242.19 Aligned_cols=255 Identities=23% Similarity=0.270 Sum_probs=189.1
Q ss_pred HhccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--E
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~ 520 (782)
..+.|...++||+|.|++||++.+. ...||+|.+..... ...+.+|+++|..+ .+-||+.+.+++..+. +
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3456889999999999999999862 45899999976533 45689999999999 5999999999986554 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeeccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARL 599 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~ 599 (782)
+|+||++.....+++.. ++..++..++..++.||.++|.+| ||||||||+|+|.+. -+.-.|+|||||..
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 99999999998887732 667889999999999999999999 999999999999974 35678999999973
Q ss_pred ccccc------c------------------------c---------ccccccccccCCcccCChhhhh-cCCCCCchhHH
Q 040785 600 VPAVA------E------------------------N---------VTQYHLTSTAGTFCYIDPEYQQ-TGMLGVKSDVY 639 (782)
Q Consensus 600 ~~~~~------~------------------------~---------~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVw 639 (782)
..... . . .........+||++|.|||++. .+..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 0 0 0001112457999999999755 55689999999
Q ss_pred HHHHHHHHHHhCCCCCCChH-----H------------HHHHHHhCc--ccc--------------------cCCC----
Q 040785 640 SLGILLLQLITAKQPMGLTH-----F------------VERSIENGT--LGE--------------------MLDP---- 676 (782)
Q Consensus 640 SlGvil~elltG~~Pf~~~~-----~------------~~~~~~~~~--~~~--------------------~ld~---- 676 (782)
|.|||++-+++++.||-... . ...+.-.|. +.+ .+.+
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999994110 1 111111122 111 0001
Q ss_pred --CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 677 --TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 677 --~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
....|....+..+.+|+.+|++.+|.+|-++++.|.+.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 00111222334688999999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-26 Score=274.46 Aligned_cols=197 Identities=18% Similarity=0.226 Sum_probs=139.5
Q ss_pred hcCC-CCeeeeccccc-------C--ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 040785 502 CIRH-PNMVLLLGACP-------E--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571 (782)
Q Consensus 502 ~l~H-pnIv~l~g~~~-------~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 571 (782)
.++| +||+.++++|. + ..++++||+ +++|.++|... ..++++.+++.|+.||+.||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 57888888771 1 225678887 66999998643 245999999999999999999999999 9
Q ss_pred eecCCCCceEEEcC-------------------CCceeeeccccccccccccc----cc-------cccccccccCCccc
Q 040785 572 VHRDLKPGNILLDH-------------------NYVSKISDVGLARLVPAVAE----NV-------TQYHLTSTAGTFCY 621 (782)
Q Consensus 572 iHrDLKp~NILld~-------------------~~~~kL~DFGla~~~~~~~~----~~-------~~~~~~~~~Gt~~Y 621 (782)
|||||||+||||+. ++.+||+|||+++....... .. .........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566677777654311000 00 00011224689999
Q ss_pred CChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCc
Q 040785 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRR 701 (782)
Q Consensus 622 ~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P 701 (782)
||||++.+..|+.++|||||||+||||++|.+|+.........+... .+.+.. .........++.+||+.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~~~----~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPPQI----LLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcChhh----hhcCHHHHHHHHHhCCCCh
Confidence 99999999999999999999999999999999975332221112111 111111 1112335688899999999
Q ss_pred CCCCChHHhhh
Q 040785 702 KDRPDLGKVVL 712 (782)
Q Consensus 702 ~~RPs~~~vl~ 712 (782)
.+||++.+++.
T Consensus 254 ~~Rps~~eil~ 264 (793)
T PLN00181 254 SCRPSMSELLQ 264 (793)
T ss_pred hhCcChHHHhh
Confidence 99999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=213.30 Aligned_cols=163 Identities=23% Similarity=0.263 Sum_probs=124.3
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|.+++...+ .++++.+++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~------ 61 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP------ 61 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc------
Confidence 78999886543 35999999999999999999999986 999999999999999 999876532
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---HhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---ENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~~~~~~~~ld~~~~~~p~~~ 685 (782)
....||+.|||||++.+..++.++|||||||++|||++|+.||.........+ ..+.. . .++.....+...
T Consensus 62 ----~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~ 135 (176)
T smart00750 62 ----EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-A-DDPRDRSNLESV 135 (176)
T ss_pred ----ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-c-CCccccccHHHH
Confidence 11268999999999999999999999999999999999999996543221111 11111 1 111111112222
Q ss_pred HH--HHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 686 TL--GFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 686 ~~--~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
.. .+.+++.+||..+|.+||++.+++.+...
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 22 58999999999999999999999864433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=207.64 Aligned_cols=145 Identities=52% Similarity=0.833 Sum_probs=120.5
Q ss_pred eEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHHHhh
Q 040785 17 LIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCT 96 (782)
Q Consensus 17 ~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~ 96 (782)
+||||||+|+.|.+||+||++++...+++|++|||.+++....... . .............+.+++++..+...|.
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 75 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSS--G---KLEVASAYKQEEDKEAKELLLPYRCFCS 75 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCc--c---chHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 4999999999999999999999998999999999997543211100 0 0000011223344667789999999998
Q ss_pred cCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCcccccccc-CchhhhhhcCCCccEEEEEecC
Q 040785 97 RKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKA-DVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 97 ~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~g-SVa~~V~k~ap~~c~V~vV~kg 166 (782)
..++.++.+++.|++|+++|+++|++.++|+||||+||++++.++|+| ||+.+|++++|++|||+||++|
T Consensus 76 ~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 76 RKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred hcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 889999999999889999999999999999999999999999999887 6999999999999999999998
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=229.94 Aligned_cols=251 Identities=26% Similarity=0.322 Sum_probs=187.9
Q ss_pred cccccceeeeeCcEeEEEEEECC---eeEEEEEecCCchhhHHHHHHHHHHHHhcCC----CCeeeeccccc-C--ccEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDH---TPVAVKVLRPDAAQGRSQFQREIEVLSCIRH----PNMVLLLGACP-E--YGII 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~---~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~g~~~-~--~~~l 521 (782)
.|.+.++||+|+||.||+|.... ..+|+|+...........+..|+.++..+.. +++..+++... . ..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 69999999999999999999844 3699998876533333378899999998863 57788877762 3 3489
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-----Cceeeecccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-----YVSKISDVGL 596 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-----~~~kL~DFGl 596 (782)
||+.+ |.+|.++..... ...|+..+++.|+.|++.+|.+||+.| +|||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 889999765544 456999999999999999999999999 9999999999999755 4689999999
Q ss_pred ccccc---ccccccccc-c-cccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCc
Q 040785 597 ARLVP---AVAENVTQY-H-LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGT 669 (782)
Q Consensus 597 a~~~~---~~~~~~~~~-~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~ 669 (782)
++.+. ......... . .....||..|+++....+...+.+.|+||+++++.+|+.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99432 111110111 1 23456999999999999999999999999999999999999999543311 11111111
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
....... .....+..+..+...+-..+..++|++..+.
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 1111111 1222344577888888889999999997765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=218.71 Aligned_cols=249 Identities=21% Similarity=0.271 Sum_probs=189.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeeccccc--CccEEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACP--EYGIIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV~Ey 525 (782)
-.|.+.++||+|+||..|.|.. ++.+||||.-...+ ..-++..|....+.| ..++|...|.+.+ .++.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3599999999999999999986 88999999864332 234677788887777 4678877765544 455899998
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-----Cceeeecccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-----YVSKISDVGLARLV 600 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-----~~~kL~DFGla~~~ 600 (782)
+ |-||+|++.-.+. .|+..++..||.|++.-++|+|.+. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 8899998765554 4999999999999999999999999 9999999999999643 46899999999987
Q ss_pred ccc--cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH---HHHHHHhCcccccCC
Q 040785 601 PAV--AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF---VERSIENGTLGEMLD 675 (782)
Q Consensus 601 ~~~--~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~ld 675 (782)
.+. ..........+..||.+||+--...+...+.+.|+-|||-+++++|-|..||..... -+..-..|.-... .
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~-T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS-T 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc-C
Confidence 332 223334445677899999999999999999999999999999999999999964322 1111111111100 0
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGK 709 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~ 709 (782)
.+.......|.+|+.-+...-.++..+-|+++-
T Consensus 259 -~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 259 -PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred -CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 011122334567888888888999999999843
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=208.08 Aligned_cols=247 Identities=19% Similarity=0.294 Sum_probs=189.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCC-CCeeeeccccc--CccEEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH-PNMVLLLGACP--EYGIIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~--~~~~lV~E 524 (782)
...|..+++||.|+||.+|.|.. .|..||||+-...... .++..|..+...|+| ..|..+..+.. ++..+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34699999999999999999987 7889999998665433 467889999999864 56666665554 44589999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC---Cceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN---YVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~---~~~kL~DFGla~~~~ 601 (782)
.+ |.||++++.-... .|+..+++-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.|+|||||+.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 8899998754432 4899999999999999999999999 9999999999999643 468899999999874
Q ss_pred ccc--ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH-----HHHhCcccccC
Q 040785 602 AVA--ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER-----SIENGTLGEML 674 (782)
Q Consensus 602 ~~~--~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~-----~~~~~~~~~~l 674 (782)
+.. ............||.+|.+--...+-..+.+.|+-|+|++|.++.-|..||........ .+.+.++.-.+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 322 22233344567899999999988888889999999999999999999999965433211 12222222111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChH
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLG 708 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ 708 (782)
.....++ |.+|.-.+..|-.+.-++-|+..
T Consensus 246 e~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 246 EVLCKGF----PAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHhCCC----cHHHHHHHHHHhhcCCCCCCcHH
Confidence 1112233 44588899999999999999973
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=229.00 Aligned_cols=167 Identities=20% Similarity=0.175 Sum_probs=128.7
Q ss_pred HHhccccccceeeeeCcEeEEEEEE---CCeeEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCCeee-ecccccCc
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYL---DHTPVAVKVLRPD-----AAQGRSQFQREIEVLSCIRHPNMVL-LLGACPEY 518 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~---~~~~vAvK~l~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~-l~g~~~~~ 518 (782)
...+.|...+.||+|+||+||+|.+ +++.||||++... .......|.+|+++|..++|+||+. ++++ ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--~~ 92 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--GK 92 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--CC
Confidence 3456799999999999999999987 3567899987533 1223556899999999999999985 4442 34
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCceEEEcCCCceeeeccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDL-KPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL-Kp~NILld~~~~~kL~DFGla 597 (782)
.||||||++|++|.. + . . .. ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~-~-~--~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-A-R--P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHH-h-C--c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 699999999999963 2 1 1 11 1467889999999999999 999999 999999999999999999999
Q ss_pred ccccccccccc---ccccccccCCcccCChhhhhc
Q 040785 598 RLVPAVAENVT---QYHLTSTAGTFCYIDPEYQQT 629 (782)
Q Consensus 598 ~~~~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~ 629 (782)
+.+........ ....+...|++.|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 97743221111 111246789999999997653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-22 Score=210.95 Aligned_cols=257 Identities=31% Similarity=0.440 Sum_probs=195.5
Q ss_pred ccccceeeeeCcEeEEEEEECCeeEEEEEecCCchh---hHHHHHHHHHHHHhcCCC-CeeeecccccCcc--EEEEEeC
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQ---GRSQFQREIEVLSCIRHP-NMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~---~~~~~~~Ei~iL~~l~Hp-nIv~l~g~~~~~~--~lV~Ey~ 526 (782)
|.....||.|+||.||++.+. ..+++|.+...... ....|.+|+.++..+.|+ +|+.+++.+.... +++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 567788999999999999887 88899999765333 366799999999999988 7999999885554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeeccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVPAVAE 605 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~~ 605 (782)
.++++.+.+........+.......++.|++.+|.|+|..+ ++||||||+|||++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966543321125888999999999999999999999 99999999999999988 799999999986532211
Q ss_pred cccc-cccccccCCcccCChhhhhc---CCCCCchhHHHHHHHHHHHHhCCCCCCChHH------HHHHHHhCcccccCC
Q 040785 606 NVTQ-YHLTSTAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQLITAKQPMGLTHF------VERSIENGTLGEMLD 675 (782)
Q Consensus 606 ~~~~-~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~~------~~~~~~~~~~~~~ld 675 (782)
.... .......||..|++||.+.. ..+....|+||+|++++++++|..||..... ....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1111 13456789999999998887 5789999999999999999999999865542 112222211110000
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+.....+......+.+++..|+..+|..|.+.......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00011111122458899999999999999999887754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=197.51 Aligned_cols=169 Identities=20% Similarity=0.204 Sum_probs=132.9
Q ss_pred HhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHH---H------HHHHHHHHHhcCCCCeeeeccccc---
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRS---Q------FQREIEVLSCIRHPNMVLLLGACP--- 516 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~---~------~~~Ei~iL~~l~HpnIv~l~g~~~--- 516 (782)
..++|...++||.|+||.||+...++..+|||++++....... . +.+|+..+.++.||+|..+..++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5678999999999999999998777789999999865332222 2 689999999999999998877643
Q ss_pred -------CccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 517 -------EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 517 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
...+|||||++|.+|.+.. .++. ....+++.+|..||..+ |+||||||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 1248999999999997763 1332 24569999999999999 99999999999999988 9
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLI 649 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ell 649 (782)
+|+|||......... ...-++....|..++|+|+|||++..+.
T Consensus 174 ~liDfg~~~~~~e~~-----------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRK-----------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchh-----------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 999999886442110 0011455556778999999999987654
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=180.83 Aligned_cols=140 Identities=16% Similarity=0.111 Sum_probs=107.9
Q ss_pred CCCeEEEEeCCC--cchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKD--KSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTF 91 (782)
Q Consensus 14 ~~~~IlVaVD~s--~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 91 (782)
+.++||||||+| +.|.+|++||+.++.. +++|++|||.++........ .. . ......+...+..++.|..+
T Consensus 1 m~~~ILv~vD~S~~~~s~~al~~A~~la~~-~~~l~llhv~~~~~~~~~~~---~~-~--~~~~~~~~~~~~~~~~l~~~ 73 (142)
T PRK15456 1 MYKTIIMPVDVFEMELSDKAVRHAEFLAQD-DGVIHLLHVLPGSASLSLHR---FA-A--DVRRFEEHLQHEAEERLQTM 73 (142)
T ss_pred CCccEEEeccCCchhHHHHHHHHHHHHHhc-CCeEEEEEEecCcccccccc---cc-c--chhhHHHHHHHHHHHHHHHH
Confidence 368999999999 4899999999998876 56999999997543211100 00 0 11112233345566677777
Q ss_pred HHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 92 RCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 92 ~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
...+...+++++.++.. |++++.|+++|++.++|+||||+||++ +.+.|+|||+.+|+++++ |||+||+
T Consensus 74 ~~~~~~~~~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~llGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 74 VSHFTIDPSRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPS-ISTHLLGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred HHHhCCCCcceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCC-ccceecCccHHHHHHcCC--CCEEEeC
Confidence 76666567888888888 589999999999999999999999976 788888999999999999 9999984
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=189.12 Aligned_cols=188 Identities=15% Similarity=0.083 Sum_probs=142.2
Q ss_pred ccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhh----HHHHHHHHHHHHhcC-CCCeeeecccccCccEEEEEeCC
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQG----RSQFQREIEVLSCIR-HPNMVLLLGACPEYGIIVYEYLA 527 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~----~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lV~Ey~~ 527 (782)
+.+...|++|+||+||.+...+.+++.+.+....... ...|.+|+++|.+|. |++++.++++ ...+++|+|+.
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~ 81 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLA 81 (218)
T ss_pred cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeec
Confidence 3456789999999999888888899888876553321 225889999999995 5889998886 34599999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCceEEEcCCCceeeeccccccccccccc-
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDL-KPGNILLDHNYVSKISDVGLARLVPAVAE- 605 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL-Kp~NILld~~~~~kL~DFGla~~~~~~~~- 605 (782)
|.+|...+.. ....++.|++.+|.++|..| |+|||| ||+|||++.++.++|+|||+|........
T Consensus 82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9988654311 11347789999999999999 999999 79999999999999999999986532221
Q ss_pred -------cccccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHhCCCCC
Q 040785 606 -------NVTQYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 606 -------~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf 655 (782)
+..........+++.|++|+...-- .--...++++-|+.+|.++||+.|+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 1111111123478899999853322 2235789999999999999999886
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.2e-21 Score=191.55 Aligned_cols=138 Identities=17% Similarity=0.186 Sum_probs=107.9
Q ss_pred cceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhh---------H-----------------HHHHHHHHHHHhcCCCCe
Q 040785 456 SRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQG---------R-----------------SQFQREIEVLSCIRHPNM 508 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~---------~-----------------~~~~~Ei~iL~~l~HpnI 508 (782)
...||+|+||.||+|.+ +++.||||+++...... . ....+|+.+|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998 68899999997642110 0 122359999999987776
Q ss_pred eeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCceEEEcCCC
Q 040785 509 VLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL-HQTKPEPLVHRDLKPGNILLDHNY 587 (782)
Q Consensus 509 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrDLKp~NILld~~~ 587 (782)
...........+|||||++++++....... .++++..+..++.|++.+|.|| |+.+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 433333233458999999998776543322 3588999999999999999999 6888 99999999999998 47
Q ss_pred ceeeecccccccc
Q 040785 588 VSKISDVGLARLV 600 (782)
Q Consensus 588 ~~kL~DFGla~~~ 600 (782)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-21 Score=192.02 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=186.8
Q ss_pred ccceeeeeCcEeEEEEEECCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC--ccEEEEEeCCCCC
Q 040785 455 ESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE--YGIIVYEYLANGS 530 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gs 530 (782)
..-+|.+...|..|+|++.+..+++|+++... ......|..|.-.|+.+.||||+.++|+|.. +..++..||+.|+
T Consensus 194 l~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34568888999999999999999999986542 2234679999999999999999999999954 4588999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee-cCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH-RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 531 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH-rDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
|+..|+.... -.+.-.++.+++.++++|+.|||+..| +|- --|....|+||++.+.+|+- +-+++ .
T Consensus 274 lynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarism-ad~kf---------s 340 (448)
T KOG0195|consen 274 LYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISM-ADTKF---------S 340 (448)
T ss_pred HHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheec-cccee---------e
Confidence 9999976532 346777899999999999999999884 554 35888999999999887741 11111 1
Q ss_pred cccccccCCcccCChhhhhcCCC---CCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGML---GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~---s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
+......-.+.||+||.++..+- -..+|+|||.+++|||.|...||......+.-... ..+.+. ...|+...
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--aleglr---v~ippgis 415 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--ALEGLR---VHIPPGIS 415 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--hhcccc---ccCCCCcc
Confidence 11123345788999998876653 35799999999999999999999766555432211 111222 23466677
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+.+|+.-|++.||.+||.+..++ +.|+++
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv-pilekm 446 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV-PILEKM 446 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh-hhHHHh
Confidence 7899999999999999999997776 666654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=225.63 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=180.5
Q ss_pred cccceeeeeCcEeEEEEEE--CCeeEEEEEec----CC-chhh-HHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 454 TESRKIGEGGYGPVYKCYL--DHTPVAVKVLR----PD-AAQG-RSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~----~~-~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.....+|.|+||.|+.... ....++.|..+ +. .... ...+..|+.+-..+.|||++..+..+.+.. +-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999998887765 22333333322 11 1111 112556777888899999988777664433 3349
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|||++ +|..++.... .+...++..++.|++.||.|||+.| |.||||||+|+++..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999886542 3777889999999999999999999 999999999999999999999999999876432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCC-chhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCC--
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGV-KSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTD-- 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~-ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~-- 680 (782)
... ........+|+-.|+|||.+....|.+ ..||||.||+++.|++|+.||......+..........-..-..+.
T Consensus 474 ~e~-~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 474 WEK-NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred cch-hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 221 123456678999999999999988866 5899999999999999999996554332221000000000000111
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.-...+.....++.++|+.+|..|-++.+++.
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11234556789999999999999999999984
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=176.53 Aligned_cols=142 Identities=13% Similarity=0.103 Sum_probs=108.0
Q ss_pred CCCeEEEEeCCCcc--hHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKS--SQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTF 91 (782)
Q Consensus 14 ~~~~IlVaVD~s~~--S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 91 (782)
+.++||||||+|+. +.+|++||+..+...+++|++|||+++.+... .. ..... ..........+.+++.+..+
T Consensus 1 m~~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~--~~-~~~~~--~~~~~~~~~~~~~~~~l~~~ 75 (144)
T PRK15005 1 MNRTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYA--SL-GLAYS--AELPAMDDLKAEAKSQLEEI 75 (144)
T ss_pred CCccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccc--cc-ccccc--ccchHHHHHHHHHHHHHHHH
Confidence 36899999999988 58999999999999999999999997543210 00 00000 00000112334455566666
Q ss_pred HHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 92 RCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 92 ~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
...+...++.++.++.. |+|++.|+++|+++++|+||||+| ++++.+.|+|||+.+|++++| |||+||+
T Consensus 76 ~~~~~~~~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~llGS~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 76 IKKFKLPTDRVHVHVEE-GSPKDRILELAKKIPADMIIIASH-RPDITTYLLGSNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred HHHhCCCCCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCC-CCCchheeecchHHHHHHhCC--CCEEEeC
Confidence 66666667788888887 589999999999999999999999 467889899999999999999 9999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=185.73 Aligned_cols=138 Identities=20% Similarity=0.210 Sum_probs=110.0
Q ss_pred cceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhh--------------------------HHHHHHHHHHHHhcCCCCe
Q 040785 456 SRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQG--------------------------RSQFQREIEVLSCIRHPNM 508 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~--------------------------~~~~~~Ei~iL~~l~HpnI 508 (782)
...||+|+||.||+|.+ +++.||||++++..... ...+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998 58899999998652110 1124679999999999987
Q ss_pred eeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCC
Q 040785 509 VLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNY 587 (782)
Q Consensus 509 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~ 587 (782)
.....+.....+|||||++++++....... ..++...+..++.|++.+|.+||+ .+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 544333334469999999988654432222 247788899999999999999999 88 99999999999999 88
Q ss_pred ceeeecccccccc
Q 040785 588 VSKISDVGLARLV 600 (782)
Q Consensus 588 ~~kL~DFGla~~~ 600 (782)
.++|+|||++...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-21 Score=221.17 Aligned_cols=247 Identities=20% Similarity=0.259 Sum_probs=176.9
Q ss_pred cccccceeeeeCcEeEEEEEECCeeEEEEEecCCc-hhhHHHHHHHHHH--HHhcCCCCeeeeccccc--CccEEEEEeC
Q 040785 452 FFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA-AQGRSQFQREIEV--LSCIRHPNMVLLLGACP--EYGIIVYEYL 526 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ei~i--L~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 526 (782)
.|...+.||.+.|=+|.+|.++...|+||++-+.. ......|.++++- ...++|||.+.+--+-. ...|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 46667889999999999999977779999985543 3445555554443 34458999998866543 3348888998
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc--ccc-
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV--PAV- 603 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~--~~~- 603 (782)
.+ +|+|+|.- .+-+..-+...|+.||+.||.-+|..| |+|+|||.+||||+.-.-+.|+||.--+-. +.+
T Consensus 104 kh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 55 88888833 344677788889999999999999999 999999999999998888999999876532 211
Q ss_pred cccccccccccccCCcccCChhhhhcCC-----------CCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCccc
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGM-----------LGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLG 671 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----------~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~ 671 (782)
..+.+.+..| ...-.||+|||.|.... .+++.||||+||+++||++ |++||.+.....-.-......
T Consensus 177 Padf~fFFDT-SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 177 PADFTFFFDT-SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred cccceEEEec-CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 1122222222 33445899999775421 6789999999999999998 899998766543211100000
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.+-..+ +...+.+|++.|++++|..|-++++.|.
T Consensus 256 e~~Le~I------ed~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 256 EQLLEKI------EDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred HHHHHhC------cCccHHHHHHHHHccCchhccCHHHHHH
Confidence 0000001 1114899999999999999999988873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-21 Score=215.59 Aligned_cols=221 Identities=25% Similarity=0.318 Sum_probs=175.5
Q ss_pred eeeeCcEeEEEEEE-----CCeeEEEEEecCCchhh--HHHHHHHHHHHHhcC-CCCeeeecccccCcc--EEEEEeCCC
Q 040785 459 IGEGGYGPVYKCYL-----DHTPVAVKVLRPDAAQG--RSQFQREIEVLSCIR-HPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 459 LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~~~--~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
+|.|+||.|+++.. .+..+|+|++++..... +.....|..++..++ ||.+|.+...+.... +++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998753 56679999987643221 224567888998887 999999998886554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|.|...+... ..+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-..
T Consensus 82 g~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~----- 150 (612)
T KOG0603|consen 82 GDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE----- 150 (612)
T ss_pred chhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh-----
Confidence 9998877444 34777778888899999999999999 999999999999999999999999999865211
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 688 (782)
...|||..|||||++. ......|+||||++++||+||..||.. ........ .-...|......
T Consensus 151 ----~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-~~~~~Il~----------~~~~~p~~l~~~ 213 (612)
T KOG0603|consen 151 ----KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-DTMKRILK----------AELEMPRELSAE 213 (612)
T ss_pred ----hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-HHHHHHhh----------hccCCchhhhHH
Confidence 1128999999999988 567889999999999999999999976 22222111 112345566666
Q ss_pred HHHHHHHhhccCcCCCCCh
Q 040785 689 FAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 689 l~~li~~cl~~~P~~RPs~ 707 (782)
..+++..+...+|..|--.
T Consensus 214 a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 214 ARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHhhCHHHHhcc
Confidence 8888999999999988765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=183.21 Aligned_cols=229 Identities=23% Similarity=0.310 Sum_probs=147.2
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCC----------CC------eeee
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRH----------PN------MVLL 511 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~H----------pn------Iv~l 511 (782)
+.....||.|+|+.||.+++ ++..+|||++.... ....+.+.+|.-....+.+ -. ++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 45568899999999999999 45899999985432 2345667776655544332 11 1222
Q ss_pred ccc---c---c-------CccEEEEEeCCCCChhHHHh---hcCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 040785 512 LGA---C---P-------EYGIIVYEYLANGSLDDRIF---RRGNT-PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574 (782)
Q Consensus 512 ~g~---~---~-------~~~~lV~Ey~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHr 574 (782)
-+- + . -+.+++|+-+ .++|.+++. ..... ..+....+..+..|+++.+++||..| |+|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 110 0 0 1226777776 567877643 33222 23444556777799999999999999 9999
Q ss_pred CCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcC--------CCCCchhHHHHHHHHH
Q 040785 575 DLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG--------MLGVKSDVYSLGILLL 646 (782)
Q Consensus 575 DLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--------~~s~ksDVwSlGvil~ 646 (782)
||||+|+|++.+|.++|+||+........ ... ...+..|.+||..... .++.+.|.|+||+++|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR------YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE------EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce------eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999887654321 111 2345779999965442 4788999999999999
Q ss_pred HHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCC
Q 040785 647 QLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDR 704 (782)
Q Consensus 647 elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~R 704 (782)
.|++|..||+....... . +.....+. +.+..+..||..+|+.+|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~------~----~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEAD------P----EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGST------S----GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCcccc------c----cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999975532110 0 00233344 667779999999999999988
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=171.28 Aligned_cols=138 Identities=12% Similarity=0.066 Sum_probs=103.7
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
++++||||||+|+.|.+|+++|+.++...+++|++|||.++.+... .. .... ..........+.+++.+..+..
T Consensus 2 ~~k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~--~~--~~~~--~~~~~~~~~~~~~~~~l~~~~~ 75 (142)
T PRK09982 2 AYKHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELY--PG--IYFP--ATEDILQLLKNKSDNKLYKLTK 75 (142)
T ss_pred CceEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhc--hh--hhcc--chHHHHHHHHHHHHHHHHHHHH
Confidence 3689999999999999999999999999999999999986543210 00 0000 0111222233445556666655
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
.+. ...++..+.. |+|++.|+++|++.+||+||||+| ++++.++| | ||++|+++++ |||+||..
T Consensus 76 ~~~--~~~~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~-~-va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 76 NIQ--WPKTKLRIER-GEMPETLLEIMQKEQCDLLVCGHH-HSFINRLM-P-AYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred hcC--CCcceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHH-H-HHHHHHhcCC--CCEEEecC
Confidence 443 2356666666 689999999999999999999987 88998887 5 9999999998 99999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=177.52 Aligned_cols=135 Identities=16% Similarity=0.257 Sum_probs=105.3
Q ss_pred ccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhc-----CCCCeeeecccccCc---cE---E
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-----RHPNMVLLLGACPEY---GI---I 521 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~g~~~~~---~~---l 521 (782)
+.....||+|+||.||.-..++ ..+||++........+.+.+|+.++..+ .||||++++|++.+. ++ +
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~-~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDA-QRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECCCCc-CeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456789999999999622233 3479998765444567899999999999 579999999999765 23 7
Q ss_pred EEEe--CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCceEEEcC----CCceeeecc
Q 040785 522 VYEY--LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL-LFLHQTKPEPLVHRDLKPGNILLDH----NYVSKISDV 594 (782)
Q Consensus 522 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~iiHrDLKp~NILld~----~~~~kL~DF 594 (782)
|+|| +++|+|.+++.+. .+++. ..++.+++.++ .|||+++ ||||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 6679999999542 25555 35678888887 9999999 999999999999974 348999995
Q ss_pred ccc
Q 040785 595 GLA 597 (782)
Q Consensus 595 Gla 597 (782)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=160.09 Aligned_cols=132 Identities=17% Similarity=0.220 Sum_probs=113.2
Q ss_pred eEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHHHhh
Q 040785 17 LIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCT 96 (782)
Q Consensus 17 ~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~ 96 (782)
+||||||+++.+..||++|..++...+.+|+++||++++..... .......+..++.+..+..++.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~ 66 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP--------------SQLEVNVQRARKLLRQAERIAA 66 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc--------------chhHHHHHHHHHHHHHHHHHhh
Confidence 59999999999999999999999988999999999976432100 0111233556778888888888
Q ss_pred cCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 97 RKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 97 ~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
..|++++..+..++++.++|+++++++++|+||||+++++++.+.++||++.+|+++++ |||++|+
T Consensus 67 ~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 67 SLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred hcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEeC
Confidence 89999998888778999999999999999999999999999988889999999999999 9999984
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=159.70 Aligned_cols=123 Identities=15% Similarity=0.159 Sum_probs=104.1
Q ss_pred eEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHHHhh
Q 040785 17 LIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCT 96 (782)
Q Consensus 17 ~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~ 96 (782)
+||||||+++.+++||+||+.++...++.|++|||.++... ...+..++.++.+...+.
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~---------------------~~~~~~~~~l~~~~~~~~ 59 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLN---------------------RLSEAERRRLAEALRLAE 59 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccc---------------------cCCHHHHHHHHHHHHHHH
Confidence 59999999999999999999999989999999999864321 122344667777777777
Q ss_pred cCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEE
Q 040785 97 RKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163 (782)
Q Consensus 97 ~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV 163 (782)
..+++ ..++.+++++++|+++++++++|+||||+|+++++.++|+||++.+|++++ ..|+|+|+
T Consensus 60 ~~~~~--~~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 60 ELGAE--VVTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred HcCCE--EEEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 66654 445667899999999999999999999999999999999999999999999 23999987
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=165.98 Aligned_cols=138 Identities=15% Similarity=0.120 Sum_probs=97.4
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+.++||||+|+|+.|..||+||+.++...+++|++|||..+... ... ... . .......+...+...+. +..
T Consensus 2 ~~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~--~~~--~~~-~-~~~~~~~~~~~~~~~~~---l~~ 72 (144)
T PRK15118 2 AYKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSD--LYT--GLI-D-VNLGDMQKRISEETHHA---LTE 72 (144)
T ss_pred CceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhh--hhh--hhh-h-cchHHHHHHHHHHHHHH---HHH
Confidence 36899999999999999999999999888999999999532211 000 000 0 00011111112222233 334
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
++...|+.+...++..|+|+++|+++|++.++|+||||+|| +.+. . +||||++|+++++ |||+||..
T Consensus 73 ~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~-~-lgSva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 73 LSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-DFWS-K-LMSSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred HHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-cHHH-H-HHHHHHHHHhhCC--CCEEEecC
Confidence 44556777655555447899999999999999999999996 4444 3 4899999999999 99999974
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=196.30 Aligned_cols=241 Identities=21% Similarity=0.253 Sum_probs=172.9
Q ss_pred HHHHhccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC---CCCeeeeccc--ccCcc
Q 040785 446 IEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR---HPNMVLLLGA--CPEYG 519 (782)
Q Consensus 446 ~~~~t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~--~~~~~ 519 (782)
++.....|.+.+.||+|+||.||+|.. +++.||+|+-++..... |--=.+++.+|+ -+-|+.+..+ |.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 334456689999999999999999987 68899999998765542 211223444555 1223333332 45666
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-------CCCceeee
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-------HNYVSKIS 592 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-------~~~~~kL~ 592 (782)
+||+||.+-|+|.+++. ....++|..+..++.|++..+..||..+ |||+||||+|+||. ++..++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999985 4456899999999999999999999999 99999999999993 34568999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGE 672 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 672 (782)
|||.+-.+.... ........++|-.+-.+|+..+..++..+|.|.|.-+++-||.|+. .+ ...|.. .
T Consensus 844 DfG~siDm~lfp---~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y-------~q--~~~g~~-~ 910 (974)
T KOG1166|consen 844 DFGRSIDMKLFP---DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY-------ME--VKNGSS-W 910 (974)
T ss_pred ecccceeeeEcC---CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH-------HH--hcCCcc-e
Confidence 999986552221 1123345678889999999999999999999999999999999863 22 222322 2
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHh
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
.++..+..+. ...-+.+|...+|+.+...=|.+.++
T Consensus 911 ~~~~~~~Ry~--~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 911 MVKTNFPRYW--KRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred eccccchhhh--hHHHHHHHHHHHhCcCcccchhHHHH
Confidence 2222222221 11236777888888555555555433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.4e-18 Score=197.86 Aligned_cols=209 Identities=23% Similarity=0.308 Sum_probs=143.5
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCccEEEEEeCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLAN 528 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~lV~Ey~~~ 528 (782)
++|..++.|-.|+||.||..++. .+.+|+|+ +++.. +.+- ||.....|. .|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npf-------------vv------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPF-------------VV------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCcc-------------ee------
Confidence 46899999999999999999885 66899854 32211 1110 233233333 33
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc-----
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV----- 603 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~----- 603 (782)
|+-...+. +..+++.. ++.+++|||+.+ |+|||+||+|+||..-|++|++|||+++..-..
T Consensus 136 gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 33333332 22234332 278899999999 999999999999999999999999998754111
Q ss_pred -----cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH---HHHHHHhCcccccCC
Q 040785 604 -----AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF---VERSIENGTLGEMLD 675 (782)
Q Consensus 604 -----~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~ld 675 (782)
.....+......+||+.|+|||++....|+..+|||++|+|+||++-|..||..... +...+.+ ++..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd----~i~w 277 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD----DIEW 277 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----hccc
Confidence 011122333456999999999999999999999999999999999999999975532 1111111 1111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
|. -....+.+.++++.+.|+.+|..|--.
T Consensus 278 pE---~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 278 PE---EDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred cc---cCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11 112234568999999999999999753
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.7e-18 Score=158.36 Aligned_cols=140 Identities=22% Similarity=0.308 Sum_probs=102.5
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
|.++||||+|+++.+..|++||+.++...+++|++|||.+.......... .....................
T Consensus 1 M~~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~ 71 (140)
T PF00582_consen 1 MYKRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAA---------EDEESEEEAEEEEQARQAEAE 71 (140)
T ss_dssp -TSEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHH---------HHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccc---------cccccccccchhhhhhhHHHH
Confidence 46899999999999999999999999999999999999976542110000 000000000000000111113
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
.+...+.......+..++++++|++++++.++|+||||+++++++.++++||++.+|++++| |||+||.
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 72 EAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp HHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEEEE
T ss_pred HHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEEeC
Confidence 34445566666666668999999999999999999999999999999999999999999999 9999984
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=168.40 Aligned_cols=132 Identities=26% Similarity=0.332 Sum_probs=110.2
Q ss_pred ceeeeeCcEeEEEEEECCeeEEEEEecCCchh--------hHHHHHHHHHHHHhcCCCCeeeeccc--ccCccEEEEEeC
Q 040785 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQ--------GRSQFQREIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYL 526 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~--------~~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~~~lV~Ey~ 526 (782)
+.||+|++|.||+|.+.+..|+||+....... ....+.+|+.++..+.|+||.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999999999999987643211 12457889999999999987655544 345569999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
+|++|.+.+.... + .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885322 2 77889999999999999999 99999999999999 78899999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-18 Score=188.88 Aligned_cols=177 Identities=25% Similarity=0.335 Sum_probs=133.8
Q ss_pred ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 518 YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 518 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
+.|+.|++|.-.+|.++|.++......++.....++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 357999999999999999877666678888999999999999999 77 999999999999999999999999998
Q ss_pred ccccccc-ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCcccccCC
Q 040785 598 RLVPAVA-ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEMLD 675 (782)
Q Consensus 598 ~~~~~~~-~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld 675 (782)
....... ........+...||..||+||.+.+..|+.++||||||+||+||+. -..+|..... ...+.+|.+...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t-~~d~r~g~ip~~-- 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT-LTDIRDGIIPPE-- 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh-hhhhhcCCCChH--
Confidence 7653222 1112234567789999999999999999999999999999999997 3333321111 112223322110
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGK 709 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~ 709 (782)
.+.++|. -..|+++++.+.|.+||+..+
T Consensus 481 -~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 481 -FLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -HhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 1112222 358999999999999995433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=165.14 Aligned_cols=129 Identities=24% Similarity=0.301 Sum_probs=105.9
Q ss_pred eeeeeCcEeEEEEEECCeeEEEEEecCCch--------hhHHHHHHHHHHHHhcCCCCe--eeecccccCccEEEEEeCC
Q 040785 458 KIGEGGYGPVYKCYLDHTPVAVKVLRPDAA--------QGRSQFQREIEVLSCIRHPNM--VLLLGACPEYGIIVYEYLA 527 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~~~~lV~Ey~~ 527 (782)
.||+|+||.||+|.+.+..|++|+...... .....+.+|++++..+.|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 489999999999999999999999754311 113567889999999988764 4445555556699999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
|++|.+.+.... . .++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++...
T Consensus 81 g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998774321 0 78999999999999999 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-17 Score=183.66 Aligned_cols=202 Identities=25% Similarity=0.434 Sum_probs=151.2
Q ss_pred HHhcCCCCeeeecccccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe-eecCC
Q 040785 500 LSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL-VHRDL 576 (782)
Q Consensus 500 L~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i-iHrDL 576 (782)
|+.+.|.|+.+++|.+.+.. +.|.+||..|+|.|.+.... ..++|.-...++.+|+.||.|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 45689999999999996655 78999999999999997633 34888888999999999999999876 4 99999
Q ss_pred CCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCC-------CCCchhHHHHHHHHHHHH
Q 040785 577 KPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM-------LGVKSDVYSLGILLLQLI 649 (782)
Q Consensus 577 Kp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-------~s~ksDVwSlGvil~ell 649 (782)
++.|.++|..+.+||+|||+........ .........-..-|.|||.+.... .+.+.||||||++++|++
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~---~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETA---EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccc---cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999987663210 001111122345699999877642 467799999999999999
Q ss_pred hCCCCCCChHHHH------HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 650 TAKQPMGLTHFVE------RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 650 tG~~Pf~~~~~~~------~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+...||....... ..+.+ .....+.|.+.... +....+..++..||..+|..||++.++-
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred hccCccccccccCChHHHHHHHHh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 9999997533221 11222 12223344433221 3334689999999999999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-17 Score=169.40 Aligned_cols=141 Identities=20% Similarity=0.222 Sum_probs=110.0
Q ss_pred cccccceeeeeCcEeEEEEE-E--CCeeEEEEEecCCchh------------------------hHHHHHHHHHHHHhcC
Q 040785 452 FFTESRKIGEGGYGPVYKCY-L--DHTPVAVKVLRPDAAQ------------------------GRSQFQREIEVLSCIR 504 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~-~--~~~~vAvK~l~~~~~~------------------------~~~~~~~Ei~iL~~l~ 504 (782)
.|.+.+.||+|+||.||+|. + +++.||||+++..... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 3 6889999999754210 1123578999999997
Q ss_pred CCC--eeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEE
Q 040785 505 HPN--MVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582 (782)
Q Consensus 505 Hpn--Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 582 (782)
+.+ +..+++. ...++||||+++++|...+... ..+...+...++.||+.+|.+||..+ .|+||||||+|||
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 533 3444443 2358999999998886654222 23556667889999999999999987 3999999999999
Q ss_pred EcCCCceeeecccccccc
Q 040785 583 LDHNYVSKISDVGLARLV 600 (782)
Q Consensus 583 ld~~~~~kL~DFGla~~~ 600 (782)
++ ++.++|+|||++...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=153.54 Aligned_cols=137 Identities=15% Similarity=0.107 Sum_probs=102.1
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+.++||||+|+|+.+..||++|+.++...+++|+++||++++... . .... .......+...+..++.+..
T Consensus 2 ~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~-~-----~~~~-~~~~~~~~~~~~~~~~~l~~--- 71 (142)
T PRK10116 2 SYSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMY-N-----QFAA-PMLEDLRSVMQEETQSFLDK--- 71 (142)
T ss_pred CCceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccc-h-----hhhH-HHHHHHHHHHHHHHHHHHHH---
Confidence 368999999999999999999999999889999999998654320 0 0000 00011111222333344433
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
++...++..+..++..|++.+.|+++|++.++|+||||+|+++++.+++ ||+++|+++++ |||+||.
T Consensus 72 ~~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~--s~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 72 LIQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRAS--CSAKRVIASSE--VDVLLVP 138 (142)
T ss_pred HHHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHH--HHHHHHHhcCC--CCEEEEe
Confidence 3455677665555555799999999999999999999999999998864 89999999999 9999996
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.8e-17 Score=169.72 Aligned_cols=191 Identities=20% Similarity=0.221 Sum_probs=135.4
Q ss_pred CCCCeeeecccccC-----------------------------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHH
Q 040785 504 RHPNMVLLLGACPE-----------------------------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA 554 (782)
Q Consensus 504 ~HpnIv~l~g~~~~-----------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 554 (782)
+|||||+++++|.+ ..|+||.-.+ .+|..++..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 69999999987632 1177887664 38888875443 55667778999
Q ss_pred HHHHHHHHhhhcCCCCeeecCCCCceEEE--cCCC--ceeeeccccccccccccccccc-cccccccCCcccCChhhhhc
Q 040785 555 EIATGLLFLHQTKPEPLVHRDLKPGNILL--DHNY--VSKISDVGLARLVPAVAENVTQ-YHLTSTAGTFCYIDPEYQQT 629 (782)
Q Consensus 555 qia~aL~yLH~~~~~~iiHrDLKp~NILl--d~~~--~~kL~DFGla~~~~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~ 629 (782)
|+++|+.|||.+| |.|||+|++|||| |+++ .+.|+|||++---...+-.... ....+..|...-||||++..
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4444 5689999987532221111111 11234568889999998764
Q ss_pred CC------CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCC
Q 040785 630 GM------LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKD 703 (782)
Q Consensus 630 ~~------~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~ 703 (782)
.+ --.|+|.|+.|.+.||+++...||..... ..++..++.+- .++..|..++..+.+++...|+.+|.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~Yqe~---qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRTYQES---QLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhhhhhh---hCCCCcccCChHHHHHHHHHhcCCccc
Confidence 32 12489999999999999999999964211 11222222222 233345556667899999999999999
Q ss_pred CCCh
Q 040785 704 RPDL 707 (782)
Q Consensus 704 RPs~ 707 (782)
||+.
T Consensus 501 Rvsp 504 (598)
T KOG4158|consen 501 RVSP 504 (598)
T ss_pred cCCc
Confidence 9985
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=162.28 Aligned_cols=135 Identities=22% Similarity=0.207 Sum_probs=107.2
Q ss_pred cccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh----------------------hHHHHHHHHHHHHhcCCCC-
Q 040785 452 FFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ----------------------GRSQFQREIEVLSCIRHPN- 507 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~----------------------~~~~~~~Ei~iL~~l~Hpn- 507 (782)
.|...+.||.|+||.||+|.. +++.||||++...... ....+.+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 477789999999999999988 6889999997653200 1123678899999998874
Q ss_pred -eeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC
Q 040785 508 -MVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586 (782)
Q Consensus 508 -Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~ 586 (782)
+...++. ...++||||++|++|...... .....++.+++.++.++|..+ |+||||||+||+++.+
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 4444443 334999999999998764321 234578899999999999998 9999999999999999
Q ss_pred Cceeeecccccccc
Q 040785 587 YVSKISDVGLARLV 600 (782)
Q Consensus 587 ~~~kL~DFGla~~~ 600 (782)
+.++|+|||++...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.7e-17 Score=187.38 Aligned_cols=138 Identities=21% Similarity=0.236 Sum_probs=111.6
Q ss_pred HHhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCc--------hhhHHHHHHHHHHHHhcCCCCeeeecccc--cC
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--------AQGRSQFQREIEVLSCIRHPNMVLLLGAC--PE 517 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~ 517 (782)
.....|...+.||+|+||.||+|.+.+..+++|+..... ......+.+|++++..++|++++....++ ..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 334556778999999999999999877777666543211 11235688999999999999988765544 34
Q ss_pred ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 518 YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 518 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
..++||||+++++|.+.+. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 5699999999999998774 34678999999999999999 9999999999999 6788999999999
Q ss_pred ccc
Q 040785 598 RLV 600 (782)
Q Consensus 598 ~~~ 600 (782)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-16 Score=169.35 Aligned_cols=146 Identities=12% Similarity=0.024 Sum_probs=113.2
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+.++||||+|+|+.+..|++||+..+...+++|++|||++.... ... ...... ......+...+..++.++.+..
T Consensus 2 ~~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~-~~~--~~~~~~--~~~~~~~~~~~~~~~~l~~~~~ 76 (305)
T PRK11175 2 KYQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSY-EMT--TLLSPD--EREAMRQGVISQRTAWIREQAK 76 (305)
T ss_pred CcceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchh-hhh--cccchh--HHHHHHHHHHHHHHHHHHHHHH
Confidence 36899999999999999999999999999999999999864321 000 000000 0000111112334556676666
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
.+...+++++..+..+|++.++|+++|.++++|+||||++|.+++.+.++||++.++++++| |||++|..+
T Consensus 77 ~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 77 PYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred HHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEeccc
Confidence 67778899998887667999999999999999999999999999999999999999999999 999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=145.48 Aligned_cols=134 Identities=24% Similarity=0.291 Sum_probs=112.0
Q ss_pred ccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCC--CCeeeecccccC--ccEEEEEeCCCCC
Q 040785 455 ESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH--PNMVLLLGACPE--YGIIVYEYLANGS 530 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~--~~~lV~Ey~~~gs 530 (782)
+.+.||.|.++.||++...+..+++|....... ...+.+|+.++..++| ++++++++++.. ..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 357899999999999999888999999876543 4678999999999976 588888887754 4599999999887
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 531 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+... +......++.+++.+|.+||.....+++|+||+|.|||++..+.++++|||++...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7543 44566778999999999999864344999999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=152.92 Aligned_cols=135 Identities=24% Similarity=0.268 Sum_probs=96.8
Q ss_pred cceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhh--HHH----------------------HHHHHHHHHhcCCCC--e
Q 040785 456 SRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQG--RSQ----------------------FQREIEVLSCIRHPN--M 508 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~--~~~----------------------~~~Ei~iL~~l~Hpn--I 508 (782)
.+.||+|+||.||+|.+. ++.||||++++..... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999985 8899999987642111 111 135666666664433 3
Q ss_pred eeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCC
Q 040785 509 VLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNY 587 (782)
Q Consensus 509 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~ 587 (782)
...+++ ...++||||++++++......... .. ..+..++.+++.++.++|. .+ |+||||||+||+++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 333332 345899999999654322111110 11 5677899999999999999 88 99999999999999 89
Q ss_pred ceeeecccccccc
Q 040785 588 VSKISDVGLARLV 600 (782)
Q Consensus 588 ~~kL~DFGla~~~ 600 (782)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.4e-15 Score=135.72 Aligned_cols=130 Identities=31% Similarity=0.414 Sum_probs=110.0
Q ss_pred eEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHHHhh
Q 040785 17 LIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCT 96 (782)
Q Consensus 17 ~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~ 96 (782)
+||||+|+++.+..+++||.+.+...+++|++|||.++..... ...........++.|..+...|.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~--------------~~~~~~~~~~~~~~l~~~~~~~~ 66 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSA--------------AELAELLEEEARALLEALREALA 66 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcc--------------hhHHHHHHHHHHHHHHHHHHHHh
Confidence 5999999999999999999999999999999999986533100 01122344566788888988888
Q ss_pred cCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEE
Q 040785 97 RKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163 (782)
Q Consensus 97 ~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV 163 (782)
..++.+...+.. ++++++|++++++.++|+||||+++++.+.+.+.|+++.+++++++ |||++|
T Consensus 67 ~~~~~~~~~~~~-~~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 67 EAGVKVETVVLE-GDPAEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAP--CPVLVV 130 (130)
T ss_pred cCCCceEEEEec-CCCHHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCC--CCEEeC
Confidence 889999888887 4569999999999999999999999999988888999999999987 999975
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-15 Score=159.26 Aligned_cols=142 Identities=16% Similarity=0.181 Sum_probs=101.1
Q ss_pred CCCeEEEEeCCCcch-------HHHHHHHHHhccCC-CCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHH
Q 040785 14 GNGLIAVAVDKDKSS-------QHALKWAADNLLNR-GQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIR 85 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S-------~~Al~wAl~~~~~~-g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (782)
..++||||+|+|+.+ ..||++|+..+... +++|++|||.+........ .. .........+...+.
T Consensus 151 ~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~---~~--~~~~~~~~~~~~~~~-- 223 (305)
T PRK11175 151 EGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAI---EL--PEFDPSVYNDAIRGQ-- 223 (305)
T ss_pred CCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccc---cc--cccchhhHHHHHHHH--
Confidence 368999999999653 68999999999887 9999999998654321000 00 000001111111122
Q ss_pred HHHHHHHHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 86 DLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 86 ~~l~~~~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
....+..++...++..+..++..|++.++|+++|++.++|+||||++|++++.+.|+||++.+|+++++ |||++|+.
T Consensus 224 -~~~~l~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv~~ 300 (305)
T PRK11175 224 -HLLAMKALRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAIKP 300 (305)
T ss_pred -HHHHHHHHHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEEcC
Confidence 222334444455666543344447899999999999999999999999999999999999999999999 99999964
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=151.32 Aligned_cols=133 Identities=20% Similarity=0.202 Sum_probs=104.9
Q ss_pred cceee-eeCcEeEEEEEECCeeEEEEEecCCc-------------hhhHHHHHHHHHHHHhcCCCCe--eeecccccC--
Q 040785 456 SRKIG-EGGYGPVYKCYLDHTPVAVKVLRPDA-------------AQGRSQFQREIEVLSCIRHPNM--VLLLGACPE-- 517 (782)
Q Consensus 456 ~~~LG-~G~fg~Vy~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~-- 517 (782)
...|| .||.|+||.+...+..++||.+.... ......+.+|++++..|.|++| +..++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45788 89999999999988999999875311 1223567889999999998875 556655322
Q ss_pred ----ccEEEEEeCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 518 ----YGIIVYEYLAN-GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 518 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
..++||||++| .+|.+++... +++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 12599999997 6888877432 35543 3568999999999999 9999999999999999999999
Q ss_pred ccccccc
Q 040785 593 DVGLARL 599 (782)
Q Consensus 593 DFGla~~ 599 (782)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999874
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-14 Score=135.35 Aligned_cols=147 Identities=20% Similarity=0.254 Sum_probs=113.7
Q ss_pred CCCeEEEEeC-CCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 14 GNGLIAVAVD-KDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 14 ~~~~IlVaVD-~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
..++|++++| +++.+..|+.+|+..+...+..+.++||.+.............. . ..............+.+..+.
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~ 80 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALAD-A--PIPLSEEELEEEAEELLAEAK 80 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEeccccccccccccccc-c--hhhhhHHHHHHHHHHHHHHHH
Confidence 4689999999 99999999999999999999999999998654421110000000 0 000011223455677888888
Q ss_pred HHhhcCCCce-EEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 93 CYCTRKDIKC-FDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 93 ~~c~~~~v~~-e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
......++.. +..+..|..+...|++++.+.++|+||||++|++++.++++|||+++|+++++ |||++|.-
T Consensus 81 ~~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 81 ALAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCC--CCEEEEcc
Confidence 8888888884 77777754447999999999999999999999999999888999999999999 99999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-15 Score=176.87 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=182.0
Q ss_pred cccccceeeeeCcEeEEEEEEC---CeeEEEEEecCCc--hhhHHHHHHHHHHHHhcC-CCCeeeecccccCc--cEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD---HTPVAVKVLRPDA--AQGRSQFQREIEVLSCIR-HPNMVLLLGACPEY--GIIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~---~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~lV~ 523 (782)
.|...+.||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++..... .+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4777888999999999887762 2346666664432 222334455777777776 99999999987544 48899
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCceEEEcCCC-ceeeeccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH-QTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVP 601 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~~ 601 (782)
+|..+|++.+.+... .....+....-.++.|+..+|.|+| ..+ +.||||||+|.+++..+ .++++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999998877322 1113555667788999999999999 888 99999999999999999 99999999999875
Q ss_pred cccccccccccccccC-CcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCC--
Q 040785 602 AVAENVTQYHLTSTAG-TFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPT-- 677 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~G-t~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~-- 677 (782)
.. ..........+| ++.|+|||.+.+ ....+..|+||.|+++.-+++|..||....... +.+.......
T Consensus 177 ~~--~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 177 NK--NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSNKGR 249 (601)
T ss_pred cc--CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeecccccc
Confidence 41 112333445678 999999998777 456788999999999999999999996544322 1111111111
Q ss_pred --CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 --VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 --~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...| ........+++.+++..+|..|.+.+++-.
T Consensus 250 ~~~~~~-~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FTQLPW-NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCcc-ccCChhhhhcccccccCCchhccccccccc
Confidence 1111 223334678889999999999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=8e-13 Score=149.66 Aligned_cols=138 Identities=23% Similarity=0.277 Sum_probs=99.0
Q ss_pred cceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhH----------------------------------------HHHH
Q 040785 456 SRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGR----------------------------------------SQFQ 494 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~----------------------------------------~~~~ 494 (782)
.+.||.|++|.||+|++ +|+.||||+.++...... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999998 789999999987531110 0244
Q ss_pred HHHHHHHhcC-----CCCee--eecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHhhhc
Q 040785 495 REIEVLSCIR-----HPNMV--LLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIAT-GLLFLHQT 566 (782)
Q Consensus 495 ~Ei~iL~~l~-----HpnIv--~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~ 566 (782)
+|+..+.+++ ++++. .++..+....+|||||++|++|.+........ + .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence 5666555552 33322 23322234459999999999998876432111 2 23456666665 47888998
Q ss_pred CCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 567 ~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
| ++|+|+||.||+++.++.++|+|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.6e-13 Score=139.55 Aligned_cols=202 Identities=22% Similarity=0.294 Sum_probs=141.2
Q ss_pred HHHHhcCCCCeeeecccccCcc-------EEEEEeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 040785 498 EVLSCIRHPNMVLLLGACPEYG-------IIVYEYLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569 (782)
Q Consensus 498 ~iL~~l~HpnIv~l~g~~~~~~-------~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 569 (782)
.-|-.+-|.|||+++.++.+.. .++.|||..|+|..+|.+.. ....+......+|+.||+.||.|||+.. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3345567999999999885433 68999999999999998653 3356788888899999999999999987 4
Q ss_pred CeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHH
Q 040785 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLI 649 (782)
Q Consensus 570 ~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ell 649 (782)
||+|+++..+-|++..+|.+||.----...-+. .............|-++|.+||+-.....+..+|||+||+..++|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s-~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPS-VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchh-hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 699999999999999999988753221111110 0111111222345678999999877777888999999999999998
Q ss_pred hCCCCC-CChHH--HHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 650 TAKQPM-GLTHF--VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 650 tG~~Pf-~~~~~--~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.|..-- +.... ++..+....+ .+... .=+.++.+|++..|..||++..++.+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~--~len~----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVII--GLENG----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhhee--eccCc----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 876532 21111 1111111111 01000 02467889999999999999988744
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=129.02 Aligned_cols=131 Identities=21% Similarity=0.190 Sum_probs=101.2
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-eeecccccCccEEEEEeCCCCChhHH
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-VLLLGACPEYGIIVYEYLANGSLDDR 534 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~~gsL~~~ 534 (782)
.+.|+.|.++.||++...+..|++|+...... ....+.+|+.++..+.+.++ ..++++.....++||||++|.++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 45789999999999999999999999865432 22356889999998865544 45566555567999999999887643
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 535 IFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK--PEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 535 l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
. . ....++.+++.+|..||..+ +..++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ----~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 ----D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ----c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 1 11245679999999999987 23369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-11 Score=135.27 Aligned_cols=105 Identities=16% Similarity=0.225 Sum_probs=83.2
Q ss_pred CCCCeEEEEeCCCcchHHHHHHHHHhccCC--CCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHH
Q 040785 13 GGNGLIAVAVDKDKSSQHALKWAADNLLNR--GQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLT 90 (782)
Q Consensus 13 ~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~--g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 90 (782)
.+.++||||||||+.|++|+++|++++... +++|++|||.+..... . . ........+++++.
T Consensus 3 ~~ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~---~-----------~--~~~~~~~~eelle~ 66 (357)
T PRK12652 3 MAANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVD---P-----------E--GQDELAAAEELLER 66 (357)
T ss_pred cccCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccc---c-----------c--hhHHHHHHHHHHHH
Confidence 467999999999999999999999999874 5999999999753210 0 0 11233455566777
Q ss_pred HHHHhhc------CCCceEEEEEec-------CCHHHHHHHHHHHcCCCEEEeccC
Q 040785 91 FRCYCTR------KDIKCFDVLLED-------VDIVKAITEYVSFAAIEDLVLGAP 133 (782)
Q Consensus 91 ~~~~c~~------~~v~~e~~v~~g-------~~v~~~Iv~~a~~~~~d~IVmGs~ 133 (782)
++..+.. .|+.++..++.+ |+|+++|++||++++||+||||-.
T Consensus 67 ~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 67 VEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred HHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 7766654 589999999874 799999999999999999999964
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.1e-11 Score=139.98 Aligned_cols=141 Identities=21% Similarity=0.251 Sum_probs=92.6
Q ss_pred hccccccceeeeeCcEeEEEEEE-C-CeeEEEEEecCCchhh----------------------------------HH--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-D-HTPVAVKVLRPDAAQG----------------------------------RS-- 491 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-~-~~~vAvK~l~~~~~~~----------------------------------~~-- 491 (782)
...|+. +.||.|++|.||+|++ + |+.||||++++..... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 7899999999999998 4 8899999998753110 01
Q ss_pred ----HHHHHHHHHHhcC----CCCeeeecccc---cCccEEEEEeCCCCChhHH--HhhcCC-CCCCCHHHHHHHHHHHH
Q 040785 492 ----QFQREIEVLSCIR----HPNMVLLLGAC---PEYGIIVYEYLANGSLDDR--IFRRGN-TPPLSWQQRFRIAAEIA 557 (782)
Q Consensus 492 ----~~~~Ei~iL~~l~----HpnIv~l~g~~---~~~~~lV~Ey~~~gsL~~~--l~~~~~-~~~l~~~~~~~i~~qia 557 (782)
.|.+|+..+.+++ +.+.+.+-.++ ....+|||||++|+.+.+. +...+. ...+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 1344554444442 33333332333 3345899999999999764 222221 0112222333333333
Q ss_pred HHHHHhhhcCCCCeeecCCCCceEEEcCCC----ceeeeccccccccc
Q 040785 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNY----VSKISDVGLARLVP 601 (782)
Q Consensus 558 ~aL~yLH~~~~~~iiHrDLKp~NILld~~~----~~kL~DFGla~~~~ 601 (782)
+..| ++|+|+||.||+++.++ .++++|||++..++
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3467 99999999999999888 99999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.5e-12 Score=142.11 Aligned_cols=246 Identities=22% Similarity=0.219 Sum_probs=172.2
Q ss_pred cccccceeee--eCcEeEEEEEE----CCeeEEEEEecCC--chhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--E
Q 040785 452 FFTESRKIGE--GGYGPVYKCYL----DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 452 ~f~~~~~LG~--G~fg~Vy~~~~----~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~ 520 (782)
.|.+...+|. |.+|.||.+.. ....+|+|.-+.. .......=.+|+....++ .|+|.++.+..+.+.. +
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3677888999 99999999876 4557888874322 222233335667666666 4999999888887665 6
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeeccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIAT----GLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVG 595 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFG 595 (782)
+-.|++ +.+|..+...... -++....+.++.+... ||..+|+.+ |+|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 667777 5677766654433 3677778888888888 999999999 9999999999999988 889999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh-HHHHHHHHhCcccccC
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT-HFVERSIENGTLGEML 674 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~-~~~~~~~~~~~~~~~l 674 (782)
+...+....-...........|...|++||. ..+.++..+|+|++|.++++..+|..++... ...+..++.+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----
Confidence 9987743321111111223367888999995 4667899999999999999999887765322 11112222211
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+ .++.......+...+..+++.+|..|++...+.
T Consensus 343 ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 343 IP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred Cc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11 011112233456688899999999999986654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.9e-12 Score=146.04 Aligned_cols=248 Identities=21% Similarity=0.218 Sum_probs=173.2
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchh---hHHHHHHHHHHHHhcCCCCeeeeccc--ccCccEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQ---GRSQFQREIEVLSCIRHPNMVLLLGA--CPEYGIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~~~lV~ 523 (782)
+.|.+.+.+-.|.|+.++.+.-. +...++|+....... ..+....+-.++-..++|-++..... |....+||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 45777788999999999987653 323444544332111 12223344444444567888877666 455669999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
+|+.+++|...|+..+ +.+..-....+..+..+++|||... ++|||++|.|+|+..+++.+++|||+.......
T Consensus 884 ~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence 9999999999886554 3455556667788999999999998 999999999999999999999999854432110
Q ss_pred ---ccc--------------------c---cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 040785 604 ---AEN--------------------V---TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGL 657 (782)
Q Consensus 604 ---~~~--------------------~---~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~ 657 (782)
... . .-.......||+.|.+||...+......+|+|++|++++|.++|.+||+.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000 0 00123346799999999999999999999999999999999999999975
Q ss_pred hHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChH
Q 040785 658 THFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLG 708 (782)
Q Consensus 658 ~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ 708 (782)
...-.. .++ .+. .+...+..+........+++...+..+|..|-.+.
T Consensus 1038 ~tpq~~-f~n-i~~--~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI-FEN-ILN--RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh-hhc-ccc--CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 543221 111 110 11222333445556688899999999999988765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.4e-10 Score=114.83 Aligned_cols=135 Identities=16% Similarity=0.160 Sum_probs=97.4
Q ss_pred ceeeeeCcEeEEEEEEC--------CeeEEEEEecCCch----------------------hhHHHHH----HHHHHHHh
Q 040785 457 RKIGEGGYGPVYKCYLD--------HTPVAVKVLRPDAA----------------------QGRSQFQ----REIEVLSC 502 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~--------~~~vAvK~l~~~~~----------------------~~~~~~~----~Ei~iL~~ 502 (782)
..||.|--+.||.|... +..+|||+.+.... ..+..+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999763 36899999863210 0122333 89999998
Q ss_pred cCC--CCeeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCc
Q 040785 503 IRH--PNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL-HQTKPEPLVHRDLKPG 579 (782)
Q Consensus 503 l~H--pnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrDLKp~ 579 (782)
+.. -++...+++ ...+|||||+.++.+..-..+. ..++..+...+..+++.+|..| |..+ |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 853 345555543 5679999999765442211111 1245556677889999999999 8899 999999999
Q ss_pred eEEEcCCCceeeecccccccc
Q 040785 580 NILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 580 NILld~~~~~kL~DFGla~~~ 600 (782)
|||++ ++.+.|+|||.+-..
T Consensus 155 NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-CCcEEEEECCCceeC
Confidence 99997 467999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.6e-11 Score=136.14 Aligned_cols=238 Identities=24% Similarity=0.203 Sum_probs=166.0
Q ss_pred hccccccceeeeeCcEeEEEEEE---CCeeEEEEEecCCchhhHHHH--HHHHHHHHhc-CCCCeeeeccccc--CccEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL---DHTPVAVKVLRPDAAQGRSQF--QREIEVLSCI-RHPNMVLLLGACP--EYGII 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~~~~~~~--~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~l 521 (782)
+..|..+..||.|.|+.||.+.. ++..+++|-+.........++ ..|+-+...+ .|.+++.++..+. +..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 44688899999999999998875 466888888765433322221 3566666655 4888888776553 34488
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeecccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLV 600 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla~~~ 600 (782)
--|||.++++...+.- ...+.+..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||+...+
T Consensus 344 p~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 8899999988766622 234677788999999999999999999 9999999999999875 88899999998642
Q ss_pred ccccccccccccccccCCccc-CChhhhhcCCCCCchhHHHHHHHHHHHHhCCCC-CCChHHHHHHHHhCcccccCCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCY-IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP-MGLTHFVERSIENGTLGEMLDPTV 678 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y-~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P-f~~~~~~~~~~~~~~~~~~ld~~~ 678 (782)
. .......-++..| .+|.......+..+.|+||||..+.+.++|..- ....++ ..+....
T Consensus 418 ~-------~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----------~~i~~~~ 479 (524)
T KOG0601|consen 418 A-------FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----------LTIRSGD 479 (524)
T ss_pred c-------eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----------eeeeccc
Confidence 1 1111122233344 356666667788999999999999999998652 211111 1111111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
....+.....+..+...++..++..||.+.++.
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 111122235577888889999999999986665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.7e-10 Score=109.32 Aligned_cols=129 Identities=26% Similarity=0.363 Sum_probs=101.5
Q ss_pred ceeeeeCcEeEEEEEECCeeEEEEEecCCc--------hhhHHHHHHHHHHHHhcCC--CCeeeecccccCccEEEEEeC
Q 040785 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--------AQGRSQFQREIEVLSCIRH--PNMVLLLGACPEYGIIVYEYL 526 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~~~~lV~Ey~ 526 (782)
..|++|+-+.+|.+.+-+.++++|.=.+.. .-....-.+|+.+|.+++- -+...++.+.+....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 357899999999998877777777643321 1123446789999998863 445567777788889999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
+|..|.+.+... ...++..+-.-+.-||..+ |||+||.++||++..++ +.++||||+..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888543 2456778888888999999 99999999999997765 89999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.2e-10 Score=115.19 Aligned_cols=139 Identities=27% Similarity=0.365 Sum_probs=108.0
Q ss_pred ceeeeeCcEeEEEEEECC-eeEEEEEecCCch-hhHHHHHHHHHHHHhcCC--CCeeeecccccC-----ccEEEEEeCC
Q 040785 457 RKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAA-QGRSQFQREIEVLSCIRH--PNMVLLLGACPE-----YGIIVYEYLA 527 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~-----~~~lV~Ey~~ 527 (782)
+.||.|.++.||++...+ ..+++|+...... .....+.+|+.++..+.+ .++.+++.++.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998865 7999999865432 134578999999999975 345666776655 3489999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK---------------------------------------- 567 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 567 (782)
|.++.+.+.. ..++......++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 23677778888889999999888531
Q ss_pred -------------CCCeeecCCCCceEEEcC--CCceeeeccccccc
Q 040785 568 -------------PEPLVHRDLKPGNILLDH--NYVSKISDVGLARL 599 (782)
Q Consensus 568 -------------~~~iiHrDLKp~NILld~--~~~~kL~DFGla~~ 599 (782)
+..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 67789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.9e-09 Score=104.52 Aligned_cols=141 Identities=20% Similarity=0.217 Sum_probs=104.0
Q ss_pred ccceeeeeCcEeEEEEEECCeeEEEEEecCC--------chhhHHHHHHHHHHHHhcCCCCee--eecccccCccEEEEE
Q 040785 455 ESRKIGEGGYGPVYKCYLDHTPVAVKVLRPD--------AAQGRSQFQREIEVLSCIRHPNMV--LLLGACPEYGIIVYE 524 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~--------~~~~~~~~~~Ei~iL~~l~HpnIv--~l~g~~~~~~~lV~E 524 (782)
.+..|-+|+-+.|+++.+.|+.+.||.--+. ....+....+|+.+|.+++--.|. .++-+-...++|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678999999999999999999888864221 122355678999999998643332 222222345599999
Q ss_pred eCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC---ceeeeccccccc
Q 040785 525 YLAN-GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY---VSKISDVGLARL 599 (782)
Q Consensus 525 y~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~---~~kL~DFGla~~ 599 (782)
|++| .++.+++.........+ .-...++..|-..|.-||.++ |||+||..+||+|..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 47788887654433222 223678888999999999999 99999999999996554 458999999863
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=121.25 Aligned_cols=162 Identities=22% Similarity=0.267 Sum_probs=119.3
Q ss_pred CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHH
Q 040785 473 DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRF 550 (782)
Q Consensus 473 ~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~ 550 (782)
++.+|.|...+...........+-+.-|+.+|||||+.++..+.... |||.|-+. .|...+.+. ......
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHHHH
Confidence 56688888876654433455677888999999999999999997766 99999874 355555332 345667
Q ss_pred HHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcC
Q 040785 551 RIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG 630 (782)
Q Consensus 551 ~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 630 (782)
..+.||+.||.|||..+ .++|++|.-+-|+++..|..||++|-++........ ......--..|..|+.....
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-----~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-----PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-----ccccchhhhcccChhhcCcc
Confidence 78999999999998655 299999999999999999999999998865432111 00111112246667643322
Q ss_pred CCCCchhHHHHHHHHHHHHhC
Q 040785 631 MLGVKSDVYSLGILLLQLITA 651 (782)
Q Consensus 631 ~~s~ksDVwSlGvil~elltG 651 (782)
. ...|.|-|||++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 457999999999999999
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.9e-09 Score=127.82 Aligned_cols=126 Identities=14% Similarity=0.201 Sum_probs=101.2
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
...+|||+|++++.+.+++++|...|.+.++.+++|||..+... ....+....+ ..+..
T Consensus 249 ~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~--------------------~~~~~~~~~l-~~~~~ 307 (895)
T PRK10490 249 TRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLH--------------------RLPEKKRRAI-LSALR 307 (895)
T ss_pred cCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcC--------------------cCCHHHHHHH-HHHHH
Confidence 45789999999999999999999999999999999999854210 0111222333 33445
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
+|...|.+ .+++.|+|++++|++||++++|+.||||.++++++ ++.||++..+++.++ ...|+||..
T Consensus 308 lA~~lGa~--~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~--~~~~s~~~~l~r~~~-~idi~iv~~ 374 (895)
T PRK10490 308 LAQELGAE--TATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRW--WRRESFADRLARLGP-DLDLVIVAL 374 (895)
T ss_pred HHHHcCCE--EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCC--ccCCCHHHHHHHhCC-CCCEEEEeC
Confidence 77777766 56778899999999999999999999999998875 345899999999998 699999963
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=8.9e-08 Score=105.70 Aligned_cols=166 Identities=22% Similarity=0.313 Sum_probs=124.9
Q ss_pred cEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc------cEEEEEeCCC-CChhHH
Q 040785 464 YGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------GIIVYEYLAN-GSLDDR 534 (782)
Q Consensus 464 fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~lV~Ey~~~-gsL~~~ 534 (782)
-.+.|++.. +|..|++|+++-+..........-+++++++.|+|+|.|..+|... .+|||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357888876 7889999999544333222334457889999999999999887522 2899999988 478877
Q ss_pred HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 535 IFRRG------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 535 l~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
.+... .+...++..+|.++.|+..||.++|+.| +..+-|.|.+||++.+..++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 65332 1234788999999999999999999999 99999999999999998999998887765422
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P 654 (782)
.. .+| +.. -.+-|.=.||.+++-|.||..-
T Consensus 446 d~-----------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP-----------------TEP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC-----------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 11 011 111 1356888999999999999643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=9.8e-08 Score=102.81 Aligned_cols=254 Identities=18% Similarity=0.240 Sum_probs=161.8
Q ss_pred ccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeee--------ecccccCc-cEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVL--------LLGACPEY-GIIV 522 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~--------l~g~~~~~-~~lV 522 (782)
....+.||+|+-+.+|-.-.-+ ..+.|+.+........+ -+..|... .||-+-. |+|--... .-+.
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred cCCCccccCCccceeeecchhh-chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3456889999999999542222 23447776543221111 23334443 5664432 22221111 1466
Q ss_pred EEeCCCCC-hhHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 523 YEYLANGS-LDDRI---FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 523 ~Ey~~~gs-L~~~l---~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
|..+++.. +.+++ .++...+...|.-.++++..++.+..-||..| .+-+|+.++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776642 22222 13444567899999999999999999999999 8899999999999999999988743221
Q ss_pred ccccccccccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhC-CCCCCCh-------HHHHHHH
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITA-KQPMGLT-------HFVERSI 665 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG-~~Pf~~~-------~~~~~~~ 665 (782)
.- ......-..+|...|.+||... +-.-+...|.|.|||++++||.| ++||... ...+..|
T Consensus 166 i~------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 166 IN------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ec------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 11 0112223457899999999654 23456789999999999999986 9999643 2345556
Q ss_pred HhCcccccCCC------CCCCCChh-HHHHHHHHHHHhhcc--CcCCCCChHHhhhHHHHHHHH
Q 040785 666 ENGTLGEMLDP------TVTDWPFE-ETLGFAKLALQCSEL--RRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 666 ~~~~~~~~ld~------~~~~~p~~-~~~~l~~li~~cl~~--~P~~RPs~~~vl~~~l~~l~~ 720 (782)
..|.+..--+. ....||.. .+..+..|..+|+.. ++.-||+...-+ ..|..++.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~-aAl~al~~ 302 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV-AALDALRQ 302 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHHHHH
Confidence 66665544332 22344433 344577888888875 367899986544 35555543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5e-08 Score=103.30 Aligned_cols=138 Identities=17% Similarity=0.066 Sum_probs=98.9
Q ss_pred ceeeeeCcEeEEEEEECCeeEEEEEecCCchh-hH----------HHHHHHHHHHHhcCCCCee--eecccc-------c
Q 040785 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQ-GR----------SQFQREIEVLSCIRHPNMV--LLLGAC-------P 516 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~-~~----------~~~~~Ei~iL~~l~HpnIv--~l~g~~-------~ 516 (782)
+.+-......|+++.+.|+.+.||........ .. ..+.+|...+.+|..-+|. ..+++. .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 34444445557788888999999977543211 01 1478999998888433322 222232 1
Q ss_pred CccEEEEEeCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-------CCc
Q 040785 517 EYGIIVYEYLANG-SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-------NYV 588 (782)
Q Consensus 517 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-------~~~ 588 (782)
...+||+|++++. +|.+++..... .+.+...+..++.+++..+.-||..| |+|+|+++.|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 2358999999986 88888753221 23556677789999999999999999 999999999999975 468
Q ss_pred eeeecccccc
Q 040785 589 SKISDVGLAR 598 (782)
Q Consensus 589 ~kL~DFGla~ 598 (782)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=3e-08 Score=99.32 Aligned_cols=123 Identities=28% Similarity=0.290 Sum_probs=79.5
Q ss_pred eEEEEEE-CCeeEEEEEecCCchh--------------------------hHHHHHHHHHHHHhcCCC--Ceeeeccccc
Q 040785 466 PVYKCYL-DHTPVAVKVLRPDAAQ--------------------------GRSQFQREIEVLSCIRHP--NMVLLLGACP 516 (782)
Q Consensus 466 ~Vy~~~~-~~~~vAvK~l~~~~~~--------------------------~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~ 516 (782)
.||.|.. ++..+|||+.+..... ......+|.+.|.++..- ++...+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899987 7889999998642100 012356899999999755 34555543
Q ss_pred CccEEEEEeCC--CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCceEEEcCCCceeeec
Q 040785 517 EYGIIVYEYLA--NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF-LHQTKPEPLVHRDLKPGNILLDHNYVSKISD 593 (782)
Q Consensus 517 ~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~iiHrDLKp~NILld~~~~~kL~D 593 (782)
...+|||||++ |..+..+. ... ++......++.+++..+.. +|..| |||+||.+.|||++++ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35699999998 55554432 221 1123345677788885555 57888 9999999999999887 899999
Q ss_pred cccccc
Q 040785 594 VGLARL 599 (782)
Q Consensus 594 FGla~~ 599 (782)
||.+..
T Consensus 150 f~qav~ 155 (188)
T PF01163_consen 150 FGQAVD 155 (188)
T ss_dssp GTTEEE
T ss_pred cCccee
Confidence 998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-07 Score=109.77 Aligned_cols=132 Identities=17% Similarity=0.145 Sum_probs=109.3
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
...+|||+|+++..|.+.+++|...|.+.++..++|||..+... ...+.....+.....
T Consensus 247 ~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~---------------------~~~~~~~~~l~~~~~ 305 (890)
T COG2205 247 ARERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPELH---------------------RLSEKEARRLHENLR 305 (890)
T ss_pred ccceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEeccccc---------------------cccHHHHHHHHHHHH
Confidence 45789999999999999999999999999999999999865331 111222344555566
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecCccc
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKIS 169 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kgki~ 169 (782)
+|..- ..+.+++.|++++++|++||..+++..||||.+.++...++|.||.+.++++.++ ...|.+|..+...
T Consensus 306 Lae~l--Gae~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~~l~~~L~~~~~-~idv~ii~~~~~~ 378 (890)
T COG2205 306 LAEEL--GAEIVTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKGSLADRLAREAP-GIDVHIVALDAPP 378 (890)
T ss_pred HHHHh--CCeEEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhcccHHHHHHhcCC-CceEEEeeCCCCc
Confidence 66655 4567788889999999999999999999999999998888888999999999987 6999999977654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.3e-07 Score=93.86 Aligned_cols=133 Identities=24% Similarity=0.177 Sum_probs=92.7
Q ss_pred cccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh----------------------hHHHHHHHHHHHHhcCCC--
Q 040785 452 FFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ----------------------GRSQFQREIEVLSCIRHP-- 506 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~----------------------~~~~~~~Ei~iL~~l~Hp-- 506 (782)
-+.+..+||-|--+.||.|.. .+.++|||.-+..... .+...++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 355678999999999999998 5899999987532111 122356899999988543
Q ss_pred CeeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC
Q 040785 507 NMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586 (782)
Q Consensus 507 nIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~ 586 (782)
.+..-+++ +..++||||++|-.|...- +.....-.|+..|++-+.-+-..| |||+|+.+-|||++++
T Consensus 172 ~VP~P~~~--nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAW--NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCcccc--ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 34444332 3348999999986665422 112223334445555555455777 9999999999999999
Q ss_pred Cceeeeccccc
Q 040785 587 YVSKISDVGLA 597 (782)
Q Consensus 587 ~~~kL~DFGla 597 (782)
|.+.++||--+
T Consensus 239 g~~~vIDwPQ~ 249 (304)
T COG0478 239 GDIVVIDWPQA 249 (304)
T ss_pred CCEEEEeCccc
Confidence 99999999544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=7.9e-07 Score=90.81 Aligned_cols=105 Identities=25% Similarity=0.276 Sum_probs=79.6
Q ss_pred HHHHHHHHHHHHhcCCCCe--eeeccccc------CccEEEEEeCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040785 490 RSQFQREIEVLSCIRHPNM--VLLLGACP------EYGIIVYEYLANG-SLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560 (782)
Q Consensus 490 ~~~~~~Ei~iL~~l~HpnI--v~l~g~~~------~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 560 (782)
.....+|...+..|..-+| ...+++.. ...+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 4467889888888753332 23333332 2238999999985 78888865322 45566778999999999
Q ss_pred HHhhhcCCCCeeecCCCCceEEEcCCC---ceeeecccccccc
Q 040785 561 LFLHQTKPEPLVHRDLKPGNILLDHNY---VSKISDVGLARLV 600 (782)
Q Consensus 561 ~yLH~~~~~~iiHrDLKp~NILld~~~---~~kL~DFGla~~~ 600 (782)
.-||..| |+|+|++|.|||++.+. .+.|+||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=5e-06 Score=84.08 Aligned_cols=136 Identities=17% Similarity=0.148 Sum_probs=102.3
Q ss_pred eeeeCcEeEEEEEECCeeEEEEEecCC------chhhHHHHHHHHHHHHhcCCCC--eeeeccccc---C----ccEEEE
Q 040785 459 IGEGGYGPVYKCYLDHTPVAVKVLRPD------AAQGRSQFQREIEVLSCIRHPN--MVLLLGACP---E----YGIIVY 523 (782)
Q Consensus 459 LG~G~fg~Vy~~~~~~~~vAvK~l~~~------~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~---~----~~~lV~ 523 (782)
-|+||.+-|+...+.|..+=+|.-... .......|.+|+..|..|..-+ +...+ ++. . ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 478999999999888888888876421 1235678999999999985332 33333 221 1 138999
Q ss_pred EeCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc--eeeeccccccc
Q 040785 524 EYLAN-GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV--SKISDVGLARL 599 (782)
Q Consensus 524 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~--~kL~DFGla~~ 599 (782)
|-+.| -+|.+++.... ..+.+...+..++.+++..|.-||..| +.|+|+-+.|||++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98865 48888774432 234677778899999999999999999 999999999999986666 99999986653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.8e-06 Score=97.44 Aligned_cols=137 Identities=20% Similarity=0.296 Sum_probs=89.1
Q ss_pred ceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHH----------------------------------------HHHH
Q 040785 457 RKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRS----------------------------------------QFQR 495 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~----------------------------------------~~~~ 495 (782)
..|+.++-|.||+|.+ +|+.||||+.+++...... .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999 5899999999875322110 0234
Q ss_pred HHHHHHhcC-----CCCe--eeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHhhhcC
Q 040785 496 EIEVLSCIR-----HPNM--VLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG-LLFLHQTK 567 (782)
Q Consensus 496 Ei~iL~~l~-----HpnI--v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~~ 567 (782)
|..-+.+++ .|++ .+++--+.....|+|||++|-.+.+...-... .++... |+..++.+ +.-+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhcC
Confidence 444444432 2322 12222123345899999999988887432221 244333 33333332 22222355
Q ss_pred CCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 568 ~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
++|.|..|.||+++.+|.+.+.|||+...++
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.3e-06 Score=85.93 Aligned_cols=142 Identities=25% Similarity=0.308 Sum_probs=84.2
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCC--Ceeeeccccc---C--ccEEEEEeCCC
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP--NMVLLLGACP---E--YGIIVYEYLAN 528 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~---~--~~~lV~Ey~~~ 528 (782)
++.|+.|..+.||+....+..+++|+.... .....+.+|..++..+... .+..++..+. . ..+++|+|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 467999999999999997789999998654 4456788899998888533 2445554331 1 13789999999
Q ss_pred CChhH----------------HHh---hc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHhhh-
Q 040785 529 GSLDD----------------RIF---RR-GNTPPLSWQQR---------FRI------------AAEIAT-GLLFLHQ- 565 (782)
Q Consensus 529 gsL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~yLH~- 565 (782)
..+.. .+. .. ....++.+... ... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 111 11 11111121110 000 011222 2333332
Q ss_pred ---cCCCCeeecCCCCceEEEc-CCCceeeeccccccc
Q 040785 566 ---TKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARL 599 (782)
Q Consensus 566 ---~~~~~iiHrDLKp~NILld-~~~~~kL~DFGla~~ 599 (782)
..+..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1344599999999999999 666668999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.3e-05 Score=80.48 Aligned_cols=105 Identities=23% Similarity=0.238 Sum_probs=84.3
Q ss_pred HHHHHHHHhcCC-CCeeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 040785 494 QREIEVLSCIRH-PNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572 (782)
Q Consensus 494 ~~Ei~iL~~l~H-pnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ii 572 (782)
..|.-+|..+.+ +++.+++|+|- .++|.||...+++.............+|..+.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 457888888876 69999999994 488999998887653211101112368999999999999999999987666688
Q ss_pred ecCCCCceEEEcCCCceeeecccccccc
Q 040785 573 HRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 573 HrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
-.|++|+|+-++++|.+|++|...+...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 8999999999999999999999887655
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.4e-07 Score=105.92 Aligned_cols=153 Identities=19% Similarity=0.293 Sum_probs=102.8
Q ss_pred HHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc-ccccccc---ccccCCcccCChhhhh
Q 040785 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE-NVTQYHL---TSTAGTFCYIDPEYQQ 628 (782)
Q Consensus 553 ~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~---~~~~Gt~~Y~aPE~~~ 628 (782)
+.+++.||.|+|..- .+||+.|.|++|.++.++..||+.|+.+-....... ....+.. ....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999764 399999999999999999999999998765432111 0111111 1113456799999999
Q ss_pred cCCCCCchhHHHHHHHHHHHHhCCCC-CCChHHH-HHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 629 TGMLGVKSDVYSLGILLLQLITAKQP-MGLTHFV-ERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 629 ~~~~s~ksDVwSlGvil~elltG~~P-f~~~~~~-~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
+...+.++|+||+||++|-+..|..+ +...... ......+ ..+......+...+.++.+=+.+++..++.-||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 98889999999999999999854444 3221111 1111111 1112222334556667888899999999999997
Q ss_pred hHHhh
Q 040785 707 LGKVV 711 (782)
Q Consensus 707 ~~~vl 711 (782)
+..+.
T Consensus 259 ~~~l~ 263 (700)
T KOG2137|consen 259 LDLLL 263 (700)
T ss_pred hhhhh
Confidence 75543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=9.6e-06 Score=84.03 Aligned_cols=138 Identities=16% Similarity=0.222 Sum_probs=79.9
Q ss_pred ceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe--eeecccccC--ccEEEEEeCCCCC-h
Q 040785 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM--VLLLGACPE--YGIIVYEYLANGS-L 531 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~--~~~lV~Ey~~~gs-L 531 (782)
..||.|..+.||+. .+..+++|+..... ......+|.+++..+..-++ ...++++.. ...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57999999999984 35567889886533 23456889999988753333 444555433 2378999999864 2
Q ss_pred hHHH--------------hh----cCC--CCCCCHHHHHH-HHHH----------HHH-HHHHhhhc-CCCCeeecCCCC
Q 040785 532 DDRI--------------FR----RGN--TPPLSWQQRFR-IAAE----------IAT-GLLFLHQT-KPEPLVHRDLKP 578 (782)
Q Consensus 532 ~~~l--------------~~----~~~--~~~l~~~~~~~-i~~q----------ia~-aL~yLH~~-~~~~iiHrDLKp 578 (782)
...+ -+ -.. ....+...... +..+ +.. ...+|... .+..++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 00 000 00111111100 0000 001 11222211 123478999999
Q ss_pred ceEEEcCCCceeeeccccccc
Q 040785 579 GNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 579 ~NILld~~~~~kL~DFGla~~ 599 (782)
.||++++++ +.|+||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.3e-06 Score=83.26 Aligned_cols=135 Identities=21% Similarity=0.213 Sum_probs=93.0
Q ss_pred HhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHH---------HHHHHHHHhcCCCC---eeeecccc-
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQF---------QREIEVLSCIRHPN---MVLLLGAC- 515 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~---------~~Ei~iL~~l~Hpn---Iv~l~g~~- 515 (782)
..++|...+.+-......|.+-..++..+.+|..+.......+.| .+++..+.+++-.+ +..++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 456688888888888888988888999999999876543322222 24444444443222 22222111
Q ss_pred ------cCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 516 ------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 516 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
....+|+|||++|..|.+.. .++. .++..+..+|.-||..| ++|+|+.|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 22336899999998876643 1222 24556778899999999 99999999999998665 8
Q ss_pred eeecccccc
Q 040785 590 KISDVGLAR 598 (782)
Q Consensus 590 kL~DFGla~ 598 (782)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-05 Score=91.40 Aligned_cols=137 Identities=20% Similarity=0.218 Sum_probs=89.7
Q ss_pred ceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhh----H---------------------------H------HHHHHHH
Q 040785 457 RKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQG----R---------------------------S------QFQREIE 498 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~----~---------------------------~------~~~~Ei~ 498 (782)
+.||.-+.|.||+|++ +|..||||+-++.-... . + .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999998 78889999988753221 0 0 1344544
Q ss_pred HHHh----cCCCC------eeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 040785 499 VLSC----IRHPN------MVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568 (782)
Q Consensus 499 iL~~----l~Hpn------Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 568 (782)
-..+ +.|-+ |.++|-.+.....|+||||+|..+.|...-... .++...+..-+.+...-+ |=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~q--If~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQ--IFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHH--HHhcC-
Confidence 3333 34555 444554455556999999999877665332221 144444333333322222 22345
Q ss_pred CCeeecCCCCceEEEcC----CCceeeecccccccc
Q 040785 569 EPLVHRDLKPGNILLDH----NYVSKISDVGLARLV 600 (782)
Q Consensus 569 ~~iiHrDLKp~NILld~----~~~~kL~DFGla~~~ 600 (782)
++|.|-.|.||+++. ++.+.+-|||+...+
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 999999999999983 678999999998766
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.9e-05 Score=81.15 Aligned_cols=150 Identities=22% Similarity=0.232 Sum_probs=92.9
Q ss_pred cHHHHHHHhccccccc---eeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHH---------H---------------H
Q 040785 442 TIEDIEEATQFFTESR---KIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRS---------Q---------------F 493 (782)
Q Consensus 442 ~~~~~~~~t~~f~~~~---~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~---------~---------------~ 493 (782)
+.+.+....++..+.. .|..|--+.||+|.. ++..+|||+.+.......+ . .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3344444444444443 455677789999886 6889999999754322111 0 1
Q ss_pred HHHHHHHHhcCC--CCeeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 040785 494 QREIEVLSCIRH--PNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEP 570 (782)
Q Consensus 494 ~~Ei~iL~~l~H--pnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ 570 (782)
.+|+.-|.++.- -.+.+-+++ ..+.|||||+....+ ---.... .++...+...+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~--~~nVLvMEfIg~~g~--pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--- 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF--RNNVLVMEFIGDDGL--PAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--- 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee--cCCeEEEEeccCCCC--CCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC---
Confidence 245555555532 122222222 245899999965411 0000011 123333567778888888888877 67
Q ss_pred eeecCCCCceEEEcCCCceeeecccccccc
Q 040785 571 LVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 571 iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||+||..-|||+. ++.+.|+|||-|...
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 889999999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.8e-07 Score=103.04 Aligned_cols=188 Identities=20% Similarity=0.125 Sum_probs=132.1
Q ss_pred HhccccccceeeeeCcEeEEEEEECCe-eEEEEEecCCchhhHHHHHHHHHHHHhcCCCC-eeeecccccC--ccEEEEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDHT-PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN-MVLLLGACPE--YGIIVYE 524 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~~-~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~--~~~lV~E 524 (782)
-+.++...+-+++|+++.+|+.+...+ ....+++... ....-++++|.+++||| .+..++-+.. +..++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 455566677789999999999876443 2334544322 33456889999999999 6666666543 3378999
Q ss_pred eCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 525 YLANG-SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|+.++ +........ .-.|...+...+...-+++|+|||+.. =+||| |||..+ +..|..||+...-+...
T Consensus 315 i~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 221111000 001333344556666778899999875 58999 887765 67899999988765321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGL 657 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~ 657 (782)
.......+|+.++|||+...+.+....|+|++|+--.+|--|-+|-..
T Consensus 385 ------~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 ------MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ------cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 134567899999999999999999999999999988888888887654
|
|
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.1e-05 Score=70.12 Aligned_cols=84 Identities=21% Similarity=0.187 Sum_probs=72.8
Q ss_pred EEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHHHhhc
Q 040785 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTR 97 (782)
Q Consensus 18 IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~ 97 (782)
|+||++++..|..++.||.... ..+..++++|+.
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH---------------------------------------------
Confidence 6899999999999999999976 446788888774
Q ss_pred CCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCcccccccc-CchhhhhhcCCCccEEEE
Q 040785 98 KDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKA-DVPSSVSKAAPDFCNIYV 162 (782)
Q Consensus 98 ~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~g-SVa~~V~k~ap~~c~V~v 162 (782)
-..+.+.++|++.++++||+|+++.....+.+.| +++.++++.++ |+|+.
T Consensus 35 -------------~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 35 -------------AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred -------------HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--CceeC
Confidence 3567888899999999999999999888887777 99999999988 88874
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.9e-05 Score=81.17 Aligned_cols=137 Identities=15% Similarity=0.129 Sum_probs=81.7
Q ss_pred eeeeCc-EeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccC--ccEEEEEeCCCCChhHH
Q 040785 459 IGEGGY-GPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPE--YGIIVYEYLANGSLDDR 534 (782)
Q Consensus 459 LG~G~f-g~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~~ 534 (782)
|-.|.+ ..||+....+..+.||+..... ...+.+|+.++..+. +--+.++++++.. ..++||+|++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 8899998777788889875442 345678999988873 3334466666544 35999999999877643
Q ss_pred H-------------------hhcCC-CCCCCHH--HHHHHHHH--------------------HHHHHHHhhh----cCC
Q 040785 535 I-------------------FRRGN-TPPLSWQ--QRFRIAAE--------------------IATGLLFLHQ----TKP 568 (782)
Q Consensus 535 l-------------------~~~~~-~~~l~~~--~~~~i~~q--------------------ia~aL~yLH~----~~~ 568 (782)
. +.... ..++... ........ +...+..|-. ..+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11000 0011100 00000000 1111112111 112
Q ss_pred CCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 569 EPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 569 ~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 348999999999999998888999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.4e-05 Score=78.82 Aligned_cols=72 Identities=15% Similarity=0.226 Sum_probs=45.7
Q ss_pred cceeeeeCcE-eEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCC---CeeeecccccC-----ccEEEEEeC
Q 040785 456 SRKIGEGGYG-PVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP---NMVLLLGACPE-----YGIIVYEYL 526 (782)
Q Consensus 456 ~~~LG~G~fg-~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~g~~~~-----~~~lV~Ey~ 526 (782)
.+.|+.||.. .||+. +..+++|+.... .....+.+|.++|..+... .+...++.+.. ..+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567877776 59975 345777876542 2245788999999877421 23333433322 237899999
Q ss_pred CCCChh
Q 040785 527 ANGSLD 532 (782)
Q Consensus 527 ~~gsL~ 532 (782)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=4e-05 Score=74.74 Aligned_cols=130 Identities=18% Similarity=0.190 Sum_probs=91.7
Q ss_pred cccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCccEEEEEeCCCCChhH
Q 040785 454 TESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGSLDD 533 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~lV~Ey~~~gsL~~ 533 (782)
...+.||+|++|.||+|.+.+..+|+|+-+.++ .+..+..|+++|..+..-++..=+..+. ..++.|||+.|-.|.+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg-~~~i~me~i~G~~L~~ 101 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG-EDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec-hhhhhhhhhcCcchhh
Confidence 345779999999999999999999999987654 3577999999999887665543222221 2356699999988876
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC-CceEEEcCCCceeeeccccccc
Q 040785 534 RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLK-PGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 534 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK-p~NILld~~~~~kL~DFGla~~ 599 (782)
.-... .- +-+..+++.-.-|...| |-|..|. |..++|-.++.+.|+||.-|+.
T Consensus 102 ~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 54211 11 22345555555566677 8888875 5555555556899999998873
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.3e-05 Score=91.48 Aligned_cols=145 Identities=20% Similarity=0.307 Sum_probs=90.6
Q ss_pred cceeeeeCcEeEEEEEECC----eeEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCCe--eeecccccCc-----cEEE
Q 040785 456 SRKIGEGGYGPVYKCYLDH----TPVAVKVLRPDA-AQGRSQFQREIEVLSCIR-HPNM--VLLLGACPEY-----GIIV 522 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnI--v~l~g~~~~~-----~~lV 522 (782)
...|+.|.++.+|+....+ ..+++|+..... ......+.+|+.+|+.+. |+++ .+++++|.+. .|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 5678999999999987744 367778764432 123357889999999995 6665 6777877653 4899
Q ss_pred EEeCCCCChhH--------------------H---HhhcCC--------CCCCCH--HHHHHHH---------------H
Q 040785 523 YEYLANGSLDD--------------------R---IFRRGN--------TPPLSW--QQRFRIA---------------A 554 (782)
Q Consensus 523 ~Ey~~~gsL~~--------------------~---l~~~~~--------~~~l~~--~~~~~i~---------------~ 554 (782)
|||++|..+.+ . |+.... ..+..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998865321 1 111100 001111 1111111 1
Q ss_pred HHHHHHHHhhhcCCC--------CeeecCCCCceEEEcC-C-Cceeeecccccccc
Q 040785 555 EIATGLLFLHQTKPE--------PLVHRDLKPGNILLDH-N-YVSKISDVGLARLV 600 (782)
Q Consensus 555 qia~aL~yLH~~~~~--------~iiHrDLKp~NILld~-~-~~~kL~DFGla~~~ 600 (782)
.+...+.+|..+-|. .+||+|+++.|||++. + ..+-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 123345667544332 3999999999999975 2 34679999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=7.8e-05 Score=78.67 Aligned_cols=138 Identities=14% Similarity=0.087 Sum_probs=80.1
Q ss_pred eeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-eeecccccCccEEEEEeCCCCChhHH---
Q 040785 459 IGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-VLLLGACPEYGIIVYEYLANGSLDDR--- 534 (782)
Q Consensus 459 LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~~gsL~~~--- 534 (782)
+..|-.+.+|+...++..+++|+.......-.-...+|..++..+...++ ..+++.+ ..++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCccccccccc
Confidence 55677889999988888899998654322211235789999988853322 2333333 35799999998765321
Q ss_pred --------------HhhcC-CCCCCCHHHH-HHHHHHH---------HHHHHHhhhc-----CCCCeeecCCCCceEEEc
Q 040785 535 --------------IFRRG-NTPPLSWQQR-FRIAAEI---------ATGLLFLHQT-----KPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 535 --------------l~~~~-~~~~l~~~~~-~~i~~qi---------a~aL~yLH~~-----~~~~iiHrDLKp~NILld 584 (782)
|+... ...+++.... ..+..++ ...+..+-.. .+..++|+|+.|.|||++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 11111 1112222211 1111111 1111111111 123489999999999999
Q ss_pred CCCceeeeccccccc
Q 040785 585 HNYVSKISDVGLARL 599 (782)
Q Consensus 585 ~~~~~kL~DFGla~~ 599 (782)
+++ +.|+||..|..
T Consensus 162 ~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 162 PQG-LKLIDWEYASD 175 (256)
T ss_pred CCC-CEEEeccccCc
Confidence 887 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00019 Score=74.47 Aligned_cols=73 Identities=15% Similarity=0.215 Sum_probs=48.6
Q ss_pred cceeeeeCcEeEEEEEEC---CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC-eeeecccccCccEEEEEeCCCCCh
Q 040785 456 SRKIGEGGYGPVYKCYLD---HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN-MVLLLGACPEYGIIVYEYLANGSL 531 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~---~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lV~Ey~~~gsL 531 (782)
.+.|..|-...+|+.... +..|++|+....... .-...+|+.++..+...+ ..++++.+. ..++|||++|.++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l 79 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTL 79 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcC
Confidence 356778888999999875 468889987643221 123357888888885333 334444433 3589999998766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00035 Score=75.54 Aligned_cols=74 Identities=19% Similarity=0.161 Sum_probs=54.5
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCC---CCeeeecccccC-----ccEEEEEeCC
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH---PNMVLLLGACPE-----YGIIVYEYLA 527 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~g~~~~-----~~~lV~Ey~~ 527 (782)
...||.|..+.||.....+..+.+|+.+.. .....|..|...|+.|.- ..+.+++++|.. ..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 467999999999998775556777885431 123578999999988843 356677776642 2499999999
Q ss_pred CCCh
Q 040785 528 NGSL 531 (782)
Q Consensus 528 ~gsL 531 (782)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0005 Score=69.58 Aligned_cols=127 Identities=24% Similarity=0.330 Sum_probs=86.7
Q ss_pred ccceeeeeCcEeEEEEEECCeeEEEEEecCCc----------------hhhHHHHHHHHHHHHhcC------CCCeeeec
Q 040785 455 ESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA----------------AQGRSQFQREIEVLSCIR------HPNMVLLL 512 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~Ei~iL~~l~------HpnIv~l~ 512 (782)
....||.|+.-.||.-- .+....||+.++.. .....++.+|+.-...+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 34679999999999532 45567899998765 122456677777666655 78899999
Q ss_pred ccccCcc--EEEEEeCCC------CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 513 GACPEYG--IIVYEYLAN------GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 513 g~~~~~~--~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
|+...+. -+|+|.+.+ -+|.+++.... ++. .... .+-.-..||-..+ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 9987654 678877643 26778774332 444 3333 3334455777777 99999999999995
Q ss_pred CC---C-ceeeec
Q 040785 585 HN---Y-VSKISD 593 (782)
Q Consensus 585 ~~---~-~~kL~D 593 (782)
.+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00061 Score=76.13 Aligned_cols=75 Identities=21% Similarity=0.206 Sum_probs=56.0
Q ss_pred cceeeeeCcEeEEEEEECC--eeEEEEEecCCc-------hhhHHHHHHHHHHHHhcC---CCCeeeecccccCccEEEE
Q 040785 456 SRKIGEGGYGPVYKCYLDH--TPVAVKVLRPDA-------AQGRSQFQREIEVLSCIR---HPNMVLLLGACPEYGIIVY 523 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~--~~vAvK~l~~~~-------~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lV~ 523 (782)
.+.||.|.+..||++...+ +.|.||.-.+.. ......+..|.+.|..+. ..++..++.+..+..++||
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVM 110 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVM 110 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEE
Confidence 3578999999999999854 389999854221 123456778888888763 3467788888887789999
Q ss_pred EeCCCCC
Q 040785 524 EYLANGS 530 (782)
Q Consensus 524 Ey~~~gs 530 (782)
||+++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=4.9e-05 Score=93.23 Aligned_cols=175 Identities=13% Similarity=0.049 Sum_probs=126.3
Q ss_pred eEEEEEecCCchhh-----HHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEEEeCCCCChhHHHhhc-CCCCCCC
Q 040785 476 PVAVKVLRPDAAQG-----RSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVYEYLANGSLDDRIFRR-GNTPPLS 545 (782)
Q Consensus 476 ~vAvK~l~~~~~~~-----~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~Ey~~~gsL~~~l~~~-~~~~~l~ 545 (782)
.+.+|+.+...-+. ++....|.+-++...|+++...+.-.++. .+.+++|+.+|.+.+.+.+. ...+++.
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 34566665433222 33345566666778899998777655433 38899999999999988764 3334454
Q ss_pred HHHHHHHHHHHHHHHHHhhhc--CCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCC
Q 040785 546 WQQRFRIAAEIATGLLFLHQT--KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623 (782)
Q Consensus 546 ~~~~~~i~~qia~aL~yLH~~--~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~a 623 (782)
..-+.....+...+..-+|+. +....+|++||+.|.+|..+..+|++++|+.+.... .....+...+++.|+.
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-----~~sf~Gl~l~sp~~v~ 1408 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-----VLSFFGLELCSPIYVL 1408 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc-----hHhhhhhhhCCHHHHH
Confidence 444444444446666665643 234579999999999999999999999999984321 1223345678889999
Q ss_pred hhhhhcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 040785 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 624 PE~~~~~~~s~ksDVwSlGvil~elltG~~Pf 655 (782)
|++...-.++.++|+|..|+.+|++..|..+|
T Consensus 1409 qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1409 QLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99988888999999999999999999998887
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00059 Score=68.70 Aligned_cols=123 Identities=23% Similarity=0.299 Sum_probs=89.4
Q ss_pred ccccccceeeeeCc-EeEEEEEECCeeEEEEEecC---Cch------------------hhHHHHHHHHHHHHhcC---C
Q 040785 451 QFFTESRKIGEGGY-GPVYKCYLDHTPVAVKVLRP---DAA------------------QGRSQFQREIEVLSCIR---H 505 (782)
Q Consensus 451 ~~f~~~~~LG~G~f-g~Vy~~~~~~~~vAvK~l~~---~~~------------------~~~~~~~~Ei~iL~~l~---H 505 (782)
..++.++.||.|.- |.||++...+..+|+|+++. ... .....|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 56888999999999 99999999999999999321 100 11234778888888774 4
Q ss_pred CCe--eeecccccC----------------c----cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040785 506 PNM--VLLLGACPE----------------Y----GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563 (782)
Q Consensus 506 pnI--v~l~g~~~~----------------~----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL 563 (782)
.++ |+++|+..- . ..||.||++... .+... -+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHHH
Confidence 455 888887610 0 047888876643 12222 345677778889
Q ss_pred hhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 564 H~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
|..| |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999986 3489999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00041 Score=74.73 Aligned_cols=140 Identities=17% Similarity=0.197 Sum_probs=85.5
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC--eeeecccc--------cCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN--MVLLLGAC--------PEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~--------~~~~~lV~Ey 525 (782)
.+.|..|....+|+....+..+++|+... .....+..|+.++..+.+.+ +..++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 45677788899999887777899998864 22345677888888874332 34443321 2223789999
Q ss_pred CCCCChhH----H----------HhhcCC--C------CCCCHHHHH----------HHHHHHHHHHHHhhh----cCCC
Q 040785 526 LANGSLDD----R----------IFRRGN--T------PPLSWQQRF----------RIAAEIATGLLFLHQ----TKPE 569 (782)
Q Consensus 526 ~~~gsL~~----~----------l~~~~~--~------~~l~~~~~~----------~i~~qia~aL~yLH~----~~~~ 569 (782)
++|..+.. . ++.... . ....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876531 0 111100 0 011222111 011123334445443 2234
Q ss_pred CeeecCCCCceEEEcCCCceeeecccccc
Q 040785 570 PLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 570 ~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 59999999999999998888999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0043 Score=67.64 Aligned_cols=140 Identities=16% Similarity=0.216 Sum_probs=76.7
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-----CCCeeeec-c----cccCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-----HPNMVLLL-G----ACPEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~-g----~~~~~~~lV~Ey 525 (782)
.+.|+.|....+|+...++..+++|+.... ....+..|+.++..|. -|.++.-. | ......+++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 355777888899998876668999987521 1233444556665553 33333210 1 112233899999
Q ss_pred CCCCChh-----------HHH---hhcCCC--------CCCCH-HHHHH------------HHHH-HHHHHHHhhhc---
Q 040785 526 LANGSLD-----------DRI---FRRGNT--------PPLSW-QQRFR------------IAAE-IATGLLFLHQT--- 566 (782)
Q Consensus 526 ~~~gsL~-----------~~l---~~~~~~--------~~l~~-~~~~~------------i~~q-ia~aL~yLH~~--- 566 (782)
++|..+. ..| +..... ..+.| ...+. .+.+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987541 111 111100 01112 11111 1111 11122333211
Q ss_pred -CCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 567 -KPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 567 -~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
-|..+||+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24459999999999999977667899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0049 Score=66.91 Aligned_cols=141 Identities=18% Similarity=0.231 Sum_probs=82.1
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC--eeeecccc--------cCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN--MVLLLGAC--------PEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~--------~~~~~lV~Ey 525 (782)
...|+.|-...+|+...++..+++|+.+... ....+..|++++..|...+ +...+... ....+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4567777778999987766678899876532 1234556777777774222 33443322 1223789999
Q ss_pred CCCCChh-----------H---HHhhcCCC--CC-------CCHHHHHH------------HHHHHHHHHHHhhh----c
Q 040785 526 LANGSLD-----------D---RIFRRGNT--PP-------LSWQQRFR------------IAAEIATGLLFLHQ----T 566 (782)
Q Consensus 526 ~~~gsL~-----------~---~l~~~~~~--~~-------l~~~~~~~------------i~~qia~aL~yLH~----~ 566 (782)
++|..+. . .++..... .+ -.|..... ....+...+.+|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9886432 1 11111110 00 11111100 01123334555543 2
Q ss_pred CCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 567 ~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
-+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 24459999999999999998878999999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0012 Score=71.50 Aligned_cols=139 Identities=24% Similarity=0.281 Sum_probs=82.8
Q ss_pred ceeeeeCcEeEEEEEEC--------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-eeecccccCccEEEEEeCC
Q 040785 457 RKIGEGGYGPVYKCYLD--------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-VLLLGACPEYGIIVYEYLA 527 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~--------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~ 527 (782)
+.|..|-...||+.... +..+++|+..... .......+|..++..+...++ .++++++. +.+|++|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--NGRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--CCchhheeC
Confidence 45666777899998864 3688999976543 223456788888888753222 34455554 356899998
Q ss_pred CCChhHH-----------------HhhcCCCC------CCC--HHHHHHH--------------------------HHHH
Q 040785 528 NGSLDDR-----------------IFRRGNTP------PLS--WQQRFRI--------------------------AAEI 556 (782)
Q Consensus 528 ~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~i--------------------------~~qi 556 (782)
|.++... ++...... .++ |.....+ ...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8766431 11111110 111 1111111 1122
Q ss_pred HHHHHHhhh------cCCCCeeecCCCCceEEEcCC----Cceeeecccccc
Q 040785 557 ATGLLFLHQ------TKPEPLVHRDLKPGNILLDHN----YVSKISDVGLAR 598 (782)
Q Consensus 557 a~aL~yLH~------~~~~~iiHrDLKp~NILld~~----~~~kL~DFGla~ 598 (782)
...+.+|-. ..+..++|+|+.|.|||++++ +.+.|+||..|.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222334432 234568999999999999875 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0014 Score=79.75 Aligned_cols=195 Identities=20% Similarity=0.172 Sum_probs=131.6
Q ss_pred HHHHHHHHHHhcCCCCeeeecccccCcc------EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040785 492 QFQREIEVLSCIRHPNMVLLLGACPEYG------IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565 (782)
Q Consensus 492 ~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 565 (782)
....|++.+.++.|+|++.++++..+.. .+..+|+..-++...+..-+ .++....+.+..++.+||.|+|.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHH
Confidence 3456777888889999999988764332 23457888878877775544 47788888899999999999999
Q ss_pred cCCCCeeecCCCCc---eEEEcCCCceeee--ccccccccccccccccccccccccCCcccCChhhhhcCCCCC--chhH
Q 040785 566 TKPEPLVHRDLKPG---NILLDHNYVSKIS--DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGV--KSDV 638 (782)
Q Consensus 566 ~~~~~iiHrDLKp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~--ksDV 638 (782)
.. ..|.-|..+ +...+..+.+.++ ||+..+..+..... ....-+..|.+||......+.. ..|+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~------~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS------FSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc------hhhcCccccccccccccccchhhhhhHH
Confidence 86 555544444 4444566777776 88887765332211 1123345577888666655544 4799
Q ss_pred HHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 639 YSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 639 wSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
|.+|..+..+..|..+-.....+. .+++.. ......++..+|+..++++|++..+++...
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~~---------~~l~~~-------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVPV---------SLLDVL-------STSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccchh---------hhhccc-------cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999999999999876542221111 111111 111367788899999999999998888433
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0036 Score=69.90 Aligned_cols=73 Identities=15% Similarity=0.136 Sum_probs=53.9
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCch-------hhHHHHHHHHHHHHhcC---CCCeeeecccccCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAA-------QGRSQFQREIEVLSCIR---HPNMVLLLGACPEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~-------~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lV~Ey 525 (782)
.+.||.|....||+....+..++||.-.+... .....-..|.+.|..+. ..++.+++.+|.+..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 46789999999999988777799998652111 12333445577776653 347888999999999999999
Q ss_pred CCC
Q 040785 526 LAN 528 (782)
Q Consensus 526 ~~~ 528 (782)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0041 Score=68.73 Aligned_cols=140 Identities=20% Similarity=0.255 Sum_probs=81.6
Q ss_pred ceeeeeCcEeEEEEEEC------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-eeecccccCccEEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-VLLLGACPEYGIIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~~g 529 (782)
..|-.|-...+|++... +..|++|+......... ...+|..++..+..-++ .++++.+.. + .|++|+++.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g-~v~efi~g~ 118 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G-RVEEFIHAR 118 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c-eEEEeeCCC
Confidence 45555788899998752 25788998866532222 23678888888853333 244565543 3 689999887
Q ss_pred ChhHH-----------------HhhcCC---CCCCCHHHHHHHHHHH-----------------HHHHHHh----hh-cC
Q 040785 530 SLDDR-----------------IFRRGN---TPPLSWQQRFRIAAEI-----------------ATGLLFL----HQ-TK 567 (782)
Q Consensus 530 sL~~~-----------------l~~~~~---~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~-~~ 567 (782)
+|... ++.... ..+..+..+..++.++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 111110 1112233333333221 1111112 21 22
Q ss_pred CCCeeecCCCCceEEEcC-CCceeeeccccccc
Q 040785 568 PEPLVHRDLKPGNILLDH-NYVSKISDVGLARL 599 (782)
Q Consensus 568 ~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~ 599 (782)
+..++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 334899999999999986 47899999988764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0088 Score=64.79 Aligned_cols=134 Identities=22% Similarity=0.315 Sum_probs=78.7
Q ss_pred eeeeeCcEeEEEEEECCeeEEEEEecC--CchhhHHHHHHHHHHHHhcCC--CCeeeecccccCcc----EEEEEeCCCC
Q 040785 458 KIGEGGYGPVYKCYLDHTPVAVKVLRP--DAAQGRSQFQREIEVLSCIRH--PNMVLLLGACPEYG----IIVYEYLANG 529 (782)
Q Consensus 458 ~LG~G~fg~Vy~~~~~~~~vAvK~l~~--~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~~~----~lV~Ey~~~g 529 (782)
.+-.|-...+|.....++.+++. ... ..........+|..+|..+.- .-+...++.|.+.. +.||+|+.|.
T Consensus 32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred eccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 33333334445444457778887 221 122234456788888887642 22345567776555 8999999885
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHH-HHHHHHHH-----------------------------------------------
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIA-AEIATGLL----------------------------------------------- 561 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~-~qia~aL~----------------------------------------------- 561 (782)
.+.+.+.... .. .+++ ..++..|.
T Consensus 111 ~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 111 VVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred eccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 3332221100 00 0111 13333333
Q ss_pred ---HhhhcC-----CCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 562 ---FLHQTK-----PEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 562 ---yLH~~~-----~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
||+.+. +..++|+|+.+.||+++.++-+=|.||+++.+-
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 443332 346999999999999999988999999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0021 Score=68.43 Aligned_cols=147 Identities=14% Similarity=0.162 Sum_probs=95.4
Q ss_pred ccccccHHHHHHHhc---cccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh----------------------hH
Q 040785 437 RYRRYTIEDIEEATQ---FFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ----------------------GR 490 (782)
Q Consensus 437 ~~~~~~~~~~~~~t~---~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~----------------------~~ 490 (782)
.|.-|.+--|....+ -++..+.||-|.-+-||.+-+ .|++.++|+-+..... .+
T Consensus 75 Ty~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 75 TYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred eeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 344555444444333 477889999999999999988 5899999975432100 01
Q ss_pred HHHHHHHHHHHhcC-CCC-eeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 040785 491 SQFQREIEVLSCIR-HPN-MVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568 (782)
Q Consensus 491 ~~~~~Ei~iL~~l~-Hpn-Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 568 (782)
-...+|+..|+.|. |-. +...++++ ..|+|||++.+-.|...-+- ....+ +...+..-+.-|-..|
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD~~--RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPIDHN--RHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCccccc--ceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC-
Confidence 11346777777774 221 22233322 23899999988777543211 12223 3334444455677788
Q ss_pred CCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 569 EPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 569 ~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
+||+|..-=||++++++.++++||--+
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999999644
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.012 Score=62.83 Aligned_cols=69 Identities=20% Similarity=0.109 Sum_probs=40.2
Q ss_pred eeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-C-CC-eeeecccccCccEEEEEeCCCCCh
Q 040785 459 IGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-H-PN-MVLLLGACPEYGIIVYEYLANGSL 531 (782)
Q Consensus 459 LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-H-pn-Iv~l~g~~~~~~~lV~Ey~~~gsL 531 (782)
.+.|-...||.... ++..+++|+-+.. .....+.+|..+|..+. + |- +..++. .+..+++|++++|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~vpvP~~~~--~~~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPVQVPDWRV--HTPELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCCCCCceee--ecCceEEEeccCCCcc
Confidence 34444456666544 4778888887532 23456789999999884 2 21 112222 2234677777776543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 782 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-38 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-28 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-95
Identities = 112/309 (36%), Positives = 164/309 (53%), Gaps = 24/309 (7%)
Query: 419 KESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPV 477
K ++ + A S+ R + D+EEAT F IG G +G VYK L D V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 478 AVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRI 535
A+K P+++QG +F+ EIE LS RHP++V L+G C E I++Y+Y+ NG+L +
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 536 FRRGN-TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594
+ T +SW+QR I A GL +LH ++HRD+K NILLD N+V KI+D
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183
Query: 595 GLARLVPAVAENVTQYHLTST--AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAK 652
G+++ + + HL ST GT YIDPEY G L KSDVYS G++L +++ A+
Sbjct: 184 GISKKGTELDQT----HL-STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 653 ------QPMGLTHFVE---RSIENGTLGEMLDPT-VTDWPFEETLGFAKLALQCSELRRK 702
P + + E S NG L +++DP E F A++C L +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 703 DRPDLGKVV 711
DRP +G V+
Sbjct: 299 DRPSMGDVL 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 4e-89
Identities = 101/313 (32%), Positives = 157/313 (50%), Gaps = 36/313 (11%)
Query: 420 ESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFF------TESRKIGEGGYGPVYKCYLD 473
E+ ++++ + ++ +++ T F K+GEGG+G VYK Y++
Sbjct: 1 ENKSLEVSDTRF-------HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN 53
Query: 474 HTPVAVKVLR----PDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527
+T VAVK L + + QF +EI+V++ +H N+V LLG + +VY Y+
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587
NGSL DR+ TPPLSW R +IA A G+ FLH+ +HRD+K NILLD +
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAF 170
Query: 588 VSKISDVGLARLVPAVAEN-VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 646
+KISD GLAR A+ +T + GT Y+ PE G + KSD+YS G++LL
Sbjct: 171 TAKISDFGLARASEKFAQTVMT----SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLL 225
Query: 647 QLITAKQPMGLT----HFVE--RSI--ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSE 698
++IT + ++ I E T+ + +D + D +A QC
Sbjct: 226 EIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLH 285
Query: 699 LRRKDRPDLGKVV 711
++ RPD+ KV
Sbjct: 286 EKKNKRPDIKKVQ 298
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 3e-88
Identities = 99/290 (34%), Positives = 159/290 (54%), Gaps = 21/290 (7%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGR-SQFQRE 496
+R+++ +++ A+ F+ +G GG+G VYK L D T VAVK L+ + QG QFQ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 497 IEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIF-RRGNTPPLSWQQRFRIA 553
+E++S H N++ L G C ++VY Y+ANGS+ + R + PPL W +R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 554 AEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLT 613
A GL +LH ++HRD+K NILLD + + + D GLA+L+ +VT T
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT----T 193
Query: 614 STAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM-----------GLTHFVE 662
+ GT +I PEY TG K+DV+ G++LL+LIT ++ L +V+
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 663 RSIENGTLGEMLDPTV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
++ L ++D + ++ EE ++AL C++ +RP + +VV
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-63
Identities = 68/318 (21%), Positives = 126/318 (39%), Gaps = 47/318 (14%)
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLS 501
E++ + G +G V+K L + VAVK+ Q Q + E+ L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSLP 73
Query: 502 CIRHPNMVLLLGAC-------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA 554
++H N++ +GA + ++ + GSL D + +SW + IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKAN----VVSWNELCHIAE 128
Query: 555 EIATGLLFLHQ--------TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606
+A GL +LH+ KP + HRD+K N+LL +N + I+D GLA
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLALKFE---AG 184
Query: 607 VTQYHLTSTAGTFCYIDPEYQQTGMLG-----VKSDVYSLGILLLQLITAKQPMGLTH-- 659
+ GT Y+ PE + + ++ D+Y++G++L +L +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 660 ----FVERSIENGTLGEM--------LDPTVTD-WPFEETLG-FAKLALQCSELRRKDRP 705
F E ++ +L +M P + D W + + +C + + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 706 DLGKVVLPELNRLRELAD 723
G V + +++ L +
Sbjct: 305 SAGCVGE-RITQMQRLTN 321
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-62
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLL 512
+G G +G V K VA+K + + R F E+ LS + HPN+V L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLY 67
Query: 513 GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
GAC +V EY GSL + + P + + + G+ +LH +P+ L+
Sbjct: 68 GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 573 HRDLKPGNILLDHNY-VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
HRDLKP N+LL V KI D G A + Q H+T+ G+ ++ PE +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI--------QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 632 LGVKSDVYSLGILLLQLITAKQP 654
K DV+S GI+L ++IT ++P
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP 202
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-59
Identities = 84/276 (30%), Positives = 132/276 (47%), Gaps = 23/276 (8%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
KIG G +G V++ + VAVK+L A+ ++F RE+ ++ +RHPN+VL +GA
Sbjct: 43 EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 515 C---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P I+ EYL+ GSL + + G L ++R +A ++A G+ +LH P P+
Sbjct: 103 VTQPPNLSIVT-EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PI 160
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
VHR+LK N+L+D Y K+ D GL+RL + T S AGT ++ PE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 632 LGVKSDVYSLGILLLQLITAKQP-MGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFA 690
KSDVYS G++L +L T +QP L + + + P A
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVGFKCKRLEI---PRNLNPQVA 269
Query: 691 KLALQCSELRRKDRPDLGKVVLPELNRLRELADESM 726
+ C RP ++ + LR L ++
Sbjct: 270 AIIEGCWTNEPWKRPSFATIM----DLLRPLIKSAV 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-56
Identities = 77/301 (25%), Positives = 134/301 (44%), Gaps = 39/301 (12%)
Query: 437 RYRRYTIEDIEEATQFFTESRKIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGRS--- 491
+ R T+ E ++IG+GG+G V+K D + VA+K L ++G +
Sbjct: 10 KSRLPTL-ADNE----IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 492 ----QFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
+FQRE+ ++S + HPN+V L G +V E++ G L R+ + + P+ W
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWS 122
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-----HNYVSKISDVGLARLVPA 602
+ R+ +IA G+ ++ P P+VHRDL+ NI L +K++D GL++
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 603 VAENVTQYHLTSTAGTFCYIDPE--YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF 660
+ + ++ G F ++ PE + K+D YS ++L ++T + P +
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233
Query: 661 VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720
+ N E L PT+ P + + C K RP +V L E
Sbjct: 234 GKIKFINMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIV----KELSE 286
Query: 721 L 721
L
Sbjct: 287 L 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRP----DAAQGRSQFQREIEVLSCIRHPNMVLLL 512
IG GG+G VY+ + VAVK R D +Q ++E ++ + ++HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 513 GAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G C P +++ E+ G L+ + + + A +IA G+ +LH
Sbjct: 73 GVCLKEPNLCLVM-EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 570 PLVHRDLKPGNILLD--------HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
P++HRDLK NIL+ N + KI+D GLAR + S AG + +
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-------WHRTTKMSAAGAYAW 180
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ PE + M SDV+S G+LL +L+T + P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-55
Identities = 44/207 (21%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRS--QFQREIEVLSCIRHPNMVLLLGA 514
K+ E G ++K + VKVL+ R F E L HPN++ +LGA
Sbjct: 16 TKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 515 C----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
C + ++ ++ GSL + + G + Q + A ++A G+ FLH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-L 133
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE---YQ 627
+ L ++++D + ++IS + + ++ PE +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS----------FQSPGRMYAPAWVAPEALQKK 183
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
+D++S +LL +L+T + P
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 28/278 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRS--QFQREIEVLSCIRHPNMVLLLGA 514
++IG G +G VYK H VAVK+L A + F+ E+ VL RH N++L +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 515 C--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
P+ I+ ++ SL + + ++ IA + A G+ +LH + ++
Sbjct: 89 STAPQLAIVT-QWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE---YQQT 629
HRDLK NI L + KI D GLA + + +G+ ++ PE Q +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATE---KSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP-MGLTHF--VERSIENGTLGEMLDPTVTDWPFEET 686
+SDVY+ GI+L +L+T + P + + + + G+L L ++ P
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR-- 257
Query: 687 LGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADE 724
+L +C + +R +RP +++ + ELA E
Sbjct: 258 --MKRLMAECLKKKRDERPSFPRIL----AEIEELARE 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 67/282 (23%), Positives = 113/282 (40%), Gaps = 36/282 (12%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRP--DAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
IG+G +G VY H VA++++ D F+RE+ RH N+VL +GA
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 515 C---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
C P II +L + R L + +IA EI G+ +LH + +
Sbjct: 98 CMSPPHLAIIT-SLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
+H+DLK N+ D+ V I+D GL + + + L G C++ PE +
Sbjct: 152 LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 632 LGV---------KSDVYSLGILLLQLITAKQP-MGLTHF-VERSIENGTLGEMLDPTVTD 680
SDV++LG + +L + P + + G + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVV-----LPELNR 717
+ + L C +++RP K++ LP+ NR
Sbjct: 271 -------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-51
Identities = 68/307 (22%), Positives = 103/307 (33%), Gaps = 49/307 (15%)
Query: 444 EDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEV--LS 501
+ IG G YG VYK LD PVAVKV R F E + +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSF---ANRQNFINEKNIYRVP 62
Query: 502 CIRHPNMVLLLGACPEYGI-------IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA 554
+ H N+ + +V EY NGSL + W R+A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAH 118
Query: 555 EIATGLLFLHQTKPE------PLVHRDLKPGNILLDHNYVSKISDVGLARLV---PAVAE 605
+ GL +LH P + HRDL N+L+ ++ ISD GL+ + V
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 606 NVTQYHLTSTAGTFCYIDPEY-------QQTGMLGVKSDVYSLGILLLQLITAKQPMGLT 658
S GT Y+ PE + + D+Y+LG++ ++ +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL--- 235
Query: 659 HFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSEL--RRKDRPDLGKVVLPELN 716
++ E F+ +G L R K RP +
Sbjct: 236 ------FPGESVPEYQ------MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283
Query: 717 RLRELAD 723
+R L +
Sbjct: 284 AVRSLKE 290
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-50
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 34/302 (11%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
+G+G +G K T + +K L + + F +E++V+ C+ HPN++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 515 C--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
+ + EY+ G+L I + W QR A +IA+G+ +LH ++
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 573 HRDLKPGNILLDHNYVSKISDVGLARLVP---------AVAENVTQYHLTSTAGTFCYID 623
HRDL N L+ N ++D GLARL+ + + + G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP----MGLTHFVERSIENGTLGEMLDPTVT 679
PE K DV+S GI+L ++I + T ++ + P
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRYCP--P 246
Query: 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFFGGSLGPSS 739
+ P F + ++C +L + RP K+ + L L G G L
Sbjct: 247 NCP----PSFFPITVRCCDLDPEKRPSFVKLE----HWLETLRMHLAGHLPLGPQLEQLD 298
Query: 740 KS 741
+
Sbjct: 299 RG 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEV--LSCIRHPNMVLLLGA 514
+G+G YG V++ VAVK+ + + RE E+ +RH N++ + +
Sbjct: 14 ECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 515 C-------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH--- 564
+ +I Y GSL D + L RI IA+GL LH
Sbjct: 71 DMTSRHSSTQLWLIT-HYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 565 ---QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
Q KP + HRDLK NIL+ N I+D+GLA + + N GT Y
Sbjct: 126 FGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ-STNQLDVGNNPRVGTKRY 183
Query: 622 IDPE------YQQTGMLGVKSDVYSLGILLLQLITAKQPMG 656
+ PE + D+++ G++L ++ G
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-47
Identities = 77/348 (22%), Positives = 133/348 (38%), Gaps = 57/348 (16%)
Query: 413 AEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL 472
L++ E +S + S L +R + I+ ++IG+G YG V+
Sbjct: 6 PPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQM-------VKQIGKGRYGEVWMGKW 58
Query: 473 DHTPVAVKVLRPDAAQGRSQFQREIEV--LSCIRHPNMVLLLGAC-------PEYGIIVY 523
VAVKV + + RE E+ +RH N++ + A + +I
Sbjct: 59 RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT- 114
Query: 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH------QTKPEPLVHRDLK 577
+Y NGSL D + + L + ++A +GL LH Q KP + HRDLK
Sbjct: 115 DYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP-AIAHRDLK 169
Query: 578 PGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE------YQQTGM 631
NIL+ N I+D+GLA + N + GT Y+ PE +
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFIS-DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228
Query: 632 LGVKSDVYSLGILLLQLITAKQPMGLT-----HFVERSIENGTLGEMLDPTVTD------ 680
+ +D+YS G++L ++ G+ + + + + +M +
Sbjct: 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 681 ---WPFEETL-GFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADE 724
W +E L KL +C R +V L ++++
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK----KTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 458 KIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEV--LSCIRHPNMVLLLGAC 515
IG+G +G V++ VAVK+ + + RE E+ +RH N++ + A
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 516 -------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH---- 564
+ ++ +Y +GSL D + N ++ + ++A A+GL LH
Sbjct: 106 NKDNGTWTQLWLVS-DYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 565 --QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
Q KP + HRDLK NIL+ N I+D+GLA + A + GT Y+
Sbjct: 161 GTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTKRYM 218
Query: 623 DPE-YQQTGMLGV-----KSDVYSLGILLLQLITAKQPMG 656
PE + + ++D+Y++G++ ++ G
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 457 RKIGEGGYGPVYKCYLD------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMV 509
R +GEG +G V C D VAVK L+P++ + ++EIE+L + H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 510 LLLGACPEYGI----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
G C E G ++ E+L +GSL + + N ++ +Q+ + A +I G+ +L
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAG 617
+ VHRDL N+L++ + KI D GL + + + Y + A
Sbjct: 145 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE---TDKEYYTVKDDRDSPVFWYA- 197
Query: 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE + SDV+S G+ L +L+T
Sbjct: 198 ------PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 457 RKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
+++G+G +G V C D VAVK L+ + F+REIE+L ++H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 511 LLGACPEYGI----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
G C G ++ EYL GSL D + + + + + + ++I G+ +L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGT 618
+ +HRDL NIL+++ KI D GL +++P ++ + + A
Sbjct: 134 R---YIHRDLATRNILVENENRVKIGDFGLTKVLP---QDKEFFKVKEPGESPIFWYA-- 185
Query: 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE V SDV+S G++L +L T
Sbjct: 186 -----PESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 457 RKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
+++G+G +G V C D VAVK L+ + F+REIE+L ++H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 511 LLGACPEYGI----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
G C G ++ EYL GSL D + + + + + + ++I G+ +L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGT 618
+ +HRDL NIL+++ KI D GL +++P ++ Y + A
Sbjct: 165 R---YIHRDLATRNILVENENRVKIGDFGLTKVLP---QDKEYYKVKEPGESPIFWYA-- 216
Query: 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE V SDV+S G++L +L T
Sbjct: 217 -----PESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 457 RKIGEGGYGPVYKCYLD------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
++G+G +G V C D VAVK L+ + FQREI++L + +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 511 LLGACPEYGI----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
G G +V EYL +G L D F + + L + +++I G+ +L
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGT 618
+ VHRDL NIL++ KI+D GLA+L+P + Y + A
Sbjct: 147 R---CVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWYA-- 198
Query: 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE + +SDV+S G++L +L T
Sbjct: 199 -----PESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 27/223 (12%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLR-PDAAQGRSQFQREIEVLSCIRHPNMV 509
F + +G GG+G V++ +D A+K +R P+ R + RE++ L+ + HP +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 510 LLLGA--------------CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAE 555
A Y I + +L D + R I +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV-------PAVAENVT 608
IA + FLH L+HRDLKP NI + V K+ D GL + +
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA 651
T GT Y+ PE K D++SLG++L +L+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
F E +G+G +G V K LD A+K +R + S E+ +L+ + H +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 511 LLGACPEYGI---------------IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAE 555
A E I EY NG+L D I + +R+ +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQ 124
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV---------PAVAEN 606
I L ++H ++HRDLKP NI +D + KI D GLA+ V +
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 607 VTQYHLTSTAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQLIT 650
+ +LTS GT Y+ E TG K D+YSLGI+ ++I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 37/226 (16%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT---PVAVKVLRPDAAQG---RSQF 493
RY I K+G GG VY D VA+K + + +F
Sbjct: 12 RYKIV------------DKLGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRF 58
Query: 494 QREIEVLSCIRHPNMVLLLGACPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFR 551
+RE+ S + H N+V ++ E +V EY+ +L + I G PLS
Sbjct: 59 EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAIN 115
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
+I G+ H + +VHRD+KP NIL+D N KI D G+A+ A++E
Sbjct: 116 FTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSET----S 165
Query: 612 LTSTA---GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
LT T GT Y PE + +D+YS+GI+L +++ + P
Sbjct: 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT---PVAVKVLRPDAAQG---RSQF 493
RY + +G GG V+ D VAVKVLR D A+ +F
Sbjct: 13 RYELG------------EILGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 494 QREIEVLSCIRHPNMVLLL------GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
+RE + + + HP +V + IV EY+ +L D + G P++ +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPK 116
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
+ + A+ L F HQ ++HRD+KP NI++ K+ D G+AR + +V
Sbjct: 117 RAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 608 TQYHLTSTA-GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
TQ T+ GT Y+ PE + + +SDVYSLG +L +++T + P
Sbjct: 174 TQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-37
Identities = 64/224 (28%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLG 513
+IG G +G V+ L D+T VAVK R +++F +E +L HPN+V L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 514 AC----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
C P Y IV E + G F R L + ++ + A G+ +L
Sbjct: 180 VCTQKQPIY--IVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY--IDPEYQ 627
+HRDL N L+ V KISD G++R Y + PE
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQVPVKWTAPEAL 287
Query: 628 QTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
G +SDV+S GILL + + P L++ +E G
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 36/213 (16%)
Query: 457 RKIGEGGYGPVYKCYLD------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMV 509
R +GEG +G V D VAVK L+ DA Q RS +++EI++L + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 510 LLLGACPEYGI----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
G C + G +V EY+ GSL D + ++ + Q A +I G+ +LH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHS--IGLAQLLLFAQQICEGMAYLHA 152
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAG 617
+HRDL N+LLD++ + KI D GLA+ VP E Y + A
Sbjct: 153 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP---EGHEYYRVREDGDSPVFWYA- 205
Query: 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE + SDV+S G+ L +L+T
Sbjct: 206 ------PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 28/223 (12%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPN 507
+ S +G+G V++ T A+KV + RE EVL + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 508 MVLLL----GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
+V L + +++ E+ GSL + N L + + ++ G+ L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 564 HQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTF 619
+ +VHR++KPGNI+ D V K++D G AR + S GT
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------DDEQFVSLYGTE 179
Query: 620 CYIDPEYQQTGML--------GVKSDVYSLGILLLQLITAKQP 654
Y+ P+ + +L G D++S+G+ T P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 52/246 (21%), Positives = 104/246 (42%), Gaps = 34/246 (13%)
Query: 427 ASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT-PVAVKVLRPD 485
+ +L T++L ++ +++ ++ ++IG GG V++ + A+K + +
Sbjct: 9 SGVDLGTENLYFQSMSVKGRI-----YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 486 AAQGRS--QFQREIEVLSCIRHPNM--VLLLGAC--PEYGIIVYEYLANGSLDDRIFRRG 539
A ++ ++ EI L+ ++ + + L +Y +V E N L+ + ++
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122
Query: 540 NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599
+ +R + + +HQ +VH DLKP N L+ + K+ D G+A
Sbjct: 123 ---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIAN- 174
Query: 600 VPAVAENVTQYHLTSTAGTFCYIDPE-----------YQQTGMLGVKSDVYSLGILLLQL 648
+ + T S GT Y+ PE + + KSDV+SLG +L +
Sbjct: 175 --QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 649 ITAKQP 654
K P
Sbjct: 233 TYGKTP 238
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 457 RKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+++G G +G V VA+K+++ + +F E +V+ + H +V L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P + I+ EY+ANG L + + R QQ + ++ + +L +
Sbjct: 89 TKQRPIF--IITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 141
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID---PEYQQ 628
+HRDL N L++ V K+SD GL+R V +Y TS+ G+ + PE
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-----DEY--TSSVGSKFPVRWSPPEVLM 194
Query: 629 TGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
KSD+++ G+L+ ++ + K P T+ I G
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 7e-36
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 37/226 (16%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT---PVAVKVLRPDAAQG---RSQF 493
Y + R +G GG G VY+ D VA+K++ + R++
Sbjct: 35 PYRLR------------RLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRM 81
Query: 494 QREIEVLSCIRHPNMVLLLGACPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFR 551
QRE ++ P++V + G + + L + R+G PL+ +
Sbjct: 82 QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVA 138
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
I +I + L H HRD+KP NIL+ + + + D G+A A +
Sbjct: 139 IVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS---ATTDE----K 188
Query: 612 LTSTA---GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
LT GT Y+ PE ++D+Y+L +L + +T P
Sbjct: 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 28/232 (12%)
Query: 454 TESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPN 507
R IG+G +G VY + A+K L Q F RE ++ + HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 508 MVLLLGAC-----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
++ L+G + ++ Y+ +G L F R + + ++A G+ +
Sbjct: 84 VLALIGIMLPPEGLPH--VLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
L + K VHRDL N +LD ++ K++D GLAR + + Y + +
Sbjct: 140 LAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI----LDREYYSVQQHRHARLPV 192
Query: 623 D---PEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
E QT KSDV+S G+LL +L+T P + F + + G
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 446 IEEATQFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEV 499
I ++ + IG G +G VY L AVK L SQF E +
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 500 LSCIRHPNMVLLLGACPEYG---IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEI 556
+ HPN++ LLG C ++V Y+ +G L + F R T + + ++
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQV 137
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA 616
A G+ +L K VHRDL N +LD + K++D GLAR + + Y + +
Sbjct: 138 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKT 190
Query: 617 GTFCYID---PEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
G + E QT KSDV+S G+LL +L+T P + F + + G
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 80/254 (31%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 457 RKIGEGGYGPVYKC-YLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
K+G+G +G V+ + T VA+K L+P F +E +V+ +RH +V L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 516 PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
E I IV EY++ GSL D + L Q +AA+IA+G+ ++ + VHR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 575 DLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGV 634
DL+ NIL+ N V K++D GLARL+ E+ + PE G +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 635 KSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENGTLGEMLDPTVTDWPFEETLGFAK 691
KSDV+S GILL +L T + P G+ + V +E G M P + P
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--YRMPCP--PECPES----LHD 412
Query: 692 LALQCSELRRKDRP 705
L QC ++RP
Sbjct: 413 LMCQCWRKEPEERP 426
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 75/311 (24%), Positives = 120/311 (38%), Gaps = 40/311 (12%)
Query: 384 KERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRY-RRYT 442
+ RA A + + + + + LS + + S+ + +N DL
Sbjct: 16 RRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPEL 75
Query: 443 IEDIEEATQFFTES-----RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRS 491
++ ++ + IG G +G VY L AVK L S
Sbjct: 76 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 135
Query: 492 QFQREIEVLSCIRHPNMVLLLGACPEYG---IIVYEYLANGSLDDRIFRRGNTPPLSWQQ 548
QF E ++ HPN++ LLG C ++V Y+ +G L + F R T + +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKD 193
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
++A G+ FL K VHRDL N +LD + K++D GLAR + +
Sbjct: 194 LIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFD 248
Query: 609 QYHLTS--------TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLT 658
H + A E QT KSDV+S G+LL +L+T P +
Sbjct: 249 SVHNKTGAKLPVKWMA-------LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 659 HF-VERSIENG 668
F + + G
Sbjct: 302 TFDITVYLLQG 312
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 26/223 (11%)
Query: 457 RKIGEGGYGPVYKC-YLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
++IG G +G V+ +L+ VA+K +R A F E EV+ + HP +V L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P +V E++ +G L D + R + + + ++ G+ +L + +
Sbjct: 73 LEQAPIC--LVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID---PEYQQ 628
+HRDL N L+ N V K+SD G+ R V QY TS+ GT + PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-----DQY--TSSTGTKFPVKWASPEVFS 178
Query: 629 TGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
KSDV+S G+L+ ++ + K P ++ V I G
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 36/228 (15%)
Query: 457 RKIGEGGYGPVYKC-YLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+++G G +G V + VAVK+++ + +F +E + + + HP +V G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 516 ----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
P Y IV EY++NG L + + R + L Q + ++ G+ FL +
Sbjct: 73 SKEYPIY--IVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---F 125
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFCYID 623
+HRDL N L+D + K+SD G+ R V QY + +A
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-----DQYVSSVGTKFPVKWSA------- 173
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE KSDV++ GIL+ ++ + K P T+ V + G
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 457 RKIGEGGYGPVYKC-YLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
++G G +G V+ Y HT VAVK L+ + F E ++ ++H +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 516 PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
+ I I+ EY+ NGSL D + + + L+ + +AA+IA G+ F+ + +HR
Sbjct: 78 TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 575 DLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFCYIDPEY 626
DL+ NIL+ KI+D GLARL+ +Y TA PE
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTA-------PEA 181
Query: 627 QQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
G +KSDV+S GILL +++T + P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 38/263 (14%)
Query: 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
K+G G YG VY+ VAVK L+ D + +F +E V+ I+HPN+V LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 515 C----PEYGIIVYEYLANGSLDDRIF-RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
C P Y I+ E++ G+L D + R N +S +A +I++ + +L +
Sbjct: 285 CTREPPFY--IITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 338
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID---PEY 626
+HR+L N L+ N++ K++D GL+RL+ Y T+ AG I PE
Sbjct: 339 -FIHRNLAARNCLVGENHLVKVADFGLSRLM-----TGDTY--TAHAGAKFPIKWTAPES 390
Query: 627 QQTGMLGVKSDVYSLGILLLQLIT-AKQP---MGLTHFVERSIENGTLGEMLDPTVTDWP 682
+KSDV++ G+LL ++ T P + L+ E +E M P P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKD--YRMERP--EGCP 445
Query: 683 FEETLGFAKLALQCSELRRKDRP 705
+ +L C + DRP
Sbjct: 446 EK----VYELMRACWQWNPSDRP 464
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 35/231 (15%)
Query: 457 RKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMV 509
+ +G G +G VYK PVA+K LR + + E V++ + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 510 LLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
LLG C + ++ + + G L D + R + + Q +IA G+ +L +
Sbjct: 81 RLLGICLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFC 620
LVHRDL N+L+ KI+D GLA+L+ + + A
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIKWMA---- 187
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
E + +SDV+S G+ + +L+T +P G+ + +E G
Sbjct: 188 ---LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 30/224 (13%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPN 507
+ S +G+G V++ T A+KV + RE EVL + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 508 MVLLLGACPEYG-----IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
+V L A E +++ E+ GSL + N L + + ++ G+
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 563 LHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
L + +VHR++KPGNI+ D V K++D G AR + S GT
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------DDEQFVSLYGT 178
Query: 619 FCYIDPEYQQTGML--------GVKSDVYSLGILLLQLITAKQP 654
Y+ P+ + +L G D++S+G+ T P
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 34/238 (14%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
F E IG GG+G V+K +D +K ++ + +RE++ L+ + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVH 68
Query: 511 LLGACPEYGI------------------IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI 552
G + I E+ G+L+ I +R L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALEL 127
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
+I G+ ++H K L++RDLKP NI L KI D GL + +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK------R 178
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTL 670
T + GT Y+ PE + G + D+Y+LG++L +L+ T + +G +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII 236
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 71/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
R++GEG +G V+ D VAVK L+ R FQRE E+L+ ++H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 510 LLLGAC----PEYGIIVYEYLANGSLDD--RIFR-----------RGNTPPLSWQQRFRI 552
G C P +V+EY+ +G L+ R R L Q I
Sbjct: 81 KFYGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
A++IA+G+++L VHRDL N L+ N + KI D G++R V T Y+
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDV-----YSTDYYR 190
Query: 613 TSTAGTF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIEN 667
++ PE +SDV+S G++L ++ T KQP L++ V I
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 668 G 668
G
Sbjct: 251 G 251
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 19/218 (8%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
+ +K+GEGG+ V D A+K + Q R + QRE ++ HPN++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 511 LLGACPEYG------IIVYEYLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFL 563
L+ C ++ + G+L + I R L+ Q + I GL +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL----VPAVAENVTQYHLTSTAGTF 619
H HRDLKP NILL + D+G V + +T + T
Sbjct: 151 HAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 620 CYIDPE---YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
Y PE Q ++ ++DV+SLG +L ++ + P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 38/233 (16%)
Query: 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVL 510
+ IG G G V L PVA+K L+ + R F E ++ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 511 LLGAC----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
L G IV EY+ NGSLD F R + + Q + + G+ +L
Sbjct: 115 LEGVVTRGRLAM--IVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGT 618
VHRDL N+L+D N V K+SD GL+R+ + ++ + T+ TA
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRV---LEDDPDAAYTTTGGKIPIRWTA-- 222
Query: 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE SDV+S G+++ +++ ++P +T+ V S+E G
Sbjct: 223 -----PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 457 RKIGEGGYGPVYKCYLDHT-PVAVKV--LRPDAAQGRSQFQREIEVLSCIRHPNM--VLL 511
++IG GG V++ + A+K L Q ++ EI L+ ++ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 512 LGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
+Y +V E N L+ + ++ + +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG-- 128
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE---- 625
+VH DLKP N L+ + K+ D G+A + + T S GT Y+ PE
Sbjct: 129 -IVHSDLKPANFLIVDGML-KLIDFGIAN---QMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 626 -------YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ + KSDV+SLG +L + K P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-34
Identities = 80/254 (31%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 457 RKIGEGGYGPVYKC-YLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
K+G+G +G V+ + T VA+K L+P F +E +V+ +RH +V L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 516 PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
E I IV EY++ GSL D + L Q +AA+IA+G+ ++ + VHR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 575 DLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGV 634
DL+ NIL+ N V K++D GLARL+ E+ + PE G +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 635 KSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENGTLGEMLDPTVTDWPFEETLGFAK 691
KSDV+S GILL +L T + P G+ + V +E G M P + P
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--YRMPCP--PECPES----LHD 495
Query: 692 LALQCSELRRKDRP 705
L QC ++RP
Sbjct: 496 LMCQCWRKEPEERP 509
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 31/235 (13%)
Query: 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMV 509
R +G+G +G V + L VAVK+L+ D +F RE + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 510 LLLGACPEYG--------IIVYEYLANGSLDD--RIFRRGNTP-PLSWQQRFRIAAEIAT 558
L+G +++ ++ +G L R G P L Q R +IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
G+ +L +HRDL N +L + ++D GL+R + Y+ A
Sbjct: 149 GMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKI-----YSGDYYRQGCASK 200
Query: 619 F--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
++ E + V SDV++ G+ + +++T + P G+ + + + G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 55/263 (20%), Positives = 103/263 (39%), Gaps = 30/263 (11%)
Query: 428 SSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVL 482
SS L + + +ED+ + +GEG +G V + L VAVK +
Sbjct: 11 SSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM 70
Query: 483 RPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-------IIVYEYLANGSLDD 533
+ D + + +F E + HPN++ LLG C E +++ ++ G L
Sbjct: 71 KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT 130
Query: 534 --RIFR-RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSK 590
R + Q + +IA G+ +L +HRDL N +L +
Sbjct: 131 YLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187
Query: 591 ISDVGLARLVPAVAENVTQYHLTSTAGTF--CYIDPEYQQTGMLGVKSDVYSLGILLLQL 648
++D GL++ + Y+ +I E + KSDV++ G+ + ++
Sbjct: 188 VADFGLSKKI-----YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242
Query: 649 IT-AKQP-MGLTHF-VERSIENG 668
T P G+ + + + +G
Sbjct: 243 ATRGMTPYPGVQNHEMYDYLLHG 265
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 65/250 (26%), Positives = 104/250 (41%), Gaps = 56/250 (22%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNM 508
++GE +G VYK +L VA+K L+ A R +F+ E + + ++HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 509 VLLLGAC----PEYGIIVYEYLANGSLDDRIFRRGNTP---------------PLSWQQR 549
V LLG P +++ Y ++G L + F +P L
Sbjct: 75 VCLLGVVTKDQPLS--MIFSYCSHGDLHE--FLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 550 FRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609
+ A+IA G+ +L +VH+DL N+L+ KISD+GL R V
Sbjct: 131 VHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV----YAADY 183
Query: 610 YHLTS--------TAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTH 659
Y L A PE G + SD++S G++L ++ + QP G ++
Sbjct: 184 YKLLGNSLLPIRWMA-------PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 660 F-VERSIENG 668
V I N
Sbjct: 237 QDVVEMIRNR 246
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 68/242 (28%), Positives = 109/242 (45%), Gaps = 42/242 (17%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
++GEG +G V+ D VAVK L+ + R FQRE E+L+ ++H ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 510 LLLGAC----PEYGIIVYEYLANGSLDDRIFRRGNTP--------------PLSWQQRFR 551
G C P +V+EY+ +G L+ F R + P PL Q
Sbjct: 107 RFFGVCTEGRPLL--MVFEYMRHGDLNR--FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
+A+++A G+++L VHRDL N L+ V KI D G++R + + T Y+
Sbjct: 163 VASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-----TDYY 214
Query: 612 LTSTAGTF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIE 666
++ PE +SDV+S G++L ++ T KQP L++ I
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274
Query: 667 NG 668
G
Sbjct: 275 QG 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 39/232 (16%)
Query: 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVL 510
R +GEG +G VY+ + VAVK + D + +F E ++ + HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 511 LLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L+G P + I+ E G L + N L + +I + +L
Sbjct: 78 LIGIIEEEPTW--IIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTF 619
VHRD+ NIL+ K+ D GL+R + Y+ S +
Sbjct: 134 ---CVHRDIAVRNILVASPECVKLGDFGLSRYI-----EDEDYYKASVTRLPIKWMS--- 182
Query: 620 CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE SDV+ + + ++++ KQP L + V +E G
Sbjct: 183 ----PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 26/224 (11%)
Query: 457 RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
K+G G YG VY+ VAVK L+ D + +F +E V+ I+HPN+V LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 515 C----PEYGIIVYEYLANGSLDDRIF-RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
C P Y I+ E++ G+L D + R N +S +A +I++ + +L +
Sbjct: 78 CTREPPFY--IITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY--IDPEYQ 627
+HRDL N L+ N++ K++D GL+RL+ + F PE
Sbjct: 132 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAHAGAKFPIKWTAPESL 184
Query: 628 QTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
+KSDV++ G+LL ++ T P G+ V +E
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 23/239 (9%)
Query: 427 ASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKV--L 482
N D+ + +F +IG G + VYK T VA
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 483 RPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG------IIVYEYLANGSLDDRIF 536
R R +F+ E E+L ++HPN+V + ++V E + +G+L +
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121
Query: 537 RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVG 595
R + + +I GL FLH P P++HRDLK NI + KI D+G
Sbjct: 122 RFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
LA L + GT ++ PE + DVY+ G+ +L++ T++ P
Sbjct: 178 LATL-------KRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 39/232 (16%)
Query: 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVL 510
R IGEG +G V++ VA+K + R +F +E + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 511 LLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L+G P + I+ E G L F + L A +++T L +L +
Sbjct: 81 LIGVITENPVW--IIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTF 619
VHRD+ N+L+ N K+ D GL+R + + Y+ S A
Sbjct: 137 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMA--- 185
Query: 620 CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE SDV+ G+ + +++ +P G+ + V IENG
Sbjct: 186 ----PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-34
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 457 RKIGEGGYGPVYKC-YLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC 515
+K+G G +G V+ Y HT VAVK ++P + F E V+ ++H +V L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 516 PEYGI-IVYEYLANGSLDDRIF-RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ I I+ E++A GSL D F + + +A+IA G+ F+ Q +H
Sbjct: 253 TKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 574 RDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY--IDPEYQQTGM 631
RDL+ NIL+ + V KI+D GLAR++ +Y F PE G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVI-----EDNEY-TAREGAKFPIKWTAPEAINFGS 361
Query: 632 LGVKSDVYSLGILLLQLIT 650
+KSDV+S GILL++++T
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNM 508
R++G+G +G VY+ T VA+K + A + R +F E V+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 509 VLLLGAC----PEYGIIVYEYLANGSLDD-------RIFRRGNTPPLSWQQRFRIAAEIA 557
V LLG P ++ E + G L + P S + ++A EIA
Sbjct: 91 VRLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
G+ +L+ K VHRDL N ++ ++ KI D G+ R + T Y+ G
Sbjct: 149 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRKGGKG 200
Query: 618 TF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
++ PE + G+ SDV+S G++L ++ T A+QP GL++ V R + G
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 49/237 (20%), Positives = 95/237 (40%), Gaps = 41/237 (17%)
Query: 457 RKIGEGGYGPVYK---------CYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
+G+G + ++K L T V +KVL F ++S + H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 508 MVLLLGAC----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
+VL G C +V E++ GSLD + + N ++ + +A ++A + FL
Sbjct: 74 LVLNYGVCVCGDENI--LVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 564 HQTKPEPLVHRDLKPGNILLD--------HNYVSKISDVGLARLVPAVAENVTQYHLTST 615
+ L+H ++ NILL + K+SD G++ V + +++ Q +
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQERIPWV 184
Query: 616 AGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE + L + +D +S G L ++ + +P L + E+
Sbjct: 185 P-------PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 54/269 (20%), Positives = 100/269 (37%), Gaps = 55/269 (20%)
Query: 419 KESDEVKIASSNLS-TKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV 477
D + S+ + K ++ + I D + R + +G + + C D+
Sbjct: 5 SMKDILSNYSNLIYLNKYVKEKDKYIND-------YRIIRTLNQGKFNKIILCEKDNKFY 57
Query: 478 AVKVL-----------------RPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGI 520
A+K + F+ E+++++ I++ + GI
Sbjct: 58 ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC------EGI 111
Query: 521 I--------VYEYLANGSLDDRIFRRG-----NTPPLSWQQRFRIAAEIATGLLFLHQTK 567
I +YEY+ N S+ T + Q I + ++H K
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-- 625
+ HRD+KP NIL+D N K+SD G + + + + GT+ ++ PE
Sbjct: 172 N--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV-------DKKIKGSRGTYEFMPPEFF 222
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
++ G K D++SLGI L + P
Sbjct: 223 SNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 51/282 (18%)
Query: 421 SDEVKIASSNLSTKDLRYRRY----TIEDIEEATQFF---------TESRKIGEGGYGPV 467
SDE ++ N K R + T ED + F + + +G G +G V
Sbjct: 2 SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEV 61
Query: 468 YKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGAC----PE 517
L VA+K L+ + R F E ++ HPN++ L G P
Sbjct: 62 CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121
Query: 518 YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLK 577
IV EY+ NGSLD F R + + Q + IA+G+ +L VHRDL
Sbjct: 122 M--IVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLA 174
Query: 578 PGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFCYIDPEYQQT 629
NIL++ N V K+SD GL R+ + ++ + T T+ PE
Sbjct: 175 ARNILINSNLVCKVSDFGLGRV---LEDDPEAAYTTRGGKIPIRWTS-------PEAIAY 224
Query: 630 GMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
SDV+S GI+L ++++ ++P +++ V ++++ G
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 457 RKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMV 509
+ +G G +G V+K PV +KV+ + Q + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 510 LLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
LLG CP + +V +YL GSL D R + L Q +IA G+ +L +
Sbjct: 79 RLLGLCPGSSLQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFC 620
+VHR+L N+LL +++D G+A L+ + L S A
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLL----PPDDKQLLYSEAKTPIKWMA---- 185
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
E G +SDV+S G+ + +L+T
Sbjct: 186 ---LESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 70/234 (29%), Positives = 107/234 (45%), Gaps = 39/234 (16%)
Query: 457 RKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMV 509
+ IG G +G VYK L PVA+K L+ + R F E ++ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 510 LLLGAC----PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
L G P I+ EY+ NG+LD F R S Q + IA G+ +L
Sbjct: 110 RLEGVISKYKPMM--IITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAG 617
VHRDL NIL++ N V K+SD GL+R+ + ++ + TS TA
Sbjct: 166 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRV---LEDDPEATYTTSGGKIPIRWTA- 218
Query: 618 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE SDV+S GI++ +++T ++P L++ V ++I +G
Sbjct: 219 ------PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 64/229 (27%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC- 515
+ IG+G +G V VAVK ++ DA F E V++ +RH N+V LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 516 ----PEYGIIVYEYLANGSLDDRIF-RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
Y IV EY+A GSL D + R L + + ++ + +L
Sbjct: 85 EEKGGLY--IVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 137
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFCYI 622
VHRDL N+L+ + V+K+SD GL + TA
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPVKWTA------ 182
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE + KSDV+S GILL ++ + + P + V +E G
Sbjct: 183 -PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 64/246 (26%), Positives = 99/246 (40%), Gaps = 44/246 (17%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPN 507
+ +G G +G V + VAVK+L+P A R E++VLS + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 508 MVLLLGAC----PEYGIIVYEYLANGSLDD---------------RIFRRGNTPPLSWQQ 548
+V LLGAC P ++ EY G L + + L +
Sbjct: 89 IVNLLGACTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
+ ++A G+ FL +HRDL NILL H ++KI D GLAR +
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI-----KND 198
Query: 609 QYHLTSTAGTF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP---MGLTHFVE 662
++ ++ PE + +SDV+S GI L +L + P M +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 663 RSIENG 668
+ I+ G
Sbjct: 259 KMIKEG 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 32/211 (15%)
Query: 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDAAQGRSQ---FQREIEVLSCIRHPNM 508
K+G+G +G V + VAVK L+PD F RE+ + + H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 509 VLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
+ L G + +V E GSL D R + R A ++A G+ +L +
Sbjct: 84 IRLYGVVLTPPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTF 619
+HRDL N+LL + KI D GL R +P +N Y + A
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALP---QNDDHYVMQEHRKVPFAWCA--- 192
Query: 620 CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE +T SD + G+ L ++ T
Sbjct: 193 ----PESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 34/236 (14%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNM 508
R +G G +G VY+ + VAVK L Q F E ++S H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 509 VLLLGAC----PEYGIIVYEYLANGSLDD--RIFR--RGNTPPLSWQQRFRIAAEIATGL 560
V +G P + I+ E +A G L R R L+ +A +IA G
Sbjct: 96 VRCIGVSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 561 LFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
+L + +HRD+ N LL V+KI D G+AR + Y+
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----ASYYRKGGCA 205
Query: 618 TF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
++ PE G+ K+D +S G+LL ++ + P ++ V + +G
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-33
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 39/208 (18%)
Query: 457 RKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC- 515
+ IG+G +G V VAVK ++ DA F E V++ +RH N+V LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 516 ----PEYGIIVYEYLANGSLDDRIF-RRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
Y IV EY+A GSL D + R L + + ++ + +L
Sbjct: 257 EEKGGLY--IVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 309
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFCYI 622
VHRDL N+L+ + V+K+SD GL + TA
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPVKWTA------ 354
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE + KSDV+S GILL ++ +
Sbjct: 355 -PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 56/265 (21%), Positives = 102/265 (38%), Gaps = 30/265 (11%)
Query: 409 RRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTI-EDIEEATQFFTESRKIGEGGYGPV 467
R + + + + S +L T D + E I + ++ ++IG GG V
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKV 72
Query: 468 YKCYLDHT-PVAVKV--LRPDAAQGRSQFQREIEVLSCIRHPNM--VLLLGAC--PEYGI 520
++ + A+K L Q ++ EI L+ ++ + + L +Y
Sbjct: 73 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGN 580
+V E N L+ + ++ + +R + + +HQ +VH DLKP N
Sbjct: 133 MVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 185
Query: 581 ILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-----------YQQT 629
L+ + K+ D G+A + + T S G Y+ PE +
Sbjct: 186 FLIVDGML-KLIDFGIAN---QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
+ KSDV+SLG +L + K P
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 67/240 (27%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPN 507
+ +G G +G V + VAVK+L+ A A + E++++S + +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 508 MVLLLGAC----PEYGIIVYEYLANGSLDD--RIFRR---------GNTPPLSWQQRFRI 552
+V LLGAC P ++ EY G L + R R S +
Sbjct: 112 IVNLLGACTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
++++A G+ FL +HRD+ N+LL + +V+KI D GLAR +
Sbjct: 170 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI------------ 214
Query: 613 TSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQLIT-AKQP 654
D Y L VK SDV+S GILL ++ + P
Sbjct: 215 --------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-33
Identities = 51/212 (24%), Positives = 78/212 (36%), Gaps = 36/212 (16%)
Query: 457 RKIGEGGYGPVYKCY---LDHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMV--- 509
I GG G +Y ++ PV +K L A+ ++ E + L+ + HP++V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 510 ----LLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
G IV EY+ SL + L + EI L +LH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS 200
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA---GTFCYI 622
LV+ DLKP NI+L + K+ D+G + S GT +
Sbjct: 201 ---IGLVYNDLKPENIMLTEEQL-KLIDLGAVS------------RINSFGYLYGTPGFQ 244
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE V +D+Y++G L L
Sbjct: 245 APE-IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 457 RKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMV 509
+ +G G +G VYK PVA+K LR + + E V++ + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 510 LLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
LLG C + ++ + + G L D + R + + Q +IA G+ +L +
Sbjct: 81 RLLGICLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFC 620
LVHRDL N+L+ KI+D GLA+L+ + + A
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIKWMA---- 187
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
E + +SDV+S G+ + +L+T
Sbjct: 188 ---LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 65/249 (26%), Positives = 97/249 (38%), Gaps = 76/249 (30%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNM 508
+ +GEG +G V K +T VAVK+L+ +A+ E VL + HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 509 VLLLGAC----PEYGIIVYEYLANGSL---------------------DDRIFRRGNTPP 543
+ L GAC P ++ EY GSL + +
Sbjct: 89 IKLYGACSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
L+ A +I+ G+ +L + K LVHRDL NIL+ KISD GL+R V
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDV--- 200
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLL 646
Y + Y + G + VK SDV+S G+LL
Sbjct: 201 -----------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 647 QLIT-AKQP 654
+++T P
Sbjct: 244 EIVTLGGNP 252
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 18/205 (8%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG---RSQFQREIEVLSCIRHPNMVLL 511
R +G+GG+ ++ T A K++ R + EI + + H ++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 512 LG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G ++ +V E SL + RR L+ + +I G +LH+ +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR-- 135
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDLK GN+ L+ + KI D GLA E + GT YI PE
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYDGERKKV-LCGTPNYIAPEVLSK 189
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
+ DV+S+G ++ L+ K P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 32/229 (13%)
Query: 457 RKIGEGGYGPVYKCYL----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLL 511
++G G +G V + VA+KVL+ + RE +++ + +P +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 512 LGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+G C + +V E G L F G + + +++ G+ +L +
Sbjct: 76 IGVCQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFCYI 622
VHRDL N+LL + + +KISD GL++ + + + Y S A
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALG---ADDSYYTARSAGKWPLKWYA------ 181
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE +SDV+S G+ + + ++ ++P + V IE G
Sbjct: 182 -PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 52/254 (20%), Positives = 89/254 (35%), Gaps = 18/254 (7%)
Query: 407 AQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGP 466
A + K N + + E + T ++G G +G
Sbjct: 14 ASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGE 73
Query: 467 VYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGI--IV 522
V++ T AVK +R + + E+ + + P +V L GA E I
Sbjct: 74 VHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128
Query: 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582
E L GSL I + G L + + GL +LH + ++H D+K N+L
Sbjct: 129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVL 182
Query: 583 LDHNYVS-KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-YQQTGMLGVKSDVYS 640
L + + D G A + + GT ++ PE K D++S
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWS 241
Query: 641 LGILLLQLITAKQP 654
++L ++ P
Sbjct: 242 SCCMMLHMLNGCHP 255
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRS---QF 493
R++ +ED F R +G+G +G VY + +A+KVL + Q
Sbjct: 4 RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 56
Query: 494 QREIEVLSCIRHPNMVLLLG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFR 551
+RE+E+ S +RHPN++ L G ++ EY G++ + + Q+
Sbjct: 57 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTAT 113
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
E+A L + H + ++HRD+KP N+LL KI+D G + P
Sbjct: 114 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSR 163
Query: 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
T GT Y+ PE + M K D++SLG+L + + K P
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 69/258 (26%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPN 507
+ +G G +G V + VAVK+L+ A E+++L I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 508 MVLLLGACPEYGI---IVYEYLANGSLDD-------------RIFRRGNTPPLSWQQRFR 551
+V LLGAC + G ++ E+ G+L L+ +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
+ ++A G+ FL K +HRDL NILL V KI D GLAR +
Sbjct: 153 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI----------- 198
Query: 612 LTSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQLIT-AKQ 653
Y DP+Y + L +K SDV+S G+LL ++ +
Sbjct: 199 ---------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 654 P---MGLTHFVERSIENG 668
P + + R ++ G
Sbjct: 250 PYPGVKIDEEFCRRLKEG 267
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 63/244 (25%), Positives = 100/244 (40%), Gaps = 71/244 (29%)
Query: 457 RKIGEGGYGPVYKCYL---------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RH 505
+ +GEG +G V + VAVK+L+ DA + S E+E++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 506 PNMVLLLGAC----PEYGIIVYEYLANGSL-------------DDRIFRRGNTPPLSWQQ 548
N++ LLGAC P Y ++ EY + G+L R ++++
Sbjct: 101 KNIINLLGACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
++A G+ +L K +HRDL N+L+ N V KI+D GLAR +
Sbjct: 159 LVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI-------- 207
Query: 609 QYHLTSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQLIT- 650
Y++T G L VK SDV+S G+L+ ++ T
Sbjct: 208 ------------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 651 AKQP 654
P
Sbjct: 256 GGSP 259
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 57/213 (26%), Positives = 82/213 (38%), Gaps = 16/213 (7%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNM 508
+ IG G YG K D + K L + + E+ +L ++HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 509 VLLLGACPEYG----IIVYEYLANGSLDDRI-FRRGNTPPLSWQQRFRIAAEIATGLLFL 563
V + IV EY G L I L + R+ ++ L
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 564 HQTKPEPL--VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
H+ +HRDLKP N+ LD K+ D GLAR++ N + GT Y
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFAKTFVGTPYY 182
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ PE KSD++SLG LL +L P
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 457 RKIGEGGYGPVYKCYLD----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVL 510
IGEG +G V K + A+K ++ A F E+EVL + HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 511 LLGAC----PEYGIIVYEYLANGSLDD-------------RIFRRGNTPPLSWQQRFRIA 553
LLGAC Y + EY +G+L D LS QQ A
Sbjct: 91 LLGACEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 554 AEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLT 613
A++A G+ +L Q + +HRDL NIL+ NYV+KI+D GL+R + ++
Sbjct: 149 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVK 197
Query: 614 STAGTF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654
T G ++ E + SDV+S G+LL ++++ P
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 457 RKIGEGGYGPVY--KCYLDHTPVAVKVL---RPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+G+G + VY + VA+K++ A + Q E+++ ++HP+++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 512 LG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
Y +V E NG ++ + R P S + +I TG+L+LH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDL N+LL N KI+D GLA + + H T GT YI PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLA----TQLKMPHEKHYT-LCGTPNYISPEIATR 186
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
G++SDV+SLG + L+ + P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 31/261 (11%)
Query: 457 RKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVL 510
R IGEG +G V++ VA+K + R +F +E + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 511 LLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L+G P + I+ E G L F + L A +++T L +L +
Sbjct: 456 LIGVITENPVW--IIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
VHRD+ N+L+ N K+ D GL+R + E+ T Y + ++ PE
Sbjct: 512 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPESI 564
Query: 628 QTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENGTLGEMLDPTVTDWPFE 684
SDV+ G+ + +++ +P G+ + V IEN GE L P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPM-----PPN 616
Query: 685 ETLGFAKLALQCSELRRKDRP 705
L +C RP
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRP 637
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 18/205 (8%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG---RSQFQREIEVLSCIRHPNMVLL 511
R +G+GG+ ++ T A K++ R + EI + + H ++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 512 LG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G ++ +V E SL + RR L+ + +I G +LH+ +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR-- 161
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDLK GN+ L+ + KI D GLA E + GT YI PE
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYDGERKKV-LCGTPNYIAPEVLSK 215
Query: 630 GMLGVKSDVYSLGILLLQLITAKQP 654
+ DV+S+G ++ L+ K P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 57/211 (27%), Positives = 80/211 (37%), Gaps = 20/211 (9%)
Query: 451 QFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAA--QGRSQFQREIEVLSCI-RH 505
Q F ++G G YG V+K D AVK + R++ E+ + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 506 PNMVLLLGACPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
P V L A E GI + E SL G L Q + + L L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHL 173
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
H LVH D+KP NI L K+ D GL + T G Y+
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL------GTAGAGEVQEGDPRYMA 224
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE Q G +DV+SLG+ +L++ +
Sbjct: 225 PELLQGS-YGTAADVFSLGLTILEVACNMEL 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVK---VLRPDAAQGRSQFQREIEVLSCIRHPN 507
F +KIG G + VY+ LD PVA+K + A+ R+ +EI++L + HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTP-PLSWQQRFRIAAEIATGLLFLH 564
++ + E IV E G L I + + ++ ++ + L +H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ ++HRD+KP N+ + V K+ D+GL R + S GT Y+ P
Sbjct: 154 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSP 205
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E KSD++SLG LL ++ + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 34/236 (14%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNM 508
R +G G +G VY+ + VAVK L Q F E ++S H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 509 VLLLGAC----PEYGIIVYEYLANGSLDD--RIFR--RGNTPPLSWQQRFRIAAEIATGL 560
V +G P + I+ E +A G L R R L+ +A +IA G
Sbjct: 137 VRCIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 561 LFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
+L + +HRD+ N LL V+KI D G+AR + Y+
Sbjct: 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----AGYYRKGGCA 246
Query: 618 TF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
++ PE G+ K+D +S G+LL ++ + P ++ V + +G
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 33/235 (14%), Positives = 75/235 (31%), Gaps = 28/235 (11%)
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP-------VAVKVLRPDAAQGRSQFQ 494
+ + ++ +GEG + VY+ +KV +P
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 495 REIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTP--PLSWQQRF 550
+ +E L + A ++V E + G+L + I NTP +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 551 RIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS-----------KISDVGLARL 599
A + + +H + ++H D+KP N +L + ++ + D+G +
Sbjct: 176 SFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ + T+ T + E + D + + + ++
Sbjct: 233 MKLFPKGTI---FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 35/238 (14%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQRE 496
R + R + EGG+ VY+ A+K L + + +E
Sbjct: 28 LRLRVR------------RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75
Query: 497 IEVLSCIR-HPNMVLLLGAC---------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSW 546
+ + + HPN+V A + ++ L G L + + + + PLS
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV---PAV 603
+I + + +H+ KP P++HRDLK N+LL + K+ D G A + P
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 604 AENVTQYHLTSTAGTFC----YIDPE---YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ + + L T Y PE +G K D+++LG +L L + P
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 66/266 (24%), Positives = 101/266 (37%), Gaps = 79/266 (29%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPN 507
+ +G G +G V VAVK+L+ A + R E+++++ + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 508 MVLLLGAC----PEYGIIVYEYLANGSL--------------------DDRIFRRGNTPP 543
+V LLGAC P Y +++EY G L R+ +
Sbjct: 111 IVNLLGACTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
L+++ A ++A G+ FL VHRDL N+L+ H V KI D GLAR +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI--- 222
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLL 646
D Y L VK SDV+S GILL
Sbjct: 223 -----------------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 647 QLIT-AKQP---MGLTHFVERSIENG 668
++ + P + + + I+NG
Sbjct: 266 EIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNM 508
+ +KIGEG +G D +K + ++ R + +RE+ VL+ ++HPN+
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 509 VLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
V + E G IV +Y G L RI + Q +I L +H
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDR 144
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
K ++HRD+K NI L + ++ D G+AR++ N T + GT Y+ PE
Sbjct: 145 K---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-----NSTVELARACIGTPYYLSPEI 196
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ KSD+++LG +L +L T K
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 66/249 (26%), Positives = 107/249 (42%), Gaps = 76/249 (30%)
Query: 457 RKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNM 508
R IGEG +G V++ T VAVK+L+ +A A ++ FQRE +++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 509 VLLLGAC----PEYGIIVYEYLANGSLDD---------------------RIFRRGNTPP 543
V LLG C P +++EY+A G L++ PP
Sbjct: 113 VKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
LS ++ IA ++A G+ +L + K VHRDL N L+ N V KI+D GL+R +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI--- 224
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLL 646
Y Y+ + ++ SDV++ G++L
Sbjct: 225 -----------------YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 647 QLIT-AKQP 654
++ + QP
Sbjct: 268 EIFSYGLQP 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 63/244 (25%), Positives = 101/244 (41%), Gaps = 71/244 (29%)
Query: 457 RKIGEGGYGPVYKCYL---------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RH 505
+ +GEG +G V + VAVK+L+ DA + S E+E++ I +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 506 PNMVLLLGAC----PEYGIIVYEYLANGSLDD-------------RIFRRGNTPPLSWQQ 548
N++ LLGAC P Y ++ EY + G+L + R ++++
Sbjct: 147 KNIINLLGACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
++A G+ +L K +HRDL N+L+ N V KI+D GLAR +
Sbjct: 205 LVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI-------- 253
Query: 609 QYHLTSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQLIT- 650
Y++T G L VK SDV+S G+L+ ++ T
Sbjct: 254 ------------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301
Query: 651 AKQP 654
P
Sbjct: 302 GGSP 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-31
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLL- 512
++G GG+G V + T VA+K R + + R ++ EI+++ + HPN+V
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 513 -------GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
A + ++ EY G L + + N L + ++I++ L +LH+
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 566 TKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
+ ++HRDLKP NI+L + KI D+G A+ + T GT Y+
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD------QGELCTEFVGTLQYL 190
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE + V D +S G L + IT +P
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 34/232 (14%)
Query: 455 ESRKIGEGGYGPVYKCYL----DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNM 508
E +++G G +G V K Y VAVK+L+ +A + + E V+ + +P +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 509 VLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
V ++G C +V E G L+ + + N + + + +++ G+ +L ++
Sbjct: 81 VRMIGICEAESWMLVMEMAELGPLNK--YLQQN-RHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTF 619
VHRDL N+LL + +KISD GL++ + + Y + A
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALR---ADENYYKAQTHGKWPVKWYA--- 188
Query: 620 CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP-MGLTHF-VERSIENG 668
PE KSDV+S G+L+ + + ++P G+ V +E G
Sbjct: 189 ----PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 432 STKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG 489
+ ++ R++TI+D F R +G+G +G VY +A+KVL +
Sbjct: 2 ALAEMPKRKFTIDD-------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK 54
Query: 490 RS---QFQREIEVLSCIRHPNMVLLLG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPL 544
Q +REIE+ S +RHPN++ + + ++ E+ G L + + G
Sbjct: 55 EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RF 111
Query: 545 SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604
Q+ E+A L + H+ K ++HRD+KP N+L+ + KI+D G + P
Sbjct: 112 DEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP--- 165
Query: 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ GT Y+ PE + K D++ G+L + + P
Sbjct: 166 ----SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 22/221 (9%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAA--QGRSQFQREIEVLSCI-RHPN 507
F E KIG G +G V+KC LD A+K + A RE+ + + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTP-PLSWQQRFRIAAEIATGLLFLH 564
+V A E +I EY GSL D I + + ++ GL ++H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN---------VTQYHLTST 615
LVH D+KP NI + + + A + VT+
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 616 -AGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
G ++ E Q+ K+D+++L + ++ A+
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 71/244 (29%)
Query: 457 RKIGEGGYGPVYKCYL---------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RH 505
+ +GEG +G V T VAVK+L+ DA + S E+E++ I +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 506 PNMVLLLGAC----PEYGIIVYEYLANGSLDD--RIFR-----------RGNTPPLSWQQ 548
N++ LLGAC P Y ++ EY + G+L + + R LS +
Sbjct: 135 KNIINLLGACTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
A ++A G+ +L K +HRDL N+L+ + V KI+D GLAR +
Sbjct: 193 LVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI-------- 241
Query: 609 QYHLTSTAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQLIT- 650
+ Y++T G L VK SDV+S G+LL ++ T
Sbjct: 242 ------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289
Query: 651 AKQP 654
P
Sbjct: 290 GGSP 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 63/275 (22%), Positives = 122/275 (44%), Gaps = 26/275 (9%)
Query: 414 EMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLD 473
++ L+ ++ + T+ + +D E+ ++G G G V+K
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHK 55
Query: 474 HT--PVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGA-CPEYGI-IVYEYLAN 528
+ +A K++ + R+Q RE++VL P +V GA + I I E++
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV 588
GSLD + ++ + Q +++ + GL +L + ++HRD+KP NIL++
Sbjct: 116 GSLDQ-VLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGE 170
Query: 589 SKISDVGLA-RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQ 647
K+ D G++ +L+ ++A S GT Y+ PE Q V+SD++S+G+ L++
Sbjct: 171 IKLCDFGVSGQLIDSMA--------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 648 LITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682
+ + P+ E + G E P
Sbjct: 223 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 458 KIGEGGYGPVYKCYL----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLL 512
++G G +G V + VA+KVL+ + RE +++ + +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 513 GACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
G C + +V E G L F G + + +++ G+ +L +
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---F 457
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTS--------TAGTFCYID 623
VHR+L N+LL + + +KISD GL++ A+ + + Y S A
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSK---ALGADDSYYTARSAGKWPLKWYA------- 507
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLIT 650
PE +SDV+S G+ + + ++
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 459 IGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP 516
+G+G YG VY +A+K + ++ EI + ++H N+V LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 517 EYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574
E G I E + GSL + + + Q +I GL +LH + +VHR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHR 146
Query: 575 DLKPGNILLD-HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE--YQQTGM 631
D+K N+L++ ++ V KISD G ++ + + + GT Y+ PE +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINP-----CTETFTGTLQYMAPEIIDKGPRG 201
Query: 632 LGVKSDVYSLGILLLQLITAKQP 654
G +D++SLG ++++ T K P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-29
Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 23/214 (10%)
Query: 453 FTESRKIGEGGYGP-VYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLS-CIRHPNMVL 510
F +G G G VY+ D+ VAVK + P+ S RE+++L HPN++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 511 LLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
++ I E L +L + + ++ + + + +GL LH
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 569 EPLVHRDLKPGNILL-----DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
+VHRDLKP NIL+ + ISD GL + + + + GT +I
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL--AVGRHSFSRRSGVPGTEGWIA 194
Query: 624 PEY---QQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE D++S G + +I+
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTP----VAVKVL-RPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+ +GEG YG V + VAVK++ A ++EI + + H N+V
Sbjct: 13 QTLGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 512 LG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G + EY + G L DRI P Q+ F ++ G+++LH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG-- 125
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA-GTFCYIDPE-YQ 627
+ HRD+KP N+LLD KISD GLA V + L + GT Y+ PE +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLA----TVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
+ DV+S GI+L ++ + P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 56/245 (22%), Positives = 108/245 (44%), Gaps = 24/245 (9%)
Query: 419 KESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--P 476
++ + S ++ + + + D + KIGEG G V H+
Sbjct: 13 LGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 477 VAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGI-----IVYEYLANGSL 531
VAVK++ Q R E+ ++ +H N+V + + Y + ++ E+L G+L
Sbjct: 73 VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS---YLVGEELWVLMEFLQGGAL 129
Query: 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591
D I + L+ +Q + + L +LH ++HRD+K +ILL + K+
Sbjct: 130 TD-IVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182
Query: 592 SDVGL-ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
SD G A++ V + S GT ++ PE + + D++SLGI++++++
Sbjct: 183 SDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 651 AKQPM 655
+ P
Sbjct: 237 GEPPY 241
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 45/376 (11%), Positives = 96/376 (25%), Gaps = 61/376 (16%)
Query: 396 AEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTE 455
+ KR EL R A + + V+ ++ + ++ ++ + + +
Sbjct: 12 RDLLKREEELIGYCREEAL---KEPAAMVEAVTATVWPQNAETTVDSL--LSQGERKLKL 66
Query: 456 SRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRS---QFQREIEVLSCIRHPNMVL 510
+ G V+ A+KV A RS + + + +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 511 LLGACP---------------------------EYGIIVYEYLANGSLDDRIFRRGNTP- 542
++ A+ L+
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 543 ---PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599
+ A++ L LVH P N+ + + + DV
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 600 VPAVAENVTQYHLTSTAGTFCYIDPEY--QQTGMLGVKSDVYSLGILLLQLITAKQPMGL 657
V +++ Y E+ T + + LG+ + ++ P GL
Sbjct: 244 VGTR--------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 658 THFVERSIENGTLGEMLDPTVTDWPFEETLGF---AK-LALQCSELRRKDRPDLGKVVL- 712
+ + P F K L + R+ R + +
Sbjct: 296 V--TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
Query: 713 PELNRLRELADESMGQ 728
PE +L+ S+
Sbjct: 354 PEFLQLQNEISSSLST 369
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 36/232 (15%)
Query: 451 QFFTESRKIGEGGYGPVYKCY-LDHTPVAVKVLRPDAAQGRSQFQREIEVLS-CIRHPNM 508
+ +G G G V PVAVK + D EI++L+ HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNV 71
Query: 509 VLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAE----IATGLLF 562
+ + + I E N +L D + + + Q+ IA+G+
Sbjct: 72 IRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 563 LHQTKPEPLVHRDLKPGNILLDH-------------NYVSKISDVGLARLVPAVAENVTQ 609
LH K ++HRDLKP NIL+ N ISD GL + + + ++ +
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS-GQSSFR 186
Query: 610 YHLTSTAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+L + +GT + PE Q L D++S+G + +++ +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
+ +T KIG+G G VY T VA++ + + EI V+ ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 508 MVLLLGACPEYGI-----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
+V L + Y + +V EYLA GSL D + + Q + E L F
Sbjct: 79 IVNYLDS---YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEF 131
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFCY 621
LH + ++HRD+K NILL + K++D G A++ P ++ ++ GT +
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR------STMVGTPYW 182
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
+ PE G K D++SLGI+ +++I + P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVL-SCIRHPNM 508
++G G G V+K +AVK +R + + +++V+ P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 509 VLLLGAC-PEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
V G + I E + + R P+ + ++ I L +L +
Sbjct: 87 VQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEK 143
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFCY---- 621
++HRD+KP NILLD K+ D G+ RLV A++ +AG Y
Sbjct: 144 HG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-------RSAGCAAYMAPE 194
Query: 622 -IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
IDP +++DV+SLGI L++L T + P
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHTP----VAVKVL-RPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+ +GEG YG V + VAVK++ A ++EI + + H N+V
Sbjct: 13 QTLGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 512 LG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G + EY + G L DRI P Q+ F ++ G+++LH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG-- 125
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA-GTFCYIDPE-YQ 627
+ HRD+KP N+LLD KISD GLA V + L + GT Y+ PE +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLA----TVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 628 QTGMLGVKSDVYSLGILL 645
+ DV+S GI+L
Sbjct: 181 RREFHAEPVDVWSCGIVL 198
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAA-QGRSQFQREIEV-LSCIRHP 506
++G G YG V K H P +AVK +R Q + + ++++ + + P
Sbjct: 9 LEPIMELGRGAYGVVEKMR--HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 507 NMVLLLGACPEYG--IIVYEYLANGSLDD---RIFRRGNT---PPLSWQQRFRIAAEIAT 558
V GA G I E + + SLD ++ +G T L +IA I
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVK 120
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAG 617
L LH ++HRD+KP N+L++ K+ D G+ LV VA++ AG
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-------IDAG 171
Query: 618 TFCY-----IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
Y I+PE Q G VKSD++SLGI +++L + P
Sbjct: 172 CKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFP 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 458 KIGEGGYGPVYKCYLDHTP----VAVKVLRPDAA-QGRSQFQREIEV-LSCIRHPNMVLL 511
+IG G YG V K H P +AVK +R + + Q +++V + P +V
Sbjct: 29 EIGRGAYGSVNKMV--HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 512 LGACPEYG--IIVYEYLANGSLDD--RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
GA G I E ++ S D + + + +I L L +
Sbjct: 87 YGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
++HRD+KP NILLD + K+ D G+ +LV ++A+ T AG Y+ PE
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-------TRDAGCRPYMAPER 196
Query: 627 QQTGMLG----VKSDVYSLGILLLQLITAKQP 654
V+SDV+SLGI L +L T + P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 54/249 (21%), Positives = 101/249 (40%), Gaps = 35/249 (14%)
Query: 418 LKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTE----SRKIGEGGYGPVYKCYLD 473
L + E+ ++ S K + T++D + + S+ +G G G V +
Sbjct: 100 LNNNSEIALSLS--RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER 157
Query: 474 HT--PVAVKVLRPDAAQGRS--------QFQREIEVLSCIRHPNMVLLLGACPEYGI-IV 522
T VA++++ S + EIE+L + HP ++ + IV
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIV 217
Query: 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582
E + G L D++ L ++ + +LH+ ++HRDLKP N+L
Sbjct: 218 LELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVL 271
Query: 583 L---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE---YQQTGMLGVKS 636
L + + + KI+D G ++++ + + GT Y+ PE T
Sbjct: 272 LSSQEEDCLIKITDFGHSKILG------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 325
Query: 637 DVYSLGILL 645
D +SLG++L
Sbjct: 326 DCWSLGVIL 334
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
+ + ++G+G +G VYK T A KV+ + + + EIE+L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 508 MVLLLGACPEYGI-----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
+V LLGA Y I+ E+ G++D + L+ Q + ++ L F
Sbjct: 78 IVKLLGA---YYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNF 132
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG---TF 619
LH + ++HRDLK GN+L+ +++D G++ T +F
Sbjct: 133 LHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA------------KNLKTLQKRDSF 177
Query: 620 C---Y------IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
Y + E + K+D++SLGI L+++ + P +
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 37/218 (16%)
Query: 444 EDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLS 501
DI + ++T IG G +G V T A K + + +F++EIE++
Sbjct: 5 GDINQ---YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
+ HPN++ L +V E G L +R+ + RI ++ +
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSA 118
Query: 560 LLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTA 616
+ + H+ + HRDLKP N L + K+ D GLA + +
Sbjct: 119 VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP------GKMMRTKV 169
Query: 617 GTFCYIDPE-----YQQTGMLGVKSDVYSLG----ILL 645
GT Y+ P+ Y G + D +S G +LL
Sbjct: 170 GTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLL 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLR----PDAAQGRSQFQREIEVLSCIRHPNMVL 510
+GEG YG V + AVK+L+ G + ++EI++L +RH N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 511 L----LGACPEYGIIVYEYLANGSLD--DRIFRRGNTPPLS-WQQR--FRIAAEIATGLL 561
L + +V EY G + D + + Q F ++ GL
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAHGYFC---QLIDGLE 123
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
+LH +VH+D+KPGN+LL KIS +G+A + A + ++ G+ +
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD---DTCRTSQGSPAF 177
Query: 622 IDPE--YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE G K D++S G+ L + T P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVL--RPDAAQGRSQFQREIEVLSCIRH 505
++ + +K+G G YG V C T A+K++ + S+ E+ VL + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 506 PNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
PN++ L +V E G L D I R + I ++ +G+ +L
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYL 152
Query: 564 HQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
H+ +VHRDLKP N+LL + + + KI D GL+ + Q + GT
Sbjct: 153 HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE------NQKKMKERLGTAY 203
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
YI PE + K DV+S+G++L L+ P
Sbjct: 204 YIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 453 FTESRKIGEGGYGPVYK--CYLDHTPVAVKVLRPDAAQGR-SQFQREIEVLSCIRHPNMV 509
+ IG G V C VA+K + + Q + +EI+ +S HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 510 LLLGACPEYGI-----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFR---IAA---EIAT 558
+ + + +V + L+ GS+ D I + IA E+
Sbjct: 77 SYYTS---FVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
GL +LH+ +HRD+K GNILL + +I+D G++ + + + GT
Sbjct: 133 GLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 619 FCYIDPE-YQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
C++ PE +Q K+D++S GI ++L T P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 429 SNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVL---R 483
+L + +++ + + R +G+G +G V C + AVKV+ +
Sbjct: 7 DHLHATPGMFVQHSTAIFSD---RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 484 PDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNT 541
+ RE+++L + HPN++ L Y +V E G L D I R
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR- 122
Query: 542 PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLAR 598
S RI ++ +G+ ++H+ K +VHRDLKP N+LL + +I D GL+
Sbjct: 123 --FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ GT YI PE G K DV+S G++L L++ P
Sbjct: 178 HFE------ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
+ F K+GEG YG VYK T VA+K + + +EI ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 508 MVLLLGACPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+V G+ + IV EY GS+ D I R L+ + I GL +LH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHF 143
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ +HRD+K GNILL+ +K++D G+ +L T + GT ++ P
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD------TMAKRNTVIGTPFWMAP 194
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
E Q +D++SLGI +++ K P
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQ-FQREIEVLSCIRHP 506
+ FT+ KIG+G +G V+K + T VA+K++ + A+ + Q+EI VLS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 507 NMVLLLGACPEYGI-----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLL 561
+ G+ Y I+ EYL GS D + G PL Q I EI GL
Sbjct: 81 YVTKYYGS---YLKDTKLWIIMEYLGGGSALD-LLEPG---PLDETQIATILREILKGLD 133
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL-ARLVPAVAENVTQYHLTSTAGTFC 620
+LH K +HRD+K N+LL + K++D G+ +L + T GT
Sbjct: 134 YLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT------FVGTPF 184
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659
++ PE + K+D++SLGI ++L + P H
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 52/268 (19%), Positives = 101/268 (37%), Gaps = 57/268 (21%)
Query: 428 SSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKV---- 481
+ ++L ++ ++ ++++ + IG+G YG V + T A+K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQK---KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 482 -LRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRR 538
+R + + + E+ ++ + HPN+ L +Y +V E G L D++
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 539 GNTPPLSWQQRF---------------------------------RIAAE----IATGLL 561
+ ++ + I + L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 562 FLHQTKPEPLVHRDLKPGNILL--DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTF 619
+LH + HRD+KP N L + ++ K+ D GL++ N Y +T+ AGT
Sbjct: 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK-LNNGEYYGMTTKAGTP 238
Query: 620 CYIDPE--YQQTGMLGVKSDVYSLGILL 645
++ PE G K D +S G+LL
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 457 RKIGEGGYGPVYKCYLDHTP----VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPNMV 509
+G G +G V H VAVK+L + + + +REI+ L RHP+++
Sbjct: 17 DTLGVGTFGKVKIGE--HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 510 LLLG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L + P +V EY++ G L D I + G + ++ F+ +I + + + H+
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCHRHM 131
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA-GTFCYIDPE- 625
+VHRDLKP N+LLD + +KI+D GL+ + ++ T+ G+ Y PE
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAAPEV 181
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
G + D++S G++L L+ P
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 49/246 (19%), Positives = 97/246 (39%), Gaps = 20/246 (8%)
Query: 406 EAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYG 465
++ + + K +D K + + + ++ ++G G +G
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYD---YYDILEELGSGAFG 65
Query: 466 PVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGII 521
V++C T K + + + EI +++ + HP ++ L A ++
Sbjct: 66 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNI 581
+ E+L+ G L DRI +S + + GL +H+ +VH D+KP NI
Sbjct: 126 ILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENI 180
Query: 582 LLDHNYVS--KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVY 639
+ + S KI D GLA + + T T + PE +G +D++
Sbjct: 181 MCETKKASSVKIIDFGLATKLNP------DEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 640 SLGILL 645
++G+L
Sbjct: 235 AIGVLG 240
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 45/212 (21%), Positives = 81/212 (38%), Gaps = 26/212 (12%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVL--------RPDAAQGRSQFQREIEVLSCIRHP 506
+G G +G V+ + V VK + + EI +LS + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 507 NMVLLLG--ACPEYGIIVYEYLANGS-LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
N++ +L + +V E +G L I R FR ++ + + +L
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR---QLVSAVGYL 146
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
++HRD+K NI++ ++ K+ D G A + + GT Y
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE------RGKLFYTFCGTIEYCA 197
Query: 624 PE-YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE G + +++SLG+ L L+ + P
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLL 512
+ IG+G + V L VA+K++ + RE+ ++ + HPN+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 513 G--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+ ++ EY + G + D + G + ++ +I + + + HQ +
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-YQQT 629
+VHRDLK N+LLD + KI+D G + L + G Y PE +Q
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEF------TVGGKLDAFCGAPPYAAPELFQGK 188
Query: 630 GMLGVKSDVYSLGILLLQLITAKQPM 655
G + DV+SLG++L L++ P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPF 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 42/174 (24%), Positives = 63/174 (36%), Gaps = 12/174 (6%)
Query: 490 RSQFQREIEVLSCIRHPNMVLLLGACPEYGI--IVYEYLANGSLDDRIFRRGNTPPLSWQ 547
+I + N V L I + +L D + RR +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV------- 600
I +IA + FLH L+HRDLKP NI + V K+ D GL +
Sbjct: 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ T GT Y+ PE K D++SLG++L +L+ +
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 18/60 (30%), Positives = 33/60 (55%), Gaps = 3/60 (5%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLR-PDAAQGRSQFQREIEVLSCIRHPNMV 509
F + +G GG+G V++ +D A+K +R P+ R + RE++ L+ + HP +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 50/259 (19%), Positives = 102/259 (39%), Gaps = 20/259 (7%)
Query: 393 VEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQF 452
+ E +R ++ S+ + + + +
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD---H 158
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
+ ++G G +G V++ T A K + + ++EI+ +S +RHP +V
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 511 LLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L A +++YE+++ G L +++ N +S + ++ GL +H+
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 569 EPLVHRDLKPGNILLDHNYVS--KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
VH DLKP NI+ + K+ D GL + + + T GT + PE
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD------PKQSVKVTTGTAEFAAPEV 327
Query: 627 QQTGMLGVKSDVYSLGILL 645
+ +G +D++S+G+L
Sbjct: 328 AEGKPVGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 65/259 (25%), Positives = 103/259 (39%), Gaps = 36/259 (13%)
Query: 416 NRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT 475
+ S + ++ Y R I E + + RK+G G YG V C +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGE---SYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 476 --PVAVKVLR-------------PDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEY 518
A+KV++ + + + EI +L + HPN++ L +Y
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKP 578
+V E+ G L ++I R I +I +G+ +LH+ +VHRD+KP
Sbjct: 121 FYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174
Query: 579 GNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVK 635
NILL + KI D GL+ Y L GT YI PE + K
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFS------KDYKLRDRLGTAYYIAPEVLK-KKYNEK 227
Query: 636 SDVYSLGILLLQLITAKQP 654
DV+S G+++ L+ P
Sbjct: 228 CDVWSCGVIMYILLCGYPP 246
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 36/213 (16%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507
+ F +G G + V+ T A+K ++ A S + EI VL I+H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 508 MVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAE----IATG 559
+V L + +V + ++ G L DRI RG + + A+ + +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSA 118
Query: 560 LLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTA 616
+ +LH+ +VHRDLKP N+L + N I+D GL+++ +++
Sbjct: 119 VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-------NGIMSTAC 168
Query: 617 GTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 645
GT Y+ PE D +S+G ILL
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 437 RYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQ-F 493
R Y I++ F RK+G G +G V+ + +K + D +Q +
Sbjct: 11 RENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI 67
Query: 494 QREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF- 550
+ EIEVL + HPN++ + IV E G L +RI +
Sbjct: 68 EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR-----GKALS 122
Query: 551 -RIAAE----IATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPA 602
AE + L + H +VH+DLKP NIL + KI D GLA L
Sbjct: 123 EGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK- 178
Query: 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
+ H T+ AGT Y+ PE + + K D++S G+++
Sbjct: 179 -----SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR--SQFQREIEVLSCIRH 505
+ + +G+G +G V KC T AVKV+ +A+ + S RE+E+L + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 506 PNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
PN++ L IV E G L D I +R S RI ++ +G+ ++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYM 137
Query: 564 HQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
H+ +VHRDLKP NILL + + KI D GL+ + GT
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ------QNTKMKDRIGTAY 188
Query: 621 YIDPE-----YQQTGMLGVKSDVYSLG----ILL 645
YI PE Y K DV+S G ILL
Sbjct: 189 YIAPEVLRGTY------DEKCDVWSAGVILYILL 216
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 36/299 (12%), Positives = 81/299 (27%), Gaps = 62/299 (20%)
Query: 406 EAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYT--IEDIEEATQFFTESRKIGEGG 463
E R+ R A S +ST + ++ E + +G+
Sbjct: 26 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 85
Query: 464 YGPVYKCY--LDHTPVAVKVLR----------------------------PDAAQGRSQF 493
+ V V A+ +F
Sbjct: 86 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145
Query: 494 QREIEVLSCIRHPNMVLLLGACPEYGIIVY---EYLANGSLDDR---IFRRGNT-PPLSW 546
+++ + M+ + + ++ +L + +T L
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606
R ++ ++ L LH LVH L+P +I+LD ++
Sbjct: 206 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----- 257
Query: 607 VTQYHLTSTAGTFCYIDPEY-----------QQTGMLGVKSDVYSLGILLLQLITAKQP 654
++ + + PE + ++ D ++LG+++ + A P
Sbjct: 258 ----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVL------RPDAAQGRSQFQREIEVLSCIRH--P 506
+G GG+G VY D+ PVA+K + ++ E+ +L +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 507 NMVLLLG--ACPEYGIIVYEYLAN-GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
++ LL P+ +++ E L D I RG L + ++ +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 165
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVS-KISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
H ++HRD+K NIL+D N K+ D G L+ T GT Y
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-------DTVYTDFDGTRVYS 215
Query: 623 DPEY-QQTGMLGVKSDVYSLGILLLQLITAKQP 654
PE+ + G + V+SLGILL ++ P
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 68/236 (28%), Positives = 99/236 (41%), Gaps = 35/236 (14%)
Query: 433 TKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR 490
R Y E + +G+G +G V KC T AVKV+ +A+ +
Sbjct: 7 HSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 491 --SQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSW 546
S RE+E+L + HPN++ L IV E G L D I +R S
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSE 120
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAV 603
RI ++ +G+ ++H+ +VHRDLKP NILL + + KI D GL+
Sbjct: 121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-- 175
Query: 604 AENVTQYHLTSTAGTFCYIDPE-----YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ GT YI PE Y K DV+S G++L L++ P
Sbjct: 176 ----QNTKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 28/244 (11%), Positives = 62/244 (25%), Gaps = 49/244 (20%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLR--------------------------- 483
+G+ + V V
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 484 -PDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVY---EYLANGSLDDR---IF 536
A+ +F +++ + M+ + + ++ +L +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 537 RRGNTP-PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595
+T L R ++ ++ L LH LVH L+P +I+LD ++
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPE-----YQQTGMLGVKSDVYSLGILLLQLIT 650
A A + ++ D ++LG+ + +
Sbjct: 257 HLVRDGASAVSPI----GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 651 AKQP 654
A P
Sbjct: 313 ADLP 316
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 26/229 (11%)
Query: 443 IEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVL 500
+ + + F +G G YG VYK T A+KV+ + ++EI +L
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINML 74
Query: 501 S-CIRHPNMVLLLGA-----CPEYGI---IVYEYLANGSLDDRIFRRGNTPPLSWQQRFR 551
H N+ GA P +V E+ GS+ D + + L +
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAY 133
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
I EI GL LHQ K ++HRD+K N+LL N K+ D G++ + T
Sbjct: 134 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-----TVGR 185
Query: 612 LTSTAGTFCYIDPE-----YQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
+ GT ++ PE KSD++SLGI +++ P+
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 44/221 (19%), Positives = 78/221 (35%), Gaps = 28/221 (12%)
Query: 453 FTESRKIGEG--GYGPVYK--CYLDHTPVAVKVLRPDAAQGR--SQFQREIEVLSCIRHP 506
+ IG+G V V V+ + +A + Q E+ V HP
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 507 NMVLLLGACPEYGI-----IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAA---EIAT 558
N+V + +V ++A GS D + ++ IA +
Sbjct: 87 NIVPYRAT---FIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELA---IAYILQGVLK 139
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG-LARLVPAVA-ENVTQYHLTSTA 616
L ++H VHR +K +IL+ + +S + ++ + V +
Sbjct: 140 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 617 GTFCYIDPEYQQTGMLG--VKSDVYSLGILLLQLITAKQPM 655
++ PE Q + G KSD+YS+GI +L P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/215 (24%), Positives = 81/215 (37%), Gaps = 30/215 (13%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVL------RPDAAQGRSQFQREIEVLSCIR---- 504
+G+GG+G V+ + D VA+KV+ E+ +L +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 505 HPNMVLLLG--ACPEYGIIVYEYLANGS-LDDRIFRRGNTPPLSWQQRFRIAAEIATGLL 561
HP ++ LL E ++V E L D I +G L ++ +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVS-KISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
H +VHRD+K NIL+D K+ D G L+ T GT
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-------DEPYTDFDGTRV 203
Query: 621 YIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQP 654
Y PE+ + + V+SLGILL ++ P
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 45/258 (17%)
Query: 415 MNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDH 474
M+ S + + R+ ED F + +GEG + V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELA 53
Query: 475 T--PVAVKVLRPDAAQGRSQFQ---REIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLA 527
T A+K+L ++ RE +V+S + HP V L E Y
Sbjct: 54 TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 528 NGSLDDRIFRRGNTPPLSWQQRFRI------AAEIATGLLFLHQTKPEPLVHRDLKPGNI 581
NG L + + F AEI + L +LH ++HRDLKP NI
Sbjct: 114 NGEL----LKY-----IRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENI 161
Query: 582 LLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKS 636
LL+ + ++ +I+D G A+++ ++ + A +F Y+ PE S
Sbjct: 162 LLNEDMHI-QITDFGTAKVLSPESKQ-------ARANSFVGTAQYVSPELLTEKSACKSS 213
Query: 637 DVYSLGILLLQLITAKQP 654
D+++LG ++ QL+ P
Sbjct: 214 DLWALGCIIYQLVAGLPP 231
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVL---------------RPDAAQGRS-------- 491
+IG+G YG V Y D+T A+KVL P +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 492 ---QFQREIEVLSCIRHPNMVLL---LGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPL 544
Q +EI +L + HPN+V L L E + +V+E + G + + + PL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK---PL 134
Query: 545 SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604
S Q ++ G+ +LH K ++HRD+KP N+L+ + KI+D G++
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF---- 187
Query: 605 ENVTQYHLTSTAGTFCYIDPE---YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ L++T GT ++ PE + G DV+++G+ L + + P
Sbjct: 188 -KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLR------PDAAQGRSQFQREIEVLS 501
+ ++G G + V KC T A K ++ R + +RE+ +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
IRHPN++ L +++ E ++ G L D + + + L+ + + +I G
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDG 120
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVS----KISDVGLARLVPAVAENVTQYHLTST 615
+ +LH + + H DLKP NI+L V K+ D G+A + A +
Sbjct: 121 VHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA------GNEFKNI 171
Query: 616 AGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 645
GT ++ PE LG+++D++S+G ILL
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 459 IGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVL-SCIRHPNMVLLLGAC 515
+GEG + V C T AVK++ RS+ RE+E+L C H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 516 --PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVH 573
+ +V+E + GS+ I +R + + + + ++A+ L FLH + H
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 574 RDLKPGNILL---DHNYVSKISDVGLARLVP--AVAENVTQYHLTSTAGTFCYIDPE--- 625
RDLKP NIL + KI D L + ++ L + G+ Y+ PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 626 --YQQTGMLGVKSDVYSLGILL 645
++ + + D++SLG++L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLR------PDAAQGRSQFQREIE 498
++ F+ ++G G + V KC T A K ++ R + +RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 499 VLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEI 556
+L + H N++ L +++ E ++ G L D + ++ + LS ++ +I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARLVPAVAENVTQYHL 612
G+ +LH K + H DLKP NI+L K+ D GLA +
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------EDGVEF 175
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
+ GT ++ PE LG+++D++S+G++
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 62/283 (21%), Positives = 112/283 (39%), Gaps = 28/283 (9%)
Query: 370 EARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASS 429
E + + S + R+ A E A + + + ++ + +
Sbjct: 17 ENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHR 76
Query: 430 NLSTKDLRYR-RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDA 486
++ K YT+ E +G G +G V+KC T +A K+++
Sbjct: 77 IVTAKQGAVNSFYTVSKTEI----------LGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 487 AQGRSQFQREIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPL 544
+ + + + EI V++ + H N++ L A ++V EY+ G L DRI L
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--L 184
Query: 545 SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS--KISDVGLARLVPA 602
+ +I G+ +HQ ++H DLKP NIL + KI D GLAR
Sbjct: 185 TELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK- 240
Query: 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
+ L GT ++ PE + +D++S+G++
Sbjct: 241 -----PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 50/223 (22%), Positives = 89/223 (39%), Gaps = 43/223 (19%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRS--------QFQRE 496
+ + S+ +G G G V + T VA+K++ S + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 497 IEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RI 552
IE+L + HP ++ + +Y IV E + G L D++ R
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK---------RLKEAT 115
Query: 553 AAE----IATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAE 605
+ + +LH+ ++HRDLKP N+LL + + + KI+D G ++++
Sbjct: 116 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---- 168
Query: 606 NVTQYHLTSTAGTFCYIDPE---YQQTGMLGVKSDVYSLGILL 645
+ + GT Y+ PE T D +SLG++L
Sbjct: 169 --ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLR------PDAAQGRSQFQREIE 498
++ F+ ++G G + V KC T A K ++ R + +RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 499 VLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEI 556
+L + HPN++ L +++ E ++ G L D + ++ + LS ++ +I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARLVPAVAENVTQYHL 612
G+ +LH K + H DLKP NI+L K+ D GLA +
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED------GVEF 175
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
+ GT ++ PE LG+++D++S+G++
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVL---RPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
+GEG +G V VA+K + + + +REI L +RHP+++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 512 LG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
P ++V EY A G L D I + ++ F+ +I + + H+ K
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQ---QIICAIEYCHRHK-- 128
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA-GTFCYIDPE-YQ 627
+VHRDLKP N+LLD N KI+D GL+ + +T + T+ G+ Y PE
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSPNYAAPEVIN 180
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
G + DV+S GI+L ++ + P
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 444 EDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLR------PDAAQGRSQFQR 495
E++++ ++ ++G G + V KC T A K ++ R +R
Sbjct: 7 ENVDD---YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 496 EIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIA 553
E+ +L I+HPN++ L I++ E +A G L D + + + L+ ++
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 554 AEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS----KISDVGLARLVPAVAENVTQ 609
+I G+ +LH + + H DLKP NI+L V KI D GLA +
Sbjct: 121 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID------FG 171
Query: 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
+ GT ++ PE LG+++D++S+G++
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVL---------RPDAAQGRSQFQREIE 498
+ + +G G V +C T AVK++ + + R +E++
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 499 VLSCI-RHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAE 555
+L + HPN++ L + +V++ + G L D + + LS ++ +I
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRA 132
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
+ + LH+ +VHRDLKP NILLD + K++D G + + L
Sbjct: 133 LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP------GEKLREV 183
Query: 616 AGTFCYIDPE------YQQTGMLGVKSDVYSLGILL 645
GT Y+ PE G + D++S G+++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVL--RPDAAQGRSQFQREIEVLSCIRH 505
+ + ++G+G + V +C T A K++ + +A+ + +RE + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 506 PNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
PN+V L + + +V++ + G L + I R S +I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 121
Query: 564 HQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
H +VHR+LKP N+LL K++D GLA V AGT
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------SEAWHGFAGTPG 172
Query: 621 YIDPEYQQTGMLGVKSDVYSLG----ILL 645
Y+ PE + D+++ G ILL
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 445 DIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVL-S 501
+ + + +GEG + KC + AVK++ + Q+EI L
Sbjct: 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKL 61
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
C HPN+V L + +V E L G L +RI ++ + S + I ++ +
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSA 118
Query: 560 LLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTA 616
+ +H +VHRDLKP N+L + N KI D G ARL P L +
Sbjct: 119 VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-----DNQPLKTPC 170
Query: 617 GTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
T Y PE D++SLG++L
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 43/205 (20%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIR 504
+E + + + +G G +G V++C + K ++ + ++EI +L+ R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR 59
Query: 505 HPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
H N++ L + E ++++E+++ + +RI L+ ++ ++ L F
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQF 117
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVS--KISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
LH + H D++P NI+ S KI + G AR + +
Sbjct: 118 LHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL------KPGDNFRLLFTAPE 168
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILL 645
Y PE Q ++ +D++SLG L+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 25/216 (11%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR---SQFQREIEVLSCIR 504
+ F++ R+IG G +G VY VA+K + Q +E+ L +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 505 HPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
HPN + G +V EY + D + PL + + GL +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 169
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
LH ++HRD+K GNILL + K+ D G A + S GT ++
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFG-------SASIMAPA--NSFVGTPYWM 217
Query: 623 DPE---YQQTGMLGVKSDVYSLGILLLQLITAKQPM 655
PE G K DV+SLGI ++L K P+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 37/238 (15%)
Query: 427 ASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVL-- 482
AS + R + + + + + ++G+G + V +C T A K++
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 483 RPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGN 540
+ +A+ + +RE + ++HPN+V L + + +V++ + G L + I R
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE- 123
Query: 541 TPPLSWQQRF--RIAAE----IATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKI 591
+ A+ I + + H +VHR+LKP N+LL K+
Sbjct: 124 --------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL 172
Query: 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 645
+D GLA V AGT Y+ PE + D+++ G ILL
Sbjct: 173 ADFGLAIEVND------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 44/214 (20%), Positives = 82/214 (38%), Gaps = 31/214 (14%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKV-----LRPDAAQGRSQFQREIEVLSC 502
+ IG+G + V +C T AVK+ +RE +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 503 IRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAE--- 555
++HP++V LL +V+E++ L I +R + + +A+
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMR 137
Query: 556 -IATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYH 611
I L + H ++HRD+KP +LL +++ K+ G+A + +
Sbjct: 138 QILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-----SGLV 189
Query: 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
GT ++ PE + G DV+ G++L
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 58/315 (18%), Positives = 109/315 (34%), Gaps = 55/315 (17%)
Query: 360 WRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLK 419
+ AR +L ++R ++ + EA++ A +
Sbjct: 11 VDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA-----Q 65
Query: 420 ESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PV 477
+ ++ +D ++ + + IG G V +C T
Sbjct: 66 PKGTENLYFQSMGPEDELPDWAAAKEFYQ---KYDPKDVIGRGVSSVVRRCVHRATGHEF 122
Query: 478 AVKVL--------RPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGAC--PEYGIIVYEYL 526
AVK++ + R +RE +L + HP+++ L+ + + +V++ +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 527 ANGSLDDRIFRRGNTPPLSWQQRF--RIAAE----IATGLLFLHQTKPEPLVHRDLKPGN 580
G L D + + + + + FLH +VHRDLKP N
Sbjct: 183 RKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPEN 230
Query: 581 ILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE------YQQTGMLGV 634
ILLD N ++SD G + + L GT Y+ PE + G
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEP------GEKLRELCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 635 KSDVYSLG----ILL 645
+ D+++ G LL
Sbjct: 285 EVDLWACGVILFTLL 299
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 457 RKIGEGGYGPVYKCYLDHTP----VAVKVL---RPDAAQGRSQFQREIEVLSCIRHPNMV 509
+G G +G V H VAVK+L + + + +REI+ L RHP+++
Sbjct: 22 DTLGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 510 LLLG--ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L + P +V EY++ G L D I + G ++ F+ +I +G+ + H+
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ---QILSGVDYCHRHM 136
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTA-GTFCYIDPE- 625
+VHRDLKP N+LLD + +KI+D GL+ + ++ T+ G+ Y PE
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAAPEV 186
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
G + D++S G++L L+ P
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-23
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVL--RPDAAQGRSQFQREIEVLSCIRH 505
T+ + ++G+G + V +C A ++ + +A+ + +RE + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 506 PNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAE----IA 557
PN+V L + + ++++ + G L + I R + A+ I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQIL 120
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTS 614
+L HQ +VHR+LKP N+LL K++D GLA V Q
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-----EQQAWFG 172
Query: 615 TAGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 645
AGT Y+ PE + G D+++ G ILL
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 59/196 (30%), Positives = 86/196 (43%), Gaps = 20/196 (10%)
Query: 457 RKIGEGGYGPVY--KCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL--L 512
+ IG G +G + L VAVK + A QREI +RHPN+V +
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 513 GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
P + I+ EY + G L +RI G + F+ ++ +G+ + H + +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---QLLSGVSYCHSMQ---IC 138
Query: 573 HRDLKPGNILLDHNYVS--KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE-YQQT 629
HRDLK N LLD + KI D G + +V ST GT YI PE +
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 630 GMLGVKSDVYSLGILL 645
G +DV+S G+ L
Sbjct: 193 EYDGKIADVWSCGVTL 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 29/206 (14%), Positives = 53/206 (25%), Gaps = 49/206 (23%)
Query: 457 RKIGEGGYGPVYKCYLDHT---PVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVL 510
G ++ D VA+ + P + LS I P +
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 511 LL--GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
+L G++V E++ GSL + +P R +A H+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-DTSPSPV----GAIRAMQSLAAAADAAHR--- 147
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
+ P + +S G L +
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVVL-----------------AYPATMPDA--- 179
Query: 629 TGMLGVKSDVYSLGILLLQLITAKQP 654
+ D+ +G L L+ + P
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWP 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 40/219 (18%)
Query: 444 EDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLS 501
+ + + FF ++G G VY+C T P A+KVL + + EI VL
Sbjct: 49 DALSD---FFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLL 103
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAE-- 555
+ HPN++ L P +V E + G L DRI +G + R AA+
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAV 154
Query: 556 --IATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQY 610
I + +LH+ +VHRDLKP N+L + KI+D GL+++V Q
Sbjct: 155 KQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH------QV 205
Query: 611 HLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 645
+ + GT Y PE + G + D++S+G ILL
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 36/211 (17%)
Query: 450 TQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVL-SCIRHP 506
T + IG G Y +C T AVK++ EIE+L +HP
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEIEILLRYGQHP 76
Query: 507 NMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
N++ L +Y +V E + G L D+I R+ S ++ + I + +LH
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLH 133
Query: 565 QTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
+VHRDLKP NIL + +I D G A+ + A L + T
Sbjct: 134 AQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-----ENGLLMTPCYTAN 185
Query: 621 YIDPE------YQQTGMLGVKSDVYSLGILL 645
++ PE Y D++SLG+LL
Sbjct: 186 FVAPEVLERQGY------DAACDIWSLGVLL 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVL-SCIRHPNMVLLLGA 514
+G G G V +C+ T A+K+L + ++E++ P++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 515 ------CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAE----IATGLLF 562
+I+ E + G L RI RG+ Q F R AAE I T + F
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQF 143
Query: 563 LHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTF 619
LH + HRD+KP N+L + + V K++D G A+ TQ L + T
Sbjct: 144 LHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-------TTQNALQTPCYTP 193
Query: 620 CYIDPEYQQTGMLGVKSDVYSLGILL 645
Y+ PE D++SLG+++
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 96.9 bits (240), Expect = 7e-22
Identities = 42/195 (21%), Positives = 64/195 (32%), Gaps = 47/195 (24%)
Query: 449 ATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLR---PDAAQGRSQ-----FQREIEVL 500
T+ KIGEG +G V++ DHTPVA+K++ PD G Q EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 501 ---------SCIRHPNMVLLL------GACPEYGIIVYEYLA--NGSLDDRIFRRGNT-- 541
C R + L G+ P + +++ GS +DR +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 542 ------------------PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583
S I ++ L HRDL GN+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195
Query: 584 DHNYVSKISDVGLAR 598
+ K+ +
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 57/231 (24%), Positives = 88/231 (38%), Gaps = 33/231 (14%)
Query: 432 STKDLRYRRYTIEDIEEATQFFT-ESRKIGEGGYGPVYKCYLDHT--PVAVKVL--RPDA 486
S DL + +E F+ S+++G G + V +C T A K L R
Sbjct: 9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG 68
Query: 487 AQGRSQFQREIEVLSCIRH-PNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPP 543
R++ EI VL + P ++ L I++ EY A G +
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL---- 124
Query: 544 LSWQQRF--RIAAE----IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS---KISDV 594
+ I G+ +LHQ +VH DLKP NILL Y KI D
Sbjct: 125 ---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
G++R + L GT Y+ PE + +D++++GI+
Sbjct: 179 GMSRKIGH------ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 39/213 (18%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVL-SCIRHPN 507
+ S+ +G G G V + + T A+K+L+ + +RE+E+ + P+
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPH 116
Query: 508 MVLLLGAC------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAE---- 555
+V ++ + +IV E L G L RI RG+ Q F R A+E
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKS 169
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHL 612
I + +LH + HRD+KP N+L N + K++D G A+ + L
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS------HNSL 220
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 645
T+ T Y+ PE D++SLG+++
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-20
Identities = 74/321 (23%), Positives = 119/321 (37%), Gaps = 44/321 (13%)
Query: 356 ELQRWRL-DEERRLEEAR-----FAEETALS----LAEKERARCKAAVEAAEAAKRIAEL 405
+ + + +++R R F T + + C +E EL
Sbjct: 86 GVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQEL 145
Query: 406 EAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYG 465
+ + + + L K L + T F + R +G+GG+G
Sbjct: 146 TRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNT-------FRQYRVLGKGGFG 198
Query: 466 PVYKCYLDHTPV--AVKVLRPDAAQGRSQFQ---REIEVLSCIRHPNMVLLLGA--CPEY 518
V C + T A K L + R E ++L + +V L A +
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258
Query: 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKP 578
+V + G L I+ G + F AAEI GL LH+ + +V+RDLKP
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YAAEICCGLEDLHRER---IVYRDLKP 314
Query: 579 GNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLG 633
NILLD + ++ +ISD+GLA VP T Y+ PE +
Sbjct: 315 ENILLDDHGHI-RISDLGLAVHVPE----------GQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 634 VKSDVYSLGILLLQLITAKQP 654
D ++LG LL ++I + P
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 74/315 (23%), Positives = 121/315 (38%), Gaps = 33/315 (10%)
Query: 356 ELQRWRL-DEERRLEEAR-----FAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQR 409
+++ + D+ R ++A+ + E A A A A L
Sbjct: 91 DIEDYDTADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAV 150
Query: 410 RLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYK 469
+E + L K L + + F + R +G GG+G V+
Sbjct: 151 LAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDW-------FLDFRVLGRGGFGEVFA 203
Query: 470 CYLDHTPV--AVKVLRPDAAQGRSQFQR---EIEVLSCIRHPNMVLLLGA--CPEYGIIV 522
C + T A K L + R +Q E ++L+ + +V L A +V
Sbjct: 204 CQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263
Query: 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNI 581
+ G + I+ P + R A+I +GL LHQ +++RDLKP N+
Sbjct: 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENV 320
Query: 582 LLDHN-YVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYIDPEYQQTGMLGVKSDVY 639
LLD + V +ISD+GLA E T AGT ++ PE D +
Sbjct: 321 LLDDDGNV-RISDLGLAV------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 640 SLGILLLQLITAKQP 654
+LG+ L ++I A+ P
Sbjct: 374 ALGVTLYEMIAARGP 388
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR-SQFQREIEVLSCIRHPNMVLLLGA 514
K+G G Y VYK T VA+K ++ D+ +G S REI ++ ++H N+V L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 515 CPEYGII--VYEYLAN--GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+ V+E++ N D L ++ GL F H+ K
Sbjct: 72 IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLAR 598
++HRDLKP N+L++ K+ D GLAR
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 11/151 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR-SQFQREIEVLSCIRHPNMV 509
+ + K+GEG Y VYK T VA+K +R + +G RE+ +L ++H N+V
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 510 LLLGACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L + V+EYL D + + ++ ++ GL + H+ K
Sbjct: 64 TLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
++HRDLKP N+L++ K++D GLAR
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 49/148 (33%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR--SQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG VYK T VA+K +R D S REI +L + HPN+V LL
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 514 ACPEYGII--VYEYLANGSLD-DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+ V+E+L D + + ++ GL F H +
Sbjct: 70 VIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLAR 598
++HRDLKP N+L++ K++D GLAR
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 438 YRRYTIEDIE-EATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQ 494
Y Y +E + RK+G G Y V++ ++ V VK+L+P + + +
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78
Query: 495 REIEVLSCIR-HPNMVLLL----GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQ- 548
REI++L +R PN++ L +V+E++ N L+
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDI 132
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARLVPAVAENV 607
RF + EI L + H ++HRD+KP N+++DH + ++ D GLA
Sbjct: 133 RFYMY-EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE----FYHPG 184
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPM 655
+Y + + PE ++ + D++SLG +L +I K+P
Sbjct: 185 QEY--NVRVASRYFKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 33/168 (19%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVL-SCIRHPN 507
+ S+ +G G G V + + T A+K+L+ + +RE+E+ + P+
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPH 72
Query: 508 MVLLLGAC------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF--RIAAE---- 555
+V ++ + +IV E L G L RI RG+ Q F R A+E
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKS 125
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLV 600
I + +LH + HRD+KP N+L N + K++D G A+
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 47/159 (29%), Positives = 68/159 (42%), Gaps = 12/159 (7%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG--RSQFQREIEVLSCIRHPNMVLLLG 513
+GEG YG V KC T VA+K + REI++L +RH N+V LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 514 ACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
C + V+E++ L +Q + +I G+ F H
Sbjct: 92 VCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI--- 145
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQY 610
+HRD+KP NIL+ + V K+ D G AR + A E
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 45/159 (28%), Positives = 66/159 (41%), Gaps = 12/159 (7%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG--RSQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG V+KC T VA+K + REI +L ++HPN+V LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 514 ACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ V+EY + I + + F H+
Sbjct: 70 VFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQY 610
+HRD+KP NIL+ + V K+ D G ARL+ ++
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/265 (21%), Positives = 100/265 (37%), Gaps = 46/265 (17%)
Query: 412 SAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY 471
+E +KE + ++ F + +G G +G V
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVMLVK 61
Query: 472 LDHT--PVAVKVLRPDAAQGRSQFQ---REIEVLSCIRHPNMVLLLGAC--PEYGIIVYE 524
+ A+K+L Q + E +L + P +V L + +V E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 525 YLANGSLDDRIFRRGN-TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583
Y+A G + + R G + P + RF AA+I +LH L++RDLKP N+L+
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHA---RF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLI 174
Query: 584 DHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDV 638
D Y+ +++D G A+ V T C + PE + D
Sbjct: 175 DQQGYI-QVTDFGFAKRVK------------GRTWTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 639 YSLGILLLQLIT------AKQPMGL 657
++LG+L+ ++ A QP+ +
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQI 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 50/224 (22%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR-- 495
+Y+++D F R +G G +G V+ H A+KVL+ + Q +
Sbjct: 2 KYSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN 54
Query: 496 -EIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI 552
E +LS + HP ++ + G + ++ +Y+ G L F L QRF
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSL-----LRKSQRFPN 105
Query: 553 ------AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAE 605
AAE+ L +LH +++RDLKP NILLD N ++ KI+D G A+ VP
Sbjct: 106 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHI-KITDFGFAKYVP---- 157
Query: 606 NVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILL 645
T C YI PE T D +S GIL+
Sbjct: 158 --------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 58/267 (21%), Positives = 98/267 (36%), Gaps = 56/267 (20%)
Query: 412 SAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY 471
+ + K D + K +R R ED + + IG G +G V
Sbjct: 38 FPALRKNKNIDNFLSRYKDTINK-IRDLRMKAED-------YEVVKVIGRGAFGEVQLVR 89
Query: 472 LDHTP--VAVKVLRPDAAQGRSQ---FQREIEVLSCIRHPNMVLLLGA--CPEYGIIVYE 524
T A+K+L RS F E ++++ P +V L A Y +V E
Sbjct: 90 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149
Query: 525 YLANGSLDDRIFRRGNTPPLSWQQRFRI--------AAEIATGLLFLHQTKPEPLVHRDL 576
Y+ G L ++ + + AE+ L +H +HRD+
Sbjct: 150 YMPGGDL------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 194
Query: 577 KPGNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQT-- 629
KP N+LLD + ++ K++D G + T YI PE ++
Sbjct: 195 KPDNMLLDKSGHL-KLADFGTCMKMNKEGMVRCD--------TAVGTPDYISPEVLKSQG 245
Query: 630 --GMLGVKSDVYSLGILLLQLITAKQP 654
G G + D +S+G+ L +++ P
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 67/250 (26%), Positives = 103/250 (41%), Gaps = 40/250 (16%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQ-GR-SQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG V+K T VA+K +R D G S REI +L ++H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 514 ACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ V+E+ D + + L + ++ GL F H +
Sbjct: 69 VLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM 631
+HRDLKP N+L++ N K+++ GLAR A + ++ T Y P+ +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVRCYSAEVVTLWYRPPDV----L 173
Query: 632 LGVKS-----DVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD----PTVTDWP 682
G K D++S G + +L A +P+ F + L + PT WP
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL----FPGND-VDDQLKRIFRLLGTPTEEQWP 228
Query: 683 FEETLGFAKL 692
KL
Sbjct: 229 -----SMTKL 233
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 57/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQFQ-- 494
+ F R IG+G +G V + T A+K + R++ +
Sbjct: 10 EDVNFDH-------FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 495 -REIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFR 551
+E++++ + HP +V L + E +V + L G L L F+
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL----RYH-----LQQNVHFK 113
Query: 552 I------AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
E+ L +L + ++HRD+KP NILLD + I+D +A ++P E
Sbjct: 114 EETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RE 168
Query: 606 NVTQYHLTSTAGTFCYIDPE-YQQTGMLGVKSDV--YSLGILLLQLITAKQPMGLTHFVE 662
T+ AGT Y+ PE + G V +SLG+ +L+ ++P +
Sbjct: 169 TQI----TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-----YHI 219
Query: 663 RSIEN 667
RS +
Sbjct: 220 RSSTS 224
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR--SQFQREIEVLSCIRHPNMVLLLG 513
KIGEG YG VYK ++ A+K +R + S REI +L ++H N+V L
Sbjct: 9 KIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 514 ACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ V+E+L D + L ++ G+ + H + +
Sbjct: 68 VIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---V 121
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLAR 598
+HRDLKP N+L++ KI+D GLAR
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 49/159 (30%), Positives = 69/159 (43%), Gaps = 24/159 (15%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQ-GRSQFQ----REIEVL---SCIRHPN 507
+IG G YG VYK H+ VA+K +R G RE+ +L HPN
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 508 MVLLLGACPEYGI-------IVYEYLANGSLD-DRIFRRGNTPPLSWQQRFRIAAEIATG 559
+V L+ C +V+E++ D + P L + + + G
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
L FLH +VHRDLKP NIL+ K++D GLAR
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 63/234 (26%), Positives = 93/234 (39%), Gaps = 41/234 (17%)
Query: 437 RYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQFQ 494
T+ D F+ R IG GG+G VY C T A+K L + +
Sbjct: 182 LNIHLTMND-------FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET 234
Query: 495 -----REI-EVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSW 546
R + ++S P +V + A P+ + + + G L + + G
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---- 290
Query: 547 QQRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
+ R AAEI GL +H +V+RDLKP NILLD + +ISD+GLA
Sbjct: 291 EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS---- 343
Query: 606 NVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKS-DVYSLGILLLQLITAKQP 654
Y+ PE Q G+ S D +SLG +L +L+ P
Sbjct: 344 -------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 36/238 (15%)
Query: 433 TKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGR 490
T ++ R ED F + IG G +G V L + A+K+L R
Sbjct: 63 TSKVKQMRLHRED-------FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 491 SQ---FQREIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLS 545
++ F+ E +VL + L A +V +Y G L + + + P
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175
Query: 546 WQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
RF AE+ + +HQ VHRD+KP NIL+D N +++D G +
Sbjct: 176 MA-RF-YLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 606 NVTQYHLTSTAGTFC----YIDPE-----YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ YI PE G G + D +SLG+ + +++ + P
Sbjct: 231 VQSS--------VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 56/281 (19%), Positives = 95/281 (33%), Gaps = 44/281 (15%)
Query: 405 LEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRK------ 458
++ + D + L +L +Y + ++ A ++
Sbjct: 2 MQQLVLDPGFLGLEPLLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRD 61
Query: 459 -------IGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQ---FQREIEVLSCIRHP 506
IG G + V + T A+K++ R + F+ E +VL
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 507 NMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
+ L A Y +V EY G L + + G P RF AEI + +H
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RF-YLAEIVMAIDSVH 179
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC---- 620
+ VHRD+KP NILLD +++D G + + S
Sbjct: 180 RLG---YVHRDIKPDNILLDRCGHIRLADFGSC------LKLRADGTVRSL--VAVGTPD 228
Query: 621 YIDPEYQQTGMLGVKSDVY-------SLGILLLQLITAKQP 654
Y+ PE Q G + Y +LG+ ++ + P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 13/147 (8%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGR--SQFQREIEVLSCIRHPNMVLLLG 513
K+GEG YG VYK D VA+K +R DA S REI +L + HPN+V L+
Sbjct: 28 KVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 514 ACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
+ V+E++ D + N L Q ++ G+ HQ + +
Sbjct: 87 VIHSERCLTLVFEFM---EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---I 140
Query: 572 VHRDLKPGNILLDHNYVSKISDVGLAR 598
+HRDLKP N+L++ + K++D GLAR
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR-- 495
+ T+ D F + +G+G +G V T A+K+LR + + +
Sbjct: 1 KVTMND-------FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 53
Query: 496 -EIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI 552
E VL RHP + L A + V EY G L F LS ++ F
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFH-----LSRERVFTE 104
Query: 553 ------AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAE 605
AEI + L +LH +V+RD+K N++LD + ++ KI+D GL + E
Sbjct: 105 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI-KITDFGLCK------E 154
Query: 606 NVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
++ TFC Y+ PE + G D + LG+++ +++ + P
Sbjct: 155 GISDGATMK---TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 68/306 (22%), Positives = 117/306 (38%), Gaps = 50/306 (16%)
Query: 366 RRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVK 425
R L+ E T +ER + A + + +A + ++ +
Sbjct: 76 RCLQWTTVIERTFHVETPEER---EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAE 132
Query: 426 IASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV--AVKVLR 483
+L+ R T+ + F + +G+G +G V T A+K+L+
Sbjct: 133 EMEVSLAKPK---HRVTMNE-------FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK 182
Query: 484 PDAAQGRSQFQR---EIEVLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRR 538
+ + + E VL RHP + L + + V EY G L F
Sbjct: 183 KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFH 238
Query: 539 GNTPPLSWQQRFRI------AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592
LS ++ F AEI + L +LH K +V+RDLK N++LD + KI+
Sbjct: 239 -----LSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKIT 291
Query: 593 DVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQL 648
D GL + E + TFC Y+ PE + G D + LG+++ ++
Sbjct: 292 DFGLCK------EGIKDGATMK---TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 649 ITAKQP 654
+ + P
Sbjct: 343 MCGRLP 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 39/233 (16%)
Query: 437 RYRRYTIEDIEEATQFFTESRKIGEGGYGPVY---KCYLDHTPV--AVKVLRPDAAQGRS 491
+ + F + +G+G +G V+ K A+KVL+ + R
Sbjct: 17 GHEKADPSQ-------FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69
Query: 492 QFQREIE--VLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
+ + ++E +L + HP +V L A ++ ++L G L R+ + +
Sbjct: 70 RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT----E 125
Query: 548 QRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAE 605
+ + AE+A L LH +++RDLKP NILLD ++ K++D GL++ E
Sbjct: 126 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHI-KLTDFGLSK------E 175
Query: 606 NVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
++ A +FC Y+ PE +D +S G+L+ +++T P
Sbjct: 176 SIDH---EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 65/275 (23%), Positives = 103/275 (37%), Gaps = 61/275 (22%)
Query: 455 ESRKIGEGGYGPVYKCYLDHTP----VAVKVLRPDAAQGRSQF-QREIEVLSCIRHPNMV 509
E K+G G YG VYK A+K + G S REI +L ++HPN++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVI 81
Query: 510 LLLGACPEYGI----IVYEYLAN---GSLDDRIFRRGNTP--PLSWQQRFRIAAEIATGL 560
L + ++++Y + + + N L + +I G+
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVS----KISDVGLARL--VPAVAENVTQYHLTS 614
+LH ++HRDLKP NIL+ KI+D+G ARL P L
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP----LKPLADLDP 194
Query: 615 TAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAKQPMGLTHFVERS-IENG 668
TF Y PE +LG + D++++G + +L+T +P+ F R
Sbjct: 195 VVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLT-SEPI----FHCRQEDIKT 245
Query: 669 TLGEMLD-----------PTVTDWPFEETLGFAKL 692
+ D P DW K+
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWE-----DIKKM 275
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 21/153 (13%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQ--------REIEVLSCIRHPN 507
+GEG + VYK +T VA+K ++ RS+ + REI++L + HPN
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLLQELSHPN 73
Query: 508 MVLLLGACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
++ LL A I V++++ D + + N+ L+ GL +LHQ
Sbjct: 74 IIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
++HRDLKP N+LLD N V K++D GLA+
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 24/155 (15%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQ-GR-SQFQREIEVLSCIRHPNMVLLLG 513
K+GEG YG VYK T VA+K +R + + G RE+ +L ++H N++ L
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 514 ACPEYGII--VYEYLAN---GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
+ ++EY N +D P +S + ++ G+ F H +
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMD-------KNPDVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 569 EPLVHRDLKPGNILLDHNYVS-----KISDVGLAR 598
+HRDLKP N+LL + S KI D GLAR
Sbjct: 154 ---LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 67/230 (29%), Positives = 94/230 (40%), Gaps = 38/230 (16%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR- 495
+ IED F + +G+G +G V+ T A+K L+ D +
Sbjct: 12 IKLKIED-------FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 496 --EIEVLS-CIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF 550
E VLS HP + + E V EYL G L I R
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRA 120
Query: 551 RI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVT 608
AAEI GL FLH +V+RDLK NILLD + ++ KI+D G+ + EN+
Sbjct: 121 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI-KIADFGMCK------ENML 170
Query: 609 QYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
T+ TFC YI PE D +S G+LL +++ + P
Sbjct: 171 GDAKTN---TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 47/246 (19%)
Query: 429 SNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVY---KCYLDHTPV--AVKVLR 483
S+ ++ + + E F R +G+GGYG V+ K +T A+KVL+
Sbjct: 2 SSETSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK 54
Query: 484 PDAAQGRSQFQREIE-------VLSCIRHPNMVLLLGA--CPEYGIIVYEYLANGSLDDR 534
++ +L ++HP +V L+ A ++ EYL+ G L +
Sbjct: 55 KAMIVRN---AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 111
Query: 535 IFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKIS 592
+ R G + AEI+ L LHQ +++RDLKP NI+L+H +V K++
Sbjct: 112 LEREGIFM----EDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHV-KLT 163
Query: 593 DVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQL 648
D GL + E++ + TFC Y+ PE D +SLG L+ +
Sbjct: 164 DFGLCK------ESIHD---GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214
Query: 649 ITAKQP 654
+T P
Sbjct: 215 LTGAPP 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 26/158 (16%)
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQ-G-RSQFQREIEVLSCIRHPNMVLLLG 513
KIG+G +G V+K T VA+K + + + G REI++L ++H N+V L+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 514 ACPEYGI----------IVYEYLAN---GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
C +V+++ + G L + + + R+ + GL
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSEIKRVMQMLLNGL 137
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
++H+ K ++HRD+K N+L+ + V K++D GLAR
Sbjct: 138 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 7e-16
Identities = 77/417 (18%), Positives = 133/417 (31%), Gaps = 42/417 (10%)
Query: 252 RPSSDHSPSMHYEFVDVGRNSRISTSSEHSLGSFRLGLRYNDRSSPYDLSSISQDSGATS 311
Y + R I + +D L +
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 312 CSCSSQNLDEVEAEMRRLKLEL-KQTMDMYSTACKEALVAKQKALELQRWRLDEERRLEE 370
+L+ E R +L+ + + L ++ + + + E ++
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 371 ARFAEETALSLAEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSN 430
+ + + E R A+ + K ++ + +N
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 431 LSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQ 488
+ R + D F +G+G +G V T AVK+L+ D
Sbjct: 333 GNR-----DRMKLTD-------FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 380
Query: 489 GRSQF---QREIEVLSCI-RHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTP 542
E VL+ + P + L + V EY+ G L I + G
Sbjct: 381 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 440
Query: 543 PLSWQQRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601
+ AAEIA GL FL +++RDLK N++LD KI+D G+ +
Sbjct: 441 ----EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--- 490
Query: 602 AVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
EN+ T TFC YI PE G D ++ G+LL +++ + P
Sbjct: 491 ---ENIWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 30/166 (18%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT-PVAVKVLRPDAAQGRSQFQ-REIEVLSCIRHPNMVL 510
+T + IG G +G V++ L + VA+K + D +F+ RE++++ ++HPN+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVD 96
Query: 511 LLGACPEYGI--------IVYEYLANGSLD-----DRIFRRGNTPPLSWQQRFRIAAEIA 557
L G +V EY+ + T P+ + + ++
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV---PETVYRASRHYAKLKQTMPMLLIKLYMY--QLL 151
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLAR-LVP 601
L ++H + HRD+KP N+LLD + V K+ D G A+ L+
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 63/253 (24%), Positives = 102/253 (40%), Gaps = 38/253 (15%)
Query: 416 NRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT 475
+ E + + N ++D F R IG G Y V L T
Sbjct: 24 GAMGSGIEEEKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAKVLLVRLKKT 76
Query: 476 PV--AVKVLRPDAAQGRSQF---QREIEVLSCI-RHPNMVLLLGAC---PEYGIIVYEYL 526
A++V++ + Q E V HP +V L +C V EY+
Sbjct: 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYV 135
Query: 527 ANGSLDDRIFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH 585
G L + R+ P ++ R +AEI+ L +LH+ +++RDLK N+LLD
Sbjct: 136 NGGDLMFHMQRQRKLP----EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDS 188
Query: 586 NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSL 641
K++D G+ + E + TS TFC YI PE + G D ++L
Sbjct: 189 EGHIKLTDYGMCK------EGLRPGDTTS---TFCGTPNYIAPEILRGEDYGFSVDWWAL 239
Query: 642 GILLLQLITAKQP 654
G+L+ +++ + P
Sbjct: 240 GVLMFEMMAGRSP 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 67/246 (27%), Positives = 101/246 (41%), Gaps = 48/246 (19%)
Query: 428 SSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV--AVKVLRPD 485
S ++ D F + IG+G +G V V AVKVL+
Sbjct: 22 SQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKK 74
Query: 486 AAQGRSQFQR---EIEVLS-CIRHPNMVLLLGA--CPEYGIIVYEYLANGSL-----DDR 534
A + + + E VL ++HP +V L + + V +Y+ G L +R
Sbjct: 75 AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 134
Query: 535 IFRRGNTPPLSWQQRFRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKIS 592
F + R R AAEIA+ L +LH +V+RDLKP NILLD ++ ++
Sbjct: 135 CFL---------EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHI-VLT 181
Query: 593 DVGLARLVPAVAENVTQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQL 648
D GL + EN+ ST TFC Y+ PE D + LG +L ++
Sbjct: 182 DFGLCK------ENIEH---NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 232
Query: 649 ITAKQP 654
+ P
Sbjct: 233 LYGLPP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 44/233 (18%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQFQR- 495
R I++ F R +G+G +G V + T AVKVL+ D +
Sbjct: 18 NRLGIDN-------FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT 70
Query: 496 --EIEVLSCI-RHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF 550
E +LS HP + L P+ V E++ G L I + + R
Sbjct: 71 MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARA 126
Query: 551 RI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609
R AAEI + L+FLH +++RDLK N+LLDH K++D G+ + E +
Sbjct: 127 RFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICN 177
Query: 610 YHLTSTAGTFC----YIDPE---YQQTGMLGVKS-DVYSLGILLLQLITAKQP 654
T+ TFC YI PE G + D +++G+LL +++ P
Sbjct: 178 GVTTA---TFCGTPDYIAPEILQEMLYG----PAVDWWAMGVLLYEMLCGHAP 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPV--AVKVLRPDAAQGRSQF--- 493
++D F R IG G Y V L T A+KV++ +
Sbjct: 4 DPLGLQD-------FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV 56
Query: 494 QREIEVLSCI-RHPNMVLLLGAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQR 549
Q E V HP +V L +C V EY+ G L + R+ P ++
Sbjct: 57 QTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEH 111
Query: 550 FRI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENV 607
R +AEI+ L +LH+ +++RDLK N+LLD ++ K++D G+ + E +
Sbjct: 112 ARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHI-KLTDYGMCK------EGL 161
Query: 608 TQYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
TS TFC YI PE + G D ++LG+L+ +++ + P
Sbjct: 162 RPGDTTS---TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 38/230 (16%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTP--VAVKVLRPDAAQGRSQF--- 493
R + D F +G+G +G V T AVK+L+ D
Sbjct: 15 DRMKLTD-------FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 67
Query: 494 QREIEVLSCI-RHPNMVLLLGA--CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF 550
E VL+ + P + L + V EY+ G L I + G +
Sbjct: 68 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHA 123
Query: 551 RI-AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVT 608
AAEIA GL FL +++RDLK N++LD ++ KI+D G+ + EN+
Sbjct: 124 VFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHI-KIADFGMCK------ENIW 173
Query: 609 QYHLTSTAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
T TFC YI PE G D ++ G+LL +++ + P
Sbjct: 174 D---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 22/157 (14%)
Query: 458 KIGEGGYGPVYKCYLDHTP---VAVKVLRPDAAQGR--SQFQREIEVL---SCIRHPNMV 509
+IGEG YG V+K VA+K +R + RE+ VL HPN+V
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 510 LLLGACPEYGI-------IVYEYLANGSLD-DRIFRRGNTPPLSWQQRFRIAAEIATGLL 561
L C +V+E++ D + P + + + ++ GL
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
FLH + +VHRDLKP NIL+ + K++D GLAR
Sbjct: 135 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 67/277 (24%), Positives = 104/277 (37%), Gaps = 59/277 (21%)
Query: 406 EAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYG 465
SA+ E + + IE+ F + +G G YG
Sbjct: 16 GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-------FELLKVLGTGAYG 68
Query: 466 PVY---KCYLDHTPV--AVKVLRPDAAQGRSQFQREIE-------VLSCIRHPNMVLLLG 513
V+ K T A+KVL+ + + E VL IR ++ L
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVLKKATIVQK---AKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 514 AC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI------AAEIATGLLFLH 564
++ +Y+ G L F LS ++RF EI L LH
Sbjct: 126 YAFQTETKLHLILDYINGGEL----FTH-----LSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 565 QTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC--- 620
+ +++RD+K NILLD N +V ++D GL++ E V T A FC
Sbjct: 177 KLG---IIYRDIKLENILLDSNGHV-VLTDFGLSK------EFVADE--TERAYDFCGTI 224
Query: 621 -YIDPEYQQTGMLGVKSDV--YSLGILLLQLITAKQP 654
Y+ P+ + G G V +SLG+L+ +L+T P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 54/247 (21%)
Query: 432 STKDLRYRRYTIEDIE-EATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAA 487
S +D + I D + + + IG G G V Y VA+K + RP
Sbjct: 5 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--- 61
Query: 488 QGRSQFQ---------REIEVLSCIRHPNMVLLLGA-CPEYGI-------IVYEYLANGS 530
FQ RE+ ++ C+ H N++ LL P+ + IV E +
Sbjct: 62 -----FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---D 113
Query: 531 LD-DRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589
+ ++ + L ++ + ++ G+ LH ++HRDLKP NI++ +
Sbjct: 114 ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 166
Query: 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVK----SDVYSLGILL 645
KI D GLAR T + +T T Y PE +LG+ D++S+G ++
Sbjct: 167 KILDFGLARTAG------TSFMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIM 216
Query: 646 LQLITAK 652
++I
Sbjct: 217 GEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 56/243 (23%), Positives = 98/243 (40%), Gaps = 57/243 (23%)
Query: 437 RYRRYTIEDIE-EATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAAQGRSQ 492
+ + + E + + +G G YG V + VA+K + RP
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------- 60
Query: 493 FQ---------REIEVLSCIRHPNMVLLLGA-CPEYGI-------IVYEYLANGSLD-DR 534
FQ RE+ +L ++H N++ LL P + +V ++ D +
Sbjct: 61 FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---DLQK 117
Query: 535 IFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594
I S ++ + ++ GL ++H +VHRDLKPGN+ ++ + KI D
Sbjct: 118 IMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDF 170
Query: 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLI 649
GLAR +T Y T Y PE +L D++S+G ++ +++
Sbjct: 171 GLAR---HADAEMTGY-----VVTRWYRAPEV----ILSWMHYNQTVDIWSVGCIMAEML 218
Query: 650 TAK 652
T K
Sbjct: 219 TGK 221
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 53/246 (21%), Positives = 103/246 (41%), Gaps = 60/246 (24%)
Query: 435 DLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQ 492
+ RY + RK+G G + V+ +++T VA+K++R
Sbjct: 15 PYKDARYILV------------RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEA 61
Query: 493 FQREIEVLSCIR-----------HPNMVLLL------GACPEYGIIVYEYLANGSLDDRI 535
+ EI++L + +++ LL G + ++V+E L +L I
Sbjct: 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI 120
Query: 536 FRRGNTP-PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS----- 589
+ + PL + ++ + ++ GL ++H + ++H D+KP N+L++
Sbjct: 121 KKYEHRGIPLIYVKQI--SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 590 -KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVK----SDVYSLGIL 644
KI+D+G A H T++ T Y PE +LG +D++S L
Sbjct: 177 IKIADLGNACWYD--------EHYTNSIQTREYRSPEV----LLGAPWGCGADIWSTACL 224
Query: 645 LLQLIT 650
+ +LIT
Sbjct: 225 IFELIT 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 34/165 (20%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQ-REIEVLSCIRHPNMV 509
+T+++ IG G +G VY+ L + VA+K + D +F+ RE++++ + H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIV 110
Query: 510 LLLGACPEYGI--------IVYEYLA---NGSLDDRIFRRGNTPPLSWQ----QRFRIAA 554
L G +V +Y+ + P + + Q FR
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--- 167
Query: 555 EIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLAR 598
L ++H + HRD+KP N+LLD + V K+ D G A+
Sbjct: 168 ----SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 60/225 (26%), Positives = 85/225 (37%), Gaps = 42/225 (18%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQ--FQ---------REIEV 499
+T R I G YG V D PVA+K + + GR+ REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 500 LSCIRHPNMVLLLGACPEYGI-------IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI 552
L+ HPN++ L + +V E + L I +S Q
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQYF 139
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
I GL LH+ +VHRDL PGNILL N I D LAR E+ +
Sbjct: 140 MYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR------EDTADANK 190
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
T Y PE ++ K D++S G ++ ++ K
Sbjct: 191 THYVTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 62/279 (22%), Positives = 114/279 (40%), Gaps = 55/279 (19%)
Query: 402 IAELEAQRRLSAEMNRLKESDEVKIA---SSNLSTKDLRYRRYTIEDIE-EATQFFTESR 457
+E +++ K+ D IA + + S D ++ + D + + +
Sbjct: 9 CSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLK 68
Query: 458 KIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAAQGRSQFQ---------REIEVLSCIRH 505
IG G G V Y VA+K + RP FQ RE+ ++ C+ H
Sbjct: 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--------FQNQTHAKRAYRELVLMKCVNH 120
Query: 506 PNMVLLLGA-CPEYGI-------IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIA 557
N++ LL P+ + +V E + + ++ + L ++ + ++
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQM----ELDHERMSYLLYQML 174
Query: 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAG 617
G+ LH ++HRDLKP NI++ + KI D GLAR T + +T
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG------TSFMMTPYVV 225
Query: 618 TFCYIDPEYQQTGMLGVK----SDVYSLGILLLQLITAK 652
T Y PE +LG+ D++S+G ++ +++ K
Sbjct: 226 TRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 56/272 (20%), Positives = 95/272 (34%), Gaps = 57/272 (20%)
Query: 432 STKDLRYRRYTIEDIE-EATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAA 487
R Y + IG G YG VY Y +T VA+K V R
Sbjct: 6 HHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--- 62
Query: 488 QGRSQFQ---------REIEVLSCIRHPNMVLLLGACPEYGI-------IVYEYLANGSL 531
F+ REI +L+ ++ ++ L + IV E +
Sbjct: 63 -----FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS--- 114
Query: 532 DD--RIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589
D ++F+ L+ + I + G F+H++ ++HRDLKP N LL+ +
Sbjct: 115 -DLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSV 168
Query: 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-TG------------MLGVKS 636
K+ D GLAR + + + L + +Q T +L ++
Sbjct: 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN 228
Query: 637 -----DVYSLGILLLQLITAKQPMGLTHFVER 663
D++S G + +L+ Q
Sbjct: 229 YTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 54/232 (23%), Positives = 86/232 (37%), Gaps = 56/232 (24%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQ---------REIEVLS 501
F +GEG YG V T VA+K + P F REI++L
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILK 64
Query: 502 CIRHPNMVLLLGACPEYGI-------IVYEYLANGSLDD--RIFRRGNTPPLSWQQRFRI 552
+H N++ + I+ E + D R+ T LS
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVIS---TQMLSDDHIQYF 117
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
+ + LH + ++HRDLKP N+L++ N K+ D GLAR++ A + ++
Sbjct: 118 IYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 613 TSTAGTFCYIDPEYQQTG-------MLGVKS-----DVYSLGILLLQLITAK 652
+ E+ T ML DV+S G +L +L +
Sbjct: 175 QQSGMV------EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 56/242 (23%)
Query: 438 YRRYTIEDIE-EATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAAQGRSQF 493
+ R + E + + + +G G YG V T VA+K + RP F
Sbjct: 11 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--------F 62
Query: 494 Q---------REIEVLSCIRHPNMVLLLGA-CPEYGI-------IVYEYLANGSLD-DRI 535
Q RE+ +L +RH N++ LL P+ + +V ++ D ++
Sbjct: 63 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKL 119
Query: 536 FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595
+ L + + ++ GL ++H ++HRDLKPGN+ ++ + KI D G
Sbjct: 120 MKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173
Query: 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLIT 650
LAR +T Y T Y PE +L D++S+G ++ ++IT
Sbjct: 174 LAR---QADSEMTGY-----VVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMIT 221
Query: 651 AK 652
K
Sbjct: 222 GK 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 50/261 (19%), Positives = 93/261 (35%), Gaps = 40/261 (15%)
Query: 382 AEKERARCKAAVEAAEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRY 441
+ E A + + ++ E Q+R ++ S + + RY
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP------DRY 55
Query: 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQ---RE 496
I IG G YG V + Y VA+K + + + RE
Sbjct: 56 EIR------------HLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILRE 102
Query: 497 IEVLSCIRHPNMVLLLGACPEYGI-------IVYEYLANGSLD-DRIFRRGNTPPLSWQQ 548
I +L+ + H ++V +L + +V E D ++FR L+
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---DSDFKKLFRTPV--YLTELH 157
Query: 549 RFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608
+ + G+ ++H ++HRDLKP N L++ + K+ D GLAR V +
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 609 QYHLTSTAGTFCYIDPEYQQT 629
Q ++ + + +
Sbjct: 215 QLPISPREDDMNLVTFPHTKN 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 56/242 (23%)
Query: 438 YRRYTIEDIE-EATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAAQGRSQF 493
+ R + E + + +G G YG V + T VAVK + RP F
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--------F 66
Query: 494 Q---------REIEVLSCIRHPNMVLLLGA-CPEYGI-------IVYEYLANGSLD-DRI 535
Q RE+ +L ++H N++ LL P + +V + D + I
Sbjct: 67 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNI 123
Query: 536 FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595
+ L+ + +I GL ++H ++HRDLKP N+ ++ + KI D G
Sbjct: 124 VK---CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177
Query: 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLIT 650
LAR A+ +T Y T Y PE ML D++S+G ++ +L+T
Sbjct: 178 LAR---HTADEMTGYVATRW-----YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 651 AK 652
+
Sbjct: 226 GR 227
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 50/234 (21%), Positives = 89/234 (38%), Gaps = 51/234 (21%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAAQGRSQFQREIE---VL 500
+ F R G+G +G V T VA+K V+ Q RE++ L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNRELQIMQDL 73
Query: 501 SCIRHPNMVLLL---------GACPEYGIIVYEYLA---NGSLDDRIFRRGNTPPLSWQ- 547
+ + HPN+V L Y +V EY+ + + R+ PP+ +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 548 ---QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVPAV 603
Q R + LH + HRD+KP N+L++ + K+ D G A+ +
Sbjct: 134 FLFQLIR-------SIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
N + + Y PE + G + D++S+G + +++ +
Sbjct: 186 EPN------VAYICSRYYRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 49/230 (21%)
Query: 448 EATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQ---------RE 496
+ +T IGEG YG V Y + VA+K + P F+ RE
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75
Query: 497 IEVLSCIRHPNMVLLLGACPEYGI-------IVYEYLANGSLDD--RIFRRGNTPPLSWQ 547
I++L RH N++ + I IV + + D ++ + T LS
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLK---TQHLSND 128
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
+I GL ++H ++HRDLKP N+LL+ KI D GLAR+ ++
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD--PDHD 183
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
LT T Y PE ML K D++S+G +L ++++ +
Sbjct: 184 HTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 34/222 (15%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
+ + + +G GG G V+ + VA+K + Q REI+++ + H N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 511 LLGA-CPEYGIIVYEYLANGSLDD-------------RIFRRGNTPPLSWQQRFRIAAEI 556
+ P + + + L+ + +G PL + ++
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQL 129
Query: 557 ATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVPAVAENVTQYHLTST 615
GL ++H ++HRDLKP N+ ++ + V KI D GLAR++ + HL+
Sbjct: 130 LRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD--PHYSHKGHLSEG 184
Query: 616 AGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQLITAK 652
T Y P +L + D+++ G + +++T K
Sbjct: 185 LVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 58/234 (24%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVK-VLRPDAAQGRSQFQ---------REIEVLSCIR 504
+K+G+G YG V+K T VAVK + FQ REI +L+ +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFREIMILTELS 66
Query: 505 -HPNMVLLLGAC-PE-----YGIIVYEYLANGSLDD--RIFRRGNTPPLSWQQRFRIAAE 555
H N+V LL + Y +V++Y+ D + R L + + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVY--LVFDYMET----DLHAVIR---ANILEPVHKQYVVYQ 117
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
+ + +LH L+HRD+KP NILL+ K++D GL+R + L+
Sbjct: 118 LIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 616 AGTFCYIDPEYQQTG------------MLGVKS-----DVYSLGILLLQLITAK 652
T + D + T +LG D++SLG +L +++ K
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 58/233 (24%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDH---TPVAVKVLRPDAAQGRSQFQRE 496
RY + + IG+G +G V K Y DH VA+K++R + Q E
Sbjct: 98 RYEVLKV------------IGKGSFGQVVKAY-DHKVHQHVALKMVRNEKRF-HRQAAEE 143
Query: 497 IEVLSCIRH------PNMVLLLGA-------CPEYGIIVYEYLANGSLDDRIFRRGNTPP 543
I +L +R N++ +L C + +E L+ +L + I ++
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHIC-----MTFELLSM-NLYELI-KKNKFQG 196
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS--KISDVGLARLVP 601
S + A I L LH+ + ++H DLKP NILL S K+ D G +
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253
Query: 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVK----SDVYSLGILLLQLIT 650
+ V Y + Y PE +LG + D++SLG +L +L+T
Sbjct: 254 ---QRVYTYIQSR-----FYRAPEV----ILGARYGMPIDMWSLGCILAELLT 294
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 31/111 (27%), Positives = 51/111 (45%), Gaps = 10/111 (9%)
Query: 542 PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601
L+ + + ++A G+ FL K +HRDL NILL V KI D GLAR +
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI- 243
Query: 602 AVAENVTQYHLTSTAGTF--CYIDPEYQQTGMLGVKSDVYSLGILLLQLIT 650
++ ++ PE + ++SDV+S G+LL ++ +
Sbjct: 244 ----YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 12/109 (11%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPN 507
+ +G G +G V + VAVK+L+ A E+++L I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 508 MVLLLGACPEYG---IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIA 553
+V LLGAC + G +++ E+ G+L + + N + R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 40/258 (15%), Positives = 90/258 (34%), Gaps = 68/258 (26%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQF-QREIEVLSCI 503
E +++ ++ + +G G +G V + + + A+K + D ++ RE++++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVL 57
Query: 504 RHPNMVLLL--------GACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRF----- 550
H N++ L+ G + + Q ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 551 --------RIAAEIAT-------------------GLLFLHQTKPEPLVHRDLKPGNILL 583
++ + F+H + HRD+KP N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLV 174
Query: 584 D-HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKS-----D 637
+ + K+ D G A+ + + + + Y PE MLG D
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPS------VAYICSRFYRAPEL----MLGATEYTPSID 224
Query: 638 VYSLGILLLQLITAKQPM 655
++S+G + +LI +P+
Sbjct: 225 LWSIGCVFGELIL-GKPL 241
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 54/246 (21%), Positives = 82/246 (33%), Gaps = 62/246 (25%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDH---TPVAVKVLRPDAAQGRSQFQRE 496
+ + +G+G +G V C AVKV+R + E
Sbjct: 36 AFLVIRK------------MGDGTFGRVLLCQ-HIDNKKYYAVKVVRNIKKY-TRSAKIE 81
Query: 497 IEVLSCIRH-----PNMVLLLGA-------CPEYGIIVYEYLANGSLDDRIFRRGNTPPL 544
++L I++ N+V G C +++E L SL + I R N
Sbjct: 82 ADILKKIQNDDINNNNIVKYHGKFMYYDHMC-----LIFEPLGP-SLYEII-TRNNYNGF 134
Query: 545 SWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604
+ EI L +L + L H DLKP NILLD Y K
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI---TVRRVTDG 188
Query: 605 ENVTQYHLTSTA------GTFCYID---PEYQQT-------GMLGVK----SDVYSLGIL 644
+ + Y ST G + T +L + SD++S G +
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248
Query: 645 LLQLIT 650
L +L T
Sbjct: 249 LAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 52/248 (20%), Positives = 89/248 (35%), Gaps = 70/248 (28%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDH----TPVAVKVLRPDAAQGRSQFQR 495
RY I +GEG +G V +C DH + VA+K++R R +
Sbjct: 20 RYEIVGN------------LGEGTFGKVVECL-DHARGKSQVALKIIRNVGKY-REAARL 65
Query: 496 EIEVLSCIRHP------NMVLLLGA-------CPEYGIIVYEYLANGSLDDRIFRRGNTP 542
EI VL I+ VL+ C I +E L + + + + N
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC-----IAFELLGK-NTFEFL-KENNFQ 118
Query: 543 PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602
P +A ++ L FLH+ + L H DLKP NIL ++ +
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFET---------LYN 166
Query: 603 VAENVTQYHLTSTA------GTFCYID---PEYQQTG-------MLGVK----SDVYSLG 642
++ + + +T+ G+ + T +L + DV+S+G
Sbjct: 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIG 226
Query: 643 ILLLQLIT 650
+L +
Sbjct: 227 CILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 58/248 (23%), Positives = 89/248 (35%), Gaps = 70/248 (28%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDH----TPVAVKVLRPDAAQGRSQFQR 495
RY I D +GEG +G V +C DH VAVK+++ +
Sbjct: 15 RYEIVDT------------LGEGAFGKVVECI-DHKAGGRHVAVKIVKNVDRY-CEAARS 60
Query: 496 EIEVLSCIRHP------NMVLLLGA-------CPEYGIIVYEYLANGSLDDRIFRRGNTP 542
EI+VL + V +L C IV+E L S D I +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC-----IVFELLGL-STYDFI-KENGFL 113
Query: 543 PLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602
P ++A +I + FLH K L H DLKP NIL + ++ + + R
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR---- 166
Query: 603 VAENVTQYHLTSTA------GTFCYID---PEYQQTG-------MLGVK----SDVYSLG 642
+ L + G+ Y D T +L + DV+S+G
Sbjct: 167 -----DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIG 221
Query: 643 ILLLQLIT 650
+L++
Sbjct: 222 CILIEYYL 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 56/233 (24%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT---PVAVKVLRPDAAQGRSQFQRE 496
RY I+ + IG+G +G V K Y D VA+K+++ A +Q Q E
Sbjct: 55 RYEIDSL------------IGKGSFGQVVKAY-DRVEQEWVAIKIIKNKKAF-LNQAQIE 100
Query: 497 IEVLSCIRHP------NMVLLLGA-------CPEYGIIVYEYLANGSLDDRIFRRGNTPP 543
+ +L + +V L C +V+E L+ +L D + R N
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC-----LVFEMLSY-NLYDLL-RNTNFRG 153
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS--KISDVGLARLVP 601
+S + A ++ T LLFL + ++H DLKP NILL + S KI D G +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ-- 210
Query: 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVK----SDVYSLGILLLQLIT 650
+ + + QY + Y PE +LG+ D++SLG +L+++ T
Sbjct: 211 -LGQRIYQYIQSR-----FYRSPEV----LLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 38/152 (25%), Positives = 64/152 (42%), Gaps = 20/152 (13%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH----PNMVL 510
RKIG G +G +Y VA+K+ Q E ++ ++ P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPT-IR 71
Query: 511 LLGACPEYGIIVYEYLANG-SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
GA +Y ++V E L G SL+D S + +A ++ + + ++H
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 570 PLVHRDLKPGNILL---DHNYVSKISDVGLAR 598
+HRD+KP N L+ + I D GLA+
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 41/151 (27%), Positives = 62/151 (41%), Gaps = 31/151 (20%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-----HPN-- 507
RK+G G + V+ + VA+KV++ A EI +L +R PN
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 508 -MVLLLGA-----------CPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAE 555
+V LL C +V+E L + L I + N L +I +
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-----MVFEVLGH-HLLKWI-IKSNYQGLPLPCVKKIIQQ 154
Query: 556 IATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586
+ GL +LH ++H D+KP NILL N
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVN 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 36/161 (22%), Positives = 68/161 (42%), Gaps = 36/161 (22%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH----PNMVL 510
R+IGEG +G +++ L++ VA+K + Q + E + PN V
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPN-VY 72
Query: 511 LLGACPEYGIIVYEYLANG-SLDDRIFRRGNTPPLSWQQRF------RIAAEIATGLLFL 563
G + ++V + L G SL+D + ++F A ++ + +
Sbjct: 73 YFGQEGLHNVLVIDLL--GPSLED-LLDLCG-------RKFSVKTVAMAAKQMLARVQSI 122
Query: 564 HQTKPEPLVHRDLKPGNILL------DHNYVSKISDVGLAR 598
H+ LV+RD+KP N L+ + N + + D G+ +
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 34/160 (21%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH----PNMVL 510
+KIG G +G + + VA+K+ + Q E + P V
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQ-VY 71
Query: 511 LLGACPEYGIIVYEYLANG-SLDDRIFRRGNTPPLSWQQRF------RIAAEIATGLLFL 563
G C +Y +V E L G SL+D +F + + F IA ++ + + ++
Sbjct: 72 YFGPCGKYNAMVLELL--GPSLED-LFDLCD-------RTFSLKTVLMIAIQLISRMEYV 121
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSK-----ISDVGLAR 598
H L++RD+KP N L+ I D LA+
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 8e-08
Identities = 68/476 (14%), Positives = 131/476 (27%), Gaps = 131/476 (27%)
Query: 13 GGNG--LIAVAVDKDKSSQHALK----WAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQV 66
G+G +A+ V Q + W NL N ++ + Q+ + +
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWL--NLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 67 YDASATTNPHQKQPDKQIRDLFLT---FRCY------CTRKDIKCFD----VLLEDVDIV 113
D S+ ++R L + C K F+ +LL
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF-- 274
Query: 114 KAITEYVSFAAIEDLVLGAPSRHGF--------IRKF----KADVPSSVSKAAPDFCNIY 161
K +T+++S A + L + K+ D+P V P +I
Sbjct: 275 KQVTDFLSAATTTHISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 162 VVSKGKISSKRNASRSAPFTSPLLDQLQSQNDIS-DTQSRYSMNLRDRTSFKPRMSFEES 220
S + + + D+L + + S + R F F S
Sbjct: 334 AESI-----RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY----RKMFDRLSVFPPS 384
Query: 221 AKSPAR-----------------GRGFDRKSFMDSSESDT-----DISFVSSGRPSSDHS 258
A P + S ++ ++ I + ++
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL--KVKLENE 442
Query: 259 PSMHYEFVDVGRNSRISTSSEHSLGSFRLGLRY--NDRSSP-----------YDLSSISQ 305
++H VD + + + +D P + L +I
Sbjct: 443 YALHRSIVD----------------HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486
Query: 306 DSGATSCSCSSQNLDEVEAEMRRLKLE---LKQTMDMYSTACKEALVAKQKALELQRWR- 361
E R + L+ L+Q + STA + +L+ ++
Sbjct: 487 --------------PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP 532
Query: 362 --LDEERRLEEARFAEETALSLAEKERARCKAA--VEAA----------EAAKRIA 403
D + + E A L E+ K + A EA K++
Sbjct: 533 YICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 18/151 (11%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH----PNMVL 510
RKIG G +G +Y + VA+K+ Q E ++ ++ PN V
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPN-VR 69
Query: 511 LLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
G +Y ++V + L SL+D + LS + +A ++ + F+H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLED--LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 571 LVHRDLKPGNILLDHNYVSK---ISDVGLAR 598
+HRD+KP N L+ + I D GLA+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 32/168 (19%), Positives = 60/168 (35%), Gaps = 35/168 (20%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV----- 509
+KIG GG+G +Y + A V++ + Q E++ + + +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 510 ----------------LLLGACPEYGIIVYEYLANG-SLDDRIFRRGNTPPLSWQQRFRI 552
L Y +V E L G L I + T ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGT--FKKSTVLQL 156
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI--SDVGLAR 598
+ L ++H+ + VH D+K N+LL + ++ +D GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 30/173 (17%), Positives = 49/173 (28%), Gaps = 42/173 (24%)
Query: 457 RKIGEGGYGPVY----------KCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP 506
G +Y ++K+ D + E P
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKP 102
Query: 507 NMVLL---LGACPEYGI---------------IVYEYLANG-SLDDRIFRRGNTPPLSWQ 547
V L + P I +V L G SL LS +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSER 159
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI--SDVGLAR 598
++A + L FLH+ + VH ++ NI +D S++ + G A
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 Length = 175 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 27/158 (17%), Positives = 55/158 (34%), Gaps = 16/158 (10%)
Query: 18 IAVAVD---------KDKSSQHALKWAADNLLNRGQT---VVLIHVAQRTSVSSVSSQSQ 65
+ VAV+ S + A +W + ++ + ++L+HV Q
Sbjct: 8 VMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHV-QVVDEDGFDDVDS 66
Query: 66 VYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAI 125
+Y + ++ + L F C + C + ++ D I + V
Sbjct: 67 IYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGC-EAWIKTGDPKDVICQEVKRVRP 125
Query: 126 EDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163
+ LV+G+ F + F V + K A C + +
Sbjct: 126 DFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTI 161
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} Length = 138 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-07
Identities = 25/125 (20%), Positives = 49/125 (39%), Gaps = 13/125 (10%)
Query: 18 IAVAVDKDKSSQHALKWAADNL-LNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPH 76
+ A+D ++ + A ++ D + T+ LIHV + + V A
Sbjct: 4 LLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEA----VLAAYDEIEMK 59
Query: 77 QKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDL-VLGAPSR 135
+++ K + F TF T K I F V+ E + V+ + E +L ++G+
Sbjct: 60 EEEKAKLLTQKFSTF---FTEKGINPFVVIKEG-EPVEMVLEEAKDY---NLLIIGSSEN 112
Query: 136 HGFIR 140
+
Sbjct: 113 SFLNK 117
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 4e-06
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 11/85 (12%)
Query: 350 AKQKALE---LQRWRLDEERRLEEARFAEETALSLAEKERARCKAAVEAAEAAKRIAELE 406
A + E +++WR EE+ R E A S ++ R KA + E +R +E
Sbjct: 77 ADRLTQEPESIRKWR--EEQ---RKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSE-- 129
Query: 407 AQRRLSAEMNRLKESDEVKIASSNL 431
Q + NR+ + + +++
Sbjct: 130 -QVEKNKINNRIADKAFYQQPDADI 153
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 5e-06
Identities = 31/203 (15%), Positives = 71/203 (34%), Gaps = 14/203 (6%)
Query: 261 MHYEFVDVGRNSRISTSSEHSLGSFRLGLRYNDRSSPYDLSSISQDSG-ATSCSCSSQNL 319
H + R + G L + + + + S S Q
Sbjct: 591 FHKNSARIIRMAVFGFEMSEDTGPDGTLLPKARDQAVFPQNGLVVSSVDVQSVEPVDQRT 650
Query: 320 DEVEAEMRRLKLELKQTMDMYSTACKEALVAKQKALELQRWRLDEERRLEEARF------ 373
+ +L +E+ + + + ++ L+R ++ ++ E+AR
Sbjct: 651 RDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQKILDQSEAEKARKELLELE 710
Query: 374 AEETALSLAEKERARCKAAVEAA----EAAKRIAELEAQRRLS---AEMNRLKESDEVKI 426
A A+ +A ++ EAA E + A+L+AQ AE+ R+K+ E+++
Sbjct: 711 AMSMAVESTGNAKAEAESRAEAARIEGEGSVLQAKLKAQALAIETEAELERVKKVREMEL 770
Query: 427 ASSNLSTKDLRYRRYTIEDIEEA 449
+ + + + ++E
Sbjct: 771 IYARAQLELEVSKAQQLANVEAK 793
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 31/173 (17%), Positives = 55/173 (31%), Gaps = 42/173 (24%)
Query: 457 RKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
IG+GG+G +Y + P VKV D E++ P +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN----GPLFTELKFYQRAAKPEQI 96
Query: 510 LLLGACP---------------------EYGIIVYEYLANG-SLDDRIFRRGNTPPLSWQ 547
Y ++ + G L S +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKR--FSRK 152
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI--SDVGLAR 598
+++ I L ++H+ + VH D+K N+LL++ ++ D GLA
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} Length = 319 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 21/156 (13%), Positives = 44/156 (28%), Gaps = 7/156 (4%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
+ V +D ++ Q AL+ A + G + S + S + +
Sbjct: 10 LLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAM-----R 64
Query: 78 KQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHG 137
K Q Y I+ ++ +AI E V + L+ A
Sbjct: 65 KGVINQKTAWIKQQARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDK 124
Query: 138 FIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKRN 173
+ + + P +++V +
Sbjct: 125 LGSLIFTPLDWQLLRKCP--APVWMVKDKEWPEYGT 158
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* Length = 268 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 21/159 (13%), Positives = 45/159 (28%), Gaps = 9/159 (5%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVS---SVSSQSQVYDASATTN 74
I +A D ++ A A + ++ V + +
Sbjct: 3 ILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRT 62
Query: 75 PHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPS 134
++ + + R + + +LE+ +AI A + LVLG
Sbjct: 63 ELERALALRGEAVLERVRQSALAAGVAV-EAVLEEGVPHEAILRRARAADL--LVLGRSG 119
Query: 135 R-HGFIRKFKADVPSSVSKAAPDFCNIYVVSKGKISSKR 172
HG V +A+P + + + +
Sbjct: 120 EAHGDGFGGLGSTADRVLRASP--VPVLLAPGEPVELEG 156
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.85 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.84 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.83 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.83 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.82 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.82 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.81 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.81 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.81 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.8 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.79 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.73 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.68 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.68 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.66 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.66 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.66 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.65 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.62 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.61 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.59 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.46 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.39 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.66 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.11 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 91.71 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 90.61 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.11 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=451.99 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=205.0
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~ 527 (782)
+.|...++||+|+||+||+|.+.+ .||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+.. |||||||+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~ 114 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCE 114 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCC
Confidence 457788999999999999998755 5999999753 3345678999999999999999999999996554 99999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.++|.... ..++|.+++.|+.|||.||.|||+.+ ||||||||+||||++++.+||+|||+|+......
T Consensus 115 gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~--- 186 (307)
T 3omv_A 115 GSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS--- 186 (307)
T ss_dssp SCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC---
Confidence 999999997554 35999999999999999999999999 9999999999999999999999999998764221
Q ss_pred cccccccccCCcccCChhhhhc---CCCCCchhHHHHHHHHHHHHhCCCCCCChH---HHHHHHHhCcccccCCCCCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQLITAKQPMGLTH---FVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~---~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.... .....+..+. ..|.+...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~----~~p~~~~~ 262 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY----ASPDLSKL 262 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC----CCCCSTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----CCCCcccc
Confidence 1223345789999999999864 468999999999999999999999996533 2223333332 23444455
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
+..++..+.+|+.+||+.+|++||++.+++. .|+.|+
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~-~Le~l~ 299 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILS-SIELLQ 299 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH-HHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHH-HHHHHh
Confidence 5666778999999999999999999999873 455443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=451.31 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=210.4
Q ss_pred ccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
++|...+.||+|+||.||+|.+. ++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.. ||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45888899999999999999862 5689999998877777788999999999999999999999997644 99
Q ss_pred EEEeCCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 522 VYEYLANGSLDDRIFRRG----------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
|||||++|+|.++|...+ ....|+|.+++.|+.|||.||.|||+++ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 2346999999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhC
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENG 668 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~ 668 (782)
+|||+|+...... .........||+.|||||++.++.|+.++|||||||+||||+| |+.||......+ ..+..+
T Consensus 170 ~DFGla~~~~~~~---~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 170 GDFGMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp CCCSCHHHHTGGG---CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred CCcccceecCCCC---ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998663221 1112234579999999999999999999999999999999999 999997544322 233333
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
.. ...|...+..+.+|+.+||+.+|++||++.+++ ..|+.+..
T Consensus 247 ~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~-~~L~~~~~ 289 (299)
T 4asz_A 247 RV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH-TLLQNLAK 289 (299)
T ss_dssp CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHH
T ss_pred CC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH-HHHHHHHh
Confidence 21 223445566799999999999999999999885 45655543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=451.68 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=204.5
Q ss_pred ccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
++|...++||+|+||.||+|.+. ++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.. ||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34778899999999999999863 5689999998877777788999999999999999999999997654 99
Q ss_pred EEEeCCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 522 VYEYLANGSLDDRIFRRGN------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
|||||++|+|.++|..... ..+++|.+++.|+.|||.||.|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 246999999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIE 666 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~ 666 (782)
||+|||+|+.+.... .....+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||......+ ..+.
T Consensus 198 Ki~DFGla~~~~~~~---~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTD---YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred EEcccccceeccCCC---cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999998763221 1122345689999999999999999999999999999999999 999997554332 2233
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+. ....|...+..+.+|+.+||+.+|++||++.+++ ..|+.+.
T Consensus 275 ~g~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~-~~L~~l~ 318 (329)
T 4aoj_A 275 QGR--------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH-ARLQALA 318 (329)
T ss_dssp HTC--------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH-HHHHHHH
T ss_pred cCC--------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHH-HHHHHHh
Confidence 332 1123445566799999999999999999999987 3555554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=453.70 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=202.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|.+++.||+|+||+||+|.+ +++.||||++... .....+.|.+|+.+|++|+|||||+++++|.+.. |||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4699999999999999999998 5789999999764 2344678999999999999999999999997655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
||+||+|.++|...+. ..+++.+++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999999975543 35899999999999999999999999 999999999999999999999999999976421
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p 682 (782)
....+..+||+.|||||++.+..|+.++|||||||+||||+||+.||........ .+..+.+ +..+
T Consensus 179 ----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------~~~~ 246 (350)
T 4b9d_A 179 ----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--------PPVS 246 (350)
T ss_dssp ----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------CCCC
T ss_pred ----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--------CCCC
Confidence 1123456899999999999999999999999999999999999999976554332 2223322 1223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
...+.++.+||.+||+.||++||++.+++.+.
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 34456799999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=445.78 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=203.5
Q ss_pred ccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
+...++||+|+||+||+|.+ +++.||||+++.... ...+.|.+|+.+|++++|||||+++|+|.+.. |||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 66778999999999999986 346899999976532 34578999999999999999999999996544 999
Q ss_pred EEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 523 YEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
||||++|+|.++|..... ...++|.+++.|+.|||.||.|||+++ ||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 999999999999975432 235999999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIE 666 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~ 666 (782)
||+|||+|+.+.... .....+..+||+.|||||++.++.|+.++|||||||+||||+| |..||......+ ..+.
T Consensus 185 Ki~DFGlar~~~~~~---~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 185 KISDLGLFREVYAAD---YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp EECCSCCBCGGGGGG---CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred EECCcccceeccCCC---ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999998764321 1223455789999999999999999999999999999999998 899997544322 2233
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+.. ...|..++..+.+|+.+||+.+|++||++.+++
T Consensus 262 ~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~ 298 (308)
T 4gt4_A 262 NRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 298 (308)
T ss_dssp TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 3321 223455666799999999999999999999987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=447.43 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=206.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
..|+..++||+|+||.||+|.+ +++.||||++........+.+.+|+.+|+.++|||||+++++|.+.. |||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 3588899999999999999998 57899999997665555677999999999999999999999996554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
+||+|.+++.+. .+++.++..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 223 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 223 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence 999999988653 3899999999999999999999999 999999999999999999999999999876321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~ 684 (782)
....+..+||+.|||||++.+..|+.++|||||||+||||++|++||......+. .+..+ ..+.+. .+..
T Consensus 224 --~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-----~~~~~~-~~~~ 295 (346)
T 4fih_A 224 --VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-----LPPRLK-NLHK 295 (346)
T ss_dssp --SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----SCCCCS-CGGG
T ss_pred --CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----CCCCCC-cccc
Confidence 2234567999999999999999999999999999999999999999976544332 22222 122222 2234
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+.+|+.+||..||++||++.+++.
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 5567999999999999999999998874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=444.70 Aligned_cols=247 Identities=21% Similarity=0.236 Sum_probs=199.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.+.|...++||+|+||.||+|.+ +++.||||+++... .+.+|+.+|+.++|||||+++++|.+.. ||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35688899999999999999998 57799999997542 2357999999999999999999996654 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~ 604 (782)
|+||+|.++|.+.+ .|++.++..|+.||+.||.|||+++ ||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999997654 4999999999999999999999999 99999999999999887 69999999999774332
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p 682 (782)
...........+||+.|||||++.+..|+.++|||||||+||||+||++||...... ...+..+. +.....|
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 279 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------PPIREIP 279 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC------CGGGGSC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC------CCchhcC
Confidence 221222334568999999999999999999999999999999999999999643211 11111211 1112334
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+..+.+|+.+||+.||.+||++.+++.+
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 4556679999999999999999999988743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=437.53 Aligned_cols=242 Identities=26% Similarity=0.313 Sum_probs=205.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|.+.+.||+|+||+||+|.+ +++.||||++.+.. ....+.+.+|+++|+.|+|||||+++++|.+.. |||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 499999999999999999998 57799999997542 223567899999999999999999999997655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
||+||+|.+++.+.+ .+++.++..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 113 y~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999997654 4999999999999999999999999 9999999999999999999999999999764221
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
......+.+||+.|||||++.+..|+.++|||||||+||+|+||++||...+... ..+..+.+ .+|
T Consensus 187 ---~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~~p 254 (311)
T 4aw0_A 187 ---KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY---------DFP 254 (311)
T ss_dssp ---TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------CCC
T ss_pred ---CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------CCC
Confidence 2233456799999999999999999999999999999999999999997654332 22223321 233
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
...+.++.+|+.+||..||.+||++.+++
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 44456789999999999999999998876
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=450.32 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=206.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+.|+..++||+|+||.||+|.+ +++.||||++........+.+.+|+.+|+.++|||||+++++|.+.. |||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4589999999999999999998 57899999998765566778999999999999999999999996554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
+||+|.+++... .+++.++..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--- 300 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 300 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence 999999988543 3899999999999999999999999 999999999999999999999999999876321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCChh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
....+..+||+.|||||++.+..|+.++|||||||++|||++|++||....... ..+..+ ..+.+.. +..
T Consensus 301 --~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-----~~~~~~~-~~~ 372 (423)
T 4fie_A 301 --VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-----LPPRLKN-LHK 372 (423)
T ss_dssp --CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----CCCCCSC-TTS
T ss_pred --CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----CCCCCcc-ccc
Confidence 223456789999999999999999999999999999999999999997654433 222222 1122221 233
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+.+|+.+||..||++||++.+++.
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4557999999999999999999998874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=430.06 Aligned_cols=241 Identities=26% Similarity=0.407 Sum_probs=195.4
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC------ccEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------YGIIV 522 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~lV 522 (782)
|...++||+|+||+||+|.+ ++..||||++... .....+.|.+|+++|++|+|||||+++++|.+ ..|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35567899999999999998 4668999999653 23446779999999999999999999999843 23899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCceeeeccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVP 601 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~kL~DFGla~~~~ 601 (782)
||||+||+|.+++.+.+ .+++..+..|+.||+.||.|||++++ +||||||||+||||+ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999997654 48999999999999999999999863 599999999999997 48999999999998642
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH---HHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~ld~~~ 678 (782)
. ......+||+.|||||++. +.|+.++|||||||+||||+||+.||....... ..+..+.. |
T Consensus 184 ~-------~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-----~-- 248 (290)
T 3fpq_A 184 A-------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----P-- 248 (290)
T ss_dssp T-------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----C--
T ss_pred C-------CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-----C--
Confidence 1 1234578999999999876 469999999999999999999999996433222 22222211 1
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..++...+.++.+|+.+||+.||++||++.+++.
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223446899999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=432.49 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=197.6
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc------cEEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------GIIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~lV~E 524 (782)
.+|...++||+|+||+||+|.++++.||||+++..... ...+..|+.++..++|||||+++|+|.+. .|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 34778899999999999999999999999999754322 22344566666789999999999999643 389999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK-----PEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
||++|+|.++|... +++|..+.+|+.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999654 3899999999999999999999871 12399999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhcC------CCCCchhHHHHHHHHHHHHhCCCCCCChHH-------------
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTG------MLGVKSDVYSLGILLLQLITAKQPMGLTHF------------- 660 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~ksDVwSlGvil~elltG~~Pf~~~~~------------- 660 (782)
....... ........+||+.|||||++.+. .|+.++|||||||+||||+||.+||+....
T Consensus 158 ~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 158 HDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EETTTTE-ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ccCCCCc-eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 6432211 11223346899999999998754 367899999999999999999887642110
Q ss_pred HHHHHHhCcccccCCCCCCCC--ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 661 VERSIENGTLGEMLDPTVTDW--PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 661 ~~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
....+........++|.++.. +.+.+..+.+|+.+||+.||++||++.+++ ..|..+.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~-~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK-KTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHH-HHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHH-HHHHHHH
Confidence 011111222233345544432 234556799999999999999999999987 3555543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=436.84 Aligned_cols=264 Identities=27% Similarity=0.381 Sum_probs=214.0
Q ss_pred cccHHHHHHHhccccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCch-hhHHHHHHHHHHHHhcCC-CCeee
Q 040785 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDAA-QGRSQFQREIEVLSCIRH-PNMVL 510 (782)
Q Consensus 440 ~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~H-pnIv~ 510 (782)
.|...+++...++|.+.+.||+|+||.||+|.+.+ +.||||+++.... ...+.|.+|+.+|.++.| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34455555566789999999999999999998743 4699999976543 345679999999999965 99999
Q ss_pred ecccccCc---cEEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 040785 511 LLGACPEY---GIIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHR 574 (782)
Q Consensus 511 l~g~~~~~---~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHr 574 (782)
++|+|.+. .|||||||++|+|.++|..... ...+++.+++.|+.|||.||.|||+++ ||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence 99998542 3899999999999999975421 245899999999999999999999999 9999
Q ss_pred CCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCC
Q 040785 575 DLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQ 653 (782)
Q Consensus 575 DLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~ 653 (782)
||||+||||++++.+||+|||+|+.+.... .....+..+||+.|||||++.++.|+.++|||||||+||||+| |+.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~---~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCC---CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 999999999999999999999998763221 2223345689999999999999999999999999999999998 999
Q ss_pred CCCChH---HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 654 PMGLTH---FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 654 Pf~~~~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
||.... .+...+..+.. ...|...+.++.+|+.+||+.||++||++.+++. .|..+
T Consensus 287 Pf~~~~~~~~~~~~i~~g~~--------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~-~L~~l 345 (353)
T 4ase_A 287 PYPGVKIDEEFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE-HLGNL 345 (353)
T ss_dssp SSTTCCCSHHHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCC--------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHH-HHHHH
Confidence 996432 33344444421 1233445567999999999999999999999884 45444
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=421.31 Aligned_cols=242 Identities=28% Similarity=0.454 Sum_probs=190.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|++.+.||+|+||+||+|.+ +++.||||++++.. ......+.+|+.+|+.++|||||++++++.+.. |+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4699999999999999999997 57899999997642 223567999999999999999999999996554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+ +|+|.+.+.+.+ .+++.++..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999 789999887654 4999999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
.....+.+||+.|||||++.+..| +.++|||||||++|+|+||+.||....... ..+..+.. .
T Consensus 165 -----~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~---------~ 230 (275)
T 3hyh_A 165 -----GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY---------T 230 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------C
T ss_pred -----CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---------C
Confidence 122345789999999999988776 689999999999999999999997654322 22333321 2
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+|...+..+.+|+.+||+.||++||++.+++.+.
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 2334456789999999999999999999988544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=430.58 Aligned_cols=238 Identities=26% Similarity=0.324 Sum_probs=193.6
Q ss_pred ccccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
++|++.+.||+|+||+||+|+. .++.||||+++... ......+.+|+++|++++|||||+++++|.+.. ||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4599999999999999999987 35679999997642 223456889999999999999999999996654 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
|||||+||+|.+++.+.+ .+++.++..|+.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999997654 4999999999999999999999999 9999999999999999999999999998653
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
.. .......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+..+ ..+..+.+
T Consensus 178 ~~-----~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------- 243 (304)
T 3ubd_A 178 DH-----EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--------- 243 (304)
T ss_dssp --------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CC-----CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC---------
Confidence 21 123345789999999999999999999999999999999999999997654433 22222221
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLG 708 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~ 708 (782)
.+|...+.++.+|+.+||+.||++||++.
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence 23444556799999999999999999953
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=423.51 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=190.0
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----------
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY---------- 518 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---------- 518 (782)
+|++.+.||+|+||+||+|.+ +++.||||+++... ....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 499999999999999999998 57899999996543 33456799999999999999999999987431
Q ss_pred ----cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecc
Q 040785 519 ----GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594 (782)
Q Consensus 519 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DF 594 (782)
.|+|||||++|+|.+++..........+..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 3799999999999999987665556778889999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccc-------cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh
Q 040785 595 GLARLVPAVAENV-------TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN 667 (782)
Q Consensus 595 Gla~~~~~~~~~~-------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~ 667 (782)
|+|+.+....... .....+..+||+.|||||++.+..|+.++|||||||+||||++ ||.........+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9998774322111 1123345689999999999999999999999999999999996 88654322222111
Q ss_pred CcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 668 GTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 668 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. ....+..+......+.+|+.+||+.||.+||++.+++.
T Consensus 240 ~~-----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 240 VR-----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Hh-----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 11111111233345788999999999999999998874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=417.15 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=198.9
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC--------c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE--------Y 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~ 518 (782)
++|.+.+.||+|+||+||+|.+ +++.||||+++... ....+.+.+|+.+|+.|+|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5699999999999999999998 57899999997542 3345678899999999999999999998742 2
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.|||||||. |+|.+++... .++++.++..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 399999995 6799988654 35999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH----HhCccccc
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI----ENGTLGEM 673 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~----~~~~~~~~ 673 (782)
.+..... ......+..+||+.|||||++.+. .|+.++||||+|||+|||++|++||...+..+... ..+.....
T Consensus 207 ~~~~~~~-~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPA-EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC--------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecccCcc-ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 7633211 123344567999999999988765 57999999999999999999999997654433211 11221111
Q ss_pred CCCC---------------CCCCC-----hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 LDPT---------------VTDWP-----FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 ld~~---------------~~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.... ....+ +.....+.+|+.+||..||.+||++.++|.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1000 00001 123456889999999999999999998874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=402.24 Aligned_cols=197 Identities=25% Similarity=0.363 Sum_probs=164.9
Q ss_pred HhccccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--E
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~ 520 (782)
..+.|.+.++||+|+||+||+|.+ .+..||||++.... ....+.+|+++|..+ .|||||+++++|.+.. |
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 456799999999999999999986 24689999987643 235688999999998 6999999999986544 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeeccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARL 599 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla~~ 599 (782)
|||||+++|+|.+++. .+++.++..|+.||+.||.|||+++ ||||||||+||||+.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999882 3899999999999999999999999 9999999999999877 7999999999986
Q ss_pred cccccccc-----------------------cccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCC
Q 040785 600 VPAVAENV-----------------------TQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 600 ~~~~~~~~-----------------------~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf 655 (782)
........ .....+..+||+.|||||++.+. .|+.++||||+|||+|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 53211100 11123456899999999988775 5899999999999999999999999
Q ss_pred C
Q 040785 656 G 656 (782)
Q Consensus 656 ~ 656 (782)
.
T Consensus 248 ~ 248 (361)
T 4f9c_A 248 Y 248 (361)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=424.38 Aligned_cols=246 Identities=21% Similarity=0.342 Sum_probs=205.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++........+.+.+|+.+|+.|+|||||+|+++|.+.. |||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5699999999999999999998 57799999998776666778999999999999999999999997655 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC--Cceeeecccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN--YVSKISDVGLARLVPAVA 604 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~--~~~kL~DFGla~~~~~~~ 604 (782)
+||+|.++|.... ..|++.++..|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 237 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred CCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999886443 35999999999999999999999999 9999999999999854 89999999999876421
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p 682 (782)
......+||+.|||||++.+..|+.++|||||||+||||++|++||......+. .+..+.+. +.+ ..+
T Consensus 311 -----~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--~~~---~~~ 380 (573)
T 3uto_A 311 -----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDD---SAF 380 (573)
T ss_dssp -----SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCS---GGG
T ss_pred -----CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--CCc---ccc
Confidence 223456899999999999999999999999999999999999999976554332 22222211 111 111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+||.+||..||.+||++.+++.
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234456899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=418.28 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=195.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHH---HHHHHhcCCCCeeeecccccCcc--E
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQRE---IEVLSCIRHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E---i~iL~~l~HpnIv~l~g~~~~~~--~ 520 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++.+... .....+.+| +.+++.++|||||+++++|.+.. |
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4599999999999999999998 577999999965321 112233444 56667789999999999996654 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
||||||+||+|.++|.+.+ .|++..+..|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999997654 4999999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHH-----HHHHHHhCcccccC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHF-----VERSIENGTLGEML 674 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~l 674 (782)
.. ....+.+||+.|||||++.. ..|+.++||||||||||||++|++||..... ....+....
T Consensus 343 ~~-------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~----- 410 (689)
T 3v5w_A 343 SK-------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----- 410 (689)
T ss_dssp SS-------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-----
T ss_pred CC-------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-----
Confidence 32 12345789999999999875 4799999999999999999999999964321 111111111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCC-----hHHhhhH
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPD-----LGKVVLP 713 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs-----~~~vl~~ 713 (782)
..+|...+.++.+||.+||..||.+|++ +.+++.+
T Consensus 411 ----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1234455667999999999999999998 4666543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=378.04 Aligned_cols=274 Identities=38% Similarity=0.652 Sum_probs=224.7
Q ss_pred ccccHHHHHHHhccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC
Q 040785 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE 517 (782)
Q Consensus 439 ~~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~ 517 (782)
.++.+.++...+++|...+.||+|+||.||+|.+ ++..||||++........+.+.+|+.++..++||||++++++|.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3455556667788999999999999999999997 478999999987766667889999999999999999999999965
Q ss_pred cc--EEEEEeCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecc
Q 040785 518 YG--IIVYEYLANGSLDDRIFRRGN-TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594 (782)
Q Consensus 518 ~~--~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DF 594 (782)
.. ++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 44 999999999999998865432 235999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH---------HHHHHH
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH---------FVERSI 665 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---------~~~~~~ 665 (782)
|+++...... .........||+.|+|||++.++.++.++|||||||++|+|++|+.||.... +.....
T Consensus 184 g~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 184 GISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp TTCEECSSSS---CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred cccccccccc---ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 9998653211 1112234568999999999999999999999999999999999999995321 122333
Q ss_pred HhCcccccCCCCCC-CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 666 ENGTLGEMLDPTVT-DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 666 ~~~~~~~~ld~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+.+...+++... ..+...+..+.+++.+||+.+|++||++.+++. .|+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~-~L~~~l 314 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW-KLEYAL 314 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH-HHHHHh
Confidence 45556666666553 456777888999999999999999999998873 555443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=372.04 Aligned_cols=247 Identities=26% Similarity=0.373 Sum_probs=205.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
++|...+.||+|+||.||+|.+ +++.||||++........+.+.+|+.+++.++||||++++++|.... |+||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 4689999999999999999987 67799999997665555678999999999999999999999986443 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 169 (297)
T 3fxz_A 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (297)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred CCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc---
Confidence 999999998654 3899999999999999999999999 999999999999999999999999999866321
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||................ .+. ...+...+
T Consensus 170 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~-~~~~~~~~ 243 (297)
T 3fxz_A 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TPE-LQNPEKLS 243 (297)
T ss_dssp --TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC---SCC-CSCGGGSC
T ss_pred --ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCC-CCCccccC
Confidence 122345689999999999999999999999999999999999999997654433221110000 011 12234455
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+.+|+.+||+.+|.+||++.+++.+
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 679999999999999999999999853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=369.08 Aligned_cols=275 Identities=37% Similarity=0.608 Sum_probs=226.4
Q ss_pred cccccccHHHHHHHhcccccc------ceeeeeCcEeEEEEEECCeeEEEEEecCCc----hhhHHHHHHHHHHHHhcCC
Q 040785 436 LRYRRYTIEDIEEATQFFTES------RKIGEGGYGPVYKCYLDHTPVAVKVLRPDA----AQGRSQFQREIEVLSCIRH 505 (782)
Q Consensus 436 ~~~~~~~~~~~~~~t~~f~~~------~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l~H 505 (782)
..+..|++.++..++++|... +.||+|+||.||+|.++++.||||++.... ....+.|.+|+.++..++|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 456789999999999999887 899999999999999999999999996532 2345679999999999999
Q ss_pred CCeeeecccccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 506 PNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 506 pnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
|||+++++++.+.. ++||||+++|+|.+++.......++++..++.|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999996544 999999999999999976655567999999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH---
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF--- 660 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~--- 660 (782)
+.++.+||+|||+++...... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFA---QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCS---SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred cCCCcEEEeeccccccccccc---ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 999999999999998653221 1122234579999999998764 589999999999999999999999964321
Q ss_pred ---HHHHHH--hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 661 ---VERSIE--NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 661 ---~~~~~~--~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
....+. ...+...+++.+...+...+..+.+++.+||+.+|.+||++.+++ ..|+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~-~~L~~l 304 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ-QLLQEM 304 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHH-HHHHHH
T ss_pred HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHH-HHHHHH
Confidence 111111 222344455666667778888899999999999999999998887 355544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=377.55 Aligned_cols=270 Identities=36% Similarity=0.628 Sum_probs=220.8
Q ss_pred cccccHHHHHHHhccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh-hHHHHHHHHHHHHhcCCCCeeeecccc
Q 040785 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSCIRHPNMVLLLGAC 515 (782)
Q Consensus 438 ~~~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 515 (782)
...|++.++...+++|...+.||+|+||.||+|.+ +++.||||++...... ....|.+|+.++..++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 46789999999999999999999999999999987 5789999999765322 234689999999999999999999998
Q ss_pred cCcc--EEEEEeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 516 PEYG--IIVYEYLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 516 ~~~~--~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
.+.. ++||||+++|+|.+++.... ...++++..+..|+.|++.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 6544 99999999999999997653 34569999999999999999999999911129999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-----------H
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF-----------V 661 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-----------~ 661 (782)
|||+++..... .........||+.|+|||++.++.++.++|||||||++|+|++|+.||..... .
T Consensus 177 Dfg~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 177 DFGLAKLMDYK----DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp CCSSCEECCSS----SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred cCccccccCcc----cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99999876322 11223445699999999999999999999999999999999999999963221 1
Q ss_pred HHHHHhCcccccCCCCC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 662 ERSIENGTLGEMLDPTV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 662 ~~~~~~~~~~~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
........+..+.+... ...+...+..+.+++.+||+.+|.+||++.+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 303 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHH
Confidence 11222333444444443 245667778899999999999999999999887
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=373.24 Aligned_cols=258 Identities=32% Similarity=0.491 Sum_probs=201.6
Q ss_pred HhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
..++|.+.+.||+|+||.||+|.+.++.||||++.... ......|.+|+.+|.+++||||++++++|.+.. ++|||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 34579999999999999999999999999999997653 334567899999999999999999999996654 99999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++........+++..++.|+.||+.||.|||+.++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 192 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST- 192 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccccc-
Confidence 99999999999765433458999999999999999999999873 5999999999999999999999999999864321
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChh
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ......|..
T Consensus 193 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~ 263 (309)
T 3p86_A 193 ----FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-----CKRLEIPRN 263 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS-----CCCCCCCTT
T ss_pred ----ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----CCCCCCCcc
Confidence 12234567999999999999999999999999999999999999999765443322111100 011123344
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+..+.+|+.+||+.+|.+||++.+++ ..|..+
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll-~~L~~~ 296 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIM-DLLRPL 296 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHH-HHHHHH
Confidence 556799999999999999999998887 344444
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=372.05 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=203.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|+.++||||+++++++.... |+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 34699999999999999999998 6789999999654 2334567889999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999765321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCC-CchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLG-VKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||....... ..+..+.+ .
T Consensus 168 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~ 232 (328)
T 3fe3_A 168 ------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---------R 232 (328)
T ss_dssp ------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred ------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------C
Confidence 223456899999999999888875 79999999999999999999997654432 22333322 2
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.|...+..+.+|+.+||..||.+||++.+++.
T Consensus 233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23344566899999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=372.33 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=203.0
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc------cEEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------GIIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~lV~E 524 (782)
++|.+.+.||+|+||.||+|.+.++.||||++.... .....+.+|+.+|..++||||++++++|.+. .++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 569999999999999999999999999999997653 3344567799999999999999999998653 289999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCCeeecCCCCceEEEcCCCceeeecc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT----------KPEPLVHRDLKPGNILLDHNYVSKISDV 594 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------~~~~iiHrDLKp~NILld~~~~~kL~DF 594 (782)
|+++|+|.+++... .+++..++.|+.||+.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 103 ~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 103 FHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999653 389999999999999999999998 8 999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhhcC-----CCCCchhHHHHHHHHHHHHhCCCCCCChH------HH--
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-----MLGVKSDVYSLGILLLQLITAKQPMGLTH------FV-- 661 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG~~Pf~~~~------~~-- 661 (782)
|+++.+.... .........||+.|+|||++.+. .++.++|||||||++|||+||+.||.... +.
T Consensus 176 g~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 176 GLALKFEAGK---SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp TTCEEECTTS---CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred Cccccccccc---CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 9998764321 11223346799999999998763 45678999999999999999999995321 00
Q ss_pred ------HHHHHhCcccccCCCCCCCC--ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHHH
Q 040785 662 ------ERSIENGTLGEMLDPTVTDW--PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLREL 721 (782)
Q Consensus 662 ------~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~~ 721 (782)
...+..........+..... +...+..+.+|+.+||+.+|++||++.+++ ..|..+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell-~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG-ERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH-HHHHHHHHH
Confidence 00111111111222222221 123456699999999999999999998887 466666543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=367.73 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=205.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
++|...+.||+|+||.||+|.+ ++..||+|++..........|.+|+.+|..++||||++++++|.+.. ++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4588999999999999999998 47789999997766677788999999999999999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.... ..+++.+++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999997643 34899999999999999999999999 999999999999999999999999999876332111
Q ss_pred cc---------ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCC
Q 040785 607 VT---------QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPT 677 (782)
Q Consensus 607 ~~---------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 677 (782)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||........... ......++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhccccc-
Confidence 00 1111256899999999999999999999999999999999999999853211000000 000000000
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHHH
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLREL 721 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~~ 721 (782)
..+...+..+.+|+.+||+.+|++||++.+++ ..|..++..
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~-~~L~~l~~~ 283 (310)
T 3s95_A 243 --YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE-HWLETLRMH 283 (310)
T ss_dssp --TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHHH
T ss_pred --cCCCCCCHHHHHHHHHHccCChhhCcCHHHHH-HHHHHHHHh
Confidence 01223334589999999999999999998887 466766654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=367.38 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=209.3
Q ss_pred cccHHHHHHHhcc----------ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC
Q 040785 440 RYTIEDIEEATQF----------FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN 507 (782)
Q Consensus 440 ~~~~~~~~~~t~~----------f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn 507 (782)
.++.+++..+++. |...++||+|+||.||+|.+ +++.||||++........+.+.+|+.++..++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666666543 77788999999999999998 57899999998766566778999999999999999
Q ss_pred eeeecccccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC
Q 040785 508 MVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH 585 (782)
Q Consensus 508 Iv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~ 585 (782)
|++++++|.... ++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999986543 899999999999998853 24899999999999999999999999 999999999999999
Q ss_pred CCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--
Q 040785 586 NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER-- 663 (782)
Q Consensus 586 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~-- 663 (782)
++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCcEEEeeeeeeeecccCc-----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999998663211 122456899999999999999999999999999999999999999975543322
Q ss_pred HHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 664 SIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 664 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.... .+.. ..+...+..+.+|+.+||+.+|++||++.+++.
T Consensus 252 ~~~~~~-----~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLRDSP-----PPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHSS-----CCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCC-----CCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122211 1111 112334556999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.22 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=204.0
Q ss_pred ccccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC----ccE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE----YGI 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 520 (782)
++|++.+.||+|+||.||+|.+ +++.||||++........+.|.+|+.+|..++||||++++++|.. ..+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4689999999999999999984 567899999987766667889999999999999999999998843 348
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999976532 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH-HHhCcc---------
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS-IENGTL--------- 670 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~--------- 670 (782)
..... .........||..|+|||++.+..++.++|||||||++|+|++|..||......... +.....
T Consensus 165 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 165 PQDKE--FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cCCcc--eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 43211 112223456788899999999999999999999999999999999999754321110 000000
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 671 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+........|...+..+.+|+.+||+.+|.+||++.+++ ..|..++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~-~~L~~l~ 290 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA-LRVDQIR 290 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH-HHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHH-HHHHHHH
Confidence 00001111223445556799999999999999999998887 3555554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=375.16 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=207.0
Q ss_pred ccccccceeeeeCcEeEEEEEEC---------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 519 (782)
++|.+.+.||+|+||.||+|.+. +..||||+++... ......+.+|+.+|..+ +||||++++++|.+..
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 46899999999999999999862 2369999997653 33456799999999999 8999999999996554
Q ss_pred --EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 520 --IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
|+||||+++|+|.+++..... ...+++.+++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 999999999999999976532 235899999999999999999999999 99999999999999
Q ss_pred CCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV-- 661 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~-- 661 (782)
.++.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCC---TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCCCEEEccccCCcccCccc---ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999998663221 1112234567899999999999999999999999999999999 99999654321
Q ss_pred HHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHHH
Q 040785 662 ERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLREL 721 (782)
Q Consensus 662 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~~ 721 (782)
...+..+. ....|...+..+.+|+.+||+.+|.+||++.+++. .|+.+...
T Consensus 315 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~-~L~~il~~ 365 (370)
T 2psq_A 315 FKLLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRILTL 365 (370)
T ss_dssp HHHHHTTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHHH
T ss_pred HHHHhcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHHHH
Confidence 12222221 11233445567999999999999999999998874 66665543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=367.94 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=203.4
Q ss_pred ccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
++|.+.+.||+|+||.||+|.+. +..||||+++.. .....+.|.+|+.+|..++||||++++++|.+.. |+|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46889999999999999999982 346999999765 3344677999999999999999999999997654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 129 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999986543 34999999999999999999999999 99999999999999999999999999987643
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+. ..
T Consensus 204 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------~~ 273 (325)
T 3kul_A 204 DPD--AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--------RL 273 (325)
T ss_dssp -----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--------CC
T ss_pred Ccc--ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--------CC
Confidence 211 1222334567889999999999999999999999999999999 999996544322 2222221 11
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+...+..+.+|+.+||..+|.+||++.+++ ..|+.+.
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil-~~L~~l~ 312 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV-SVLDALI 312 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHHHHH-HHHHHHH
Confidence 12334456799999999999999999999887 3555553
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.10 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=201.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
.++|.+.+.||+|+||.||+|.+ .+..||||++... .....+.|.+|+.++..++||||+++++++.+.. |+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35699999999999999999998 5778999998543 2334567899999999999999999999997654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++...+ ++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997654 4899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .....+.....+
T Consensus 164 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~ 237 (294)
T 4eqm_A 164 TS----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI--QDSVPNVTTDVR 237 (294)
T ss_dssp ---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH--SSCCCCHHHHSC
T ss_pred cc----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hccCCCcchhcc
Confidence 11 112234579999999999999999999999999999999999999997665443322111 111111111123
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
...+..+.+++.+||+.+|.+||+..+.+...|..
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 34456799999999999999999666666555544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=361.03 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=199.2
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCccEEEEEeCCCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYGIIVYEYLANGS 530 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~lV~Ey~~~gs 530 (782)
++|.+.+.||+|+||.||+|.+.++.||||++... ...+.|.+|+.+|.+++||||++++++|.+..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 35888999999999999999999999999999754 3457899999999999999999999999988899999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc-eeeeccccccccccccccccc
Q 040785 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV-SKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 531 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~-~kL~DFGla~~~~~~~~~~~~ 609 (782)
|.+++......+.+++..++.++.|++.||.|||+.++.+|+||||||+|||++.++. +||+|||++.....
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~------- 158 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT------- 158 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-------
Confidence 9999976655556899999999999999999999943333999999999999988886 79999999975532
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH--H--HHHHHHhCcccccCCCCCCCCChhH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH--F--VERSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~--~--~~~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... . .......+.. ...+...
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 229 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--------PPLIKNL 229 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--------CCCBTTC
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--------CCccccc
Confidence 1223469999999999999999999999999999999999999996421 1 1111122211 1122334
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+..+.+|+.+||+.+|.+||++.+++ ..|..+
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell-~~L~~~ 261 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIV-KIMTHL 261 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHH-HHHHHH
Confidence 45689999999999999999998887 345544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=372.31 Aligned_cols=247 Identities=22% Similarity=0.362 Sum_probs=202.7
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh------hHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ------GRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.+.|.+.+.||+|+||.||+|.+ ++..||||+++..... ..+.+.+|+.+|..++||||++++++|.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45699999999999999999998 4779999999764322 2467899999999999999999999996654
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC----ceeeeccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY----VSKISDVG 595 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~----~~kL~DFG 595 (782)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 8999999999999998543 35999999999999999999999999 99999999999998777 79999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCccccc
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEM 673 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ 673 (782)
+++.+... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+.+.
T Consensus 165 ~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-- 236 (361)
T 2yab_A 165 LAHEIEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD-- 236 (361)
T ss_dssp SCEECCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--
T ss_pred CceEcCCC------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--
Confidence 99876321 12345679999999999999999999999999999999999999997554332 222222111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+++ ..+...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 237 ~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 FDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0112234568999999999999999999999843
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=367.94 Aligned_cols=243 Identities=24% Similarity=0.282 Sum_probs=202.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|...+.||+|+||.||+|.. +++.||||++++.. ......+.+|+.+|..++||||++++++|.+.. |+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 4699999999999999999998 57799999997542 223567889999999999999999999996554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc-
Confidence 9999999999887654 4899999999999999999999999 99999999999999999999999999985422
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+. ..+
T Consensus 158 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------~~~ 224 (337)
T 1o6l_A 158 ----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRF 224 (337)
T ss_dssp ----TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CCC
T ss_pred ----CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CCC
Confidence 1122345689999999999999999999999999999999999999997544322 2222221 123
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCC-----ChHHhhhH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRP-----DLGKVVLP 713 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~~ 713 (782)
|...+..+.+|+.+||+.+|.+|| ++.+++.+
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 344556799999999999999999 78887754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=365.18 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=200.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------- 518 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+|++++||||++++++|.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35699999999999999999998 57899999997543 33457799999999999999999999987321
Q ss_pred ---------------------------------------------------cEEEEEeCCCCChhHHHhhcCCCCCCCHH
Q 040785 519 ---------------------------------------------------GIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547 (782)
Q Consensus 519 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 547 (782)
.++||||+++|+|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 48999999999999999877666667888
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc-------ccccccccCCcc
Q 040785 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT-------QYHLTSTAGTFC 620 (782)
Q Consensus 548 ~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~~~~Gt~~ 620 (782)
.++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987643221111 122345679999
Q ss_pred cCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccC
Q 040785 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELR 700 (782)
Q Consensus 621 Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~ 700 (782)
|+|||++.+..++.++|||||||++|+|++|..|+............+. .+..+......+.+|+.+||+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~ 313 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK--------FPLLFTQKYPQEHMMVQDMLSPS 313 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTC--------CCHHHHHHCHHHHHHHHHHHCSS
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccC--------CCcccccCChhHHHHHHHHccCC
Confidence 9999999999999999999999999999999888633222222222221 11112233456899999999999
Q ss_pred cCCCCChHHhhh
Q 040785 701 RKDRPDLGKVVL 712 (782)
Q Consensus 701 P~~RPs~~~vl~ 712 (782)
|.+||++.+++.
T Consensus 314 p~~Rps~~~~l~ 325 (332)
T 3qd2_B 314 PTERPEATDIIE 325 (332)
T ss_dssp GGGSCCHHHHHH
T ss_pred CCcCCCHHHHhh
Confidence 999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=371.17 Aligned_cols=265 Identities=27% Similarity=0.383 Sum_probs=211.6
Q ss_pred cccHHHHHHHhccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeee
Q 040785 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVL 510 (782)
Q Consensus 440 ~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~ 510 (782)
.+....++...++|.+.+.||+|+||.||+|.+ +++.||||+++... ....+.+.+|+.+|.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 445555556678899999999999999999985 23689999997653 33456799999999999 7999999
Q ss_pred ecccccCc---cEEEEEeCCCCChhHHHhhcCC-----------------------------------------------
Q 040785 511 LLGACPEY---GIIVYEYLANGSLDDRIFRRGN----------------------------------------------- 540 (782)
Q Consensus 511 l~g~~~~~---~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------- 540 (782)
++++|.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 99998653 4899999999999999976532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 541 ----------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 541 ----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999999 9999999999999999999999999998663221
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH---HHHHHHHhCcccccCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH---FVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~---~~~~~~~~~~~~~~ld~~~~~ 680 (782)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .....+..+.. ..
T Consensus 248 ---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 316 (359)
T 3vhe_A 248 ---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--------MR 316 (359)
T ss_dssp ---TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC--------CC
T ss_pred ---cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC--------CC
Confidence 2223345678999999999999999999999999999999998 999996432 22233333321 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.|...+..+.+++.+||+.+|.+||++.+++. .|..+.
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~-~L~~~~ 354 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE-HLGNLL 354 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH-HHHHHH
Confidence 23334456999999999999999999998874 455443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=371.90 Aligned_cols=246 Identities=25% Similarity=0.312 Sum_probs=197.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.. |+||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 5699999999999999999998 577999999965432 23467899999999999999999999997654 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 159 (323)
T 3tki_A 87 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 159 (323)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred CCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC-
Confidence 9999999988543 34899999999999999999999999 9999999999999999999999999998663221
Q ss_pred cccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHH---HHHHHhCcccccCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFV---ERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~ld~~~~~~ 681 (782)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ...+..... .+ ..
T Consensus 160 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~-----~~ 230 (323)
T 3tki_A 160 --RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YL-----NP 230 (323)
T ss_dssp --EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TS-----TT
T ss_pred --cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cC-----Cc
Confidence 1222345689999999999987775 77999999999999999999999643321 111111110 00 11
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+..+.+|+.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1234456889999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.20 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=205.6
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+++|..++||||+++++++... .|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56899999999999999999984 7799999997543 23356788999999999999999999988542 38999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE----cCCCceeeeccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARL 599 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----d~~~~~kL~DFGla~~ 599 (782)
||+++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999987655556999999999999999999999999 9999999999999 8888999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhh--------cCCCCCchhHHHHHHHHHHHHhCCCCCCChH-------HHHHH
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQ--------TGMLGVKSDVYSLGILLLQLITAKQPMGLTH-------FVERS 664 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~s~ksDVwSlGvil~elltG~~Pf~~~~-------~~~~~ 664 (782)
.... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.... .....
T Consensus 166 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 166 LEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CCTT------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred cCCC------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 6321 1223467999999999886 4678999999999999999999999995211 11111
Q ss_pred HHhCcccccC----------------CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 665 IENGTLGEML----------------DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 665 ~~~~~~~~~l----------------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
+ .+.....+ -+.....+...+..+.+|+.+||+.||++||++.+++.+..+
T Consensus 240 ~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 240 I-TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp H-HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred h-cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 1 11111000 011123445677789999999999999999999999865443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.48 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=205.2
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
++|...+.||+|+||.||+|.+ ++..||||++..... ..+.+.+|+.++.+++||||++++++|.+.. ++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4589999999999999999998 677899999976532 3467999999999999999999999997654 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 159 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---- 159 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH----
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc----
Confidence 999999986543 35899999999999999999999999 999999999999999999999999999865322
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||........ .+..+. . ...+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~~ 231 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----R---LYKPRL 231 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----C---CCCCTT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----c---CCCCCc
Confidence 1122334567889999999999999999999999999999999 9999976544322 122221 1 111233
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+..+.+++.+||+.+|.+||++.+++. .|..+.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~-~l~~l~ 265 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLR-QLAEIA 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHH-HHHHHH
Confidence 3456999999999999999999988873 454443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=352.14 Aligned_cols=244 Identities=30% Similarity=0.470 Sum_probs=192.8
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCch----hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAA----QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|...+.||+|+||.||+|.+.++.||||+++.... ...+.+.+|+.++..++||||++++++|.+.. ++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4688999999999999999999999999999875432 22467899999999999999999999996554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC--------CCceeeecccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH--------NYVSKISDVGL 596 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~--------~~~~kL~DFGl 596 (782)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 87 FARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred cCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999998842 35899999999999999999999998556899999999999986 77899999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH--HhCcccccC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--ENGTLGEML 674 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~l 674 (782)
++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .....
T Consensus 163 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 231 (271)
T 3dtc_A 163 AREWHRT-------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL---- 231 (271)
T ss_dssp --------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC----
T ss_pred ccccccc-------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC----
Confidence 9865321 1224579999999999999999999999999999999999999997654332221 11111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 232 ---ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11223344566999999999999999999998873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=366.58 Aligned_cols=255 Identities=30% Similarity=0.467 Sum_probs=206.5
Q ss_pred HhccccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG- 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 519 (782)
..++|...+.||+|+||.||+|.+.+ +.||||+++... ......|.+|+.++..++||||++++++|.+..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 35679999999999999999999853 689999997653 334567999999999999999999999986544
Q ss_pred -EEEEEeCCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN---------------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLK 577 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK 577 (782)
++||||+++|+|.+++..... ...+++.+++.|+.||+.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 999999999999999976431 146999999999999999999999999 9999999
Q ss_pred CceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 040785 578 PGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMG 656 (782)
Q Consensus 578 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~ 656 (782)
|+|||++.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG---CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEEECCCCeEEEeecCCCcccccCc---cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999998653221 1122234578999999999999999999999999999999999 999997
Q ss_pred ChHHHH--HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 657 LTHFVE--RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 657 ~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
...... ..+..+.. ...|...+..+.+|+.+||+.+|.+||++.+++ ..|..+
T Consensus 279 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~-~~L~~~ 333 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIH-RILQRM 333 (343)
T ss_dssp TSCHHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHT
T ss_pred CCChHHHHHHHhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH-HHHHHH
Confidence 554322 22223321 122334456799999999999999999998886 345444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=370.22 Aligned_cols=238 Identities=25% Similarity=0.323 Sum_probs=194.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~l 521 (782)
.++|...+.||+|+||.||+|.+ +++.||||+++... ......+.+|+.+|..+ .||||++++++|.+.. |+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 35699999999999999999998 46799999997542 22345678999999988 6999999999996654 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999987654 4899999999999999999999999 9999999999999999999999999998542
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... ..+..+.+
T Consensus 176 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------- 241 (353)
T 3txo_A 176 C-----NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--------- 241 (353)
T ss_dssp C--------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred c-----CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 1 1122345689999999999999999999999999999999999999997654332 22222211
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
.+|...+..+.+|+.+||..+|.+||++
T Consensus 242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 242 VYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 2233445568999999999999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=366.17 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=200.0
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-----
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG----- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----- 519 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||+++... ......|.+|+.++..++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35699999999999999999997 67899999997653 233457899999999999999999999885432
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
|+||||+++|+|.+++...+ .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 89999999999999997654 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCC
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTV 678 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 678 (782)
.+..... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ....+
T Consensus 165 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~-- 239 (311)
T 3ork_A 165 AIADSGN--SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPP-- 239 (311)
T ss_dssp -------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CCCCH--
T ss_pred ccccccc--ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-CCCCc--
Confidence 7643211 111223457999999999999999999999999999999999999999765543322111100 00000
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
...+...+..+.+|+.+||+.+|.+||+..+++.+.|.++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00112234568999999999999999999999877766553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=367.89 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=202.0
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-----hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--E
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-----QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~ 520 (782)
.+.|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.++..++||||++++++|.+.. |
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34699999999999999999998 578999999864321 13567999999999999999999999986554 8
Q ss_pred EEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc---eeeecccc
Q 040785 521 IVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV---SKISDVGL 596 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~---~kL~DFGl 596 (782)
+||||+++|+|.+.+... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887654 23345899999999999999999999999 999999999999976654 99999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH-HHHHHhCcccccCC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV-ERSIENGTLGEMLD 675 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~ld 675 (782)
++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+.+.. .
T Consensus 180 a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~--~ 252 (351)
T 3c0i_A 180 AIQLGES-----GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM--N 252 (351)
T ss_dssp CEECCTT-----SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCC--C
T ss_pred eeEecCC-----CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCC--C
Confidence 9876321 12234568999999999999999999999999999999999999999765321 12222222110 0
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+ ......+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 253 ~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 253 P---RQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp H---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred c---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 0 00012345689999999999999999999998544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=357.23 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=196.3
Q ss_pred hccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHh--cCCCCeeeecccccCc------cEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSC--IRHPNMVLLLGACPEY------GII 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~~------~~l 521 (782)
.++|.+.+.||+|+||.||+|.++++.||||++... ....+.+|.+++.. ++||||+++++++.+. .++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 456999999999999999999999999999999753 34566777777776 7999999999986332 389
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCceEEEcCCCceeeec
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH--------QTKPEPLVHRDLKPGNILLDHNYVSKISD 593 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~iiHrDLKp~NILld~~~~~kL~D 593 (782)
||||+++|+|.+++.. ..+++..++.|+.||+.||.||| +.+ |+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 9999999999999843 24899999999999999999999 777 99999999999999999999999
Q ss_pred cccccccccccccccccccccccCCcccCChhhhhcC------CCCCchhHHHHHHHHHHHHhC----------CCCCCC
Q 040785 594 VGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG------MLGVKSDVYSLGILLLQLITA----------KQPMGL 657 (782)
Q Consensus 594 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~ksDVwSlGvil~elltG----------~~Pf~~ 657 (782)
||+++........ .........||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 157 fg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CTTCEEEETTTTE-EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCeeeccccccc-ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999866332111 11123345899999999998876 455799999999999999999 888843
Q ss_pred hH-------HHHHHHHhCcccccCCCCCCC--CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 658 TH-------FVERSIENGTLGEMLDPTVTD--WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 658 ~~-------~~~~~~~~~~~~~~ld~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
.. ........ ....+..+. .+...+..+.+|+.+||+.+|.+||++.+++. .|..
T Consensus 236 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~-~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK-TLTK 299 (301)
T ss_dssp TSCSSCCHHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH-HHHH
T ss_pred cCCCCcchhhhhHHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH-HHhc
Confidence 21 11111111 111222211 12346677999999999999999999988873 4443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=364.01 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=201.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh------hHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ------GRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|...+.||+|+||.||+|.+ ++..||||++...... ....+.+|+.+|..++||||++++++|.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35699999999999999999998 4779999999754321 3567999999999999999999999986554
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC----ceeeeccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY----VSKISDVG 595 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~----~~kL~DFG 595 (782)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 8999999999999998543 35899999999999999999999999 99999999999998887 79999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCccccc
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEM 673 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ 673 (782)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+......
T Consensus 164 ~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-- 235 (326)
T 2y0a_A 164 LAHKIDFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-- 235 (326)
T ss_dssp TCEECCTT------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC--
T ss_pred CCeECCCC------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC--
Confidence 99876321 122346799999999999999999999999999999999999999965443221 12221110
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+. ...+...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 236 ~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 FE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC---HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cC---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00112234568999999999999999999999843
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=371.89 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=204.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++|...+.||+|+||.||+|.+ +++.||||+++... ......|.+|+.+|+.++||||++++++|.+.. |+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 35689999999999999999998 57899999997653 233467899999999999999999999996544 99999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++...+ ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999997654 24899999999999999999999999 9999999999999999999999999998643211
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~ 681 (782)
.........+|+.|+|||++.++.++.++|||||||++|||++ |..||...... ...+..+.. ...
T Consensus 268 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 336 (377)
T 3cbl_A 268 ---YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR--------LPC 336 (377)
T ss_dssp ---EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC--------CCC
T ss_pred ---eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCC
Confidence 1111122346778999999999999999999999999999998 99999754432 222333211 122
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
|...+..+.+|+.+||+.+|.+||++.+++ ..|..++
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~-~~L~~i~ 373 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIY-QELQSIR 373 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHH-HHHHHHH
Confidence 334455699999999999999999998887 4566554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.48 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=204.3
Q ss_pred hccccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.++|...+.||+|+||.||+|.+. +..||||++..... ....+.+|+.++..++||||++++++|.+.. ++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 356899999999999999999884 45899999976532 3467999999999999999999999997654 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 158 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-- 158 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh--
Confidence 9999999997653 24899999999999999999999999 9999999999999999999999999998663221
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCcccccCCCCCCCCChhH
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
........||+.|+|||++.+..++.++||||||+++|+|++ |..||.................. ..|...
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~ 230 (268)
T 3sxs_A 159 --YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL------YRPHLA 230 (268)
T ss_dssp --EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------CCCTTS
T ss_pred --hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC------CCCCcC
Confidence 122234567888999999999899999999999999999999 99999765443322211111111 112223
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+..+.+++.+||+.+|.+||++.+++. .|+.+
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~-~L~~l 262 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLS-SIEPL 262 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHH-HHGGG
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHh
Confidence 456999999999999999999998873 44443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=367.01 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=203.8
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
..++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|..++||||++++++|.+.. |+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456799999999999999999998 47799999997542 334567899999999999999999999997654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC---Cceeeeccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN---YVSKISDVGLARL 599 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~---~~~kL~DFGla~~ 599 (782)
|||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999988654 35899999999999999999999999 9999999999999764 4699999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPT 677 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~ 677 (782)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+.+.. .
T Consensus 181 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~ 250 (362)
T 2bdw_A 181 VNDS------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY----P 250 (362)
T ss_dssp CTTC------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----C
T ss_pred ecCC------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----C
Confidence 6321 1234568999999999999999999999999999999999999999654432 22233332211 1
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
...| ...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 251 ~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 251 SPEW-DTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp TTGG-GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred cccc-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 1111 23455689999999999999999999998543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=365.00 Aligned_cols=248 Identities=20% Similarity=0.300 Sum_probs=202.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|.+.+.||+|+||.||+|.+ ++..||+|++.... .....+.+|+.+|..++||||++++++|.+.. ++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 45799999999999999999998 57789999997653 34567899999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC--CCceeeeccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH--NYVSKISDVGLARLVPAV 603 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~--~~~~kL~DFGla~~~~~~ 603 (782)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999885433 35899999999999999999999999 999999999999987 789999999999876321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+.... ++ ..
T Consensus 158 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~---~~ 226 (321)
T 1tki_A 158 ------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--DE---EA 226 (321)
T ss_dssp ------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CH---HH
T ss_pred ------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC--Ch---hh
Confidence 12234579999999999998889999999999999999999999997554322 2222222110 00 00
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
....+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 012345689999999999999999999998543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=362.84 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=198.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCe----eEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHT----PVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
++|...+.||+|+||.||+|.+ ++. +||+|.+.... ....+.|.+|+.++..++||||++++++|.+.. ++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 4589999999999999999997 333 46888886432 234578999999999999999999999997655 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
++|+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999997654 34899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ....+..+.. .
T Consensus 170 ~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~ 238 (327)
T 3poz_A 170 EE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--------L 238 (327)
T ss_dssp TC---C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------C
T ss_pred Cc---ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC--------C
Confidence 21 2222334567889999999999999999999999999999999 9999964322 2222332221 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+...+..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~-~l~~~ 276 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELII-EFSKM 276 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH-HHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHH-HHHHH
Confidence 223445567999999999999999999999874 44444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=370.72 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=203.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.+.|.+.+.||+|+||.||+|.+ ++..||+|++..........+.+|+.+|..++||||++++++|.+.. ++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 45799999999999999999998 56789999998766556678999999999999999999999986554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC--CCceeeeccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH--NYVSKISDVGLARLVPAV 603 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~--~~~~kL~DFGla~~~~~~ 603 (782)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999886443 35899999999999999999999999 999999999999974 578999999999876321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~ 681 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+... +++ ..
T Consensus 205 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~---~~ 273 (387)
T 1kob_A 205 ------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE--FDE---DA 273 (387)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC--CCS---ST
T ss_pred ------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCc---cc
Confidence 112345799999999999999999999999999999999999999976544322 12222111 111 11
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+..+.+|+.+||..+|.+||++.+++.
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 2234456999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=370.35 Aligned_cols=237 Identities=25% Similarity=0.333 Sum_probs=195.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|...+.||+|+||.||+|.+ +++.||||++++.. ......+.+|..+|.++ +||||++++++|.+.. |+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 4599999999999999999998 46789999997642 22345688999999887 8999999999996654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999887654 4899999999999999999999999 99999999999999999999999999985321
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH-----------HHHHHHHhCccc
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH-----------FVERSIENGTLG 671 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~-----------~~~~~~~~~~~~ 671 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+..+.
T Consensus 206 -----~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 278 (396)
T 4dc2_A 206 -----PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 278 (396)
T ss_dssp -----TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred -----CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence 1122345789999999999999999999999999999999999999995321 1112222221
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
..+|...+..+.+|+.+||+.+|.+||+.
T Consensus 279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 12344455679999999999999999995
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.44 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=194.8
Q ss_pred hccccccceeeeeCcEeEEEEEECCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYL 526 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~ 526 (782)
.++|.+.++||+|+||.||+|.+.+ .||||+++... ....+.|.+|+.+|+.++||||+.+++++.... ++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence 3568899999999999999998755 59999997543 344577999999999999999999999876544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++++|.+.+.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 174 (289)
T 3og7_A 102 EGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-- 174 (289)
T ss_dssp CEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred CCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc--
Confidence 9999999886543 35899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChH---HHHHHHHhCcccccCCCCCCC
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTH---FVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---~~~~~~~~~~~~~~ld~~~~~ 680 (782)
.........||+.|+|||++. +..++.++|||||||++|+|++|+.||.... .....+..+... +....
T Consensus 175 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~ 249 (289)
T 3og7_A 175 -GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS----PDLSK 249 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC----CCTTS
T ss_pred -ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC----cchhh
Confidence 122234467999999999886 5678899999999999999999999996533 223333344332 22233
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
.+...+..+.+|+.+||+.+|.+||++.+++. .|+.
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~-~L~~ 285 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA-EIEE 285 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHH-HHHH
Confidence 33445567999999999999999999988873 4443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=366.88 Aligned_cols=244 Identities=26% Similarity=0.384 Sum_probs=201.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||++++++|.... ++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999998 677999999965321 22357899999999999999999999996554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+ +|+|.+.+...+ .+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 999 789998887654 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ..+...+.......|
T Consensus 161 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~p 228 (336)
T 3h4j_B 161 -----GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-------PNLFKKVNSCVYVMP 228 (336)
T ss_dssp -----SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-------TTCBCCCCSSCCCCC
T ss_pred -----CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCCCCCc
Confidence 122345689999999999887776 7899999999999999999999964321 111112222223345
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
...+..+.+|+.+||..||.+||++.+++.+.
T Consensus 229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 55667799999999999999999999998644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=362.29 Aligned_cols=237 Identities=25% Similarity=0.334 Sum_probs=196.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|...+.||+|+||.||+|.+ +++.||||+++... ......+.+|+.++..+ +||||++++++|.+.. |+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 3599999999999999999998 47789999997642 23356688999999988 8999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999987654 4899999999999999999999999 99999999999999999999999999985421
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh-----------HHHHHHHHhCccc
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT-----------HFVERSIENGTLG 671 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~-----------~~~~~~~~~~~~~ 671 (782)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ......+..+.
T Consensus 163 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 235 (345)
T 3a8x_A 163 P-----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 235 (345)
T ss_dssp T-----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--
T ss_pred C-----CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--
Confidence 1 12234568999999999999999999999999999999999999999542 11112222221
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
..+|...+..+.+|+.+||..+|.+||+.
T Consensus 236 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 12334455679999999999999999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.65 Aligned_cols=257 Identities=19% Similarity=0.192 Sum_probs=200.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ....+.+|+.++..+ +||||+.+++++.... ++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35699999999999999999997 67899999987543 235689999999999 9999999999886544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc-----eeeeccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV-----SKISDVGLARL 599 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~-----~kL~DFGla~~ 599 (782)
|+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 999999987643 35999999999999999999999999 999999999999998887 99999999987
Q ss_pred ccccccc--ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh---HHHH--HHHHhCcccc
Q 040785 600 VPAVAEN--VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT---HFVE--RSIENGTLGE 672 (782)
Q Consensus 600 ~~~~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~---~~~~--~~~~~~~~~~ 672 (782)
+...... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+ ..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6332111 1111234578999999999999999999999999999999999999999642 1111 1111111100
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
... ......+ .+.+|+..||..+|.+||++.+++. .|..+..
T Consensus 240 ~~~----~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~-~l~~~~~ 281 (330)
T 2izr_A 240 PIE----VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK-LFTDLFD 281 (330)
T ss_dssp CHH----HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH-HHHHHHH
T ss_pred CHH----HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH-HHHHHHH
Confidence 000 0011123 7999999999999999999988873 5554433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=369.24 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=204.6
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|...+.||+|+||.||+|.+ .+..||||+++.. .......+.+|+.++..++||||++++++|.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999985 3457999999754 3444567899999999999999999999996544
Q ss_pred EEEEEeCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC---ceeee
Q 040785 520 IIVYEYLANGSLDDRIFRRGN----TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY---VSKIS 592 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~---~~kL~ 592 (782)
++||||+++|+|.+++..... ...+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976532 235899999999999999999999999 99999999999998544 59999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGT 669 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~ 669 (782)
|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++ |..||....... ..+..+.
T Consensus 227 DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 227 DFGMARDIYRAG---YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp CCHHHHHHHHHS---SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred CCcccccccccc---ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999998653221 1122234578999999999999999999999999999999998 999997554322 2222222
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
. ...+...+..+.+|+.+||+.+|.+||++.+++. .|..+.
T Consensus 304 ~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~-~l~~~~ 344 (367)
T 3l9p_A 304 R--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCT 344 (367)
T ss_dssp C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred C--------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHH-HHHHHh
Confidence 1 1223344556999999999999999999998873 455443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.36 Aligned_cols=243 Identities=26% Similarity=0.306 Sum_probs=201.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~l 521 (782)
.++|...+.||+|+||.||+|.+ +++.||||+++... ......+..|..+|..+ +||||++++++|.+.. |+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 45699999999999999999998 57789999997642 22345678899999877 9999999999996544 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 96 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999987654 4899999999999999999999999 9999999999999999999999999998542
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+. .
T Consensus 170 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------~ 235 (345)
T 1xjd_A 170 L-----GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------P 235 (345)
T ss_dssp C-----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred c-----CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------C
Confidence 1 1122345789999999999999999999999999999999999999997554322 2222221 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChH-Hhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLG-KVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~-~vl~ 712 (782)
.+|...+..+.+|+.+||..+|.+||++. +++.
T Consensus 236 ~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 23334456799999999999999999997 6653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=366.48 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=208.3
Q ss_pred hccccccceeeeeCcEeEEEEEECC---------eeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH---------TPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 518 (782)
.++|.+.+.||+|+||.||+|.+.+ ..||||+++... ......+.+|++++..+ +||||++++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4679999999999999999998632 469999997653 33457789999999999 999999999999665
Q ss_pred c--EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
. ++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 4 999999999999999976542 235999999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE 662 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~ 662 (782)
+.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCC---TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCcEEEcccCccccccccc---ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998663221 1122334568899999999999999999999999999999999 999997544322
Q ss_pred --HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 663 --RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 663 --~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
..+..+.. ...+...+..+.+|+.+||+.+|++||++.+++. .|..+..
T Consensus 302 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~-~L~~~~~ 352 (382)
T 3tt0_A 302 LFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRIVA 352 (382)
T ss_dssp HHHHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred HHHHHHcCCC--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHHH
Confidence 22222221 1223344556999999999999999999998873 5666543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.33 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=193.0
Q ss_pred ccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
++|.+.+.||+|+||.||+|.+. +..||||+++.. .....+.|.+|+.+|.+++||||++++++|.+.. ++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46999999999999999999863 557999999765 3344668999999999999999999999997654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... ..+++.+++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999996543 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..+..+.. .
T Consensus 200 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--------~ 269 (373)
T 2qol_A 200 DPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--------L 269 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE--------C
T ss_pred CCc--cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------C
Confidence 211 1111223346788999999999999999999999999999998 999996543322 22222211 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+...+..+.+|+.+||+.+|.+||++.+++ ..|..+.
T Consensus 270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~-~~L~~~~ 308 (373)
T 2qol_A 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV-SILDKLI 308 (373)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHH
T ss_pred CCCccccHHHHHHHHHHhCcChhhCcCHHHHH-HHHHHHH
Confidence 12234456799999999999999999999887 3555554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.92 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=193.7
Q ss_pred hccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
.++|.+.+.||+|+||.||+|.+. +..||||++... .....+.|.+|+.++..++||||+++++++.+.. ++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 356999999999999999999873 346999998764 2344567999999999999999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999997553 34899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
. .........||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+.. .
T Consensus 169 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~--------~ 236 (281)
T 1mp8_A 169 S----TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------L 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------C
T ss_pred c----cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC--------C
Confidence 2 1112234467889999999999999999999999999999997 9999964332 1122222211 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+...+..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~-~l~~~ 274 (281)
T 1mp8_A 237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA-QLSTI 274 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHH
Confidence 223445567999999999999999999988873 55544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=374.64 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=203.5
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
..+.|.+.+.||+|+||.||+|.+ ++..||+|++.... ......+.+|+.+|+.++||||++++++|.+.. |+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356799999999999999999988 67899999997643 334567899999999999999999999997654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeeeccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARL 599 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~DFGla~~ 599 (782)
|||+++|+|.+.+...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999887654 4899999999999999999999999 99999999999998 568899999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPT 677 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~ 677 (782)
.... ........||+.|+|||++.+..|+.++|||||||++|+|++|.+||...... ...+..+.+.. ..+
T Consensus 163 ~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~- 235 (444)
T 3soa_A 163 VEGE-----QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF-PSP- 235 (444)
T ss_dssp CCTT-----CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-CTT-
T ss_pred ecCC-----CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-Ccc-
Confidence 6321 12234568999999999999999999999999999999999999999655432 23333333211 111
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.| ...+..+.+|+.+||+.||.+||++.++|.+
T Consensus 236 --~~-~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 --EW-DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --TT-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --cc-ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 2334568999999999999999999999843
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.03 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=194.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--------------------------hHHHHHHHHHHHHh
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--------------------------GRSQFQREIEVLSC 502 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--------------------------~~~~~~~Ei~iL~~ 502 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.+|+.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4689999999999999999988 5789999999754211 13568899999999
Q ss_pred cCCCCeeeecccccC----ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040785 503 IRHPNMVLLLGACPE----YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKP 578 (782)
Q Consensus 503 l~HpnIv~l~g~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp 578 (782)
++||||+++++++.+ ..|+||||+++|+|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999864 2389999999999987542 235999999999999999999999999 99999999
Q ss_pred ceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCC---CCCchhHHHHHHHHHHHHhCCCCC
Q 040785 579 GNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 579 ~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~Pf 655 (782)
+|||++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS-----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS-----SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHEEECCCCCEEEecCCCccccccc-----cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999866321 11234467999999999887665 378899999999999999999999
Q ss_pred CChHHHH--HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 656 GLTHFVE--RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 656 ~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
....... ..+...... .+.. ...+..+.+|+.+||+.+|++||++.+++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~---~~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQALE---FPDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp CCSSHHHHHHHHHHCCCC---CCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred CCccHHHHHHHHhcccCC---CCCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 7654322 222222211 1111 23345699999999999999999999998543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=358.60 Aligned_cols=239 Identities=26% Similarity=0.339 Sum_probs=200.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.. +++.||||+++.... .....+.+|+.+|..++||||++++++|.+.. |+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 4599999999999999999998 577999999975422 23456789999999999999999999997654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999997643 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~ 681 (782)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+. ..+
T Consensus 159 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------~~~ 222 (318)
T 1fot_A 159 -------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------LRF 222 (318)
T ss_dssp -------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---------CCC
T ss_pred -------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCC
Confidence 12346899999999999999999999999999999999999999975543221 122221 123
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
|...+..+.+|+.+||..+|.+|| ++.+++.
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 334456799999999999999999 7777764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.47 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=201.6
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~E 524 (782)
++|...+.||+|+||.||+|.++++.||||+++... ....+.|.+|+.+++.++||||++++++|.+. .++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 458899999999999999999999999999997653 34456799999999999999999999998653 389999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.... ...+++..++.|+.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp CCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred ccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 999999999996543 235899999999999999999999876 359999999999999999999999999875421
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCC---chhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGV---KSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~---ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||............ ...... ...
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~---~~~ 232 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--ALEGLR---PTI 232 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH--HHSCCC---CCC
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH--HhcCCC---CCC
Confidence 12357899999999988765544 899999999999999999999755433221111 001111 122
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+...+..+.+++.+||+.+|.+||++.+++ ..|..+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il-~~L~~l 268 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIV-PILEKM 268 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHH-HHHHHh
Confidence 344556799999999999999999998887 355444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.46 Aligned_cols=243 Identities=28% Similarity=0.503 Sum_probs=198.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhh-------HHHHHHHHHHHHhcCCCCeeeecccccCccEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQG-------RSQFQREIEVLSCIRHPNMVLLLGACPEYGII 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~l 521 (782)
++|...+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.++..++||||+++++++.+..++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence 5689999999999999999998 57799999986543221 16789999999999999999999999988899
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc-----eeeecccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV-----SKISDVGL 596 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~-----~kL~DFGl 596 (782)
||||+++|+|.+.+.... ..+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|||+
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 999999999999886543 35999999999999999999999987 35999999999999988776 99999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhh--cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH----HHHHHhCcc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ--TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV----ERSIENGTL 670 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~~ 670 (782)
++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ...+.....
T Consensus 176 ~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 176 SQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred cccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 975421 223467999999999883 455789999999999999999999999643211 111111111
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 671 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+ ..+...+..+.+|+.+||+.+|.+||++.+++
T Consensus 248 ----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 281 (287)
T 4f0f_A 248 ----RP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281 (287)
T ss_dssp ----CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ----CC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 11 22344456799999999999999999999887
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=375.79 Aligned_cols=246 Identities=29% Similarity=0.422 Sum_probs=203.3
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC---ccEEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YGIIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lV~Ey~~ 527 (782)
+.|...+.||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||++++++|.+ ..|+||||++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 458889999999999999999999999999998654 45789999999999999999999999743 3489999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++...+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 271 ~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 341 (450)
T 1k9a_A 271 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 341 (450)
T ss_dssp TCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc-----
Confidence 9999999976543 34799999999999999999999999 99999999999999999999999999985421
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... +...+..+.. ...|..
T Consensus 342 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------~~~p~~ 410 (450)
T 1k9a_A 342 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPDG 410 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--------CCCCTT
T ss_pred ---cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCCCCc
Confidence 1122367889999999999999999999999999999998 9999964322 2222333311 122344
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+..+.+|+.+||+.+|.+||++.+++. .|+.+.
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~-~L~~i~ 444 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLRE-QLEHIR 444 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHHH
Confidence 5567999999999999999999988873 555543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=376.50 Aligned_cols=254 Identities=23% Similarity=0.240 Sum_probs=202.4
Q ss_pred HHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh---hHHHHHHHHHHHHhcCCCCeeeecccccCcc--E
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ---GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~ 520 (782)
..+++|...++||+|+||.||+|.+ +++.||||++++.... ....+.+|+.+|..++||||++++++|.+.. |
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 3456799999999999999999998 4678999999753221 2334889999999999999999999997655 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
|||||+++|+|.+++.+.. ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++..
T Consensus 151 lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999997643 34999999999999999999999999 999999999999999999999999999765
Q ss_pred ccccccccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCccccc
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEM 673 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ 673 (782)
... ........+||+.|+|||++. .+.|+.++|||||||++|||++|+.||......+.. +..... .
T Consensus 226 ~~~----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~- 299 (437)
T 4aw2_A 226 MED----GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-R- 299 (437)
T ss_dssp CTT----SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-H-
T ss_pred ccC----CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-c-
Confidence 321 112234568999999999887 456899999999999999999999999765443221 111100 0
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCC--CCChHHhhhHH
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKD--RPDLGKVVLPE 714 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPs~~~vl~~~ 714 (782)
...+......+..+.+|+.+||..+|++ ||++.+++.+.
T Consensus 300 --~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 300 --FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp --CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred --ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 1111222234556899999999888888 99999887543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.50 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=198.9
Q ss_pred hccccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
.++|...+.||+|+||.||+|.+. +..||||++..... ..+.+.+|+.++..++||||++++++|.+.. ++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 356999999999999999999984 55899999976532 3467999999999999999999999997654 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 174 (283)
T 3gen_A 102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-- 174 (283)
T ss_dssp TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH--
T ss_pred CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc--
Confidence 9999999986533 24899999999999999999999999 9999999999999999999999999998663221
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 683 (782)
........||+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .+..+. .. ..+.
T Consensus 175 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~~ 244 (283)
T 3gen_A 175 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-----RL---YRPH 244 (283)
T ss_dssp --HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CC---CCCT
T ss_pred --cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-----CC---CCCC
Confidence 122234567889999999999999999999999999999998 9999975543322 222221 11 1122
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+|+.+||+.+|.+||++.+++.
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 273 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLS 273 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 33456899999999999999999998874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.53 Aligned_cols=252 Identities=25% Similarity=0.289 Sum_probs=194.5
Q ss_pred hccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++|.+.++||+|+||.||+|.+ +++.||||++...... ....+.+|+.+|+.++||||+++++++.+.. ++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 45699999999999999999998 6789999999754322 2467889999999999999999999996654 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++ +|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP- 172 (311)
T ss_dssp CCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred CCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence 9975 7888776543 34899999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHH---HHHHHH-hCcccccCCC---
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHF---VERSIE-NGTLGEMLDP--- 676 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~---~~~~~~-~~~~~~~ld~--- 676 (782)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...... .+.......+
T Consensus 173 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 ----VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp ----CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred ----cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 122344678999999998876 5689999999999999999999999964321 111111 1110000000
Q ss_pred -----------CCCC-----CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 677 -----------TVTD-----WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 677 -----------~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.... .......++.+|+.+||+.||.+||++.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 01123356889999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=363.28 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=198.6
Q ss_pred ccccccceeeeeCcEeEEEEEEC--Cee----EEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTP----VAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~----vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
++|...+.||+|+||.||+|.+. +.. ||+|++.... ......+.+|+.++..++||||++++++|.+.. ++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 35889999999999999999973 333 8888875432 233456789999999999999999999997554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999986542 34888999999999999999999999 99999999999999999999999999987643
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
.. .........||+.|+|||++.++.++.++|||||||++|+|++ |..||..... ....+..+...
T Consensus 168 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 236 (325)
T 3kex_A 168 DD---KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL-------- 236 (325)
T ss_dssp CT---TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC--------
T ss_pred cc---ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--------
Confidence 22 2222345678889999999999999999999999999999999 9999965432 22333332211
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+...+..+.+++.+||..+|.+||++.+++. .|..+
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~-~l~~~ 274 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELAN-EFTRM 274 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH-HHHHH
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 112223345889999999999999999998873 44444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=366.42 Aligned_cols=260 Identities=20% Similarity=0.228 Sum_probs=200.4
Q ss_pred hccccccceeeee--CcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 450 TQFFTESRKIGEG--GYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 450 t~~f~~~~~LG~G--~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
.++|.+.+.||+| +||.||+|.+ +++.||||++.... ......+.+|+.+|+.++||||++++++|.+.. |+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3569999999999 9999999998 47799999997543 334567889999999999999999999986554 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999876532 34999999999999999999999999 9999999999999999999999999987653
Q ss_pred ccccc--ccccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH--HhCcccccCC
Q 040785 602 AVAEN--VTQYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI--ENGTLGEMLD 675 (782)
Q Consensus 602 ~~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~ld 675 (782)
..... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ..+.+..+++
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 22111 11112234579999999999887 579999999999999999999999996432111110 0111110000
Q ss_pred C-------------------------------------CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 676 P-------------------------------------TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 676 ~-------------------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
. ....++...+..+.+|+.+||+.||.+||++.+++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0001223345569999999999999999999999853
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.01 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=203.6
Q ss_pred HhccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 519 (782)
..++|...+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|.++ +||||++++++|....
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456799999999999999999997 23479999997542 23456799999999999 8999999999986544
Q ss_pred --EEEEEeCCCCChhHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040785 520 --IIVYEYLANGSLDDRIFRRGNT--------------------PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLK 577 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK 577 (782)
++||||+++|+|.+++...... ..+++..++.|+.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 9999999999999999765321 34899999999999999999999999 9999999
Q ss_pred CceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 040785 578 PGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMG 656 (782)
Q Consensus 578 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~ 656 (782)
|+||||+.++.+||+|||++....... .........||+.|+|||++.++.++.++|||||||++|+|+| |..||.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCc---cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999998763321 1122334568899999999999999999999999999999998 999996
Q ss_pred ChH---HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 657 LTH---FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 657 ~~~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
... .....+..+. . ...+...+..+.+|+.+||..+|.+||++.+++. .|..+
T Consensus 277 ~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~-~l~~~ 332 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGF-----K---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS-FLGCQ 332 (344)
T ss_dssp TCCCSHHHHHHHHTTC-----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred cCCcHHHHHHHHhcCC-----C---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH-HHHHH
Confidence 532 2223333321 1 1223344567999999999999999999998873 44433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.32 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=196.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|..++||||++++++|.+.. |+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4599999999999999999998 46689999996542 223467889999999999999999999996554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+.+|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 999999999988654 34999999999999999999999999 99999999999999999999999999987632
Q ss_pred cccccccccccccCCcccCChhhhhc---CCCCCchhHHHHHHHHHHHHhCCCCCCChHH-----HHHHHHhCcccccCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQLITAKQPMGLTHF-----VERSIENGTLGEMLD 675 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~ld 675 (782)
.......+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||..... ....+...
T Consensus 168 -----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------- 235 (384)
T 4fr4_A 168 -----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------- 235 (384)
T ss_dssp -----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-------
T ss_pred -----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-------
Confidence 122345789999999998864 4589999999999999999999999963211 11111111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCC-hHHhh
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPD-LGKVV 711 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs-~~~vl 711 (782)
...+|...+..+.+|+.+||+.+|.+||+ +.+++
T Consensus 236 --~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 --VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred --ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 12234445567999999999999999999 55544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=362.23 Aligned_cols=239 Identities=22% Similarity=0.322 Sum_probs=201.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|..++||||+++++++.+.. |+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4599999999999999999998 577999999975422 23467889999999999999999999986654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999997654 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+.+ .+
T Consensus 194 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------~~ 257 (350)
T 1rdq_E 194 -------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------RF 257 (350)
T ss_dssp -------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------CC
T ss_pred -------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---------CC
Confidence 1234679999999999999999999999999999999999999997554322 22223321 22
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCC-----hHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPD-----LGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs-----~~~vl~ 712 (782)
|...+..+.+|+.+||+.+|.+||+ +.+++.
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 3344567999999999999999998 666664
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.66 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=205.4
Q ss_pred hccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|.+.+.||+|+||.||+|.+. +..||||+++... ....+.+.+|+.+|+.++||||++++++|.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 456999999999999999999862 3689999997643 344577899999999999999999999986554
Q ss_pred EEEEEeCCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040785 520 IIVYEYLANGSLDDRIFRRGN---------------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKP 578 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp 578 (782)
++||||+++|+|.+++..... ...+++.+++.|+.||+.||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976543 134899999999999999999999999 99999999
Q ss_pred ceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 040785 579 GNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGL 657 (782)
Q Consensus 579 ~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~ 657 (782)
+|||++.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEED---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTS---CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred heEEEcCCCCEEEccccccccccccc---cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998663221 1122334567899999999999999999999999999999999 9999964
Q ss_pred hHH--HHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 658 THF--VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 658 ~~~--~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
... ....+..+.. ...+...+..+.+|+.+||+.+|.+||++.+++. .|..+
T Consensus 256 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~-~l~~~ 309 (314)
T 2ivs_A 256 IPPERLFNLLKTGHR--------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK-DLEKM 309 (314)
T ss_dssp CCGGGHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCHHHHHHHhhcCCc--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHH
Confidence 332 2222222221 1223344567999999999999999999998873 44443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=359.24 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=190.8
Q ss_pred hccccccceeeeeCcEeEEEEEECCe-----eEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc---
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDHT-----PVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~~-----~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--- 519 (782)
.++|.+.+.||+|+||.||+|.+..+ .||||+++.. .....+.|.+|+.+++.++||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 45699999999999999999987332 7999999765 2344678999999999999999999999985432
Q ss_pred -----EEEEEeCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 520 -----IIVYEYLANGSLDDRIFRRG---NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 520 -----~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 89999999999999986542 2225899999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhC
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENG 668 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~ 668 (782)
+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..+
T Consensus 179 ~Dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 179 ADFGLSRKIYSGD---YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp CCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred eeccccccccccc---cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 9999998763221 1112234567889999999999999999999999999999999 99999643321 1112121
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
. ....+...+..+.+|+.+||+.+|.+||++.+++. .|..+
T Consensus 256 ~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~-~l~~~ 296 (323)
T 3qup_A 256 N--------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM-ELENI 296 (323)
T ss_dssp C--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH-HHHHH
T ss_pred C--------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHH
Confidence 1 11223344567999999999999999999988873 44443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=358.89 Aligned_cols=242 Identities=28% Similarity=0.357 Sum_probs=191.1
Q ss_pred ccccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc----hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA----AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
++|...+.||+|+||.||+|.. +++.||||+++... ......+.+|+.+|..++||||++++++|.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4599999999999999999987 46789999997642 223456789999999999999999999986544
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999987654 4889999999999999999999999 99999999999999999999999999975
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPT 677 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 677 (782)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+.
T Consensus 171 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------- 237 (327)
T 3a62_A 171 SIHD-----GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-------- 237 (327)
T ss_dssp -------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------
T ss_pred cccC-----CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------
Confidence 4221 112234679999999999999999999999999999999999999997654322 1122221
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
...|...+..+.+|+.+||..+|.+|| ++.+++.
T Consensus 238 -~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 123334456799999999999999999 5666653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.29 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=200.9
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
..++|...+.||+|+||.||+|.+ ++..||||+++.... .....+.+|+.+|..++||||++++++|.+.. |+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 345699999999999999999998 467899999975321 12345889999999999999999999997654 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++...
T Consensus 147 V~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 99999999999988653 3899999999999999999999999 9999999999999999999999999998663
Q ss_pred cccccccccccccccCCcccCChhhhhcCC----CCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGM----LGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLD 675 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld 675 (782)
.. ........+||+.|+|||++.+.. |+.++|||||||++|||++|+.||........ .+..+.. ...-
T Consensus 220 ~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~ 294 (410)
T 3v8s_A 220 KE----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-SLTF 294 (410)
T ss_dssp TT----SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-HCCC
T ss_pred cC----CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-cccC
Confidence 21 112234578999999999988665 88999999999999999999999976543321 1111110 0111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCC--CCChHHhhhHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKD--RPDLGKVVLPE 714 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPs~~~vl~~~ 714 (782)
|.. ...+..+.+|+.+||..+|.+ ||++.+++.+.
T Consensus 295 p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 295 PDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 111 123456899999999999988 99999988543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=367.55 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=196.2
Q ss_pred cccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCCC
Q 040785 454 TESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANG 529 (782)
Q Consensus 454 ~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 529 (782)
...+.||+|+||.||+|.+ ++..||||+++.......+.|.+|+.+|.+++||||++++++|.+.. +|||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3367899999999999998 57799999998776666788999999999999999999999996654 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE--cCCCceeeeccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL--DHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl--d~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|.+.+.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---- 242 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---- 242 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT----
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc----
Confidence 9999886543 24899999999999999999999999 9999999999999 56789999999999876321
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCChhH
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+...... ..... ....
T Consensus 243 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~----~~~~ 315 (373)
T 2x4f_A 243 --EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-LEDEE----FQDI 315 (373)
T ss_dssp --CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-SCSGG----GTTS
T ss_pred --cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CChhh----hccC
Confidence 122345799999999999988999999999999999999999999975543321 11121110 00111 1233
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
+..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 456899999999999999999999985443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.45 Aligned_cols=241 Identities=25% Similarity=0.279 Sum_probs=192.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|...++||+|+||+||+|.+ +++.||||++.... ......+..|+..+..+ +||||++++++|.+.. |+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999998 57899999986542 23344556666666655 8999999999997654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+ +++|.+.+...+ ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 779998887654 35999999999999999999999999 999999999999999999999999998765321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.......||+.|+|||++.+ .++.++|||||||++|||++|..||........ +..+.... .++.
T Consensus 211 ------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~-------~~~~ 275 (311)
T 3p1a_A 211 ------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-LRQGYLPP-------EFTA 275 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-HTTTCCCH-------HHHT
T ss_pred ------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-HhccCCCc-------cccc
Confidence 12234579999999998765 799999999999999999999776654433322 22221111 1122
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+|+.+||+.+|++||++.+++.
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 33456999999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=359.64 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=206.3
Q ss_pred ccccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccccc--Cc--cE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP--EY--GI 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~--~~ 520 (782)
++|...+.||+|+||.||+|.+ .+..||||++........+.+.+|+.++..++||||+++++++. +. .+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4589999999999999999984 46789999998876666778999999999999999999999874 22 38
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976432 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH--hC------c-cc
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE--NG------T-LG 671 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~--~~------~-~~ 671 (782)
..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||........... .. . ..
T Consensus 178 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 178 PLDKD--YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CTTCS--EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ccCCc--cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 43211 11223445789999999999999999999999999999999999999965432110000 00 0 00
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+........+...+..+.+|+.+||+.+|.+||++.+++. .|+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~-~L~~~ 301 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP-QLDML 301 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHC
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 00001112234455567999999999999999999998873 44444
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.78 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=194.9
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|...+.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4689999999999999999998 4779999999765322 2467889999999999999999999986543 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++ +|.+.+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-- 153 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence 975 8988886543 34899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCccc---------
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGTLG--------- 671 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~~~--------- 671 (782)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... .. .+...
T Consensus 154 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 1122345789999999988764 5899999999999999999999999754432211 11 01100
Q ss_pred -ccCCCCCC--------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 -EMLDPTVT--------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 -~~ld~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...++... ......+..+.+|+.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111111 011234566899999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=363.37 Aligned_cols=245 Identities=28% Similarity=0.387 Sum_probs=186.4
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
..++|.+.+.||+|+||.||+|.+ +++.||||+++... ..+.+.+|+.+|..++||||++++++|.+.. ++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 456799999999999999999998 45689999997643 3467889999999999999999999996554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---CCceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~~~~kL~DFGla~~~~ 601 (782)
|+++|+|.+++... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999988654 34899999999999999999999999 999999999999975 8899999999998653
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH---HHHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV---ERSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~ld~~~ 678 (782)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+... ..
T Consensus 203 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-----~~ 271 (349)
T 2w4o_A 203 HQ------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-----FI 271 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-----CC
T ss_pred cc------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-----cC
Confidence 21 1223467999999999999999999999999999999999999999644322 2222222211 11
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+....+..+.+|+.+||..+|++||++.+++.
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1222344567999999999999999999998873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=374.75 Aligned_cols=251 Identities=22% Similarity=0.222 Sum_probs=199.4
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
..++|...+.||+|+||.||+|.+ +++.||||++++... .....+.+|+.+|..++||||++++++|.+.. ||
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 346699999999999999999998 578999999975321 22345889999999999999999999997654 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++.+.+. .+++..+..++.||+.||.|||+.+ ||||||||+||||+.++++||+|||+++...
T Consensus 139 VmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheecc
Confidence 9999999999999976542 4899999999999999999999999 9999999999999999999999999998763
Q ss_pred cccccccccccccccCCcccCChhhhh-------cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccc
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQ-------TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGE 672 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~ 672 (782)
... .......+||+.|+|||++. .+.|+.++|||||||++|||++|+.||......... +..... .
T Consensus 214 ~~~----~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~ 288 (412)
T 2vd5_A 214 ADG----TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-H 288 (412)
T ss_dssp TTS----CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-H
T ss_pred CCC----ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-C
Confidence 211 11223468999999999887 356899999999999999999999999765443221 111100 0
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCC---CChHHhhhH
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDR---PDLGKVVLP 713 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~R---Ps~~~vl~~ 713 (782)
. ..+..+...+..+.+|+.+||. +|.+| |++.+++.+
T Consensus 289 ~---~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 289 L---SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp C---CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred c---CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 1111122344569999999999 99998 578877643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.71 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=203.8
Q ss_pred hccccccceeeeeCcEeEEEEEECC-----eeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH-----TPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
.++|...+.||+|+||.||+|.+.+ ..||||++... .....+.|.+|+.++..++||||+++++++.+.. ++|
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 4569999999999999999998632 25999999765 3345678999999999999999999999987654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 91 MELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999997654 34899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH--FVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~ld~~~~ 679 (782)
. .........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.... .....+..+.. .
T Consensus 166 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~--------~ 233 (281)
T 3cc6_A 166 E----DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--------L 233 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC--------C
T ss_pred c----cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC--------C
Confidence 1 1122234567889999999999999999999999999999998 999995322 12222222211 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELA 722 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~~~ 722 (782)
..+...+..+.+++.+||..+|.+||++.+++. .|..+....
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~-~L~~~~~~~ 275 (281)
T 3cc6_A 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC-SLSDVYQME 275 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH-HHHHHHHhh
Confidence 112334456999999999999999999998873 666665443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=362.37 Aligned_cols=237 Identities=25% Similarity=0.296 Sum_probs=197.2
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|...+.||+|+||.||+|.+. ++.||||+++... ......+.+|..+|..+ +||||+.+++++.+.. |+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 46999999999999999999984 5689999997642 22345688999999988 8999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 100 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999997654 4899999999999999999999999 99999999999999999999999999985421
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+. ..
T Consensus 174 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------~~ 239 (353)
T 2i0e_A 174 -----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VA 239 (353)
T ss_dssp -----TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CC
T ss_pred -----CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 1122345689999999999999999999999999999999999999997654322 2222221 12
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
+|...+..+.+|+.+||..+|.+||+.
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 334455679999999999999999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.82 Aligned_cols=244 Identities=23% Similarity=0.373 Sum_probs=203.0
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|.+.+.||+|+||.||+|.+. +..||+|++........+.+.+|+.++..++||||++++++|.+.. ++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457999999999999999999984 5589999997765556778999999999999999999999997655 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---cCCCceeeecccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---d~~~~~kL~DFGla~~~~~ 602 (782)
+++++|.+.+.... .+++..++.|+.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999887654 4899999999999999999999999 9999999999999 8889999999999986532
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
. .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... ..+..+.. .
T Consensus 162 ~------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~ 225 (277)
T 3f3z_A 162 G------KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF---------T 225 (277)
T ss_dssp T------SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred c------cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------C
Confidence 1 12234579999999998765 48999999999999999999999997654332 22222221 1
Q ss_pred CCh----hHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 681 WPF----EETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 681 ~p~----~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.+. ..+..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 111 23456899999999999999999999986443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=376.29 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=203.7
Q ss_pred HHhccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEe
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEY 525 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey 525 (782)
...+.|...+.||+|+||.||+|.+ .+..||||+++... ...+.|.+|+.+|+.++||||+++++++.+.. |+||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEee
Confidence 3456799999999999999999998 46789999998654 34678999999999999999999999986544 999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~- 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 338 (454)
T ss_dssp CTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence 999999999975421 24789999999999999999999999 9999999999999999999999999998763211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
........+|+.|+|||++..+.++.++|||||||+||||+| |+.||......+ ..+..+.. ...|
T Consensus 339 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------~~~~ 407 (454)
T 1qcf_A 339 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------MPRP 407 (454)
T ss_dssp ---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--------CCCC
T ss_pred ---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCCC
Confidence 111233457889999999999999999999999999999999 999996543322 22333211 1123
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
...+..+.+|+.+||+.+|.+||++.+++
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 34456799999999999999999998887
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.96 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=200.6
Q ss_pred HHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCCeeeeccccc
Q 040785 444 EDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD-----AAQGRSQFQREIEVLSCIRHPNMVLLLGACP 516 (782)
Q Consensus 444 ~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~ 516 (782)
.++....++|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.+|..++||||++++++|.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 34556778899999999999999999998 5668999998653 2234567999999999999999999999997
Q ss_pred Ccc--EEEEEeCCCCChhHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHH
Q 040785 517 EYG--IIVYEYLANGSLDDRIFRRG-------------------------------------NTPPLSWQQRFRIAAEIA 557 (782)
Q Consensus 517 ~~~--~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia 557 (782)
+.. |+||||+++|+|.+++.... ....+++..++.|+.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 655 89999999999999884210 011246778889999999
Q ss_pred HHHHHhhhcCCCCeeecCCCCceEEEcCCC--ceeeeccccccccccccccccccccccccCCcccCChhhhhc--CCCC
Q 040785 558 TGLLFLHQTKPEPLVHRDLKPGNILLDHNY--VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT--GMLG 633 (782)
Q Consensus 558 ~aL~yLH~~~~~~iiHrDLKp~NILld~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s 633 (782)
.||.|||+.+ |+||||||+||||+.++ .+||+|||+++.+..... ..........||+.|+|||++.+ ..++
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-GEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-C--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCc-cccccccccCCCccccCchhhccCCCCCC
Confidence 9999999999 99999999999998776 899999999986633211 12223345689999999999875 6789
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 634 VKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 634 ~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.++|||||||++|+|++|+.||......... +..+... ...+. ....+..+.+|+.+||+.+|.+||++.+++
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-FENPN----YNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-TTSGG----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-cCCcc----cccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9999999999999999999999755443221 1111110 00111 122345699999999999999999999998
Q ss_pred hH
Q 040785 712 LP 713 (782)
Q Consensus 712 ~~ 713 (782)
.+
T Consensus 330 ~h 331 (345)
T 3hko_A 330 QH 331 (345)
T ss_dssp HS
T ss_pred cC
Confidence 43
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=354.46 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=186.3
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++|...+.||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+|+.++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 34689999999999999999987 477999999976532 23467889999999999999999999997654 89999
Q ss_pred eCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRG---NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59998886542 2235899999999999999999999999 9999999999999999999999999998653
Q ss_pred cccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHH-hCcccccCC-
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIE-NGTLGEMLD- 675 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~-~~~~~~~ld- 675 (782)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ... .+.......
T Consensus 160 ~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IP-----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SC-----CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred CC-----cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 21 112334679999999999876 4689999999999999999999999975543221 111 111111110
Q ss_pred ---------CCCCC-------------CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 676 ---------PTVTD-------------WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 676 ---------~~~~~-------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.... .+...+..+.+|+.+||+.||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 01123456899999999999999999998874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=348.91 Aligned_cols=246 Identities=28% Similarity=0.361 Sum_probs=195.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.|...+.||+|+||.||+|.. ++..||+|++.... ....+.+.+|+.+|..++||||++++++|.+.. ++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4699999999999999999998 46789999997653 234578999999999999999999999997654 899999
Q ss_pred CCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---cCCCceeeeccccccccc
Q 040785 526 LANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVP 601 (782)
Q Consensus 526 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---d~~~~~kL~DFGla~~~~ 601 (782)
+++|+|.+.+... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988653 22345999999999999999999999999 9999999999999 456889999999998653
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~ 679 (782)
.. .......||+.|+|||++. +.++.++|||||||++|+|++|+.||......... ...... ...
T Consensus 179 ~~------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------~~~ 245 (285)
T 3is5_A 179 SD------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP------NYA 245 (285)
T ss_dssp --------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------CCC
T ss_pred Cc------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc------ccc
Confidence 21 1223467999999999875 57899999999999999999999999765433221 111111 111
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......+..+.+|+.+||+.+|++||++.+++.
T Consensus 246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111113346889999999999999999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=363.22 Aligned_cols=261 Identities=25% Similarity=0.300 Sum_probs=204.5
Q ss_pred ccccHHHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-----CCCeeee
Q 040785 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-----HPNMVLL 511 (782)
Q Consensus 439 ~~~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l 511 (782)
..|++.+.....++|.+.++||+|+||.||+|.+ +++.||||+++.. ......+..|+.++..+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3455555555678899999999999999999998 6778999999754 334567888999999986 9999999
Q ss_pred cccccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC----
Q 040785 512 LGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---- 585 (782)
Q Consensus 512 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---- 585 (782)
+++|.... |+||||+ +++|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99986544 8999999 9999999876543 35899999999999999999999999 999999999999975
Q ss_pred ---------------------CCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHH
Q 040785 586 ---------------------NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGIL 644 (782)
Q Consensus 586 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvi 644 (782)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC--------CCcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 78999999999986422 1234679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCChHHHHHH--HHh--Cc-------------ccccCCCC--CCCCCh--------------------hH
Q 040785 645 LLQLITAKQPMGLTHFVERS--IEN--GT-------------LGEMLDPT--VTDWPF--------------------EE 685 (782)
Q Consensus 645 l~elltG~~Pf~~~~~~~~~--~~~--~~-------------~~~~ld~~--~~~~p~--------------------~~ 685 (782)
+|+|++|+.||......... +.. +. ....++.. ...||. ..
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 99999999999754332211 000 00 00000000 001111 01
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+.+|+.+||+.||.+||++.++|.+
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1457899999999999999999999853
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=351.85 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=204.8
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCCeeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 519 (782)
.++|...+.||+|+||.||+|.+ .+..||||+++.... ...+.+.+|+.+|.++ +||||++++++|.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45699999999999999999985 346899999976533 3457799999999999 9999999999986544
Q ss_pred -EEEEEeCCCCChhHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN---------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 999999999999999976542 125899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH---
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH--- 659 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~--- 659 (782)
+.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDS---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCT---TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCCEEEccccccccccccc---cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 999999999999998764321 1122334567889999999999999999999999999999999 999996432
Q ss_pred HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 660 FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 660 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
.....+..+. .+ ..+...+..+.+|+.+||..+|.+||++.+++. .|+.
T Consensus 256 ~~~~~~~~~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-~L~~ 304 (313)
T 1t46_A 256 KFYKMIKEGF-----RM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ-LIEK 304 (313)
T ss_dssp HHHHHHHHTC-----CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHH
T ss_pred HHHHHhccCC-----CC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH-HHHH
Confidence 2222232221 11 112334456999999999999999999998874 4433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.13 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=202.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.++|.+.+.||+|+||.||+|.+ ++..||+|++.... ......+.+|+.++..++||||+++++++.+.. ++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999998 47799999996542 334567889999999999999999999997654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc---eeeecccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV---SKISDVGLARLV 600 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~---~kL~DFGla~~~ 600 (782)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999998887653 4899999999999999999999999 999999999999976654 999999999765
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTV 678 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 678 (782)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..+..+.... ..+..
T Consensus 159 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 231 (284)
T 3kk8_A 159 NDS------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-PSPEW 231 (284)
T ss_dssp CSS------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CTTTT
T ss_pred ccC------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC-Cchhh
Confidence 321 12234679999999999999999999999999999999999999996544322 2233332211 11111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
...+..+.+|+.+||+.+|++||++.+++.+.
T Consensus 232 ----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 232 ----DTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp ----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred ----cccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 23345689999999999999999999998543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=375.56 Aligned_cols=242 Identities=24% Similarity=0.277 Sum_probs=191.9
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|...+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|..++||||+.++++|.+.. |+||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 4599999999999999999998 5779999999753 2233456789999999999999999999996554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
||+++|+|.+.+.... .+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++.+||+|||+++....
T Consensus 228 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 228 EYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999887654 48999999999999999999998 88 99999999999999999999999999986422
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.... ..
T Consensus 302 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------~~ 367 (446)
T 4ejn_A 302 -----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IR 367 (446)
T ss_dssp ----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CC
T ss_pred -----CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 1122345789999999999999999999999999999999999999996554322 2222211 12
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
+|...+..+.+|+.+||+.||.+|| ++.+++.
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2334456799999999999999999 8888874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.58 Aligned_cols=242 Identities=28% Similarity=0.419 Sum_probs=199.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ ++..||||++..... .....+.+|+.+++.++||||++++++|.+.. ++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 4599999999999999999998 456899999965321 22456889999999999999999999997655 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 89 e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999999987653 4899999999999999999999999 99999999999999999999999999865432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~ 681 (782)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .+.... ...
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~ 226 (279)
T 3fdn_A 162 ------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------FTF 226 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------CCC
T ss_pred ------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC---------CCC
Confidence 122345799999999999999999999999999999999999999976554332 122211 122
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
|...+..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 333455689999999999999999999998543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=357.63 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=196.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCee----EEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTP----VAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~----vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
++|...+.||+|+||.||+|.+ ++.. ||+|.+... .......+.+|+.++..++||||++++++|.... ++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 4589999999999999999997 3443 577777543 2334678999999999999999999999986655 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
++|+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp ECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999999987654 34899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
.. .........||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+. ..
T Consensus 170 ~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------~~ 238 (327)
T 3lzb_A 170 EE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------RL 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------CC
T ss_pred cc---ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CC
Confidence 21 2222334567889999999999999999999999999999999 9999965332 222222222 11
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+...+..+.+|+.+||..+|.+||++.+++. .|..+.
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-~L~~~~ 277 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELII-EFSKMA 277 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHHH
Confidence 223345556999999999999999999998873 555543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=348.88 Aligned_cols=251 Identities=25% Similarity=0.282 Sum_probs=195.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..++||||+++++++.+.. ++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4689999999999999999998 577899999975432 23467889999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++ +|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-- 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-- 153 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS--
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC--
Confidence 9976 5655554433 35999999999999999999999999 99999999999999999999999999986532
Q ss_pred ccccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCC-CChHHH---HHHHH-hCcccccCC---
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPM-GLTHFV---ERSIE-NGTLGEMLD--- 675 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf-~~~~~~---~~~~~-~~~~~~~ld--- 675 (782)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..|| ...... ..... .+.......
T Consensus 154 ---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 154 ---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp ---CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ---ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 122234567899999999987765 899999999999999999988885 322221 11111 111100000
Q ss_pred ---------------CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 676 ---------------PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 676 ---------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..........+..+.+|+.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0011122334567899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.43 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=208.2
Q ss_pred ccHHHHHHHhccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeec
Q 040785 441 YTIEDIEEATQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLL 512 (782)
Q Consensus 441 ~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~ 512 (782)
+..++++...++|.+.+.||+|+||.||+|.+. ++.||||++.... ......|.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455556778999999999999999999864 4689999997543 33456789999999999999999999
Q ss_pred ccccCcc--EEEEEeCCCCChhHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 513 GACPEYG--IIVYEYLANGSLDDRIFRRG-------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 513 g~~~~~~--~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
+++.+.. ++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 9986544 99999999999999987532 1245799999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE 662 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~ 662 (782)
+.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETD---YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGG---CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred cCCCeEEECcCcccccccccc---ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 999999999999998653221 1112234567899999999999999999999999999999999 899997543322
Q ss_pred --HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 663 --RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 663 --~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.. ...+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 249 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 249 VLRFVMEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp HHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22222221 1223344566999999999999999999998874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=358.95 Aligned_cols=241 Identities=27% Similarity=0.404 Sum_probs=196.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
+.|...+.||+|+||.||+|.+ +++.||||++.... ......|.+|+.+|..++||||++++++|.+.. ++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999997 67899999997542 233467899999999999999999999986544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+. |+|.+.+.... .++++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 68888776543 35899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTV 678 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~ 678 (782)
.....||+.|+|||++. .+.++.++|||||||++|||++|+.||......... +..+.. +..
T Consensus 207 --------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~ 273 (348)
T 1u5q_A 207 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PAL 273 (348)
T ss_dssp --------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCC
T ss_pred --------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----CCC
Confidence 12457999999999885 567899999999999999999999999655433222 111111 111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+...+..+.+|+.+||+.+|++||++.+++.+
T Consensus 274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 112234458999999999999999999998843
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.13 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=204.6
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
++|...+.||+|+||.||+|.+ ++..||||++..... ..+.+.+|+.++..++||||++++++|.+.. ++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4688999999999999999998 667899999986533 3467999999999999999999999986544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~---- 157 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---- 157 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH----
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc----
Confidence 999999987643 35899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.........||+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ..+..+.. ...+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~--------~~~~~~ 229 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYKPRL 229 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------CCCCTT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc--------CCCCcc
Confidence 1112234567889999999999999999999999999999999 999997554332 22222211 111223
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+..+.+++.+||+.+|.+||++.+++. .|..+.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~-~L~~l~ 263 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLR-QLAEIA 263 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHH
Confidence 3456899999999999999999988873 555543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.46 Aligned_cols=257 Identities=17% Similarity=0.213 Sum_probs=201.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ....+.+|+.++..+ +||||+.+++++.+.. ++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35699999999999999999996 68899999986543 335688999999999 7999999999986544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc-----eeeeccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV-----SKISDVGLARL 599 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~-----~kL~DFGla~~ 599 (782)
|+ +++|.+++...+ ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999997653 34899999999999999999999999 999999999999987766 99999999987
Q ss_pred ccccccc--ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH---H--HHHHHHhCcccc
Q 040785 600 VPAVAEN--VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH---F--VERSIENGTLGE 672 (782)
Q Consensus 600 ~~~~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---~--~~~~~~~~~~~~ 672 (782)
....... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... . ....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6432111 11122345689999999999999999999999999999999999999996521 1 111111111000
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.........+..+.+|+.+||+.+|.+||++.+++ ..|..+.
T Consensus 241 ----~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~-~~l~~~~ 282 (298)
T 1csn_A 241 ----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ-GLFSKVL 282 (298)
T ss_dssp ----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH-HHHHHHH
T ss_pred ----cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHH-HHHHHHH
Confidence 00011112345699999999999999999998887 3555443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=353.76 Aligned_cols=260 Identities=29% Similarity=0.406 Sum_probs=204.0
Q ss_pred ccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GII 521 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~l 521 (782)
|...+.||+|+||.||++.+ +++.||||+++... ......|.+|+.+|+.++||||++++++|.+. .++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 58999999999999999875 56789999998653 34467799999999999999999999998653 289
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++.... +++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999986543 899999999999999999999999 9999999999999999999999999998764
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH--------hCccccc
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE--------NGTLGEM 673 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~--------~~~~~~~ 673 (782)
.... .........||..|+|||++.+..++.++|||||||++|+|++|..||........... ...+...
T Consensus 186 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 186 EGHE--YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TTCS--EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccc--ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 3211 11223345688999999999999999999999999999999999999975432110000 0000000
Q ss_pred C-CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHHHH
Q 040785 674 L-DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELA 722 (782)
Q Consensus 674 l-d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~~~ 722 (782)
+ .......+...+..+.+|+.+||+.+|.+||++.+++ ..|+.+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell-~~L~~l~~~~ 312 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI-PILKTVHEKY 312 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH-HHHHHHHHhh
Confidence 0 0111122344556799999999999999999999887 4666665443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=373.50 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=192.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|+.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 45799999999999999999988 5789999999754 233456788999999999999999999998532
Q ss_pred -cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
.|+||||++++ |.+.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 28999999764 6555522 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---H-hCccc--
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---E-NGTLG-- 671 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~-~~~~~-- 671 (782)
+.... ....+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+...... . .|...
T Consensus 212 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eecCC------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 86532 223345789999999999999999999999999999999999999997654332111 1 01000
Q ss_pred ----------ccC--CCCCCCC------C-----------hhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 672 ----------EML--DPTVTDW------P-----------FEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 672 ----------~~l--d~~~~~~------p-----------~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
..+ .+..... + ......+.+|+.+||..||++||++.+++.+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000 0000000 0 11255689999999999999999999998543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=360.16 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=194.1
Q ss_pred hccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCC--CCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRH--PNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~~~--~lV 522 (782)
.+.|.+.+.||+|+||.||+|.+ +++.||||++... .......|.+|+.+|..++| |||+++++++.+.. |+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45699999999999999999987 5678999999754 23345778999999999986 99999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|| +.+|+|.+++.... .+++.++..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 56889999997643 4899999999999999999999999 99999999999997 67899999999987642
Q ss_pred ccccccccccccccCCcccCChhhhhc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCChH-HHHHHHHhCcc
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQT-----------GMLGVKSDVYSLGILLLQLITAKQPMGLTH-FVERSIENGTL 670 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~Pf~~~~-~~~~~~~~~~~ 670 (782)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......
T Consensus 160 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---- 232 (343)
T 3dbq_A 160 DT---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---- 232 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH----
T ss_pred cc---ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH----
Confidence 21 1222345689999999999875 678999999999999999999999996422 1111110
Q ss_pred cccCCC-CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 671 GEMLDP-TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 671 ~~~ld~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
.+++ ....+|...+..+.+|+.+||+.+|.+||++.+++.+.+-
T Consensus 233 --~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 233 --IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp --HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred --HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 1111 1112333344568999999999999999999999865543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.17 Aligned_cols=244 Identities=24% Similarity=0.343 Sum_probs=203.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
.++|...+.||+|+||.||++.+ ++..||+|++... .......+.+|+.++..++||||++++++|.+.. |+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45699999999999999999998 4668999998654 2334567899999999999999999999997654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++++|.+++.... .+++.+++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999886653 4899999999999999999999999 99999999999999999999999999986632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~ 680 (782)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +..+.. .
T Consensus 194 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~ 259 (335)
T 2owb_A 194 DG-----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------S 259 (335)
T ss_dssp TT-----CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------C
T ss_pred Cc-----ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---------C
Confidence 11 1223467999999999999999999999999999999999999999765433221 222211 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 260 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223344568999999999999999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.21 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=196.9
Q ss_pred HHhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhc--CCCCeeeecccccCc------c
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCI--RHPNMVLLLGACPEY------G 519 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~g~~~~~------~ 519 (782)
...++|.+.+.||+|+||.||+|.+.++.||||++... ....+.+|.+++..+ +||||+++++++.+. .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 34567999999999999999999999999999999643 234556666666654 899999999988543 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------CCCCeeecCCCCceEEEcCCCceee
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT--------KPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~--------~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
++||||+++|+|.+++... .+++..++.|+.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEE
T ss_pred EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEE
Confidence 8999999999999999653 489999999999999999999998 7 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCc------hhHHHHHHHHHHHHhC----------CCCC
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVK------SDVYSLGILLLQLITA----------KQPM 655 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k------sDVwSlGvil~elltG----------~~Pf 655 (782)
+|||+++.+...... .........||+.|+|||++.+..++.. +|||||||++|||++| ..||
T Consensus 184 ~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 184 ADLGLAVKFISDTNE-VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeCCCceeecccccc-ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 999999766332211 1122235689999999999988777665 9999999999999999 6666
Q ss_pred CChH-------HHHHHHHhCcccccCCCCCCCC--ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 656 GLTH-------FVERSIENGTLGEMLDPTVTDW--PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 656 ~~~~-------~~~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.... .....+.. ..+.+..+.. +...+..+.+|+.+||+.+|.+||++.+++. .|..+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~-~L~~l~ 330 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK-TLAKMS 330 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH-HHHHHH
T ss_pred hhhcCCCCchhhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH-HHHHHH
Confidence 4211 11111111 1122222211 1256777999999999999999999988873 555554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=353.96 Aligned_cols=253 Identities=27% Similarity=0.323 Sum_probs=196.7
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-----hhHHHHHHHHHHHHhcC---CCCeeeecccccCc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-----QGRSQFQREIEVLSCIR---HPNMVLLLGACPEY 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-----~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~ 518 (782)
.+++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999996 677999999864321 11346778888887775 99999999998542
Q ss_pred -------cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 519 -------GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 519 -------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
.++||||+. |+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 389999996 599998866543 34999999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-h
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-N 667 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~ 667 (782)
+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|++||......... .. .
T Consensus 162 ~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSY------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTT------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeCccccccCC------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999986532 12234567999999999999999999999999999999999999999755433211 11 1
Q ss_pred CcccccCCCCC-----------C-----CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 668 GTLGEMLDPTV-----------T-----DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 668 ~~~~~~ld~~~-----------~-----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.......+.. . ......+..+.+|+.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11100000000 0 001234457899999999999999999999884
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=347.34 Aligned_cols=239 Identities=21% Similarity=0.340 Sum_probs=193.7
Q ss_pred ccccccceeeeeCcEeEEEEEECC---------eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH---------TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
++|...+.||+|+||.||+|.+.. ..||+|++........+.|.+|+.+++.++||||++++++|.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 458999999999999999998733 469999997766666788999999999999999999999986543
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc--------eee
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV--------SKI 591 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~--------~kL 591 (782)
++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999997653 23899999999999999999999999 999999999999998887 999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhC-CCCCCChHHHHHHHHhCc
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITA-KQPMGLTHFVERSIENGT 669 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~ 669 (782)
+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||..............
T Consensus 163 ~Dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 233 (289)
T 4fvq_A 163 SDPGISITVLPK---------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233 (289)
T ss_dssp CCCCSCTTTSCH---------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred ccCcccccccCc---------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence 999998754221 22457889999999887 6799999999999999999995 555544333221111110
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
. ...+...+..+.+|+.+||+.+|.+||++.+++
T Consensus 234 ~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 267 (289)
T 4fvq_A 234 R--------HQLPAPKAAELANLINNCMDYEPDHRPSFRAII 267 (289)
T ss_dssp T--------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHH
T ss_pred c--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 0 011112233488999999999999999998887
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=358.68 Aligned_cols=238 Identities=25% Similarity=0.369 Sum_probs=175.2
Q ss_pred cceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccCcc--EEEEEeCCCCC
Q 040785 456 SRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG--IIVYEYLANGS 530 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~~~gs 530 (782)
.+.||+|+||.||+|.+ +++.||||++... ....+.+|+.++..+. ||||++++++|.+.. |+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999998 4779999999643 3457889999999997 999999999997654 89999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC---ceeeeccccccccccccccc
Q 040785 531 LDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY---VSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 531 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~---~~kL~DFGla~~~~~~~~~~ 607 (782)
|.+++.... .+++.++..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---- 162 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD---- 162 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC----
Confidence 999997643 5999999999999999999999999 99999999999997665 8999999999865321
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH---------HHHHHHhCcccccCCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF---------VERSIENGTLGEMLDPTV 678 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~---------~~~~~~~~~~~~~ld~~~ 678 (782)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.+.. .
T Consensus 163 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-----~ 236 (325)
T 3kn6_A 163 -NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-----E 236 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-----C
T ss_pred -CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-----C
Confidence 1223456789999999999999999999999999999999999999965332 111222221100 0
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.......+..+.+|+.+||..+|.+||++.+++.
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0001224557999999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=354.06 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=201.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh------hHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ------GRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|.+.+.||+|+||.||+|.+ ++..||||++...... ....+.+|+.+|..++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45699999999999999999998 5779999999764321 3567999999999999999999999986554
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC----ceeeeccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY----VSKISDVG 595 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~----~~kL~DFG 595 (782)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 8999999999999998653 35899999999999999999999999 99999999999999888 79999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCccccc
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEM 673 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ 673 (782)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... +..+.. .
T Consensus 165 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~ 236 (321)
T 2a2a_A 165 LAHEIEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY--D 236 (321)
T ss_dssp TCEECCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--C
T ss_pred cceecCcc------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--c
Confidence 99866321 1223467999999999999999999999999999999999999999755433221 222111 0
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+++ ..+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 237 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 FDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 010 001123456899999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.24 Aligned_cols=246 Identities=25% Similarity=0.306 Sum_probs=189.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|...+.||+|+||.||++.+ +++.||||++..... ....+.+|+.+++.++||||++++++|.+.. |+||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 35699999999999999999998 577899999976532 3467889999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc--eeeeccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV--SKISDVGLARLVPAV 603 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~--~kL~DFGla~~~~~~ 603 (782)
+++|+|.+++...+ .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 99999999986654 4899999999999999999999999 999999999999987765 99999999974321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCc-hhHHHHHHHHHHHHhCCCCCCChHH----HH--HHHHhCcccccCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVK-SDVYSLGILLLQLITAKQPMGLTHF----VE--RSIENGTLGEMLDP 676 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-sDVwSlGvil~elltG~~Pf~~~~~----~~--~~~~~~~~~~~ld~ 676 (782)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... .. ..+.....
T Consensus 171 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~------ 239 (361)
T 3uc3_A 171 -----HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY------ 239 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC------
T ss_pred -----cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC------
Confidence 112234579999999999988887665 8999999999999999999965322 11 11111111
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
..+. ....+..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 240 ~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 240 SIPD-DIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 0111 1123456899999999999999999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.33 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=202.0
Q ss_pred ccccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----G 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 519 (782)
.+|...+.||+|+||.||+|.+ .++.||||++.... ......+.+|+.+|..++||||++++++|.+. .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4589999999999999999984 56789999997543 23357789999999999999999999998643 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 89999999999999996654 34899999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCc---------c
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGT---------L 670 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---------~ 670 (782)
...... .........||..|+|||++.+..++.++|||||||++|+|++|..|+.............. .
T Consensus 176 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 176 IETDKE--YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCTTCC--EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccCCCc--ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 643211 11233456789999999999999999999999999999999999998754322110000000 0
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 671 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+........+...+..+.+|+.+||+.+|.+||++.+++. .|..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~-~L~~l 300 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE-GFEAL 300 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH-HHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHH
Confidence 000001111233445567999999999999999999998873 44443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.75 Aligned_cols=251 Identities=29% Similarity=0.448 Sum_probs=203.7
Q ss_pred hccccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLA 527 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~ 527 (782)
.+.|...+.||+|+||.||+|.+. +..||||++.... ...+.|.+|+++|..++||||+++++++.+.. ++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCC
Confidence 456999999999999999999984 5689999997653 33568999999999999999999999986544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 163 (279)
T 1qpc_A 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--- 163 (279)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC---
T ss_pred CCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc---
Confidence 9999998854321 24899999999999999999999999 9999999999999999999999999998763221
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
........||..|+|||++.++.++.++|||||||++|+|++ |+.||....... ..+..+. . ...+..
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~~ 234 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----R---MVRPDN 234 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----C---CCCCTT
T ss_pred -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-----C---CCCccc
Confidence 112234567889999999999999999999999999999999 999996544322 2222221 1 112234
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+..+.+|+.+||..+|++||++.+++ ..|+.+
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~-~~l~~~ 267 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLR-SVLEDF 267 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHH-HHHHHH
Confidence 455799999999999999999998887 345444
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.06 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=197.6
Q ss_pred ccccccceeeeeCcEeEEEEEECC-----eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccC---ccEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH-----TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YGII 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~l 521 (782)
..|...+.||+|+||.||+|.+.. ..||+|.+.... ....+.+.+|+.++++++||||++++++|.+ ..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458889999999999999998632 258999987643 3445779999999999999999999998643 2389
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999996543 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~ 678 (782)
.... ..........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||...... ...+..+..
T Consensus 180 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------- 250 (298)
T 3f66_A 180 DKEY-YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------- 250 (298)
T ss_dssp CGGG-CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC--------
T ss_pred ccch-hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC--------
Confidence 3221 11222345678899999999999999999999999999999999 66677543221 111222211
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
...+...+..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~-~L~~~ 289 (298)
T 3f66_A 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS-RISAI 289 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 1112333456999999999999999999988873 44443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=362.87 Aligned_cols=240 Identities=27% Similarity=0.288 Sum_probs=190.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHH-HHhcCCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEV-LSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~i-L~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
++|...+.||+|+||.||+|.+ ++..||||++++... .....+.+|..+ +..++||||++++++|.+.. |+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 4599999999999999999998 466899999976432 223456777777 46789999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999987654 4889999999999999999999999 99999999999999999999999999985421
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+..+.+ .
T Consensus 192 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------~ 257 (373)
T 2r5t_A 192 -----HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------Q 257 (373)
T ss_dssp -----CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---------C
T ss_pred -----CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------C
Confidence 1123345689999999999999999999999999999999999999997554332 12222211 2
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKV 710 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~v 710 (782)
++...+..+.+|+.+||+.+|.+||++.+.
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 233445568999999999999999998543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.57 Aligned_cols=261 Identities=17% Similarity=0.191 Sum_probs=197.3
Q ss_pred hccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCchhhH-----------HHHHHHHHHHHhcCCCCeeee
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAAQGR-----------SQFQREIEVLSCIRHPNMVLL 511 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~~~-----------~~~~~Ei~iL~~l~HpnIv~l 511 (782)
+++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 457999999999999999999883 36899999876542211 123456667778889999999
Q ss_pred cccccCc------cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-
Q 040785 512 LGACPEY------GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD- 584 (782)
Q Consensus 512 ~g~~~~~------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld- 584 (782)
+++|... .||||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998543 48999999 999999987643 35999999999999999999999999 99999999999999
Q ss_pred -CCCceeeecccccccccccccccc--ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH--
Q 040785 585 -HNYVSKISDVGLARLVPAVAENVT--QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH-- 659 (782)
Q Consensus 585 -~~~~~kL~DFGla~~~~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~-- 659 (782)
.++.+||+|||+++.+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999987643221111 112234569999999999999999999999999999999999999996421
Q ss_pred --HHHHHH--HhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 660 --FVERSI--ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 660 --~~~~~~--~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
...... ....+..++++.+. +...+..+.+|+..||..+|.+||++.+++. .|..+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~-~l~~~~ 328 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRD-ILLQGL 328 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH-HHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH-HHHHHH
Confidence 111000 01112222222211 0123456999999999999999999988873 444443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=358.55 Aligned_cols=239 Identities=22% Similarity=0.322 Sum_probs=198.3
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--------hhHHHHHHHHHHHHhcCCCCeeeecccccCc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--------QGRSQFQREIEVLSCIRHPNMVLLLGACPEY 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~ 518 (782)
..++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|..++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999987 678999999976521 1334678899999999999999999999765
Q ss_pred c--EEEEEeCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 519 G--IIVYEYLANG-SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 519 ~--~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
. ++||||+.+| +|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 5 8999999777 9998886543 4899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccC
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEML 674 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l 674 (782)
+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..
T Consensus 176 ~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~ 237 (335)
T 3dls_A 176 SAAYLERG------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TV 237 (335)
T ss_dssp TCEECCTT------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GT
T ss_pred cceECCCC------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------HH
Confidence 99876321 12234679999999999988876 8899999999999999999999964221 11
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
... ...|...+..+.+|+.+||+.+|++||++.+++.
T Consensus 238 ~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 238 EAA-IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp TTC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhc-cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1122334556999999999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.40 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=198.1
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLAN 528 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 528 (782)
|.....||+|+||.||+|.+ ++..||||++........+.+.+|+.++..++||||++++++|.+.. ++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 55567899999999999998 56789999998765555678999999999999999999999996554 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeeccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~~~~ 607 (782)
++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~---- 176 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI---- 176 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC----
Confidence 999999977655556789999999999999999999999 999999999999987 899999999999865321
Q ss_pred cccccccccCCcccCChhhhhcCC--CCCchhHHHHHHHHHHHHhCCCCCCChHHHH-HHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQLITAKQPMGLTHFVE-RSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
........||+.|+|||++.++. ++.++|||||||++|+|++|+.||....... .....+.. ......+..
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 250 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-----KVHPEIPES 250 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-----CCCCCCCTT
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-----ccccccccc
Confidence 11223457999999999987754 8899999999999999999999995432111 11111110 011123344
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+..+.+|+.+||+.+|++||++.+++.+
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 45679999999999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.22 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=196.7
Q ss_pred ccccccceeeeeCcEeEEEEEECC------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
..|...+.||+|+||.||+|.+.. ..||||+++... ......|.+|+.++..++||||+++++++.+.. ++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 357788999999999999998732 259999997653 334567899999999999999999999997654 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999987643 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~ 678 (782)
.... .........||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... ...+..+..
T Consensus 199 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-------- 268 (333)
T 1mqb_A 199 DDPE--ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------
T ss_pred cccc--cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc--------
Confidence 3211 1112233457889999999999999999999999999999999 99999654332 222222211
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
...+...+..+.+|+.+||+.+|.+||++.+++. .|..+.
T Consensus 269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~-~L~~~~ 308 (333)
T 1mqb_A 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS-ILDKLI 308 (333)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH-HHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHH
Confidence 1123344566999999999999999999988873 555544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.72 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=206.6
Q ss_pred hccccccceeeeeCcEeEEEEEEC---------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 518 (782)
.++|.+.+.||+|+||.||+|.+. +..||||+++... ......+.+|+.++..+ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 356999999999999999999863 4579999997653 33456789999999999 899999999999655
Q ss_pred c--EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
. ++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 4 899999999999999976532 134899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE 662 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~ 662 (782)
+.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTS---SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCCEEEccccccccccccc---cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999998663221 1112234567899999999999999999999999999999999 999996543322
Q ss_pred --HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHHH
Q 040785 663 --RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLREL 721 (782)
Q Consensus 663 --~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~~ 721 (782)
..+..+.. ...+...+..+.+|+.+||..+|.+||++.+++ ..|..+...
T Consensus 268 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell-~~L~~l~~~ 319 (334)
T 2pvf_A 268 LFKLLKEGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV-EDLDRILTL 319 (334)
T ss_dssp HHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHHH
T ss_pred HHHHHhcCCC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHH-HHHHHHHhc
Confidence 22222221 112334455699999999999999999999887 466665544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=343.66 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=203.3
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
.++|...+.||+|+||.||+|.+. ++.||+|++.... ......+.+|+.+++.++||||++++++|.+.. ++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356899999999999999999984 6789999986542 334567899999999999999999999996654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999886543 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~ 680 (782)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.. +..+. ..
T Consensus 168 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~ 233 (294)
T 2rku_A 168 DG-----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------YS 233 (294)
T ss_dssp TT-----CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------CC
T ss_pred Cc-----cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc---------CC
Confidence 11 1223467999999999999989999999999999999999999999765443322 11211 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.|...+..+.+|+.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 233344568999999999999999999999854
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.94 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=203.6
Q ss_pred ccccccc-eeeeeCcEeEEEEEE----CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEE
Q 040785 451 QFFTESR-KIGEGGYGPVYKCYL----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVY 523 (782)
Q Consensus 451 ~~f~~~~-~LG~G~fg~Vy~~~~----~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 523 (782)
++|.+.. .||+|+||.||+|.+ .+..||||+++... ....+.+.+|+.++..++||||+++++++.... ++||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 3466665 999999999999986 46689999998753 345677999999999999999999999995444 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999886433 35899999999999999999999999 999999999999999999999999999876322
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~ 680 (782)
.. .........||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... ...+..+.. ..
T Consensus 164 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~--------~~ 233 (287)
T 1u59_A 164 DS--YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------ME 233 (287)
T ss_dssp SC--EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------CC
T ss_pred cc--eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc--------CC
Confidence 11 1112234467899999999998899999999999999999998 99999654322 222333221 12
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.|...+..+.+++.+||..+|.+||++.+++. .|..+.
T Consensus 234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~-~l~~~~ 271 (287)
T 1u59_A 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ-RMRACY 271 (287)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHH
Confidence 33445567999999999999999999998874 444443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.14 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=199.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.+.|...+.||+|+||.||+|.+ +++.||||++.... ..+.+|+++|.++ +||||++++++|.+.. |+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45699999999999999999998 47799999997543 2345789999888 7999999999997655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC----Cceeeecccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN----YVSKISDVGLARLV 600 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~----~~~kL~DFGla~~~ 600 (782)
|+++|+|.+.+...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999986543 4899999999999999999999999 9999999999998433 35999999999866
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh-----HHHHHHHHhCcccccCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT-----HFVERSIENGTLGEMLD 675 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~~~ld 675 (782)
... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||... ......+..+.+..
T Consensus 171 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~--- 242 (342)
T 2qr7_A 171 RAE-----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL--- 242 (342)
T ss_dssp BCT-----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC---
T ss_pred cCC-----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc---
Confidence 321 11234568999999999998888999999999999999999999999642 12223333443221
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
....+...+..+.+|+.+||..||++||++.+++.+.+
T Consensus 243 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 243 --SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp --CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred --CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 11122344567999999999999999999999986543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.76 Aligned_cols=264 Identities=27% Similarity=0.382 Sum_probs=209.5
Q ss_pred ccHHHHHHHhccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeee
Q 040785 441 YTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLL 511 (782)
Q Consensus 441 ~~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l 511 (782)
+....+....++|.+.+.||+|+||.||+|.+ +++.||||+++... ......+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 33444444567899999999999999999985 24689999997653 23456789999999999 79999999
Q ss_pred cccccCc---cEEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 040785 512 LGACPEY---GIIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRD 575 (782)
Q Consensus 512 ~g~~~~~---~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD 575 (782)
+++|... .++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 9998543 4899999999999999976542 123889999999999999999999999 99999
Q ss_pred CCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCC
Q 040785 576 LKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQP 654 (782)
Q Consensus 576 LKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P 654 (782)
|||+|||++.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccceEEECCCCCEEECCCccccccccCc---cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999998663221 1222344568999999999999999999999999999999998 9999
Q ss_pred CCChH---HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 655 MGLTH---FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 655 f~~~~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
|.... .....+..+... ..+...+..+.+++.+||+.+|.+||++.+++. .|..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-~L~~~~ 309 (316)
T 2xir_A 251 YPGVKIDEEFCRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE-HLGNLL 309 (316)
T ss_dssp STTCCCSHHHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CcccchhHHHHHHhccCccC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHH
Confidence 96432 222333333211 122334456999999999999999999998874 444443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.59 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=206.3
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|...+.||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+++.++||||++++++|.+.. ++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 467999999999999999999984 7789999997653 34678999999999999999999999997654 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 164 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-- 164 (288)
T ss_dssp CTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS--
T ss_pred CCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC--
Confidence 999999999876433 45999999999999999999999999 999999999999999999999999999876322
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||..... ....+.... ....+
T Consensus 165 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 234 (288)
T 3kfa_A 165 --TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------RMERP 234 (288)
T ss_dssp --SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------CCCCC
T ss_pred --ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC--------CCCCC
Confidence 1122334567889999999999999999999999999999999 9999964332 122222211 11223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
...+..+.+|+.+||..+|.+||++.+++ ..|..+
T Consensus 235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~-~~l~~~ 269 (288)
T 3kfa_A 235 EGCPEKVYELMRACWQWNPSDRPSFAEIH-QAFETM 269 (288)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHH
T ss_pred CCCCHHHHHHHHHHhCCChhhCcCHHHHH-HHHHHH
Confidence 34456799999999999999999999887 355444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=376.55 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=203.2
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
...|...+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|.+++||||++++++|.+.. |+||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 456899999999999999999984 6799999997653 34678999999999999999999999996543 999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++..... ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 298 ~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 371 (495)
T 1opk_A 298 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-- 371 (495)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC--
T ss_pred cCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC--
Confidence 999999999976433 45899999999999999999999999 999999999999999999999999999876321
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.........+|+.|+|||++.++.++.++|||||||+||||++ |..||..... +...+..+. ....|
T Consensus 372 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 441 (495)
T 1opk_A 372 --TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------RMERP 441 (495)
T ss_dssp --CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------CCCCC
T ss_pred --ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 1112234457889999999999999999999999999999999 9999964432 222222221 11223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
...+..+.+|+.+||+.+|.+||++.+++
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~ 470 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIH 470 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 44556799999999999999999999887
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.18 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=205.4
Q ss_pred HhccccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 519 (782)
..++|...+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+|..+ +||||++++++|.+..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45679999999999999999999732 369999997653 33456799999999999 8999999999996544
Q ss_pred --EEEEEeCCCCChhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC
Q 040785 520 --IIVYEYLANGSLDDRIFRRGN-----------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN 586 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~ 586 (782)
++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 999999999999999875421 245899999999999999999999999 9999999999999999
Q ss_pred CceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH---HHH
Q 040785 587 YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH---FVE 662 (782)
Q Consensus 587 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~---~~~ 662 (782)
+.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|+| |..||.... ...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT---TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CeEEECcccccccccccc---ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 999999999998663221 1122334567889999999999999999999999999999998 999996432 222
Q ss_pred HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 663 RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 663 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+..+.. + ..+...+..+.+|+.+||+.+|.+||++.+++. .|..+.
T Consensus 278 ~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~-~L~~~~ 325 (333)
T 2i1m_A 278 KLVKDGYQ-----M---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS-FLQEQA 325 (333)
T ss_dssp HHHHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred HHHhcCCC-----C---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH-HHHHHH
Confidence 22222211 1 112333456899999999999999999998874 555443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.53 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=180.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ ++..||||++..... .....+.+|+.++..++||||+++++++.+.. ++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4699999999999999999997 678999999965422 12467899999999999999999999996654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++.... .++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999886543 35899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCCh
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +. ...... ...|.
T Consensus 166 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~-~~~~~ 233 (278)
T 3cok_A 166 H-----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LN-----KVVLAD-YEMPS 233 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSC-CCCCT
T ss_pred C-----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HH-----HHhhcc-cCCcc
Confidence 1 112345799999999999988999999999999999999999999964432111 01 111111 12334
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+..+.+|+.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 45567999999999999999999999884
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.43 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=193.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
.++|...+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 45799999999999999999998 5779999999653 233456789999999999999999999998543
Q ss_pred -cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
.|+||||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 28999999 88999988652 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---H-hCccc-
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---E-NGTLG- 671 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~-~~~~~- 671 (782)
+.... ..+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+...... . .|...
T Consensus 176 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccc--------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 86531 2345679999999998877 679999999999999999999999997654332111 0 11110
Q ss_pred -------------------ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 -------------------EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 -------------------~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
......+.......+..+.+|+.+||..||.+||++.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00011111222344567999999999999999999999884
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.03 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=202.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ ++..||||++..... .....+.+|+.++..++||||+++++++.+.. ++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3599999999999999999998 467899999965421 22467899999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+.+...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999987654 4899999999999999999999999 99999999999999999999999999875532
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~ 681 (782)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .+.... ..+
T Consensus 167 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~ 231 (284)
T 2vgo_A 167 ------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------LKF 231 (284)
T ss_dssp ------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------CCC
T ss_pred ------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------cCC
Confidence 122346799999999999999999999999999999999999999976543322 122211 123
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
|...+..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 344456789999999999999999999998543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.95 Aligned_cols=244 Identities=26% Similarity=0.373 Sum_probs=200.7
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC---------
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--------- 517 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------- 517 (782)
..++|...+.||+|+||.||+|.+ +++.||||++.... ..+.+|++++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 345699999999999999999998 47899999997643 357799999999999999999998742
Q ss_pred ---------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc
Q 040785 518 ---------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV 588 (782)
Q Consensus 518 ---------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~ 588 (782)
..++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 1389999999999999997543 235899999999999999999999999 999999999999999999
Q ss_pred eeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhC
Q 040785 589 SKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENG 668 (782)
Q Consensus 589 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 668 (782)
+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........+..+
T Consensus 161 ~kl~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKND------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234 (284)
T ss_dssp EEECCCTTCEESSCC------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTT
T ss_pred EEECcchhheecccc------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcc
Confidence 999999999866321 12234579999999999999999999999999999999999999985433322223222
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.+ +...+..+.+|+.+||..+|.+||++.+++. .|..+
T Consensus 235 ~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~-~l~~~ 272 (284)
T 2a19_B 235 II-----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILR-TLTVW 272 (284)
T ss_dssp CC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred cc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHH
Confidence 21 1223345899999999999999999988873 44443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=361.26 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=202.7
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc----cEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY----GIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+++|..++||||+++++++.+. .|+||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56899999999999999999984 7799999997543 23356788999999999999999999988543 38999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE----cCCCceeeeccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKISDVGLARL 599 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----d~~~~~kL~DFGla~~ 599 (782)
||+++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976655455999999999999999999999999 9999999999999 7888899999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCh------HHHHHHH
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQT--------GMLGVKSDVYSLGILLLQLITAKQPMGLT------HFVERSI 665 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~ksDVwSlGvil~elltG~~Pf~~~------~~~~~~~ 665 (782)
.... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||... ......+
T Consensus 166 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 166 LEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp CCCG------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred ccCC------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 6322 12234679999999998875 56788999999999999999999999521 1111112
Q ss_pred HhCcccccC----------------CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 ENGTLGEML----------------DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~~~~~~~l----------------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+.....+ .+.....+...+..+.+++.+||+.||++||++.+++.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 222211100 01112344567778999999999999999999998863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=362.38 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=189.0
Q ss_pred cccccc-ceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHh-cCCCCeeeecccccC------ccE
Q 040785 451 QFFTES-RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSC-IRHPNMVLLLGACPE------YGI 520 (782)
Q Consensus 451 ~~f~~~-~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~------~~~ 520 (782)
+.|... +.||+|+||.||+|.+ +++.||||+++.. ..+.+|+.++.+ .+||||++++++|.. ..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 346665 7899999999999998 4678999999642 457789998754 589999999998743 238
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---CCceeeeccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGLA 597 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~~~~kL~DFGla 597 (782)
|||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999976432 35999999999999999999999999 999999999999987 789999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH------HHHHHHhCccc
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF------VERSIENGTLG 671 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~------~~~~~~~~~~~ 671 (782)
+.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+. ....+..+.+.
T Consensus 212 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 212 KETTS------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp EECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccCC------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 86532 1223456899999999999999999999999999999999999999964331 12223333221
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
. ..+ .| ...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 286 ~-~~~---~~-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 F-PNP---EW-SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C-CTT---TT-TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred C-CCc---cc-ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 1 111 11 23445689999999999999999999998543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.62 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=197.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++..+ +||||+++++++.+.. ++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 45699999999999999999998 57899999997642 33456788999999999 9999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC---------------
Q 040785 523 YEYLANGSLDDRIFRRGN-TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN--------------- 586 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~--------------- 586 (782)
|||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976421 245899999999999999999999999 9999999999999844
Q ss_pred ----CceeeeccccccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHH
Q 040785 587 ----YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFV 661 (782)
Q Consensus 587 ----~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~ 661 (782)
+.+||+|||++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS---------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTC---------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred cCCceEEEEcccccccccCC---------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 4799999999986532 1234599999999998766 5678999999999999999999887655443
Q ss_pred HHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 662 ERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 662 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. +..+.. ...|...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 238 ~~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 HE-IRQGRL--------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH-HHTTCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHcCCC--------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 33 222222 2233344566999999999999999999999884
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=346.38 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=196.7
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC---ccEEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YGIIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lV~Ey~~ 527 (782)
++|...+.||+|+||.||+|.+.++.||||+++... ..+.|.+|+.++..++||||+++++++.+ ..++||||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 469999999999999999999999999999997653 45679999999999999999999998643 3499999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 99 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 9999999875432 23789999999999999999999999 999999999999999999999999998755321
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ...+..+. ....+..
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 238 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------KMDAPDG 238 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------CCCCCTT
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------CCCCccc
Confidence 123467889999999999999999999999999999998 99999654321 12222221 1122334
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+..+.+++.+||+.+|.+||++.+++ ..|+.++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~-~~L~~i~ 272 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLR-EQLEHIK 272 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHH-HHHHHHH
Confidence 456799999999999999999998887 3555554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=371.65 Aligned_cols=246 Identities=31% Similarity=0.440 Sum_probs=198.0
Q ss_pred HhccccccceeeeeCcEeEEEEEECC-eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeC
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYL 526 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~ 526 (782)
..+.|...+.||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||++++++|.+.. ++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence 34668999999999999999999954 679999998654 33568999999999999999999999987644 9999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 334 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 334 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc--
Confidence 9999999996432 134899999999999999999999999 9999999999999999999999999998763211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 683 (782)
........+|+.|+|||++.++.++.++|||||||++|||++ |+.||......+ ..+..+. ....|.
T Consensus 335 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~~~ 404 (452)
T 1fmk_A 335 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCPP 404 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCT
T ss_pred --eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCC
Confidence 111233457889999999999999999999999999999999 999996543322 2222221 112234
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+..+.+|+.+||+.+|.+||++.+++
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~ 432 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQ 432 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 4556799999999999999999998887
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.22 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=197.3
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.+.|.+.+.||+|+||.||+|.+. +..||+|++..........+.+|+.++..++||||++++++|.... ++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 456999999999999999999984 7789999998766566778999999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999887644 24899999999999999999999999 999999999999999999999999998643211
Q ss_pred cccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTV 678 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~ 678 (782)
........||+.|+|||++. ...++.++|||||||++|+|++|..||......... +..+....
T Consensus 171 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 241 (302)
T 2j7t_A 171 ---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT------ 241 (302)
T ss_dssp ---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------
T ss_pred ---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc------
Confidence 11123457999999999874 567899999999999999999999999765443322 11221111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112334556999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=371.40 Aligned_cols=243 Identities=26% Similarity=0.407 Sum_probs=201.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++.... |+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4588999999999999999998 578999999975422 23457899999999999999999999986544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999988643 35899999999999999999999999 999999999999999999999999999875321
Q ss_pred cccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+... ..+..+.+ .
T Consensus 170 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------~ 234 (476)
T 2y94_A 170 ------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---------Y 234 (476)
T ss_dssp ------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---------C
T ss_pred ------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---------C
Confidence 12345689999999999988765 789999999999999999999997544322 22222221 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.|...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 2333445689999999999999999999998543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=346.46 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=195.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.++..++||||++++++|.+.. ++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4699999999999999999997 6789999999753 2344667899999999999999999999986544 8999
Q ss_pred EeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
||+++|+|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988653 22345899999999999999999999999 99999999999999999999999999986532
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH----HHHHHHHhCcccccCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH----FVERSIENGTLGEMLDPTV 678 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~----~~~~~~~~~~~~~~ld~~~ 678 (782)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+..+.+...
T Consensus 189 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 258 (310)
T 2wqm_A 189 KT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL----- 258 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC-----
T ss_pred CC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC-----
Confidence 11 12234578999999999999999999999999999999999999996432 11122222222111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHHHHhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADE 724 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~~~~~ 724 (782)
.+...+..+.+|+.+||..+|.+||++.+++ ..|..+.....+
T Consensus 259 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~il-~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 --PSDHYSEELRQLVNMCINPDPEKRPDVTYVY-DVAKRMHACTAS 301 (310)
T ss_dssp --CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHHHHC-
T ss_pred --cccccCHHHHHHHHHHcCCChhhCCCHHHHH-HHHHHHHHhhhh
Confidence 0123345699999999999999999998887 577777665443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=364.60 Aligned_cols=248 Identities=15% Similarity=0.141 Sum_probs=191.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC---chhhHHHHHHHHH---HHHhcCCCCeeeecccc------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD---AAQGRSQFQREIE---VLSCIRHPNMVLLLGAC------ 515 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ei~---iL~~l~HpnIv~l~g~~------ 515 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .....+.|.+|+. +|+.++||||+++++.|
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45689999999999999999996 5789999999743 2334578999995 55556899999998443
Q ss_pred -cC-------------------ccEEEEEeCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 040785 516 -PE-------------------YGIIVYEYLANGSLDDRIFRRGN----TPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571 (782)
Q Consensus 516 -~~-------------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 571 (782)
.+ ..|+||||+ +|+|.+++...+. ...+++..++.|+.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 22 148999999 6899999976432 122446888999999999999999999 9
Q ss_pred eecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcC-----------CCCCchhHHH
Q 040785 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-----------MLGVKSDVYS 640 (782)
Q Consensus 572 iHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----------~~s~ksDVwS 640 (782)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 9999999999999999999999999985321 2234567 999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH-HHHHH
Q 040785 641 LGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE-LNRLR 719 (782)
Q Consensus 641 lGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~-l~~l~ 719 (782)
|||++|||++|+.||...... .....+. .... ..+..+.+|+.+||+.+|.+||++.+++.+. +..++
T Consensus 299 lG~il~elltg~~Pf~~~~~~------~~~~~~~-~~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAAL------GGSEWIF-RSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHHHHHSSCCC------------CCSGGGG-SSCC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccc------cchhhhh-hhcc----CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999999999543221 1111111 1112 2345689999999999999999999998643 34444
Q ss_pred HH
Q 040785 720 EL 721 (782)
Q Consensus 720 ~~ 721 (782)
..
T Consensus 368 ~~ 369 (377)
T 3byv_A 368 TE 369 (377)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.03 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=200.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++..........+.+|+.++..++||||+++++++.+.. ++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45699999999999999999998 57899999998765545567899999999999999999999986654 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---cCCCceeeecccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---d~~~~~kL~DFGla~~~~~ 602 (782)
+++|+|.+.+...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999887654 4899999999999999999999999 9999999999999 7889999999999975421
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~ 680 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+... .. ..
T Consensus 162 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~----~~ 229 (304)
T 2jam_A 162 -------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FE----SP 229 (304)
T ss_dssp -------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-CC----TT
T ss_pred -------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CC----cc
Confidence 1123356999999999999999999999999999999999999999654332 2223333221 11 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223345569999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.92 Aligned_cols=247 Identities=22% Similarity=0.358 Sum_probs=199.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh------hHHHHHHHHHHHHhcCCCCeeeecccccCcc--E
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ------GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~ 520 (782)
++|...+.||+|+||.||+|.+ +++.||||+++..... ..+.+.+|+.++..++||||++++++|.+.. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5699999999999999999998 4779999998754221 3567999999999999999999999986554 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC----ceeeecccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY----VSKISDVGL 596 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~----~~kL~DFGl 596 (782)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999986543 4899999999999999999999999 99999999999998877 899999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEML 674 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l 674 (782)
+...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......... +...... .
T Consensus 159 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~ 230 (283)
T 3bhy_A 159 AHKIEAG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--F 230 (283)
T ss_dssp CEECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--C
T ss_pred ceeccCC------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--C
Confidence 9865321 1223457999999999999999999999999999999999999999765433221 1111110 0
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.+ ..+...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 231 ~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 231 DE---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CH---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred cc---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 00 01122345689999999999999999999998644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=354.74 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=202.3
Q ss_pred HHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--------hhHHHHHHHHHHHHhc-CCCCeeeecc
Q 040785 445 DIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--------QGRSQFQREIEVLSCI-RHPNMVLLLG 513 (782)
Q Consensus 445 ~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~Ei~iL~~l-~HpnIv~l~g 513 (782)
......++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.++..+ +||||+.+++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3445567899999999999999999998 478999999976431 1245688999999999 7999999999
Q ss_pred cccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 514 ACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 514 ~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
+|.... |+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 986544 89999999999999987543 4899999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcC------CCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--H
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG------MLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--R 663 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~ 663 (782)
+|||++..+... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .
T Consensus 242 ~DfG~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 315 (365)
T 2y7j_A 242 SDFGFSCHLEPG------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315 (365)
T ss_dssp CCCTTCEECCTT------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EecCcccccCCC------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999876321 123456899999999988643 58899999999999999999999997543322 2
Q ss_pred HHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 664 SIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 664 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+..... .+. | ...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 316 ~i~~~~~~~~-~~~---~-~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQYQFS-SPE---W-DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCCCCC-HHH---H-SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCCC-Ccc---c-ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222221100 000 0 123346899999999999999999999884
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=359.93 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=188.2
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcC-CCCeeeecccccC----cc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIR-HPNMVLLLGACPE----YG 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~----~~ 519 (782)
..++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|..+. ||||++++++|.. ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 356799999999999999999998 5779999998643 3344567889999999997 9999999999843 23
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||++ |+|...+... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 5898888653 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccccc----------------cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH
Q 040785 600 VPAVAE----------------NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE 662 (782)
Q Consensus 600 ~~~~~~----------------~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~ 662 (782)
+..... .......+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 532110 001223455689999999998876 679999999999999999999999997554332
Q ss_pred HH---HHh-Ccccc-----cC------------------CCCCCCC-------------ChhHHHHHHHHHHHhhccCcC
Q 040785 663 RS---IEN-GTLGE-----ML------------------DPTVTDW-------------PFEETLGFAKLALQCSELRRK 702 (782)
Q Consensus 663 ~~---~~~-~~~~~-----~l------------------d~~~~~~-------------p~~~~~~l~~li~~cl~~~P~ 702 (782)
.. +.. +.... +. ....... +...+..+.+|+.+||..||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 21 110 00000 00 0000000 012345689999999999999
Q ss_pred CCCChHHhhh
Q 040785 703 DRPDLGKVVL 712 (782)
Q Consensus 703 ~RPs~~~vl~ 712 (782)
+||++.+++.
T Consensus 319 ~R~t~~e~l~ 328 (388)
T 3oz6_A 319 KRISANDALK 328 (388)
T ss_dssp GSCCHHHHTT
T ss_pred cCCCHHHHhC
Confidence 9999998874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=356.28 Aligned_cols=250 Identities=13% Similarity=0.137 Sum_probs=200.0
Q ss_pred HhccccccceeeeeCcEeEEEEE-----E--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC---CCCeeeecccccCc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCY-----L--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR---HPNMVLLLGACPEY 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~-----~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~ 518 (782)
..+.|.+.+.||+|+||.||+|. . .++.||||++.... ...+.+|+.++..++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45679999999999999999994 2 67799999997653 356788888888886 99999999998543
Q ss_pred --cEEEEEeCCCCChhHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---------
Q 040785 519 --GIIVYEYLANGSLDDRIFRRG--NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH--------- 585 (782)
Q Consensus 519 --~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~--------- 585 (782)
.|+||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 499999999999999997532 2346999999999999999999999999 999999999999998
Q ss_pred --CCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH
Q 040785 586 --NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER 663 (782)
Q Consensus 586 --~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~ 663 (782)
++.+||+|||+|+.+.... .....+..+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--- 290 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFP---KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG--- 290 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSC---TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET---
T ss_pred cccCCEEEeeCchhhhhhccC---CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC---
Confidence 8999999999997653221 22234557899999999999999999999999999999999999999943211
Q ss_pred HHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 664 SIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 664 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+. ..+.......+ ....+.+++..|++.+|.+||+..+.+...|..+
T Consensus 291 ----~~--~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 291 ----GE--CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ----TE--EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ----Cc--eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 11 11112222222 2456889999999999999977666665555544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.14 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=191.7
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHH--HHhcCCCCeeeeccccc-----C--ccEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEV--LSCIRHPNMVLLLGACP-----E--YGII 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~i--L~~l~HpnIv~l~g~~~-----~--~~~l 521 (782)
++|.+.+.||+|+||.||+|.++++.||||++.... ...+..|.++ +..++||||+++++.+. . ..++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 458999999999999999999999999999997542 3445555555 44589999999997442 2 2279
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCCeeecCCCCceEEEcCCCceeee
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT---------KPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~---------~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
||||+++|+|.+++.... +++..++.|+.||+.||.|||+. + |+||||||+||||+.++.+||+
T Consensus 90 v~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 999999999999996543 58899999999999999999999 7 9999999999999999999999
Q ss_pred cccccccccccccc---ccccccccccCCcccCChhhhhc-------CCCCCchhHHHHHHHHHHHHhCCCCCCChH---
Q 040785 593 DVGLARLVPAVAEN---VTQYHLTSTAGTFCYIDPEYQQT-------GMLGVKSDVYSLGILLLQLITAKQPMGLTH--- 659 (782)
Q Consensus 593 DFGla~~~~~~~~~---~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvil~elltG~~Pf~~~~--- 659 (782)
|||+++.+...... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 99999876422110 11222335679999999999876 456779999999999999999977763110
Q ss_pred -----------------HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 660 -----------------FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 660 -----------------~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
.....+........+..... .....+..+.+|+.+||+.+|.+||++.+++ ..|..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l-~~L~~ll~ 318 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK-ENSLAVRSLKETIEDCWDQDAEARLTAQXAE-ERMAELMM 318 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC-CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH-HHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc-cccchHHHHHHHHHHHhcCChhhCcchHHHH-HHHHHHHH
Confidence 00111111111111111111 1234566799999999999999999998887 35555543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=344.93 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=202.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
+.|...+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++..++||||++++++|.+.. ++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4589999999999999999988 57799999997543 334578999999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 172 (303)
T 3a7i_A 102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-- 172 (303)
T ss_dssp CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc--
Confidence 999999998843 35899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 683 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+.. ...+.
T Consensus 173 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 241 (303)
T 3a7i_A 173 ---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--------PTLEG 241 (303)
T ss_dssp ---BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--------CCCCS
T ss_pred ---ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC--------CCCcc
Confidence 1223456799999999999999999999999999999999999999975543322 1222211 11223
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
..+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 3445699999999999999999999998543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=346.65 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=193.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|...+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.++..++||||++++++|.+.. ++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5699999999999999999998 477999999865432 23567889999999999999999999996554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999998877543 34899999999999999999999999 9999999999999999999999999998763211
Q ss_pred ccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH-----------------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----------------- 666 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----------------- 666 (782)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 157 -----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred -----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 12234579999999998876 6689999999999999999999999975543221110
Q ss_pred hCc-ccccCCCCCCCC------ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 667 NGT-LGEMLDPTVTDW------PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 667 ~~~-~~~~ld~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
... +.....+..... ....+..+.+|+.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000000110000 0234456899999999999999999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.01 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=193.0
Q ss_pred cccccc-ceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTES-RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~-~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+.|.+. +.||+|+||.||+|.+ +++.||||++..........+.+|+.+|.++ +||||+++++++.+.. |+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457774 7899999999999987 5789999999776555567899999999985 7999999999986544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc---eeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV---SKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~---~kL~DFGla~~~~ 601 (782)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999997653 4899999999999999999999999 999999999999988775 9999999998653
Q ss_pred cccc--cccccccccccCCcccCChhhhhc-----CCCCCchhHHHHHHHHHHHHhCCCCCCChH---------------
Q 040785 602 AVAE--NVTQYHLTSTAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQLITAKQPMGLTH--------------- 659 (782)
Q Consensus 602 ~~~~--~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~Pf~~~~--------------- 659 (782)
.... ..........+||+.|+|||++.. ..++.++|||||||++|+|++|+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2111 111122234579999999998875 568999999999999999999999996431
Q ss_pred --HHHHHHHhCcccccCCCCCCCCCh----hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 660 --FVERSIENGTLGEMLDPTVTDWPF----EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 660 --~~~~~~~~~~~~~~ld~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+..+.+ .+|. ..+..+.+|+.+||..||.+||++.+++.
T Consensus 246 ~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11122222221 1121 23456899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=372.90 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|..++||||+.++++|.+.. |+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5699999999999999999998 578999999975422 22456889999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRRGN-TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
||++||+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999876532 346999999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH------HHHHHHHhCcccccCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH------FVERSIENGTLGEMLDP 676 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~~ld~ 676 (782)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... .....+..+.
T Consensus 342 ~-----~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~------- 409 (543)
T 3c4z_A 342 G-----QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA------- 409 (543)
T ss_dssp T-----CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-------
T ss_pred C-----CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-------
Confidence 1 112234589999999999999999999999999999999999999996532 1112222211
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCChH
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPDLG 708 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ 708 (782)
..+|...+..+.+|+.+||..+|.+||++.
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 123444556799999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=348.57 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=206.7
Q ss_pred ccccccceeeeeCcEeEEEEEE------CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC----ccE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL------DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE----YGI 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 520 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++........+.|.+|+.+|..++||||+++++++.. ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4588999999999999999985 567899999987766667789999999999999999999998754 348
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999997653 34899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH-HHHHHhCc--------cc
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV-ERSIENGT--------LG 671 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~--------~~ 671 (782)
..... .........||..|+|||++.+..++.++|||||||++|+|++|..||...... ........ +.
T Consensus 196 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 196 PQDKE--YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CSSCS--EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccc--ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 43211 111123456788999999999989999999999999999999999998644211 11000000 00
Q ss_pred ccC-CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 672 EML-DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 672 ~~l-d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
..+ .......+...+..+.+|+.+||..+|.+||++.+++ ..|..++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~-~~L~~l~~ 322 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA-LRVDQIRD 322 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH-HHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHH-HHHHHHHH
Confidence 000 0011122344556799999999999999999998887 35665543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=366.91 Aligned_cols=255 Identities=20% Similarity=0.264 Sum_probs=181.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC-------cc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------YG 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~ 519 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|..++||||++++++|.. ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 5699999999999999999987 5778999999653 23345678999999999999999999999832 23
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||+ +|+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 8999998 57898888543 35999999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccc----------------------cccccccccCCcccCChhhh-hcCCCCCchhHHHHHHHHHHHHh------
Q 040785 600 VPAVAENV----------------------TQYHLTSTAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQLIT------ 650 (782)
Q Consensus 600 ~~~~~~~~----------------------~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~ksDVwSlGvil~ellt------ 650 (782)
........ .....+..+||++|+|||++ ....|+.++||||||||||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 63221100 01234556899999999976 45679999999999999999999
Q ss_pred -----CCCCCCChHHH-----------------------HHHHH-hCccc----------------ccC----CCCCCCC
Q 040785 651 -----AKQPMGLTHFV-----------------------ERSIE-NGTLG----------------EML----DPTVTDW 681 (782)
Q Consensus 651 -----G~~Pf~~~~~~-----------------------~~~~~-~~~~~----------------~~l----d~~~~~~ 681 (782)
|+++|...... ..... .|... ..+ ...+...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 66666432210 00000 00000 000 0000111
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+..+.+|+.+||..||.+||++.++|.
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1233556899999999999999999999884
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=375.49 Aligned_cols=245 Identities=28% Similarity=0.368 Sum_probs=202.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
.++|...+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|..++||||++++++|.+.. |+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 45699999999999999999998 57899999996542 123456889999999999999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||++||+|.+++...+. ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999998876542 34999999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH------HHHHHHHhCcccccCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH------FVERSIENGTLGEMLDP 676 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~~ld~ 676 (782)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... .....+....
T Consensus 339 ~------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------- 405 (576)
T 2acx_A 339 G------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------- 405 (576)
T ss_dssp T------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC-------
T ss_pred C------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc-------
Confidence 1 12234589999999999999899999999999999999999999996532 1222222211
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCC-----ChHHhhhH
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRP-----DLGKVVLP 713 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~~ 713 (782)
..++...+..+.+|+.+||..+|.+|| ++.+++.+
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 123344556799999999999999999 66777644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.58 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC------ccEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------YGII 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~l 521 (782)
.++|...+.||+|+||.||+|.. +++.||||++..........+.+|+.++..++||||++++++|.. ..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45799999999999999999997 678999999977666667889999999999999999999999852 2389
Q ss_pred EEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 522 VYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
||||+++|+|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988763 22356999999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccc----cccccccccCCcccCChhhhhcCC---CCCchhHHHHHHHHHHHHhCCCCCCChHH----HHHHHHhCc
Q 040785 601 PAVAENV----TQYHLTSTAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQLITAKQPMGLTHF----VERSIENGT 669 (782)
Q Consensus 601 ~~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~ 669 (782)
....... .........||+.|+|||++.... ++.++|||||||++|+|++|+.||..... ....+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~ 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-Q 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-c
Confidence 3211100 011123356899999999887544 78999999999999999999999953211 1111111 0
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
...+ .+...+..+.+|+.+||+.+|.+||++.+++
T Consensus 264 ---~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 298 (317)
T 2buj_A 264 ---LSIP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298 (317)
T ss_dssp -----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---CCCC----ccccCCHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 0011 1223345699999999999999999998887
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.96 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=201.3
Q ss_pred HHHHHhcccccc-ceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcC-CCCeeeecccccCc
Q 040785 445 DIEEATQFFTES-RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIR-HPNMVLLLGACPEY 518 (782)
Q Consensus 445 ~~~~~t~~f~~~-~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~ 518 (782)
..+...++|.+. +.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..+. ||||++++++|.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556778887 8999999999999998 478999999976432 23567899999999994 69999999999665
Q ss_pred c--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---CCceeeec
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISD 593 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~~~~kL~D 593 (782)
. ++||||+++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence 4 8999999999999987543 2345999999999999999999999999 999999999999987 78999999
Q ss_pred cccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCccc
Q 040785 594 VGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLG 671 (782)
Q Consensus 594 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~ 671 (782)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +......
T Consensus 178 fg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 178 FGMSRKIGHA------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp GGGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CccccccCCc------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 9999876321 1223467999999999999999999999999999999999999999765443322 2222111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 252 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 -----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111122334456899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.41 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=200.0
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|...+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|..++||||++++++|.+.. ++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 45899999999999999999984 7799999997653 334577999999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
+++|+|.+++.... .+++..+..|+.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 99999999997654 489999999999999999999996 8 99999999999999999999999999975521
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcc-----c--------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTL-----G-------- 671 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-----~-------- 671 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||............+.. .
T Consensus 185 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 185 -----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp -----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred -----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 1223457999999999999999999999999999999999999999654322111000000 0
Q ss_pred -----------------------ccCCCCCCCCC-hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 672 -----------------------EMLDPTVTDWP-FEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 672 -----------------------~~ld~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.+........+ ...+..+.+|+.+||+.+|.+||++.+++.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00000000111 123456999999999999999999999986544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.61 Aligned_cols=259 Identities=25% Similarity=0.271 Sum_probs=194.9
Q ss_pred cHHHHHHHhccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCch-----------hhHHHHHHHHHHHHhcCCCCee
Q 040785 442 TIEDIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAA-----------QGRSQFQREIEVLSCIRHPNMV 509 (782)
Q Consensus 442 ~~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~-----------~~~~~~~~Ei~iL~~l~HpnIv 509 (782)
.+.++....++|.+.+.||+|+||.||+|.+ .+..||||++..... ...+.+.+|+.+|..++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3456677788999999999999999999987 677999999864321 1236789999999999999999
Q ss_pred eeccccc-----C--ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEE
Q 040785 510 LLLGACP-----E--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582 (782)
Q Consensus 510 ~l~g~~~-----~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 582 (782)
+++++|. . ..|+||||+. |+|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999882 2 2389999997 68888776433 35899999999999999999999999 999999999999
Q ss_pred EcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHH
Q 040785 583 LDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFV 661 (782)
Q Consensus 583 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~ 661 (782)
++.++.+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp ECTTCCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EcCCCCEEEEecCccccccc------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999975432 122234679999999998877 67999999999999999999999999765432
Q ss_pred HHH---HHh-Cc-------------ccccCCCCCC--------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 662 ERS---IEN-GT-------------LGEMLDPTVT--------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 662 ~~~---~~~-~~-------------~~~~ld~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
... ... +. ....+..... ..+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 211 100 00 0000000010 111233456899999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.65 Aligned_cols=256 Identities=21% Similarity=0.356 Sum_probs=195.1
Q ss_pred HhccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc---
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--- 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--- 518 (782)
..++|.+.+.||+|+||.||+|.+. +..||||+++.. .......+.+|+.++..++||||++++++|.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3466999999999999999999872 237999999754 233456799999999999999999999998543
Q ss_pred ----cEEEEEeCCCCChhHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 519 ----GIIVYEYLANGSLDDRIFRR---GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 519 ----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
.++||||+++|+|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 28999999999999988543 23356999999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhC
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENG 668 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~ 668 (782)
+|||+++...... .........|++.|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..+
T Consensus 189 ~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 189 ADFGLSKKIYSGD---YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp CSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred eecCcceeccccc---ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 9999998663221 1112234567889999999999999999999999999999999 99999643321 1222222
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
. ....+...+..+.+|+.+||..+|.+||++.+++. .|..+.
T Consensus 266 ~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~-~L~~l~ 307 (313)
T 3brb_A 266 H--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL-QLEKLL 307 (313)
T ss_dssp C--------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred C--------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHH
Confidence 1 11223344567999999999999999999988873 555443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=350.20 Aligned_cols=253 Identities=26% Similarity=0.310 Sum_probs=192.7
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-----hHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-----GRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
..++|...+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.++..++||||++++++|.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 346799999999999999999998 4778999999754221 1346889999999999999999999986543
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+++ +|.+.+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 8888775433 35888999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHH-hCcccccC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIE-NGTLGEML 674 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~-~~~~~~~l 674 (782)
+... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||........ .+. .+......
T Consensus 162 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSP-----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTSC-----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccCC-----cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 6321 1223456799999999988654 589999999999999999999999976543321 111 11111111
Q ss_pred CCCC------------CCCC-----hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 675 DPTV------------TDWP-----FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 675 d~~~------------~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+.. ...+ ...+..+.+|+.+||..+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1110 1111 223467999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.79 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=193.2
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcC--CCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIR--HPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~--~lV~ 523 (782)
..|.+.+.||+|+||.||+|.+ .++.||||++... .......+.+|+.+|..++ ||||+++++++.... |+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999987 5778999999654 2344677999999999996 599999999885544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
| +.+++|.+++.... .+++.++..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999987654 5889999999999999999999999 99999999999995 588999999999876322
Q ss_pred cccccccccccccCCcccCChhhhhc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCChH-HHHHHHHhCccc
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQT-----------GMLGVKSDVYSLGILLLQLITAKQPMGLTH-FVERSIENGTLG 671 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~Pf~~~~-~~~~~~~~~~~~ 671 (782)
. ........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ......
T Consensus 208 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------ 278 (390)
T 2zmd_A 208 T---TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------ 278 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------
T ss_pred C---ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH------
Confidence 1 1122345689999999998865 468999999999999999999999996432 111110
Q ss_pred ccCCCCC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 672 EMLDPTV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 672 ~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.++++.. ..+|...+..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 0111111 1222233456899999999999999999999986544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.44 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=189.0
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh--hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ--GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
..++|.+.+.||+|+||.||+|.+ +++.||||+++..... ....+.+|+.+|+.++||||+++++++.+.. |+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 345799999999999999999987 6789999999765322 2456789999999999999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE-----cCCCceeeeccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL-----DHNYVSKISDVGLA 597 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl-----d~~~~~kL~DFGla 597 (782)
|||++ |+|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 59999886653 4899999999999999999999999 9999999999999 45566999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCcccc
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGTLGE 672 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~~ 672 (782)
+..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||........... .+....
T Consensus 185 ~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 185 RAFGIP-----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccCCc-----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 865321 1223445789999999998775 489999999999999999999999976544322211 111100
Q ss_pred cCCCCC---CCC----------------ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 673 MLDPTV---TDW----------------PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 673 ~ld~~~---~~~----------------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+.. ..| +...+..+.+|+.+||+.||.+||++.+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 000 0113456899999999999999999998874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.60 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=190.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhh-HHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|...+.||+|+||.||+|.+ +++.||||++....... ...+.+|+.+|..++||||+++++++.+.. ++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4689999999999999999998 57789999997643221 234568999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
++ |+|.+++...+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 153 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence 97 58888886654 35899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---H-hCcccccCCCCC--
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---E-NGTLGEMLDPTV-- 678 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~-~~~~~~~ld~~~-- 678 (782)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+... . .+.......+..
T Consensus 154 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 154 ---TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 122234578999999998876 568999999999999999999999997654332111 1 111110000000
Q ss_pred ---------C--------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 ---------T--------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ---------~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
. ..+...+..+.+|+.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 001123456899999999999999999999884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.59 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=189.9
Q ss_pred cccccceeeeeCcEeEEEEEEC---C--eeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccC---ccEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD---H--TPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YGIIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~---~--~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lV 522 (782)
.|...+.||+|+||.||+|.+. + ..||||.++.. .......|.+|+.+|++++||||++++++|.+ ..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4777889999999999999872 2 36899998654 23446789999999999999999999998743 33899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999996543 34889999999999999999999999 99999999999999999999999999986632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
.... .........||+.|+|||++.+..++.++|||||||++|||++ |.+||..... ....+..+.. .
T Consensus 245 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--------~ 315 (373)
T 3c1x_A 245 KEFD-SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------L 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--------C
T ss_pred cccc-cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--------C
Confidence 2111 1112234568889999999999999999999999999999999 7888854322 1122222221 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..|...+..+.+++.+||+.+|++||++.+++. .|..+
T Consensus 316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~-~L~~i 353 (373)
T 3c1x_A 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS-RISAI 353 (373)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 123344556999999999999999999988873 44443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=340.71 Aligned_cols=242 Identities=25% Similarity=0.382 Sum_probs=194.9
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc------cEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------GII 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~l 521 (782)
.|...+.||+|+||.||+|.+ ++..||+|++... .....+.+.+|+.+|+.++||||++++++|... .++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 477888999999999999998 4568999998654 234467789999999999999999999987431 389
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCceeeecccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLV 600 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~kL~DFGla~~~ 600 (782)
||||+++|+|.+++.... .+++..++.|+.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999997653 4899999999999999999999986 3499999999999997 7899999999999754
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HHhCcccccCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IENGTLGEMLDPT 677 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~~~~~~~~ld~~ 677 (782)
.. .......||+.|+|||++. +.++.++|||||||++|+|++|+.||......... +..+....
T Consensus 183 ~~-------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 249 (290)
T 1t4h_A 183 RA-------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----- 249 (290)
T ss_dssp CT-------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-----
T ss_pred cc-------cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc-----
Confidence 22 1223457999999999776 56999999999999999999999999653322222 11111110
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 250 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 --SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112223346999999999999999999999984
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.93 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=200.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC----ccEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE----YGII 521 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~l 521 (782)
.++|.+.+.||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+++.++||||++++++|.+ ..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35699999999999999999998 57789999997542 3346679999999999999999999998732 2389
Q ss_pred EEEeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 522 VYEYLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFLHQTK--PEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987542 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccCCC
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEMLDP 676 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ld~ 676 (782)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ...+..+...
T Consensus 165 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----- 234 (279)
T 2w5a_A 165 ILNHDT-----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----- 234 (279)
T ss_dssp HC---C-----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred eecccc-----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-----
Confidence 653211 1122356899999999999999999999999999999999999999765432 2233333321
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 235 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 235 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 223344556999999999999999999999984
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=341.05 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=199.6
Q ss_pred ccccccc-eeeeeCcEeEEEEEE----CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 451 QFFTESR-KIGEGGYGPVYKCYL----DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 451 ~~f~~~~-~LG~G~fg~Vy~~~~----~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
++|.+.+ .||+|+||.||+|.+ .+..||||+++.... ...+.|.+|+.++..++||||+++++++.... ++|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv 95 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV 95 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEE
Confidence 4577777 999999999999965 346899999976532 23567999999999999999999999995444 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999997643 4899999999999999999999999 99999999999999999999999999987633
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~ 679 (782)
... .........||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ...+..+.. .
T Consensus 170 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~ 239 (291)
T 1xbb_A 170 DEN--YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------M 239 (291)
T ss_dssp TCS--EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------C
T ss_pred CCC--cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------C
Confidence 211 1112233457889999999999889999999999999999999 99999754432 222323221 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+...+..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~-~L~~~ 277 (291)
T 1xbb_A 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL-RLRNY 277 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH-HHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 223445567999999999999999999988873 44444
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=341.48 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=184.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hh-HHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QG-RSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.++|...+.||+|+||.||+|.+ +++.||||+++.... .. ...+..+..+++.++||||++++++|.+.. ++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35699999999999999999998 688999999976422 22 233445555678889999999999986544 8999
Q ss_pred EeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 524 EYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||++ |+|.+.+... .....+++..++.|+.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5887777542 2334699999999999999999999998 8 9999999999999999999999999998663
Q ss_pred cccccccccccccccCCcccCChhhh----hcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH----HHHHHhCccccc
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQ----QTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV----ERSIENGTLGEM 673 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~~~~~ 673 (782)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... ...+....
T Consensus 162 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 231 (290)
T 3fme_A 162 DD------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---- 231 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC----
T ss_pred cc------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC----
Confidence 21 122334799999999986 5667899999999999999999999999642211 11121111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
+.. .+...+..+.+|+.+||+.+|++||++.+++.+.+-.
T Consensus 232 --~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 232 --PQL--PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp --CCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred --CCc--ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 111 1123345699999999999999999999998655443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=344.42 Aligned_cols=246 Identities=27% Similarity=0.382 Sum_probs=198.5
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.+.|.+.+.||+|+||.||+|.+. ++.||||++.... ....+.+|+.++..++||||+++++++.+.. ++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 456999999999999999999984 7899999997643 3467899999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 106 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 106 CGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp CTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 99999999986443 35899999999999999999999999 999999999999999999999999999765321
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH--hCcccccCCCCCCCCCh
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE--NGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~--~~~~~~~ld~~~~~~p~ 683 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........... ... .+. ...+.
T Consensus 179 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~-~~~~~ 249 (314)
T 3com_A 179 ---MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-----PPT-FRKPE 249 (314)
T ss_dssp ---BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----CCC-CSSGG
T ss_pred ---ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----Ccc-cCCcc
Confidence 1122345799999999999999999999999999999999999999976544332221 111 111 11223
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+..+.+|+.+||..+|.+||++.+++.+
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 345569999999999999999999999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.96 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=199.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++..++||||+++++++.+.. ++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 35699999999999999999998 47799999996542 234567899999999999999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999987533 35899999999999999999999999 9999999999999999999999999998663221
Q ss_pred ccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHH---HHHHHHhCcccccCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHF---VERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~ 680 (782)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....+..... .. .
T Consensus 160 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~-~ 229 (276)
T 2yex_A 160 ---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------YL-N 229 (276)
T ss_dssp ---EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT------TS-T
T ss_pred ---chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc------cc-C
Confidence 1122345679999999999887765 7899999999999999999999964332 1111111110 00 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+..+.+|+.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11234456899999999999999999998873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=358.96 Aligned_cols=255 Identities=19% Similarity=0.277 Sum_probs=189.6
Q ss_pred hccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCchh-----------hHHHHHHHHHHHHhcCCCCeeeecc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDAAQ-----------GRSQFQREIEVLSCIRHPNMVLLLG 513 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~~-----------~~~~~~~Ei~iL~~l~HpnIv~l~g 513 (782)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356999999999999999999983 468999999765321 1233668889999999999999999
Q ss_pred cccC------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC
Q 040785 514 ACPE------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY 587 (782)
Q Consensus 514 ~~~~------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~ 587 (782)
++.. ..|+||||+ +++|.+++...+ .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9854 238999999 999999886554 5999999999999999999999999 99999999999998887
Q ss_pred --ceeeeccccccccccccccc--cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh--HHH
Q 040785 588 --VSKISDVGLARLVPAVAENV--TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT--HFV 661 (782)
Q Consensus 588 --~~kL~DFGla~~~~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~--~~~ 661 (782)
.+||+|||+++.+....... .........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999998764322111 111224568999999999999999999999999999999999999999431 111
Q ss_pred HHHHHhCcccccCCCCCCCC--ChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 662 ERSIENGTLGEMLDPTVTDW--PFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 662 ~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
............+.+.+..+ +...+..+.+|+.+||..+|.+||++.+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 320 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALK 320 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 11000000000011000000 013345699999999999999999998887
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.43 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=182.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~E 524 (782)
.++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.++..++||||+++++++... .++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 45799999999999999999987 67899999986543 23356788999999999999999999998544 489999
Q ss_pred eCCCCChhHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 525 YLANGSLDDRIFRR-----GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 525 y~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+++|+|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999988642 12345899999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDP 676 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~ 676 (782)
.................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 643221111222334579999999998876 56899999999999999999999999653322111 111111111000
Q ss_pred -CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 677 -TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 677 -~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.........+..+.+|+.+||+.+|.+||++.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001112234456899999999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=354.48 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=189.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
.++|...+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 35699999999999999999988 5789999999753 233456788999999999999999999988543
Q ss_pred -cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
.|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 3899999975 78777742 3889999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH--h--Cccc--
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE--N--GTLG-- 671 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~--~--~~~~-- 671 (782)
+.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........... . +...
T Consensus 175 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred ccccc------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86532 1123456799999999999999999999999999999999999999976543321111 0 0000
Q ss_pred --cc----------CCCCCCC-----------------CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 672 --EM----------LDPTVTD-----------------WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 672 --~~----------ld~~~~~-----------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.. -.+.... .+...+..+.+|+.+||..||.+||++.+++.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00 0000000 01123567999999999999999999999986443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=368.61 Aligned_cols=248 Identities=28% Similarity=0.475 Sum_probs=198.2
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.+.|...+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++||||++++++|.+.. |+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45699999999999999999998 56789999997643 233567899999999999999999999997654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---CCceeeecccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGLARLV 600 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~~~~kL~DFGla~~~ 600 (782)
||+++|+|.+.+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999887654 4899999999999999999999999 999999999999975 456999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTV 678 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 678 (782)
... ......+||+.|+|||++. +.|+.++|||||||++|+|++|.+||....... ..+..+.+.. ..+.
T Consensus 190 ~~~------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~- 260 (494)
T 3lij_A 190 ENQ------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF-DSPE- 260 (494)
T ss_dssp BTT------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CSGG-
T ss_pred CCC------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-Cchh-
Confidence 321 2234567999999999875 579999999999999999999999997654332 2233333211 0111
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
| ...+..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 261 --~-~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 261 --W-KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp --G-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred --c-ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 1 123456899999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.67 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=198.5
Q ss_pred HHHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccC--
Q 040785 443 IEDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPE-- 517 (782)
Q Consensus 443 ~~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~-- 517 (782)
+.++....++|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334444567899999999999999999998 67899999997643 3356789999999999 89999999999843
Q ss_pred ------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceee
Q 040785 518 ------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591 (782)
Q Consensus 518 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL 591 (782)
..++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 3489999999999999987643 235899999999999999999999999 999999999999999999999
Q ss_pred eccccccccccccccccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--
Q 040785 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS-- 664 (782)
Q Consensus 592 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~-- 664 (782)
+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.........
T Consensus 171 ~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (326)
T 2x7f_A 171 VDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245 (326)
T ss_dssp CCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred eeCcCceecCcCc-----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 9999998653211 1223457999999999886 567899999999999999999999999765443322
Q ss_pred HHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 665 IENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 665 ~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+........ .+...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 246 ~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 246 IPRNPAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHSCCCCC-------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred hhcCccccC-------CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 112111111 1122345699999999999999999999998543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=348.73 Aligned_cols=251 Identities=30% Similarity=0.472 Sum_probs=198.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCee--EEEEEecCC-chhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTP--VAVKVLRPD-AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~--vAvK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|...+.||+|+||.||+|.+ ++.. +|||.+... .......+.+|+.+|.++ +||||+++++++.+.. ++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 3599999999999999999987 4554 599998753 233456789999999999 8999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 523 YEYLANGSLDDRIFRRG-------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
|||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999987543 2346999999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIE 666 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~ 666 (782)
||+|||+++.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||........ .+.
T Consensus 182 kL~Dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 182 KIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp EECCTTCEESSCE------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred EEcccCcCccccc------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999975421 112233467889999999999889999999999999999998 9999976544321 121
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+. ....+...+..+.+|+.+||..+|.+||++.+++. .|..+.
T Consensus 256 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-~L~~~~ 299 (327)
T 1fvr_A 256 QGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV-SLNRML 299 (327)
T ss_dssp GTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred cCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHH
Confidence 211 11223344567999999999999999999998873 444443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=347.98 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=203.3
Q ss_pred HHHHhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHh--cCCCCeeeecccccCc-----
Q 040785 446 IEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSC--IRHPNMVLLLGACPEY----- 518 (782)
Q Consensus 446 ~~~~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~~----- 518 (782)
.....++|.+.+.||+|+||.||+|.++++.||||++... ....+.+|++++.. ++||||+++++++...
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3455678999999999999999999999999999999643 34567889999987 7899999999998543
Q ss_pred -cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCceEEEcCCCce
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH--------QTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
.++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +.+ |+||||||+||||+.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 48999999999999999653 4899999999999999999999 777 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCC------CCCchhHHHHHHHHHHHHhC----------CC
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM------LGVKSDVYSLGILLLQLITA----------KQ 653 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------~s~ksDVwSlGvil~elltG----------~~ 653 (782)
||+|||++......... .........||+.|+|||++.+.. ++.++|||||||++|||++| ..
T Consensus 187 kL~Dfg~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EECCCTTCEEEETTTTE-EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEECCCceeccccccc-cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 99999999866332111 111234567999999999987663 33689999999999999999 77
Q ss_pred CCCChH-------HHHHHHHhCcccccCCCCCCC-C-ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 654 PMGLTH-------FVERSIENGTLGEMLDPTVTD-W-PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 654 Pf~~~~-------~~~~~~~~~~~~~~ld~~~~~-~-p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
||.... .....+. ...+.+.++. + ....+..+.+|+.+||+.+|.+||++.+++. .|..+.
T Consensus 266 p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~-~L~~i~ 335 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK-TLSQLS 335 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CccccCcCcccHHHHHHHHH----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH-HHHHHH
Confidence 885421 1111111 1222333322 1 2355667999999999999999999988873 555543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=341.02 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=196.0
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC---ccEEEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YGIIVY 523 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lV~ 523 (782)
..++|...+.||+|+||.||+|.+ +++.||||++.... ....+.+|+.++..++|++++..++.|.. ..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 356799999999999999999997 67899999876543 23468899999999999988877776632 338999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---cCCCceeeecccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLV 600 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---d~~~~~kL~DFGla~~~ 600 (782)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999986543 34999999999999999999999999 9999999999999 88999999999999876
Q ss_pred ccccccc--cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH------HHHHHHHhCcccc
Q 040785 601 PAVAENV--TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH------FVERSIENGTLGE 672 (782)
Q Consensus 601 ~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~ 672 (782)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-EKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH-HHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh-cccccc
Confidence 4322110 1122345689999999999999999999999999999999999999996421 111111 111000
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
... ......+..+.+|+.+||+.+|++||++.+++ ..|..+.
T Consensus 238 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~-~~l~~~~ 279 (296)
T 4hgt_A 238 PIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR-QLFRNLF 279 (296)
T ss_dssp CHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHH-HHHHHHH
T ss_pred hhh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHH-HHHHHHH
Confidence 000 00112235699999999999999999998887 3555544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=340.30 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=198.7
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC---ccEEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YGIIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lV~E 524 (782)
.++|...+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.++..++|++++..++.+.. ..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 45799999999999999999997 678999999876432 3568999999999999987777766632 2389999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---cCCCceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---d~~~~~kL~DFGla~~~~ 601 (782)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999986443 35999999999999999999999999 9999999999999 588999999999998764
Q ss_pred cccccc--cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH------HHHHHHHhCccccc
Q 040785 602 AVAENV--TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH------FVERSIENGTLGEM 673 (782)
Q Consensus 602 ~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~~ 673 (782)
...... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .... +........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-ISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH-HHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh-hcccccCCc
Confidence 322110 1112345689999999999999999999999999999999999999996421 1111 111111000
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
. ...+...+..+.+|+.+||+.+|.+||++.+++ ..|..+.
T Consensus 239 ~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~-~~l~~~~ 279 (296)
T 3uzp_A 239 I----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR-QLFRNLF 279 (296)
T ss_dssp H----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHH-HHHHHHH
T ss_pred h----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHH-HHHHHHH
Confidence 0 001122335699999999999999999998887 3555443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=351.86 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=197.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccC---------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPE--------- 517 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------- 517 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|..++||||++++++|..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4699999999999999999998 577999999865432 224578899999999999999999998854
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..|+||||+.+ +|.+.+.... ..+++.++..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 23899999975 7777775443 34999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH----HhCccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI----ENGTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~----~~~~~~ 671 (782)
++.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... ..+...
T Consensus 171 a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSS-SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccc-cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9876422111 2223355689999999998876 458999999999999999999999997654322111 111111
Q ss_pred ccCCCCCCC--------------CChh-------HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTD--------------WPFE-------ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~--------------~p~~-------~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+.... .... ....+.+|+.+||+.||.+||++.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111000 0000 1345889999999999999999998874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=344.29 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=191.7
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..++||||+++++++.... |+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 35699999999999999999998 577999999976432 23467899999999999999999999986544 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999987653 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
. .........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..+.... +....
T Consensus 187 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~~ 256 (309)
T 2h34_A 187 E----KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI------PRPST 256 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC------CCGGG
T ss_pred c----ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC------CCccc
Confidence 1 1112234579999999999999999999999999999999999999997655432 1111111 11112
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCC-ChHHhhhHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRP-DLGKVVLPELNR 717 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RP-s~~~vl~~~l~~ 717 (782)
.+...+..+.+++.+||+.+|++|| ++.+++ ..|..
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~-~~l~~ 293 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS-AAAHA 293 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH-HHHHH
Confidence 2233445699999999999999999 666555 34443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=369.21 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=191.2
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--------hhhHHHHHHHHHHHHhcCCCCeeeecccccCc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--------AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--------~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~ 518 (782)
..++|...+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|.+++||||+++++++...
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 456799999999999999999998 46799999996532 11223588999999999999999999998654
Q ss_pred c-EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC---Cceeeecc
Q 040785 519 G-IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN---YVSKISDV 594 (782)
Q Consensus 519 ~-~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~---~~~kL~DF 594 (782)
. |+||||+++|+|.+.+... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred ceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 4 8999999999999887543 35899999999999999999999999 9999999999999654 45999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChH---HHHHHHHhC
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTH---FVERSIENG 668 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---~~~~~~~~~ 668 (782)
|+++.... .......+||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .....+..+
T Consensus 287 G~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~ 360 (419)
T 3i6u_A 287 GHSKILGE------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360 (419)
T ss_dssp STTTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred ccceecCC------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence 99987632 12234567999999999875 3668899999999999999999999996432 122233333
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.... ........+..+.+|+.+||+.+|++||++.+++.+.
T Consensus 361 ~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 361 KYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp CCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCC-----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 2211 0000112345689999999999999999999998543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=369.23 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=203.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
.++|...+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+.++||||++++++|.+.. |+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45799999999999999999998 57799999996542 234677999999999999999999999997654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---cCCCceeeeccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARL 599 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---d~~~~~kL~DFGla~~ 599 (782)
|||+.+|+|.+.+.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999886543 4899999999999999999999999 9999999999999 5678999999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPT 677 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 677 (782)
+... .......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||....... ..+..+.+.. .
T Consensus 179 ~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~ 247 (484)
T 3nyv_A 179 FEAS------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF----E 247 (484)
T ss_dssp BCCC------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----C
T ss_pred cccc------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC----C
Confidence 5321 12234579999999998765 79999999999999999999999997654432 2333333211 1
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.+.| ...+..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 248 ~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 248 LPQW-KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp SGGG-GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred Cccc-ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 1111 234556999999999999999999999986543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.21 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=199.0
Q ss_pred cccccceeeeeCcEeEEEEEE--CCe---eEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--c-EEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHT---PVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--G-IIV 522 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~---~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~-~lV 522 (782)
.|...+.||+|+||.||+|.+ ++. .||+|++.... ....+.|.+|+.+++.++||||++++++|.+. . ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 366779999999999999986 222 69999997543 34467899999999999999999999998543 2 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+.+|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999986533 35899999999999999999999999 99999999999999999999999999986632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCC-CCCChHH--HHHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQ-PMGLTHF--VERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 679 (782)
... ..........||+.|+|||.+.+..++.++|||||||++|+|++|.. ||..... ....+..+.. .
T Consensus 177 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~ 247 (298)
T 3pls_A 177 REY-YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR--------L 247 (298)
T ss_dssp GGG-GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC--------C
T ss_pred Ccc-cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC--------C
Confidence 211 11222344578999999999999999999999999999999999554 4543222 1222222221 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+...+..+.+|+.+||+.+|.+||++.+++. .|..+.
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~-~l~~~~ 286 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG-EVEQIV 286 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHH
Confidence 122334456999999999999999999988873 444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=378.93 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=197.6
Q ss_pred ccccc-eeeeeCcEeEEEEEE----CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEe
Q 040785 453 FTESR-KIGEGGYGPVYKCYL----DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEY 525 (782)
Q Consensus 453 f~~~~-~LG~G~fg~Vy~~~~----~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey 525 (782)
|.... .||+|+||.||+|.+ .+..||||+++... ....+.|.+|+.+|..++||||++++++|.... ++||||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~ 416 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEM 416 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEEC
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEe
Confidence 44444 799999999999987 24479999997653 234678999999999999999999999996544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 417 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 417 AGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp CTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred CCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999986543 35999999999999999999999999 99999999999999999999999999987632211
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHF--VERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.........+|+.|+|||++.++.++.++|||||||+||||++ |+.||..... +...+..+.. ...|
T Consensus 492 --~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--------~~~p 561 (613)
T 2ozo_A 492 --YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------MECP 561 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--------CCCC
T ss_pred --eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------CCCC
Confidence 1111223356789999999999999999999999999999998 9999965432 2233333321 1233
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
...+..+.+|+.+||+.+|.+||++.+++. .|..+
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~-~L~~~ 596 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQ-RMRAC 596 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH-HHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHH
Confidence 445567999999999999999999998873 44443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.93 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=185.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeeccccc--------Cc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACP--------EY 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--------~~ 518 (782)
..+|.+.+.||+|+||.||+|.+ +++.||||++..........+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45799999999999999999998 67899999997766666778999999999996 999999999872 22
Q ss_pred --cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 --GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
.++||||+. |+|.+++........+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 289999995 799998876444456999999999999999999999976 2499999999999999999999999999
Q ss_pred ccccccccccc-------cccccccccCCcccCChhhh---hcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH
Q 040785 597 ARLVPAVAENV-------TQYHLTSTAGTFCYIDPEYQ---QTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE 666 (782)
Q Consensus 597 a~~~~~~~~~~-------~~~~~~~~~Gt~~Y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~ 666 (782)
++......... .........||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~ 262 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--V 262 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--h
Confidence 98764321100 00111245699999999988 566789999999999999999999999964332211 1
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
.+... .+. +...+..+.+|+.+||+.+|.+||++.+++. .|..+..
T Consensus 263 ~~~~~---~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~-~l~~~~~ 308 (337)
T 3ll6_A 263 NGKYS---IPP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVH-QLQEIAA 308 (337)
T ss_dssp ---CC---CCT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred cCccc---CCc----ccccchHHHHHHHHHccCChhhCcCHHHHHH-HHHHHHh
Confidence 11111 011 1112234889999999999999999988873 5555543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.11 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=197.1
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|...+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.++..++||||++++++|.+.. ++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46999999999999999999984 7799999986543 233556889999999999999999999996554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP- 177 (331)
T ss_dssp CCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC-
Confidence 999999988764433 4899999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH-----------------H
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI-----------------E 666 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~-----------------~ 666 (782)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .
T Consensus 178 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 ----GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ----ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 1222346799999999998775 68999999999999999999999997544322111 0
Q ss_pred h-CcccccCCCCCCCC------ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHH
Q 040785 667 N-GTLGEMLDPTVTDW------PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELN 716 (782)
Q Consensus 667 ~-~~~~~~ld~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~ 716 (782)
. ..+.....+..... .+..+..+.+|+.+||+.+|.+||++.+++.+.+-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0 01111111111111 12345679999999999999999999999965543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.81 Aligned_cols=256 Identities=12% Similarity=0.048 Sum_probs=182.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhc--CCCCeeeeccccc-------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCI--RHPNMVLLLGACP------- 516 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l--~HpnIv~l~g~~~------- 516 (782)
..|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..| +||||++++..+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3488999999999999999997 578899999987532 3355678886655555 6999887553321
Q ss_pred -------------------CccEEEEEeCCCCChhHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCCe
Q 040785 517 -------------------EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQR------FRIAAEIATGLLFLHQTKPEPL 571 (782)
Q Consensus 517 -------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~~i 571 (782)
...|+||||++ |+|.+++...+. .+.+..+ +.++.||+.||.|||+.+ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 22489999998 899999976532 2455556 778899999999999999 9
Q ss_pred eecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHH
Q 040785 572 VHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLI 649 (782)
Q Consensus 572 iHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~ell 649 (782)
+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||+||+|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999865321 113457799999999987 67999999999999999999
Q ss_pred hCCCCCCChHHHHHH-HHhCcccccCCCCC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH-HHHHHH
Q 040785 650 TAKQPMGLTHFVERS-IENGTLGEMLDPTV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE-LNRLRE 720 (782)
Q Consensus 650 tG~~Pf~~~~~~~~~-~~~~~~~~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~-l~~l~~ 720 (782)
+|+.||......... .............. ...+...+..+.+|+.+||+.+|++||++.+++.+. +..+.+
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred hCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 999999654211000 00000000000000 011124456799999999999999999999998544 334433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=346.87 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=200.1
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|.+.+.||+|+||.||+|.+ .+..||||++... .......+.+|+.++..++||||+++++++.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35699999999999999999984 3557999999654 3344567899999999999999999999986544
Q ss_pred EEEEEeCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeee
Q 040785 520 IIVYEYLANGSLDDRIFRRGN----TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKIS 592 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~ 592 (782)
|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976532 135899999999999999999999999 99999999999998 44569999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGT 669 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~ 669 (782)
|||++....... .........||+.|+|||++.++.++.++|||||||++|+|++ |..||....... ..+..+.
T Consensus 186 Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 186 DFGMARDIYRAS---YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp CCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred cccccccccccc---ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999997653211 1112234568999999999999999999999999999999998 999997544322 2222221
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
. ...+...+..+.+|+.+||+.+|.+||++.+++. .|..+.
T Consensus 263 ~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~-~l~~~~ 303 (327)
T 2yfx_A 263 R--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCT 303 (327)
T ss_dssp C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred C--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH-HHHHHh
Confidence 1 1123344556999999999999999999998874 444443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=368.34 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=199.7
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-------------hhHHHHHHHHHHHHhcCCCCeeeecc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-------------QGRSQFQREIEVLSCIRHPNMVLLLG 513 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-------------~~~~~~~~Ei~iL~~l~HpnIv~l~g 513 (782)
..+.|.+.++||+|+||.||+|.+ ++..||||++..... .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 467899999999999999999998 467899999975421 22467889999999999999999999
Q ss_pred cccCcc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC---c
Q 040785 514 ACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY---V 588 (782)
Q Consensus 514 ~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~---~ 588 (782)
+|.+.. |+||||+++|+|.+.+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 997655 89999999999999887654 4899999999999999999999999 99999999999998776 6
Q ss_pred eeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHH
Q 040785 589 SKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIE 666 (782)
Q Consensus 589 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~ 666 (782)
+||+|||+++.+.. ........||+.|+|||++. +.++.++|||||||++|+|++|.+||....... ..+.
T Consensus 188 ~kl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSK------DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCT------TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCC------CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999987632 12234567999999999876 569999999999999999999999997654332 2233
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.+.+... ...| ...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 261 ~~~~~~~----~~~~-~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 261 KGKYYFD----FNDW-KNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HCCCCCC----HHHH-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCCCCC----cccc-CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 3322110 0000 12345689999999999999999999998543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.01 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=193.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccC--c--cEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPE--Y--GIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~--~~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ +++.||||+++... .+.+.+|+.+|..++ ||||+++++++.+ . .++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5699999999999999999987 67799999997543 467899999999997 9999999999865 2 38999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~~~ 602 (782)
||+++++|.+++. .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999998873 2889999999999999999999999 99999999999999776 899999999986632
Q ss_pred ccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHH----------------HHHHH
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHF----------------VERSI 665 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~----------------~~~~~ 665 (782)
. .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+
T Consensus 184 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 184 G------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp T------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred C------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 1 12344679999999999877 6799999999999999999999999942210 00111
Q ss_pred HhCcccccCCC----------------CC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 ENGTLGEMLDP----------------TV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~~~~~~~ld~----------------~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...... +++ .. ...+...+..+.+|+.+||+.||.+||++.+++.
T Consensus 258 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIE--LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCC--CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccc--cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111100 000 00 0111224567999999999999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=375.26 Aligned_cols=246 Identities=30% Similarity=0.431 Sum_probs=202.6
Q ss_pred HhccccccceeeeeCcEeEEEEEECC-eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeC
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDH-TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYL 526 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~ 526 (782)
..+.|.+.++||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|+.++||||++++++|.+.. ||||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 34668999999999999999999954 679999998654 33568999999999999999999999997644 9999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.... ...+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--
T ss_pred cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--
Confidence 9999999996532 134899999999999999999999999 9999999999999999999999999998763211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
........+|..|+|||++.++.++.++|||||||+||||++ |+.||...... ...+..+.. ...+.
T Consensus 418 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------~~~~~ 487 (535)
T 2h8h_A 418 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPCPP 487 (535)
T ss_dssp --HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCT
T ss_pred --eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCCCC
Confidence 111233457889999999999999999999999999999999 99999654332 222333211 11233
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+..+.+|+.+||+.+|++||++.+++
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~ 515 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQ 515 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 4456799999999999999999998887
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=378.78 Aligned_cols=240 Identities=25% Similarity=0.391 Sum_probs=193.9
Q ss_pred ceeeeeCcEeEEEEEE----CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYL----DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~----~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~g 529 (782)
+.||+|+||.||+|.+ .++.||||+++.... ...+.|.+|+.+|..++|||||+++++|.... ++||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 5799999999999976 346899999976432 23578999999999999999999999996554 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.+++.... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 455 ~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~--~~ 526 (635)
T 4fl3_A 455 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YY 526 (635)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc--cc
Confidence 9999996543 4899999999999999999999999 99999999999999999999999999987643211 11
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChhHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
...+...||+.|+|||++.+..++.++|||||||+||||++ |+.||...... ...+..+.. ...|...+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--------~~~p~~~~ 598 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------MGCPAGCP 598 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCTTCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCC
Confidence 12234467889999999999999999999999999999998 99999754432 233333321 12334455
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+.+|+.+||+.+|++||++.+++.
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 67999999999999999999998873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=352.59 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=196.4
Q ss_pred ccccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc-
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA----AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG- 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 519 (782)
++|.+.+.||+|+||.||+|.. +++.||||+++... ......+.+|+.+|..+ .||||+.+++++....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4699999999999999999998 57799999997532 22345678899999999 6999999999986544
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 89999999999999997654 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHhCCCCCCChH------HHHHHHHhCcc
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLITAKQPMGLTH------FVERSIENGTL 670 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~ 670 (782)
.+.... .......+||+.|+|||++.++ .++.++|||||||++|+|++|+.||.... .....+...
T Consensus 208 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-- 281 (355)
T 1vzo_A 208 EFVADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 281 (355)
T ss_dssp ECCGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--
T ss_pred ecccCC----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--
Confidence 653211 1223346799999999998863 47899999999999999999999995321 111111111
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 671 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
...++...+..+.+|+.+||..+|.+|| ++.+++.
T Consensus 282 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 282 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 1223444556789999999999999999 7777764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=367.29 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=199.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+.++||||+++++++.+.. |+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45699999999999999999998 57799999996432 223567899999999999999999999997654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeeecccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARLV 600 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~DFGla~~~ 600 (782)
||+.+|+|.+.+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887654 4899999999999999999999999 99999999999995 5668999999999865
Q ss_pred ccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTV 678 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 678 (782)
... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||....... ..+..+.+.. ..
T Consensus 175 ~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~~ 243 (486)
T 3mwu_A 175 QQN------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF----DL 243 (486)
T ss_dssp CCC----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS----CS
T ss_pred CCC------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CC
Confidence 321 12345679999999998764 69999999999999999999999997554332 2233333221 11
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+.| ...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 244 ~~~-~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQW-RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGG-GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ccc-CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 2344568999999999999999999998853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.77 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=192.9
Q ss_pred ccccccceeeeeCcEeEEEEEEC---Ce--eEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD---HT--PVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~---~~--~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~l 521 (782)
++|.+.+.||+|+||.||+|.+. ++ .||||+++... ....+.+.+|+.++..++||||+++++++.+.. ++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 46999999999999999999862 22 58999987642 234577899999999999999999999986554 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+.+.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 98 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 999999999999987653 24899999999999999999999999 9999999999999999999999999998764
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHH--HHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVER--SIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~ 678 (782)
.... .........||+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .+..... .
T Consensus 173 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------~ 243 (291)
T 1u46_A 173 QNDD--HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-------R 243 (291)
T ss_dssp C-CC--EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-------C
T ss_pred cccc--chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC-------C
Confidence 3211 1112234568889999999999889999999999999999999 9999975543221 1111111 0
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
...+...+..+.+++.+||..+|.+||++.+++. .|..
T Consensus 244 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~-~l~~ 281 (291)
T 1u46_A 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD-FLLE 281 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHH
T ss_pred CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH-HHHH
Confidence 1122344566999999999999999999988873 4443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.66 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=192.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..++||||+++++++.+.. ++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 4688999999999999999998 478999999965422 23457889999999999999999999986544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ..+..+. ..
T Consensus 165 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~ 229 (276)
T 2h6d_A 165 ------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---------FY 229 (276)
T ss_dssp ------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CC
T ss_pred ------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------cc
Confidence 11234578999999999887765 689999999999999999999997554322 2222221 11
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.|...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 233344568999999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=346.40 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=195.5
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--------hhHHHHHHHHHHHHhcCCCCeeeecccccCc
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--------QGRSQFQREIEVLSCIRHPNMVLLLGACPEY 518 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~ 518 (782)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|..++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346799999999999999999998 567999999965421 1234588999999999999999999998654
Q ss_pred c-EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc---eeeecc
Q 040785 519 G-IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV---SKISDV 594 (782)
Q Consensus 519 ~-~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~---~kL~DF 594 (782)
. |+||||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 8999999999999988543 35899999999999999999999999 999999999999987654 999999
Q ss_pred ccccccccccccccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHhCCCCCCChH---HHHHHHHhC
Q 040785 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLITAKQPMGLTH---FVERSIENG 668 (782)
Q Consensus 595 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---~~~~~~~~~ 668 (782)
|+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|..||.... .....+..+
T Consensus 162 g~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 162 GHSKILGET------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp TTCEECCCC------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred ccceecccc------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 999866321 1123457999999999874 4678999999999999999999999996432 122223333
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.... .+..+...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 236 ~~~~-----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 236 KYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccc-----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 2211 000111234568999999999999999999999854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.10 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=200.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---------hhhHHHHHHHHHHHHhcC-CCCeeeecccccC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---------AQGRSQFQREIEVLSCIR-HPNMVLLLGACPE 517 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---------~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~ 517 (782)
.++|...+.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+|.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 45699999999999999999998 56799999997542 122456889999999996 9999999999966
Q ss_pred cc--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 518 YG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 518 ~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
.. ++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 54 89999999999999987653 4899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhh------cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHh
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ------TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIEN 667 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~ 667 (782)
++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||....... ..+..
T Consensus 170 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 170 FSCQLDPG------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp TCEECCTT------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred chhhcCCC------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 99865321 1223467999999999875 4568899999999999999999999996544322 22223
Q ss_pred CcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 668 GTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 668 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.... ..+ .....+..+.+|+.+||+.+|.+||++.+++.
T Consensus 244 ~~~~~-~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQF-GSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCCC-CTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCccc-Ccc----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 32211 011 11234556999999999999999999999884
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=357.19 Aligned_cols=199 Identities=26% Similarity=0.336 Sum_probs=163.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 35799999999999999999998 5678999999753 233456789999999999999999999998543
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.|+||||+. |+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 389999986 5999988543 34899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccc-----------------cccccccccCCcccCChhhh-hcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 040785 599 LVPAVAENV-----------------TQYHLTSTAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 599 ~~~~~~~~~-----------------~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~Pf 655 (782)
......... .....+..+||++|+|||++ ....|+.++|||||||++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 764321110 00224567899999999986 5567999999999999999999855444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=378.63 Aligned_cols=237 Identities=25% Similarity=0.295 Sum_probs=198.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|.+.+.||+|+||.||+|.+ +++.||||+++... ......+..|..+|..+ +||||+.+++++.+.. |||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 4599999999999999999998 45679999997542 22345688999999987 7999999999987654 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++...+ .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++....
T Consensus 421 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999997654 4899999999999999999999999 99999999999999999999999999985421
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||......+ ..+..+. ..
T Consensus 495 -----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------~~ 560 (674)
T 3pfq_A 495 -----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VA 560 (674)
T ss_dssp -----TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------CC
T ss_pred -----CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 1122345789999999999999999999999999999999999999997654332 2222221 12
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
+|...+..+.+|+.+||+.+|.+||++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 344556679999999999999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=359.96 Aligned_cols=250 Identities=22% Similarity=0.231 Sum_probs=192.3
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC------c--cE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------Y--GI 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~--~~ 520 (782)
..|...+.||+|+||.||+|.+ ++..||||++.... ..+.+|+++|+.++||||++++++|.. . .+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3588999999999999999998 57899999986542 234579999999999999999998732 1 36
Q ss_pred EEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeecccccc
Q 040785 521 IVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLAR 598 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla~ 598 (782)
+||||+++ +|.+.+... .....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999976 566555432 22346999999999999999999999999 9999999999999955 678999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH--------
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-------- 666 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-------- 666 (782)
.+... .......||+.|+|||++.+. .|+.++|||||||+||||++|+.||......+.. +.
T Consensus 206 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTT------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred hcccC------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 65321 122346789999999988765 7999999999999999999999999765432211 11
Q ss_pred -----hCcccccCCCCCCC------CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 667 -----NGTLGEMLDPTVTD------WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 667 -----~~~~~~~ld~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
...+.....+.... ++...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 01111111111111 1223456799999999999999999999998544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.78 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=197.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------c
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------G 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~ 519 (782)
.++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|..++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45799999999999999999998 57789999997543 33456789999999999999999999988432 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+||||+. |+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 89999997 5899888543 3899999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHH---HHHHH-hCccc---
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFV---ERSIE-NGTLG--- 671 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~---~~~~~-~~~~~--- 671 (782)
...... .........||+.|+|||++.++ .++.++|||||||++|+|++|+.||...... ..... .+...
T Consensus 178 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGC--BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred cCCCCC--ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643221 11123456899999999986654 5899999999999999999999999654321 11110 00000
Q ss_pred --------------ccCCCCCCC---CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 --------------EMLDPTVTD---WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 --------------~~ld~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+.... .....+..+.+|+.+||..+|.+||++.+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 11233456899999999999999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=350.81 Aligned_cols=256 Identities=17% Similarity=0.199 Sum_probs=196.6
Q ss_pred ccccccceeeeeCcEeEEEEEEC----------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeee---------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD----------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL--------- 511 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~----------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l--------- 511 (782)
++|.+.+.||+|+||.||+|.+. +..||||++... ..+.+|+.++.+++||||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 56999999999999999999984 578999999754 468899999999999999984
Q ss_pred ------cccccC---ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEE
Q 040785 512 ------LGACPE---YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNIL 582 (782)
Q Consensus 512 ------~g~~~~---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 582 (782)
++++.. ..|+||||+ +++|.+++.... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 444432 238999999 999999997642 235999999999999999999999999 999999999999
Q ss_pred EcCCC--ceeeeccccccccccccccc--cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCCh
Q 040785 583 LDHNY--VSKISDVGLARLVPAVAENV--TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT 658 (782)
Q Consensus 583 ld~~~--~~kL~DFGla~~~~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~ 658 (782)
++.++ .+||+|||+++.+....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 99999999998764322111 111224458999999999999999999999999999999999999999654
Q ss_pred H--H--HHHHHH--hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 659 H--F--VERSIE--NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 659 ~--~--~~~~~~--~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
. . ...... ......+.++... ....+..+.+|+.+||..+|.+||++.+++. .|..+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~-~L~~~~ 335 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRN-NLEALL 335 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHH-HHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHH-HHHHHH
Confidence 2 1 111111 1111111111100 0123456999999999999999999988873 444443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.47 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=198.1
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc----hhhHHHHHHHHHHHHhcCCCCeeeecccc--cC--cc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA----AQGRSQFQREIEVLSCIRHPNMVLLLGAC--PE--YG 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~--~~ 519 (782)
.++|.+.+.||+|+||.||+|.+ ++..||||+++... ......+.+|+.++..++||||+++++++ .+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 35799999999999999999998 56789999997542 22356789999999999999999999988 33 33
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+++| |.+.+.... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 8999999877 777665543 345999999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcCC--CCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLD 675 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld 675 (782)
..... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ..+..+..
T Consensus 159 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----- 230 (305)
T 2wtk_C 159 LHPFA---ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY----- 230 (305)
T ss_dssp CCTTC---SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----
T ss_pred cCccc---cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-----
Confidence 53211 112223457999999999887654 3789999999999999999999997654332 22222221
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
..+...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 231 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1233345568999999999999999999999853
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=352.28 Aligned_cols=253 Identities=18% Similarity=0.243 Sum_probs=194.8
Q ss_pred HHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC--------
Q 040785 448 EATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------- 517 (782)
Q Consensus 448 ~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------- 517 (782)
...++|...+.||+|+||.||+|.+ ++..||||++..+. ..+.+|+.+|+.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4456799999999999999999998 67899999986542 234579999999999999999998721
Q ss_pred ------------------------------c--cEEEEEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040785 518 ------------------------------Y--GIIVYEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLH 564 (782)
Q Consensus 518 ------------------------------~--~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH 564 (782)
. .++||||++ |+|.+.+... .....+++..+..|+.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1 379999998 5887777542 22346999999999999999999999
Q ss_pred hcCCCCeeecCCCCceEEEc-CCCceeeeccccccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHH
Q 040785 565 QTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLG 642 (782)
Q Consensus 565 ~~~~~~iiHrDLKp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlG 642 (782)
+.+ |+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||||
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999 99999999999998 6899999999999865321 122345789999999988765 499999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHHHHHh----C------------cccccCCCCCC--C----CChhHHHHHHHHHHHhhccC
Q 040785 643 ILLLQLITAKQPMGLTHFVERSIEN----G------------TLGEMLDPTVT--D----WPFEETLGFAKLALQCSELR 700 (782)
Q Consensus 643 vil~elltG~~Pf~~~~~~~~~~~~----~------------~~~~~ld~~~~--~----~p~~~~~~l~~li~~cl~~~ 700 (782)
|++|+|++|+.||......+..... | .+....-+... . .+...+..+.+|+.+||..+
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999999765433221110 1 11111111111 1 12334566999999999999
Q ss_pred cCCCCChHHhhhHH
Q 040785 701 RKDRPDLGKVVLPE 714 (782)
Q Consensus 701 P~~RPs~~~vl~~~ 714 (782)
|.+||++.+++.+.
T Consensus 310 P~~R~t~~e~l~hp 323 (383)
T 3eb0_A 310 PDLRINPYEAMAHP 323 (383)
T ss_dssp GGGSCCHHHHHTSG
T ss_pred hhhCCCHHHHhcCH
Confidence 99999999998644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.31 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=191.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC----------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE---------- 517 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---------- 517 (782)
.++|...+.||+|+||.||+|.+ +++.||||++... ......+.+|+.++..++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45699999999999999999997 5789999999653 3445778999999999999999999998732
Q ss_pred -----ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 518 -----YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 518 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 2389999999999999997643 34788999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccccc---------ccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHH
Q 040785 593 DVGLARLVPAVAEN---------VTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVE 662 (782)
Q Consensus 593 DFGla~~~~~~~~~---------~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~ 662 (782)
|||++......... ..........||+.|+|||++.+. .++.++|||||||++|+|++ ||.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999866321100 001223456799999999998754 68999999999999999998 564332221
Q ss_pred HH---HHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 663 RS---IENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 663 ~~---~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. +.... ..+ ...++...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~--~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVS--IEF---PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTT--CCC---CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccc--ccc---CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 11111 111 12334455567899999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=353.24 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=180.5
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC--------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------- 517 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------- 517 (782)
.++|...+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 45799999999999999999987 5789999999653 23345678899999999999999999998853
Q ss_pred ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 518 YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 518 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
..|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 238999999 7899988754 34999999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCcccc
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGTLGE 672 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~~~~ 672 (782)
+.... ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... .. .|....
T Consensus 180 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTAD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccccc--------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 86531 1234679999999998877 67999999999999999999999999765433211 11 111100
Q ss_pred cCC---------------CCCCCCC-----hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 673 MLD---------------PTVTDWP-----FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 673 ~ld---------------~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
... +.....+ ...+..+.+|+.+||..||.+||++.+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 0001111 123456899999999999999999999885
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.56 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=197.6
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC--------CCCeeeeccccc---
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR--------HPNMVLLLGACP--- 516 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l~g~~~--- 516 (782)
.++|.+.++||+|+||.||+|.+ +++.||||+++.. ......+.+|+.+|..++ ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999987 5779999999765 344567899999999986 788999999875
Q ss_pred -C--ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCC-----
Q 040785 517 -E--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNY----- 587 (782)
Q Consensus 517 -~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~----- 587 (782)
+ ..|+||||+ +++|.+.+..... ..+++..++.|+.||+.||.|||+. + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 2 238999999 6677666655432 3599999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------ceeeeccccccccccccccccccccccccCCcccCC
Q 040785 588 --------------------------------------------VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623 (782)
Q Consensus 588 --------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~a 623 (782)
.+||+|||+++.... ......||+.|+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--------~~~~~~gt~~y~a 261 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--------HFTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--------CSCSCCSCGGGCC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--------cCccCCCCCcccC
Confidence 799999999986532 1244579999999
Q ss_pred hhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH---------HHHHHH-----------HhCccc-----------c
Q 040785 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH---------FVERSI-----------ENGTLG-----------E 672 (782)
Q Consensus 624 PE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---------~~~~~~-----------~~~~~~-----------~ 672 (782)
||++.+..++.++|||||||+||+|++|+.||.... ...... ..+... .
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999999999999999999999999999996321 111110 011110 0
Q ss_pred cCCC----------CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 673 MLDP----------TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 673 ~ld~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
+.+. ....++...+..+.+|+.+||+.+|++||++.+++.+
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 0013456677789999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=357.48 Aligned_cols=196 Identities=26% Similarity=0.335 Sum_probs=168.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc------CCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI------RHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~g~~~~~~-- 519 (782)
..+|.+.+.||+|+||.||+|.+ +++.||||+++... .....+.+|+.++..+ .||||+.++++|....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45699999999999999999988 46799999997653 3356788899998887 5779999999986443
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc--eeeeccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV--SKISDVGLA 597 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~--~kL~DFGla 597 (782)
|+||||+. ++|.+++..... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 89999995 689998876543 35999999999999999999999999 999999999999999887 999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~ 659 (782)
+.... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||....
T Consensus 250 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQ--------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTC--------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCC--------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 75421 2234689999999999999999999999999999999999999997544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=340.70 Aligned_cols=250 Identities=26% Similarity=0.291 Sum_probs=198.1
Q ss_pred hccccccceeeeeCcEeEEEEEE---CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC------eeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL---DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN------MVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~g~~~~~~- 519 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||+++... .....+.+|+.++..++|+| |+.+++++....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35699999999999999999987 56789999997543 34567889999999987654 899999886544
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-------------
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH------------- 585 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~------------- 585 (782)
|+||||+ +++|.+++..... .++++..+..|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 8999999 8899998876543 35899999999999999999999999 999999999999987
Q ss_pred ------CCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH
Q 040785 586 ------NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659 (782)
Q Consensus 586 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~ 659 (782)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE--------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS--------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccCCCceEeeCcccccCcc--------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 67899999999976421 1234679999999999999999999999999999999999999997543
Q ss_pred HHHHH--HH--hCccc----------ccCCC-----------------------CCCCCChhHHHHHHHHHHHhhccCcC
Q 040785 660 FVERS--IE--NGTLG----------EMLDP-----------------------TVTDWPFEETLGFAKLALQCSELRRK 702 (782)
Q Consensus 660 ~~~~~--~~--~~~~~----------~~ld~-----------------------~~~~~p~~~~~~l~~li~~cl~~~P~ 702 (782)
..... +. .+.+. ..... .....+...+..+.+|+.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 32211 00 00000 00000 00111234566799999999999999
Q ss_pred CCCChHHhhhH
Q 040785 703 DRPDLGKVVLP 713 (782)
Q Consensus 703 ~RPs~~~vl~~ 713 (782)
+||++.+++.+
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.42 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=192.3
Q ss_pred hccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccccc-----------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP----------- 516 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----------- 516 (782)
.++|...+.||+|+||.||+|.+. ++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 356999999999999999999984 7899999998776666788999999999999999999998763
Q ss_pred -----CccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCcee
Q 040785 517 -----EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSK 590 (782)
Q Consensus 517 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~k 590 (782)
...++||||+. |+|.+++.. .++++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 12389999997 699998843 34899999999999999999999999 99999999999997 567999
Q ss_pred eeccccccccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH
Q 040785 591 ISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE 666 (782)
Q Consensus 591 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~ 666 (782)
|+|||+++....... .........||..|+|||++.. ..++.++|||||||++|+|++|+.||......... ..
T Consensus 162 l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYS--HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EccCccccccCCCcc--cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999987632211 1112234568999999998765 67899999999999999999999999765432211 11
Q ss_pred hCcc-------------c-----ccCCCC--CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 667 NGTL-------------G-----EMLDPT--VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 667 ~~~~-------------~-----~~ld~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.... . ....+. ....+...+..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 1000 0 000000 0011123455699999999999999999999998543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.76 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=200.7
Q ss_pred hccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhh-----------------HHHHHHHHHHHHhcCCCCeeeec
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQG-----------------RSQFQREIEVLSCIRHPNMVLLL 512 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~-----------------~~~~~~Ei~iL~~l~HpnIv~l~ 512 (782)
.++|.+.+.||+|+||.||+|.+++..||||++....... ...|.+|+.++..++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3569999999999999999999999999999997542221 17899999999999999999999
Q ss_pred ccccCcc--EEEEEeCCCCChhHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEE
Q 040785 513 GACPEYG--IIVYEYLANGSLDDR------IFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 513 g~~~~~~--~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILl 583 (782)
+++.+.. ++||||+++|+|.++ +... ....+++..++.++.||+.||.|||+ .+ |+||||||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9986554 899999999999987 4332 23569999999999999999999999 88 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcC-CCCC-chhHHHHHHHHHHHHhCCCCCCChHH-
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGV-KSDVYSLGILLLQLITAKQPMGLTHF- 660 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~-ksDVwSlGvil~elltG~~Pf~~~~~- 660 (782)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||.....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred cCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999865321 23456799999999998877 5666 99999999999999999999975432
Q ss_pred --HHHHHHhCcccccCCCC--C--------CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 661 --VERSIENGTLGEMLDPT--V--------TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 661 --~~~~~~~~~~~~~ld~~--~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+..+......+.. . ...+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22223222211110000 0 0001334567999999999999999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=339.15 Aligned_cols=253 Identities=27% Similarity=0.365 Sum_probs=198.5
Q ss_pred HhccccccceeeeeCcEeEEEEEE---CCeeEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCCeeeeccccc----
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL---DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCI---RHPNMVLLLGACP---- 516 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~---- 516 (782)
+.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346799999999999999999998 367899999865422 1234577888888777 8999999999885
Q ss_pred -C--ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeec
Q 040785 517 -E--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISD 593 (782)
Q Consensus 517 -~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~D 593 (782)
. ..++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 2 2389999997 699998876543 34899999999999999999999999 99999999999999999999999
Q ss_pred cccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH---HHHHh-Cc
Q 040785 594 VGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIEN-GT 669 (782)
Q Consensus 594 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~---~~~~~-~~ 669 (782)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.. +.
T Consensus 164 fg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGG------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CcccccccCC------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999866321 12345679999999999999999999999999999999999999997554322 11111 10
Q ss_pred ccc----------------cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 LGE----------------MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ~~~----------------~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
... .........+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000011122344567899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.96 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=195.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-----------CCCeeeecccccC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-----------HPNMVLLLGACPE 517 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~g~~~~ 517 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+|+.++.++. ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 4699999999999999999997 67899999997643 34567889999999886 8999999999854
Q ss_pred ------ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEc------
Q 040785 518 ------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLD------ 584 (782)
Q Consensus 518 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld------ 584 (782)
..++||||+ +++|.+++..... ..+++..+..|+.||+.||.|||+. + |+||||||+||||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 238999999 8999998876433 3489999999999999999999998 8 99999999999994
Q ss_pred CCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH----
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF---- 660 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~---- 660 (782)
..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 173 ~~~~~kl~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCC--------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 445899999999986532 12345799999999999999999999999999999999999999964321
Q ss_pred -----HHHHHH-hCcc---------------------cccCC----------CCCCCCChhHHHHHHHHHHHhhccCcCC
Q 040785 661 -----VERSIE-NGTL---------------------GEMLD----------PTVTDWPFEETLGFAKLALQCSELRRKD 703 (782)
Q Consensus 661 -----~~~~~~-~~~~---------------------~~~ld----------~~~~~~p~~~~~~l~~li~~cl~~~P~~ 703 (782)
....+. .+.+ ..+.. ......+...+..+.+|+.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 111110 0000 00000 0011234566778999999999999999
Q ss_pred CCChHHhhh
Q 040785 704 RPDLGKVVL 712 (782)
Q Consensus 704 RPs~~~vl~ 712 (782)
||++.+++.
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=351.52 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=191.2
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC------c--cEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------Y--GII 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~--~~l 521 (782)
..|...+.||+|+||.||+|.+ .+..||+|.+.... ....+|+.+|+.++||||++++++|.. . .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4599999999999999999998 45569999886432 223479999999999999999998832 1 379
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCceeeecccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLV 600 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~kL~DFGla~~~ 600 (782)
||||++++.+............+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987654443333333346999999999999999999999999 99999999999999 7999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----C-------
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----G------- 668 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~------- 668 (782)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||............ +
T Consensus 193 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IAG------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CTT------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCC------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 321 122346789999999988665 5999999999999999999999999765433221110 0
Q ss_pred -----cccccCCCCCCC------CChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 669 -----TLGEMLDPTVTD------WPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 669 -----~~~~~ld~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+....-+.... ++...+..+.+|+.+||..+|.+||++.+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 011111111111 12234567999999999999999999999884
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=348.91 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=192.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG------ 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 519 (782)
.++|...+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||++++++|....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 45799999999999999999998 57899999997642 333567889999999999999999999985432
Q ss_pred --EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 520 --IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
|+||||+. ++|.+.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 89999997 68877662 23899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Cccc-
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTLG- 671 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~- 671 (782)
+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ +...
T Consensus 192 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 192 RHADA--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccc--------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 86532 1234678999999998877 67999999999999999999999999765433211110 0000
Q ss_pred ----------------ccCCCCC---CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 ----------------EMLDPTV---TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ----------------~~ld~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..... ...+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000 0111233567999999999999999999999884
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.02 Aligned_cols=257 Identities=18% Similarity=0.212 Sum_probs=186.4
Q ss_pred HHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccC-----
Q 040785 445 DIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPE----- 517 (782)
Q Consensus 445 ~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----- 517 (782)
......++|.+.+.||+|+||.||+|.+ ++..||||++.... .....+.+|+..+..++||||++++++|..
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3445667899999999999999999998 47799999986543 234467788888999999999999998832
Q ss_pred ----ccEEEEEeCCCCChhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCceEEEcC-CCce
Q 040785 518 ----YGIIVYEYLANGSLDDRIFR-RGNTPPLSWQQRFRIAAEIATGLLFLH--QTKPEPLVHRDLKPGNILLDH-NYVS 589 (782)
Q Consensus 518 ----~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~iiHrDLKp~NILld~-~~~~ 589 (782)
..++||||+++ +|.+.+.. ......+++..+..++.||+.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 13799999986 44444432 234456899999999999999999999 888 999999999999996 8999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---H
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---I 665 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~ 665 (782)
||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......... .
T Consensus 172 kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPS------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTT------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEeeCCCceecCCC------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 99999999876421 1223457899999999886554 899999999999999999999999755432211 1
Q ss_pred Hh-Ccc--------------cccCCC-------CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 EN-GTL--------------GEMLDP-------TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~-~~~--------------~~~ld~-------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. +.. ....+. .....+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 10 000 000000 011122235667999999999999999999999884
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=344.80 Aligned_cols=255 Identities=23% Similarity=0.255 Sum_probs=196.3
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccC-------cc
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------YG 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~ 519 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|..++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 45799999999999999999998 47899999997543 3345678899999999999999999998753 23
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
++||||+. |+|.+.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 89999997 6898888653 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccc-----cccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCc
Q 040785 600 VPAVAENV-----TQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGT 669 (782)
Q Consensus 600 ~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~ 669 (782)
........ .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 64221110 0112234579999999998765 6789999999999999999999999976543322110 011
Q ss_pred ccc--cCC--------------CCCC-----CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 LGE--MLD--------------PTVT-----DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ~~~--~ld--------------~~~~-----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
... .+. +... ..+...+..+.+|+.+||..||++||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 000 0000 011234556899999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=342.81 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=194.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCc--------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------- 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------- 518 (782)
++|...+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++..++||||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 4689999999999999999998 57899999997542 23356788999999999999999999998543
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.|+||||+. |+|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 289999997 58877652 23899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCc----
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGT---- 669 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~---- 669 (782)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .. .+.
T Consensus 175 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADA--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp C----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred CCCC--------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 6532 1234578999999998877 67899999999999999999999999755432211 10 000
Q ss_pred ----------------ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 ----------------LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ----------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+.....+.....+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011111222233445667999999999999999999999884
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=350.99 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=177.2
Q ss_pred cccc-cceeeeeCcEeEEEEEEC----CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeeccccc--C--ccEEE
Q 040785 452 FFTE-SRKIGEGGYGPVYKCYLD----HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACP--E--YGIIV 522 (782)
Q Consensus 452 ~f~~-~~~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~--~~~lV 522 (782)
.|.+ .++||+|+||.||+|.+. +..||||++..... ...+.+|+.+|+.++||||++++++|. . ..|+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3665 458999999999999963 56899999975432 356889999999999999999999983 2 23899
Q ss_pred EEeCCCCChhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE----cCCCceeee
Q 040785 523 YEYLANGSLDDRIFRR------GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL----DHNYVSKIS 592 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----d~~~~~kL~ 592 (782)
|||+. |+|.+.+... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 5787777532 12234999999999999999999999999 9999999999999 778999999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHH-----------
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHF----------- 660 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~----------- 660 (782)
|||+++.+..... ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 175 Dfg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 175 DMGFARLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp CTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred ECCCceecCCCCc--ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999987642211 11223456899999999988874 589999999999999999999999953221
Q ss_pred -HHHHHH-hCcccccCCCCCCCCC---------------------------hhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 661 -VERSIE-NGTLGEMLDPTVTDWP---------------------------FEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 661 -~~~~~~-~~~~~~~ld~~~~~~p---------------------------~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
....+. .|.......+.+...+ ......+.+|+.+||..||.+||++.++|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111111 1111000000000000 00134578999999999999999999988
Q ss_pred h
Q 040785 712 L 712 (782)
Q Consensus 712 ~ 712 (782)
.
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.77 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=195.1
Q ss_pred hccccccceeeeeCcEeEEEEEECCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|.+.+.||+|+||.||+|.+.+ .||+|+++... ....+.|.+|+.++..++||||+++++++.+.. ++||||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 4568999999999999999998865 59999987542 223456889999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.......
T Consensus 111 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 111 CKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999986543 35899999999999999999999999 99999999999998 67999999999876532222
Q ss_pred cccccccccccCCcccCChhhhhc---------CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQT---------GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEML 674 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~---------~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l 674 (782)
...........||+.|+|||++.. ..++.++|||||||++|+|++|+.||....... ..+..+..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---- 260 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK---- 260 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC----
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC----
Confidence 112223344579999999998864 457899999999999999999999997554332 22222221
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
+.... ...+..+.+|+.+||..+|.+||++.+++ ..|..+.
T Consensus 261 -~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~-~~l~~l~ 301 (319)
T 2y4i_B 261 -PNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLM-DMLEKLP 301 (319)
T ss_dssp -CCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHH-HHHTTC-
T ss_pred -CCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHH-HHHHHHH
Confidence 11111 11233489999999999999999998887 3555443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=358.80 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=195.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCee-eecccc--cCccEEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV-LLLGAC--PEYGIIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~g~~--~~~~~lV~E 524 (782)
.++|.+.++||+|+||.||+|.+ ++..||||++..... ...+.+|++++..+.|++++ .+..++ .+..|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35699999999999999999997 578999999875432 34688999999999875544 443333 334489999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---cCCCceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---d~~~~~kL~DFGla~~~~ 601 (782)
|+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999987543 34999999999999999999999999 9999999999999 688999999999998764
Q ss_pred cccccc--cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHH-----HHHHHHhCcccccC
Q 040785 602 AVAENV--TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHF-----VERSIENGTLGEML 674 (782)
Q Consensus 602 ~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~l 674 (782)
...... .........||+.|+|||++.+..++.++||||||||||||++|+.||..... ....+....+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 322111 11223356899999999999999999999999999999999999999964211 01111111111111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.. ++...+..+.+|+..||+.+|++||++.+++ ..|..+.
T Consensus 238 ~~----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~-~~L~~l~ 277 (483)
T 3sv0_A 238 EA----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLK-RLFRDLF 277 (483)
T ss_dssp HH----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH-HHHHHHH
T ss_pred HH----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHH-HHHHHHH
Confidence 11 1112234699999999999999999998887 3555443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.18 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=192.9
Q ss_pred HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh------hHHHHHHHHHHHHhc----CCCCeeeeccc
Q 040785 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ------GRSQFQREIEVLSCI----RHPNMVLLLGA 514 (782)
Q Consensus 447 ~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l----~HpnIv~l~g~ 514 (782)
+...++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34456799999999999999999987 5778999999764321 233466899999998 89999999999
Q ss_pred ccCc--cEEEEEe-CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCcee
Q 040785 515 CPEY--GIIVYEY-LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSK 590 (782)
Q Consensus 515 ~~~~--~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~k 590 (782)
+.+. .++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 8654 3899999 78999999997654 4899999999999999999999999 99999999999999 899999
Q ss_pred eeccccccccccccccccccccccccCCcccCChhhhhcCCCC-CchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCc
Q 040785 591 ISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLG-VKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGT 669 (782)
Q Consensus 591 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 669 (782)
|+|||++..... .......||..|+|||++.+..+. .++|||||||++|+|++|+.||....... ...
T Consensus 181 l~dfg~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~ 249 (312)
T 2iwi_A 181 LIDFGSGALLHD-------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL----EAE 249 (312)
T ss_dssp ECCCSSCEECCS-------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HTC
T ss_pred EEEcchhhhccc-------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh----hhc
Confidence 999999987632 122346799999999998877764 58999999999999999999997653221 111
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..++...+..+.+|+.+||+.+|++||++.+++.
T Consensus 250 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 250 ---------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123344556899999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=368.50 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=202.2
Q ss_pred HhccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-II 521 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~l 521 (782)
..++|...+.||+|+||.||+|.+. +..||||+++... ....+.|.+|+.+|..++||||++++++|.+.. ++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 3467999999999999999999873 3469999987543 334577999999999999999999999986544 99
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 468 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999997553 34899999999999999999999999 9999999999999999999999999998763
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 678 (782)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |..||....... ..+..+..
T Consensus 543 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-------- 610 (656)
T 2j0j_A 543 DS----TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------- 610 (656)
T ss_dssp C--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC--------
T ss_pred CC----cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 22 1122234567889999999999999999999999999999997 999997544322 22222221
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
...|...+..+.+|+.+||..+|.+||++.+++. .|..+
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~-~L~~i 649 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA-QLSTI 649 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHH
Confidence 1223445567999999999999999999998873 45444
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.43 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=194.5
Q ss_pred hccccccceeeeeCcEeEEEEEEC--C-eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC------eeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD--H-TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN------MVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~--~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~g~~~~~~- 519 (782)
.++|.+.+.||+|+||.||+|.+. + ..||||+++.. ......+.+|+.++..++|++ ++.+++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 457999999999999999999983 3 68999999764 344567889999999998766 888888775443
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE---------------
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL--------------- 583 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl--------------- 583 (782)
|+||||+ +++|.+.+..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 8999999 6677777765432 35999999999999999999999999 9999999999999
Q ss_pred ----cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH
Q 040785 584 ----DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659 (782)
Q Consensus 584 ----d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~ 659 (782)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE--------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCCcEEEeecCccccccc--------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 6788999999999976421 1234679999999999999999999999999999999999999997543
Q ss_pred HHHHHH--H--hCccc----------ccCC------C-----------------CCCCCChhHHHHHHHHHHHhhccCcC
Q 040785 660 FVERSI--E--NGTLG----------EMLD------P-----------------TVTDWPFEETLGFAKLALQCSELRRK 702 (782)
Q Consensus 660 ~~~~~~--~--~~~~~----------~~ld------~-----------------~~~~~p~~~~~~l~~li~~cl~~~P~ 702 (782)
...... . .+.+. .... + .........+..+.+|+.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 322110 0 00000 0000 0 00011123455789999999999999
Q ss_pred CCCChHHhhh
Q 040785 703 DRPDLGKVVL 712 (782)
Q Consensus 703 ~RPs~~~vl~ 712 (782)
+||++.+++.
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.91 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=199.2
Q ss_pred HhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEE
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 522 (782)
..++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++++++||||+++++++.+.. ++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 345799999999999999999998 57799999996542 234567899999999999999999999986554 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC---Cceeeeccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN---YVSKISDVGLARL 599 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~---~~~kL~DFGla~~ 599 (782)
|||+++++|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999887654 4899999999999999999999999 9999999999999654 4799999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPT 677 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 677 (782)
.... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ..+..+.....+ +.
T Consensus 174 ~~~~------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 245 (287)
T 2wei_A 174 FQQN------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-PQ 245 (287)
T ss_dssp BCCC------SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-GG
T ss_pred ecCC------CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-hh
Confidence 5321 11233468999999998765 58999999999999999999999997554322 223333321110 11
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
. ...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 246 ~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 W----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp G----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1 1234568999999999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.41 Aligned_cols=202 Identities=26% Similarity=0.314 Sum_probs=169.0
Q ss_pred HHHHHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CC-----Ceeeecccc
Q 040785 444 EDIEEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HP-----NMVLLLGAC 515 (782)
Q Consensus 444 ~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~g~~ 515 (782)
.......++|.+.+.||+|+||.||+|.+ +++.||||+++... .....+.+|+.++..++ |+ +|+.++++|
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 33344567899999999999999999998 57789999997542 34567888999998885 55 488998888
Q ss_pred cCc--cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh--cCCCCeeecCCCCceEEEc--CCCce
Q 040785 516 PEY--GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ--TKPEPLVHRDLKPGNILLD--HNYVS 589 (782)
Q Consensus 516 ~~~--~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~--~~~~~iiHrDLKp~NILld--~~~~~ 589 (782)
... .|+||||+. |+|.+++..... ..+++..+..|+.||+.||.|||. .+ ||||||||+||||+ .++.+
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcE
Confidence 543 489999996 599998876542 348999999999999999999995 56 99999999999994 57889
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH 659 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~ 659 (782)
||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 201 kL~DFG~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ--------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EECCCTTCEETTC--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeccCceeccc--------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999986531 1234689999999999999999999999999999999999999997544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.99 Aligned_cols=252 Identities=25% Similarity=0.312 Sum_probs=176.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHH-HHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIE-VLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|...+.||+|+||.||+|.+ +++.||||++.... ......+..|+. +++.++||||+++++++.+.. ++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 4688999999999999999998 47899999997653 233455666766 667789999999999986544 89999
Q ss_pred eCCCCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRR--GNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
|+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 777776531 2234689999999999999999999998 8 9999999999999999999999999998663
Q ss_pred cccccccccccccccCCcccCChhhh----hcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQ----QTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPT 677 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 677 (782)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.........+... .....+.
T Consensus 178 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~ 249 (327)
T 3aln_A 178 DS------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDPPQ 249 (327)
T ss_dssp ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC--CCSCCCC
T ss_pred cc------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH--hcCCCCC
Confidence 21 112334799999999988 45678999999999999999999999997543322211111 0111111
Q ss_pred CC-CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 678 VT-DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 678 ~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+. ..+...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 11 11123455799999999999999999999998543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=337.25 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=194.0
Q ss_pred HHHHHHhccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcC--CCCeeeecccccCc
Q 040785 444 EDIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIR--HPNMVLLLGACPEY 518 (782)
Q Consensus 444 ~~~~~~t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~ 518 (782)
..+....++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.++..++ ||||+++++++.+.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 33334567799999999999999999988 5678999999654 2344678899999999997 59999999998655
Q ss_pred c--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
. ++||| +.+++|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 4 89999 56889999987643 5899999999999999999999999 999999999999964 8999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-----------GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI 665 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~ 665 (782)
++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+
T Consensus 173 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 173 ANQMQPDT---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp SCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred cccccCcc---ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 98763221 1112234579999999998875 468899999999999999999999996432111111
Q ss_pred HhCcccccCCCCC-CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 666 ENGTLGEMLDPTV-TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 666 ~~~~~~~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
.. .+++.. ..++...+..+.+|+.+||..+|.+||++.+++.+.
T Consensus 250 ~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 250 HA-----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HH-----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HH-----HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 00 011111 122233345689999999999999999999998543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.60 Aligned_cols=240 Identities=25% Similarity=0.359 Sum_probs=197.1
Q ss_pred HHHhccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh------hHHHHHHHHHHHHhcC--CCCeeeeccccc
Q 040785 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ------GRSQFQREIEVLSCIR--HPNMVLLLGACP 516 (782)
Q Consensus 447 ~~~t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~ 516 (782)
....++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.++.+++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34566799999999999999999988 6789999999754321 2345778999999996 599999999996
Q ss_pred Ccc--EEEEEeCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCceeee
Q 040785 517 EYG--IIVYEYLAN-GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKIS 592 (782)
Q Consensus 517 ~~~--~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~kL~ 592 (782)
+.. ++||||+.+ ++|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 544 899999976 89999987653 4899999999999999999999999 99999999999999 78999999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCccc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLG 671 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 671 (782)
|||+++.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .+..
T Consensus 193 Dfg~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~- 260 (320)
T 3a99_A 193 DFGSGALLKD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV- 260 (320)
T ss_dssp CCTTCEECCS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HCCC-
T ss_pred eCcccccccc-------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----cccc-
Confidence 9999986632 12234579999999999887775 788999999999999999999997553211 1111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.++...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 261 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 --------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112233456899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.86 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=169.8
Q ss_pred hccccccc-eeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHH-HHHHhcCCCCeeeecccccC----c--c
Q 040785 450 TQFFTESR-KIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREI-EVLSCIRHPNMVLLLGACPE----Y--G 519 (782)
Q Consensus 450 t~~f~~~~-~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei-~iL~~l~HpnIv~l~g~~~~----~--~ 519 (782)
.++|.+.+ .||+|+||.||+|.+ +++.||||++.... ...+|+ ..+..+.||||+++++++.. . .
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45688855 699999999999998 47899999996542 122333 34566799999999999853 2 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---CCceeeecccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGL 596 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~~~~kL~DFGl 596 (782)
++||||+++|+|.+++..... ..+++.+++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999976543 46999999999999999999999999 999999999999975 45699999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEML 674 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l 674 (782)
++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..........
T Consensus 178 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 178 AKETTQ-------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp CEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ceeccc-------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 986532 1223467899999999998888999999999999999999999999644321110 0000000000
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
... .......+..+.+|+.+||..+|.+||++.+++.+
T Consensus 251 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 GFP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 01112345569999999999999999999999853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=348.10 Aligned_cols=253 Identities=25% Similarity=0.289 Sum_probs=185.9
Q ss_pred ccccccceeeeeCcEeEEEEE-ECCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCY-LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+.|...+.||+|+||+||.+. .+++.||||++..+. ...+.+|+.+|..+ +||||+++++++.+.. |+||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 346667899999999997554 478899999986532 35678999999886 8999999999986554 8999999
Q ss_pred CCCChhHHHhhcCCCCC----CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-------------Cce
Q 040785 527 ANGSLDDRIFRRGNTPP----LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-------------YVS 589 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~----l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-------------~~~ 589 (782)
. |+|.+++........ ..+..++.|+.||+.||.|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 699999976532211 133346789999999999999999 9999999999999754 489
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT-------GMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV 661 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~ 661 (782)
||+|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++ |..||+.....
T Consensus 168 kL~DFG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSS-FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEcccccceecCCCCcc-ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999876432111 1112234689999999999875 568999999999999999999 99999765433
Q ss_pred HHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 662 ERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 662 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+..+.... .......+...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 247 ~~~i~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ESNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHHTCCCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 33333332211 110111234566789999999999999999999999853
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=329.02 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=176.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hh-HHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QG-RSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|...+.||+|+||.||+|.+ +++.||||++..... .. ...+..+..++..++||||+++++++.+.. ++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 5699999999999999999998 578999999976532 22 233444556778889999999999986554 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT-KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|+ ++.+..+..... ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 555555544332 3589999999999999999999995 8 999999999999999999999999999765321
Q ss_pred cccccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHH---HHHHHHhCcccccCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHF---VERSIENGTLGEMLD 675 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~ld 675 (782)
.......||+.|+|||++. ...++.++|||||||++|+|++|+.||..... ....+..+..
T Consensus 179 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 247 (318)
T 2dyl_A 179 ------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP----- 247 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-----
T ss_pred ------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-----
Confidence 1123457999999999984 56689999999999999999999999965221 1111112211
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
+.... ....+..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 248 ~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 248 PLLPG-HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CCCCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCCCc-cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 11111 1123456899999999999999999999986543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=344.33 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=186.4
Q ss_pred hccccccceeeeeCcEe-EEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGP-VYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~-Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
...|...+.||+|+||+ ||++..+++.||||++.... ...+.+|+.+|..+ +||||+++++++.+.. |+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34588899999999998 55555688999999997543 23467899999999 7999999999986654 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-----CCceeeecccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-----NYVSKISDVGLARLV 600 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-----~~~~kL~DFGla~~~ 600 (782)
+. |+|.+++..... .+.+..++.|+.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 699998875542 2445567789999999999999999 999999999999943 235789999999876
Q ss_pred ccccccccccccccccCCcccCChhhhh---cCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHHHHhCcccccCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERSIENGTLGEMLDP 676 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~ 676 (782)
..... .........||+.|+|||++. ...++.++|||||||++|||++ |..||+...........+... .
T Consensus 174 ~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~----~ 247 (432)
T 3p23_A 174 AVGRH--SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS----L 247 (432)
T ss_dssp --------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC----C
T ss_pred cCCCc--ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC----c
Confidence 42211 112334568999999999987 4567889999999999999999 999997554333222222111 1
Q ss_pred CCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 677 TVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 677 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.....+......+.+|+.+||+.+|.+||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111123445568899999999999999999999843
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=359.24 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=198.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccC--------cc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE--------YG 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~~ 519 (782)
++|.+.+.||+|+||.||+|.+ +++.||||+++.. .......|.+|+.+|..++||||+++++++.. ..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5699999999999999999987 5789999998764 33446779999999999999999999998743 23
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCc---eeeecccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYV---SKISDVGL 596 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~---~kL~DFGl 596 (782)
|+||||+++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 899999999999999987665556999999999999999999999999 999999999999987664 89999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--------HHhC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--------IENG 668 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--------~~~~ 668 (782)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....
T Consensus 171 a~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQG------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTSC------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccccc------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 9876321 1224568999999999999999999999999999999999999999643221110 0000
Q ss_pred cccccCC---------CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 669 TLGEMLD---------PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 669 ~~~~~ld---------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+. +.....+...+..+.+|+.+||..||++||++.+++.
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 0000000 1112334557788999999999999999999988763
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=337.99 Aligned_cols=247 Identities=16% Similarity=0.138 Sum_probs=183.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHHHHHHHhcCC-CCeee--------------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRH-PNMVL-------------- 510 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~H-pnIv~-------------- 510 (782)
..|...+.||+|+||.||+|.+ +++.||||+++.... ...+.|.+|+.++..+.| +|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577889999999999999998 488999999974322 235779999999999987 32211
Q ss_pred -------ecccccC-------ccEEEEEeCCCCChhHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 040785 511 -------LLGACPE-------YGIIVYEYLANGSLDDRIFR----RGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572 (782)
Q Consensus 511 -------l~g~~~~-------~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ii 572 (782)
++.++.. ..+++|+++ +++|.+++.. ......+++..++.|+.||+.||.|||+.+ ||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 125666654 7899988842 122345888999999999999999999999 99
Q ss_pred ecCCCCceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhh----------hcCCCCCchhHHHHH
Q 040785 573 HRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ----------QTGMLGVKSDVYSLG 642 (782)
Q Consensus 573 HrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----------~~~~~s~ksDVwSlG 642 (782)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999999999999999998865321 344577 999999988 444588899999999
Q ss_pred HHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH-HHHHHHH
Q 040785 643 ILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPE-LNRLREL 721 (782)
Q Consensus 643 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~-l~~l~~~ 721 (782)
|++|||++|+.||...... .....++. ... ..+..+.+|+.+||+.+|++||++.+++.+. +..+...
T Consensus 305 vil~elltg~~Pf~~~~~~------~~~~~~~~-~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAAL------GGSEWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGG------SCSGGGGS-SCC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCcchh------hhHHHHHh-hcc----cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence 9999999999999654321 11111111 111 2335699999999999999999999998543 3444443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=358.56 Aligned_cols=235 Identities=25% Similarity=0.322 Sum_probs=191.7
Q ss_pred ccccccceeeeeCcEeEEEEEE---CCeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL---DHTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY-------G 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~---~~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~ 519 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++... .......|.+|+.+|..++||||++++++|... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 5699999999999999999998 4689999998654 334456789999999999999999999998532 3
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
||||||+++++|.+.+.. .+++.+++.|+.||+.||.|||+.+ ||||||||+||||+.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 899999999999887633 4999999999999999999999999 9999999999999886 899999999986
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 679 (782)
.... +...||+.|+|||++.++. +.++|||||||++|+|++|.+||... ....+. .
T Consensus 231 ~~~~---------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~-----------~~~~~~---~ 286 (681)
T 2pzi_A 231 INSF---------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR-----------YVDGLP---E 286 (681)
T ss_dssp TTCC---------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE-----------ECSSCC---T
T ss_pred cccC---------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc-----------cccccc---c
Confidence 5321 3467999999999987764 89999999999999999999998531 111110 1
Q ss_pred CCC-hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 680 DWP-FEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 680 ~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
..+ ......+.+|+.+||+.+|.+||+..+.+.+.|..+
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 111 123356899999999999999998888887777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.91 Aligned_cols=236 Identities=19% Similarity=0.184 Sum_probs=181.2
Q ss_pred hccccccceeeeeCcEeEEEEEECCeeEEEEEecCCch--------hhHHHHHHHHHHHHhcC---------CCCee---
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAA--------QGRSQFQREIEVLSCIR---------HPNMV--- 509 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ei~iL~~l~---------HpnIv--- 509 (782)
.++|.+.+.||+|+||.||+|.++++.||||++..... ...+.+.+|+.+|+.++ ||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 35699999999999999999999999999999976421 22367899999999886 55554
Q ss_pred --------------eeccccc---------------CccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040785 510 --------------LLLGACP---------------EYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560 (782)
Q Consensus 510 --------------~l~g~~~---------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 560 (782)
+++++|. ...||||||+++|++.+.+.+ ..+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 4444443 234999999999987766633 3489999999999999999
Q ss_pred HHhh-hcCCCCeeecCCCCceEEEcCCC--------------------ceeeeccccccccccccccccccccccccCCc
Q 040785 561 LFLH-QTKPEPLVHRDLKPGNILLDHNY--------------------VSKISDVGLARLVPAVAENVTQYHLTSTAGTF 619 (782)
Q Consensus 561 ~yLH-~~~~~~iiHrDLKp~NILld~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~ 619 (782)
.||| +.+ ||||||||+||||+.++ .+||+|||+|+.... ...+||+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----------~~~~gt~ 241 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----------GIVVFCD 241 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----------TEEECCC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----------CcEEEee
Confidence 9999 899 99999999999999887 899999999986532 1347999
Q ss_pred ccCChhhhhcCCCCCchhHHHHHHH-HHHHHhCCCCCCChHHHHHH----HHhCcccccCCCCCCCCChhHHHHHHHHHH
Q 040785 620 CYIDPEYQQTGMLGVKSDVYSLGIL-LLQLITAKQPMGLTHFVERS----IENGTLGEMLDPTVTDWPFEETLGFAKLAL 694 (782)
Q Consensus 620 ~Y~aPE~~~~~~~s~ksDVwSlGvi-l~elltG~~Pf~~~~~~~~~----~~~~~~~~~ld~~~~~~p~~~~~~l~~li~ 694 (782)
.|+|||++.+.. +.++||||||++ .+++++|..||....+.... ........ ......+...+..+.+|+.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT---KCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS---CCCSHHHHHHHHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc---ccchhhhhhcCHHHHHHHH
Confidence 999999988665 889999998777 77899999999543221211 11111111 1111123456778999999
Q ss_pred HhhccCcCCCCChHHhh
Q 040785 695 QCSELRRKDRPDLGKVV 711 (782)
Q Consensus 695 ~cl~~~P~~RPs~~~vl 711 (782)
+||+.+ ++.+++
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999966 777776
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.49 Aligned_cols=224 Identities=23% Similarity=0.351 Sum_probs=176.0
Q ss_pred cccccc-ceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHH-HhcCCCCeeeecccccC----c--cE
Q 040785 451 QFFTES-RKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVL-SCIRHPNMVLLLGACPE----Y--GI 520 (782)
Q Consensus 451 ~~f~~~-~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~g~~~~----~--~~ 520 (782)
++|.+. +.||+|+||.||+|.+ ++..||||++... ..+.+|+.++ +.++||||+++++++.. . .+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 7899999999999998 5779999999642 4577899988 55689999999998854 2 38
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---CCceeeeccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGLA 597 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~~~~kL~DFGla 597 (782)
+||||+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999976543 35999999999999999999999999 999999999999998 789999999998
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCC
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPT 677 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 677 (782)
.... +..++.++|||||||++|+|++|+.||......... ... ...+...
T Consensus 168 ~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~-~~~~~~~ 217 (299)
T 3m2w_A 168 KETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGM-KTRIRMG 217 (299)
T ss_dssp EECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCS-CCSSCTT
T ss_pred cccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--HHH-HHHHhhc
Confidence 6431 134678999999999999999999999654432211 111 1111111
Q ss_pred CCCCC----hhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 678 VTDWP----FEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 678 ~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
....+ ...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11222 2345679999999999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.98 Aligned_cols=224 Identities=12% Similarity=0.071 Sum_probs=175.2
Q ss_pred ccccccceeeeeCcEeEEEEEEC--CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+. ++.||||++.... ......|.+|+.++..++||||+++++++.+.. |+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56999999999999999999984 7899999997653 233477899999999999999999999986554 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++++|.+++.. + ....++..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~-~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-S----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT-C----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc-C----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999833 2 345578899999999999999999 9999999999999999999998543
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCCCCCC---C
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT---D 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~---~ 680 (782)
|++| ++.++|||||||++|+|+||+.||.......... .....+..... .
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQPIEPAD 227 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSCBCCHHH
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccCCCChhh
Confidence 3333 6889999999999999999999996432110000 00000011000 1
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+...+..+.+|+.+||+.||++| ++.+++ ..|..+.
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~-~~L~~~~ 264 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLL-NLMQQAT 264 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHH-HHHHHHH
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHH-HHHHHHh
Confidence 122345679999999999999999 998887 3555543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=299.12 Aligned_cols=181 Identities=15% Similarity=0.095 Sum_probs=126.6
Q ss_pred eeeeCcEeEEEEEE--CCeeEEEEEecCCc----------hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEEE
Q 040785 459 IGEGGYGPVYKCYL--DHTPVAVKVLRPDA----------AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 459 LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~----------~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++.|++|.+..++. .+..+++|++..+. ....+.|.+|+++|+++ .|+||+++++++.+.. ||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566665554433 57889999997642 22356799999999999 6999999999997765 9999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||++|++|.++|.+.+ +++.. .|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999997654 36554 58899999999999999 999999999999999999999999999876432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P 654 (782)
....++.+||+.|||||++.+ .+..++|+||+|+++++|++|..|
T Consensus 393 -----~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -----CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -----CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 122345789999999998764 567889999999998887666544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-27 Score=271.31 Aligned_cols=187 Identities=17% Similarity=0.154 Sum_probs=146.1
Q ss_pred ccccceeeeeCcEeEEEEEECCeeEEEEEecCCch--------hhHHHHHHHHHHHHhcCCCCee--eecccccCccEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAA--------QGRSQFQREIEVLSCIRHPNMV--LLLGACPEYGIIV 522 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ei~iL~~l~HpnIv--~l~g~~~~~~~lV 522 (782)
+...++||+|+||.||+|...+..+++|....... ...+.|.+|+++|++++||||+ .++++..+..|||
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ----------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 45567899999999999988899999998754311 1234589999999999999999 6666666677999
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.. +..|+.||+.||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998854 4579999999999999999 999999999999998 999999999998743
Q ss_pred cccccc--ccccccccCCcccCChhhhhc--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 040785 603 VAENVT--QYHLTSTAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 603 ~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~Pf 655 (782)
...... ........||+.|||||++.. ..|+..+|+|+.++-.++.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 211100 011235689999999999887 56888899999999999988888776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=221.12 Aligned_cols=150 Identities=15% Similarity=0.113 Sum_probs=119.5
Q ss_pred HHHHHhccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCch------------------hhHHHHHHHHHHHHhcCC
Q 040785 445 DIEEATQFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAA------------------QGRSQFQREIEVLSCIRH 505 (782)
Q Consensus 445 ~~~~~t~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~------------------~~~~~~~~Ei~iL~~l~H 505 (782)
.+......|...+.||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+|..++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 3334455677789999999999999998 578999999975321 13456899999999998
Q ss_pred CCeeeecccccC-ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 506 PNMVLLLGACPE-YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 506 pnIv~l~g~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
| +.+++++.. ..|+||||++||+|.+ +. + .....++.||+.||.|||+.+ |+||||||+|||++
T Consensus 163 -~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAWEGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEEETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred -C-CCcCeEEeccceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 5 666665533 3499999999999988 41 1 124579999999999999999 99999999999999
Q ss_pred CCCceeeeccccccccccccccccccccccccCCcccCChhhhhc
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 629 (782)
++.+||+|||+|+. +..|+|||++..
T Consensus 228 -~~~vkl~DFG~a~~------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE------------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE------------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE------------------CCCCCHHHHHHH
Confidence 99999999999863 335789998753
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=183.43 Aligned_cols=144 Identities=17% Similarity=0.158 Sum_probs=117.7
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+.++||||+|+|+.|.+|++||+.++...+++|++|||.+++...... .. ...........+...+..++.++.+..
T Consensus 1 M~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~ 77 (147)
T 3hgm_A 1 MFNRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEAS-LS--MARPEQLDIPDDALKDYATEIAVQAKT 77 (147)
T ss_dssp CCSEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHT-BS--SCCCGGGCCCTTHHHHHHHHHHHHHHH
T ss_pred CCceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccc-cc--ccChhhhhhHHHHHHHHHHHHHHHHHH
Confidence 468999999999999999999999999889999999999754310000 00 000001122334455777889999999
Q ss_pred HhhcCCCce---EEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEE
Q 040785 94 YCTRKDIKC---FDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163 (782)
Q Consensus 94 ~c~~~~v~~---e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV 163 (782)
.+...|+++ +..+.. |+++++|+++|+++++|+||||++|++++.+.|+|||+.+|+++++ |||+||
T Consensus 78 ~~~~~g~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 78 RATELGVPADKVRAFVKG-GRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp HHHHTTCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCS--SCEEEC
T ss_pred HHHhcCCCccceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCC--CCEEEC
Confidence 999999988 888887 5899999999999999999999999999999999999999999999 999986
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.84 E-value=4.3e-21 Score=182.43 Aligned_cols=142 Identities=16% Similarity=0.148 Sum_probs=118.8
Q ss_pred CCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 13 GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 13 ~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
.+.++||||+|+|+.|..|++||+.++...+++|++|||.+++........ . ......+...+.+++.++.+.
T Consensus 3 ~~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~l~~~~ 75 (146)
T 3s3t_A 3 ARYTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALD--P-----VLSELLDAEAAHAKDAMRQRQ 75 (146)
T ss_dssp CCCCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGH--H-----HHHHHHHHHHHHHHHHHHHHH
T ss_pred CccceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccc--c-----ccHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999999999999999988999999999986543111000 0 001122344567778899999
Q ss_pred HHhhcCCC-ceEEEEEecCCHHHHHHH-HHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 93 CYCTRKDI-KCFDVLLEDVDIVKAITE-YVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 93 ~~c~~~~v-~~e~~v~~g~~v~~~Iv~-~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
..+...|+ .++..+..| +++++|++ +|++.++|+||||++|++++.+.|+|||+.+|+++++ |||+||.
T Consensus 76 ~~~~~~g~~~~~~~~~~g-~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 76 QFVATTSAPNLKTEISYG-IPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp HHHTTSSCCCCEEEEEEE-CHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred HHHHhcCCcceEEEEecC-ChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCC--CCEEEeC
Confidence 99998999 999998884 89999999 9999999999999999999999999999999999999 9999984
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=182.21 Aligned_cols=151 Identities=13% Similarity=0.141 Sum_probs=117.2
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCC-----CCCcccCcc-cccCCcc-CCCcccCCchHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRT-----SVSSVSSQS-QVYDASA-TTNPHQKQPDKQIRD 86 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~-----~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~ 86 (782)
+.++||||||+|+.|.+|++||+.++...+++|++|||.++. ......... +..+... ......+...+.+++
T Consensus 4 ~~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (162)
T 1mjh_A 4 MYKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKN 83 (162)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHH
Confidence 578999999999999999999999999889999999999753 110000000 0000000 000112233456678
Q ss_pred HHHHHHHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 87 LFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 87 ~l~~~~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
.|+.+...+...|++++..+.. |+++++|+++|++.++|+||||++|++++.+.|+|||+.+|+++++ |||+||..+
T Consensus 84 ~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~--~pVlvv~~~ 160 (162)
T 1mjh_A 84 KMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 160 (162)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHHHcCCceEEEEcC-CCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCC--CCEEEEeCC
Confidence 8888988888899999988888 5899999999999999999999999999999999999999999998 999999864
Q ss_pred c
Q 040785 167 K 167 (782)
Q Consensus 167 k 167 (782)
.
T Consensus 161 ~ 161 (162)
T 1mjh_A 161 N 161 (162)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=181.74 Aligned_cols=146 Identities=14% Similarity=0.149 Sum_probs=112.9
Q ss_pred ccccCCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEE--EEecCCCCCcccCcccccCCccCCCcccCCchHHHHH
Q 040785 9 VKKTGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLI--HVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRD 86 (782)
Q Consensus 9 ~~~~~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~ll--HV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (782)
+......++||||||+|+.|..|++||+.++. .+++|++| ||.+++... .... . ......+...+..++
T Consensus 11 ~~~~~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~--~~~~-~-----~~~~~~~~~~~~~~~ 81 (163)
T 1tq8_A 11 HMSLSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDAR--AADI-L-----KDESYKVTGTAPIYE 81 (163)
T ss_dssp --CCCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC----------------------------CCTHHH
T ss_pred ccccccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccc--cccc-c-----ccHHHHHHHHHHHHH
Confidence 34455679999999999999999999999999 99999999 887643210 0000 0 001122234455677
Q ss_pred HHHHHHHHhhcCCCc-eEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 87 LFLTFRCYCTRKDIK-CFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 87 ~l~~~~~~c~~~~v~-~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
.|+.+...+...|++ ++..+.. |+++++|+++|++.++|+||||++|++++.++|+|||+.+|+++++ |||+||..
T Consensus 82 ~l~~~~~~~~~~gv~~v~~~v~~-G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~--~PVlvV~~ 158 (163)
T 1tq8_A 82 ILHDAKERAHNAGAKNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHT 158 (163)
T ss_dssp HHHHHHHHHHTTTCCEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECC
T ss_pred HHHHHHHHHHHcCCCeEEEEEec-CCHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCC--CCEEEEeC
Confidence 888888888888998 9988887 5899999999999999999999999999999999999999999998 99999975
Q ss_pred C
Q 040785 166 G 166 (782)
Q Consensus 166 g 166 (782)
.
T Consensus 159 ~ 159 (163)
T 1tq8_A 159 T 159 (163)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=178.77 Aligned_cols=141 Identities=16% Similarity=0.220 Sum_probs=115.9
Q ss_pred cCCCCeEEEEeC--CCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHH
Q 040785 12 TGGNGLIAVAVD--KDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFL 89 (782)
Q Consensus 12 ~~~~~~IlVaVD--~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 89 (782)
..+.++|||||| +|+.|.+|++||+.++...+++|++|||.++....... . ..........+.+++.|.
T Consensus 12 ~~~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~---~------~~~~~~~~~~~~~~~~l~ 82 (156)
T 3fg9_A 12 PLVYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFD---S------LTPSKIQAKRKHVEDVVA 82 (156)
T ss_dssp CCCCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCC---S------SHHHHHHHHHHHHHHHHH
T ss_pred cccCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccc---c------CCHHHHHHHHHHHHHHHH
Confidence 346799999999 99999999999999999889999999999765421100 0 001222334567778889
Q ss_pred HHHHHhhcCCC-ceEEEEEecCCHHHHHHHH-HHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 90 TFRCYCTRKDI-KCFDVLLEDVDIVKAITEY-VSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 90 ~~~~~c~~~~v-~~e~~v~~g~~v~~~Iv~~-a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
.+...+...|+ .++..+..+|+++++|+++ |++.++|+||||++|++++.+ |+|||+.+|+++++ |||+||.
T Consensus 83 ~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~-~~Gs~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 83 EYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSK-IAGAIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp HHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSS-SCSCHHHHHHHHCS--SEEEEEC
T ss_pred HHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccce-eecchHHHHHHhCC--CCEEEeC
Confidence 89888888899 5888888857899999999 999999999999999999975 78999999999999 9999984
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.8e-20 Score=179.13 Aligned_cols=151 Identities=9% Similarity=0.022 Sum_probs=115.6
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCccc-ccCC-ccCCCcccCCchHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQ-VYDA-SATTNPHQKQPDKQIRDLFLTF 91 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~l~~~ 91 (782)
+.++||||||+|+.|.+||+||+.++...+++|++|||.++....+...... .+.. ........+...+.+++.|+.+
T Consensus 4 m~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 83 (170)
T 2dum_A 4 MFRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEK 83 (170)
T ss_dssp CCSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHH
T ss_pred ccceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999999999999999999999997543211000000 0000 0011122223446667788888
Q ss_pred HHHhhcCCCceEE--EEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecCc
Q 040785 92 RCYCTRKDIKCFD--VLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGK 167 (782)
Q Consensus 92 ~~~c~~~~v~~e~--~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kgk 167 (782)
...+...|++++. .+.. |+++++|+++|+++++|+||||++|++++.+.|+|||+.+|+++++ |||+||..+.
T Consensus 84 ~~~~~~~g~~~~~~~~~~~-g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~PVlvv~~~~ 158 (170)
T 2dum_A 84 AEEVKRAFRAKNVRTIIRF-GIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTK--KPVLIIKEVD 158 (170)
T ss_dssp HHHHHHHTTCSEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCS--SCEEEECCCC
T ss_pred HHHHHHcCCceeeeeEEec-CChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCC--CCEEEEccCC
Confidence 8888888999887 7777 5899999999999999999999999999999999999999999998 9999998543
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-20 Score=174.88 Aligned_cols=135 Identities=19% Similarity=0.267 Sum_probs=113.2
Q ss_pred CeEEEEeCCCcchHHHHHHHHHhc-cCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCch-HHHHHHHHHHHH
Q 040785 16 GLIAVAVDKDKSSQHALKWAADNL-LNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPD-KQIRDLFLTFRC 93 (782)
Q Consensus 16 ~~IlVaVD~s~~S~~Al~wAl~~~-~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~ 93 (782)
++||||+|+|+.|..|++||+.++ ...+++|++|||.+++...... .. ......+... +..++.++.+..
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~l~~~~~ 73 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEA---VL-----AAYDEIEMKEEEKAKLLTQKFST 73 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHH---HH-----HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCccccc---cc-----CcHHHHHHHHHHHHHHHHHHHHH
Confidence 789999999999999999999999 8889999999999765421100 00 0011223344 667788999999
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
.+...|++++..+.. |+++++|+++|+ ++|+||||++|++++.+.| |||+.+|+++++ |||++|.
T Consensus 74 ~~~~~g~~~~~~v~~-g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 74 FFTEKGINPFVVIKE-GEPVEMVLEEAK--DYNLLIIGSSENSFLNKIF-ASHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp HHHTTTCCCEEEEEE-SCHHHHHHHHHT--TCSEEEEECCTTSTTSSCC-CCTTCHHHHHCS--SCEEEEC
T ss_pred HHHHCCCCeEEEEec-CChHHHHHHHHh--cCCEEEEeCCCcchHHHHh-CcHHHHHHhcCC--CCEEEeC
Confidence 999899999998888 589999999999 9999999999999999999 999999999998 9999984
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.3e-20 Score=172.28 Aligned_cols=136 Identities=16% Similarity=0.171 Sum_probs=106.5
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+.++||||+|+|+.|..|++||+.++...+++|++|||.++... .. ... ......+...+.+++.|+.+..
T Consensus 1 m~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~-~~---~~~-----~~~~~~~~~~~~~~~~l~~~~~ 71 (137)
T 2z08_A 1 MFKTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPD-YL---GEP-----FFEEALRRRLERAEGVLEEARA 71 (137)
T ss_dssp CCSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC-----------------------CHHHHHHHHHHHHHHH
T ss_pred CcceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCc-cc---ccc-----chHHHHHHHHHHHHHHHHHHHH
Confidence 36899999999999999999999999988999999999974321 00 000 0011222334556666666544
Q ss_pred HhhcCCC-ceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 94 YCTRKDI-KCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 94 ~c~~~~v-~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
. .|+ +++..+.. |+++++|+++|++.++|+||||++|++++.+.++|||+.+|+++++ |||+||.
T Consensus 72 ~---~g~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 72 L---TGVPKEDALLLE-GVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp H---HCCCGGGEEEEE-SSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCS--SCEEEEC
T ss_pred H---cCCCccEEEEEe-cCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCC--CCEEEeC
Confidence 3 678 88888777 5899999999999999999999999999999999999999999998 9999984
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.81 E-value=6.9e-20 Score=180.03 Aligned_cols=150 Identities=17% Similarity=0.261 Sum_probs=106.1
Q ss_pred CCCeEEEEeCCCc---------chHHHHHHHHHhccC---CCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCch
Q 040785 14 GNGLIAVAVDKDK---------SSQHALKWAADNLLN---RGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPD 81 (782)
Q Consensus 14 ~~~~IlVaVD~s~---------~S~~Al~wAl~~~~~---~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (782)
..++||||||+|+ .|..||+||+.++.+ .+++|++|||.++....... ....+..........+...
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 82 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDD-VDSIYASPEDFRDMRQSNK 82 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC-----------CCCCSHHHHHHHTTSHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccc-cccccCCHHHHHHHHHHHH
Confidence 4689999999999 999999999998755 48899999998643211100 0000000000011223344
Q ss_pred HHHHHHHHHHHHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEE
Q 040785 82 KQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIY 161 (782)
Q Consensus 82 ~~~~~~l~~~~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~ 161 (782)
+..++.|+.+...+...|+.++.++.. |+++++|+++|++.++|+||||++|++++.+.|+|||+.+|+++++ |||+
T Consensus 83 ~~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~--~pVl 159 (175)
T 2gm3_A 83 AKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVM 159 (175)
T ss_dssp HHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEE
T ss_pred HHHHHHHHHHHHHHHHCCCceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCC--CCEE
Confidence 566778888888888889999988888 5899999999999999999999999999999999999999999998 9999
Q ss_pred EEecCc
Q 040785 162 VVSKGK 167 (782)
Q Consensus 162 vV~kgk 167 (782)
||..+.
T Consensus 160 vv~~~~ 165 (175)
T 2gm3_A 160 TIKRNA 165 (175)
T ss_dssp EEECCG
T ss_pred EEcCCc
Confidence 998543
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.3e-20 Score=177.16 Aligned_cols=132 Identities=16% Similarity=0.139 Sum_probs=114.0
Q ss_pred CCCCeEEEEeCC-CcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHH
Q 040785 13 GGNGLIAVAVDK-DKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTF 91 (782)
Q Consensus 13 ~~~~~IlVaVD~-s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 91 (782)
-+.++||||||+ |+.|..|++||+.++...+++|++|||.+.+.. ......+..++.++.+
T Consensus 22 mm~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~------------------~~~~~~~~~~~~l~~~ 83 (155)
T 3dlo_A 22 MIYMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR------------------TKDEDIIEAKETLSWA 83 (155)
T ss_dssp CCCCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT------------------SCHHHHHHHHHHHHHH
T ss_pred cccCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc------------------ccHHHHHHHHHHHHHH
Confidence 357999999999 999999999999999988999999999964321 0123445677888888
Q ss_pred HHHhhcCCCceEEEE-EecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 92 RCYCTRKDIKCFDVL-LEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 92 ~~~c~~~~v~~e~~v-~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
...+...++.++..+ +..|+++++|+++|++.++|+||||++|++++.+.|+|||+.+|+++++ |||+||+
T Consensus 84 ~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 84 VSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKAN--KPVICIK 155 (155)
T ss_dssp HHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCC--CCEEEeC
Confidence 888888898887643 4557999999999999999999999999999999999999999999998 9999984
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.2e-20 Score=192.96 Aligned_cols=136 Identities=19% Similarity=0.172 Sum_probs=106.5
Q ss_pred cccccceeeeeCcEeEEEEEE--CCee--EEEEEecCCchh------------------------hHHHHHHHHHHHHhc
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTP--VAVKVLRPDAAQ------------------------GRSQFQREIEVLSCI 503 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~--vAvK~l~~~~~~------------------------~~~~~~~Ei~iL~~l 503 (782)
.|.+.+.||+|+||.||+|.+ +++. ||||+++..... ....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 7888 999998653211 113578999999999
Q ss_pred CCCCe--eeecccccCccEEEEEeCCC-C----ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecC
Q 040785 504 RHPNM--VLLLGACPEYGIIVYEYLAN-G----SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH-QTKPEPLVHRD 575 (782)
Q Consensus 504 ~HpnI--v~l~g~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~iiHrD 575 (782)
.|+|+ ..+++ ....+|||||+.+ | +|.+.... +++..+..++.||+.||.||| ..+ |||||
T Consensus 128 ~~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HHTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred HhCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 88764 23332 2456999999942 4 66665422 224467789999999999999 998 99999
Q ss_pred CCCceEEEcCCCceeeecccccccc
Q 040785 576 LKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 576 LKp~NILld~~~~~kL~DFGla~~~ 600 (782)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999988 8999999999754
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.2e-19 Score=170.30 Aligned_cols=143 Identities=16% Similarity=0.165 Sum_probs=98.1
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+.++||||||+|+.|..|++||+.++...+++|++|||.++....... ...... .......+...+.+++.|..+
T Consensus 5 ~~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~l~~~-- 79 (150)
T 3tnj_A 5 VYHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTP-YGTAIP--LDTETTYDAMLDVEKQKLSQI-- 79 (150)
T ss_dssp CCSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC---------CTTCCC--SSSCCCHHHHHHHHHHHHHHH--
T ss_pred ccceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccc-cccccC--cCHHHHHHHHHHHHHHHHHHH--
Confidence 579999999999999999999999999889999999999764321000 000000 011112222334444555544
Q ss_pred HhhcCCCc-eEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 94 YCTRKDIK-CFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 94 ~c~~~~v~-~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
+...|+. ++..+.. |+++++|+++|+++++|+||||++|++++. .++|||+.+|+++++ |||+||...
T Consensus 80 -~~~~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~-~~~Gs~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 80 -GNTLGIDPAHRWLVW-GEPREEIIRIAEQENVDLIVVGSHGRHGLA-LLLGSTANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp -HHHHTCCGGGEEEEE-SCHHHHHHHHHHHTTCSEEEEEEC---------CCCHHHHHHHHCS--SEEEEEECC
T ss_pred -HHHcCCCcceEEEec-CCHHHHHHHHHHHcCCCEEEEecCCCCCcC-eEecchHHHHHHhCC--CCEEEEeCC
Confidence 4444676 4666666 689999999999999999999999999999 888999999999998 999999753
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=168.41 Aligned_cols=137 Identities=10% Similarity=0.071 Sum_probs=106.5
Q ss_pred CeEEEEeCCCcc--hHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 16 GLIAVAVDKDKS--SQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 16 ~~IlVaVD~s~~--S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
++||||||+|+. |..|++||+.++...+++|++|||.++..... ..... .........+..++.+..+..
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~--~~~~~------~~~~~~~~~~~~~~~~~~l~~ 73 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYA--SLGMA------YTAELPGMDELREGSETQLKE 73 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC------------------------CHHHHHHHHHHHHHH
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccc--ccccc------ccchhhhHHHHHHHHHHHHHH
Confidence 789999999999 99999999999998899999999997643210 00000 011122334555667777777
Q ss_pred HhhcCC---CceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 94 YCTRKD---IKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 94 ~c~~~~---v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
++...+ +.++..+.. |+++++|+++|+++++|+||||+++ +++.+.|+|||+.+|+++++ |||+||.
T Consensus 74 ~~~~~~~~~~~v~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~Gs~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 74 IAKKFSIPEDRMHFHVAE-GSPKDKILALAKSLPADLVIIASHR-PDITTYLLGSNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp HHTTSCCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred HHHHcCCCCCceEEEEEe-cChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeeeccHHHHHHHhCC--CCEEEeC
Confidence 777765 456888887 5899999999999999999999996 88999999999999999998 9999984
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.4e-18 Score=160.01 Aligned_cols=138 Identities=17% Similarity=0.135 Sum_probs=101.9
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+.++||||+|+|+.|..|++||+.++...+++|++|||.++.+... ...... ......+...+.+++.|..+
T Consensus 1 m~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~l~~~-- 72 (141)
T 1jmv_A 1 MYKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLY-TGLIDV-----NMSSMQDRISTETQKALLDL-- 72 (141)
T ss_dssp CCSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGC-CCCEEH-----HHHHHTTCCCCHHHHHHHHH--
T ss_pred CCceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhh-cccccc-----chHHHHHHHHHHHHHHHHHH--
Confidence 3689999999999999999999999998899999999985322100 000000 00011122233445555544
Q ss_pred HhhcCCCce-EEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 94 YCTRKDIKC-FDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 94 ~c~~~~v~~-e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
+...|+.+ +..+.. |+++++|+++|++.++|+||||++ ++++.+ | |||+.+|+++++ |||+||..+
T Consensus 73 -~~~~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-l-gs~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 73 -AESVDYPISEKLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-L-MSSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp -HHHSSSCCCCEEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-H-HHHHHHHHTTCC--SEEEEEECC
T ss_pred -HHHcCCCceEEEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-h-cchHHHHHhcCC--CCEEEeeCC
Confidence 33457776 455555 689999999999999999999999 998887 3 999999999998 999999854
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=150.43 Aligned_cols=132 Identities=10% Similarity=0.006 Sum_probs=100.1
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEe-cC-CCCCcccCcccccCCccCCCcccCCchHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVA-QR-TSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTF 91 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 91 (782)
+.++||||+|+|+.|..|++||+.++...+++|++|||. +. +...... ...... .....+...+.+++.|..+
T Consensus 3 ~~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~l~~~ 77 (138)
T 1q77_A 3 AMKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANV--TFGLPF---PPEIKEESKKRIERRLREV 77 (138)
T ss_dssp CCEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHH--HHCCCC---CTHHHHHHHHHHHHHHHHH
T ss_pred cccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEeccccccccccc--ccCCCC---ChHHHHHHHHHHHHHHHHH
Confidence 468999999999999999999999999889999999998 63 1100000 000000 0112223345566777777
Q ss_pred HHHh--hcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 92 RCYC--TRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 92 ~~~c--~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
..+ ...| .++..+.. |+++++|+++|++.++|+||||++|+ ||+.+|+++++ |||+||.
T Consensus 78 -~~~~~~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~g~---------sv~~~vl~~a~--~PVlvv~ 138 (138)
T 1q77_A 78 -WEKLTGSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS---------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp -HHHHHSCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG---------GGTHHHHHHSS--SEEEECC
T ss_pred -HHHhhccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCCCC---------chHHHHHHhCC--CceEeeC
Confidence 663 5566 77877776 68999999999999999999999976 99999999999 9999984
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.6e-17 Score=171.77 Aligned_cols=142 Identities=18% Similarity=0.082 Sum_probs=112.4
Q ss_pred CeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcc-------cCCchHHHHHHH
Q 040785 16 GLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPH-------QKQPDKQIRDLF 88 (782)
Q Consensus 16 ~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l 88 (782)
++||||+|+|+.|..|++||+.++...+++|++|||.++..... ............. .+...+.+++.+
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 76 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARI----PELLDFGALTVPVPVLRTELERALALRGEAVL 76 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTH----HHHC-------CHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCccc----ccccCchHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999999998899999999986532100 0000000000111 122345667888
Q ss_pred HHHHHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCC-ccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 89 LTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRH-GFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 89 ~~~~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~-~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
+.+...+...|++++..+.. |+++++|+++ +.++|+||||++|++ ++.+.++||++.+|+++++ |||++|..+
T Consensus 77 ~~~~~~~~~~g~~~~~~~~~-g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 77 ERVRQSALAAGVAVEAVLEE-GVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHHHHHTTCCEEEEEEE-ECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHHHHHhCCCCeEEEEec-CCHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCC--CCEEEECCC
Confidence 99988898899999998887 5899999999 899999999999999 9999999999999999998 999999854
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=172.42 Aligned_cols=148 Identities=14% Similarity=0.072 Sum_probs=115.4
Q ss_pred CCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 13 GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 13 ~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
.+.++||||+|+|+.|..||+||+.++...+++|++|||+++.+... . . .. .............+.+++.+..+.
T Consensus 5 ~~~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~-~--~-~~-~~~~~~~~~~~~~~~~~~~l~~~~ 79 (319)
T 3olq_A 5 EKYQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDM-T--T-LL-SPDERNAMRKGVINQKTAWIKQQA 79 (319)
T ss_dssp CCSCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGC-T--T-TS-CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhh-c--c-cc-ChhhHHHHHHHHHHHHHHHHHHHH
Confidence 35689999999999999999999999999999999999986432100 0 0 00 000001111223345567788888
Q ss_pred HHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecCc
Q 040785 93 CYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGK 167 (782)
Q Consensus 93 ~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kgk 167 (782)
..+...|+.++..+...+++..+|+++|++.++|+||||++|++++.+.|+||++.+|+++++ |||+||..+.
T Consensus 80 ~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~~ 152 (319)
T 3olq_A 80 RYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCP--APVWMVKDKE 152 (319)
T ss_dssp HHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCS--SCEEEEESSC
T ss_pred HHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCC--CCEEEecCcc
Confidence 888888999999988447899999999999999999999999999999999999999999998 9999998653
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=167.88 Aligned_cols=136 Identities=16% Similarity=0.084 Sum_probs=103.5
Q ss_pred CCCeEEEEeCCCcc-------hHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHH
Q 040785 14 GNGLIAVAVDKDKS-------SQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRD 86 (782)
Q Consensus 14 ~~~~IlVaVD~s~~-------S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (782)
..++||||+|+|+. |.+|++||+.++...+++|++|||.++...... .+ .. ...+...+..++
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~------~~---~~-~~~~~~~~~~~~ 202 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA------DP---TF-QLSETIEARYRE 202 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC------------------CH-HHHHHHHHHHHH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc------Cc---hh-HHHHHHHHHHHH
Confidence 57899999999998 999999999999989999999999976442100 00 00 111112233334
Q ss_pred HHHHHHHHhhcCCCc-eEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 87 LFLTFRCYCTRKDIK-CFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 87 ~l~~~~~~c~~~~v~-~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
.+.. ++...|+. ++..+.. |+++++|+++|+++++|+||||++|++++.++|+|||+.+|+++++ |||++|..
T Consensus 203 ~l~~---~~~~~g~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 203 ACRT---FQAEYGFSDEQLHIEE-GPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HHHH---HHHHHTCCTTTEEEEE-SCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCS--SEEEEECC
T ss_pred HHHH---HHHHcCCCcceEEEec-cCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCC--CCEEEECC
Confidence 4443 44445774 5666666 5899999999999999999999999999999999999999999998 99999974
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.7e-17 Score=171.76 Aligned_cols=144 Identities=13% Similarity=0.115 Sum_probs=117.7
Q ss_pred CCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 13 GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 13 ~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
-+.++||||+|+|+.|..|++||+.++...+++|++|||.+.+...... .............+.+++.++.+.
T Consensus 20 ~m~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~~~ 92 (294)
T 3loq_A 20 FQSNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVS-------GGIDIDHYIDEMSEKAEEVLPEVA 92 (294)
T ss_dssp STTCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC------------CCCTTHHHHHHHHHHHHHHHHHH
T ss_pred HhhccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCccccccc-------ccccHHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999999999999999999999765431100 000112223344567788899999
Q ss_pred HHhhcCCCceEE-EEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecCc
Q 040785 93 CYCTRKDIKCFD-VLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKGK 167 (782)
Q Consensus 93 ~~c~~~~v~~e~-~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kgk 167 (782)
..+...|++++. .+...|+++++| ++++.++|+||||++|++++.+.++||++.+|+++++ |||++|..+.
T Consensus 93 ~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~~ 164 (294)
T 3loq_A 93 QKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSK--VPVYIFKHDM 164 (294)
T ss_dssp HHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCS--SCEEEECCCT
T ss_pred HHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCC--CCEEEecCcc
Confidence 999989999998 666236899999 9999999999999999999999999999999999998 9999998553
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-16 Score=171.03 Aligned_cols=143 Identities=15% Similarity=0.175 Sum_probs=112.9
Q ss_pred cCCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHH
Q 040785 12 TGGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTF 91 (782)
Q Consensus 12 ~~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 91 (782)
....++||||+|+|+.|..|++||+.++...+++|++|||+++... .+.. .. ..........+.+++.++.+
T Consensus 16 ~~~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~-~~~~---~~----~~~~~~~~~~~~~~~~l~~~ 87 (309)
T 3cis_A 16 GNSSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVA-TWLE---VP----LPPGVLRWQQDHGRHLIDDA 87 (309)
T ss_dssp --CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCC-CTTC---CC----CCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCccc-cccc---CC----CCchhhHHHHHHHHHHHHHH
Confidence 4467999999999999999999999999988999999999974321 1000 00 00111122345666778888
Q ss_pred HHHhhcC-----CCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 92 RCYCTRK-----DIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 92 ~~~c~~~-----~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
...+... |++++..+.. |+++++|+++|+ ++|+||||++|++++.+.|+||++.+|+++++ |||+||..+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 88 LKVVEQASLRAGPPTVHSEIVP-AAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp HHHHHHHCSSSCCSCEEEEEES-SCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCS--SCEEEECTT
T ss_pred HHHHHHhcccCCCceEEEEEec-CCHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCC--CCEEEEcCC
Confidence 7777754 8999988887 689999999986 89999999999999999999999999999998 999999855
Q ss_pred c
Q 040785 167 K 167 (782)
Q Consensus 167 k 167 (782)
.
T Consensus 163 ~ 163 (309)
T 3cis_A 163 D 163 (309)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-16 Score=166.40 Aligned_cols=125 Identities=10% Similarity=0.015 Sum_probs=108.9
Q ss_pred CCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 13 GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 13 ~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
.+.++||||+|+|+.+..|++||+.++...+++|++|||.++ + ..++.++.+.
T Consensus 5 ~~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~-----------------------~----~~~~~l~~~~ 57 (290)
T 3mt0_A 5 QAIRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR-----------------------R----DHSAALNDLA 57 (290)
T ss_dssp TTCCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS-----------------------S----CCHHHHHHHH
T ss_pred hhhceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc-----------------------H----HHHHHHHHHH
Confidence 357999999999999999999999999999999999999852 1 1233445555
Q ss_pred HHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 93 CYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 93 ~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
..+...|++++..+..+++++++|+++|++.++|+||||++|++++.+.++||++.+|+++++ |||++|..+
T Consensus 58 ~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~--~PVlvv~~~ 129 (290)
T 3mt0_A 58 QELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAP--CPVLMTKTA 129 (290)
T ss_dssp HHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCS--SCEEEECCC
T ss_pred HHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCC--CCEEEecCC
Confidence 555678999999998778999999999999999999999999999999999999999999998 999999843
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=174.38 Aligned_cols=135 Identities=13% Similarity=0.145 Sum_probs=96.5
Q ss_pred cccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh--------------hHHHH--------HHHHHHHHhcCCCCe
Q 040785 452 FFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ--------------GRSQF--------QREIEVLSCIRHPNM 508 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--------------~~~~~--------~~Ei~iL~~l~HpnI 508 (782)
-|.+...||.|+||.||+|.. +|+.||||+++..... ..... .+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 489999999999999999987 6889999998643110 01111 245555555544333
Q ss_pred eeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-
Q 040785 509 VLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY- 587 (782)
Q Consensus 509 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~- 587 (782)
....-+.....+|||||++|++|..+.. . .....++.||+.+|.|||..| ||||||||.||||++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 2111111233489999999988865321 1 134568899999999999999 99999999999998776
Q ss_pred ---------ceeeecccccc
Q 040785 588 ---------VSKISDVGLAR 598 (782)
Q Consensus 588 ---------~~kL~DFGla~ 598 (782)
.+.|+||+-+-
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCE
T ss_pred cccccccccceEEEEeCCcc
Confidence 38999998764
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=162.90 Aligned_cols=124 Identities=17% Similarity=0.165 Sum_probs=109.1
Q ss_pred CCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 13 GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 13 ~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
...++|+||+|+++.+.+|++||+.++...+++|++|||.++.. .++.++.+.
T Consensus 168 ~~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~---------------------------~~~~l~~~~ 220 (294)
T 3loq_A 168 SLFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD---------------------------KTADLRVME 220 (294)
T ss_dssp CTTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC---------------------------CHHHHHHHH
T ss_pred ccCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch---------------------------HHHHHHHHH
Confidence 45689999999999999999999999988899999999985311 234556666
Q ss_pred HHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 93 CYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 93 ~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
..+...+++++..+.. ++++++|+++|++.++|+||||++|++++.++|+|||+.+|+++++ |||++|..+
T Consensus 221 ~~l~~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 221 EVIGAEGIEVHVHIES-GTPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp HHHHHTTCCEEEEEEC-SCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCS--SCEEEECSC
T ss_pred HHHHHcCCcEEEEEec-CCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCC--CCEEEECCC
Confidence 6777789999888877 5999999999999999999999999999999999999999999998 999999865
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=162.77 Aligned_cols=135 Identities=16% Similarity=0.175 Sum_probs=105.7
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
..++|+||+|+|+.|..||+||+.++...+++|++|||.++.... .. . ........+..++.+..+..
T Consensus 170 ~~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~------~~--~----~~~~~~~~~~~~~~l~~~~~ 237 (309)
T 3cis_A 170 QQAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVS------EW--P----GIDWPATQSMAEQVLAERLA 237 (309)
T ss_dssp CCCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCT------TC--S----SCCHHHHHHHHHHHHHHHHT
T ss_pred CCCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeeccccc------CC--C----cccHHHHHHHHHHHHHHHHH
Confidence 457999999999999999999999998889999999998653310 00 0 00011122344444555444
Q ss_pred Hhhc--CCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 94 YCTR--KDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 94 ~c~~--~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
.+.. .++.++..+.. |+++++|+++|+ ++|+||||++|++++.++|+|||+.+|+++++ |||+||..
T Consensus 238 ~~~~~~~~~~~~~~~~~-g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 238 GWQERYPNVAITRVVVR-DQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp THHHHCTTSCEEEEEES-SCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCS--SCEEEECC
T ss_pred HHHhhCCCCcEEEEEEc-CCHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCC--CCEEEeCC
Confidence 3332 58889988877 689999999997 89999999999999999999999999999998 99999974
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.1e-15 Score=162.24 Aligned_cols=143 Identities=13% Similarity=0.069 Sum_probs=105.8
Q ss_pred CCCeEEEEeCCCc-------chHHHHHHHHHhccCC--CCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHH
Q 040785 14 GNGLIAVAVDKDK-------SSQHALKWAADNLLNR--GQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQI 84 (782)
Q Consensus 14 ~~~~IlVaVD~s~-------~S~~Al~wAl~~~~~~--g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (782)
..++||||+|+|+ .|.+||+||+.++... +++|++|||.++....... ...........+...+..
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 229 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAI-----ELPDFDPNLYNNALRGQH 229 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCT-----TCTTCCHHHHHHHHHHHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhc-----cCCcccHHHHHHHHHHHH
Confidence 4689999999998 5799999999999887 9999999999765421100 000000001111222333
Q ss_pred HHHHHHHHHHhhcCCC-ceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEE
Q 040785 85 RDLFLTFRCYCTRKDI-KCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163 (782)
Q Consensus 85 ~~~l~~~~~~c~~~~v-~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV 163 (782)
.+.| ..++...++ .++..+.. |+++++|+++|+++++|+||||++|++++.++|+|||+.+|+++++ |||+||
T Consensus 230 ~~~l---~~~~~~~~~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv 303 (319)
T 3olq_A 230 LIAM---KELRQKFSIPEEKTHVKE-GLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIK--CDLLAI 303 (319)
T ss_dssp HHHH---HHHHHHTTCCGGGEEEEE-SCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCC--SEEEEE
T ss_pred HHHH---HHHHHHhCCCcccEEEec-CCcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCC--CCEEEE
Confidence 3344 344555666 35566666 6899999999999999999999999999999999999999999998 999999
Q ss_pred ecCc
Q 040785 164 SKGK 167 (782)
Q Consensus 164 ~kgk 167 (782)
....
T Consensus 304 ~~~~ 307 (319)
T 3olq_A 304 KPDG 307 (319)
T ss_dssp CCTT
T ss_pred CCCC
Confidence 7543
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=145.36 Aligned_cols=116 Identities=16% Similarity=0.115 Sum_probs=99.7
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
..++|+||+|+|+.|.+|++||...+...+++|++|||.++. +..++.++.+..
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~--------------------------~~~~~~l~~~~~ 206 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP--------------------------ARAEAWALEAEA 206 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH--------------------------HHHHHHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH--------------------------HHHHHHHHHHHH
Confidence 457999999999999999999999988889999999998431 133455666677
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
.+...|++++..+.. |+++++|+++|++. |+||||+ ++.++|+|||+.+|+++++ |||++|.
T Consensus 207 ~l~~~~~~~~~~~~~-g~~~~~i~~~a~~~--dliV~G~----~~~~~~~Gs~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 207 YLRDHGVEASALVLG-GDAADHLLRLQGPG--DLLALGA----PVRRLVFGSTAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp HHHHTTCCEEEEEEC-SCHHHHHHHHCCTT--EEEEEEC----CCSCCSSCCHHHHHHHHCS--SCEEEEC
T ss_pred HHHHcCCceEEEEeC-CChHHHHHHHHHhC--CEEEECC----cccccEeccHHHHHHhcCC--CCEEEeC
Confidence 777789999988777 68999999999998 9999999 6778889999999999998 9999984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3e-12 Score=133.52 Aligned_cols=143 Identities=15% Similarity=0.103 Sum_probs=110.7
Q ss_pred HhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccCcc--EEEEEe
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
....|.....+|.|+++.||++...+..+++|+...........+.+|+.+|..+. +.++.++++++.+.+ |+||||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred HhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 33468888888999999999998888899999987532233456899999999884 667778888775543 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK-------------------------------------- 567 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------- 567 (782)
++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999877531 11223468889999999999821
Q ss_pred ------------------CCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 568 ------------------PEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 568 ------------------~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998776678999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.5e-10 Score=124.77 Aligned_cols=141 Identities=17% Similarity=0.266 Sum_probs=107.1
Q ss_pred ccceeeeeCcEeEEEEEECCeeEEEEEec--CCc-hhhHHHHHHHHHHHHhcC--CCCeeeecccccCc-----cEEEEE
Q 040785 455 ESRKIGEGGYGPVYKCYLDHTPVAVKVLR--PDA-AQGRSQFQREIEVLSCIR--HPNMVLLLGACPEY-----GIIVYE 524 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~--~~~-~~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~-----~~lV~E 524 (782)
..+.|+.|.++.||+....+..+++|+.. ... ......+.+|+.+|..|. +..+.++++++.+. .|+|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 35678999999999998878889999876 332 122457889999999997 45577888887654 589999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK------------------------------------- 567 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------- 567 (782)
|++|..+.+.. ...++..++..++.+++..|..||...
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998875421 123778888899999999999999731
Q ss_pred ------------------CCCeeecCCCCceEEEcCCC--ceeeecccccccc
Q 040785 568 ------------------PEPLVHRDLKPGNILLDHNY--VSKISDVGLARLV 600 (782)
Q Consensus 568 ------------------~~~iiHrDLKp~NILld~~~--~~kL~DFGla~~~ 600 (782)
+..++|+|++|.|||++.++ .+.|+||+.+.+-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 24599999999999998765 3689999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.6e-10 Score=119.46 Aligned_cols=133 Identities=16% Similarity=0.130 Sum_probs=95.4
Q ss_pred ccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC--eeeecccccCc--cEEEEEeCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN--MVLLLGACPEY--GIIVYEYLA 527 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~~--~~lV~Ey~~ 527 (782)
|......+.|.++.||++.. ++..+++|+.... ....+.+|+.+|..+.+.+ +.++++++... .++||||++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 44333334555699999976 3568999998654 2356889999999986544 44577766543 399999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK---------------------------------------- 567 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 567 (782)
|.+|. ... .. ...++.+++..|..||...
T Consensus 99 G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 99 GQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 98884 211 11 2256778888888888753
Q ss_pred ---------------CCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 568 ---------------PEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 568 ---------------~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
+..++|+|++|.|||+++++.+.|+|||.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998877778999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=5.1e-10 Score=119.46 Aligned_cols=181 Identities=17% Similarity=0.167 Sum_probs=122.5
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCC--eeeecccccC-----ccEEEEEeCC
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPN--MVLLLGACPE-----YGIIVYEYLA 527 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~l~g~~~~-----~~~lV~Ey~~ 527 (782)
.+.++.|.+..||+.. ..+++|+.... .....+.+|+.+|..+. +.. +...++.+.. ..|+||+|++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 67899987532 34567899999998873 322 3344444322 2389999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK---------------------------------------- 567 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 567 (782)
|.+|.+.... .++..++..++.+++..|..||...
T Consensus 100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988764431 2677778888889998888888621
Q ss_pred ---------------CCCeeecCCCCceEEEcC--CCceeeeccccccccccccccccccccccccCCccc---CChhhh
Q 040785 568 ---------------PEPLVHRDLKPGNILLDH--NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY---IDPEYQ 627 (782)
Q Consensus 568 ---------------~~~iiHrDLKp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y---~aPE~~ 627 (782)
+..++|+|++|.|||++. +..+.|+||+.+....... + ......+ ..|+..
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D--------l~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D--------FISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H--------HHTTCCTTTSCCHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H--------HHHHHhhccccCHHHH
Confidence 134899999999999998 5678999999987532110 0 0011111 233311
Q ss_pred hc-----CCC---------CCchhHHHHHHHHHHHHhCCCCC
Q 040785 628 QT-----GML---------GVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 628 ~~-----~~~---------s~ksDVwSlGvil~elltG~~Pf 655 (782)
.. +.. ....+.|++|.+++.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 10 111 12368999999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.3e-06 Score=93.20 Aligned_cols=134 Identities=19% Similarity=0.206 Sum_probs=92.7
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCC---Ceeeeccccc---CccEEEEEeCCCC
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP---NMVLLLGACP---EYGIIVYEYLANG 529 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~g~~~---~~~~lV~Ey~~~g 529 (782)
...++.|....||+. +..+++|+... ......+.+|+.+|..|.+. .+...+.++. ...++||+|++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888999999988 67889998532 33456789999999998642 2344444442 2248999999998
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT------------------------------------------- 566 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------------------------------------------- 566 (782)
+|.+.... .++..+...++.+++..|..||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88763221 134455555556666665555543
Q ss_pred --------------CCCCeeecCCCCceEEEcC---CCc-eeeeccccccc
Q 040785 567 --------------KPEPLVHRDLKPGNILLDH---NYV-SKISDVGLARL 599 (782)
Q Consensus 567 --------------~~~~iiHrDLKp~NILld~---~~~-~kL~DFGla~~ 599 (782)
.+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 344 58999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1.5e-06 Score=94.50 Aligned_cols=77 Identities=6% Similarity=0.012 Sum_probs=54.3
Q ss_pred ccee-eeeCcEeEEEEEEC--------CeeEEEEEecCCc---hhhHHHHHHHHHHHHhcC-C--CCeeeecccccCc--
Q 040785 456 SRKI-GEGGYGPVYKCYLD--------HTPVAVKVLRPDA---AQGRSQFQREIEVLSCIR-H--PNMVLLLGACPEY-- 518 (782)
Q Consensus 456 ~~~L-G~G~fg~Vy~~~~~--------~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~-H--pnIv~l~g~~~~~-- 518 (782)
.+.| +.|..+.+|+.... +..+++|+..... ......+.+|+.+|..|. + ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999998765 6788999865432 111246788999998874 2 3456677766543
Q ss_pred ---cEEEEEeCCCCChh
Q 040785 519 ---GIIVYEYLANGSLD 532 (782)
Q Consensus 519 ---~~lV~Ey~~~gsL~ 532 (782)
.++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 38999999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.9e-06 Score=88.16 Aligned_cols=132 Identities=14% Similarity=0.135 Sum_probs=90.5
Q ss_pred eeeeeCcE-eEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccCc--cEEEEEeCCCCCh
Q 040785 458 KIGEGGYG-PVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEY--GIIVYEYLANGSL 531 (782)
Q Consensus 458 ~LG~G~fg-~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~lV~Ey~~~gsL 531 (782)
.+..|..| .||+... .+..+.+|+-... ....+.+|..+|+.+. +--+.++++++.+. .++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556554 6898765 3567899987543 3456889999998874 22345666666443 4999999999888
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------------
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK-------------------------------------------- 567 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------------- 567 (782)
.+...... .....+..+++..|.-||...
T Consensus 108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 76553211 123345666666666666532
Q ss_pred -----------CCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 568 -----------PEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 568 -----------~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
+..++|+|+.|.|||++.++.+-|+||+.+.+
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999888788999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.1e-06 Score=93.47 Aligned_cols=74 Identities=20% Similarity=0.218 Sum_probs=51.7
Q ss_pred cceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-------hhHHHHHHHHHHHHhcCC--C-CeeeecccccCccEEEE
Q 040785 456 SRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-------QGRSQFQREIEVLSCIRH--P-NMVLLLGACPEYGIIVY 523 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-------~~~~~~~~Ei~iL~~l~H--p-nIv~l~g~~~~~~~lV~ 523 (782)
.+.||.|.++.||++.. .+..++||...+... .....+..|.++|..+.. | .+..++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 56799999999999964 467899998754321 123456789999988742 3 34456666666679999
Q ss_pred EeCCCC
Q 040785 524 EYLANG 529 (782)
Q Consensus 524 Ey~~~g 529 (782)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.3e-05 Score=85.87 Aligned_cols=140 Identities=19% Similarity=0.237 Sum_probs=80.7
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-----CCCeeeec-c----cccCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-----HPNMVLLL-G----ACPEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~-g----~~~~~~~lV~Ey 525 (782)
...|+.|..+.||+....+..+++|+..... ..+..|+.++..|. .|.++... | ......+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3456667889999998877779999997531 33445666665553 24444311 1 112334899999
Q ss_pred CCCCChh--------------HHHhhc--CCC-C--------CCCHHHHH------------------------------
Q 040785 526 LANGSLD--------------DRIFRR--GNT-P--------PLSWQQRF------------------------------ 550 (782)
Q Consensus 526 ~~~gsL~--------------~~l~~~--~~~-~--------~l~~~~~~------------------------------ 550 (782)
++|.++. ..++.. ... + ...|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 112221 110 0 11232211
Q ss_pred -HHHHHHHHHHHHhhh----------cCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 551 -RIAAEIATGLLFLHQ----------TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 551 -~i~~qia~aL~yLH~----------~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
.+...+..++.+|+. ..+..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345666763 1234599999999999998888999999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.91 E-value=2.8e-05 Score=86.52 Aligned_cols=73 Identities=14% Similarity=0.169 Sum_probs=46.7
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCch---------hhHHHHHHHHHHHHh-cCCCCeeeecccccCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAA---------QGRSQFQREIEVLSC-IRHPNMVLLLGACPEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~---------~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~~~~lV~Ey 525 (782)
.+.||.|..+.||++...+..++||...+... .....+..|+..+.. .....+.+++.+..+..++||||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e~ 118 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMRY 118 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEECC
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEee
Confidence 46789999999999977777899994332110 122334444433321 22345666666666677999999
Q ss_pred C-CC
Q 040785 526 L-AN 528 (782)
Q Consensus 526 ~-~~ 528 (782)
+ ++
T Consensus 119 l~~g 122 (420)
T 2pyw_A 119 LEPP 122 (420)
T ss_dssp CCTT
T ss_pred cCCc
Confidence 9 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.86 E-value=7.4e-05 Score=78.52 Aligned_cols=77 Identities=21% Similarity=0.235 Sum_probs=56.3
Q ss_pred ccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCC---CeeeecccccCccEEEEEeCCC
Q 040785 453 FTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP---NMVLLLGACPEYGIIVYEYLAN 528 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~g~~~~~~~lV~Ey~~~ 528 (782)
......+|.|..+.||+... +|+.|.+|+...........|..|+..|+.|.-. -+.+.+++ +..++||||+++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~~ 94 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeecc
Confidence 45567899999999999998 6789999987654433445788999999887421 23344433 345899999988
Q ss_pred CCh
Q 040785 529 GSL 531 (782)
Q Consensus 529 gsL 531 (782)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=7.7e-05 Score=78.94 Aligned_cols=71 Identities=11% Similarity=0.148 Sum_probs=49.0
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-eeecccccCccEEEEEeC-CCCCh
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-VLLLGACPEYGIIVYEYL-ANGSL 531 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~-~~gsL 531 (782)
.+.|+.|....+|+. ..+++|+....... .-...+|+.++..+...++ .++++++.+.+++++||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence 678999999999998 67889988653211 1234578888877742222 466677777789999999 66554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00016 Score=77.28 Aligned_cols=136 Identities=18% Similarity=0.213 Sum_probs=88.3
Q ss_pred cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcC---CCCeeeecccccC--ccEEEEEeCCCCC
Q 040785 456 SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR---HPNMVLLLGACPE--YGIIVYEYLANGS 530 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~--~~~lV~Ey~~~gs 530 (782)
.+.|+.|.+..+|+....+..+++|+.... ....|..|...|+.|. ...+.+.++++.. ..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 467899999999999887888999987543 3567889999998873 2456666666543 3499999999986
Q ss_pred hh--------H---HHhhcCCCC-------------------CCCHHHHH---HHHH----------------HHHHH-H
Q 040785 531 LD--------D---RIFRRGNTP-------------------PLSWQQRF---RIAA----------------EIATG-L 560 (782)
Q Consensus 531 L~--------~---~l~~~~~~~-------------------~l~~~~~~---~i~~----------------qia~a-L 560 (782)
+. . .|+.....+ .-+|...+ ++.. .++.. .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 52 1 223322100 01454432 1111 11111 1
Q ss_pred HHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 561 LFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 561 ~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
..|.. ..+..+||+|+.+.|||++.++ +.|+||+
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23322 1234599999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00027 Score=75.16 Aligned_cols=157 Identities=14% Similarity=0.178 Sum_probs=87.7
Q ss_pred ccHHHHHHHhccccc-----cceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC--eeeecc
Q 040785 441 YTIEDIEEATQFFTE-----SRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN--MVLLLG 513 (782)
Q Consensus 441 ~~~~~~~~~t~~f~~-----~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g 513 (782)
++.+++...-..|.. .+.|+.|....+|+....+..+++|+.... .....+..|+.++..|...+ +..++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344444444444443 355777888999999887668999998753 12345667888887764222 233332
Q ss_pred c--------ccCccEEEEEeCCCCChhH--------------HHhhcCCC--CC----C---CHHHHHHH----------
Q 040785 514 A--------CPEYGIIVYEYLANGSLDD--------------RIFRRGNT--PP----L---SWQQRFRI---------- 552 (782)
Q Consensus 514 ~--------~~~~~~lV~Ey~~~gsL~~--------------~l~~~~~~--~~----l---~~~~~~~i---------- 552 (782)
. .....+++|+|++|..+.. .++..... .+ . .|...+.-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1223478999999865421 12221110 00 1 12221110
Q ss_pred --HHHHHHHHHHhhhc----CCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 553 --AAEIATGLLFLHQT----KPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 553 --~~qia~aL~yLH~~----~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
...+...+.+|+.. .+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01133445555532 234599999999999999877678999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00037 Score=74.71 Aligned_cols=141 Identities=12% Similarity=0.088 Sum_probs=75.0
Q ss_pred ceeeeeCcEe-EEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCC--CCeeeecccccCccEEEEEeCCCCChh
Q 040785 457 RKIGEGGYGP-VYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH--PNMVLLLGACPEYGIIVYEYLANGSLD 532 (782)
Q Consensus 457 ~~LG~G~fg~-Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~~~~lV~Ey~~~gsL~ 532 (782)
+.|+.|+... +|+.... +..+++|...+.. ...+..|+.++..+.. -.+.+++.+..+.++++||++.+.++.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchH
Confidence 3465554444 6777663 6677777654321 1345567777776632 234556666666679999999776665
Q ss_pred HHHhhc---------------------CC--CCCCCHHHHH-------H-H------------HHHHHHHHHHhh---hc
Q 040785 533 DRIFRR---------------------GN--TPPLSWQQRF-------R-I------------AAEIATGLLFLH---QT 566 (782)
Q Consensus 533 ~~l~~~---------------------~~--~~~l~~~~~~-------~-i------------~~qia~aL~yLH---~~ 566 (782)
+.+... .. .+.+...... . + ...+...+..|- ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 433211 00 1112221110 0 0 001111222221 11
Q ss_pred CCCCeeecCCCCceEEEcCC----Cceeeecccccccc
Q 040785 567 KPEPLVHRDLKPGNILLDHN----YVSKISDVGLARLV 600 (782)
Q Consensus 567 ~~~~iiHrDLKp~NILld~~----~~~kL~DFGla~~~ 600 (782)
.+..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 24459999999999999874 67899999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00032 Score=78.26 Aligned_cols=72 Identities=18% Similarity=0.262 Sum_probs=49.6
Q ss_pred cceeeeeCcEeEEEEEEC---------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-eeecccccCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-VLLLGACPEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey 525 (782)
.+.|+.|-...||++... +..+.+|+...... ...+.+|..++..|...++ .++++.+.+ .+||||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEE
Confidence 456888889999999874 36789998844211 1345579999888843333 566666653 489999
Q ss_pred CCCCCh
Q 040785 526 LANGSL 531 (782)
Q Consensus 526 ~~~gsL 531 (782)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00077 Score=75.79 Aligned_cols=73 Identities=12% Similarity=0.081 Sum_probs=49.2
Q ss_pred cceeeeeCcEeEEEEEECC--eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-eeecccccCccEEEEEeCCCCCh
Q 040785 456 SRKIGEGGYGPVYKCYLDH--TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-VLLLGACPEYGIIVYEYLANGSL 531 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~--~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~~gsL 531 (782)
.+.|+.|-...+|++...+ ..+++|+....... .-...+|..++..|...++ .++++.+. ..+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--NGRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--TEEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--CeEEEEeeCCccC
Confidence 4578888899999999866 78999987543211 1122589999998865444 46677764 3469999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00058 Score=74.34 Aligned_cols=73 Identities=19% Similarity=0.190 Sum_probs=45.6
Q ss_pred cceeeeeCcEeEEEEEECC----------eeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC-eeeecccccCccEEEEE
Q 040785 456 SRKIGEGGYGPVYKCYLDH----------TPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN-MVLLLGACPEYGIIVYE 524 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~----------~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lV~E 524 (782)
...|+.|....+|+....+ ..+++|+...... .......|..++..+...+ ..++++.+ .+++||+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~~~v~e 114 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NGGRIEE 114 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CCcEEEE
Confidence 4567888889999998754 6788898755322 1123467888888874333 33555544 3689999
Q ss_pred eCCCCCh
Q 040785 525 YLANGSL 531 (782)
Q Consensus 525 y~~~gsL 531 (782)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9988543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0062 Score=64.70 Aligned_cols=158 Identities=16% Similarity=0.183 Sum_probs=87.7
Q ss_pred cccccHHHHHHHhcccc-----ccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC--ee
Q 040785 438 YRRYTIEDIEEATQFFT-----ESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN--MV 509 (782)
Q Consensus 438 ~~~~~~~~~~~~t~~f~-----~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv 509 (782)
+...+.+.+...-..|. ....|+ |....||+... ++..+++|+..+.. .....+..|..++..|...+ +.
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence 44455555554444442 234577 88889998876 45579999987532 13456777888888774222 34
Q ss_pred eeccc-------ccCccEEEEEeCCCCChh----H----------HHhhcCC------CCCCCHHHH----HHHH-----
Q 040785 510 LLLGA-------CPEYGIIVYEYLANGSLD----D----------RIFRRGN------TPPLSWQQR----FRIA----- 553 (782)
Q Consensus 510 ~l~g~-------~~~~~~lV~Ey~~~gsL~----~----------~l~~~~~------~~~l~~~~~----~~i~----- 553 (782)
.++.. .....+++|+|++|..+. + .++.... .+.+.+... ..++
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 44433 011226799999885432 1 1111100 111222211 0010
Q ss_pred ----------HHHHHHHHHhhh----cCCCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 554 ----------AEIATGLLFLHQ----TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 554 ----------~qia~aL~yLH~----~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
..+...+..|.. ..+..++|+|++|.|||++ + .+.|+||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011112222222 1334589999999999998 4 889999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0011 Score=72.58 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=83.5
Q ss_pred ceeeeeCcEeEEEEEEC---------CeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccCccEEEEEeC
Q 040785 457 RKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYGIIVYEYL 526 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lV~Ey~ 526 (782)
+.|..|-...+|++... +..+.+|+.... ......+.+|..+++.|. +.-..++++++.+ .+||||+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g~v~e~i 132 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--GRLEQYI 132 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--EEEEECC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--ccEEEEe
Confidence 56777888899998863 357889986332 223455678999998874 2223566677665 3999999
Q ss_pred CCCChhH--------------H---HhhcCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHhh--
Q 040785 527 ANGSLDD--------------R---IFRRGN--TPPL--SWQQRFRIAAEIAT-------------------GLLFLH-- 564 (782)
Q Consensus 527 ~~gsL~~--------------~---l~~~~~--~~~l--~~~~~~~i~~qia~-------------------aL~yLH-- 564 (782)
+|.+|.. . |+.... ..+. -|.++.++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 9865531 1 111111 1112 24555555544422 123332
Q ss_pred --hc-CCCCeeecCCCCceEEEcCC----Cceeeeccccccc
Q 040785 565 --QT-KPEPLVHRDLKPGNILLDHN----YVSKISDVGLARL 599 (782)
Q Consensus 565 --~~-~~~~iiHrDLKp~NILld~~----~~~kL~DFGla~~ 599 (782)
.. .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23458999999999999876 7899999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.35 E-value=0.015 Score=57.94 Aligned_cols=98 Identities=15% Similarity=0.152 Sum_probs=64.4
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH-QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
+|.++|...+ .||+++++|.++.|.+.+|.-+- ...+ ..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc----------
Confidence 7899997765 47999999999999999987662 1121 1233457999999999887664 1110
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhC
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA 651 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG 651 (782)
.....+.+||.+. ...+.+.=|||||+++|.-+--
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1122456888653 3446788899999999988763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.006 Score=65.58 Aligned_cols=32 Identities=28% Similarity=0.334 Sum_probs=28.2
Q ss_pred CCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 569 ~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 45999999999999998888999999887654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.026 Score=62.63 Aligned_cols=141 Identities=12% Similarity=0.166 Sum_probs=85.6
Q ss_pred cceeeeeCcEeEEEEEEC---------CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCC-eeeecccccCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLD---------HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPN-MVLLLGACPEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lV~Ey 525 (782)
.+.|..|-...+|+.... +..+++++..... ...-...+|..++..+..-+ ..++++.+ .+++||+|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~~~I~ef 151 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PEGRIEEF 151 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEEC
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CCCEEEEE
Confidence 456777888999999875 5789999865432 11223467888888874222 34445443 35899999
Q ss_pred CCCCChhH--------------H---Hhhc-------C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 040785 526 LANGSLDD--------------R---IFRR-------G---NTPPLSWQQRFRIAAEI-------------------ATG 559 (782)
Q Consensus 526 ~~~gsL~~--------------~---l~~~-------~---~~~~l~~~~~~~i~~qi-------------------a~a 559 (782)
++|.+|.. . |+.. . ...+..|.++..+..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99865421 0 1110 0 11122355544444322 122
Q ss_pred HHHhh---------------------hcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 560 LLFLH---------------------QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 560 L~yLH---------------------~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+.+|. ...+..++|+|+.+.||| +.++.+.|+||..|..-
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 33332 112345899999999999 88889999999988643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.11 E-value=0.22 Score=54.53 Aligned_cols=29 Identities=28% Similarity=0.410 Sum_probs=25.0
Q ss_pred eeecCCCCceEEE------cCCCceeeeccccccc
Q 040785 571 LVHRDLKPGNILL------DHNYVSKISDVGLARL 599 (782)
Q Consensus 571 iiHrDLKp~NILl------d~~~~~kL~DFGla~~ 599 (782)
++|+|+.+.|||+ +++..+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998864
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=91.71 E-value=0.52 Score=52.69 Aligned_cols=98 Identities=12% Similarity=0.129 Sum_probs=69.1
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
.+.+|+||+-|..-|..++.++.......|-.|+++||.+... .....+-....+.
T Consensus 17 ~~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr------------------------g~~s~~~~~~v~~ 72 (464)
T 3a2k_A 17 EGAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR------------------------GRESEEEMEFVKR 72 (464)
T ss_dssp CSSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC------------------------THHHHHHHHHHHH
T ss_pred CCCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC------------------------ccccHHHHHHHHH
Confidence 3568999999999999888877776555688999999974211 0122333455678
Q ss_pred HhhcCCCceEEEEEecC--------CH--------HHHHHHHHHHcCCCEEEeccCCC
Q 040785 94 YCTRKDIKCFDVLLEDV--------DI--------VKAITEYVSFAAIEDLVLGAPSR 135 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~--------~v--------~~~Iv~~a~~~~~d~IVmGs~g~ 135 (782)
+|...||++..+-+... ++ ...+.++|++++++.|++|.|..
T Consensus 73 ~~~~lgi~~~v~~~~~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~d 130 (464)
T 3a2k_A 73 FCVERRILCETAQIDVPAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHGD 130 (464)
T ss_dssp HHHHTTCEEEEEECCCHHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCHH
T ss_pred HHHHcCCcEEEEEechhhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCChH
Confidence 89888988776555310 11 24566788899999999999854
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=90.61 E-value=1.4 Score=46.60 Aligned_cols=97 Identities=10% Similarity=0.023 Sum_probs=65.1
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCE-EEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQT-VVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~-v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
.+++|+||+-|...|.-++.++.......|.. |+++||-.... ....+-....+
T Consensus 23 ~~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r-------------------------~~s~~~~~~v~ 77 (317)
T 1wy5_A 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR-------------------------ESAERDEEFCK 77 (317)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS-------------------------THHHHHHHHHH
T ss_pred CCCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC-------------------------cccHHHHHHHH
Confidence 35789999999999988887776654445667 99999963210 11222344566
Q ss_pred HHhhcCCCceEEEEEec--------CCH--------HHHHHHHHHHcCCCEEEeccCCC
Q 040785 93 CYCTRKDIKCFDVLLED--------VDI--------VKAITEYVSFAAIEDLVLGAPSR 135 (782)
Q Consensus 93 ~~c~~~~v~~e~~v~~g--------~~v--------~~~Iv~~a~~~~~d~IVmGs~g~ 135 (782)
.+|...||++..+-+.. .++ ...+.++|++.+++.|++|.|..
T Consensus 78 ~~a~~lgi~~~v~~~~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~d 136 (317)
T 1wy5_A 78 EFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (317)
T ss_dssp HHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred HHHHHcCCcEEEEEEechhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchh
Confidence 67887788876554421 111 12566778999999999999854
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.11 E-value=4.2 Score=40.26 Aligned_cols=115 Identities=11% Similarity=0.058 Sum_probs=72.9
Q ss_pred CCCCeeeecccccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 504 RHPNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 504 ~HpnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
.||+++.. .+-.+..-+++.|-...+...+-. -..++...+++++.+|+....+++. =+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 68887755 232223344444443332222111 1236788999999999988866654 3688899999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM 655 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf 655 (782)
+.++.++|.=.|+-..+++ .=+.+| .=+-.+=|++..+++|+..|
T Consensus 113 ~~~~~p~i~~RGik~~l~P-----------------~~~~ee----------~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDP-----------------LPVSEA----------EFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTTBSC-----------------CCCCHH----------HHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccCCCC-----------------CCCCHH----------HHHHHHHHHHHHHHcCCCCH
Confidence 9999999998887543211 001222 22345677888899998887
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 782 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d2gm3a1 | 171 | c.26.2.4 (A:5-175) Putative ethylene-responsive pr | 1e-11 | |
| d1tq8a_ | 147 | c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobac | 3e-08 | |
| d2z3va1 | 135 | c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 { | 4e-07 | |
| d1mjha_ | 160 | c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archa | 1e-06 | |
| d1jmva_ | 140 | c.26.2.4 (A:) Universal stress protein A, UspA {Ha | 4e-05 | |
| d1q77a_ | 138 | c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex | 2e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-65
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 17/274 (6%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVL 510
T ++IG G +G VYK H VAVK+L A Q F+ E+ VL RH N++L
Sbjct: 10 ITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 511 LLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
+G + IV ++ SL + + IA + A G+ +LH +
Sbjct: 69 FMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA---K 123
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY--- 626
++HRDLK NI L + KI D GLA + + +G+ ++ PE
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS---RWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686
Q +SDVY+ GI+L +L+T + P + + I L P ++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSPDLSKVRSNCP 239
Query: 687 LGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720
+L +C + +R +RP + +L + L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQ-ILASIELLAR 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 3e-58
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 28/297 (9%)
Query: 441 YTIEDIEEATQFFTES---------RKIGEGGYGPVYKCYLDHT-----PVAVKVLRPDA 486
+T ED EA + F + + IG G +G V +L VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 487 -AQGRSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPP 543
+ R F E ++ HPN++ L G +I+ E++ NGSLD F R N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
+ Q + IA G+ +L VHRDL NIL++ N V K+SD GL+R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER 663
+ T + PE Q SDV+S GI++ ++++ + + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDM 237
Query: 664 SIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720
+ ++ + + P + +L L C + R RP G++V L+++
Sbjct: 238 TNQD-VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN-TLDKMIR 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-58
Identities = 73/261 (27%), Positives = 113/261 (43%), Gaps = 16/261 (6%)
Query: 453 FTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
++G G +G V+ Y HT VAVK L+ + F E ++ ++H +V L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRL 73
Query: 512 LGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
+ I I+ EY+ NGSL D + L+ + +AA+IA G+ F+ +
Sbjct: 74 YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG 630
+HRDL+ NIL+ KI+D GLARL+ + + PE G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKWTAPEAINYG 185
Query: 631 MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFA 690
+KSDV+S GILL +++T + I+N L D EE
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LERGYRMVRPDNCPEE---LY 240
Query: 691 KLALQCSELRRKDRPDLGKVV 711
+L C + R +DRP +
Sbjct: 241 QLMRLCWKERPEDRPTFDYLR 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
T ++IG G +G V+ Y + VA+K +R A F E EV+ + HP +V L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 512 LGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G C +V+E++ +G L D + R + + + ++ G + +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLEEA 120
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
++HRDL N L+ N V K+SD G+ R V + T T + PE
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFPVKWASPEVFSF 176
Query: 630 GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGF 689
KSDV+S G+L+ ++ + + +E+ + G L P +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTHV 231
Query: 690 AKLALQCSELRRKDRPDLGKVVLPELNRLRELAD 723
++ C + R +DRP ++ L +L E+A+
Sbjct: 232 YQIMNHCWKERPEDRPAFSRL----LRQLAEIAE 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 66/270 (24%), Positives = 107/270 (39%), Gaps = 23/270 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLL 512
+ IG+G +G V VAVK ++ DA F E V++ +RH N+V LL
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 66
Query: 513 GAC---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G IV EY+A GSL D + RG L + + ++ + +L
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
VHRDL N+L+ + V+K+SD GL + + + + PE +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKWTAPEALRE 174
Query: 630 GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGF 689
KSDV+S GILL ++ + + R + + D P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229
Query: 690 AKLALQCSELRRKDRPDLGKVVLPELNRLR 719
++ C L RP ++ +L ++
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLRE-QLEHIK 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 9e-56
Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 22/272 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
T +++G G +G V VA+K+++ + +F E +V+ + H +V L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 512 LGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
G C I+ EY+ANG L + + + QQ + ++ + +L +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
+HRDL N L++ V K+SD GL+R V + + + PE
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 630 GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGF 689
KSD+++ G+L+ ++ + + ER + T + P +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKV 230
Query: 690 AKLALQCSELRRKDRPDLGKVVLPELNRLREL 721
+ C + +RP + L+ + ++
Sbjct: 231 YTIMYSCWHEKADERPTFKIL----LSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMV 509
F + ++G G G V+K + +A K++ + R+Q RE++VL P +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 510 LLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
GA I E++ GSLD + + G + Q +++ + GL +L +
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRD+KP NIL++ K+ D G++ + S GT Y+ PE
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVGTRSYMSPERL 175
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
Q V+SD++S+G+ L+++ + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-55
Identities = 54/267 (20%), Positives = 108/267 (40%), Gaps = 18/267 (6%)
Query: 451 QFFTESRKIGEGGYGPVYKCYL----DHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRH 505
++G G +G V + VA+KVL+ + + RE +++ + +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 506 PNMVLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
P +V L+G C + +V E G L + + + + +++ G+ +L
Sbjct: 69 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLE 126
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+ + VHRDL N+LL + + +KISD GL++ + A ++ ++ + P
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAP 181
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684
E +SDV+S G+ + + ++ Q + + + + + P E
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMKGPE-VMAFIEQGKRMECPPE 236
Query: 685 ETLGFAKLALQCSELRRKDRPDLGKVV 711
L C + +DRPD V
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 2e-54
Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 43/309 (13%)
Query: 443 IEDIEEATQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQG-RSQFQ 494
+ +E R IGEG +G V++ T VAVK+L+ +A+ ++ FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 495 REIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRG------------- 539
RE +++ +PN+V LLG C + +++EY+A G L++ +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 540 --------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKI 591
PPLS ++ IA ++A G+ +L + K VHRDL N L+ N V KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKI 181
Query: 592 SDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA 651
+D GL+R + + A ++ PE +SDV++ G++L ++ +
Sbjct: 182 ADFGLSRNIY---SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 652 KQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
+ + E + + D + P L L C DRP +
Sbjct: 239 GLQP----YYGMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 712 LPELNRLRE 720
L R+ E
Sbjct: 294 -RILQRMCE 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 63/271 (23%), Positives = 108/271 (39%), Gaps = 26/271 (9%)
Query: 451 QFFTESRKIGEGGYGPVYKCYLDHT----PVAVKVLRPDAAQG--RSQFQREIEVLSCIR 504
E +++G G +G V K Y VAVK+L+ +A + + E V+ +
Sbjct: 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66
Query: 505 HPNMVLLLGAC-PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
+P +V ++G C E ++V E G L+ + + + + + +++ G+ +L
Sbjct: 67 NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYL 123
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
+ VHRDL N+LL + +KISD GL++ + A T +
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA--QTHGKWPVKWYA 178
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQP--MGLTHF-VERSIENGTLGEMLDPTVTD 680
PE KSDV+S G+L+ + + Q G+ V +E G
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA----G 234
Query: 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
P E L C ++RP V
Sbjct: 235 CPRE----MYDLMNLCWTYDVENRPGFAAVE 261
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 22/281 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT------PVAVKVLRPDAAQG-RSQFQREIEVLSCIRH 505
T + IG G +G VYK L + PVA+K L+ + R F E ++ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 506 PNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
N++ L G +Y +I+ EY+ NG+LD F R S Q + IA G+ +L
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
VHRDL NIL++ N V K+SD GL+R++ + Y + +
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWTA 181
Query: 624 PEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPF 683
PE SDV+S GI++ +++T + ++ + D P
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----INDGFRLPTPM 236
Query: 684 EETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADE 724
+ +L +QC + R RP +V L++L D
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVS-ILDKLIRAPDS 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 9e-54
Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 22/279 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
T K+G G YG VY+ VAVK L+ D + +F +E V+ I+HPN+V
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 77
Query: 511 LLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
LLG C I+ E++ G+L D + +S +A +I++ + +L +
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK--- 133
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
+ +HRDL N L+ N++ K++D GL+RL+ T + PE
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESLA 189
Query: 629 TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVT-DWPFEETL 687
+KSDV++ G+LL ++ T I+ + E+L+ + P
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYELLEKDYRMERPEGCPE 243
Query: 688 GFAKLALQCSELRRKDRPDLGKVV--LPELNRLRELADE 724
+L C + DRP ++ + + ++DE
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 62/319 (19%), Positives = 115/319 (36%), Gaps = 54/319 (16%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIE 498
R ++ IG+G +G V++ VAVK+ + + EI
Sbjct: 3 RTIVLQ------------ESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIY 49
Query: 499 VLSCIRHPNMVLLLGAC------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI 552
+RH N++ + A +V +Y +GSL D + R ++ + ++
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKL 105
Query: 553 AAEIATGLLFLHQ-----TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
A A+GL LH + HRDLK NIL+ N I+D+GLA + A +
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDT 164
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGM------LGVKSDVYSLGILLLQLITAKQPMGLTHFV 661
GT Y+ PE + ++D+Y++G++ ++ G+
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 662 ER-------------SIENGTLGEMLDPTVTDWPF--EETLGFAKLALQCSELRRKDRPD 706
+ + + L P + + E AK+ +C R
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 707 LGKVVLPELNRLRELADES 725
++ L +L+ +
Sbjct: 285 ALRIK----KTLSQLSQQE 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 75/261 (28%), Positives = 114/261 (43%), Gaps = 16/261 (6%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT-PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLL 511
K+G+G +G V+ + T VA+K L+P F +E +V+ +RH +V L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 512 LGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEP 570
E I IV EY++ GSL D + L Q +AA+IA+G+ ++ +
Sbjct: 78 YAVVSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 571 LVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG 630
VHRDL+ NIL+ N V K++D GLARL+ E+ + PE G
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 631 MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFA 690
+KSDV+S GILL +L T + + L ++ P E
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLH 244
Query: 691 KLALQCSELRRKDRPDLGKVV 711
L QC ++RP +
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQ 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-53
Identities = 63/270 (23%), Positives = 103/270 (38%), Gaps = 22/270 (8%)
Query: 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNM 508
+ IG G YG K D + K L + + E+ +L ++HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 509 VLLLGACPEYG----IIVYEYLANGSLDDRIFRRG-NTPPLSWQQRFRIAAEIATGLLFL 563
V + IV EY G L I + L + R+ ++ L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 564 HQ--TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
H+ ++HRDLKP N+ LD K+ D GLAR++ N + GT Y
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFAKAFVGTPYY 180
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681
+ PE KSD++SLG LL +L P E G++ +
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKFRRI 234
Query: 682 PFEETLGFAKLALQCSELRRKDRPDLGKVV 711
P+ + ++ + L+ RP + +++
Sbjct: 235 PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-53
Identities = 80/317 (25%), Positives = 133/317 (41%), Gaps = 32/317 (10%)
Query: 424 VKIASSNLSTKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT-----PVA 478
V I S L+ + ++ ++ + F + IG G +G VY L A
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCA 59
Query: 479 VKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVLLLGACPEYG---IIVYEYLANGSLDDR 534
VK L G SQF E ++ HPN++ LLG C ++V Y+ +G L +
Sbjct: 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN- 118
Query: 535 IFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDV 594
F R T + + ++A G+ + VHRDL N +LD + K++D
Sbjct: 119 -FIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 595 GLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
GLAR + E + ++ T ++ E QT KSDV+S G+LL +L+T P
Sbjct: 175 GLARDMYD-KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
Query: 655 --MGLTHF-VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
+ F + + G +L P P E + L+C + + RP ++V
Sbjct: 234 PYPDVNTFDITVYLLQG--RRLLQPEYCPDPLYE------VMLKCWHPKAEMRPSFSELV 285
Query: 712 LPELNRLRELADESMGQ 728
+R+ + +G+
Sbjct: 286 ----SRISAIFSTFIGE 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-53
Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 33/274 (12%)
Query: 452 FFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPN 507
F +IG G + VYK T VA L+ R +F+ E E+L ++HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 508 MVLLLGAC------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLL 561
+V + + ++V E + +G+L + R + + +I GL
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQ 126
Query: 562 FLHQTKPEPLVHRDLKPGNILL-DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
FLH P P++HRDLK NI + KI D+GLA L + GT
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPE 178
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIENGTLGEMLDPT 677
++ PE + DVY+ G+ +L++ T++ P R + +G D
Sbjct: 179 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
++ C + +R + ++
Sbjct: 238 AIP-------EVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 27/265 (10%)
Query: 452 FFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMV 509
F+ ++G+G +G VYK T A KV+ + + + EI++L+ HPN+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 510 LLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
LL A I+ E+ A G++D + PL+ Q + + L +LH K
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK 130
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRDLK GNIL + K++D G++ T S GT ++ PE
Sbjct: 131 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-----TIQRRDSFIGTPYWMAPEVV 182
Query: 628 QTGML-----GVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680
K+DV+SLGI L+++ + P + + I +P
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------EPPTLA 236
Query: 681 WPFEETLGFAKLALQCSELRRKDRP 705
P + F +C E R
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARW 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 68/279 (24%), Positives = 110/279 (39%), Gaps = 26/279 (9%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT-----PVAVKVLRPDAA---QGRSQFQREIEVLSCIR 504
K+G+G +G V + D VAVK L+PD + F RE+ + +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 505 HPNMVLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFL 563
H N++ L G + +V E GSL DR+ + R A ++A G+ +L
Sbjct: 70 HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYL 127
Query: 564 HQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTST-AGTFCYI 622
+ +HRDL N+LL + KI D GL R +P +N Y + F +
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP---QNDDHYVMQEHRKVPFAWC 181
Query: 623 DPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWP 682
PE +T SD + G+ L ++ T Q + + + P D P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLREL 721
+ + +QC + +DRP + + L E
Sbjct: 242 QD----IYNVMVQCWAHKPEDRPTFVALR----DFLLEA 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-51
Identities = 72/282 (25%), Positives = 118/282 (41%), Gaps = 38/282 (13%)
Query: 439 RRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDA---AQGRSQF 493
R++ +ED F R +G+G +G VY + +A+KVL A Q
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 494 QREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFR 551
+RE+E+ S +RHPN++ L G ++ EY G++ + + Q+
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTAT 110
Query: 552 IAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYH 611
E+A L + H + ++HRD+KP N+LL KI+D G + P
Sbjct: 111 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSR 160
Query: 612 LTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGT 669
T+ GT Y+ PE + M K D++SLG+L + + K P + E + I
Sbjct: 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 220
Query: 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
+P T G L + + RP L +V+
Sbjct: 221 F---------TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 6e-51
Identities = 65/269 (24%), Positives = 105/269 (39%), Gaps = 30/269 (11%)
Query: 447 EEATQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQG---RSQFQREIEVLS 501
++ + F++ R+IG G +G VY + VA+K + Q +E+ L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 502 CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
+RHPN + G +V EY + D + PL + + G
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQG 127
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTF 619
L +LH ++HRD+K GNILL + K+ D G A ++ S GT
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---------PANSFVGTP 175
Query: 620 CYIDPEY---QQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDP 676
++ PE G K DV+SLGI ++L K P+ + + ++ + E
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPAL 234
Query: 677 TVTDWPFEETLGFAKLALQCSELRRKDRP 705
W F C + +DRP
Sbjct: 235 QSGHWSEY----FRNFVDSCLQKIPQDRP 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 9e-51
Identities = 80/313 (25%), Positives = 125/313 (39%), Gaps = 40/313 (12%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT----PVAVKVLRPDAA-QGRSQFQ 494
Y + D + IGEG +G V K + A+K ++ A+ F
Sbjct: 3 IYPVLDWND----IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 495 REIEVLS-CIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRR------------- 538
E+EVL HPN++ LLGAC Y + EY +G+L D + +
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 539 GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
LS QQ AA++A G+ +L Q + +HRDL NIL+ NYV+KI+D GL+R
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLT 658
T ++ E + SDV+S G+LL ++++
Sbjct: 176 GQE------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229
Query: 659 HFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718
E G L+ P L QC + +RP ++++ LNR+
Sbjct: 230 MTCAELYEKLPQGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILV-SLNRM 283
Query: 719 RELADESMGQTFF 731
E + T +
Sbjct: 284 LEERKTYVNTTLY 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 16/227 (7%)
Query: 432 STKDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQG 489
S +++ + +I + + + +T KIG+G G VY VA++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 490 RSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
+ EI V+ ++PN+V L + + +V EYLA GSL D +
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEG 116
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
Q + E L FLH + ++HRD+K NILL + K++D G +
Sbjct: 117 QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-----TP 168
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
Q ++ GT ++ PE G K D++SLGI+ +++I + P
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 40/299 (13%)
Query: 453 FTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQG-RSQFQREIEVLS-CI 503
+ + +G G +G V + VAVK+L+P A R E++VLS
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 504 RHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTP---------------PLSW 546
H N+V LLGAC +++ EY G L + + R+ ++ L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606
+ + ++A G+ FL + +HRDL NILL H ++KI D GLAR + +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE 666
V + + ++ PE + +SDV+S GI L +L + V+
Sbjct: 202 VVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADES 725
+ P E + C + RP ++ + + + ES
Sbjct: 259 KMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQI----VQLIEKQISES 309
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-50
Identities = 67/290 (23%), Positives = 115/290 (39%), Gaps = 41/290 (14%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT-------PVAVKVLRPDAAQG-RSQFQREIEVLS-CI 503
+ +G G +G V VAVK+L+ A R E+++++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 504 RHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRG--------------------NT 541
H N+V LLGAC G +++EY G L + + + +
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 542 PPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601
L+++ A ++A G+ FL + VHRDL N+L+ H V KI D GLAR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV 661
+ + V + + ++ PE G+ +KSDV+S GILL ++ + +
Sbjct: 216 SDSNYVVR---GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN----PYP 268
Query: 662 ERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711
++ + + D PF T + C + RP +
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 1e-49
Identities = 69/308 (22%), Positives = 127/308 (41%), Gaps = 32/308 (10%)
Query: 441 YTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQG-RSQ 492
Y ++ E A + T SR++G+G +G VY+ T VA+K + A+ R +
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 493 FQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRG-------NTPP 543
F E V+ ++V LLG + +++ E + G L + P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 544 LSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603
S + ++A EIA G+ +L+ VHRDL N ++ ++ KI D G+ R +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-- 184
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER 663
E ++ PE + G+ SDV+S G++L ++ T + +
Sbjct: 185 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGL 239
Query: 664 SIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELAD 723
S E L +++ + D P +L C + K RP ++ ++ ++E +
Sbjct: 240 SNEQ-VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI----ISSIKEEME 294
Query: 724 ESMGQTFF 731
+ F
Sbjct: 295 PGFREVSF 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 6e-49
Identities = 61/259 (23%), Positives = 95/259 (36%), Gaps = 19/259 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMV 509
+ + +GEG YG V T VAVK++ A ++EI + + H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 510 LLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
G + EY + G L DRI + R ++ G+++LH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
+ HRD+KP N+LLD KISD GLA + N + L GT Y+ PE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFR---YNNRERLLNKMCGTLPYVAPELL 177
Query: 628 QTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686
+ DV+S GI+L ++ + P + + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA-- 235
Query: 687 LGFAKLALQCSELRRKDRP 705
L + R
Sbjct: 236 --PLALLHKILVENPSARI 252
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-48
Identities = 66/315 (20%), Positives = 117/315 (37%), Gaps = 25/315 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT------PVAVKVLRPDA-AQGRSQFQREIEVLSCIRH 505
F + + +G G +G VYK PVA+K LR + + E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 506 PNMVLLLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
P++ LLG C + ++ + + G L D + + Q +IA G+ +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYLE 128
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
LVHRDL N+L+ KI+D GLA+L+ +YH ++
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---AEEKEYHAEGGKVPIKWMAL 182
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684
E + +SDV+S G+ + +L+T GE L P
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-----PPI 237
Query: 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFFGGSLGPSSKSNAS 744
T+ + ++C + RP ++ + ++A + G S
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFREL----IIEFSKMARDPQRYLVIQGDERMHLPSPTD 293
Query: 745 MTMQDVLSDPQPWNS 759
L D + +
Sbjct: 294 SNFYRALMDEEDMDD 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 63/279 (22%), Positives = 106/279 (37%), Gaps = 25/279 (8%)
Query: 457 RKIGEGGYGPVYKCYLDHT-----PVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMVL 510
R IGEG +G V++ VA+K + + R +F +E + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 511 LLGACPEYGI-IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
L+G E + I+ E G L F + L A +++T L +L +
Sbjct: 73 LIGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLESKR-- 128
Query: 570 PLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT 629
VHRD+ N+L+ N K+ D GL+R + E+ T Y + ++ PE
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPESINF 183
Query: 630 GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGF 689
SDV+ G+ + +++ I GE L P + P
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPT----L 238
Query: 690 AKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQ 728
L +C RP ++ +L + +E Q
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELK----AQLSTILEEEKAQ 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (422), Expect = 4e-47
Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRS---QFQREIEVLSCIRHPNMVLL 511
+G GG V+ H VAVKVLR D A+ S +F+RE + + + HP +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 512 LGAC------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
IV EY+ +L D + G P++ ++ + A+ L F HQ
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ 129
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
++HRD+KP NI++ K+ D G+AR + +VTQ + GT Y+ PE
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGTAQYLSPE 184
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEE 685
+ + +SDVYSLG +L +++T + P F S + + + + E
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 686 TL--GFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719
L + L+ ++R + +L R+
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (426), Expect = 8e-47
Identities = 62/319 (19%), Positives = 125/319 (39%), Gaps = 25/319 (7%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
++G G +G V++ A K + + ++EI+ +S +RHP +V L A
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 515 C--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
+++YE+++ G L +++ N +S + ++ GL +H+ V
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 573 HRDLKPGNILL--DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG 630
H DLKP NI+ + K+ D GL + + + T GT + PE +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLD------PKQSVKVTTGTAEFAAPEVAEGK 200
Query: 631 MLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFEETLG 688
+G +D++S+G+L L++ P G + E R++++ M D + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSGISED---- 255
Query: 689 FAKLALQCSELRRKDRPDLGKVVL-PELNRLRELADESMGQTFFGGSLGPSSKSNASMTM 747
+ R + + + P L +S + + S K+
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315
Query: 748 QDVLSDPQPWNSESLKSQS 766
+ + + N SL+
Sbjct: 316 EPLPPLGRISNYSSLRKHR 334
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-44
Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 16/209 (7%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPN 507
F + +GEG + V A+K+L RE +V+S + HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 508 MVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
V L E Y NG L I + G AEI + L +LH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG 126
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE 625
+ ++HRDLKP NILL+ + +I+D G A+++ Q S GT Y+ PE
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS---PESKQARANSFVGTAQYVSPE 180
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
SD+++LG ++ QL+ P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 65/348 (18%), Positives = 131/348 (37%), Gaps = 48/348 (13%)
Query: 434 KDLRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRS 491
K+L Y +Y I +G G +G V++C + K ++ +
Sbjct: 1 KEL-YEKYMIA------------EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QV 46
Query: 492 QFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQR 549
++EI +L+ RH N++ L + E ++++E+++ + +RI L+ ++
Sbjct: 47 LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREI 104
Query: 550 FRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH--NYVSKISDVGLARLVPAVAENV 607
++ L FLH + H D++P NI+ + KI + G AR +
Sbjct: 105 VSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------ 155
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSI 665
+ Y PE Q ++ +D++SLG L+ L++ P + +I
Sbjct: 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL-PELNRLRELADE 724
N + + E + RK R + + P L + E
Sbjct: 216 MNAEY-TFDEEAFKEISIE----AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVST 270
Query: 725 SMGQTFFGGSLGPSSKSNASMTMQD---VLSDPQPWNSESLKSQSGSS 769
+ +T + ++ +D V+S + +++SQ G S
Sbjct: 271 KVIRTL------KHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVS 312
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (400), Expect = 3e-43
Identities = 54/280 (19%), Positives = 110/280 (39%), Gaps = 28/280 (10%)
Query: 438 YRRYTIEDIEEATQ----FFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRS 491
+++Y + +E ++ ++G G +G V++C T K + +
Sbjct: 12 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 492 QFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQR 549
+ EI +++ + HP ++ L A +++ E+L+ G L DRI +S +
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEV 129
Query: 550 FRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS--KISDVGLARLVPAVAENV 607
+ GL +H+ +VH D+KP NI+ + S KI D GLA +
Sbjct: 130 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN------ 180
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSI 665
+ T T + PE +G +D++++G+L L++ P +E +++
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705
+ E + + E + + R
Sbjct: 241 KRCD-WEFDEDAFSSVSPE----AKDFIKNLLQKEPRKRL 275
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-43
Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 38/295 (12%)
Query: 453 FTESRKIGEGGYGPVYKCYL---------DHTPVAVKVLRPDAAQ-GRSQFQREIEVLSC 502
+ +GEG +G V T VAVK+L+ DA + S E+E++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 503 I-RHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTP-------------PLSW 546
I +H N++ LLGAC ++ EY + G+L + + R LS
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606
+ A ++A G+ +L + +HRDL N+L+ + V KI+D GLAR + +
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE 666
+ ++ PE + +SDV+S G+LL ++ T + +E
Sbjct: 192 KKTTN---GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP----YPGVPVE 244
Query: 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLREL 721
+ + D P T + C RP + ++ +L+R+ L
Sbjct: 245 E-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRIVAL 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (391), Expect = 8e-43
Identities = 59/275 (21%), Positives = 107/275 (38%), Gaps = 39/275 (14%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAA---------QGRSQFQREIEVLS 501
+ +G G V +C T AVK++ + R +E+++L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 502 CIR-HPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIAT 558
+ HPN++ L +V++ + G L D + + LS ++ +I +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLE 121
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
+ LH+ +VHRDLKP NILLD + K++D G + + L GT
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD------PGEKLREVCGT 172
Query: 619 FCYIDPEYQQTGML------GVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTL 670
Y+ PE + M G + D++S G+++ L+ P + R I +G
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232
Query: 671 GEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705
+ P D+ L + ++ + R
Sbjct: 233 -QFGSPEWDDYSDT----VKDLVSRFLVVQPQKRY 262
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 9e-43
Identities = 63/272 (23%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 444 EDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG-RSQFQREIEVL 500
EDI + + +G G + V T VA+K + A +G + EI VL
Sbjct: 5 EDIRD---IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 501 SCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIAT 558
I+HPN+V L + ++ + ++ G L DRI +G + + R+ ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILL---DHNYVSKISDVGLARLVPAVAENVTQYHLTST 615
+ +LH +VHRDLKP N+L D + ISD GL+++ L++
Sbjct: 119 AVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED------PGSVLSTA 169
Query: 616 AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEM 673
GT Y+ PE D +S+G++ L+ P + + I E
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-EF 228
Query: 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705
P D E + R
Sbjct: 229 DSPYWDDISDS----AKDFIRHLMEKDPEKRF 256
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 36/293 (12%)
Query: 453 FTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIR 504
+ +G G +G V + VAVK+L+ A E+++L I
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 505 H-PNMVLLLGACPEYG---IIVYEYLANGSLDDRIFRRGNTP-------------PLSWQ 547
H N+V LLGAC + G +++ E+ G+L + + N L+ +
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
+ ++A G+ FL +HRDL NILL V KI D GLAR + ++
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY---KDP 188
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN 667
++ PE + ++SDV+S G+LL ++ + + I+
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDE 244
Query: 668 GTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720
+ + T P T + L C RP ++V L L +
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE-HLGNLLQ 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-42
Identities = 67/272 (24%), Positives = 109/272 (40%), Gaps = 13/272 (4%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQG-RSQFQREIEVLSCIRHPNMV 509
+T IGEG YG V Y ++ VA+K + P Q + REI++L RH N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 510 LLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
+ P + YL + +++ T LS +I GL ++H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-- 127
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRDLKP N+LL+ KI D GLAR+ ++ LT T Y PE
Sbjct: 128 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD--PDHDHTGFLTEYVATRWYRAPEIM 184
Query: 628 QTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEET 686
D++S+G +L ++++ + H+++ N LG + P+ D
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLNCIIN 242
Query: 687 LGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718
L L + L + L
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-41
Identities = 59/210 (28%), Positives = 83/210 (39%), Gaps = 19/210 (9%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAA---QGRSQFQREIEVLS-CIRHP 506
F + +G+G +G V+ T A+K L+ D E VLS HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 507 NMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
+ + E V EYL G L I + AAEI GL FLH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH 120
Query: 565 QTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDP 624
+V+RDLK NILLD + KI+D G+ + + + GT YI P
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN-----MLGDAKTNTFCGTPDYIAP 172
Query: 625 EYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
E D +S G+LL +++ + P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (374), Expect = 2e-40
Identities = 49/266 (18%), Positives = 95/266 (35%), Gaps = 27/266 (10%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
R+IGEG +G +++ L++ VA+K + Q + E + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 515 CPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLV 572
+ G ++ L SL+D + G S + A ++ + +H+ LV
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 573 HRDLKPGNILLD-----HNYVSKISDVGLARLV--PAVAENVTQYHLTSTAGTFCYIDPE 625
+RD+KP N L+ + + + D G+ + P +++ + +GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEE 685
+ D+ +LG + + + P + +GE T P E
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----PLRE 239
Query: 686 TLG-----FAKLALQCSELRRKDRPD 706
F K L PD
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPD 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 2e-40
Identities = 53/267 (19%), Positives = 91/267 (34%), Gaps = 21/267 (7%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
RKIG G +G +Y VA+K+ Q E ++ ++ + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 515 C---PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPL 571
C +Y ++V E L D F S + +A ++ + + ++H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 572 VHRDLKPGNIL---LDHNYVSKISDVGLARLV--PAVAENVTQYHLTSTAGTFCYIDPEY 626
+HRD+KP N L + I D GLA+ +++ + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAK--QPMGLTHFVERSIENGTLGEMLDPTVTDWPFE 684
+ D+ SLG +L+ + E + +M P
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK-G 243
Query: 685 ETLGFAKLALQCSELRRKDRPDLGKVV 711
FA C LR D+PD +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 1e-39
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 441 YTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAA---QGRSQFQR 495
Y+++D F R +G G +G V+ H A+KVL+ + +
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 496 EIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIA 553
E +LS + HP ++ + G + ++ +Y+ G L + + P A
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYA 110
Query: 554 AEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLT 613
AE+ L +LH + +++RDLKP NILLD N KI+D G A+ VP
Sbjct: 111 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTY 159
Query: 614 STAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ GT YI PE T D +S GIL+ +++ P
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-39
Identities = 68/277 (24%), Positives = 107/277 (38%), Gaps = 28/277 (10%)
Query: 457 RKIGEGGYGPVYKCY---LDHTPVAVKVLRPDAAQG--RSQFQREIEV---LSCIRHPNM 508
+IGEG YG V+K VA+K +R + RE+ V L HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 509 VLLLGACPE-------YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLL 561
V L C +V+E++ P + + + ++ GL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLD 130
Query: 562 FLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
FLH +VHRDLKP NIL+ + K++D GLAR+ Q LTS T Y
Sbjct: 131 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTLWY 181
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDW 681
PE D++S+G + ++ K + V+ L + P DW
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEEDW 239
Query: 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718
P + L + ++ K D+ ++ L +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 9e-39
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAA---QGRSQFQRE---IEVLSCIR 504
F+ R IG GG+G VY C T A+K L QG + E + ++S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 505 HPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
P +V + A P+ + + + G L + + G S AAEI GL
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEH 122
Query: 563 LHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYI 622
+H +V+RDLKP NILLD + +ISD+GLA + ++ ++ GT Y+
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC-------DFSKKKPHASVGTHGYM 172
Query: 623 DPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPM 655
PE Q G+ +D +SLG +L +L+ P
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 60/209 (28%), Positives = 86/209 (41%), Gaps = 17/209 (8%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNM 508
F + KIGEG YG VYK L VA+K +R D S REI +L + HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 509 VLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
V LL +V+E+L + ++ GL F H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPE- 625
++HRDLKP N+L++ K++D GLAR V T T Y PE
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVVTLWYRAPEI 173
Query: 626 YQQTGMLGVKSDVYSLGILLLQLITAKQP 654
D++SLG + +++T +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-37
Identities = 44/213 (20%), Positives = 84/213 (39%), Gaps = 23/213 (10%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVL 510
+T+++ IG G +G VY+ L + VA+K + D + RE++++ + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 511 LLGACPEYG--------IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLF 562
L G +V +Y+ L ++ L +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 563 LHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCY 621
+H + HRD+KP N+LLD + V K+ D G A+ + + +++ +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYR 189
Query: 622 IDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
DV+S G +L +L+ +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 39/284 (13%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG------ 489
+R+ ++D ++ ++G G + V KC T A K ++ +
Sbjct: 3 FRQENVDD------YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 56
Query: 490 RSQFQREIEVLSCIRHPNMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
R +RE+ +L I+HPN++ L I++ E +A G L D + + L+ +
Sbjct: 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEE 113
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS----KISDVGLARLVPAV 603
+ +I G+ +LH + H DLKP NI+L V KI D GLA +
Sbjct: 114 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-- 168
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE- 662
+ GT ++ PE LG+++D++S+G++ L++ P E
Sbjct: 169 ----FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224
Query: 663 -RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705
++ E D ++ + K R
Sbjct: 225 LANVSAVN-YEFEDEYFSNTSAL----AKDFIRRLLVKDPKKRM 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-37
Identities = 61/288 (21%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 436 LRYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQGRSQF 493
L+ ++ I D + S+ +G G G V + + T A+K+L+ +
Sbjct: 2 LQIKKNAIID-----DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKA 51
Query: 494 QREIEVLS-CIRHPNMVLLLGAC------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSW 546
+RE+E+ + P++V ++ + +IV E L G L RI RG+ +
Sbjct: 52 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTE 110
Query: 547 QQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGLARLVPAV 603
++ I I + +LH + HRD+KP N+L N + K++D G A+ +
Sbjct: 111 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
Query: 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP------MGL 657
T + T Y+ PE D++SLG+++ L+ P + +
Sbjct: 168 NSLTTPCY------TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 658 THFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRP 705
+ ++ I G E +P ++ E L + R
Sbjct: 222 SPGMKTRIRMGQY-EFPNPEWSEVSEE----VKMLIRNLLKTEPTQRM 264
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-36
Identities = 54/293 (18%), Positives = 98/293 (33%), Gaps = 29/293 (9%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAA--QGRSQF 493
YR+ + E + + + +G G YG V VA+K L +
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 494 QREIEVLSCIRHPNMVLLLGACPEYG--------IIVYEYLANGSLDDRIFRRGNTPPLS 545
RE+ +L +RH N++ LL +V ++ G+ ++ + L
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLG 119
Query: 546 WQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605
+ + ++ GL ++H HRDLKPGN+ ++ + KI D GLAR
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR------- 169
Query: 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI 665
+ D++S+G ++ ++IT K +
Sbjct: 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQ 227
Query: 666 ENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718
+ P ++ EL +KD + P L
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 58/258 (22%), Positives = 107/258 (41%), Gaps = 26/258 (10%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG--RSQFQREIEVLSCIRHPNM 508
+ + KIG+G +G V+K T VA+K + + + REI++L ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 509 VLLLGACPEYG----------IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIAT 558
V L+ C +V+++ + + + R+ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLN 128
Query: 559 GLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
GL ++H+ K ++HRD+K N+L+ + V K++D GLAR +A+N T+ T
Sbjct: 129 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS-LAKNSQPNRYTNRVVT 184
Query: 619 FCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPM----GLTHFVERSIENGTLGEM 673
Y PE G D++ G ++ ++ T M S G++
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 674 LDPTVTDWPFEETLGFAK 691
+ P V ++ E L K
Sbjct: 245 VWPNVDNYELYEKLELVK 262
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 457 RKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAAQG-----RSQFQREIEVLSCIRHPNMV 509
+GEG + VYK +T VA+K ++ REI++L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 510 LLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
LL A +V++++ L+ GL +LHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ-- 118
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRDLKP N+LLD N V K++D GLA+ + T T Y PE
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-----PNRAYTHQVVTRWYRAPELL 172
Query: 628 QTGML-GVKSDVYSLGILLLQLITAKQP 654
+ GV D++++G +L +L+
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 135 bits (339), Expect = 7e-36
Identities = 47/207 (22%), Positives = 83/207 (40%), Gaps = 15/207 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYLDHT-PVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMV 509
+ KIGEG YG VYK ++ A+K +R + S REI +L ++H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 510 LLLGACPE--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK 567
L ++V+E+L G L ++ G+ + H +
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 568 PEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQ 627
++HRDLKP N+L++ KI+D GLAR + + +
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 628 QTGMLGVKSDVYSLGILLLQLITAKQP 654
+ D++S+G + +++
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-35
Identities = 48/212 (22%), Positives = 80/212 (37%), Gaps = 26/212 (12%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQG------RSQFQREIEVLSCIR--HP 506
+G GG+G VY D+ PVA+K + D ++ E+ +L +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 507 NMVLLLGAC--PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLH 564
++ LL P+ +++ E L + ++ + H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH 127
Query: 565 QTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYID 623
++HRD+K NIL+D N K+ D G L+ T GT Y
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-------DTVYTDFDGTRVYSP 177
Query: 624 PEYQQTGML-GVKSDVYSLGILLLQLITAKQP 654
PE+ + G + V+SLGILL ++ P
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 5e-35
Identities = 62/343 (18%), Positives = 117/343 (34%), Gaps = 55/343 (16%)
Query: 396 AEAAKRIAELEAQRRLSAEMNRLKESDEVKIASSNLSTKDLRYRRYTIEDIEEATQFFTE 455
A AAK+ +E E+ + A K ++ S + ++
Sbjct: 3 AAAAKKGSEQESVKEFLA-----KAKEDFLKKWETPSQNTAQLDQFDRI----------- 46
Query: 456 SRKIGEGGYGPVYKCYLDHT--PVAVKVLRPDAA---QGRSQFQREIEVLSCIRHPNMVL 510
+ +G G +G V + A+K+L + E +L + P +V
Sbjct: 47 -KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 511 LLGACPEYGII--VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKP 568
L + + + V EY+A G + + R G S AA+I +LH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 569 EPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
L++RDLKP N+L+D +++D G A+ + + GT + PE
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWTLCGTPEALAPEIIL 211
Query: 629 TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLG 688
+ D ++LG+L+ ++ P F + E + +P +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQ--IYEKIVSGKVRFPSHFSSD 264
Query: 689 FAKLALQCSELRRKDRPDLGKVVLPELNRLRELADESMGQTFF 731
L ++ R L+ ++ +F
Sbjct: 265 LKDLLRNLLQVDLTKRF----------GNLKNGVNDIKNHKWF 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-35
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 16/208 (7%)
Query: 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNM 508
+ + KIGEG YG V+K H VA+K +R D S REI +L ++H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 509 VLLLGACPE--YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQT 566
V L +V+E+ G+ + ++ GL F H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSR 120
Query: 567 KPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEY 626
++HRDLKP N+L++ N K+++ GLAR + +T +
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT----LWYRPPDVL 173
Query: 627 QQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ D++S G + +L A +P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 440 RYTIEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGR---SQFQ 494
+ T+ D F + +G+G +G V A+K+LR + + +
Sbjct: 1 KVTMND-------FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 53
Query: 495 REIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRI 552
E VL RHP + L A + V EY G L + R + ++
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFY 110
Query: 553 AAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHL 612
AEI + L +LH +V+RD+K N++LD + KI+D GL + + +
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-----DGATM 162
Query: 613 TSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
+ GT Y+ PE + G D + LG+++ +++ + P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 7e-31
Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 23/227 (10%)
Query: 438 YRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAA--QGRSQF 493
YR+ + I E + + +G G YG V + VAVK L +
Sbjct: 5 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 64
Query: 494 QREIEVLSCIRHPNMVLLLGAC------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQ 547
RE+ +L ++H N++ LL E+ + G+ + I + L+
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDD 121
Query: 548 QRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607
+ +I GL ++H ++HRDLKP N+ ++ + KI D GLAR +
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HT 171
Query: 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
A + D++S+G ++ +L+T +
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-30
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLG 513
RK+G G Y V++ ++ V VK+L+P + + +REI++L +R PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 514 ACPE----YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPE 569
+ +V+E++ N L+ EI L + H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 570 PLVHRDLKPGNILLDH-NYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQ 628
++HRD+KP N+++DH + ++ D GLA E + + PE
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY------NVRVASRYFKGPELLV 202
Query: 629 TGML-GVKSDVYSLGILLLQLITAKQP 654
+ D++SLG +L +I K+P
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-30
Identities = 47/214 (21%), Positives = 81/214 (37%), Gaps = 27/214 (12%)
Query: 453 FTESRKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNM 508
+ + IG G G V Y + VA+K L + RE+ ++ C+ H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 509 VLLLGAC--------PEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGL 560
+ LL + +V E + ++ + ++ G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGI 132
Query: 561 LFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFC 620
LH +HRDLKP NI++ + KI D GLAR T + +T T
Sbjct: 133 KHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG------TSFMMTPYVVTRY 183
Query: 621 YIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQP 654
Y PE D++S+G ++ +++ K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 5e-29
Identities = 70/302 (23%), Positives = 113/302 (37%), Gaps = 36/302 (11%)
Query: 430 NLSTKDL--RYRRYTIEDIEEATQFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVL 482
L T +L + IE+ F + +G G YG V+ A+KVL
Sbjct: 8 ELRTANLTGHAEKVGIEN-------FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60
Query: 483 RP----DAAQGRSQFQREIEVLSCIRH-PNMVLLLGAC--PEYGIIVYEYLANGSLDDRI 535
+ A+ + E +VL IR P +V L A ++ +Y+ G L +
Sbjct: 61 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 536 FRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595
+R + + EI L LH+ +++RD+K NILLD N ++D G
Sbjct: 121 SQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 174
Query: 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGV--KSDVYSLGILLLQLITAKQ 653
L++ A GT Y+ P+ + G G D +SLG+L+ +L+T
Sbjct: 175 LSKEFVADETERAYDF----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
Query: 654 PMGLTHFVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713
P + E +P +P E + L + K R G
Sbjct: 231 PFTVDGEKNSQAEISRRILKSEP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
Query: 714 EL 715
E+
Sbjct: 288 EI 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 5e-27
Identities = 46/291 (15%), Positives = 109/291 (37%), Gaps = 29/291 (9%)
Query: 457 RKIGEGGYGPVYKCY--LDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGA 514
RK+G G + V+ +++T VA+K++R D + EI++L + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 515 CPEYGIIVYEYLA---------------NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATG 559
+ + + ++ G + ++ + +I+ ++ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 560 LLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPAVAENVTQYHLTSTAGT 618
L ++H+ ++H D+KP N+L++ + + +A L A + + + T
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---SIQT 192
Query: 619 FCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD--- 675
Y PE G +D++S L+ +LIT + ++ + ++++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 676 --PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRELADE 724
P+ + T F + + L V+ + ++ A E
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 1e-20
Identities = 20/153 (13%), Positives = 40/153 (26%), Gaps = 19/153 (12%)
Query: 457 RKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRS----------QFQREIEVLSCIRH 505
+ +GEG V+ CY VK + + F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 506 PNMVLLLGACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ 565
+ L G ++ + + + + I + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 566 TKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598
+VH DL N+L+ + I D +
Sbjct: 122 ---RGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 171 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 61.4 bits (148), Expect = 1e-11
Identities = 25/159 (15%), Positives = 51/159 (32%), Gaps = 14/159 (8%)
Query: 18 IAVAVD---------KDKSSQHALKWAADNLLNRGQTVVLIHV--AQRTSVSSVSSQSQV 66
+ VAV+ S + A +W + ++ + I + Q +
Sbjct: 4 VMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSI 63
Query: 67 YDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIE 126
Y + ++ + L F C + C ++ D I + V +
Sbjct: 64 YASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCE-AWIKTGDPKDVICQEVKRVRPD 122
Query: 127 DLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165
LV+G+ F + F V + K A C + + +
Sbjct: 123 FLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTIKR 159
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} Length = 147 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 51.1 bits (121), Expect = 3e-08
Identities = 20/146 (13%), Positives = 45/146 (30%), Gaps = 9/146 (6%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
+ V D SS A+ AA + ++ + + + + ++
Sbjct: 8 VVVGTDGSDSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADILKDES-------YK 60
Query: 78 KQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHG 137
I ++ + K + V A+ + LV+G
Sbjct: 61 VTGTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLST 120
Query: 138 FIRKFKADVPSSVSKAAPDFCNIYVV 163
+ VP++VS+ A ++ +V
Sbjct: 121 IAGRLLGSVPANVSRRAK--VDVLIV 144
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Score = 47.6 bits (112), Expect = 4e-07
Identities = 20/146 (13%), Positives = 44/146 (30%), Gaps = 14/146 (9%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
I +A D + ++ A + A G ++++H + +
Sbjct: 4 ILLAYDGSEHARRAAEVAKAEAEAHGARLIVVH------------AYEPVPDYLGEPFFE 51
Query: 78 KQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHG 137
+ +++ + D LL + +AI + + +V+G
Sbjct: 52 EALRRRLERAEGVLEEARALTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGA 111
Query: 138 FIRKFKADVPSSVSKAAPDFCNIYVV 163
F V AP C + +V
Sbjct: 112 LGSLFLGSQSQRVVAEAP--CPVLLV 135
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} Length = 160 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Score = 46.9 bits (110), Expect = 1e-06
Identities = 19/153 (12%), Positives = 53/153 (34%), Gaps = 10/153 (6%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
I D ++++ ALK + + V+L+HV + S + + +
Sbjct: 6 ILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVE 65
Query: 78 KQPD-------KQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVL 130
+ + ++ ++ + K D+++ + I + ++ +++
Sbjct: 66 EFENELKNKLTEEAKNKMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIM 124
Query: 131 GAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163
G+ + V +V K + + VV
Sbjct: 125 GSHGKTNLKEILLGSVTENVIKKSN--KPVLVV 155
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} Length = 140 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Score = 41.9 bits (97), Expect = 4e-05
Identities = 22/146 (15%), Positives = 38/146 (26%), Gaps = 14/146 (9%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
I VAVD + S LK A + +IHV
Sbjct: 5 ILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDV---------NFSDLYTGLIDVNMS 55
Query: 78 KQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHG 137
D+ + D + L D+ + +++ + ++ LV G
Sbjct: 56 SMQDRISTETQKALLDLAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFW 115
Query: 138 FIRKFKADVPSSVSKAAPDFCNIYVV 163
V ++ VV
Sbjct: 116 SKL---MSSTRQVMNTIK--IDMLVV 136
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} Length = 138 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Score = 40.1 bits (92), Expect = 2e-04
Identities = 13/136 (9%), Positives = 38/136 (27%), Gaps = 5/136 (3%)
Query: 18 IAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQ 77
+ V D + A+ +A + G + ++ V + ++ +
Sbjct: 7 LLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEES 66
Query: 78 KQPDKQIRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHG 137
K+ ++ T + + ++ K + E +V
Sbjct: 67 KKRIERRLREVWEKLTGSTEIPGVEYRIGPLSEEVKKFVEGKG----YELVVWACYPSAY 122
Query: 138 FIRKF-KADVPSSVSK 152
+ ++ S + K
Sbjct: 123 LCKVIDGLNLASLIVK 138
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.89 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.88 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.85 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.82 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.77 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.74 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.77 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.45 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 93.18 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 84.92 | |
| d1np7a2 | 204 | Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: | 82.47 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 80.29 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=428.44 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=204.1
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~ 527 (782)
++|...+.||+|+||+||+|.+.+ .||||+++.. .....+.|.+|+.+|++++|||||+++|++.+.. ++||||++
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCE 86 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCC
Confidence 568889999999999999998754 5999999754 3445678999999999999999999999986554 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++...+ ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 87 ~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~--- 158 (276)
T d1uwha_ 87 GSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS--- 158 (276)
T ss_dssp EEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC---
Confidence 999999997554 34999999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccccCCcccCChhhhhc---CCCCCchhHHHHHHHHHHHHhCCCCCCChH---HHHHHHHhCcccccCCCCCCCC
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQLITAKQPMGLTH---FVERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~---~~~~~~~~~~~~~~ld~~~~~~ 681 (782)
.....+...||+.|||||++.+ +.|+.++|||||||+||||+||+.||.... .....+..+.. .|.....
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~p~~~~~ 234 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL----SPDLSKV 234 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC----CCCGGGS
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----CCcchhc
Confidence 2223355789999999999864 358999999999999999999999996533 22333333332 2333334
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
+...+..+.+|+.+||+.+|.+||++.+++. .|+.++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~-~Le~l~ 271 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILA-SIELLA 271 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHH-HHHHHH
Confidence 4455667999999999999999999998873 555554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=419.68 Aligned_cols=240 Identities=29% Similarity=0.431 Sum_probs=203.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|++.+.||+|+||+||+|.+ +++.||||++.+.. ......+.+|+.+|+.++|||||++++++.+.. |+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 499999999999999999998 46789999996532 223567899999999999999999999997655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+++|+|.+++.+.+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 87 y~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-- 158 (263)
T d2j4za1 87 YAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 158 (263)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred ecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC--
Confidence 999999999997654 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.......||+.|||||++.+..|+.++|||||||+||||++|+.||....... ..+..+. ...|
T Consensus 159 -----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------~~~p 224 (263)
T d2j4za1 159 -----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------FTFP 224 (263)
T ss_dssp -----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------CCCC
T ss_pred -----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CCCC
Confidence 12234689999999999999999999999999999999999999997654432 2222221 1233
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+..+.+|+.+||+.||.+||++.+++.+
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 4455679999999999999999999999853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-49 Score=426.09 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=192.8
Q ss_pred cccccceeeeeCcEeEEEEEEC--C---eeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--H---TPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~---~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
+|...++||+|+||+||+|.+. + ..||||.+... .....+.|.+|+.+|++++|||||+++|+|.+.. ++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4566789999999999999973 2 25899998764 3345678999999999999999999999996544 9999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|||++|+|.+++.... ..+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 107 Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999886543 35999999999999999999999999 999999999999999999999999999977543
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
.............||+.|||||++.++.|+.++|||||||+||||+| |+.||......+ ..+..+. ...
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~--------~~~ 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY--------RLP 253 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------CCC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCC
Confidence 22222222334568999999999999999999999999999999998 899997544322 2222221 112
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.|...+..+.+|+.+||+.+|++||++.+++. .|+++
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~-~L~~~ 290 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN-TLDKM 290 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH-HHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH-HHHHH
Confidence 34455667999999999999999999999873 55544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=423.66 Aligned_cols=242 Identities=27% Similarity=0.400 Sum_probs=205.0
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
+|+..+.||+|+||+||+|.+ +++.||||+++.......+.+.+|+.+|+.++|||||+++++|.+.. |+||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 588899999999999999997 57899999997665555678999999999999999999999986544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++.+. .+++.++..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 101 gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred CCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 99999977543 3899999999999999999999999 999999999999999999999999999876321
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.......+||+.|+|||++.++.|+.++|||||||++|+|++|+.||........ ....+. +.. ..|..
T Consensus 170 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~------~~~-~~~~~ 241 (293)
T d1yhwa1 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------PEL-QNPEK 241 (293)
T ss_dssp -TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS------CCC-SSGGG
T ss_pred -cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------CCC-CCccc
Confidence 2233456899999999999999999999999999999999999999975544332 222221 111 22344
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.+..+.+|+.+||+.||.+||++.+++.
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 5667999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=421.58 Aligned_cols=246 Identities=24% Similarity=0.301 Sum_probs=198.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|++.+.||+|+||+||+|.+ +++.||||++.... ....+.|.+|+.+|++++|||||++++++.+.. ||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4699999999999999999998 47799999997653 233567899999999999999999999996655 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++... ..+++.++..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~- 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 157 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC-
Confidence 9999999988543 35999999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHH---HHHHHhCcccccCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFV---ERSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~ld~~~~~~ 681 (782)
.....+..+||+.|||||++.+..+ +.++|||||||++|||+||+.||...... ...+..... ....
T Consensus 158 --~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------~~~~ 228 (271)
T d1nvra_ 158 --RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YLNP 228 (271)
T ss_dssp --EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-------TSTT
T ss_pred --ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------CCCc
Confidence 1223456789999999999988776 67899999999999999999999643221 111111110 0111
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+..+.+|+.+||+.+|++||++.+++.
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1234456889999999999999999998873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=420.88 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=204.6
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+.|++.+.||+|+||.||+|.+ ++..||||++........+.|.+|+++|++++|||||+++++|.+.. |+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3589999999999999999998 56789999998766666788999999999999999999999986544 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.+.. .++++.++..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--- 163 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH---
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC---
Confidence 9999999886654 34999999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccccccccCCcccCChhhhh-----cCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
........||+.|+|||++. ...|+.++|||||||++|||+||+.||......+ ..+..+.. + ..
T Consensus 164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-----~-~~ 235 (288)
T d2jfla1 164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-----P-TL 235 (288)
T ss_dssp --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-----C-CC
T ss_pred --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----C-CC
Confidence 12234578999999999884 4568999999999999999999999996543222 11222211 1 11
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..|...+..+.+|+.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223445667999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=418.53 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=195.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC--c--cEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE--Y--GIIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~--~~lV 522 (782)
++|++.+.||+|+||.||+|.+ +++.||||++.... ....+.|.+|+++|++++|||||+++++|.+ . .|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4599999999999999999998 57799999997653 3345678999999999999999999998843 2 3899
Q ss_pred EEeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC--CCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 523 YEYLANGSLDDRIFRR-GNTPPLSWQQRFRIAAEIATGLLFLHQTKP--EPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~--~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|||+++|+|.+++.+. .....+++..++.|+.||+.||.|||+.++ .+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988653 223469999999999999999999998652 3499999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCC
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPT 677 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 677 (782)
+... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+ ..+..+.+.
T Consensus 164 ~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~------ 232 (269)
T d2java1 164 LNHD-----TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------ 232 (269)
T ss_dssp C----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------
T ss_pred cccC-----CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 6421 122345789999999999999999999999999999999999999997654432 223333322
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..|...+.++.+|+.+||+.||.+||++.+++.
T Consensus 233 --~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 223344557999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=418.59 Aligned_cols=245 Identities=29% Similarity=0.438 Sum_probs=201.5
Q ss_pred hccccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCC
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLA 527 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~ 527 (782)
.++|.+.+.||+|+||.||+|.+. ++.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+.. ++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 356889999999999999999994 5789999997653 34568999999999999999999999986654 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++..... ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~---- 162 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN---- 162 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS----
T ss_pred CCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC----
Confidence 9999997754432 34899999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCC-CCCChHHH--HHHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQ-PMGLTHFV--ERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.....+...||+.|||||++.++.++.++|||||||++|||+||.. ||...... ...+..+. .+ ..|..
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-----~~---~~p~~ 234 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----RM---VRPDN 234 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----CC---CCCTT
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----CC---CCccc
Confidence 1223345679999999999999999999999999999999999654 55433322 22222221 11 22334
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.+..+.+|+.+||+.+|++||++.+++
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~ 261 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLR 261 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 456799999999999999999999887
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=412.68 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=196.0
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--cEEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--GIIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~~ 527 (782)
++|+..+.||+|+||.||+|.+ +++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+. .++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 3588899999999999999998 56789999997653 3457899999999999999999999999644 499999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++.... ..+++..++.|+.|||.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~--- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 155 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC---
Confidence 999999886543 35899999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
........||+.|+|||++.++.|+.++|||||||++|||+| |.+||...... ...+..+. . ...|..
T Consensus 156 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-----~---~~~p~~ 226 (263)
T d1sm2a_ 156 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----R---LYKPRL 226 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-----C---CCCCTT
T ss_pred -ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-----C---CCCccc
Confidence 122234679999999999999999999999999999999999 56666544332 22233321 1 112334
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
.+..+.+|+.+||+.+|.+||++++++. .|+.+.+
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~-~L~~i~e 261 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLR-QLAEIAE 261 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHH-HHHHHHh
Confidence 4567999999999999999999999874 5666543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=413.25 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=202.5
Q ss_pred ccccccc-eeeeeCcEeEEEEEEC----CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEE
Q 040785 451 QFFTESR-KIGEGGYGPVYKCYLD----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVY 523 (782)
Q Consensus 451 ~~f~~~~-~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 523 (782)
++|.... +||+|+||.||+|.+. +..||||+++... ....+.|.+|+++|++++|||||+++|+|.+.. ||||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 3466666 4999999999999762 3479999997653 344678999999999999999999999996544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++.... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999875443 35999999999999999999999999 999999999999999999999999999877432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~ 680 (782)
.. .........||+.|+|||++.++.++.++|||||||++|||+| |+.||...... ...+..+.. ..
T Consensus 163 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~--------~~ 232 (285)
T d1u59a_ 163 DS--YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------ME 232 (285)
T ss_dssp SC--EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------CC
T ss_pred cc--ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CC
Confidence 21 2222345679999999999999999999999999999999998 99999654322 233333321 22
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
.|...+..+.+|+.+||+.+|++||++.+++
T Consensus 233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 3445566799999999999999999999887
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-49 Score=418.16 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=202.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|...+.||+|+||+||+|.+ +++.||||+++.+. ...+.|.+|+.+|++++|||||+++|+|.+.. ++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 35689999999999999999998 47789999997653 34578999999999999999999999996544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+++|+|.+++..... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 95 ~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (287)
T d1opja_ 95 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-- 168 (287)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS--
T ss_pred ccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC--
Confidence 999999999876533 46999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCC-CChHH--HHHHHHhCcccccCCCCCCCCC
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM-GLTHF--VERSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf-~~~~~--~~~~~~~~~~~~~ld~~~~~~p 682 (782)
.....+...||+.|+|||++.++.|+.++|||||||++|||++|..|| ..... ....+..+. . ...|
T Consensus 169 --~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-----~---~~~~ 238 (287)
T d1opja_ 169 --TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----R---MERP 238 (287)
T ss_dssp --SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----C---CCCC
T ss_pred --CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-----C---CCCC
Confidence 112234456899999999999999999999999999999999976665 33222 122233321 1 1233
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
...+..+.+|+.+||+.+|++||++.+++
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~ 267 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIH 267 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 44556799999999999999999999886
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=423.63 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=200.9
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.++|++.++||+|+||+||+|.+ ++..||||+++... ......+.+|+.+|+.++|||||+++++|.+.. |+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45799999999999999999998 57899999997653 333567999999999999999999999996655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|+++|+|.+++.+.+ .+++..+..++.||+.||.|||+ ++ ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999999997654 48999999999999999999997 48 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH-----hCccccc-----
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE-----NGTLGEM----- 673 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~-----~~~~~~~----- 673 (782)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........... .+.....
T Consensus 158 ------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 158 ------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp ------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred ------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 122356899999999999999999999999999999999999999954321110000 0000000
Q ss_pred --------------------------CCCCCCCCC-hhHHHHHHHHHHHhhccCcCCCCChHHhhhHHH
Q 040785 674 --------------------------LDPTVTDWP-FEETLGFAKLALQCSELRRKDRPDLGKVVLPEL 715 (782)
Q Consensus 674 --------------------------ld~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l 715 (782)
.....+..+ ...+.++.+|+.+||..||.+||++.+++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 000000011 112356899999999999999999999986544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=414.91 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=201.8
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|++.+.||+|+||+||+|.+ +++.||||++.... ......+.+|+++|++++|||||+++++|.+.. |+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 3599999999999999999998 57799999997532 223467899999999999999999999996654 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999887654 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
. ........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... ..+..+.+ .+
T Consensus 162 ~---~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------~~ 229 (288)
T d1uu3a_ 162 S---KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------DF 229 (288)
T ss_dssp -----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------CC
T ss_pred C---cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC---------CC
Confidence 1 2223345689999999999999999999999999999999999999997654332 22222221 23
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
|...+..+.+|+.+||+.||.+||++.+++.
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 3445567899999999999999999998863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=409.80 Aligned_cols=240 Identities=25% Similarity=0.397 Sum_probs=195.2
Q ss_pred ceeeeeCcEeEEEEEEC----CeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCCC
Q 040785 457 RKIGEGGYGPVYKCYLD----HTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLANG 529 (782)
Q Consensus 457 ~~LG~G~fg~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~g 529 (782)
++||+|+||.||+|.+. ++.||||+++... ....+.|.+|+.+|++++|||||+++|+|.+.. +|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999862 3579999997542 223567999999999999999999999996544 8999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccccc
Q 040785 530 SLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVTQ 609 (782)
Q Consensus 530 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 609 (782)
+|.+++.... .+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 93 ~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~--~~ 164 (277)
T d1xbba_ 93 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YY 164 (277)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS--EE
T ss_pred cHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc--cc
Confidence 9999886543 4999999999999999999999999 99999999999999999999999999987643211 11
Q ss_pred cccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChhHH
Q 040785 610 YHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFEET 686 (782)
Q Consensus 610 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~ 686 (782)
.......||+.|||||++.++.++.++|||||||++|||+| |+.||...... ...+..+. ....|...+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~--------~~~~p~~~~ 236 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------RMGCPAGCP 236 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCTTCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCcccC
Confidence 22334679999999999999999999999999999999998 89999754432 23333332 122344455
Q ss_pred HHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 687 LGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 687 ~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+.+|+.+||+.+|++||++.+++.
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 67999999999999999999998863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=405.51 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=194.4
Q ss_pred ccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccC------ccEEE
Q 040785 453 FTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE------YGIIV 522 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~lV 522 (782)
|...++||+|+||+||+|.+ ++..||+|++... .....+.|.+|+++|++++|||||+++++|.+ ..|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 35567899999999999998 4668999998654 23446679999999999999999999999843 13899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc-CCCceeeeccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD-HNYVSKISDVGLARLVP 601 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld-~~~~~kL~DFGla~~~~ 601 (782)
|||+++|+|.+++.+.. .+++..+..|+.||+.||.|||+++ .+||||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999997654 4899999999999999999999976 3499999999999996 58899999999998642
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH---HHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE---RSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~ld~~~ 678 (782)
. ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||....... ..+..+.. +
T Consensus 167 ~-------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~-----~-- 231 (270)
T d1t4ha_ 167 A-------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----P-- 231 (270)
T ss_dssp T-------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----C--
T ss_pred C-------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC-----C--
Confidence 1 12235689999999998764 69999999999999999999999996433222 22222211 1
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..++...+.++.+|+.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112223456899999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=407.77 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=196.2
Q ss_pred ccccccceeeeeCcEeEEEEEECC------eeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH------TPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 521 (782)
+.|+..++||+|+||.||+|.+.. ..||||+++... ......|.+|+.+|++++|||||+++|+|.+.. ++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 348888999999999999998732 369999997653 334567999999999999999999999996544 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+.+|++.+.+.... ..+++.+++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999998876544 35999999999999999999999999 9999999999999999999999999998764
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCC-CChHH--HHHHHHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM-GLTHF--VERSIENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf-~~~~~--~~~~~~~~~~~~~ld~~~ 678 (782)
.... .........||+.|||||++.++.++.++|||||||++|||++|..|| ..... ....+..+. .
T Consensus 162 ~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~--------~ 231 (283)
T d1mqba_ 162 DDPE--ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF--------R 231 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------C
T ss_pred CCCc--cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC--------C
Confidence 3211 122234457899999999999999999999999999999999965554 32222 222233321 1
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
...|...+..+.+|+.+||+.+|++||++.+++ ..|+.+.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil-~~L~~l~ 271 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIV-SILDKLI 271 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHH-HHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHH-HHHHHHh
Confidence 223445566799999999999999999999887 3565554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-48 Score=414.39 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=198.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
..|+.++.||+|+||+||+|.+ +++.||||++.... ....+.|.+|+.+|++++|||||+++++|.+.. |+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999998 57789999997643 233567899999999999999999999986544 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|||++|+|..++... .++++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999997665443 35999999999999999999999999 99999999999999999999999999986521
Q ss_pred cccccccccccccCCcccCChhhhhc---CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--HHhCcccccCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--IENGTLGEMLDPTV 678 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~ 678 (782)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||......... +..+.... .
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-----~ 234 (309)
T d1u5ra_ 168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-----L 234 (309)
T ss_dssp --------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----C
T ss_pred --------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-----C
Confidence 234679999999998864 45899999999999999999999999655443322 12222111 1
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+...+..+.+|+.+||+.||.+||++.+++.+
T Consensus 235 --~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 112234569999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=401.05 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=205.1
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 527 (782)
++|+..++||+|+||+||+|.+ +++.||||+++.... ..+.|.+|+.++++++||||++++|+|.+.. ++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 4688899999999999999999 466899999987543 3568999999999999999999999997544 89999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.+++..... .+++..+++|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~---- 153 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 153 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS----
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC----
Confidence 9999998765543 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
.........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ..+..+. ....|..
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~--------~~~~p~~ 225 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL--------RLYRPHL 225 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--------CCCCCTT
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC--------CCCCccc
Confidence 1223344679999999999999999999999999999999998 899997655432 2232221 1122334
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+..+.+|+.+||+.+|++||++.+++.+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 45679999999999999999999988854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-48 Score=414.51 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=188.0
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
.+.|++.+.||+|+||+||+|.+ +++.||||++..... .....+.+|+.+|+.++|||||++++++.+.. |||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45699999999999999999998 477899999976532 23456889999999999999999999997655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeeeccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARLVP 601 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~DFGla~~~~ 601 (782)
||+||+|.+++...+ .+++.++..|+.||+.||.|||+++ ||||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999996543 5999999999999999999999999 99999999999994 57899999999998663
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVT 679 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 679 (782)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||....... ..+..+... +. .
T Consensus 162 ~~------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~---~ 230 (307)
T d1a06a_ 162 PG------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FD---S 230 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC--CC---T
T ss_pred CC------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CC---C
Confidence 21 12345689999999999999999999999999999999999999997654332 222222211 11 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
..+...+..+.+|+.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 122344556999999999999999999998873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=416.42 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=201.6
Q ss_pred hccccccceeeeeCcEeEEEEEECC-------eeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLDH-------TPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 519 (782)
.++|...+.||+|+||+||+|.+.+ ..||||.+.... ......|.+|+.+|.++ +|||||+++|+|.+..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3568999999999999999998732 259999986543 33456789999999998 8999999999996654
Q ss_pred -EEEEEeCCCCChhHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN--------------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKP 578 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp 578 (782)
|+|||||++|+|.++|..... ...+++..++.|+.||+.||.|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 999999999999999975432 235899999999999999999999999 99999999
Q ss_pred ceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 040785 579 GNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGL 657 (782)
Q Consensus 579 ~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~ 657 (782)
+|||++.++.+||+|||+|+...... .....+...||+.|||||++.++.|+.++|||||||+||||+| |++||..
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hccccccCCeEEEeeccccccccCCC---ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 99999999999999999998764322 2223345678999999999999999999999999999999998 8999964
Q ss_pred hH---HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 658 TH---FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 658 ~~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. .....+..+. . .+.|...+..+.+|+.+||+.+|++||++.+++.
T Consensus 270 ~~~~~~~~~~~~~~~-----~---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 270 IPVDANFYKLIQNGF-----K---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp CCCSHHHHHHHHTTC-----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHhcCC-----C---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 32 2233333321 1 1234455567999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-47 Score=418.62 Aligned_cols=246 Identities=21% Similarity=0.351 Sum_probs=205.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++........+.+.+|+.+|++++|||||+++++|.+.. |||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999998 57899999998776666788999999999999999999999986654 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc--CCCceeeecccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD--HNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld--~~~~~kL~DFGla~~~~~~~ 604 (782)
++|+|.+.+.... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 106 ~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 106 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999885443 34999999999999999999999999 99999999999995 4688999999999876421
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.......||+.|||||++.+..|+.++|||||||++|+|++|+.||...+..+ ..+..+... +. ...+
T Consensus 180 -----~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~---~~~~ 249 (350)
T d1koaa2 180 -----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MD---DSAF 249 (350)
T ss_dssp -----SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SC---CGGG
T ss_pred -----cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CC---cccc
Confidence 22245689999999999999999999999999999999999999997654332 222222211 01 1112
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+|+.+||..||++||++.+++.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234557999999999999999999998874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-47 Score=417.52 Aligned_cols=246 Identities=20% Similarity=0.330 Sum_probs=206.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEeC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEYL 526 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 526 (782)
+.|++.+.||+|+||.||+|.+ +++.||||+++.........+.+|+.+|++++|||||+++++|.+.. |||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999998 57899999998776666778999999999999999999999996655 8999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc--CCCceeeecccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD--HNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld--~~~~~kL~DFGla~~~~~~~ 604 (782)
++|+|.+.+...+ .+|++.+++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 109 SGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999998775443 35999999999999999999999999 99999999999997 6789999999999876421
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.......||+.|+|||++.+..|+.++|||||||++|+|+||+.||....... ..+..+... +. ...+
T Consensus 183 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~~---~~~~ 252 (352)
T d1koba_ 183 -----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE--FD---EDAF 252 (352)
T ss_dssp -----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC--CC---SSTT
T ss_pred -----CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CC---cccc
Confidence 22345679999999999999999999999999999999999999997654433 222233221 11 1122
Q ss_pred hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+..+.+|+.+||+.||.+||++.+++.
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 334556899999999999999999998874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-47 Score=407.38 Aligned_cols=255 Identities=30% Similarity=0.466 Sum_probs=206.8
Q ss_pred HhccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCch-hhHHHHHHHHHHHHhcCCCCeeeecccccCcc-
Q 040785 449 ATQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDAA-QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG- 519 (782)
Q Consensus 449 ~t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 519 (782)
..++|++.+.||+|+||+||+|++. ++.||||+++.... ...+.|.+|+.+|++++||||+.++++|.+..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3567999999999999999999874 36899999976543 34567999999999999999999999996544
Q ss_pred -EEEEEeCCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040785 520 -IIVYEYLANGSLDDRIFRRGN---------------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLK 577 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK 577 (782)
++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999965321 234899999999999999999999999 9999999
Q ss_pred CceEEEcCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCC-CCCC
Q 040785 578 PGNILLDHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAK-QPMG 656 (782)
Q Consensus 578 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~Pf~ 656 (782)
|+|||||.++.+||+|||+|+...... .....+...||+.|+|||++.+..|+.++|||||||++|||++|. +||.
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG---CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccceEECCCCcEEEccchhheeccCCc---cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999998653321 222334567999999999999999999999999999999999985 6776
Q ss_pred ChHHHH--HHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 657 LTHFVE--RSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 657 ~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.....+ ..+..+. ....|...+..+.+|+.+||+.+|++||++.+++ ..|+++
T Consensus 245 ~~~~~e~~~~v~~~~--------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~-~~L~~i 299 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIH-RILQRM 299 (301)
T ss_dssp TSCHHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHT
T ss_pred CCCHHHHHHHHHcCC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH-HHHHHh
Confidence 554432 2233332 2233445566799999999999999999999886 455554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=403.62 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=202.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch------hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA------QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 519 (782)
.++|.+.+.||+|+||+||+|.+ +++.||||++.+... ...+.|.+|+.+|++++|||||+++++|.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999998 477999999965321 13567999999999999999999999997655
Q ss_pred EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC----ceeeeccc
Q 040785 520 IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY----VSKISDVG 595 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~----~~kL~DFG 595 (782)
|||||||++|+|.+++...+ .+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 89999999999999987654 4999999999999999999999999 99999999999998776 59999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH--HHHhCccccc
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER--SIENGTLGEM 673 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ 673 (782)
+|+.+... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+..+....
T Consensus 163 ~a~~~~~~------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1jksa_ 163 LAHKIDFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF- 235 (293)
T ss_dssp TCEECTTS------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-
T ss_pred hhhhcCCC------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-
Confidence 99876321 223456899999999999999999999999999999999999999976544332 222221110
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 LDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+...+..+.+|+.+||+.||.+||++.+++.
T Consensus 236 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 ----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111233456899999999999999999998873
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=404.69 Aligned_cols=250 Identities=25% Similarity=0.425 Sum_probs=201.1
Q ss_pred cccccceeeeeCcEeEEEEEEC--Ce----eEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYLD--HT----PVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVY 523 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~~--~~----~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 523 (782)
.|+.+++||+|+||+||+|.+. ++ +||||.++.. .....+.|.+|+.+|++++|||||+++|+|.+.. +++|
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~ 89 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 89 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEE
Confidence 4999999999999999999873 32 5899998654 3344678999999999999999999999997655 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+.+|+|.+.+.... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 90 e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 9999999999887654 35999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHhCcccccCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH--FVERSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~ld~~~~~ 680 (782)
. .........||+.|+|||++.++.|+.++|||||||++|||+| |.+||.... .....+..+.. ..
T Consensus 165 ~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~--------~~ 233 (317)
T d1xkka_ 165 E---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--------LP 233 (317)
T ss_dssp C---C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--------CC
T ss_pred c---ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------CC
Confidence 1 1222334578999999999999999999999999999999998 899996532 22333333321 12
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
.|...+..+.+|+.+||..+|.+||++.+++. .|..+
T Consensus 234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~-~l~~~ 270 (317)
T d1xkka_ 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELII-EFSKM 270 (317)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCcccCHHHHHHHHHhCCCChhhCcCHHHHHH-HHHHH
Confidence 34455567999999999999999999999874 44444
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=399.38 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=195.3
Q ss_pred hccccccceeeeeCcEeEEEEEEC-----CeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-----HTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIV 522 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 522 (782)
.++|.+.+.||+|+||.||+|.+. +..||||.++... ....+.|.+|+.+|++++|||||+++|+|.+.. |+|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 356899999999999999999873 2368899886543 334677999999999999999999999996544 999
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999876544 35899999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVT 679 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~ 679 (782)
. .....+...||+.|+|||++.++.|+.++|||||||++|||+| |.+||...... ...+..+.. .
T Consensus 161 ~----~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~--------~ 228 (273)
T d1mp8a_ 161 S----TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------L 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------C
T ss_pred C----cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------C
Confidence 1 2223345678999999999999999999999999999999998 89999654322 222333321 1
Q ss_pred CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 680 DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 680 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..|...+..+.+|+.+||..+|.+||++.+++. .|..+.
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~-~L~~i~ 267 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA-QLSTIL 267 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH-HHHHHH
Confidence 234455567999999999999999999999874 455543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=403.05 Aligned_cols=244 Identities=30% Similarity=0.422 Sum_probs=195.3
Q ss_pred ccccccceeeeeCcEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EEEEEeCCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-IIVYEYLAN 528 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 528 (782)
++|++.+.||+|+||.||+|.+. ++.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+.. ++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 46999999999999999999984 4589999997653 34578999999999999999999999996654 899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccccc
Q 040785 529 GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENVT 608 (782)
Q Consensus 529 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 608 (782)
|+|...+..... ..++|.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+... .
T Consensus 96 g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~----~ 167 (285)
T d1fmka3 96 GSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN----E 167 (285)
T ss_dssp CBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred Cchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC----C
Confidence 999988865432 34999999999999999999999999 999999999999999999999999999876422 1
Q ss_pred ccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCC-CChHHH--HHHHHhCcccccCCCCCCCCChhH
Q 040785 609 QYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPM-GLTHFV--ERSIENGTLGEMLDPTVTDWPFEE 685 (782)
Q Consensus 609 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf-~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~ 685 (782)
....+...||+.|+|||++.++.++.++|||||||++|||++|..|| ...... ...+..+. . ...+...
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-----~---~~~~~~~ 239 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----R---MPCPPEC 239 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----C---CCCCTTS
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----C---CCCCccc
Confidence 22334567999999999999999999999999999999999965554 333222 12222221 1 1233445
Q ss_pred HHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 686 TLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 686 ~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
+..+.+|+.+||+.+|++||++.+|+
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 56799999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=408.01 Aligned_cols=242 Identities=24% Similarity=0.274 Sum_probs=203.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++++.. ......+.+|+.+|+.++||||++++++|.+.. |+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4599999999999999999998 57899999997542 223567899999999999999999999997665 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
|||++|+|.+++.+.+ .+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999987654 4899999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+... ..+..+. ..+
T Consensus 159 -----~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~---------~~~ 224 (337)
T d1o6la_ 159 -----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRF 224 (337)
T ss_dssp -----TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CCC
T ss_pred -----CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC---------CCC
Confidence 223345789999999999999999999999999999999999999997655432 2222222 123
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCC-----hHHhhh
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPD-----LGKVVL 712 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs-----~~~vl~ 712 (782)
|...+.++.+||.+||+.||.+||+ +.+++.
T Consensus 225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 4445567899999999999999996 556654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-46 Score=397.28 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=199.2
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCc------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------ 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 518 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||+++... ......|.+|+.+|+.++|||||++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35699999999999999999998 58899999997653 23356789999999999999999999988532
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.||||||++||+|.+.+...+ ++++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.++|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 379999999999999887654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHH---HHHhCcccccCC
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVER---SIENGTLGEMLD 675 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~~~~~ld 675 (782)
....... ........+||+.|+|||++.+..|+.++|||||||++|||+||++||......+. .+..+...
T Consensus 160 ~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~---- 233 (277)
T d1o6ya_ 160 AIADSGN--SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---- 233 (277)
T ss_dssp ECC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----
T ss_pred hhccccc--cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC----
Confidence 6532211 22234557899999999999999999999999999999999999999976554332 22221110
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
+ .......+..+.+|+.+||+.||.+||+..+.|++.|.+++
T Consensus 234 ~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 01112344569999999999999999954455556777764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-46 Score=403.16 Aligned_cols=238 Identities=26% Similarity=0.343 Sum_probs=200.7
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
+|++.+.||+|+||+||+|.+ +++.||||+++... ....+.+.+|+.+|+.++|||||++++++.+.. |+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 499999999999999999998 47899999997542 223567899999999999999999999996655 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|++||+|..++.... .+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 85 ~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 85 YIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred ecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999998886554 3788999999999999999999999 99999999999999999999999999987632
Q ss_pred ccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCCC
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDWP 682 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 682 (782)
.....+||+.|||||++.+..|+.++|||||||++|+|+||+.||...+..+ ..+..+.. .+|
T Consensus 157 ------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~~p 221 (316)
T d1fota_ 157 ------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------RFP 221 (316)
T ss_dssp ------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------CCC
T ss_pred ------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC---------CCC
Confidence 1235689999999999999999999999999999999999999997654432 22222221 223
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC-----ChHHhhh
Q 040785 683 FEETLGFAKLALQCSELRRKDRP-----DLGKVVL 712 (782)
Q Consensus 683 ~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~ 712 (782)
...+.++.+++.+||..+|.+|| ++++++.
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 34455699999999999999996 7777764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=397.68 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=197.8
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc---cEEEEEeCC
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY---GIIVYEYLA 527 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---~~lV~Ey~~ 527 (782)
++|+..+.||+|+||.||+|.+.++.||||+++.+. ..+.|.+|+++|++++||||++++|+|.+. .++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 358888999999999999999999999999997643 356799999999999999999999988432 389999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccccc
Q 040785 528 NGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAENV 607 (782)
Q Consensus 528 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~ 607 (782)
+|+|.++|..... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-----
Confidence 9999999975432 24899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHhCcccccCCCCCCCCChh
Q 040785 608 TQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV--ERSIENGTLGEMLDPTVTDWPFE 684 (782)
Q Consensus 608 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~ 684 (782)
......+|..|+|||++.++.++.++|||||||++|||+| |++||...... ...+..+. . ...|..
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-----~---~~~~~~ 224 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----K---MDAPDG 224 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----C---CCCCTT
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----C---CCCCcc
Confidence 1223468899999999999999999999999999999998 78888643321 22222221 1 223444
Q ss_pred HHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 685 ETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 685 ~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+..+.+|+.+||..||.+||++.+++ ..|+.++
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~-~~L~~i~ 258 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLR-EQLEHIK 258 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHH-HHHHHHH
Confidence 456799999999999999999999886 4666654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=400.50 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=195.6
Q ss_pred hccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCc--
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEY-- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~-- 518 (782)
.++|.+.++||+|+||.||+|.+. ++.||||+++... ....+.+.+|+.++.++ +||||+.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999872 2579999997543 33456788888888877 689999999987543
Q ss_pred -cEEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
.++|||||++|+|.+++..... ...+++.+++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 3899999999999999975421 235899999999999999999999999 99999999999999
Q ss_pred CCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhC-CCCCCChH---H
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA-KQPMGLTH---F 660 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~Pf~~~~---~ 660 (782)
.++.+||+|||+|+...... .....+...||+.|||||++.++.++.++|||||||++|||+|| .+||.... .
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp GGGCEEECC------CCSCT---TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CCCcEEEccCcchhhccccc---cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999998764322 22233456899999999999999999999999999999999986 56775432 2
Q ss_pred HHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 661 VERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 661 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
....+..+.. + ..|...+..+.+|+.+||+.+|++||++.+++. .|..+
T Consensus 246 ~~~~~~~~~~-----~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~-~L~~i 294 (299)
T d1ywna1 246 FCRRLKEGTR-----M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE-HLGNL 294 (299)
T ss_dssp HHHHHHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred HHHHHhcCCC-----C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHH
Confidence 3333444432 1 223344556999999999999999999999884 45554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=394.56 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=192.3
Q ss_pred ccccccceeeeeCcEeEEEEEECC-----eeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc-EE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH-----TPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG-II 521 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~l 521 (782)
++|+..+.||+|+||.||+|.+.. ..||||++++.. ....+.|.+|+.+|++++||||++++|+|.+.. ++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 358899999999999999998632 369999987642 233567999999999999999999999997654 89
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVP 601 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~ 601 (782)
||||+++|+|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876542 4999999999999999999999999 9999999999999999999999999999764
Q ss_pred cccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHHHHH--HHhCcccccCCCCC
Q 040785 602 AVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFVERS--IENGTLGEMLDPTV 678 (782)
Q Consensus 602 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~--~~~~~~~~~ld~~~ 678 (782)
.... .........||..|+|||++.+..++.++|||||||++|||+| |+.||...+..+.. +..... .+
T Consensus 163 ~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~----~~-- 234 (273)
T d1u46a_ 163 QNDD--HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE----RL-- 234 (273)
T ss_dssp C-CC--EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC----CC--
T ss_pred cCCC--cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC----CC--
Confidence 3221 1223344578899999999999999999999999999999998 89999755443321 211111 11
Q ss_pred CCCChhHHHHHHHHHHHhhccCcCCCCChHHhh
Q 040785 679 TDWPFEETLGFAKLALQCSELRRKDRPDLGKVV 711 (782)
Q Consensus 679 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl 711 (782)
..+...+..+.+|+.+||+.+|++||++.+++
T Consensus 235 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 235 -PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 22334445699999999999999999999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-46 Score=404.95 Aligned_cols=240 Identities=22% Similarity=0.317 Sum_probs=202.0
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 523 (782)
++|++++.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.. ++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 3599999999999999999998 57899999996532 223467899999999999999999999986655 8999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAV 603 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~ 603 (782)
||+.+|+|...+.+.+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 9999999999987664 4899999999999999999999999 99999999999999999999999999987632
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
......||+.|||||++.+..|+.++|||||||++|||+||+.||....... ..+..+.+ ..
T Consensus 194 -------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~~ 257 (350)
T d1rdqe_ 194 -------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------RF 257 (350)
T ss_dssp -------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------CC
T ss_pred -------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC---------CC
Confidence 1234689999999999999999999999999999999999999997654432 22222221 12
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCC-----ChHHhhhH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRP-----DLGKVVLP 713 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RP-----s~~~vl~~ 713 (782)
|...+..+.+|+.+||..||.+|+ ++.+++.+
T Consensus 258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 334455699999999999999995 77777643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-45 Score=387.68 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=202.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---------hhHHHHHHHHHHHHhcC-CCCeeeecccccCc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---------QGRSQFQREIEVLSCIR-HPNMVLLLGACPEY 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---------~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~ 518 (782)
++|++.+.||+|+||+||+|.+ +++.||||++..... ...+.+.+|+.+|+++. ||||++++++|.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4699999999999999999998 678999999965421 12346889999999997 99999999999766
Q ss_pred c--EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 519 G--IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 519 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
. ||||||+++|+|.+++...+ ++++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 5 89999999999999997654 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhc------CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQT------GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENG 668 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~ 668 (782)
++.+... ...+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ..+..+
T Consensus 157 a~~~~~~------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 157 SCQLDPG------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp CEECCTT------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred eeEccCC------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 9876421 12345689999999998764 346889999999999999999999997665432 223333
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 669 TLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 669 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.... . ...+...+.++.+|+.+||+.+|++||++.+++.
T Consensus 231 ~~~~-~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQF-G----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCC-C----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC-C----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3211 1 1112345567999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-45 Score=403.63 Aligned_cols=243 Identities=28% Similarity=0.339 Sum_probs=193.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch---hhHHHHHHH---HHHHHhcCCCCeeeecccccCcc--E
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA---QGRSQFQRE---IEVLSCIRHPNMVLLLGACPEYG--I 520 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E---i~iL~~l~HpnIv~l~g~~~~~~--~ 520 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++.+... .....+.+| +.+++.++|||||+++++|.+.. |
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 4699999999999999999998 577999999964321 122334444 66677778999999999986654 8
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
+||||+++|+|.+++.+.. .+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999997654 4889999999999999999999999 999999999999999999999999999866
Q ss_pred ccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHH--HHHHHHhCcccccCCCC
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHF--VERSIENGTLGEMLDPT 677 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~ld~~ 677 (782)
.. ......+||+.|+|||++..+ .|+.++|||||||+||||+||+.||..... ........ . ..
T Consensus 158 ~~-------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~-----~~ 224 (364)
T d1omwa3 158 SK-------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-L-----TM 224 (364)
T ss_dssp SS-------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-S-----SC
T ss_pred CC-------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-c-----cC
Confidence 32 123456899999999998754 689999999999999999999999964321 11111111 1 11
Q ss_pred CCCCChhHHHHHHHHHHHhhccCcCCCCCh-----HHhhh
Q 040785 678 VTDWPFEETLGFAKLALQCSELRRKDRPDL-----GKVVL 712 (782)
Q Consensus 678 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~~vl~ 712 (782)
....|...+..+.+||.+||..||.+||+. .+++.
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 122333455679999999999999999994 55653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=396.98 Aligned_cols=242 Identities=26% Similarity=0.320 Sum_probs=201.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc---hhhHHHHHHHHHHHH-hcCCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA---AQGRSQFQREIEVLS-CIRHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~-~l~HpnIv~l~g~~~~~~--~lV 522 (782)
++|.+.+.||+|+||+||+|.+ +++.||||++++.. ......+.+|+.++. .++|||||++++++.+.. |+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4699999999999999999998 67899999997542 223456778888776 689999999999997655 899
Q ss_pred EEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccc
Q 040785 523 YEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPA 602 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~ 602 (782)
|||+++|+|.+++.... .+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997654 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred ccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCC
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTD 680 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 680 (782)
.....+...||+.|+|||++.++.|+.++|||||||++|+|++|+.||....... ..+..+. + .
T Consensus 156 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------~---~ 221 (320)
T d1xjda_ 156 -----GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN------P---F 221 (320)
T ss_dssp -----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------C---C
T ss_pred -----ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------C---C
Confidence 2223345689999999999999999999999999999999999999997654332 2232222 1 2
Q ss_pred CChhHHHHHHHHHHHhhccCcCCCCChH-Hhhh
Q 040785 681 WPFEETLGFAKLALQCSELRRKDRPDLG-KVVL 712 (782)
Q Consensus 681 ~p~~~~~~l~~li~~cl~~~P~~RPs~~-~vl~ 712 (782)
+|...+..+.+|+.+||..+|.+||++. +++.
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 3334456799999999999999999996 5653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=391.60 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=199.1
Q ss_pred cceeeeeCcEeEEEEEECC-----eeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccC---ccEEEEEeC
Q 040785 456 SRKIGEGGYGPVYKCYLDH-----TPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPE---YGIIVYEYL 526 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lV~Ey~ 526 (782)
.++||+|+||+||+|.+.. ..||||+++.. .....+.|.+|+++|++++||||++++|+|.+ ..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999732 26899999753 44556789999999999999999999999743 238999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccccc
Q 040785 527 ANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAEN 606 (782)
Q Consensus 527 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~ 606 (782)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999886544 34788999999999999999999999 999999999999999999999999999876432211
Q ss_pred ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH---HHHHHhCcccccCCCCCCCCCh
Q 040785 607 VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV---ERSIENGTLGEMLDPTVTDWPF 683 (782)
Q Consensus 607 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~ld~~~~~~p~ 683 (782)
.........||+.|+|||++.++.++.++|||||||++|||+||..||...... ...+..|.. ...|.
T Consensus 187 -~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~--------~~~p~ 257 (311)
T d1r0pa_ 187 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------LLQPE 257 (311)
T ss_dssp -CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC--------CCCCT
T ss_pred -cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------CCCcc
Confidence 222334567999999999999999999999999999999999988887543221 122223321 12233
Q ss_pred hHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 684 EETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 684 ~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
..+..+.+|+.+||+.+|++||++.+++. .|+.+.
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~-~L~~i~ 292 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVS-RISAIF 292 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCHHHHHH-HHHHHH
Confidence 44567999999999999999999999884 455553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=394.86 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=196.1
Q ss_pred ccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc------cEEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------GIIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~lV~E 524 (782)
..|...+.||+|+||.||+|+++++.||||+++.... ....+..|+..+..++|||||+++|+|.+. .|+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3477888999999999999999999999999975422 122233455555678999999999999542 289999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK-----PEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
|+++|+|.++|.+. .++|..++.++.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999764 3899999999999999999999741 12399999999999999999999999999987
Q ss_pred cccccccccccccccccCCcccCChhhhhcCC------CCCchhHHHHHHHHHHHHhCCCCCCChHH-------------
Q 040785 600 VPAVAENVTQYHLTSTAGTFCYIDPEYQQTGM------LGVKSDVYSLGILLLQLITAKQPMGLTHF------------- 660 (782)
Q Consensus 600 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------~s~ksDVwSlGvil~elltG~~Pf~~~~~------------- 660 (782)
...... ..........||+.|+|||++.+.. ++.++|||||||+||||+||..||+....
T Consensus 158 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 158 HDSATD-TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EETTTT-EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ccCCCc-ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 743221 1222344578999999999887543 57799999999999999999988742110
Q ss_pred HHHHHHhCcccccCCCCCCCC--ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 661 VERSIENGTLGEMLDPTVTDW--PFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 661 ~~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
....+........++|.++.. +.+....+.+|+.+||..||++||++.+++ ..|..+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~-~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK-KTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH-HHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH-HHHHHHH
Confidence 011111122223334444322 123445699999999999999999999887 3555554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=391.47 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=203.8
Q ss_pred ccccccceeeeeCcEeEEEEEECC---------eeEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCCeeeecccccCcc
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLDH---------TPVAVKVLRPDAA-QGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 519 (782)
+.|.+.+.||+|+||.||+|+..+ +.||||+++.+.. .....+.+|+.++.++ +|||||+++|+|.+..
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 468899999999999999998632 3699999977643 3457789999999888 8999999999997655
Q ss_pred --EEEEEeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc
Q 040785 520 --IIVYEYLANGSLDDRIFRRGN-------------TPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD 584 (782)
Q Consensus 520 --~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld 584 (782)
++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 899999999999999975532 245899999999999999999999999 99999999999999
Q ss_pred CCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChHHH--
Q 040785 585 HNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTHFV-- 661 (782)
Q Consensus 585 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~-- 661 (782)
.++.+||+|||+++...... .........||+.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCC---TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCCeEeccchhhccccccc---cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 99999999999998774322 2223345679999999999999999999999999999999998 78899644332
Q ss_pred HHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHHH
Q 040785 662 ERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLRE 720 (782)
Q Consensus 662 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~~ 720 (782)
...+..+. ....|...+..+.+|+.+||+.+|.+||++.+++ ..|+++..
T Consensus 247 ~~~i~~~~--------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil-~~L~~i~a 296 (299)
T d1fgka_ 247 FKLLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV-EDLDRIVA 296 (299)
T ss_dssp HHHHHTTC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHH
T ss_pred HHHHHcCC--------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHH-HHHHHHhh
Confidence 22233321 1123344556799999999999999999999987 46666643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=397.66 Aligned_cols=248 Identities=20% Similarity=0.309 Sum_probs=201.8
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.++|.+.+.||+|+||+||+|.+ +++.||||+++.... ....+.+|+++|+.++|||||+++++|.+.. ||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 35699999999999999999998 577899999987643 3456889999999999999999999986544 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC--CCceeeeccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH--NYVSKISDVGLARLVPAV 603 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~--~~~~kL~DFGla~~~~~~ 603 (782)
|+||+|.+++...+ ..+++.+++.|+.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999986543 35899999999999999999999999 999999999999975 458999999999865321
Q ss_pred cccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCCCCCCCC
Q 040785 604 AENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLDPTVTDW 681 (782)
Q Consensus 604 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 681 (782)
.......||+.|+|||.+.+..|+.++|||||||++|+|++|..||....... ..+..+.+. ++. ..
T Consensus 158 ------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~---~~ 226 (321)
T d1tkia_ 158 ------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDE---EA 226 (321)
T ss_dssp ------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCH---HH
T ss_pred ------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCh---hh
Confidence 12234578999999999999999999999999999999999999997654332 222222211 000 00
Q ss_pred ChhHHHHHHHHHHHhhccCcCCCCChHHhhhHH
Q 040785 682 PFEETLGFAKLALQCSELRRKDRPDLGKVVLPE 714 (782)
Q Consensus 682 p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~ 714 (782)
+...+..+.+|+.+||..||.+||++.+++.+.
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 112345689999999999999999999998543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=393.80 Aligned_cols=251 Identities=30% Similarity=0.471 Sum_probs=199.6
Q ss_pred ccccccceeeeeCcEeEEEEEEC--Ce--eEEEEEecCC-chhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc--EEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD--HT--PVAVKVLRPD-AAQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG--IIV 522 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~--~~--~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 522 (782)
++|+..+.||+|+||.||+|.+. +. .||||.++.. .....+.|.+|+++|+++ +|||||+++|+|.+.. ++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 35888999999999999999883 33 5788887643 334566799999999998 7999999999997654 899
Q ss_pred EEeCCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCce
Q 040785 523 YEYLANGSLDDRIFRR-------------GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVS 589 (782)
Q Consensus 523 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~ 589 (782)
|||+++|+|.++|+.. .....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 22356999999999999999999999999 9999999999999999999
Q ss_pred eeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCC-CCCCChHHHH--HHHH
Q 040785 590 KISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAK-QPMGLTHFVE--RSIE 666 (782)
Q Consensus 590 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~Pf~~~~~~~--~~~~ 666 (782)
||+|||+++..... .......||..|+|||.+.++.|+.++|||||||++|||++|. +||......+ ..+.
T Consensus 167 kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred EEcccccccccccc------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999865321 1223456899999999999999999999999999999999965 5675444322 2222
Q ss_pred hCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHHH
Q 040785 667 NGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRLR 719 (782)
Q Consensus 667 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l~ 719 (782)
.+. ....|...+..+.+|+.+||+.+|++||++.+++. .|+++.
T Consensus 241 ~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~-~L~~i~ 284 (309)
T d1fvra_ 241 QGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV-SLNRML 284 (309)
T ss_dssp GTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred hcC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHHH
Confidence 221 12234455667999999999999999999999984 555554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=390.82 Aligned_cols=247 Identities=26% Similarity=0.281 Sum_probs=189.9
Q ss_pred ccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh-----hHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 455 ESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ-----GRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 455 ~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
.+++||+|+||+||+|.+ +++.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+.. |+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999998 5778999999654322 1346889999999999999999999996654 999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+.++++..++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-- 153 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 153 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC--
Confidence 998877655432 235888999999999999999999999 999999999999999999999999999866321
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH---H-hCcccccCCC----
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI---E-NGTLGEMLDP---- 676 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~---~-~~~~~~~ld~---- 676 (782)
.......+||+.|+|||++..+ .|+.++|||||||++|||+||.+||......+... . .+.......+
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 154 ---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ---cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 2223456899999999988654 58999999999999999999999997654433211 1 1111110000
Q ss_pred --------CCCCCC-----hhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 677 --------TVTDWP-----FEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 677 --------~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.....+ ...+..+.+|+.+||..||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 001111 123456899999999999999999998873
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=392.74 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=203.9
Q ss_pred hccccccceeeeeCcEeEEEEEEC-------CeeEEEEEecCC-chhhHHHHHHHHHHHHhcCCCCeeeecccccCc--c
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYLD-------HTPVAVKVLRPD-AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--G 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~ 519 (782)
.++|...++||+|+||.||+|.+. ++.||||+++.. .......|.+|++++++++|||||+++|+|... .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 356899999999999999999873 468999999754 334456789999999999999999999998643 4
Q ss_pred EEEEEeCCCCChhHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeee
Q 040785 520 IIVYEYLANGSLDDRIFRR-------GNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKIS 592 (782)
Q Consensus 520 ~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~ 592 (782)
++||||+++|+|.+++... .....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988643 22345799999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhC-CCCCCChHHHH--HHHHhCc
Q 040785 593 DVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITA-KQPMGLTHFVE--RSIENGT 669 (782)
Q Consensus 593 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~Pf~~~~~~~--~~~~~~~ 669 (782)
|||+|+.+.... .........||+.|+|||.+.++.++.++|||||||++|||+|| .+||......+ ..+..+.
T Consensus 176 DFGla~~~~~~~---~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 176 DFGMTRDIYETD---YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp CTTCCCGGGGGG---CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ecccceeccCCc---ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 999998764322 22233445789999999999999999999999999999999998 57786544322 2222322
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....|...+..+.+|+.+||+.+|++||++.+++.
T Consensus 253 --------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 --------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22233445567999999999999999999999873
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=399.80 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=194.1
Q ss_pred ccccccc-eeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhc-CCCCeeeecccccC------ccE
Q 040785 451 QFFTESR-KIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCI-RHPNMVLLLGACPE------YGI 520 (782)
Q Consensus 451 ~~f~~~~-~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------~~~ 520 (782)
++|.+.. .||+|+||+||+|.+ +++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ ..|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4688775 599999999999998 5779999999642 4578899997655 89999999998853 238
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC---CCceeeeccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH---NYVSKISDVGLA 597 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~---~~~~kL~DFGla 597 (782)
+|||||+||+|.+++...+. ..|++.++..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999976533 45999999999999999999999999 999999999999975 567999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHH--HHHHhCcccccCC
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVE--RSIENGTLGEMLD 675 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ld 675 (782)
+..... ......+||+.|||||++.+..|+.++|||||||+||+|+||+.||....... ..+....... .
T Consensus 162 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~--~ 233 (335)
T d2ozaa1 162 KETTSH------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--Q 233 (335)
T ss_dssp EECCCC------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC--S
T ss_pred eeccCC------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC--C
Confidence 876321 22345689999999999999999999999999999999999999995433211 1111110000 0
Q ss_pred CCCCC-CChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 676 PTVTD-WPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 676 ~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
...+. .....+..+.+|+.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01110 112345679999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=385.28 Aligned_cols=236 Identities=25% Similarity=0.358 Sum_probs=193.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchh------hHHHHHHHHHHHHhcC--CCCeeeecccccCcc-
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQ------GRSQFQREIEVLSCIR--HPNMVLLLGACPEYG- 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~- 519 (782)
++|.+.+.||+|+||+||+|.+ +++.||||+++..... ....+.+|+.+|++++ |||||++++++.+..
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5699999999999999999998 5789999999753211 2244779999999986 999999999996654
Q ss_pred -EEEEEeCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-CCceeeecccc
Q 040785 520 -IIVYEYLAN-GSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-NYVSKISDVGL 596 (782)
Q Consensus 520 -~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-~~~~kL~DFGl 596 (782)
++||||+.+ +++.+++.... .+++.+++.|+.||+.||.|||+++ ||||||||+||||+. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 899999976 57777775543 4899999999999999999999999 999999999999985 47999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcCCC-CCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHhCcccccCC
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQLITAKQPMGLTHFVERSIENGTLGEMLD 675 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ld 675 (782)
|+.... ...+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..+..
T Consensus 158 a~~~~~-------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i----~~~~~----- 221 (273)
T d1xwsa_ 158 GALLKD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----IRGQV----- 221 (273)
T ss_dssp CEECCS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----HHCCC-----
T ss_pred ceeccc-------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH----hhccc-----
Confidence 986532 22345789999999999988765 67799999999999999999999765422 22211
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.++...+.++.+|+.+||..||++||++.+++.
T Consensus 222 ----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 122334456999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=386.05 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=204.7
Q ss_pred hccccccceeeeeCcEeEEEEEE-------CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCCeeeecccccCcc-
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL-------DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCI-RHPNMVLLLGACPEYG- 519 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 519 (782)
.++|+..++||+|+||.||+|.+ .++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35688999999999999999986 23579999997653 33456799999999999 6999999999997654
Q ss_pred -EEEEEeCCCCChhHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEE
Q 040785 520 -IIVYEYLANGSLDDRIFRRG---------------NTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 583 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 583 (782)
++|||||++|+|.+++.+.. ....+++..+..|+.||+.||.|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 99999999999999997653 2235899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHh-CCCCCCChH---
Q 040785 584 DHNYVSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLIT-AKQPMGLTH--- 659 (782)
Q Consensus 584 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~--- 659 (782)
+.++.+||+|||+++...... .....+...||+.|+|||++.++.++.++|||||||++|||+| |.+||....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDS---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCT---TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccCcccccccchheeccCCC---cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999764322 2233455789999999999999999999999999999999999 566664332
Q ss_pred HHHHHHHhCcccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 660 FVERSIENGTLGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 660 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
.....+..+. .+ ..|...+..+.+|+.+||+.+|++||++.+++. .|++
T Consensus 256 ~~~~~i~~~~-----~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~-~L~~ 304 (311)
T d1t46a_ 256 KFYKMIKEGF-----RM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ-LIEK 304 (311)
T ss_dssp HHHHHHHHTC-----CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHH
T ss_pred HHHHHHhcCC-----CC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH-HHHH
Confidence 2333343332 11 122334456999999999999999999999883 5544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=386.08 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=195.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|++++.||+|+||+||+|.+ +++.||||+++.... .....+.+|+++|++++|||||+++++|.+.. |+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4699999999999999999998 478999999975432 23567999999999999999999999997654 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+.++ +.+.+.... ...+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-- 154 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV-- 154 (298)
T ss_dssp CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--
T ss_pred ecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC--
Confidence 99765 444443332 345999999999999999999999999 99999999999999999999999999986532
Q ss_pred ccccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHH----HhCcccccCCCC--
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPMGLTHFVERSI----ENGTLGEMLDPT-- 677 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~----~~~~~~~~ld~~-- 677 (782)
.........||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+...... ..+...+...+.
T Consensus 155 ---~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 155 ---PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp ---CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ---CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccc
Confidence 222344568999999999876665 5899999999999999999999997554332211 111111111110
Q ss_pred --------CCCC--------ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 678 --------VTDW--------PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 678 --------~~~~--------p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...+ .......+.+|+.+||..||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 0123356899999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=385.09 Aligned_cols=251 Identities=27% Similarity=0.335 Sum_probs=195.3
Q ss_pred ccccccceeeeeCcEeEEEEEEC---CeeEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCCeeeecccccC-----
Q 040785 451 QFFTESRKIGEGGYGPVYKCYLD---HTPVAVKVLRPDAA--QGRSQFQREIEVLSCI---RHPNMVLLLGACPE----- 517 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~----- 517 (782)
++|+++++||+|+||+||+|.+. ++.||||+++.... .....+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 57999999999999999999983 45799999865422 2234577888888776 79999999998832
Q ss_pred --ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccc
Q 040785 518 --YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVG 595 (782)
Q Consensus 518 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFG 595 (782)
..+++|||+.+|.+...... ....+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 23899999998876544433 2345899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCccc
Q 040785 596 LARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGTLG 671 (782)
Q Consensus 596 la~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~~~ 671 (782)
+++.... ........||+.|+|||++.+..|+.++|||||||++|||++|++||......+.. +. .+...
T Consensus 162 ~~~~~~~------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 162 LARIYSF------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCCCCG------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhhcc------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 9986532 22334578999999999999999999999999999999999999999765433211 11 01100
Q ss_pred c----------------cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 E----------------MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~----------------~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
. ........++...+..+.+|+.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000011122334566899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-44 Score=378.95 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=194.2
Q ss_pred ccccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCch--hhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAA--QGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 525 (782)
++|..+++||+|+||+||+|.+ +++.||||+++.... ...+.|.+|+.+|++++|||||+++++|.... +++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4699999999999999999998 578999999976532 23568999999999999999999999996554 899999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVAE 605 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~ 605 (782)
+.++.+..+.... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-- 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-- 153 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--
Confidence 9877666655332 35999999999999999999999999 999999999999999999999999999865321
Q ss_pred cccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCccc--------c
Q 040785 606 NVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGTLG--------E 672 (782)
Q Consensus 606 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~--------~ 672 (782)
........||+.|+|||.+... .++.++|||||||++|||++|+.||...+....... .+... .
T Consensus 154 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 2223445789999999988654 579999999999999999999999975543221110 11100 0
Q ss_pred c--CCCCC--------CCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 673 M--LDPTV--------TDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 673 ~--ld~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
. .+... ...+...+..+.+|+.+||+.||++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000 01122334578999999999999999999998753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=380.79 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=195.2
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCCeeeecccccCc------cE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-AQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------GI 520 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~ 520 (782)
+++|.++++||+|+||+||+|.+ +++.||||++.+.. ....+.+.+|+++|+.++||||++++++|... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45699999999999999999998 58899999997543 34466789999999999999999999998543 25
Q ss_pred EEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccc
Q 040785 521 IVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLV 600 (782)
Q Consensus 521 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~ 600 (782)
++++|+.+|+|.+++... .+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 667788899999998643 3899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----Cccc----
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----GTLG---- 671 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~---- 671 (782)
..... ........+||+.|+|||++.. ..++.++||||+||++|+|++|+.||............ +...
T Consensus 160 ~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGC--BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cCCCc--cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 43211 2223455789999999998754 46799999999999999999999999754322111100 0000
Q ss_pred -----------ccCCCCCCCC-----ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 -----------EMLDPTVTDW-----PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 -----------~~ld~~~~~~-----p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
....+..... .......+.+|+.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111111 1122346889999999999999999999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=378.83 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=190.0
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCC--chhhHHHHHHHHHHHHhcCCCCeeeecccccCc-------
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPD--AAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY------- 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 518 (782)
.++|.++++||+|+||+||+|.+ +++.||||+++.. .....+.+.+|+.+|+.++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45799999999999999999998 4789999999754 233456789999999999999999999998543
Q ss_pred -cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeeccccc
Q 040785 519 -GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLA 597 (782)
Q Consensus 519 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla 597 (782)
.|+||||+ +++|...+... .+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 38999999 56777665432 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHH----hCc---
Q 040785 598 RLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIE----NGT--- 669 (782)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~--- 669 (782)
+.... ..+...||+.|+|||++.+. .++.++|||||||++|+|++|++||........... .+.
T Consensus 169 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 169 RQADS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp EECCS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eccCC--------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 86532 23456899999999988764 579999999999999999999999975433221100 000
Q ss_pred -----------------ccccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 670 -----------------LGEMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 670 -----------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+..................+.+|+.+||..||.+||++.++|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0011111111122234456889999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=378.84 Aligned_cols=249 Identities=22% Similarity=0.229 Sum_probs=191.2
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccccCc--------cEE
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGACPEY--------GII 521 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--------~~l 521 (782)
.|+..++||+|+||+||+|.+ +++.||||++..+. ..+.+|+.+|++++||||++++++|... .||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 488899999999999999998 57799999997643 2345799999999999999999987321 279
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCC-ceeeecccccccc
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNY-VSKISDVGLARLV 600 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~-~~kL~DFGla~~~ 600 (782)
||||+++|.+..+.........+++.++..|+.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655544433333456999999999999999999999999 99999999999999775 8999999999866
Q ss_pred ccccccccccccccccCCcccCChhhhhc-CCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHHHHh----C-------
Q 040785 601 PAVAENVTQYHLTSTAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERSIEN----G------- 668 (782)
Q Consensus 601 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~----~------- 668 (782)
... .......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||......+..... |
T Consensus 174 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTT------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCC------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 321 22345689999999997765 56899999999999999999999999654332211100 0
Q ss_pred -----cccccCCCCCC------CCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 669 -----TLGEMLDPTVT------DWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 669 -----~~~~~ld~~~~------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
......-+... ......+..+.+|+.+||..||++||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00010001110 0112344568999999999999999999998853
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=373.94 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=192.7
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC---------
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE--------- 517 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------- 517 (782)
++|+++++||+|+||+||+|.+ +++.||||++.... ......+.+|+.+|++++||||++++++|..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5799999999999999999998 57899999986542 2335678999999999999999999988733
Q ss_pred -ccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccc
Q 040785 518 -YGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGL 596 (782)
Q Consensus 518 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGl 596 (782)
..|+||||+.++.+..... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 2389999998876654432 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH--H--HhCccc
Q 040785 597 ARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS--I--ENGTLG 671 (782)
Q Consensus 597 a~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~--~--~~~~~~ 671 (782)
++.+...... ........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...+..... + ..+...
T Consensus 164 ~~~~~~~~~~-~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp CEECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeccccccc-ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9876432211 12233446899999999988765 6899999999999999999999999754433211 1 112111
Q ss_pred ccCCCCCC--------------CCCh-------hHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 672 EMLDPTVT--------------DWPF-------EETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 672 ~~ld~~~~--------------~~p~-------~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
........ ..+. .....+.+|+.+||+.||++||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11111100 0001 01235678999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-42 Score=371.15 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=191.4
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCeeeecccc-cC--ccEEEEEe
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNMVLLLGAC-PE--YGIIVYEY 525 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~--~~~lV~Ey 525 (782)
++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+++++.++|+|++.+++.| .+ ..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4699999999999999999998 478999999876532 34688999999999888776665554 32 23889999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEc---CCCceeeecccccccccc
Q 040785 526 LANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLD---HNYVSKISDVGLARLVPA 602 (782)
Q Consensus 526 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld---~~~~~kL~DFGla~~~~~ 602 (782)
+ +|+|.+.+.... ..+++..+..++.|++.||.|||+++ ||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 566766665443 35999999999999999999999999 99999999999985 456799999999998743
Q ss_pred cccc--ccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH-----HHhCcccccCC
Q 040785 603 VAEN--VTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS-----IENGTLGEMLD 675 (782)
Q Consensus 603 ~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~-----~~~~~~~~~ld 675 (782)
.... ..........||+.|||||++.+..++.++|||||||++|||+||+.||......... .......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---- 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH----
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC----
Confidence 2211 1112334568999999999999999999999999999999999999999643221100 0010000
Q ss_pred CCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHHH
Q 040785 676 PTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNRL 718 (782)
Q Consensus 676 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~l 718 (782)
+.....+...+.++.+|+.+||+.+|.+||++.++. ..|..+
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~-~~l~~~ 276 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR-QLFRNL 276 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH-HHHHHH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHH-HHHHHH
Confidence 000011122345699999999999999999997764 344443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-41 Score=360.35 Aligned_cols=255 Identities=17% Similarity=0.224 Sum_probs=196.4
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCC-CCeeeecccccCcc--EEEEE
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRH-PNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~--~lV~E 524 (782)
.++|.+.+.||+|+||+||+|.+ +++.||||++.... ....+.+|++++..+.| +|++.+++++.+.. ++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 35799999999999999999998 57899999986543 23467889999999965 89999988876544 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcC-----CCceeeeccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDH-----NYVSKISDVGLARL 599 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~-----~~~~kL~DFGla~~ 599 (782)
|+ +|+|.+.+...+. .+++.++..|+.|++.||.|||+.+ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 7899998866543 4899999999999999999999999 999999999999964 57899999999998
Q ss_pred cccccc--cccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChH---HHH--HHHHhCcccc
Q 040785 600 VPAVAE--NVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTH---FVE--RSIENGTLGE 672 (782)
Q Consensus 600 ~~~~~~--~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~---~~~--~~~~~~~~~~ 672 (782)
+..... ..........+||+.|||||++.+..++.++|||||||++|||+||..||.... ... ..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 743211 111223345689999999999999999999999999999999999999995321 111 1111111100
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhHHHHH
Q 040785 673 MLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLPELNR 717 (782)
Q Consensus 673 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~~l~~ 717 (782)
. ....+...+.++.+++..|+..+|++||++..+. ..|..
T Consensus 236 ~----~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~-~~l~~ 275 (293)
T d1csna_ 236 P----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ-GLFSK 275 (293)
T ss_dssp C----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH-HHHHH
T ss_pred C----hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH-HHHHH
Confidence 0 0011122335699999999999999999986654 34443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=360.75 Aligned_cols=251 Identities=24% Similarity=0.270 Sum_probs=197.1
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccCcc--EEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPEYG--IIVYE 524 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 524 (782)
++|+++++||+|+||+||+|.+ +++.||||+++... ......+.+|+.+|+.++||||++++++|.+.. ++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4699999999999999999998 56789999996543 234578899999999999999999999996654 89999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccccccccc
Q 040785 525 YLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLARLVPAVA 604 (782)
Q Consensus 525 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~~~~~~~ 604 (782)
|+.+++|..++... ..+++..+..++.|++.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~- 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC-
Confidence 99999888776543 34889999999999999999999999 999999999999999999999999999876422
Q ss_pred ccccccccccccCCcccCChhhhhcCC-CCCchhHHHHHHHHHHHHhCCCCCCC-hHHHH---HHHH-hCcccc------
Q 040785 605 ENVTQYHLTSTAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQLITAKQPMGL-THFVE---RSIE-NGTLGE------ 672 (782)
Q Consensus 605 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~-~~~~~---~~~~-~~~~~~------ 672 (782)
........+++.|+|||++.... ++.++|||||||++|||++|+.||.. .+..+ .... .+....
T Consensus 155 ----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp ----CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ----CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 12223456788999999887665 69999999999999999999999732 22111 1110 111000
Q ss_pred --cC----------CCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 673 --ML----------DPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 673 --~l----------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
.. .......+......+.+|+.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00111222344556899999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-41 Score=364.35 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=191.2
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccC----ccEEEE
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPE----YGIIVY 523 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~----~~~lV~ 523 (782)
++|+++++||+|+||+||+|++ +++.||||+++... .+.+.+|+.+|..+. ||||++++++|.. ..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5699999999999999999998 57899999997543 457899999999995 9999999998742 238999
Q ss_pred EeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCC-Cceeeecccccccccc
Q 040785 524 EYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHN-YVSKISDVGLARLVPA 602 (782)
Q Consensus 524 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~-~~~kL~DFGla~~~~~ 602 (782)
||+.+|+|.... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.+ +.+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987643 24899999999999999999999999 9999999999999865 4699999999987632
Q ss_pred ccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHH-H---------------HHH
Q 040785 603 VAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFV-E---------------RSI 665 (782)
Q Consensus 603 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~-~---------------~~~ 665 (782)
. ......+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...... . ...
T Consensus 183 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 183 G------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp T------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred C------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 1 123456899999999987765 4799999999999999999999999532210 0 001
Q ss_pred HhCccc------ccCCCC--------CC-CCChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 666 ENGTLG------EMLDPT--------VT-DWPFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 666 ~~~~~~------~~ld~~--------~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
...... ..+... .. ......+.++.+|+.+||..||++||++.++|.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110000 000000 00 011223456899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=369.46 Aligned_cols=242 Identities=26% Similarity=0.324 Sum_probs=192.4
Q ss_pred ccccccceeeeeCcEeEEEEEE-----CCeeEEEEEecCCc----hhhHHHHHHHHHHHHhcCC-CCeeeecccccCcc-
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL-----DHTPVAVKVLRPDA----AQGRSQFQREIEVLSCIRH-PNMVLLLGACPEYG- 519 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~- 519 (782)
++|++.+.||+|+||+||+|.. +++.||||+++... ....+.+.+|+++|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4599999999999999999987 35789999986532 2235678899999999976 89999999986554
Q ss_pred -EEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 520 -IIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 520 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
++||||+.+|+|.+.+...+. +++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 899999999999999876653 678999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccCCcccCChhhhhcC--CCCCchhHHHHHHHHHHHHhCCCCCCChHHH--HHHHHhCcccccC
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQLITAKQPMGLTHFV--ERSIENGTLGEML 674 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l 674 (782)
.+.... ........||+.|++||.+.+. .++.++|||||||+||+|++|+.||...... ...+..+....
T Consensus 178 ~~~~~~----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-- 251 (322)
T d1vzoa_ 178 EFVADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 251 (322)
T ss_dssp ECCGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--
T ss_pred hhcccc----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC--
Confidence 763321 2223456899999999988765 4788999999999999999999999543211 01111111110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhccCcCCCCCh
Q 040785 675 DPTVTDWPFEETLGFAKLALQCSELRRKDRPDL 707 (782)
Q Consensus 675 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 707 (782)
....|...+..+.+|+.+||..+|.+||++
T Consensus 252 ---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 252 ---EPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 112334556679999999999999999963
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=368.77 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=185.5
Q ss_pred ccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC--------c
Q 040785 451 QFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE--------Y 518 (782)
Q Consensus 451 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~ 518 (782)
++|.++++||+|+||+||+|.+ +++.||||++.... ......+.+|+.+|+.++|||||+++++|.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5699999999999999999998 48899999997542 3345678999999999999999999999842 2
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.|+||||+.++.+. .+. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 38999999765444 342 24899999999999999999999999 9999999999999999999999999988
Q ss_pred ccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH---------
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE--------- 666 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~--------- 666 (782)
.... ....+..+||+.|+|||++.+..+++++||||+||++|+|++|+.||...+..... +.
T Consensus 168 ~~~~------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 168 TAGT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccc------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 6532 22334567999999999999999999999999999999999999999654322111 00
Q ss_pred ------------hCccc-----------ccCCCCCCCCChhHHHHHHHHHHHhhccCcCCCCChHHhhhH
Q 040785 667 ------------NGTLG-----------EMLDPTVTDWPFEETLGFAKLALQCSELRRKDRPDLGKVVLP 713 (782)
Q Consensus 667 ------------~~~~~-----------~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~~ 713 (782)
.+... ....+.....+...+..+.+|+.+||..||++||++.++|.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000000001112345678999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=367.17 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=191.7
Q ss_pred hccccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCCeeeecccccC-------c
Q 040785 450 TQFFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA--AQGRSQFQREIEVLSCIRHPNMVLLLGACPE-------Y 518 (782)
Q Consensus 450 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~ 518 (782)
.++|.++++||+|+||+||+|.+ +++.||||++.... ....+.+.+|+++|+.++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45799999999999999999998 58899999997543 3345678899999999999999999998742 1
Q ss_pred cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 519 GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 519 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.+++|+|+.+|+|.+++... .+++.++..|+.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 26778889999999988432 4999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccccccccccccccccCCcccCChhhhhcC-CCCCchhHHHHHHHHHHHHhCCCCCCChHHHHHH---HH-hCccccc
Q 040785 599 LVPAVAENVTQYHLTSTAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQLITAKQPMGLTHFVERS---IE-NGTLGEM 673 (782)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~---~~-~~~~~~~ 673 (782)
... .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..... .. .+....-
T Consensus 170 ~~~--------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTD--------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp CCT--------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccC--------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 642 223456799999999986665 4689999999999999999999999654332111 00 0100000
Q ss_pred C---------------CCCCCCC-----ChhHHHHHHHHHHHhhccCcCCCCChHHhhh
Q 040785 674 L---------------DPTVTDW-----PFEETLGFAKLALQCSELRRKDRPDLGKVVL 712 (782)
Q Consensus 674 l---------------d~~~~~~-----p~~~~~~l~~li~~cl~~~P~~RPs~~~vl~ 712 (782)
+ .+..... .......+.+|+.+||..||.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0000111 1123456889999999999999999998874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-37 Score=338.19 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=189.6
Q ss_pred cccccceeeeeCcEeEEEEEE--CCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-----------CCCeeeecccccCc
Q 040785 452 FFTESRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-----------HPNMVLLLGACPEY 518 (782)
Q Consensus 452 ~f~~~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~g~~~~~ 518 (782)
+|.+.++||+|+||+||+|.+ +++.||||+++.+.. ..+.+.+|+.+|+.+. ||||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 489999999999999999998 578999999987643 3467889999998875 57888998887432
Q ss_pred ----cEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCC------
Q 040785 519 ----GIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNY------ 587 (782)
Q Consensus 519 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~------ 587 (782)
.+++|+++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 26778877776655555555555679999999999999999999998 77 99999999999997665
Q ss_pred ceeeeccccccccccccccccccccccccCCcccCChhhhhcCCCCCchhHHHHHHHHHHHHhCCCCCCChHHH------
Q 040785 588 VSKISDVGLARLVPAVAENVTQYHLTSTAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQLITAKQPMGLTHFV------ 661 (782)
Q Consensus 588 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~------ 661 (782)
.+||+|||.+..... .....+||+.|+|||++....|+.++||||+||++++|++|+.||......
T Consensus 170 ~~kl~dfg~s~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred eeeEeeccccccccc--------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 389999999975421 224567999999999999999999999999999999999999999532210
Q ss_pred ---HHHH-HhCcc--------------------cccCCC-----------CCCCCChhHHHHHHHHHHHhhccCcCCCCC
Q 040785 662 ---ERSI-ENGTL--------------------GEMLDP-----------TVTDWPFEETLGFAKLALQCSELRRKDRPD 706 (782)
Q Consensus 662 ---~~~~-~~~~~--------------------~~~ld~-----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 706 (782)
...+ ..|.. ...+.. .....+......+.+|+.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 0000 00000 000000 011123456677999999999999999999
Q ss_pred hHHhhh
Q 040785 707 LGKVVL 712 (782)
Q Consensus 707 ~~~vl~ 712 (782)
+.++|.
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 998863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.5e-23 Score=207.48 Aligned_cols=164 Identities=16% Similarity=0.131 Sum_probs=121.0
Q ss_pred ccccceeeeeCcEeEEEEEE-CCeeEEEEEecCCchh------------------hHHHHHHHHHHHHhcCCCCeeeecc
Q 040785 453 FTESRKIGEGGYGPVYKCYL-DHTPVAVKVLRPDAAQ------------------GRSQFQREIEVLSCIRHPNMVLLLG 513 (782)
Q Consensus 453 f~~~~~LG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~------------------~~~~~~~Ei~iL~~l~HpnIv~l~g 513 (782)
+.+.++||+|+||.||+|.+ ++..||||+++..... ....+.+|...|.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45678999999999999987 7889999998643110 1223457889999999999998876
Q ss_pred cccCccEEEEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCceEEEcCCCceeeec
Q 040785 514 ACPEYGIIVYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDHNYVSKISD 593 (782)
Q Consensus 514 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILld~~~~~kL~D 593 (782)
+. ..+++|||++++.+.. ++...+..++.|++.+|.|||+.+ |+||||||+|||+++++ ++|+|
T Consensus 82 ~~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 82 WE--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp EE--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECC
T ss_pred ec--CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEE
Confidence 53 3589999998865533 333456789999999999999999 99999999999998665 89999
Q ss_pred cccccccccccccccccccccccCCcccCC------hhhhhcCCCCCchhHHHHHHHHH
Q 040785 594 VGLARLVPAVAENVTQYHLTSTAGTFCYID------PEYQQTGMLGVKSDVYSLGILLL 646 (782)
Q Consensus 594 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~a------PE~~~~~~~s~ksDVwSlGvil~ 646 (782)
||+|....... ...|.. .+.+ ...|+.++|+||+.--++
T Consensus 146 FG~a~~~~~~~-------------~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEG-------------WREILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTT-------------HHHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCC-------------cHHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 99987542110 001111 1222 356788999999765443
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.89 E-value=3.6e-23 Score=198.32 Aligned_cols=150 Identities=13% Similarity=0.147 Sum_probs=119.4
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCc---cCCC----cccCCchHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDAS---ATTN----PHQKQPDKQIRD 86 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~ 86 (782)
+.|+||||||+|+.|++|++||++++...+++|++|||+++................ .... ...+...+.+++
T Consensus 2 m~~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (160)
T d1mjha_ 2 MYKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKN 81 (160)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHH
T ss_pred CcCeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHH
Confidence 579999999999999999999999999999999999999765432222111111000 0000 011223456678
Q ss_pred HHHHHHHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEecC
Q 040785 87 LFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSKG 166 (782)
Q Consensus 87 ~l~~~~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~kg 166 (782)
.++.+...|...|++++.++.. |+|+++|+++|++.++|+||||+||++++.++|+|||+.+|+++++ |||+||++.
T Consensus 82 ~l~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 82 KMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHHhcCCeEEEEEEe-ccHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCC--CCEEEEcCC
Confidence 8888999999999999999998 5899999999999999999999999999999999999999999998 999999864
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.88 E-value=5.9e-23 Score=199.45 Aligned_cols=148 Identities=18% Similarity=0.276 Sum_probs=109.2
Q ss_pred CeEEEEeCCCc---------chHHHHHHHHHhccCCCC---EEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHH
Q 040785 16 GLIAVAVDKDK---------SSQHALKWAADNLLNRGQ---TVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQ 83 (782)
Q Consensus 16 ~~IlVaVD~s~---------~S~~Al~wAl~~~~~~g~---~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (782)
+|||||||+|. .|++||+||++++.+.++ .|+++||.+.......... .................+.
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 80 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVD-SIYASPEDFRDMRQSNKAK 80 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC-----------CCCCSHHHHHHHTTSHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEecccccccccccc-ccccCHHHHHHHHHHHHHH
Confidence 58999999986 799999999999998877 5999999875442111111 1111100111233455677
Q ss_pred HHHHHHHHHHHhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEE
Q 040785 84 IRDLFLTFRCYCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163 (782)
Q Consensus 84 ~~~~l~~~~~~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV 163 (782)
+.++|+.+...|...+++++.++.. |+++++|+++|++.++|+||||+||++++.+.|+|||+.+|+++++ |||+||
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVlvV 157 (171)
T d2gm3a1 81 GLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTI 157 (171)
T ss_dssp HHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHHHhcCCceEEEEEe-CChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCC--CCEEEE
Confidence 8899999999999999999998888 5899999999999999999999999999999999999999999998 999999
Q ss_pred ecCc
Q 040785 164 SKGK 167 (782)
Q Consensus 164 ~kgk 167 (782)
..+.
T Consensus 158 ~~~~ 161 (171)
T d2gm3a1 158 KRNA 161 (171)
T ss_dssp ECCG
T ss_pred eCCC
Confidence 8654
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.85 E-value=5.5e-22 Score=184.37 Aligned_cols=135 Identities=15% Similarity=0.134 Sum_probs=104.6
Q ss_pred CCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHHH
Q 040785 15 NGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCY 94 (782)
Q Consensus 15 ~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 94 (782)
+++||||||+|+.|++|++||++++...+++|+|+||+++....... ...+...+...+.+++.++.+
T Consensus 1 yk~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~~--- 68 (135)
T d2z3va1 1 FKTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGE---------PFFEEALRRRLERAEGVLEEA--- 68 (135)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCT---------THHHHHHHHHHHHHHHHHHHH---
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCcccccc---------chhHHHHHHHHHHHHHHHHHH---
Confidence 58999999999999999999999999999999999999754321000 000111122234444444444
Q ss_pred hhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEE
Q 040785 95 CTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVV 163 (782)
Q Consensus 95 c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV 163 (782)
+...++.....++.+|++.++|+++|+++++|+||||+|+++++.++++||++.+|+++++ |||++|
T Consensus 69 ~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 69 RALTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp HHHHCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred HHhcCCCeEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCC--CCEEeC
Confidence 4444555555555558999999999999999999999999999999999999999999999 999997
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.82 E-value=2.1e-20 Score=175.87 Aligned_cols=143 Identities=14% Similarity=0.142 Sum_probs=105.3
Q ss_pred CCCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 13 GGNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 13 ~~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
..+|+||||||+|+.|++|++||+.++...+..+ ++|++.+....... ... ...........+.+++.++.++
T Consensus 3 ~~yk~ILv~vD~s~~s~~al~~A~~la~~~~~~~-~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~~l~~~~ 75 (147)
T d1tq8a_ 3 SAYKTVVVGTDGSDSSMRAVDRAAQIAGADAKLI-IASAYLPQHEDARA--ADI----LKDESYKVTGTAPIYEILHDAK 75 (147)
T ss_dssp CCCCEEEEECCSSHHHHHHHHHHHHHHTTTSEEE-EEEECCC--------------------------CCTHHHHHHHHH
T ss_pred cCCCEEEEEECCCHHHHHHHHHHHHHHhcCCCEE-EEEEEecccccccc--ccc----chhhhHHHHHHHHHHHHHHHHH
Confidence 4579999999999999999999999987555445 45554332210000 000 0112223344566778888899
Q ss_pred HHhhcCCCc-eEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 93 CYCTRKDIK-CFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 93 ~~c~~~~v~-~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
..+...++. ++..+.. |+++++|+++|+++++|+||||+++++++.++|+||++.+|+++++ |||+||+.
T Consensus 76 ~~~~~~~~~~~~~~~~~-G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 76 ERAHNAGAKNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp HHHHTTTCCEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECC
T ss_pred HHHHHcCCCcEEEEEEe-cChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCC--CCEEEEec
Confidence 999888887 4555555 7899999999999999999999999999999999999999999998 99999973
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.77 E-value=1.3e-19 Score=168.99 Aligned_cols=138 Identities=17% Similarity=0.100 Sum_probs=102.4
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
++++||||||+|+.|+.|++||+.++...+++|+++||++++......... ...........+...+.+..
T Consensus 1 myk~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~--- 71 (140)
T d1jmva_ 1 MYKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLID------VNMSSMQDRISTETQKALLD--- 71 (140)
T ss_dssp CCSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEE------HHHHHHTTCCCCHHHHHHHH---
T ss_pred CCCeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccc------cchHHHHHHHHHHHHHHHHH---
Confidence 579999999999999999999999999999999999999765531111000 00011122222333444333
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEec
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVSK 165 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~k 165 (782)
.+...+......++.+++++++|+++|+++++|+||||+||+++. ++||++.+|+++++ |||++|.-
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~---~lgs~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 72 LAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWS---KLMSSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp HHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHH---HHHHHHHHHHTTCC--SEEEEEEC
T ss_pred HHHhcCCceEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCC---CcccHHHHHHhccC--CCEEEEec
Confidence 344455555555666689999999999999999999999998764 36999999999998 99999973
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.74 E-value=9.9e-19 Score=162.23 Aligned_cols=136 Identities=10% Similarity=-0.009 Sum_probs=104.2
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRC 93 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 93 (782)
+-|+||||+|+|+.|+.||+||+.++...+++|+++||+++....... .............+...+.+++.+..+..
T Consensus 3 ~mk~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~---~~~~~~~~~~~~~e~~~~~~~~~l~~~~~ 79 (138)
T d1q77a_ 3 AMKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERA---NVTFGLPFPPEIKEESKKRIERRLREVWE 79 (138)
T ss_dssp CCEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHH---HHHHCCCCCTHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCccccccc---ccccccchhhhhhhhhhhhccccchhhcc
Confidence 468999999999999999999999999999999999999743210000 00000001122223334566677777777
Q ss_pred HhhcCCCceEEEEEecCCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 94 YCTRKDIKCFDVLLEDVDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 94 ~c~~~~v~~e~~v~~g~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
.+...++.++.++.. |+|++.|+++|++.++|+||||+||++++.|.++|+ .|||+||+
T Consensus 80 ~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~-----------~~~~livk 138 (138)
T d1q77a_ 80 KLTGSTEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGL-----------NLASLIVK 138 (138)
T ss_dssp HHHSCCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHS-----------SSEEEECC
T ss_pred cccccceeEEEeeec-chhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCC-----------CCCEEEeC
Confidence 777788899888888 689999999999999999999999999999988886 38888874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=1e-07 Score=96.28 Aligned_cols=147 Identities=13% Similarity=0.103 Sum_probs=97.5
Q ss_pred HHHHHhccccccceeeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccCc--cEE
Q 040785 445 DIEEATQFFTESRKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEY--GII 521 (782)
Q Consensus 445 ~~~~~t~~f~~~~~LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~l 521 (782)
++...-..|...+..+.++.+.||+...++..+.||+...........+.+|..+|..+. +--+.+++.++.+. .++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344444456665555555567999998788888999886654444556788999887773 32244555555333 489
Q ss_pred EEEeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 040785 522 VYEYLANGSLDDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQTK---------------------------------- 567 (782)
Q Consensus 522 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------- 567 (782)
||++++|.++.+..... - ....++.+++..|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998876544211 1 12234555566666666432
Q ss_pred ----------------------CCCeeecCCCCceEEEcCCCceeeeccccccc
Q 040785 568 ----------------------PEPLVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 568 ----------------------~~~iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
+..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999887778999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=3.6e-05 Score=82.37 Aligned_cols=76 Identities=20% Similarity=0.215 Sum_probs=52.8
Q ss_pred cceeeeeCcEeEEEEEE--CCeeEEEEEecCCc-------hhhHHHHHHHHHHHHhcC-C--CCeeeecccccCccEEEE
Q 040785 456 SRKIGEGGYGPVYKCYL--DHTPVAVKVLRPDA-------AQGRSQFQREIEVLSCIR-H--PNMVLLLGACPEYGIIVY 523 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-------~~~~~~~~~Ei~iL~~l~-H--pnIv~l~g~~~~~~~lV~ 523 (782)
.+.||.|....||+... .++.++||.-.+.. .........|.++|..+. + ..+..++.+..+..++||
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm 110 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 110 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence 35689999999999976 35578899754321 112334567888887662 2 346677888888889999
Q ss_pred EeCCCCCh
Q 040785 524 EYLANGSL 531 (782)
Q Consensus 524 Ey~~~gsL 531 (782)
||+.+..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=3.2e-05 Score=76.89 Aligned_cols=127 Identities=18% Similarity=0.141 Sum_probs=78.4
Q ss_pred eeeeeC-cEeEEEEEEC-CeeEEEEEecCCchhhHHHHHHHHHHHHhcCCC--CeeeecccccCc--cEEEEEeCCCCCh
Q 040785 458 KIGEGG-YGPVYKCYLD-HTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHP--NMVLLLGACPEY--GIIVYEYLANGSL 531 (782)
Q Consensus 458 ~LG~G~-fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~~~--~~lV~Ey~~~gsL 531 (782)
.+..|. -+.||+...+ +..+.+|...... ...+..|+.+|+.+... .+.++++++.+. .++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 445555 3689998875 4468889876543 23577888888777432 245556655443 3899999988665
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------------
Q 040785 532 DDRIFRRGNTPPLSWQQRFRIAAEIATGLLFLHQ---------------------------------------------- 565 (782)
Q Consensus 532 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~---------------------------------------------- 565 (782)
.+.. +... .++.+++..|.-||.
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 1101 112222233333332
Q ss_pred -----cC----CCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 566 -----TK----PEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 566 -----~~----~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
.. +..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 1237999999999999988778899999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.77 E-value=0.0041 Score=63.29 Aligned_cols=155 Identities=12% Similarity=0.104 Sum_probs=81.3
Q ss_pred cHHHHHHHhccccccce-----eeeeCcEeEEEEEECCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe-----eee
Q 040785 442 TIEDIEEATQFFTESRK-----IGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM-----VLL 511 (782)
Q Consensus 442 ~~~~~~~~t~~f~~~~~-----LG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-----v~l 511 (782)
+.++++.....|...+. |..|--.+.|+...++..+++|+..... ....+..|+++|..|...++ +..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence 44566666666765433 3456668899998887889999986532 23456667777777743222 211
Q ss_pred c-cc----ccCccEEEEEeCCCCChhH--------------HHhhcCCC------CCCCHH------------------H
Q 040785 512 L-GA----CPEYGIIVYEYLANGSLDD--------------RIFRRGNT------PPLSWQ------------------Q 548 (782)
Q Consensus 512 ~-g~----~~~~~~lV~Ey~~~gsL~~--------------~l~~~~~~------~~l~~~------------------~ 548 (782)
. |. .......++.++.+..... .++..... ...... .
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1 11 1122255666666543210 01100000 000000 0
Q ss_pred HHHHHHHHHHHHHHhhh-cCCCCeeecCCCCceEEEcCCCceeeecccccc
Q 040785 549 RFRIAAEIATGLLFLHQ-TKPEPLVHRDLKPGNILLDHNYVSKISDVGLAR 598 (782)
Q Consensus 549 ~~~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILld~~~~~kL~DFGla~ 598 (782)
....+..+...+.-.+. .-+.++||+|+.++|||++.+...-|+||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11112222222222221 224459999999999999998888999999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0023 Score=65.90 Aligned_cols=133 Identities=17% Similarity=0.232 Sum_probs=73.9
Q ss_pred cEeEEEEEE-CCeeEEEEEecCCchhhHHHHHHHHHHHHhcCCCCe--eeeccc-------ccCccEEEEEeCCCCChh-
Q 040785 464 YGPVYKCYL-DHTPVAVKVLRPDAAQGRSQFQREIEVLSCIRHPNM--VLLLGA-------CPEYGIIVYEYLANGSLD- 532 (782)
Q Consensus 464 fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~-------~~~~~~lV~Ey~~~gsL~- 532 (782)
-..||++.. +|+.+++|+.++.. ....++..|...|..|...+| +..+.. .....+.+++|++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 368999987 67889999998753 235678889988887743222 111111 112236789998764321
Q ss_pred ---H----------HHhhc--C----CCCCCCHH----------------------HHHHHHHHHHHHHHHh-hhcCCCC
Q 040785 533 ---D----------RIFRR--G----NTPPLSWQ----------------------QRFRIAAEIATGLLFL-HQTKPEP 570 (782)
Q Consensus 533 ---~----------~l~~~--~----~~~~l~~~----------------------~~~~i~~qia~aL~yL-H~~~~~~ 570 (782)
+ .++.. . ....+++. ....++..+...+.-+ ....+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 11110 0 00111211 1111222222222211 1223456
Q ss_pred eeecCCCCceEEEcCCCceeeeccccccc
Q 040785 571 LVHRDLKPGNILLDHNYVSKISDVGLARL 599 (782)
Q Consensus 571 iiHrDLKp~NILld~~~~~kL~DFGla~~ 599 (782)
+||+|+.|.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 35899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.45 E-value=0.0026 Score=67.35 Aligned_cols=72 Identities=19% Similarity=0.254 Sum_probs=48.7
Q ss_pred cceeeeeCcEeEEEEEECC---------eeEEEEEecCCchhhHHHHHHHHHHHHhcC-CCCeeeecccccCccEEEEEe
Q 040785 456 SRKIGEGGYGPVYKCYLDH---------TPVAVKVLRPDAAQGRSQFQREIEVLSCIR-HPNMVLLLGACPEYGIIVYEY 525 (782)
Q Consensus 456 ~~~LG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lV~Ey 525 (782)
++.|+.|-.-.+|++.... ..|.+++.-.. ...-...+|..+++.+. +.-..+++++|. +.+||||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--GGRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--TEEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--CceEEEE
Confidence 3578889999999998632 34667766422 22234568999988874 333346777775 4789999
Q ss_pred CCCCCh
Q 040785 526 LANGSL 531 (782)
Q Consensus 526 ~~~gsL 531 (782)
++|.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=93.18 E-value=0.18 Score=47.85 Aligned_cols=98 Identities=10% Similarity=0.022 Sum_probs=63.8
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccCCC-CEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLNRG-QTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~~g-~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
.+++|+||+=|..-|..+|..+.......+ ..|.++||-+... +....-....+
T Consensus 23 ~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r-------------------------~~s~~~~~~~~ 77 (216)
T d1wy5a1 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR-------------------------ESAERDEEFCK 77 (216)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS-------------------------THHHHHHHHHH
T ss_pred CCCeEEEEeCCcHHHHHHHHHHHHHHHhcCCCcEEEEEeecccc-------------------------cchhhhhhHHH
Confidence 467999999999999877776655444333 4799999963211 11122223456
Q ss_pred HHhhcCCCceEEEEEecC--------CH--------HHHHHHHHHHcCCCEEEeccCCCC
Q 040785 93 CYCTRKDIKCFDVLLEDV--------DI--------VKAITEYVSFAAIEDLVLGAPSRH 136 (782)
Q Consensus 93 ~~c~~~~v~~e~~v~~g~--------~v--------~~~Iv~~a~~~~~d~IVmGs~g~~ 136 (782)
.+|...||++...-+... .. ...+.++|++.+++.|++|.|...
T Consensus 78 ~~~~~l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~dD 137 (216)
T d1wy5a1 78 EFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLND 137 (216)
T ss_dssp HHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHHH
T ss_pred HHHHhhhhhhhhhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeeccc
Confidence 778877887654433210 00 246778899999999999999643
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=84.92 E-value=1.6 Score=41.03 Aligned_cols=97 Identities=14% Similarity=0.016 Sum_probs=61.9
Q ss_pred CCCeEEEEeCCCcchHHHHHHHHHhccC-CCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHH
Q 040785 14 GNGLIAVAVDKDKSSQHALKWAADNLLN-RGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFR 92 (782)
Q Consensus 14 ~~~~IlVaVD~s~~S~~Al~wAl~~~~~-~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 92 (782)
..++|+|||=|..-|..++..+.+.... .+..|+++||-+... . ..........
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r---------------------~----~s~~~~~~~~ 66 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLS---------------------A----NADAWVTHCE 66 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC---------------------S----SHHHHHHHHH
T ss_pred CCCcEEEEecCcHHHHHHHHHHHHHHHhCCCceEEEEEeCCCCC---------------------c----chhhhHHHHH
Confidence 3579999999999998888766665433 577999999963211 0 1223334467
Q ss_pred HHhhcCCCceEEEEEecCCH----------HHHHHHHHHHcCCCEEEeccCCC
Q 040785 93 CYCTRKDIKCFDVLLEDVDI----------VKAITEYVSFAAIEDLVLGAPSR 135 (782)
Q Consensus 93 ~~c~~~~v~~e~~v~~g~~v----------~~~Iv~~a~~~~~d~IVmGs~g~ 135 (782)
.+|...++.+.......... .......+...+++.|++|.|..
T Consensus 67 ~~~~~~~i~~~i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~d 119 (227)
T d1ni5a1 67 NVCQQWQVPLVVERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHLD 119 (227)
T ss_dssp HHHHHTTCCEEEECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCHH
T ss_pred HHHhhccCcceeeeccccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 78888888776543331111 12233345567888888887743
|
| >d1np7a2 c.28.1.1 (A:1-204) Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: 1143]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Cryptochrome/photolyase, N-terminal domain superfamily: Cryptochrome/photolyase, N-terminal domain family: Cryptochrome/photolyase, N-terminal domain domain: Cryptochrome species: Synechocystis sp., pcc 6803 [TaxId: 1143]
Probab=82.47 E-value=1.8 Score=40.05 Aligned_cols=115 Identities=4% Similarity=-0.091 Sum_probs=63.4
Q ss_pred HHHHHHHHhccCCCCEEEEEEEecCCCCCcccCcccccCCccCCCcccCCchHHHHHHHHHHHHHhhcCCCceEEEEEec
Q 040785 30 HALKWAADNLLNRGQTVVLIHVAQRTSVSSVSSQSQVYDASATTNPHQKQPDKQIRDLFLTFRCYCTRKDIKCFDVLLED 109 (782)
Q Consensus 30 ~Al~wAl~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~~~v~~e~~v~~g 109 (782)
.||..|+. .++.|+.|+|.++........ ........-..=..+-|..+..-++..|+.+ +++.
T Consensus 22 ~aL~~A~~----~~~~vi~vyi~dp~~~~~~~~---------~~~~~~~~r~~fl~~sL~~L~~~L~~~g~~L--~v~~- 85 (204)
T d1np7a2 22 EPLHRALK----SGLAITAVYCYDPRQFAQTHQ---------GFAKTGPWRSNFLQQSVQNLAESLQKVGNKL--LVTT- 85 (204)
T ss_dssp HHHHHHHH----TTSEEEEEEEECGGGGSBCTT---------SCBSSCHHHHHHHHHHHHHHHHHHHHTTCCE--EEEE-
T ss_pred HHHHHHHh----cCCcEEEEEEECchHhcCccc---------ccccccHHHHHHHHHHHHHHHHHHHhccchh--hhhh-
Confidence 46666654 477999999997643210000 0000000111223344555666666677664 5667
Q ss_pred CCHHHHHHHHHHHcCCCEEEeccCCCCccccccccCchhhhhhcCCCccEEEEEe
Q 040785 110 VDIVKAITEYVSFAAIEDLVLGAPSRHGFIRKFKADVPSSVSKAAPDFCNIYVVS 164 (782)
Q Consensus 110 ~~v~~~Iv~~a~~~~~d~IVmGs~g~~~l~r~l~gSVa~~V~k~ap~~c~V~vV~ 164 (782)
|++.++|.+++++++|+.|+.-.. -+...+..--.|.+.+-++ .|.+..+.
T Consensus 86 G~~~~~l~~l~~~~~i~~V~~n~~-~~~~e~~rd~~v~~~l~~~---~i~~~~~~ 136 (204)
T d1np7a2 86 GLPEQVIPQIAKQINAKTIYYHRE-VTQEELDVERNLVKQLTIL---GIEAKGYW 136 (204)
T ss_dssp SCHHHHHHHHHHHTTEEEEEEECC-CSHHHHHHHHHHHHHHHHH---TCEEEEEC
T ss_pred hhhHHHHHHHHHHhhhhheeeecc-ccHHHHHHHHHHhhhhccc---eeeeEecc
Confidence 689999999999999999987433 3433332223444444332 14554443
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=80.29 E-value=5.5 Score=36.39 Aligned_cols=35 Identities=23% Similarity=0.270 Sum_probs=27.1
Q ss_pred CCeEEEEeCCCcchHHHHHHHHHhccCCCCEEEEEEEec
Q 040785 15 NGLIAVAVDKDKSSQHALKWAADNLLNRGQTVVLIHVAQ 53 (782)
Q Consensus 15 ~~~IlVaVD~s~~S~~Al~wAl~~~~~~g~~v~llHV~~ 53 (782)
..+|+|++=|-.-|.-++.++.+ .|..|++||+..
T Consensus 4 ~gKvvv~~SGG~DS~vla~ll~k----~g~~v~av~~~~ 38 (218)
T d2c5sa1 4 GGKVMVLLSGGIDSPVAAYLTMK----RGVSVEAVHFHS 38 (218)
T ss_dssp TEEEEEECCSSSHHHHHHHHHHH----BTEEEEEEEEEC
T ss_pred CCEEEEEecCcHHHHHHHHHHHH----cCCeEEEEEEeC
Confidence 34799999999888777666643 378999999974
|